"The mystery isn't only why Bern built a statue of a man eating children. The mystery is why Bern put its own armed bears beneath him."

Why does Bern, Switzerland have a child-eating statue above an army of armed bears?

The Kindlifresserbrunnen, also known as the Child Eater Fountain, Ogre Fountain or Kindlifresser Fountain, is one of the strangest historic monuments in Bern's Old City, Switzerland. Created in 1545–1546 and associated with Renaissance sculptor Hans Gieng, the fountain depicts a terrifying figure eating a child while carrying other children in a sack. Directly beneath the Child Eater is an extraordinary detail that is often overlooked: a military procession of armed Bernese bears, complete with weapons, a captain and a banner.

Nearly 500 years later, the meaning of Bern's Kindlifresserbrunnen remains disputed.

This episode goes backward through the history of Bern to investigate what was happening long before the Child Eater appeared. The trail reaches back to 1144 and the William of Norwich ritual-murder accusation, the founding of Bern and Nydegg Castle around 1191, the documented presence of Jews in medieval Bern, and Bern's own 1293–1294 accusation that Jews had murdered a Christian child.

The investigation then moves into the 14th and 15th centuries, when Bern was becoming a major power in the Swiss Confederacy and repeatedly confronting the Habsburgs. During the early 1400s, Roma, historically called Gypsies in European records, also appear in Switzerland and surrounding European territories. Jews and Roma were therefore both part of the historical landscape long before the Child Eater Fountain was constructed.

The episode examines the major theories surrounding the mysterious Child Eater, including Cronus or Kronos devouring his children, the Roman Saturn, the medieval Kinderschreck or bogeyman, antisemitic interpretations, blood-libel imagery and Bernese folklore. But instead of looking only at the frightening figure at the top, the investigation asks why an army of Bern's bears is marching directly underneath him.

Following the bear backward opens another trail. Bern's bear symbolism leads into the city's medieval history, the Swiss Confederacy, the Reformation, Habsburg power and the political struggles of 16th-century Europe. It also reaches further back into the Celtic world and Artio, the ancient Celtic bear goddess, whose famous bronze sculpture was discovered at Muri near Bern.

In 1528, Bern adopted the Protestant Reformation and secularized monasteries and church property. Only fifteen years later, Hans Gieng's Justice Fountain of 1543 placed powerful earthly authorities, including the Pope and Emperor, beneath the figure of Justice. Then, in 1545–1546, the Child Eater appeared above Bern's armed bears.

The bears themselves raise another unusual question. Historical Bernese bear imagery can be strikingly anatomical, including the famous red penis displayed on the male bear in Bern's heraldic tradition. When did that feature appear, and what was happening politically when Bern increasingly presented the bear as the symbol of the city and its power?

Who is the Child Eater of Bern? Why is he eating children? Why are armed bears marching beneath him? What do Bern's medieval Jewish history, the arrival of Roma/Gypsies, the Habsburg conflicts, the Reformation, Cronus and Saturn, Artio and Bern's military bear symbolism have to do with the mystery?

Instead of separating those clues, this episode puts them back onto one historical timeline and examines the entire Kindlifresserbrunnen as a single monument.

The clues have been sitting in plain sight in the middle of Bern for nearly five centuries.

How hormones work to flip sexes: Hormones

Do you have a psychopath in your life? The best way to find out is read my book. BOOK *FREE* Download – Psychopath In Your Life4

Support is Appreciated: Support the Show – Psychopath In Your Life

Download Pods here: TOP PODS – Psychopath In Your Life

My old discussion forum with last 10 years of victim stories, is back online. Psychopath Victim Support Community | Forums powered by UBB.threads™

Google Maps My HOME Address: 309 E. Klug Avenue, Norfolk, NE 68701 SMART Meters & Timelines – Psychopath In Your Life

BERN TIMELINE — CASTLE, JEWS, GYPSIES, HABSBURGS AND THE CHILD-EATER

1144 — ENGLAND

William of Norwich dies. Jews are accused of ritually murdering a Christian child. This becomes the first famous medieval European ritual-murder accusation.

1191 — BERN IS FOUNDED / NYDEGG CASTLE

Berchtold V of Zähringen establishes Bern around this period. Nydegg Castle stands at the eastern end of the settlement.

This is only about 47 years after the 1144 accusation.

1218 — ZÄHRINGEN LINE ENDS

Berchtold V dies without an heir. Bern's political relationship with the Holy Roman Empire changes, beginning a long struggle over control and independence.

1259 — JEWS DOCUMENTED IN BERN

This is the earliest surviving documentary evidence for Jews living in Bern.

1268 — NYDEGG CASTLE DESTROYED

The old Zähringen castle is demolished.

1273 — RUDOLF I OF HABSBURG BECOMES KING

Rudolf I becomes King of the Romans. Habsburg power now enters the Bern story directly.

1288–1289 — HABSBURG CONFLICT WITH BERN

Rudolf I campaigns against Bern. The city is besieged during the struggle between Bern and Habsburg power.

1293–1294 — BERN'S OWN CHILD-MURDER ACCUSATION

A Christian boy named Rudolf, or Ruff, is alleged to have been murdered by Jews in Bern.

Jews are persecuted, some executed and others expelled. Property and financial claims are confiscated. The Jewish cemetery is destroyed, and gravestones are later reused as building material.

Bern therefore has its own child-murder accusation approximately 250 years before the Child-Eater Fountain.

1353 — BERN JOINS THE SWISS CONFEDERACY

Bern is becoming one of the major political and military powers of the region.

EARLY 1400s — ROMA/GYPSIES APPEAR IN SWITZERLAND

Roma groups are documented moving through western and central Europe during the early 15th century.

They are recorded in Switzerland during this period, commonly described in contemporary European records using names translated as Gypsies, Egyptians, or similar terms.

This means Roma were present in the Swiss world more than a century before the Child-Eater Fountain was constructed.

1400s — PRESSURE AGAINST ROMA/GYPSIES INCREASES

The initial reception of traveling Roma groups changes. European governments increasingly issue restrictions, expulsions and penalties against them.

Switzerland participates in this broader development.

1528 — BERN ADOPTS THE REFORMATION

Bern embraces the Protestant Reformation. Monasteries and church property are secularized.

Bern is now openly challenging the old Catholic order during the reign of the Habsburg emperor Charles V.

1543 — JUSTICE FOUNTAIN

Hans Gieng creates Bern's Justice Fountain.

Justice stands above earthly rulers, including the Pope and Emperor.

This demonstrates that Bern's fountains could carry messages concerning religion, government and political authority.

1545–1546 — CHILD-EATER FOUNTAIN

Hans Gieng creates the Kindlifresserbrunnen, the Child-Eater Fountain.

At the top is a figure eating a child and carrying additional children in a sack.

Underneath him is a procession of armed Bernese bears, including a captain, standard-bearer and soldiers.

1144: European ritual-child-murder accusation appears.

1191: Bern and Nydegg Castle.

1293–1294: Bern's own alleged ritual murder of a Christian child.

Early 1400s: Roma/Gypsies arrive in the Swiss region.

1528: Bern's Reformation.

1543: Pope and Emperor placed beneath Justice.

1545–1546: Child-Eater placed above Bern's armed bears.

Timeline — Bern's Bear and the Red Penis

1224 — The Bern bear appears The earliest known Bern city seal depicts a bear. The bear is therefore established as Bern's symbol by the early 13th century.

1228 — The bear appears on Bernese coins The bear is now being used publicly as an identifying symbol of Bern.

Late 1300s — The familiar coat of arms takes shape Colored representations begin showing the recognizable Bern design: a black bear walking across a gold diagonal band against a red field.

1412 — Bern's coat of arms appears on the Town Hall A surviving architectural representation of the Bernese arms dates from this period. The bear is becoming a permanent civic and governmental emblem.

1400s — The explicitly male bear is established According to the Bern cantonal government's own historical account, the bear has been represented with its male sexual organ since the 15th century. Bern describes the tradition as at least 600 years old.

This is the critical point:

The penis is red.

The bear itself is black, while its tongue, claws and penis are highlighted in red.

1484–1485 — Diebold Schilling's Spiezer Chronik The famous Bernese illustrated chronicle provides surviving imagery of Bern's heraldic bear during the late 15th century.

1492 — The developed Bern coat of arms appears on coinage By the end of the century, the bear is firmly embedded in Bern's public political identity.

1500s — Bern becomes a major military and political power The bear increasingly functions as more than a city mascot. Bernese imagery presents an aggressive, armed and unmistakably male bear representing the city and its power.

1520s–1530s — Reformation transforms Bern Bern adopts the Reformation in 1528 and becomes one of the major Protestant powers in the Swiss Confederacy. The bear continues representing Bern through this enormous political and religious change.

1530s–1540s — Bern's great fountain-building period The elaborate public fountains we have been studying appear throughout Bern. Bears are incorporated repeatedly into the city's public imagery.

1542–1543 — Kindlifresserbrunnen reconstructed Hans Gieng creates the Child-Eater fountain in essentially the form we recognize today. Beneath the Child-Eater is the procession of armed Bernese bears.

So by the time the Child-Eater fountain appears, the male Bern bear is already an old political symbol.

1600s–1700s — The male bear survives The explicitly sexed bear continues appearing in Bernese heraldry. Its anatomy is part of the heraldic animal rather than a temporary artistic joke.

1800s — Some versions become sanitized During the more prudish 19th century, artists sometimes omit the genitalia from heraldic animals. This helps explain why the Bern-derived bear used by New Bern, North Carolina, lacks the conspicuous red penis.

1900s — Bern keeps the original tradition Bern does not permanently sanitize its official bear. The male attribute remains part of the heraldic specification.

2016 — It is still officially specified Bernese heraldic regulations describe the bear as "gezotet" — heraldic terminology indicating the male genitalia.

2026 — Somebody finally challenges it Bern cantonal parliamentarian Thomas Brönnimann raises the question of whether the sexual attribute should be removed from the coat of arms.

The Bern government responds that the bear has been represented this way since the 15th century, noting the roughly 600-year tradition.

Bern decides to keep it.

The word "Bohemian" has traveled an extraordinary distance. Today it can describe an interior-design style, clothing, artists, musicians, hippies, or an unconventional way of life. But the word did not begin as an artistic concept. It began with an actual place in Central Europe: Bohemia.

Understanding that history helps separate several things that eventually became tangled together: Bohemia, the Roma, the Habsburgs, artists and performers, the Beat generation, and finally the 1960s counterculture represented by musicians such as Donovan.

Ancient Origins: Bohemia Was a Place Before It Was a Lifestyle

The name Bohemia ultimately derives from the Boii, a Celtic people who inhabited parts of Central Europe. The ancient name Boiohaemum essentially meant the home of the Boii.

Bohemia developed into one of the major political territories of Central Europe, with Prague eventually becoming its principal city. For centuries it was associated with the Kingdom of Bohemia and the Holy Roman Empire.

Long before anyone called an artist a "Bohemian," therefore, Bohemia meant a geographical and political territory.

Early 1400s: Roma Appear in Central Europe

Roma groups are documented moving through Central and Western Europe by the early fifteenth century.

Some Roma made their living through mobile occupations including music, dance, entertainment, metalworking, animal trading and other specialized trades. Music in particular became strongly associated with Roma communities in several parts of Central and Eastern Europe.

Their migration would eventually play an unexpected role in changing the meaning of the word Bohemian.

1400s: France Begins Calling Roma "Bohemians"

When Roma groups appeared in France during the fifteenth century, the French used the word bohémien, derived directly from Bohême — Bohemia.

The explanation traditionally given is that Europeans believed these travelers had originated in, or had arrived through, Bohemia.

That belief about their ultimate origin was incorrect. Roma ancestry traces much farther east, ultimately to the Indian subcontinent.

But the name stuck.

This creates the first major transformation:

Bohemia was originally a place. "Bohemian" then became a European name applied to wandering Roma populations believed to have come through that place.

1526: Bohemia Comes Under Habsburg Rule

A major political change occurred in 1526.

After King Louis II of Hungary and Bohemia died at the Battle of Mohács, Ferdinand I of Habsburg acquired the crowns of Bohemia and Hungary.

Bohemia therefore became part of the expanding Habsburg dynastic world.

This also meant that Roma populations were living and traveling through territories that were increasingly under Habsburg rule, including portions of Bohemia, Hungary, Croatia and other Central European lands.

The three subjects therefore genuinely intersect historically:

Bohemia. The Habsburgs. The Roma.

That intersection does not by itself establish a connection to Bern, but it places all three within the Central European landscape of the sixteenth century.

1543: The Kindlifresserbrunnen Appears in Bern

Only seventeen years after the Habsburg acquisition of Bohemia and Hungary, the famous Kindlifresserbrunnen was erected in Bern.

The fountain dates to approximately 1543, with the present figure generally attributed to Hans Gieng.

Bern was not under Habsburg control at this point. Its conflicts with the Habsburgs belonged to an earlier chapter of Swiss history.

Nevertheless, the dates provide useful historical context. The fountain was created during the same sixteenth-century Central European world in which the Habsburg dynasty was expanding dramatically and Bohemia had just entered Habsburg rule.

There is currently no evidence demonstrating that Roma or Bohemia supplied the meaning of the Kindlifresserbrunnen. That would require another historical link.

But chronologically, these events belong to the same period.

1600s–1700s: "Bohemian" Begins Escaping Its Geographic Meaning

Over time, the European meaning of Bohemian began changing.

Because the term had become associated with people perceived as wandering outside conventional settled society, it gradually acquired broader associations with an unconventional or itinerant existence.

The word was moving farther away from its original geographical meaning.

A person increasingly could be described as Bohemian without actually coming from Bohemia.

1800s: Artists Become the New "Bohemians"

The next transformation occurred particularly strongly in nineteenth-century France.

Poor writers, painters, musicians, actors and other creative people living outside respectable bourgeois society increasingly became known as Bohemians.

The association made cultural sense at the time. Artists living irregular lives in cheap quarters, gathering in cafés and rejecting conventional careers were compared with the romanticized European image of wandering "Bohemians."

By this point the word had undergone a remarkable transformation:

A geographical identity had become a social identity.

Henri Murger helped permanently establish this meaning with his nineteenth-century work Scènes de la vie de bohème, depicting impoverished young artists living in Paris.

The story later provided the basis for Giacomo Puccini's famous opera La Bohème.

"Bohemia" was now firmly associated with the world of artists, writers, musicians and performers.

Early 1900s: Bohemian Becomes an Artistic Identity

During the early twentieth century, Bohemian culture continued to represent people living outside conventional middle-class expectations.

The word became associated with artists' colonies, writers, cafés, unconventional dress, experimental art, political radicals and alternative lifestyles.

Its connection to the actual territory of Bohemia became increasingly distant.

But the name remained.

1940s–1950s: The Beats Inherit the Bohemian Tradition

The American Beat generation became a modern continuation of this much older idea.

Writers and artists including Jack Kerouac, Allen Ginsberg and others cultivated lifestyles deliberately separated from conventional postwar American expectations.

Once again the familiar elements appeared: poetry, music, cafés, unconventional relationships, travel, experimentation and rejection of mainstream respectability.

The old Bohemian identity had found another generation.

1958: "Boho" Appears

The shortened word "boho" is recorded by Merriam-Webster from 1958.

That is significant because it occurs immediately before the explosion of the 1960s counterculture.

Bohemia had now traveled from an ancient Central European territory to a convenient modern word describing unconventional artistic culture.

1960s: Beatniks Become the Counterculture

The Beats helped provide part of the cultural foundation for the 1960s counterculture.

Music became enormously important to that transition.

Artists who previously would have existed on the cultural margins suddenly became internationally famous. The unconventional appearance, music and lifestyles associated with the underground were increasingly absorbed into popular culture itself.

That is the world in which Donovan wrote "Season of the Witch" in 1966.

One of its most revealing lines is:

"Beatniks are out to make it rich."

The outsider was entering the marketplace.

1966: Donovan's "Bohemia"

Donovan later described what was happening during this period as "bohemia infiltrating the popular culture."

His other comments indicate that he was primarily using Bohemia in its cultural sense — the artistic and Beat world moving into mainstream society.

But the word he inherited had an extraordinarily long history behind it.

When Donovan said Bohemia, he was using a cultural concept that had traveled through centuries:

Bohemia the Central European territory became associated with Roma travelers; "Bohemian" became associated with unconventional wandering; that image became attached to artists and performers; nineteenth-century artistic Bohemianism developed from it; the Beats inherited that tradition; and the 1960s counterculture inherited it from the Beats.

1970s to Today: Bohemian Becomes a Design Style

The transformation continued.

Bohemian clothing and décor increasingly incorporated an eclectic mixture of textiles, patterns, handcrafted objects, unconventional combinations and influences borrowed from numerous cultures.

Eventually the design industry shortened the concept to "boho" and "boho chic."

Periodically fashion and interior-design magazines announce that Bohemian style is back.

But underneath that modern marketing term sits a word with hundreds of years of accumulated history.

The Historical Thread

What makes this useful in examining the Bern fountain is not that Donovan proves anything about the Kindlifresserbrunnen. He does not.

The importance is that following the word backward unexpectedly returns to the same Central European landscape.

The modern word Bohemian did not appear from nowhere.

It begins with Bohemia — an actual Central European kingdom.

Roma populations appeared in Central Europe during the fifteenth century and became associated in France with the name of Bohemia.

In 1526, Bohemia passed to the Habsburgs.

In 1543, the Kindlifresserbrunnen appeared in Bern.

Centuries later, the geographical word became a cultural term for artists and outsiders.

The Beats inherited that identity.

And in 1966, Donovan could sing about beatniks and later describe what he was witnessing as "Bohemia infiltrating the popular culture."

That does not establish a hidden Bohemian meaning behind the Bern statue. But it does establish something useful for the investigation:

Bohemia, Roma history, and the Habsburg world really do intersect. The modern artistic meaning of "Bohemian" is the distant descendant of that much older Central European history.

Then there is the Bohemian Club in San Francisco, founded in 1872. The name made sense because it originally presented itself as a gathering of journalists, writers, artists, actors and musicians—precisely the people nineteenth-century society had come to call "Bohemians." It later evolved into the extremely wealthy and powerful membership associated with Bohemian Grove, which makes the transformation of the word itself rather striking: a term associated with outsiders and impoverished artists eventually became the name of an exclusive establishment club.

The Kindlifresserbrunnen: Was Bern's Child-Eater Fountain a Political Warning?

In the Old City of Bern, Switzerland, stands one of Europe's strangest public monuments.

The Kindlifresserbrunnen, commonly translated as the Child-Eater Fountain, was created by sculptor Hans Gieng around 1545–1546. The central figure is a large man consuming a child while carrying other captured children.

No surviving document conclusively explains what Gieng intended the figure to represent.

For centuries, people have attempted to solve the mystery.

Some believe the figure was simply a Kinderschreck, a bogeyman intended to frighten children into behaving. Others have connected it with Carnival traditions or Krampus. Another legend claims that it represents the supposedly insane older brother of Bern's founder, who became jealous of his brother and began eating children.

There is also an antisemitic interpretation involving the medieval blood-libel accusation. The pointed hat worn by the figure has been compared with the Judenhut historically associated with Jews in medieval Europe. However, the City of Bern notes that this interpretation of the fountain appears only in the nineteenth century, hundreds of years after the monument was constructed.

There is another theory.

The Child-Eater may represent Kronos, known to the Romans as Saturn.

Kronos and the Struggle for Power

Kronos was one of the Titans of Greek mythology. He overthrew his father, Uranus, and became ruler, only to learn that one of his own children was destined to overthrow him in turn.

Kronos attempted to prevent that prophecy from being fulfilled by swallowing his children as they were born. His wife, Rhea, eventually deceived him. She hid their son Zeus and instead gave Kronos a stone wrapped to resemble a baby. Kronos swallowed the stone, Zeus survived, and when he grew up he defeated his father and became ruler of a new generation of gods.

Seen in that context, the story is about considerably more than a frightening figure devouring children. At its center is a struggle over power and succession: an old ruler attempting to destroy the generation destined to replace him.

That matters when considering Bern's Kindlifresserbrunnen, because the Kronos interpretation was not invented in modern times simply to provide an explanation for an uncomfortable old monument.

The image of Kronos—or his Roman counterpart, Saturn—as a child-devouring figure was already established in European art before the Bern fountain was constructed. German Renaissance artist Georg Pencz depicted Saturn as a child-devouring figure shortly before Hans Gieng created the Bern fountain. Other early representations of Saturn also provide interesting parallels with the unusual headgear worn by Bern's Child-Eater.

Today, the City of Bern itself includes Kronos/Saturn among the possible interpretations of the Kindlifresser.

That does not establish that the figure is Kronos. The identity of the Child-Eater remains disputed. But it establishes something important: the Kronos/Saturn interpretation has a historical foundation that predates the fountain itself.

And yet there is another part of this monument that may be even more important.

The bears beneath him.

The Armed Bears Beneath the Child-Eater

The Child-Eater does not stand alone. Beneath him is something that can easily be overlooked when attention is focused on the horrifying figure above: a procession of armed bears representing Bern.

These are not simply decorative bears. The procession includes a captain, a standard-bearer, pikemen and musketeers. In other words, directly underneath the mysterious child-devouring figure, Bern is represented as an armed military force.

That creates a problem for some of the familiar explanations of the fountain.

If the figure is simply a bogeyman intended to frighten children, what are Bern's armed bears doing underneath him? If he represents Krampus, why the military procession? If the fountain commemorates a legendary madman who ate children, why place Bern's soldiers directly beneath that figure?

Even the later blood-libel interpretation does not readily explain why an armed representation of Bern forms such a prominent part of the monument.

The Kronos interpretation becomes considerably more interesting when the entire monument is considered rather than the Child-Eater in isolation. Kronos is not merely a figure associated with devouring children. His story concerns rulers, succession, the overthrow of an older order and the violent struggle to prevent a new generation from taking power.

To understand why that could have mattered in Bern, the fountain has to be placed back into the political world in which it was created: 1545.

The Habsburgs Began in Switzerland

The connection between the Habsburg dynasty and Switzerland reaches back centuries before the Kindlifresserbrunnen was constructed.

Around 1020–1030, Habsburg Castle was built in what is now the Swiss canton of Aargau. The castle eventually gave the Habsburg dynasty its name, and from this relatively small territorial base the family accumulated lands and influence until it became one of the great ruling houses of Europe.

A major turning point came in 1273, when Rudolf I of Habsburg was elected King of the Romans. Habsburg power increasingly shifted eastward toward Austria, while the developing Swiss Confederacy repeatedly came into conflict with Habsburg authority.

The Swiss defeated Habsburg forces at Morgarten in 1315 and again at Sempach in 1386. Then, in 1415, came an extraordinary reversal: the Swiss Confederates conquered Aargau, including the territory containing the original Habsburg Castle.

The symbolism of that reversal is difficult to miss. The dynasty that had taken its name from a Swiss castle was becoming one of Europe's most powerful ruling families at the same time that the Swiss had taken control of its ancestral homeland.

By the sixteenth century, the center of Habsburg power was no longer Switzerland.

But the history remained.

Charles V and the Protestant Reformation

The Habsburg ruler dominating European politics when the Kindlifresserbrunnen appeared was Charles V. He became King of Spain in 1516 and was elected Holy Roman Emperor in 1519, ultimately ruling territories that stretched across enormous portions of Europe and into the expanding Spanish overseas empire.

At the same time, the Protestant Reformation was breaking apart the religious unity of Western Europe, and Bern became directly involved in that struggle.

In 1528, Bern convened its major Reformation disputation to determine the religious direction of the city. Charles V opposed the proceedings, but Bern went forward. The result fundamentally transformed religious life in the city: Bern adopted the Reformation, abolished the Mass, secularized monasteries and removed religious images from its churches.

Bern had therefore asserted its own religious course in opposition to the Catholic imperial order represented by the Habsburg emperor.

That confrontation occurred only seventeen years before the Kindlifresserbrunnen was created.

Hans Gieng's Other Fountain

There is another important piece of the historical setting, and it comes from the same sculptor.

The Kindlifresserbrunnen was not Hans Gieng's only monumental fountain in Bern. In 1543, approximately two years before the Child-Eater appeared, Gieng created Bern's Justice Fountain.

The figure of Justice towers above representatives of earthly authority. Among the figures positioned beneath her are the Pope and the Emperor.

That imagery was displayed publicly in Protestant Bern only fifteen years after the city had embraced the Reformation.

Whatever interpretation is ultimately placed on the Kindlifresserbrunnen, the Justice Fountain establishes an important point about both the artist and the political environment in which he was working. Hans Gieng and the authorities of Bern were willing to place imagery involving religious and imperial power prominently in the city's public fountains.

That makes it difficult to dismiss the political context surrounding the Child-Eater as irrelevant. When Gieng created the Kindlifresserbrunnen two years later, he was working in a city whose fountains could carry meanings extending far beyond simple decoration.

Then Comes 1545

The timing of the Child-Eater Fountain is remarkable.

Around 1545–1546, Gieng created the Kindlifresserbrunnen.

In December 1545, the Council of Trent opened as the Catholic Church formally confronted the challenges created by the Protestant Reformation.

In 1546, Charles V went to war against the Protestant Schmalkaldic League.

Men from Protestant Swiss cantons, including Bern, participated with the Protestant forces fighting against Charles V.

The Kindlifresserbrunnen therefore appeared essentially on the eve of open warfare between Protestant resistance and the Habsburg emperor.

Was the Child-Eater a Political Message?

There is no surviving document proving that Hans Gieng intended the Kindlifresserbrunnen as a political warning directed at Charles V or the Habsburgs. There is no smoking gun, and that needs to be stated clearly.

What does survive, however, is a substantial collection of historical and iconographic evidence that deserves consideration when the fountain is viewed in the context of the world in which it was created.

Kronos—or Saturn in the Roman tradition—was already being depicted as a child-devouring figure before Gieng created the Bern fountain. The mythology behind that image was fundamentally concerned with power and succession. Kronos was the old ruler who attempted, through violence, to prevent the generation destined to replace him from ever coming to power.

That imagery appeared in a city with its own long history of conflict with the Habsburgs. Bern had fought Habsburg power for centuries, participated in the conquest of the dynasty's ancestral territory in Aargau, and then openly pursued the Protestant Reformation despite opposition from the Habsburg emperor Charles V.

There is also Hans Gieng's own work to consider. Only about two years before creating the Kindlifresserbrunnen, Gieng created Bern's Justice Fountain, placing representatives of both papal and imperial authority beneath the figure of Justice. Political and religious authority were therefore already present in the monumental public imagery associated with his Bern fountains.

Then, in 1545–1546, Gieng created the extraordinary figure that survives today: a man devouring children while an unmistakable procession of armed Bernese bears marches beneath him.

The timing is difficult to ignore. The fountain appeared just as Charles V's confrontation with the Protestant princes and cities of the Holy Roman Empire was escalating toward the Schmalkaldic War.

None of this proves the meaning of the Kindlifresserbrunnen. But taken together, it permits another possible reading of the monument.

The figure above may represent Kronos/Saturn—the old ruler attempting through violence to prevent the new order from replacing him—while beneath him stands armed Bern.

If that interpretation is correct, the fountain was communicating something considerably more consequential than a warning to Bern's children to behave.

It was a statement about power, resistance, succession and an old order struggling against the forces that threatened to replace it.

What Bern Says Today

Interestingly, the City of Bern no longer claims to know definitively what the Child-Eater represents.

In 2024, Bern changed the official information accompanying the fountain. The previous explanation had presented the figure as a Kinderschreck—essentially a frightening character intended to teach children obedience and proper behavior. The newer interpretation is deliberately more cautious.

The city now acknowledges that numerous theories have developed around the Kindlifresserbrunnen and that none can be conclusively proved or disproved. Among the possibilities specifically recognized is Kronos/Saturn devouring his children.

That leaves the mystery open. But perhaps one of the most important clues has been sitting underneath the Child-Eater all along.

The bears are armed, and they represent Bern.

Once those bears are included in the interpretation, the fountain begins to look very different.

There is no surviving letter from Hans Gieng explaining what he intended. Nearly five centuries later, there may never be a smoking gun. But when the monument is placed back into the historical world in which it was created, a remarkably coherent possibility emerges.

Bern had rejected the old religious order and pursued the Protestant Reformation despite opposition from Charles V. The Habsburg emperor's confrontation with Protestant resistance was moving toward military conflict. Hans Gieng had already created a public fountain in which the Emperor and Pope appeared beneath Justice.

Then, in 1545, Gieng placed a violent, child-devouring figure above a procession of the armed bears of Bern.

If that figure was deliberately intended as Kronos or Saturn, the symbolism would have been extraordinarily appropriate. The old ruler attempts to destroy the generation destined to replace him. He resorts to violence to preserve the old order. He fails, and the new order comes anyway.

I cannot prove that this was Hans Gieng's message.

But unlike many of the theories that have accumulated around the Kindlifresserbrunnen, this interpretation attempts to account for the entire monument—the Child-Eater, the armed bears beneath him, the artist who created them, and the extraordinary political and religious moment in which they appeared.

The smoking gun may be gone.

The clues are still standing in the middle of Bern.

References

City of Bern. "Kindlifresserbrunnen erhält eine neue Beschriftung." Stadt Bern, May 11, 2023. https://www.bern.ch/mediencenter/medienmitteilungen/aktuell_ptk/kindlifresserbrunnen-erhaelt-eine-neue-beschriftung.

City of Bern. Kindlifresserbrunnen: Neue Beschriftung. Bern: City of Bern, 2023. https://www.bern.ch/mediencenter/medienmitteilungen/aktuell_ptk/kindlifresserbrunnen-erhaelt-eine-neue-beschriftung/dokument/beilage-beschriftung-kindlifresser.pdf/download.

Encyclopaedia Britannica. "Cronus." Encyclopaedia Britannica. Accessed August 14, 2026. https://www.britannica.com/topic/Cronus.

Encyclopaedia Britannica. "Saturn." Encyclopaedia Britannica. Accessed August 14, 2026. https://www.britannica.com/topic/Saturn-god.

Switzerland Tourism. "Bern." MySwitzerland.com. Accessed August 14, 2026. https://www.myswitzerland.com/en-us/destinations/bern/.

"Before Bohemian meant artists hippies and boho it was a name attached to people traveling Europe under the protection of kings."

The history of Jews, Gypsies, Roma, Bohemia and European royal families contains connections rarely discussed together. Roma groups traveling through Europe in the early 1400s sometimes carried safe-conduct documents issued by kings and rulers, allowing them passage through territories controlled by local authorities. The historical use of "Bohemians" for Gypsies also developed from their association with Bohemia and royal protection rather than from Roma origins in Bohemia.

Jewish communities likewise had complicated relationships with European kings, princes and aristocratic families. Jews could be expelled from one territory while receiving protection, settlement rights and commercial privileges from another ruler. Both Jews and Roma therefore became known as outsiders while simultaneously maintaining documented relationships with the political and aristocratic authorities controlling the territories where they lived.

The powerful Esterházy family, closely connected with the Habsburg world, provides an important example. On Esterházy territory at Galánta, Jewish and Roma communities existed under the authority of the same aristocratic family. Historical records show Roma families receiving protection and occupational privileges, while Jewish families received settlement, religious and commercial privileges under Esterházy patronage.

The similarities between historical stereotypes surrounding Jews and Gypsies are also preserved in language. The derogatory expressions "gypped" and "Jewed down" both became associated with financial transactions, bargaining or cheating. These expressions reflect longstanding European stereotypes involving money, trading, outsiders and distrust rather than establishing the actual behavior of either population.

The history of Roma safe-conduct, Jewish protection agreements, the Esterházy family, the Habsburg monarchy and Galánta reveals that Jews, Gypsies and European aristocrats were not living in completely isolated worlds. They participated in the same political, economic and social systems. Following those relationships provides a different way of examining the history of Gypsies in Europe, Jewish history, Bohemia, European royalty, Roma history and the Habsburg world.

Music: Donovan - Season of the Witch (Official Audio) - YouTube

How hormones work to flip sexes: Hormones

Do you have a psychopath in your life? The best way to find out is read my book. BOOK *FREE* Download – Psychopath In Your Life4

Support is Appreciated: Support the Show – Psychopath In Your Life

Download Pods here - one click and pods load to any device fully titled and ready to listen to or archive: TOP PODS – Psychopath In Your Life

My old discussion forum with last 10 years of victim stories, is back online. Psychopath Victim Support Community | Forums powered by UBB.threads™

Google Maps My HOME Address: 309 E. Klug Avenue, Norfolk, NE 68701 SMART Meters & Timelines – Psychopath In Your Life

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:abe35449-5e0b-46fa-9d94-1461f53021aa-1" data-turn-id-container= "request-WEB:abe35449-5e0b-46fa-9d94-1461f53021aa-1" data-testid= "conversation-turn-4" data-turn="assistant"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:970fa31e-6329-48d4-b3d5-532d06bce97f-6" data-turn-id-container= "request-WEB:970fa31e-6329-48d4-b3d5-532d06bce97f-6" data-testid= "conversation-turn-14" data-turn="assistant"> Jews and Roma: Two Peoples Burdened With Remarkably Similar European Stereotypes

When the history of Jews and Roma—historically called "Gypsies" in English—is examined side by side, something striking appears. Both populations accumulated unusually broad collections of negative stereotypes in European society. These were not simply occasional insults. They became recurring ideas about money, honesty, work, movement, religion, family, criminality and whether either population truly belonged within the societies where they lived.

The comparison becomes especially interesting because Jews and Roma were very different peoples with different origins, religions and histories. Yet European societies repeatedly described them using surprisingly similar language.

Their Names Became Words for Dishonest Transactions

Perhaps the clearest surviving evidence is embedded in the English language.

"Jew" became a derogatory verb during the nineteenth century. "To Jew" somebody, and later "to Jew somebody down," meant to bargain aggressively, obtain an unfairly low price, or cheat someone financially. The Oxford English Dictionary records this derogatory verbal usage in the early nineteenth century.

Something remarkably similar happened with "Gypsy."

"Gyp" or "gypped" came to mean cheating, swindling or shortchanging someone. Merriam-Webster records the verb gyp from 1879 and identifies its probable relationship to Gypsy.

So the names of two minority populations became English verbs involving getting the better of somebody financially.

The meanings aren't identical. "Jew down" became particularly associated with bargaining a price downward, whereas "gyp" meant cheating or swindling more generally. But the linguistic parallel is difficult to miss.

Money, Trading and Bargaining

Behind those words were older stereotypes.

Jews had been associated with moneylending, commerce and finance for centuries. Part of that history resulted from the occupational environment imposed upon Jewish communities. In various European jurisdictions, Jews faced restrictions on land ownership, guild membership, government employment and other occupations. Moneylending and commerce became important economic niches in some places.

The stereotype eventually detached itself from that complicated history. Instead of asking why Jews were concentrated in particular occupations, popular culture transformed the association into a supposed Jewish characteristic: Jews were greedy, obsessed with money or unusually skilled at extracting money from others.

Roma encountered a related process.

Roma communities participated in numerous occupations, including metalworking, animal trading, entertainment, seasonal labor, crafts and horse dealing. Mobility itself was economically useful for some of those occupations. But European folklore increasingly converted particular occupations and lifestyles into supposed racial characteristics.

The traveling trader became the dishonest trader.

The horse dealer became the horse cheat.

The outsider became someone who could not be trusted.

Eventually the word Gypsy itself helped produce gyp.

The "Permanent Outsider"

Another major similarity was the idea that neither population really belonged.

Jewish communities could exist in a European territory for generations and still be described as foreigners.

Roma could similarly live within a country for centuries while continuing to be treated as outsiders.

This produced a peculiar historical situation. A family could have ancestors living within the same kingdom for hundreds of years and nevertheless remain classified socially or legally as something separate from the surrounding population.

That distinction mattered because governments repeatedly created laws specifically regulating these populations.

Governments Controlled Where They Could Live

Both Jews and Roma encountered restrictions involving residence and movement, although the laws differed enormously according to country and period.

Jews were confined to particular towns, districts or ghettos in various European jurisdictions. Governments also imposed special permissions, taxes and numerical restrictions upon Jewish settlement.

Roma faced restrictions aimed particularly at mobility. Some governments expelled them outright. Others attempted to prevent traveling and force Roma families into permanent settlements.

Under the Habsburgs, this becomes particularly important.

Maria Theresa attempted to transform Roma into settled subjects during the eighteenth century. Her government restricted Roma mobility and increasingly attempted to suppress distinguishing aspects of Romani life.

At approximately the same historical period, the Habsburg monarchy was also deciding where Jews could live, how many Jewish families could reside in particular territories, what economic activities they could undertake and under what conditions they would be tolerated.

_:empty]:hidden"> Gypsies, Jews and the Royals: What the Records Show

The history of Gypsies in Europe becomes much more interesting when you go back to their early appearances.

The familiar story is that Gypsies were wandering outsiders who arrived in Europe and were eventually driven from one place to another.

But some of the early records contain another part of the story.

When groups identified as Gypsies traveled across Europe during the early 1400s, some carried safe-conduct documents issued by rulers. These documents told local authorities to allow them to travel and, in some cases, to protect them.

That royal connection also helps explain one of the strange names attached to Gypsies in Western Europe.

Bohemians.

Gypsies did not originate in Bohemia. But groups traveling west became associated with Bohemia and with documents connected to rulers in that part of Europe. In France, Bohémien consequently became a word for Gypsy.

So the image of the completely unattached wanderer misses something important.

Some Gypsy groups moved through Europe with official protection from the people who ruled it.

The relationship did not end with medieval safe-conduct papers.

As Gypsy communities became established throughout Central Europe, particular families developed relationships with aristocratic landowners. Those relationships could involve permission to remain on estates, work, travel, practice trades or perform music.

Now put the Jews beside them.

Jewish communities had their own long history of relationships with European rulers.

Jews could be expelled by one ruler and welcomed by another. Kings and aristocrats sometimes granted Jewish communities protection and permission to settle and conduct business. In return, Jewish communities could pay special taxes, rents, protection money and other charges.

So underneath the public image of two unwanted outsider populations was a more complicated reality.

Both populations could have direct relationships with the ruling families.

This becomes particularly clear when we look at the Esterházys, one of the great aristocratic families of the Habsburg world.

The Esterházys controlled enormous estates in the Kingdom of Hungary. One of their important centers was Galánta, today in Slovakia.

And at Galánta we find Jews and Gypsies living under the authority of the same castle family.

The Esterházys had established relationships with particular Gypsy families by the seventeenth century. Surviving documents show Roma leaders receiving protection connected with the Esterházy family. Their relatives and descendants appear in the records, demonstrating that these relationships could continue across generations.

The Roma weren't simply anonymous people passing through.

They had families, leaders, occupations and established relationships with the people controlling the land.

By the eighteenth century, Galánta had also become particularly associated with Roma musicians. The Esterházys granted privileges to musicians from the community, and music became an occupation passed from parents to children.

At the same time, an established Jewish community was living at Galánta under Esterházy patronage.

By 1728, records show approximately fifteen Jewish families there. The following year the Jewish community received formal privileges from the Esterházy estate.

Jewish residents were permitted to worship and conduct economic activities. They paid the estate for various privileges, leases and protections.

The community grew substantially. By 1787, more than 300 Jews lived in Galánta, comprising roughly one-fifth of its population.

This gives us a very different picture from the simple story of unwanted outsiders.

The people in the castle weren't merely tolerating two mysterious populations they knew nothing about.

They were dealing directly with both of them.

• They knew who their leaders were.
• They knew what occupations they practiced.
• They issued privileges.
• They provided protection.
• They collected money.

And some of these relationships lasted for generations.

That becomes especially interesting when we consider how similar the stereotypes surrounding Jews and Gypsies eventually became.

• Both populations were portrayed as outsiders.
• Both were associated with trading and bargaining.
• Both were accused of cheating.
• Both were accused of maintaining strong internal family loyalties.

And both ethnic names eventually became derogatory English expressions involving financial behavior: "gypped" for being cheated and "Jewed down" for bargaining someone down.

Both populations could exist in protected relationships with the same ruling families.

Meanwhile, the ruling families themselves were anything but separate.

European royalty and aristocracy built power through marriage.

Families married into other families, inherited their property, changed names and titles and produced new branches. The royal houses that appear separate when listed by surname were frequently related by blood.

The Esterházys themselves were part of this interconnected aristocratic world.

So when we place everybody back into the same historical landscape, the picture looks considerably different from the neat categories we inherited.

At the top were interconnected royal and aristocratic families controlling land and government.

Underneath them were populations including Jews and Gypsies who could simultaneously be described as outsiders while maintaining direct relationships with those rulers.

At Galánta, those relationships existed side by side.

And this is the important result of following the story backward.

The castle was never separate from the story of the outsiders.

The Gypsies who became famous as wandering people had, in some of their earliest European appearances, traveled under royal safe-conduct.

Centuries later, particular Roma families were still living and working under aristocratic protection.

Jewish families were likewise living under arrangements negotiated with those same kinds of aristocratic rulers.

So whatever else happened between these populations over the centuries, the historical record shows something that the stereotypes obscure:

Jews, Gypsies and the people in the castles were not three isolated worlds. They were participants in the same political, economic and social system.

A few especially important examples:

• Oxford coffeehouses, 1650s — Among England's earliest. Oxford's coffeehouses became gathering places for scholars interested in experimental science and natural philosophy. This overlaps with the intellectual environment from which the Royal Society, founded in 1660, emerged.
• Jonathan's Coffee House, London, late 1600s — Stockbrokers and merchants congregated here. Jonathan's became one of the important predecessors of what developed into the London Stock Exchange.
• Edward Lloyd's Coffee House, London, c. 1686 — This one is extraordinary. Shipowners, merchants, captains and people willing to insure voyages gathered there. From that coffeehouse ultimately developed Lloyd's of London.
• Button's Coffee House, London, early 1700s — Associated with Joseph Addison, Richard Steele, Alexander Pope and London's literary world. Coffeehouses were sometimes called "penny universities" because the price of coffee effectively bought admission to conversation and information.
• Café Procope, Paris, 1686 — One of the big ones for your line of inquiry. Voltaire, Rousseau and Diderot are associated with it, and it later became connected with political figures of the French Revolution, including Danton and Marat. Benjamin Franklin also frequented it while in Paris.
• Café de Foy, Paris — Particularly interesting historically because on July 12, 1789, Camille Desmoulins famously addressed a crowd there, helping ignite the revolutionary mobilization immediately preceding the storming of the Bastille.
• Vienna's coffeehouses, 1800s–early 1900s — This becomes almost an intellectual ecosystem. Writers, journalists, psychologists, mathematicians, political thinkers and artists worked and argued in cafés. Café Central became associated with figures including Peter Altenberg, Stefan Zweig and Leon Trotsky.
• Budapest coffeehouses, late 1800s–early 1900s — This connects directly with what we were just discussing. Budapest developed an enormous café culture in which writers, journalists, mathematicians and intellectuals could essentially use cafés as offices.
• Caffè Greco, Rome, founded 1760 — Associated over time with Goethe, Byron, Keats, Shelley, Wagner and other writers and artists. It is a particularly clean example of the café becoming part of European bohemian artistic culture.
• Café de Flore and Les Deux Magots, Paris, 1900s — Associated with Sartre, Simone de Beauvoir and the existentialists, along with writers and artists. These are much closer chronologically to the eventual Beat generation.
• San Francisco's North Beach coffeehouses, 1950s — Now you arrive directly at the Beats. Places such as Caffè Trieste became associated with writers, poets and the North Beach bohemian environment in which the Beats flourished.

And there is a striking progression here that fits the question you've been developing:

1600s: merchants, scientists and political discussion 1700s: Enlightenment and revolution 1800s: writers, artists and political radicals early 1900s: European intellectuals and avant-garde movements 1950s: Beatniks 1960s: hippies/counterculture

The institution keeps changing names and clientele, but the underlying function is surprisingly durable: a semi-public meeting place outside the established institutions where information, ideas, networks and unconventional movements can develop.

That makes the Beatnik coffeehouse much less trivial historically than the stereotypical image of somebody in a black turtleneck reading poetry. It belongs to a European coffeehouse tradition several centuries old.

historically consequential coffeehouse/café intellectual circles—rather than simply famous cafés—the pattern becomes clearer.

Period Place / circle Why it matters 1650s Oxford coffeehouse circles Scholars and natural philosophers congregated in the new coffeehouses during the period when England's experimental-science networks were developing. The Royal Society followed in 1660. 1660s–1700s London coffeehouses After the Great Fire of 1666, coffeehouses became important information exchanges for merchants, scientists, politicians, writers and financiers during London's reconstruction and commercial expansion. 1680s–1700s Jonathan's Coffee House, London Brokers and traders congregated here. It became an important institutional ancestor of the London Stock Exchange. c. 1686 onward Lloyd's Coffee House, London Merchants, shipowners and underwriters exchanged shipping intelligence and arranged insurance. This eventually developed into Lloyd's of London. 1686–1700s Café Procope, Paris Enlightenment intellectual culture: Voltaire, Rousseau, Diderot and others. Later associated with revolutionary political circles. 1789 Paris revolutionary cafés Cafés became political organizing and information centers. Camille Desmoulins' famous July 12 speech at Café de Foy immediately preceded the Bastille uprising. 1800s Parisian literary/bohemian cafés Artists, writers and political outsiders increasingly made cafés their social headquarters. This is especially relevant to the development of the modern meaning of "bohemian." 1800s–early 1900s Vienna coffeehouse culture An extraordinary concentration of writers, journalists, artists, scientists, psychoanalytic thinkers and political figures circulated through Vienna's cafés. late 1800s–1930s Budapest café culture Budapest's cafés became working environments for journalists, writers, mathematicians and intellectuals. This is the environment immediately relevant to Hungary's remarkable intellectual generation. 1890s–1930s Hungarian "Martians" generation John von Neumann, Leo Szilard, Eugene Wigner, Edward Teller, Theodore von Kármán and other Hungarian émigré intellectuals emerged from Budapest's exceptional educational/intellectual environment. "Martians" was the later joke that their abilities were so extraordinary they couldn't really be human. 1920s–40s Paris Left Bank cafés Writers, artists, expatriates and political thinkers—Hemingway, Picasso and others—made café life inseparable from the image of modern bohemian Paris. 1940s–50s Existentialist Paris cafés Sartre, Simone de Beauvoir and their circle famously worked and met in cafés such as Café de Flore and Les Deux Magots. 1950s–early 60s Beat coffeehouses — New York/San Francisco Kerouac, Ginsberg and the Beat milieu carried forward the café/bohemian model: poetry, jazz, unconventional lifestyles and rejection of mainstream middle-class culture. 1960s Beat → hippie counterculture The coffeehouse culture doesn't disappear, but the cultural center increasingly moves toward music venues, communes, parks, clubs and large gatherings. "Hippie" replaces "Beatnik" as the dominant label. The particularly interesting chain

If you're following the social institution, rather than claiming that these people belonged to one continuous organization, you can trace something like:

Oxford scientific circles → London coffeehouses → Enlightenment cafés → French revolutionary cafés → Parisian bohemians → Vienna/Budapest intellectual cafés → Hungarian "Martians" → Paris existentialists → Beats → hippies.

And there are several genuine historical transformations in that chain that are stronger than coincidence. A coffeehouse could function as an unofficial institution. Lloyd's is probably the cleanest demonstration: conversation and information exchange in a coffeehouse eventually became an enormous formal financial institution.

The Martians are especially interesting because they weren't merely poets or political talkers. Von Neumann helped establish modern computing and game theory; Szilard conceived the nuclear chain reaction; Wigner won the Nobel Prize in Physics; Teller became central to thermonuclear-weapons development; von Kármán transformed aeronautics. That is an unusually consequential intellectual cluster to emerge from one relatively small Central European country and generation.

One caution worth keeping in the timeline: Budapest café culture contributed to their broader intellectual environment, but it would be too strong to say "the Martians were a coffeehouse group." Their remarkable common denominators also include Budapest's elite schools, mathematics competitions, universities, Jewish-Hungarian intellectual culture, and later migration into German, British and American scientific institutions.

That distinction actually makes the historical argument stronger: coffeehouses repeatedly appear as networking infrastructure around intellectual movements without necessarily causing those movements.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:abe35449-5e0b-46fa-9d94-1461f53021aa-4" data-turn-id-container= "request-WEB:abe35449-5e0b-46fa-9d94-1461f53021aa-4" data-testid= "conversation-turn-10" data-turn="assistant">

Yemen looks peripheral on a modern map of global power, but historically it is anything but peripheral.

Coffee is a perfect example. Yemen didn't necessarily originate the coffee plant—Coffea arabica is generally traced botanically to the Ethiopian highlands—but Yemen was crucial in turning coffee into a cultivated crop, prepared beverage, commercial commodity, and eventually a global phenomenon.

By the 15th century, Yemeni Sufis were drinking coffee, and Yemen became the center of early commercial coffee cultivation. The port of Mocha (al-Makha) became so closely identified with the coffee trade that we still say "mocha" today.

And Yemen's importance goes much deeper. Its position at the southern entrance to the Red Sea put it astride ancient trade routes connecting East Africa, Egypt, Arabia, India and the Mediterranean world. The ancient kingdoms of southern Arabia—including Saba, commonly associated with the biblical kingdom of Sheba—grew wealthy partly through the incense and spice trades.

That's what makes the coffeehouse trail unexpectedly useful. Following something as ordinary as Beatniks sitting around drinking coffee eventually takes you backward through San Francisco and New York, Paris, Budapest and Vienna, London, Constantinople and Cairo—and ultimately into Yemen and the Red Sea trading world.

And suddenly that Beatnik coffeehouse doesn't look quite so modern. It's the latest incarnation of a social institution with roughly five centuries of documented history behind it.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:abe35449-5e0b-46fa-9d94-1461f53021aa-3" data-turn-id-container= "request-WEB:abe35449-5e0b-46fa-9d94-1461f53021aa-3" data-testid= "conversation-turn-8" data-turn="assistant">

the pattern doesn't begin in London or Europe at all.

The rough historical sequence is:

1400s — Yemen: Coffee drinking becomes established among Sufi communities. Coffee was useful for remaining awake during nighttime religious observances.

Early 1500s — Mecca and Cairo: Public coffeehouses appear in major Islamic cities. Importantly, these were already more than beverage shops. Men gathered to exchange news, debate, play games and discuss politics and religion. Authorities occasionally became suspicious of them precisely because people were gathering and talking outside official institutions.

1550s — Constantinople/Istanbul: This is the major milestone. The first famous Ottoman coffeehouses in Constantinople are traditionally dated to about 1554–1555. They became centers for conversation, storytelling, news, poetry and political discussion.

1600s — Venice: Coffee and the coffeehouse model move increasingly into European commercial centers through Mediterranean/Ottoman trade.

1650 — Oxford: England's first commonly cited coffeehouse opens.

1652 — London: Pasqua Rosée establishes one of London's earliest coffeehouses. Within a few decades London has an extraordinary coffeehouse culture.

1666 onward — London after the Great Fire: This is where your observation becomes particularly interesting. Coffeehouses are already present when London is devastated, and they flourish during the period of rebuilding and enormous financial/commercial development.

Then come Lloyd's, Jonathan's, scientific circles, publishers, political factions and financial markets.

So if you're asking:

Who started the historical coffeehouse tradition that eventually reaches London, Paris, Vienna, Budapest and the Beatniks?

The trail leads most strongly to the Islamic world—Yemen, then the great urban coffeehouse cultures of Mecca, Cairo and especially Ottoman Constantinople.

And there is an intriguing chronological connection to your other research: the European coffeehouse tradition begins developing during the same broad centuries in which "Bohemian," Roma/Gypsy, Ottoman and Eastern cultural influences were moving through Europe.

That doesn't establish that these phenomena were connected. But chronologically, the coffeehouse wasn't an ancient European institution that the Beats rediscovered.

Europe imported the basic institution from the Islamic/Ottoman world and then adapted it to European intellectual, commercial and political life.

The word "Bohemian" has traveled an extraordinary distance. Today it can describe an interior-design style, clothing, artists, musicians, hippies, or an unconventional way of life. But the word did not begin as an artistic concept. It began with an actual place in Central Europe: Bohemia.

Understanding that history helps separate several things that eventually became tangled together: Bohemia, the Roma, the Habsburgs, artists and performers, the Beat generation, and finally the 1960s counterculture represented by musicians such as Donovan.

Ancient Origins: Bohemia Was a Place Before It Was a Lifestyle

The name Bohemia ultimately derives from the Boii, a Celtic people who inhabited parts of Central Europe. The ancient name Boiohaemum essentially meant the home of the Boii.

Bohemia developed into one of the major political territories of Central Europe, with Prague eventually becoming its principal city. For centuries it was associated with the Kingdom of Bohemia and the Holy Roman Empire.

Long before anyone called an artist a "Bohemian," therefore, Bohemia meant a geographical and political territory.

Early 1400s: Roma Appear in Central Europe

Roma groups are documented moving through Central and Western Europe by the early fifteenth century.

Some Roma made their living through mobile occupations including music, dance, entertainment, metalworking, animal trading and other specialized trades. Music in particular became strongly associated with Roma communities in several parts of Central and Eastern Europe.

Their migration would eventually play an unexpected role in changing the meaning of the word Bohemian.

1400s: France Begins Calling Roma "Bohemians"

When Roma groups appeared in France during the fifteenth century, the French used the word bohémien, derived directly from Bohême — Bohemia.

The explanation traditionally given is that Europeans believed these travelers had originated in, or had arrived through, Bohemia.

That belief about their ultimate origin was incorrect. Roma ancestry traces much farther east, ultimately to the Indian subcontinent.

But the name stuck.

This creates the first major transformation:

Bohemia was originally a place. "Bohemian" then became a European name applied to wandering Roma populations believed to have come through that place.

1526: Bohemia Comes Under Habsburg Rule

A major political change occurred in 1526.

After King Louis II of Hungary and Bohemia died at the Battle of Mohács, Ferdinand I of Habsburg acquired the crowns of Bohemia and Hungary.

Bohemia therefore became part of the expanding Habsburg dynastic world.

This also meant that Roma populations were living and traveling through territories that were increasingly under Habsburg rule, including portions of Bohemia, Hungary, Croatia and other Central European lands.

The three subjects therefore genuinely intersect historically:

Bohemia. The Habsburgs. The Roma.

That intersection does not by itself establish a connection to Bern, but it places all three within the Central European landscape of the sixteenth century.

1543: The Kindlifresserbrunnen Appears in Bern

Only seventeen years after the Habsburg acquisition of Bohemia and Hungary, the famous Kindlifresserbrunnen was erected in Bern.

The fountain dates to approximately 1543, with the present figure generally attributed to Hans Gieng.

Bern was not under Habsburg control at this point. Its conflicts with the Habsburgs belonged to an earlier chapter of Swiss history.

Nevertheless, the dates provide useful historical context. The fountain was created during the same sixteenth-century Central European world in which the Habsburg dynasty was expanding dramatically and Bohemia had just entered Habsburg rule.

There is currently no evidence demonstrating that Roma or Bohemia supplied the meaning of the Kindlifresserbrunnen. That would require another historical link.

But chronologically, these events belong to the same period.

1600s–1700s: "Bohemian" Begins Escaping Its Geographic Meaning

Over time, the European meaning of Bohemian began changing.

Because the term had become associated with people perceived as wandering outside conventional settled society, it gradually acquired broader associations with an unconventional or itinerant existence.

The word was moving farther away from its original geographical meaning.

A person increasingly could be described as Bohemian without actually coming from Bohemia.

1800s: Artists Become the New "Bohemians"

The next transformation occurred particularly strongly in nineteenth-century France.

Poor writers, painters, musicians, actors and other creative people living outside respectable bourgeois society increasingly became known as Bohemians.

The association made cultural sense at the time. Artists living irregular lives in cheap quarters, gathering in cafés and rejecting conventional careers were compared with the romanticized European image of wandering "Bohemians."

By this point the word had undergone a remarkable transformation:

A geographical identity had become a social identity.

Henri Murger helped permanently establish this meaning with his nineteenth-century work Scènes de la vie de bohème, depicting impoverished young artists living in Paris.

The story later provided the basis for Giacomo Puccini's famous opera La Bohème.

"Bohemia" was now firmly associated with the world of artists, writers, musicians and performers.

Early 1900s: Bohemian Becomes an Artistic Identity

During the early twentieth century, Bohemian culture continued to represent people living outside conventional middle-class expectations.

The word became associated with artists' colonies, writers, cafés, unconventional dress, experimental art, political radicals and alternative lifestyles.

Its connection to the actual territory of Bohemia became increasingly distant.

But the name remained.

1940s–1950s: The Beats Inherit the Bohemian Tradition

The American Beat generation became a modern continuation of this much older idea.

Writers and artists including Jack Kerouac, Allen Ginsberg and others cultivated lifestyles deliberately separated from conventional postwar American expectations.

Once again the familiar elements appeared: poetry, music, cafés, unconventional relationships, travel, experimentation and rejection of mainstream respectability.

The old Bohemian identity had found another generation.

1958: "Boho" Appears

The shortened word "boho" is recorded by Merriam-Webster from 1958.

That is significant because it occurs immediately before the explosion of the 1960s counterculture.

Bohemia had now traveled from an ancient Central European territory to a convenient modern word describing unconventional artistic culture.

1960s: Beatniks Become the Counterculture

The Beats helped provide part of the cultural foundation for the 1960s counterculture.

Music became enormously important to that transition.

Artists who previously would have existed on the cultural margins suddenly became internationally famous. The unconventional appearance, music and lifestyles associated with the underground were increasingly absorbed into popular culture itself.

That is the world in which Donovan wrote "Season of the Witch" in 1966.

One of its most revealing lines is:

"Beatniks are out to make it rich."

The outsider was entering the marketplace.

1966: Donovan's "Bohemia"

Donovan later described what was happening during this period as "bohemia infiltrating the popular culture."

His other comments indicate that he was primarily using Bohemia in its cultural sense — the artistic and Beat world moving into mainstream society.

But the word he inherited had an extraordinarily long history behind it.

When Donovan said Bohemia, he was using a cultural concept that had traveled through centuries:

Bohemia the Central European territory became associated with Roma travelers; "Bohemian" became associated with unconventional wandering; that image became attached to artists and performers; nineteenth-century artistic Bohemianism developed from it; the Beats inherited that tradition; and the 1960s counterculture inherited it from the Beats.

1970s to Today: Bohemian Becomes a Design Style

The transformation continued.

Bohemian clothing and décor increasingly incorporated an eclectic mixture of textiles, patterns, handcrafted objects, unconventional combinations and influences borrowed from numerous cultures.

Eventually the design industry shortened the concept to "boho" and "boho chic."

Periodically fashion and interior-design magazines announce that Bohemian style is back.

But underneath that modern marketing term sits a word with hundreds of years of accumulated history.

The Historical Thread

The modern word Bohemian did not appear from nowhere.

It begins with Bohemia — an actual Central European kingdom.

Roma populations appeared in Central Europe during the fifteenth century and became associated in France with the name of Bohemia.

In 1526, Bohemia passed to the Habsburgs.

In 1543, the Kindlifresserbrunnen appeared in Bern.

Centuries later, the geographical word became a cultural term for artists and outsiders.

The Beats inherited that identity.

And in 1966, Donovan could sing about beatniks and later describe what he was witnessing as "Bohemia infiltrating the popular culture."

That does not establish a hidden Bohemian meaning behind the Bern statue. But it does establish something useful for the investigation:

Bohemia, Roma history, and the Habsburg world really do intersect. The modern artistic meaning of "Bohemian" is the distant descendant of that much older Central European history.

Then there is the Bohemian Club in San Francisco, founded in 1872. The name made sense because it originally presented itself as a gathering of journalists, writers, artists, actors and musicians—precisely the people nineteenth-century society had come to call "Bohemians." It later evolved into the extremely wealthy and powerful membership associated with Bohemian Grove, which makes the transformation of the word itself rather striking: a term associated with outsiders and impoverished artists eventually became the name of an exclusive establishment club.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:12d18993-5b65-48c0-a61c-ecf2bd30fabd-10" data-turn-id-container= "request-WEB:12d18993-5b65-48c0-a61c-ecf2bd30fabd-10" data-testid= "conversation-turn-22" data-turn="assistant">

Yes—the striking part is its persistence. "Bohemian" has survived while countless other labels for artistic movements disappeared.

The actual Bohemia is ancient; then the name gets attached to Roma in Western Europe; then to unconventional artists and performers; then nineteenth-century Paris makes la bohème famous; the Bohemian Club adopts the name in 1872; Puccini gives the world La Bohème in 1896; the Beats inherit the Bohemian identity; hippies revive its look and lifestyle; and now boho clothing, boho weddings, boho interiors, and boho chic remain ordinary commercial terms.

I wouldn't necessarily conclude that there is a single someone deliberately keeping Bohemia alive. There's a simpler and quite interesting mechanism: each generation inherited the word from the previous one and reinvented what "Bohemian" meant.

What barely changed was the central idea: outside convention, artistic, exotic, free-spirited, slightly mysterious. That is an extraordinarily marketable identity, which probably helps explain why fashion and design keep resurrecting it.

And there's a wonderful irony in the Bohemian Club example. A word that came to signify people living outside respectable establishment society eventually became the name of one of America's most famous exclusive establishment clubs.

So for your story, you don't need to prove somebody has deliberately preserved it. The documented history is interesting enough:

Bohemia never really left the Western vocabulary. It repeatedly changed costumes.

_:empty]:hidden"> Bohemia: How an Ancient Kingdom Became Gypsies, Artists, Hippies and Boho

Most people have heard the word Bohemian without giving much thought to where it came from.

Bohemian clothing comes back into fashion every few years. Interior designers advertise Bohemian or "boho" rooms. The hippies of the 1960s were frequently described as Bohemian. Before them came the Beat generation. There is the famous Bohemian Club in San Francisco. Puccini wrote La Bohème. And Donovan later described the world surrounding his 1966 song "Season of the Witch" as "bohemia infiltrating the popular culture."

The word seems to be everywhere.

But Bohemia wasn't originally a lifestyle, a fashion or an artistic movement.

Bohemia was a real place.

And following the word backward leads into a surprisingly complicated story involving Roma or Gypsy populations, medieval rulers, Egypt, royal protection documents and the Kingdom of Bohemia.

Bohemia Begins as a Place

Bohemia is the historic region that today forms much of the western Czech Republic, including Prague.

Its name goes back much further. The ancient name Boihaemum referred to the land of the Boii, a Celtic people who once inhabited the region. The French linguistic authority CNRTL traces Bohême directly back through medieval Latin to the land of the Boii.

So long before there were Bohemian artists, Bohemian clothing or Bohemian clubs, Bohemia meant an actual Central European territory.

Early 1400s: A New Population Appears in European Records

During the early fifteenth century, European chronicles begin recording larger groups of people today identified as Roma moving through Central and Western Europe.

Their deeper origins were not actually Egyptian. Modern linguistic and genetic research has placed the distant origins of Roma populations in the Indian subcontinent.

But that is not necessarily what Europeans in the 1400s were hearing.

The travelers were repeatedly described as Egyptians, and some represented themselves as coming from Egypt or "Little Egypt."

This is the origin of the English word Gypsy: it developed from Egyptian.

But France would eventually give these same people another name:

Bohémiens — Bohemians.

And that is where the story becomes considerably more interesting.

1416: "Lord Emaus of Egypt"

The Council of Europe's history of Roma in Central Europe identifies 1416 as the first unchallenged documentary evidence of Roma in Hungary.

At Brașov in Transylvania, authorities provided food and money to a man identified as "Lord Emaus of Egypt" and his 120 companions.

Already several elements of the later pattern are visible.

There is an Egyptian identity.

There is a named leader.

There is a sizable traveling company.

And there is direct interaction with European authorities.

1417: Sigismund Enters the Story

The following year brings in one of the most important people in this history: Sigismund of Luxembourg.

Sigismund was King of Hungary and eventually Holy Roman Emperor. Crucially for this story, he was also King of Bohemia.

According to the Council of Europe, Sigismund granted Roma groups travel permits in 1417 and again in 1423.

The Council's historical account says the first group apparently possessed useful information about the Ottoman Turks after spending time in Ottoman territory. They were granted freedom to travel and then moved through Bohemia toward Western Europe.

That gives us an important reason not to picture these early groups simply as anonymous wanderers.

Some were dealing directly with political authorities.

1417–1421: The Travelers Move West

The documentary trail becomes much clearer as groups move through German-speaking Europe.

In 1417, chroniclers recorded a large unfamiliar traveling population passing through cities including Lüneburg, Hamburg, Lübeck, Wismar, Rostock and Stralsund.

By 1418, Frankfurt records people described as coming from "Little Egypt."

The Council of Europe identifies this as the earliest recorded reference to Little Egypt as the Roma homeland in this migration.

Then named leaders begin appearing.

In 1419, "Duke André of Little Egypt" appeared in France.

In 1420, Duke Andreas and approximately 100 companions appeared in Brussels and then Deventer.

By 1421, Duke Andreas appeared at Mons and produced a letter of safe conduct issued by Emperor Sigismund.

Another group arrived shortly afterward under a leader named Michael, who reportedly claimed to be Andreas's brother.

The pattern is becoming difficult to miss.

These groups use an Egyptian or Little Egyptian identity.

Their leaders use titles such as duke, count and voivode.

And some possess documents connected with powerful European rulers.

The Royal Papers Matter

Safe-conduct letters were enormously valuable in medieval Europe.

They functioned somewhat like portable credentials, identifying a leader and instructing authorities to permit that person and his company to travel safely.

The Council of Europe cautions that the documentary situation was complicated. Genuine safe-conducts existed, but documents could also be copied, passed between groups or fabricated.

That distinction is important.

It would be a mistake to assume every document was genuine.

It would be equally mistaken to assume the entire system was fabricated.

Royal protection itself was real.

1423: Ladislaus and Sigismund

The most striking document comes in 1423.

Sigismund issued a decree at Spiš to László or Ladislaus, identified as a Voivode of the Gypsies, and his people.

The House of European History states that the original decree is held by the National Archives of Hungary and that the document was based upon previous letters of privilege, probably originating in Hungary.

That last detail is important because it suggests the arrangement did not necessarily begin with Ladislaus.

Something apparently preceded it.

According to the translated charter, Ladislaus and members of his company appeared personally before Sigismund and petitioned him.

Sigismund then ordered nobles, soldiers, castle wardens, customs officials, cities and magistrates throughout his territory to assist and protect Ladislaus and the people under him.

The document went even further.

If a dispute occurred among Ladislaus's people, Sigismund ordered local authorities not to adjudicate it. Ladislaus himself was given jurisdiction.

Officials were also ordered to return the charter after reading it so that its bearer could continue carrying and presenting it.

That makes the document a genuine portable credential.

Whatever questions remain about these people's claimed origins, their interaction with royal authority cannot simply be dismissed as later folklore.

Why Would Sigismund Protect Them?

That remains one of the unanswered questions.

The Council of Europe notes that Roma in this Central European environment became known as musicians and metalworkers, and that some served in Hungarian armies. It also suggests that the earlier 1417 group may have possessed valuable military information concerning the Ottoman Turks.

Those facts provide plausible practical reasons rulers might find mobile Roma groups useful.

But there is presently no document demonstrating that Ladislaus personally received his 1423 privilege because he was a weapons maker, messenger, spy or military informant.

That would be going beyond the evidence.

The stronger observation is simpler:

Ladislaus had access to Sigismund, petitioned him personally and received substantial royal protection.

How that relationship developed remains an important question.

Egypt and Bohemia Meet

Now we reach the origin of a linguistic puzzle.

Why would people presenting themselves as Egyptians become known in France as Bohemians?

There are two closely related historical explanations.

The standard French etymological explanation is that bohémien became a name for Roma because they were believed to have originated in Bohemia. France's CNRTL records the Roma meaning by the fifteenth century and derives it from Bohême.

The French Academy gives essentially the same explanation: these communities were called bohémiens because they were believed to have come from Bohemia.

But historians of Roma migration provide a more specific mechanism.

A history published by Central European University Press explains that the newcomers presented letters of protection from Sigismund of Luxembourg, King of Bohemia, and consequently came to be regarded as people arriving from that country.

Those explanations need not actually contradict one another.

People traveling through Bohemia and carrying credentials associated with its king could quite naturally become identified by outsiders with Bohemia.

That gives us two names developing from two different perceived connections:

Egyptian → Gypsy.

Bohemia → Bohémien → Bohemian.

Neither name necessarily tells us the population's deeper geographical origin.

The Meaning Begins to Change

Then something remarkable happens.

The word Bohemian gradually escapes from both geography and ethnicity.

CNRTL records bohème being used by 1659 for a person living an irregular or unconventional life.

Eventually the word becomes associated with people living outside ordinary respectable society.

That creates the bridge into the artistic world.

The 1800s: Artists Become Bohemians

By the nineteenth century, particularly in Paris, Bohemian increasingly described writers, painters, musicians, actors and other artists living unconventional lives outside respectable bourgeois society.

They did not have to come from Bohemia.

They did not have to be Roma.

Bohemian had become a cultural identity.

Henri Murger's Scènes de la vie de bohème helped permanently establish this romantic image of impoverished young artists living unconventional lives in Paris.

Murger's world eventually inspired Puccini's 1896 opera La Bohème.

By then the transformation was nearly complete.

The name of an ancient Central European territory had become shorthand for the artistic outsider.

The Bohemian Club

The word then crossed into another world.

The Bohemian Club was founded in San Francisco in 1872, originally drawing heavily from journalists, writers, actors, musicians and artists.

The name made perfect sense in nineteenth-century language.

They were the creative people society had come to call Bohemians.

The historical irony is difficult to miss: a word associated with wandering outsiders and struggling artists eventually became attached to one of America's most famous exclusive clubs.

Beats and Beatniks

The twentieth-century Beat generation inherited much of the older Bohemian identity.

Again the familiar characteristics appear: writers, poets, musicians, cafés, unconventional clothing, travel, experimentation and rejection of conventional middle-class expectations.

The Bohemian had changed clothes again.

Now he could be called a Beat or beatnik.

Donovan and "Season of the Witch"

That brings the story into the 1960s.

Donovan's "Season of the Witch", released in 1966, contains the peculiar line:

"Beatniks are out to make it rich."

Donovan later described the cultural transformation surrounding the song as Bohemia entering or infiltrating popular culture.

That makes considerable sense when viewed against this much longer history.

The Beat or Bohemian outsider was moving into mainstream entertainment.

The underground was becoming popular culture.

Hippies Become the New Bohemians

The hippies then inherited much of the same identity.

Long hair, loose clothing, beads, embroidered garments, peasant blouses, flowing skirts, handmade jewelry, sandals and textiles borrowed from cultures around the world became part of the visual vocabulary of the late 1960s and 1970s.

Much of what was simply called hippie clothing at the time would later be marketed as Bohemian or boho fashion.

Once again, Bohemia had changed costumes.

And Finally: Boho

Today the word survives almost everywhere.

There is boho fashion.

There are boho weddings.

There is boho chic.

Interior designers continually rediscover Bohemian design.

A word whose history reaches back to an ancient Central European territory is now used to sell flowing dresses, patterned rugs, plants, pillows and living-room furniture.

Most people using the word probably have no idea how far backward it goes.

The Trail

The history can be reduced to one extraordinary progression:

Bohemia was a real Central European territory.

Roma groups appeared in Central European records during the early fifteenth century, frequently using Egyptian or Little Egyptian identities.

Some of their leaders obtained or carried royal safe-conducts, including documents associated with Sigismund of Luxembourg, King of Bohemia.

As these populations moved west, France came to call them Bohémiens.

Bohemian gradually became associated with wandering and unconventional living.

Artists inherited the name.

The Beats inherited the artistic Bohemian identity.

The hippies inherited much of the Beat and Bohemian culture.

Donovan could therefore describe the cultural revolution of the 1960s as Bohemia entering popular culture.

And modern fashion and design inherited "boho."

Bohemia never really disappeared.

It simply kept changing what it meant.

And buried underneath a word now casually used to describe clothing and interior decorating is a much older story involving Egypt, Roma migration, medieval Europe, royal safe-conducts and the King of Bohemia himself.

That is why the word is still with us.

References

Council of Europe. A New Method: Assimilation—The Four Decrees of Maria Theresia. Factsheets on Romani History. Strasbourg: Council of Europe, 2008. Council of Europe document

Douglas, George. "The Origin of the Gypsies." The Atlantic Monthly 17, no. 100 (February 1866). The Origin of the Gypsies

Etymonline. "Bohemian." Online Etymology Dictionary. Accessed September 5, 2026. Bohemian—etymology and history

Etymonline. "Bohemia." Online Etymology Dictionary. Accessed September 5, 2026. Bohemia—etymology and history

Metropolitan Opera. "Czech It Out." La Bohème Educator Guide. Accessed September 5, 2026. Metropolitan Opera—Bohemia and the Romani connection

Silber, Michael K. "Josephinian Reforms." YIVO Encyclopedia of Jews in Eastern Europe. February 12, 2010. Accessed September 5, 2026. YIVO Encyclopedia—Josephinian Reforms

Vojak, Danijel, and Neven Kovačev. "Theresian and Josephine Reform Efforts in the Regulation of the Socioeconomic Position of Roma in Croatia and Slavonia." Povijesni prilozi (Historical Contributions) 37, no. 55 (2018). Historical Contributions article

Winkler, Anita. "The Idea of Tolerance." The World of the Habsburgs. Accessed September 5, 2026. The World of the Habsburgs—The Idea of Tolerance

The World of the Habsburgs. "Maria Theresa and Her Reforms." Accessed September 5, 2026. Maria Theresa and Her Reforms

Encyclopædia Britannica. "Bohemia." 11th ed. Cambridge: Cambridge University Press, 1911. Encyclopædia Britannica—Bohemia

U.S. Commission on Security and Cooperation in Europe. Romani Human Rights in Europe. Washington, DC: Commission on Security and Cooperation in Europe, 2000. Romani Human Rights in Europe

These support the particularly important chain in the show: Roma were being called bohémiens in France by the fifteenth century; Sigismund of Luxembourg, King of Bohemia, issued protection to a Romani group in 1423; Bohemia subsequently came permanently under the Habsburg dynasty in 1526; and Maria Theresa and Joseph II later imposed extensive assimilation policies on Roma within the Habsburg lands.

The 1423 Sigismund document/protection passage is especially important because it gives the show something considerably stronger than merely saying that the French somehow confused Roma with people from Bohemia. The Metropolitan Opera's historical guide specifically identifies Sigismund of Luxembourg—King of Bohemia and later Holy Roman Emperor—and the 1423 protection granted to followers of Laszlo Voivoda as one explanation for the later association of Roma with Bohemia.

When the people can no longer live on the land, the question becomes: who gets it?

Nepal has endured a remarkable sequence of disasters involving earthquakes, floods, landslides, dams, hydropower projects and repeated displacement of mountain communities. The devastating 2015 Nepal earthquake destroyed homes and villages across the country, and years later some families were still struggling with permanent resettlement. Then came new flooding, including destructive events in 2025 and another major disaster in 2026. When the same vulnerable regions appear repeatedly in a disaster timeline, the obvious question is: what is happening to the land and the people who live there?

This episode follows what I call the spider web. Instead of looking at a flood as an isolated event, I follow the rivers, dams, tributaries, hydropower projects and upstream infrastructure. A massive dam such as China's Three Gorges Dam may attract attention first, but following the Yangtze River reveals an enormous network of additional dams and water-control projects. Nepal presents its own complicated web of rivers, dams, proposed hydropower projects, glacial lakes, landslides and downstream communities.

The investigation examines the 2015 Nepal earthquake, displacement and reconstruction, followed by flooding and evacuations in 2025 and 2026. Who was displaced? Were communities completely rebuilt before the next disaster arrived? Where were the dams and hydropower projects in relation to the flooded areas? What happened upstream before the water reached the villages? And when people repeatedly lose their homes, what ultimately happens to their land?

Nepal is also part of a much larger Himalayan water system involving China, Tibet, India and Bangladesh. Rivers do not recognize national borders. Decisions involving dams, reservoirs, hydropower construction and water releases upstream can therefore become international issues downstream. At the same time, extreme rainfall, glacial lake outburst floods, earthquakes and landslides make the Himalayas naturally hazardous. Separating those natural forces from the possible effects of human infrastructure requires following the entire watershed rather than stopping at the scene of the flood.

This is not simply a story about one flood or one dam. It is a timeline of earthquakes, repeated flooding, dams, hydropower development, displaced families, reconstruction and land. When disaster strikes the same communities again and again, it is worth putting the events side by side and asking questions that disappear when each disaster is reported as an isolated news story.

Music: Creedence Clearwater Revival - Bad Moon Rising (Official Lyric Video)

2026 Nepal floods - Wikipedia

Do you have a psychopath in your life? The best way to find out is read my book. BOOK *FREE* Download – Psychopath In Your Life4

How they flip sex with hormones: Hormones

Support is Appreciated: Support the Show – Psychopath In Your Life Tune in: Podcast Links – Psychopath In Your Life

Download Pods here - one click and pods load to any device fully titled and ready to listen to or archive: TOP PODS – Psychopath In Your Life

My old discussion forum with last 10 years of victim stories, is back online. Psychopath Victim Support Community | Forums powered by UBB.threads™

Google Maps My HOME Address: 309 E. Klug Avenue, Norfolk, NE 68701 SMART Meters & Timelines – Psychopath In Your Life

The flooding in Nepal in August 2026 was triggered by a glacial collapse. A section of a glacier and mountain debris collapsed on the north side of Lāngtāng Lirung, creating a powerful surge of water and debris that caused widespread flooding. As of August 30, 2026, the situation is as follows:

• Casualties: At least 362 people have been confirmed killed, and the death toll is expected to rise. 3
• Missing: More than 1,500 people, including at least 800 foreigners, are still missing. 5
• Damage: The flood destroyed roads, snapped bridges, toppled buildings, and cut off communications, leaving a 40-mile-long path of destruction. At least 20 schools were damaged, and six major hydropower and transmission facilities were damaged. 34
• Rescue efforts: Nepalese soldiers and rescue teams, as well as international organizations, are working to save the missing and provide assistance to the affected population.

Nepal: They Knew the Risk. They Had a Warning. So What Happened?

Three months before a wall of water, mud and rock tore through a Himalayan valley along the Nepal-China border, killing hundreds, experts and government officials from Nepal and China were sitting together in Kathmandu discussing the risk of exactly these kinds of disasters.

But this story didn't begin in 2026.

Some people displaced by the 2015 disaster were reportedly still living in vulnerable temporary settlements when another major flood struck the region in 2025. Then, in August 2026, the river system was devastated again.

And there was a warning.

China sent Nepal an alert 12 days before the catastrophe warning of heavy rainfall and the possibility of landslides and flash floods.

So before we simply label this another Himalayan natural disaster, I want to follow the entire system.

The dams. The rivers. The nuclear facilities. The hydropower projects. The trade routes. The displaced communities. The warnings. And the timeline of what actually happened.

During major flooding, reservoirs can fill rapidly, and dam operators may have to release water downstream. I have not established that water was released from dams in this area during this disaster, but that is one of the questions worth investigating.

We also have what authorities are describing as a natural dam—debris from falling ice and rock blocking the river and creating a lake behind it.

But that raises another question.

If that natural dam had already been sitting there for roughly 18 or 19 hours, what exactly produced the enormous seismic signal recorded at 8:37 the following morning?

Early reports described an earthquake in the area. Later explanations focused on collapsing ice and rock, the debris dam, the lake that formed behind it and its eventual failure.

And now another explanation is moving to the forefront: climate change.

Rising temperatures, melting glaciers and thawing permafrost are being cited as factors increasing the danger of catastrophic floods in the Himalayas.

Maybe those factors are part of the story.

We've Heard Questions Like This Before

After Hurricane Katrina in 2005, residents of the Lower Ninth Ward and nearby communities reported hearing loud explosions around the time the levees failed. Some residents alleged that the Industrial Canal levee had been deliberately blown to divert water away from more valuable parts of New Orleans.

Those allegations became prominent enough that they were discussed publicly and even entered the congressional record. A House report noted receiving numerous reports from people who said they heard what sounded like explosions or bombs.

The major engineering investigations, however, did not find evidence that explosives caused Katrina's levee breaches. Investigators attributed the failures to engineering and structural problems, overtopping, erosion and foundation failures. There were also serious allegations concerning defective construction and possible corruption surrounding some floodwall work.

But here's the historical piece that makes the Katrina suspicions particularly understandable:

New Orleans authorities really had dynamited a levee before. During the Great Mississippi Flood of 1927, political and business leaders deliberately blew the levee south of New Orleans.

The objective was to relieve pressure and protect New Orleans and its commercial interests.

The result was flooding in St. Bernard and Plaquemines parishes.

PBS's history of the event records that it ultimately took 39 tons of dynamite to open the levee sufficiently. Residents were displaced, and the compensation they had been promised proved grossly inadequate.

There was another episode during Hurricane Betsy in 1965. A congressional Katrina report states that the Florida Avenue levee was initially breached by the storm, but that the Corps subsequently intentionally breached some levee points as part of drainage management.

So there's an important distinction:

1927 — deliberate dynamiting is historical fact.

1965 — intentional breaching after the storm breach is documented in the congressional Katrina report.

2005 Katrina — deliberate dynamiting was alleged by residents, but subsequent investigations did not establish explosives as the cause of the levee failures.

And that history connects directly to what I'm examining in Nepal in one useful respect.

Deliberately altering a levee or releasing water to protect a more valuable asset is not some imaginary concept—it has happened historically.

There's also an interesting social-history paper specifically about the Katrina dynamiting allegations. Historian Ari Kelman argues that they can't really be understood without the 1927 history, when powerful interests actually did sacrifice downstream communities to protect New Orleans.

The Spider Web

Nepal has endured a remarkable sequence of disasters involving earthquakes, floods, landslides, dams, hydropower projects and repeated displacement of mountain communities.

The devastating 2015 Nepal earthquake destroyed homes and villages across the country, and years later some families were still struggling with permanent resettlement.

Then came new flooding, including destructive events in 2025 and another major disaster in 2026.

When the same vulnerable regions appear repeatedly in a disaster timeline, the obvious question is:

What is happening to the land and the people who live there?

This episode follows what I call the spider web.

Instead of looking at a flood as an isolated event, I follow the rivers, dams, tributaries, hydropower projects and upstream infrastructure.

A massive dam such as China's Three Gorges Dam may attract attention first, but following the Yangtze River reveals an enormous network of additional dams and water-control projects.

Nepal presents its own complicated web of rivers, dams, proposed hydropower projects, glacial lakes, landslides and downstream communities.

The investigation examines the 2015 Nepal earthquake, displacement and reconstruction, followed by flooding and evacuations in 2025 and 2026.

• Who was displaced?
• Were communities completely rebuilt before the next disaster arrived?
• Where were the dams and hydropower projects in relation to the flooded areas?
• What happened upstream before the water reached the villages?

And when people repeatedly lose their homes, what ultimately happens to their land?

Nepal is also part of a much larger Himalayan water system involving China, Tibet, India and Bangladesh.

At the same time, extreme rainfall, glacial lake outburst floods, earthquakes and landslides make the Himalayas naturally hazardous.

In order to figure out whether dams could be contributing to flooding, I think of the river system like a spider web.

I found the river.

I followed the water.

And then I started finding the dams and hydropower projects.

And that's when this story got very interesting.

I looked for the hydropower plants, the water, and then, at the root, the blockage.

Dams typically get built where poor people live, then the poor people can't move far away, so they end up settling next to dams.

And there is another issue here.

People are complaining: Why wasn't this problem fixed after the event in 2025?

WHAT HAPPENED TO THE WATER? What Happened in 2026?

The flooding in Nepal in August 2026 was triggered by a glacial collapse.

A section of a glacier and mountain debris collapsed on the north side of Lāngtāng Lirung, creating a powerful surge of water and debris that caused widespread flooding.

As of August 30, 2026, the situation is as follows:

Casualties: At least 362 people have been confirmed killed, and the death toll is expected to rise.

Missing: More than 1,500 people, including at least 800 foreigners, are still missing.

Damage: The flood destroyed roads, snapped bridges, toppled buildings and cut off communications, leaving a 40-mile-long path of destruction. At least 20 schools were damaged, and six major hydropower and transmission facilities were damaged.

Rescue efforts: Nepalese soldiers and rescue teams, as well as international organizations, are working to save the missing and provide assistance to the affected population.

But This Same Corridor Was Hit in 2025

This is where the timeline becomes important, because this wasn't the first catastrophic flood in this river corridor.

July 8, 2025 — catastrophic upstream glacial flood hits this corridor.

August 26, 2026 — another, vastly larger catastrophe hits essentially the same corridor.

And after the 2025 event, they unquestionably knew this particular upstream watershed could produce a sudden destructive flood.

In fact, contemporary reporting on the 2026 disaster explicitly points back to the July 8, 2025 flood as the previous similar event.

That's only 414 days apart.

But before following the people and the land, I want to understand exactly what happened upstream on August 25 and 26.

The 8:37 Seismic Event

The first important point is that instruments really did record a very large seismic event at 8:37 a.m. on August 26.

USGS initially automatically classified it as a magnitude 4.4 earthquake.

Nepal's government repeated that information publicly that morning; the foreign minister told Parliament that preliminary information indicated an earthquake at 8:37 had triggered an avalanche.

But after examining the waveform, nearby seismic stations and satellite imagery, USGS reclassified it.

Their current conclusion is explicit:

No earthquake had occurred.

Instead, the collapse of an enormous mass of ice and rock, followed by the debris flow, generated seismic energy equivalent to approximately a magnitude 5.2 earthquake.

So was the ground actually shaking?

Yes.

Nepal Flood Timeline: What Happened Before 8:37? August 25, 2026 — Approximately 1:30–2:30 p.m.

According to the rapid scientific assessment published by the Integrated Research on Disaster Risk organization, a massive failure involving ice, rock and soil occurred in the Deding/Langtang region.

The debris fell into the river system and apparently created a natural dam.

The report estimates that this blockage remained in place for approximately 18 to 19 hours.

That would put the formation of the natural dam sometime during the afternoon of August 25.

Water then began accumulating behind the obstruction.

Importantly, the disappearance or reduction of water downstream may not have been obvious.

Researchers say the Mala River and other tributaries continued feeding water into the river below the blockage.

So downstream, the river could still have appeared to be flowing while farther upstream an enormous amount of water was accumulating behind the debris.

This is the beginning of the timeline that needs much more attention.

Overnight — August 25 into August 26

If the 18–19-hour reconstruction is correct, the natural dam is now sitting across the river.

Water continues accumulating behind it.

The temporary lake grows.

Ice, rock, soil and debris are holding that water back.

What was happening to that obstruction throughout the night is not yet clear.

Was it stable?

Was it slowly eroding?

Was additional material falling from the mountain?

Was the lake rising rapidly?

Were there smaller seismic events?

Were there sounds or ground movement in the area?

And most importantly:

What do the satellite images show during these hours?

Because according to this reconstruction, the dam already exists.

August 26 — Before 8:30 a.m.

The natural dam has now supposedly existed for nearly a day.

Downstream communities apparently have no idea that a large volume of water may be accumulating upstream.

There is no major rainstorm occurring in the Nepalese portion of the watershed that would explain the catastrophe about to arrive.

Everything still appears relatively normal downstream.

Then something happens.

Approximately 8:30–8:37 a.m.

According to the IRDR rapid assessment, this is when the temporary natural dam breaches.

A tremendous volume of water, ice, rock, sediment and debris is suddenly released into the river.

But almost simultaneously, something else is recorded.

8:37:10 a.m. — The Seismic Event

Seismic instruments record an enormous event near the Nepal-Tibet border.

It is powerful enough that it is initially reported as approximately a magnitude 4.4 earthquake.

Nepalese officials consequently begin receiving information that an earthquake may have occurred.

But USGS subsequently reanalyzes the signal.

It concludes that this was not a tectonic earthquake.

Instead, USGS classifies it as a landslide event associated with the glacier and slope failure.

And USGS calculates that the event generated seismic energy equivalent to approximately a magnitude 5.2 earthquake.

That is an enormous physical event.

And this is where the two timelines collide.

Because if the natural dam had already existed for 18 or 19 hours, what exactly happened at 8:37 the following morning that generated an M5.2-equivalent seismic signal?

• Was there another enormous mountain collapse?
• Did a much larger portion of the glacier and underlying rock suddenly fall?
• Did the existing natural dam itself catastrophically collapse?
• Did the dam failure trigger additional slope failure?
• Did several of those events happen almost simultaneously?
• Or is the preliminary estimate that the natural dam existed for 18–19 hours incorrect?

That is the unresolved question.

Approximately 8:40 a.m.

Only minutes after the seismic event, the Rasuwagadhi river monitoring station is still reportedly transmitting.

• The river measurement is approximately 1.62 metres, below the warning threshold.
• Then the monitoring station disappears.
• The flood has arrived.
• That is exactly the sort of behavior we might expect downstream from a natural dam failure.
• One moment the river looks relatively normal.
• Then the wall of water arrives.

About Three Hours Later

But the seismic story isn't finished.

USGS records another seismic event.

• This one generates energy equivalent to approximately a magnitude 4.2 earthquake.
• USGS again identifies it as another landslide-type event.
• So now we have at least two substantial seismic events associated with this disaster.
• One at 8:37 a.m.
• Another approximately three hours later.
• And according to the preliminary IRDR reconstruction, we potentially have an earlier event on August 25 that originally created the natural dam.
• That gives us a possible sequence of at least three separate stages:

August 25: Something falls into the river and creates the natural dam.

August 26 at 8:37: An enormous M5.2-equivalent mass-movement event occurs at approximately the same time the natural dam reportedly breaches.

Approximately three hours later: Another M4.2-equivalent landslide event occurs.

And that is why I don't think we should treat this simply as:

"A glacier collapsed and caused a flood."

The actual chronology may be considerably more complicated.

THE DAM WAS ALREADY THERE

Everything comes back to one question.

According to the current reconstruction, the natural dam had been blocking the river for 18 to 19 hours.

Water had been accumulating behind it since the previous afternoon.

Then, at 8:37 a.m. on August 26, something enormous happened.

Seismic instruments recorded an event initially identified as an earthquake.

USGS later determined that it was not a tectonic earthquake, but that whatever moved generated seismic energy equivalent to approximately a magnitude 5.2 earthquake.

But if the dam had already been sitting there for 18 or 19 hours—

WHAT HAPPENED AT 8:37 A.M.?

What moved?

What produced that enormous seismic signal?

And why did it happen at approximately the same time the natural dam reportedly failed?

That is the hole in the timeline.

Now Follow the Water Through the Spider Web

For 18 to 19 hours, water had been accumulating behind the natural dam.

Then, around 8:30–8:37 a.m. on August 26, that obstruction gave way.

Now imagine suddenly pulling the plug on an enormous body of water sitting high in a steep Himalayan valley.

The water didn't travel alone.

It carried ice, boulders, rock, mud, sediment, trees and debris with it.

The narrow valley concentrated that mass and sent it racing downstream.

This is where the spider web begins to matter.

• The water came down the Lhende River and entered the Bhote Koshi.
• The Bhote Koshi carried it farther downstream toward the Trishuli River.
• Now the flood was moving through a river corridor containing communities, roads, bridges and a chain of hydropower projects.
• One part of the system was connected to the next.
• The flood slammed through Rasuwagadhi, then continued toward Timure and Syabrubesi and farther downstream.
• Monitoring stations began disappearing.
• Bridges were washed away.
• Roads were ripped apart.
• Hydropower facilities were hit.
• Powerhouses were damaged.
• Substations and transmission infrastructure were damaged.

And the water kept going.

The Bhote Koshi feeds the Trishuli, so what began as a natural dam failure high in the mountains was now moving into a much larger river system.

That is the spider web.

It wasn't simply:

Dam breaks. Village floods.

It was:

A huge volume of water accumulates for 18–19 hours.

The obstruction gives way.

That accumulated water enters the Lhende.

The Lhende feeds the Bhote Koshi.

The Bhote Koshi carries it into the Trishuli system.

And all along that interconnected corridor are communities, bridges, roads, hydropower plants, intakes, tunnels, substations and other infrastructure.

The flood ultimately traveled approximately 100 kilometres, according to USGS.

So when that natural dam finally let loose, it didn't release water into an isolated mountain stream.

It released that water into a spider web.

In the specific Bhote Koshi–Trishuli corridor hit by this flood, there were at least 11 operating hydropower projects, plus additional projects under construction.

Nepal's Energy Ministry later counted 27 power projects affected across the Bhote Koshi–Trishuli basins when operating and under-construction projects were included.

So this was a heavily developed hydropower river corridor, not one isolated dam.

Some hydropower plants were flooded or badly damaged, including powerhouses and associated infrastructure.

Other plants survived structurally but were shut down or disconnected as the flood passed.

As the surge traveled down the Bhote Koshi into the Trishuli system, it was passing through a chain of hydropower installations in various states—some surviving, some damaged, some knocked offline.

And that's where the spider web leads me to another part of this story.

The people.

And the land.

PART TWO — WHAT HAD ALREADY HAPPENED TO THE PEOPLE? Nepal: The Same Land, the Same People, and More Than a Decade of Displacement

There is something about this story that doesn't really hit you until you put it on a timeline.

We are looking at the Rasuwa and upper Trishuli River area of Nepal.

Today we're talking about catastrophic flooding.

But these people didn't suddenly become displaced in August 2026.

Some of these communities have been dealing with displacement, land acquisition and major infrastructure development for more than a decade. And remarkably, the hydropower interest in their land begins before the 2015 earthquake. 2009–2010 — They Begin Identifying the Land

The Upper Trishuli-1 hydropower developer began land identification and survey work in 2009 and 2010.

So this is important.

• Before the earthquake.
• Before the 2025 flood.
• Before the catastrophic 2026 flood.

They were already identifying land needed for a major hydropower project in this area.

2012–2013 — Land Acquisition Begins

By 2012, meetings were being held with communities including Haku Besi, Mailung and Gogone.

People were being told where project facilities would be located, how much land would be needed and what compensation would be offered.

Land was measured.

Compensation rates were discussed.

And acquisition proceeded.

The Upper Trishuli-1 project ultimately required approximately 109 hectares of land and affected 154 families.

More than 90 percent of those affected families were Tamang, an Indigenous population of Nepal.

Most of the project's original land acquisition occurred in 2012 and 2013.

So the land story is already underway.

Then everything changes.

April 25, 2015 — The Earthquake

The massive Gorkha earthquake strikes Nepal.

Rasuwa, where Upper Trishuli-1 is located, becomes one of the worst-affected districts.

Within the hydropower project's area of influence alone, project documents say more than 80 percent of the houses were damaged and more than 200 people were killed.

Communities including Haku Besi, Gogone, Tiru and others were devastated.

People lost homes.

People lost agricultural land.

People lost their livelihoods.

Landslides made some areas dangerous or inaccessible.

Residents fled their villages and moved into displacement camps.

And here's where this timeline becomes extraordinary.

The International Finance Corporation later acknowledged that the earthquake had changed the situation so dramatically that it became difficult to separate the effects of the hydropower project's land acquisition from the effects of earthquake displacement.

Many of the people affected by the hydropower project were now scattered among earthquake-displacement camps.

After the Earthquake — They Don't All Go Home

You might assume this was temporary.

• Earthquake happens.
• People are evacuated.
• Homes are rebuilt.
• People return.
• But that isn't what happened for everyone.
• Years passed.
• Some families remained in temporary settlements.

In 2020, five years after the earthquake, human-rights monitors reported 269 displaced families still living in temporary tin shelters at Khalte Bagar, beside the Trishuli River.

And the problem continued.

Another report documented that of approximately 1,150 families displaced by the earthquake, 174 families still had not obtained land where safe permanent housing could be constructed.

Think about that.

The original disaster happened in 2015.

These people were still dealing with the land and resettlement problem years later.

Meanwhile, Hydropower Development Continues

The earthquake didn't eliminate the strategic importance of the river.

The hydropower development continued.

The project's land requirements didn't disappear.

In fact, additional land was purchased in 2018, including land associated with relocating project infrastructure following the earthquake.

And this wasn't just one hydropower project.

The entire Trishuli River Basin was becoming an enormous hydropower-development corridor.

By 2020, an IFC basin-wide assessment identified more than 36 hydropower projects operating, under development or planned.

If the planned projects were eventually constructed, IFC estimated they would require at least 640 hectares of land.

So while families were still trying to recover from the earthquake, international institutions and developers were continuing to plan the future of this river basin.

July 2025 — The Flood Comes

Now move forward ten years from the earthquake.

A sudden flood comes down the Lhende River at Rasuwagadhi.

• It destroys the Friendship Bridge.
• It damages the customs area.
• It destroys roads.
• It damages hydropower infrastructure.

People are killed and missing.

Hundreds have to be evacuated.

And sitting beside the Trishuli River are people who were still displaced from the 2015 earthquake.

Human-rights monitors reported that residents of the Khalte Bagar displacement camp stayed awake through the night, terrified that the rising Trishuli would enter their camp.

Think about the irony of that.

They had already been displaced because their original communities were considered dangerous after the earthquake.

Now the place where they had been displaced to was threatened by another disaster.

August 26, 2026 — It Happens Again

Fourteen months later, this river corridor is devastated again.

But this time the destruction is vastly greater.

The accumulated water comes roaring downstream.

• Once again, it enters the same general river corridor.
• Once again, communities are destroyed.
• Once again, people are displaced.
• Only this time on a catastrophic scale.

2009–2010: Hydropower developers are identifying and surveying land.

2012–2013: Major land acquisition takes place.

2015: The earthquake devastates the project area and displaces many of the same communities. Some residents cannot return safely to their original land and remain in displacement camps.

2018: Additional land is acquired for the hydropower project.

2020: Hundreds of earthquake-displaced families are still reported living in temporary shelters. At the same time, the broader Trishuli basin is documented as having more than 36 hydropower projects operating, under development or planned.

2025: Another report says 174 earthquake-displaced families still lack land for safe permanent housing.

July 2025: A major flood comes down the Lhende and Bhote Koshi into the Trishuli system. People are killed and displaced. Residents still living in an earthquake-displacement camp fear that the flood will reach them.

August 26, 2026: The same general river corridor is devastated again on a vastly larger scale.

And now we have another enormous population of people who have lost homes, farms, businesses and family members.

PART THREE — FOLLOW THE LAND

What happens to these people's land?

Because the history tells us something important.

This land was strategically important before any of these disasters happened.

Developers were surveying and acquiring it before the earthquake.

Hydropower development continued after the earthquake, additional land was acquired, and the entire river basin was subsequently mapped as a major hydropower-development corridor.

Meanwhile, some of the people who lived there spent years—and in some cases apparently a decade—trying to find permanent places to live.

Now another catastrophe has hit them.

A family may own a small piece of agricultural land beside the river.

Their house is destroyed.

The road is gone.

Maybe family members were killed.

Maybe they survive but are living elsewhere.

They don't have the money to rebuild, or authorities decide that rebuilding beside the river is unsafe.

But that land hasn't suddenly become meaningless.

It may sit beside a hydropower project, access road, transmission line, substation, tunnel entrance or the China-Nepal transportation corridor.

To the family, it may now be devastated farmland.

To an infrastructure developer, it could be strategically located property.

For example, devastated riverfront land could become strategically useful in several very practical ways.

Hydropower expansion: A company needs additional land for an intake, powerhouse, tunnel portal, construction yard, spoil-storage area or access route.

New or relocated roads: If the existing highway is destroyed, engineers may redesign the road through land previously occupied by homes or farms.

Transmission infrastructure: Hydropower requires substations, transmission towers and corridors. Cleared land near existing generating facilities can become valuable for that network.

Flood-control construction: Government could designate property for new embankments, retaining structures, diversion channels or river widening.

Rebuilding hydropower differently: A damaged plant may be reconstructed with a larger footprint or its components moved to what engineers consider a safer location.

China-Nepal trade infrastructure: Around Rasuwagadhi, land can have strategic value because this is also a cross-border transportation and trade corridor. Rebuilt customs facilities, warehouses, roads, bridges and logistics areas all require land.

Construction staging: Rebuilding dozens of bridges, roads and power facilities requires equipment yards, worker camps, material storage and access roads—often close to the river.

Land consolidation: If numerous small landowners don't return, individual little parcels can eventually be purchased and assembled into a much larger contiguous site.

Ten small family plots may not interest a developer; ten adjoining abandoned or purchasable plots can become one valuable infrastructure site.

The land did not lose its strategic value just because somebody's house washed away.

That is my prediction:

A lot of these people are not going to return, and the land they leave behind is going to become very important.

And Then There Are the Land Records

That can make recovery considerably harder, especially when an entire house is destroyed rather than merely flooded.

Paper deeds, citizenship documents, tax receipts, loan records, insurance papers, inheritance records, maps and other family records can disappear with the house.

Even when the government's official land registry survives—which is important, because losing the paper deed does not normally mean losing legal ownership—the family may now have to prove its claim through government records and replacement documents.

And imagine the circumstances.

Someone has lost their home, possessions, perhaps relatives, transportation and income.

Now they're supposed to navigate government offices and establish exactly which parcel belonged to them.

The flood doesn't necessarily erase ownership. But it can make exercising and proving that ownership much harder for the people who have just lost everything.

Because in a corridor where land acquisition was already occurring before the flood, the land records after the disaster matter almost as much as the land itself.

Nepal: The Same Land, the Same People, and More Than a Decade of Displacement

There is something about this story that doesn't really hit you until you put it on a timeline.

We are looking at the Rasuwa and upper Trishuli River area of Nepal.

Today we're talking about catastrophic flooding.

But these people didn't suddenly become displaced in August 2026.

Some of these communities have been dealing with displacement, land acquisition and major infrastructure development for more than a decade.

And remarkably, the hydropower interest in their land begins before the 2015 earthquake.

2009–2010 — They Begin Identifying the Land

The Upper Trishuli-1 hydropower developer began land identification and survey work in 2009 and 2010.

So this is important.

• Before the earthquake.
• Before the 2025 flood.
• Before the catastrophic 2026 flood.

They were already identifying land needed for a major hydropower project in this area.

2012–2013 — Land Acquisition Begins

By 2012, meetings were being held with communities including Haku Besi, Mailung and Gogone.

People were being told where project facilities would be located, how much land would be needed and what compensation would be offered.

Land was measured.

Compensation rates were discussed.

And acquisition proceeded.

The Upper Trishuli-1 project ultimately required approximately 109 hectares of land.

It affected 154 families.

More than 90 percent of those affected families were Tamang, an Indigenous population of Nepal.

Most of the project's original land acquisition occurred in 2012 and 2013.

So the land story is already underway.

Then everything changes.

April 25, 2015 — The Earthquake

The massive Gorkha earthquake strikes Nepal.

Rasuwa, where Upper Trishuli-1 is located, becomes one of the worst-affected districts.

Within the hydropower project's area of influence alone, project documents say more than 80 percent of the houses were damaged and more than 200 people were killed.

Communities including Haku Besi, Gogone, Tiru and others were devastated.

People lost homes.

People lost agricultural land.

People lost their livelihoods.

Landslides made some areas dangerous or inaccessible.

Residents fled their villages and moved into displacement camps.

And here's where this timeline becomes extraordinary.

The International Finance Corporation later acknowledged that the earthquake had changed the situation so dramatically that it became difficult to separate the effects of the hydropower project's land acquisition from the effects of earthquake displacement.

Many of the people affected by the hydropower project were now scattered among earthquake-displacement camps.

After the Earthquake — They Don't All Go Home

You might assume this was temporary.

Earthquake happens.

People are evacuated.

Homes are rebuilt.

People return.

But that isn't what happened for everyone.

Years passed.

Some families remained in temporary settlements.

In 2020, five years after the earthquake, human-rights monitors reported 269 displaced families still living in temporary tin shelters at Khalte Bagar, beside the Trishuli River.

And the problem continued.

Another report documented that of approximately 1,150 families displaced by the earthquake, 174 families still had not obtained land where safe permanent housing could be constructed.

Think about that.

The original disaster happened in 2015.

These people were still dealing with the land and resettlement problem years later.

Meanwhile, Hydropower Development Continues

The earthquake didn't eliminate the strategic importance of the river.

The hydropower development continued.

The project's land requirements didn't disappear.

In fact, additional land was purchased in 2018, including land associated with relocating project infrastructure following the earthquake.

And this wasn't just one hydropower project.

The entire Trishuli River Basin was becoming an enormous hydropower-development corridor.

By 2020, an IFC basin-wide assessment identified more than 36 hydropower projects operating, under development or planned.

If the planned projects were eventually constructed, IFC estimated they would require at least 640 hectares of land.

So while families were still trying to recover from the earthquake, international institutions and developers were continuing to plan the future of this river basin.

July 2025 — The Flood Comes

Now move forward ten years from the earthquake.

A sudden flood comes down the Lhende River at Rasuwagadhi.

• It destroys the Friendship Bridge.
• It damages the customs area.
• It destroys roads.
• It damages hydropower infrastructure.

People are killed and missing.

Hundreds have to be evacuated.

And sitting beside the Trishuli River are people who were still displaced from the 2015 earthquake.

Human-rights monitors reported that residents of the Khalte Bagar displacement camp stayed awake through the night terrified that the rising Trishuli would enter their camp.

Think about the irony of that.

They had already been displaced because their original communities were considered dangerous after the earthquake.

Now the place where they had been displaced to was threatened by another disaster.

August 26, 2026 — It Happens Again

Fourteen months later, this river corridor is devastated again.

But this time the destruction is vastly greater.

According to the current scientific reconstruction, a natural dam had already been sitting upstream for approximately 18 to 19 hours.

Water was accumulating behind it.

Then at 8:37 a.m., something enormous happened.

Seismic instruments recorded an event powerful enough to be initially classified as an earthquake.

USGS later determined that it wasn't a tectonic earthquake.

It was a mass-movement event producing seismic energy equivalent to approximately a magnitude 5.2 earthquake.

And at approximately the same time, the natural dam reportedly failed.

The accumulated water came roaring downstream.

• Once again, it entered the same general river corridor.
• Once again, communities were destroyed.
• Once again, people were displaced.

Only this time on a catastrophic scale.

Now Put the Timeline Together

2009–2010: Hydropower developer begins identifying and surveying land.

2012–2013: Major land acquisition takes place.

2015: Earthquake devastates the project area and displaces many of the same communities.

2015 onward: Some residents cannot return safely to their original land and remain in displacement camps.

2018: Additional land is acquired for the hydropower project.

2020: Hundreds of earthquake-displaced families are still reported living in temporary shelters.

2020: The broader Trishuli basin is documented as having more than 36 hydropower projects operating, under development or planned.

2025: Another report says 174 earthquake-displaced families still lack land for safe permanent housing.

July 2025: A major flood comes down the Lhende and Bhote Koshi into the Trishuli system. People are killed and displaced. Residents still living in an earthquake-displacement camp fear that the flood will reach them.

August 26, 2026: The same general river corridor is devastated again on a vastly larger scale.

And now we have another enormous population of people who have lost homes, farms, businesses and family members.

What happens to these people's land?

Because the history tells us something important.

This land was strategically important before any of these disasters happened.

Developers were surveying it before the earthquake.

They were acquiring it before the earthquake.

Hydropower development continued after the earthquake.

Additional land was acquired after the earthquake.

And the entire river basin was subsequently mapped as a major hydropower-development corridor.

Meanwhile, some of the people who lived there spent years—and in some cases apparently a decade—trying to find permanent places to live.

Now another catastrophe has hit them.

Some families may have lost their documents.

Many poorer families may have little or no meaningful property insurance.

Some may not have the money to rebuild.

Some may be told their land isn't safe enough to rebuild upon.

Some may simply give up after being displaced repeatedly.

But here's the part I am going to watch:

Their inability to live on that land does not necessarily make the land worthless.

• Not to a hydropower developer.
• Not to a road builder.
• Not to a transmission company.
• Not to a government rebuilding infrastructure.
• Not to somebody who needs access to the river.

The house can disappear.

The crops can disappear.

The family can disappear.

The location doesn't disappear.

And that location had already been identified as strategically important years before these disasters.

I am not saying that proves somebody caused an earthquake or caused these floods to obtain the land.

I don't have evidence establishing that.

But I don't need to make that claim to recognize how extraordinary this timeline is.

The documented history itself gives us the question:

2009: They begin identifying the land.

2012: They begin acquiring the land.

2015: The earthquake displaces the people.

2025: The river floods them again.

2026: The river devastates them again.

And through all of it:

Who owns the land?

The Land Along Nepal's Trishuli River Was Already Being Studied and Acquired Before the Flood

One of the important things to understand about the area devastated by the August 2026 flood is that this was not an unknown river valley that developers had never examined before.

Long before this flood, the Trishuli River corridor had already been extensively studied for hydropower development.

The International Finance Corporation, part of the World Bank Group, conducted an assessment of the entire Trishuli River Basin, an area covering approximately 32,000 square kilometres.

This wasn't simply a study of one dam.

It was a basin-wide examination of what would happen as numerous hydropower projects were developed along the same interconnected river system.

The work involved stakeholder consultations, data analysis and planning workshops conducted from 2017 through 2019.

And by 2020, IFC reported something remarkable:

There were already more than 36 hydropower projects in various stages of development or planning throughout the Trishuli River Basin.

If all of those planned projects were eventually developed, IFC estimated they would require at least 640 hectares of land.

So years before this flood, developers and international financial institutions already understood that enormous amounts of land along this river system would be needed for future hydropower development.

They Were Already Acquiring Land

Upper Trishuli-1 gives us a very good example.

This is a 216-megawatt hydropower project located in Rasuwa District along the Trishuli River.

The project required approximately 109 hectares of land.

About 31 hectares were required permanently and another 78 hectares temporarily.

The land included government property, private property and monastery land being farmed by local tenants.

The acquisition affected 38 parcels of land and 36 structures.

Approximately 154 families were affected.

Some of those structures were people's primary homes.

Others were agricultural buildings, seasonal residences, water mills and storage buildings.

And more than 90 percent of the affected families were Tamang, one of Nepal's recognized Indigenous nationalities.

This process wasn't beginning in 2026.

Most of that land had already been acquired in 2012 and 2013.

Additional land was purchased in 2018.

So we're talking about more than a decade of land acquisition and development before this flood.

Then They Studied the Entire River

What happened next is particularly interesting.

Instead of looking at each hydropower project separately, IFC began examining the entire Trishuli River system.

That makes sense because these projects don't exist independently.

They share the same river.

What happens upstream affects what happens downstream.

One hydropower project sits above another.

Roads connect them.

Transmission lines connect them.

Substations connect them.

Construction areas connect them.

And communities live throughout that same corridor.

It really does begin to resemble a spider web.

IFC's own assessment recognized this problem and specifically examined the cumulative effects of putting numerous hydropower developments into the same river basin.

By 2020, therefore, the basic development map was already very well understood.

They knew where the hydropower potential was.

They knew where projects were planned.

They knew where roads would be needed.

They knew where transmission infrastructure would be required.

And they knew substantial amounts of land would have to be acquired.

They Also Knew People Would Be Displaced

This is another important part of the story.

Displacement wasn't some unforeseen consequence discovered after the August 2026 flood.

It was already part of the hydropower planning process.

IFC's basin-wide assessment specifically warned about the displacement impacts associated with land acquisition as hydropower development expanded throughout the Trishuli Basin.

Upper Trishuli-1 demonstrates what that means on the ground.

IFC reported economic displacement affecting approximately 154 families and physical displacement affecting about 14 families, most belonging to Indigenous communities.

So before the flood ever happened, people were already being moved or economically affected because their land and resources sat inside an increasingly valuable hydropower corridor.

Then Comes the August 2026 Flood

Now look at what has happened to that same corridor.

• Homes have been destroyed.
• Roads have disappeared.
• Bridges have been washed away.
• Hydropower facilities have been damaged.

Some communities have effectively been torn apart.

Families have been displaced.

Some people have been killed.

Others are missing.

And some survivors may decide that returning to the river corridor is simply too dangerous.

But the flood hasn't changed one fundamental fact:

The strategic importance of the land remains.

The river is still there.

• The hydropower potential is still there.
• The China-Nepal border is still there.
• The international trade route is still there.
• The transmission network is still there.

And eventually roads, bridges and electrical infrastructure will have to be rebuilt.

In fact, rebuilding may create entirely new decisions about where that infrastructure should be located.

Nepal Flooding: Did Hydropower Make This Land More Valuable?

There is another way to look at what is happening in Nepal, and it starts before the current flood.

Look at the land.

For generations, much of the land along the Trishuli River system was occupied by relatively poor rural communities. Families farmed small plots, raised livestock and lived in villages scattered through difficult Himalayan terrain.

On a conventional real-estate map, some of this land might not have appeared particularly valuable.

Then somebody looked at the river.

And suddenly the calculation changed.

The steep mountains and enormous volumes of water flowing out of the Himalayas make this region extremely valuable for something else:

Hydroelectric power.

Once that potential was recognized and development began, the value of the corridor wasn't simply determined by what a farmer could grow on a piece of land.

Now the location of that land mattered.

Was it beside the river?

Was it near a place suitable for a diversion structure?

Could a tunnel be driven through the mountain?

Could a powerhouse be built there?

Was there room for a substation?

Could transmission lines cross it?

Could a road reach it?

Suddenly remote mountain property was sitting inside an energy corridor.

And the scale of the plans is significant.

The International Finance Corporation, part of the World Bank Group, studied the cumulative effects of hydropower development throughout the Trishuli River Basin.

By 2020, there were already more than 36 hydropower projects operating, under development or planned throughout the basin.

If all of the contemplated projects were developed, the IFC estimated that at least 640 hectares of land would be required.

The IFC also recognized that developing project after project throughout the same river basin could produce cumulative effects involving land acquisition, displacement, urbanization, slope instability and changes to local livelihoods.

In other words, long before the August 2026 flood, the transformation of this river corridor was already underway.

One project gives us a particularly good example.

The 216-megawatt Upper Trishuli-1 Hydropower Project requires approximately 109 hectares of land.

• Some of that land is required permanently.
• Some is required temporarily during construction.
• Some is government land.
• Some is privately owned.
• Some is forest.
• Some is agricultural land.

And some had been traditionally used by local communities.

According to project documentation, 154 families were affected by land acquisition associated with Upper Trishuli-1.

More than 90 percent of those families were Tamang.

Some structures were agricultural buildings, storage facilities and water mills.

Some were people's homes.

Several families were physically displaced.

That happened before this flood.

So there was already a process underway in which land traditionally occupied or used by local residents was being incorporated into a much larger hydropower development system.

Then came the infrastructure.

Hydropower doesn't simply require a dam or powerhouse.

It requires roads.

Tunnels.

Transmission lines.

Substations.

Worker facilities.

Construction areas.

Storage areas.

Access routes.

And all of those things can change the economic value of surrounding land.

A remote piece of mountain property that was once valuable primarily to the family farming it may suddenly be sitting beside millions or billions of dollars worth of infrastructure.

That changes the neighborhood.

It also changes who might want the land.

And this is where the August flood makes the story considerably more interesting.

A catastrophic flood has now torn directly through this same corridor.

Homes have disappeared.

Villages have been devastated.

Agricultural land has been covered with rock and sediment.

Roads and bridges have been destroyed.

Some residents are questioning whether it is safe—or even possible—to rebuild where their families have lived for generations.

Now we have a new land question.

What happens if those people don't return?

Suppose a family owned a small house and piece of agricultural land beside the river.

Before hydropower development, perhaps very few outsiders had any interest in buying it.

Then hydropower arrives.

A road is constructed.

A tunnel is built nearby.

A substation appears.

Transmission lines arrive.

The river itself becomes an electricity-producing asset.

The surrounding corridor becomes economically and strategically important.

Then a catastrophic flood destroys the family's house.

The family has little money.

Perhaps they cannot afford to rebuild.

Perhaps authorities eventually tell them the area is unsafe.

Perhaps they decide themselves that they cannot live beside that river anymore.

Now their relationship with that land has completely changed.

But has the underlying economic value of the location disappeared?

That is the question.

It might actually have value for purposes entirely different from the family's original use.

Hydropower infrastructure may need additional land.

Roads may have to be rerouted.

Transmission systems may need rebuilding.

Substations may need new locations.

Flood-control infrastructure could be constructed.

Construction companies may need staging areas.

New commercial development could follow reconstructed roads.

And additional hydropower projects were already contemplated throughout the basin.

There is also another source of value running through this particular valley.

The Nepal-China trade corridor.

The Rasuwagadhi border crossing connects Nepal with Tibet.

Customs infrastructure is there.

The highway is there.

Commercial traffic is there.

Tourism is there.

The Langtang region is there.

So this isn't simply a question about electricity.

It is a river corridor containing energy, transportation, international trade, tourism and water resources.

That makes what happens to the land after the flood worth watching very carefully.

And fortunately, we don't have to guess.

There is already a paper trail.

We have pre-flood documentation showing who owned and used land affected by major hydropower projects.

We have environmental and social assessments.

We have records of previous land acquisition.

We have maps showing hydropower installations.

We know where communities were located.

We know where roads and transmission infrastructure existed.

Now August 2026 gives us another line on that timeline.

The flood.

From here, watch the ownership.

Do families rebuild on their original property?

Are they allowed to?

Are particular areas declared permanently unsafe for residential use?

Does the government purchase damaged properties?

Do hydropower companies acquire additional land?

Do infrastructure developers acquire it?

Are new roads or substations constructed on former residential or agricultural property?

Does land that suddenly has very little value to a displaced homeowner acquire considerable value for another purpose?

And perhaps most importantly:

Who owns this land five years from now?

That could tell us far more than speculation ever could.

There is another reason to keep watching.

Once enormous amounts of money have been invested in hydropower, the economic importance of the entire corridor can change.

Nepal isn't simply building electricity for nearby villages.

It has been expanding electricity production as a national economic resource, including electricity exports to neighboring countries.

That means these rivers have national economic value.

Water flowing through a remote Himalayan valley can now generate electricity worth money hundreds of kilometres away.

And once that happens, land that provides access to that water can acquire a completely different kind of value.

That doesn't tell us why the August flood occurred.

It does tell us something important about what existed before it.

Hydropower development was already transforming this corridor.

Land had already been acquired.

Families had already been displaced.

Tunnels had already been constructed.

Blasting had already occurred as part of hydropower and road development.

Roads, substations and transmission systems had already been built.

More hydropower projects were already planned.

Then one of the largest floods in Nepal's recent history tore directly through that same corridor.

Now people are displaced on a much larger scale.

So this story doesn't end when the water goes down.

In some ways, that's when the most interesting part begins.

Watch the rebuilding.

Watch the zoning.

Watch the hydropower projects.

Watch the roads.

Watch who purchases property.

Watch who receives compensation.

Watch who returns.

And watch who doesn't.

Because if this corridor has become substantially more valuable as an energy and international infrastructure corridor, then the most revealing map may not be the flood map.

It may be the land-ownership map several years after the flood.

**Follow the water now.

Then follow the land.**

"Man is descended from a hairy, tailed quadruped, probably arboreal in its habits." — Charles Darwin, The Descent of Man

Darwin, Evolution, and the Human Body

Did a Creator design the human body, or did human beings descend through evolution from earlier animal ancestors? Charles Darwin argued that humans shared ancestry with other animals and famously wrote that man descended from a "hairy, tailed quadruped." But Darwin was not alone in spreading the theory. Thomas Henry Huxley, known as "Darwin's Bulldog," became one of Darwin's fiercest public defenders, battling critics and helping establish evolutionary theory in British science and public debate.

This episode examines Charles Darwin, Thomas Henry Huxley, human evolution, natural selection, and the debate over creation and evolution. It also looks at the history of so-called vestigial organs—body parts once portrayed as evolutionary leftovers with little or no important function. The appendix and tonsils became prominent examples as physicians and scientists debated whether certain structures were remnants of humanity's evolutionary past.

But modern medicine has discovered important functions for structures once dismissed or poorly understood. The appendix is associated with immune and gut functions, while the tonsils are part of the lymphatic and immune system. Millions of people nevertheless underwent appendectomies and tonsillectomies during periods when preventive removal became common medical practice.

The larger question goes beyond Darwin himself: What happens when a scientific theory becomes embedded in medicine, education, and culture before everything about the human body is understood? From Darwin and "Darwin's Bulldog" Thomas Henry Huxley to the appendix, tonsils, vestigial organs, evolution, natural selection and intelligent design, this episode returns to the fundamental question: Who—or what—designed the human body?

Music: Liar, Liar - The Castaways (1965)

African gorilla sound

Chimpanzee scream sound effect #shorts #short

Darwinism is an Illuminati Scam - henrymakow.com

Erasmus Darwin

Charles Darwin Illuminati Family Member Exposed ! The Illuminati Evolution Deception (Video) | Alternative | Before It's News

Charles Darwin Was a Massive Satanic Fraud

Lamarckism - Wikipedia

5 books that changed our understanding of the origin of life - Big Think

(28) Evolution without Lamarck's Theory and its Use in the Darwinian Theories of Evolution

An Intimate History of Evolution by Alison Bashford review – the incredible Huxleys | History books | The Guardian

The Huxleys: how one family shaped our view of nature - History Extra podcast notes and takeaways

The X CLUB - FROM THOMAS HUXLEY TO MUSK

Eugenics | History | Research Starters | EBSCO Research

TH Huxley Research Document_ _Why is TH Huxley problematic__.pdf

Saturn - Why Are We Worshiping The Cult Of EL? - In5D

Do you have a psychopath in your life? The best way to find out is read my book. BOOK *FREE* Download – Psychopath In Your Life4

How they flip sex with hormones: Hormones

Support is Appreciated: Support the Show – Psychopath In Your Life Tune in: Podcast Links – Psychopath In Your Life

Download Pods here - one click and pods load to any device fully titled and ready to listen to or archive: TOP PODS – Psychopath In Your Life

My old discussion forum with last 10 years of victim stories, is back online. Psychopath Victim Support Community | Forums powered by UBB.threads™

Google Maps My HOME Address: 309 E. Klug Avenue, Norfolk, NE 68701 SMART Meters & Timelines – Psychopath In Your Life

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-12" data-turn-id-container= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-12" data-testid= "conversation-turn-26" data-turn="assistant"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:cacab142-3bb2-46a7-bfec-56a22bb2fefa-1" data-turn-id-container= "request-WEB:cacab142-3bb2-46a7-bfec-56a22bb2fefa-1" data-testid= "conversation-turn-4" data-turn="assistant">

Universities, especially those with biology, genetics, anthropology, and medical programs, overwhelmingly teach evolution as the foundational framework for modern biology. This is true at institutions such as:

• Harvard University
• Stanford University
• University of Oxford
• University of Cambridge
• Massachusetts Institute of Technology
• University of California, Berkeley

In biology departments, evolution is generally presented not as a single hypothesis but as the organizing principle that connects genetics, ecology, microbiology, paleontology, anatomy, and medicine.

What they teach

A typical university biology curriculum teaches that:

• Life on Earth has changed over billions of years.
• Species share common ancestry.
• Natural selection is one of several mechanisms driving evolution.
• Other mechanisms include genetic drift, mutation, gene flow, and sexual selection.
• DNA and genetics provide strong evidence for common ancestry.

Importantly, universities do not teach Darwin's original 1859 theory unchanged. They teach modern evolutionary biology, which incorporates discoveries Darwin never knew about, including:

• Gregor Mendel's work on heredity.
• DNA and molecular genetics.
• Population genetics.
• Genomics.
• Evolutionary developmental biology ("evo-devo").
• Horizontal gene transfer in microorganisms.

So, students are taught that Darwin made a major breakthrough, but that science has refined and expanded his ideas over the past 165+ years.

Are there universities that disagree?

There are some universities and colleges founded on particular religious traditions that present alternative viewpoints, including:

• Liberty University
• Bob Jones University

Some institutions associated with young-Earth creationism or Intelligent Design may teach critiques of mainstream evolutionary theory alongside or instead of the scientific consensus.

However, among mainstream research universities worldwide—including those in North America, Europe, Australia, Japan, and much of Asia—acceptance of evolution is the norm in biological sciences.

Is there debate?

Yes, but it's important to distinguish what is debated.

Within universities, researchers actively debate questions such as:

• How quickly evolution occurs.
• The relative importance of natural selection versus genetic drift.
• The origins of specific traits.
• The timing of evolutionary events.
• Details of human evolution.

They generally do not debate whether evolution has occurred. The debates are about mechanisms, evidence, timing, and interpretation within the broader evolutionary framework.

This is similar to other sciences: geologists debate the details of plate tectonics, but they do not generally debate whether continents move.

So, if you walked into the biology department of a major research university today, you would almost certainly find that evolution is taught as the central framework of modern biology, while acknowledging that Darwin's original ideas have been substantially revised and expanded by later scientific discoveries.

• Most universities, especially research universities, teach modern evolutionary biology as the scientific consensus.
• Most scientists working in biology, genetics, paleontology, anthropology, and related fields accept evolution and common ancestry.
• Not all scientists do. Some scientists hold creationist or Intelligent Design views, and some believe God guided evolution, but they are a minority within those disciplines.
• Universities are where many scientists receive their education and research training, so evolutionary theory is a standard part of that training in the life sciences.

Gorillas at the Movies: From Evolution to Hollywood

The gorilla became known to Western science relatively recently. Although African peoples had long known of these animals, the genus Gorilla was formally named in 1852, just before the great nineteenth-century arguments about evolution and humanity's relationship to other primates.

That timing matters.

1850s–1870s — The Gorilla Enters the Human-Origin Debate

By the 1860s, the gorilla had become part of one of the biggest scientific arguments of the century: Where did human beings come from, and how closely were humans related to apes?

Thomas Henry Huxley put the comparison directly before the public in his 1863 book, Evidence as to Man's Place in Nature. One of its best-known illustrations arranged the skeletons of a gibbon, orangutan, chimpanzee, gorilla, and human alongside one another.

Charles Darwin went considerably further into human evolution with The Descent of Man in 1871.

Darwin did not say that modern humans descended from modern gorillas. Evolutionary theory argues that humans and today's great apes ultimately share ancestral populations.

But popular culture did not always preserve that distinction.

The much simpler image was:

MAN — APE — EVOLUTION.

And the gorilla was perfect for the visual shorthand.

Late 1800s — The Gorilla Becomes a Sensation

Gorillas fascinated Western audiences.

They appeared in newspaper stories, scientific illustrations, museum displays, adventure literature, cartoons, and exhibitions.

Unfortunately, these portrayals frequently had another dimension.

Apes and monkeys had long been used in racist caricatures, and nineteenth- and early-twentieth-century racial ideology sometimes used supposed comparisons between Africans and apes to portray certain human populations as more "primitive."

Consequently, the history of gorilla imagery cannot be separated completely from the history of race.

Science, entertainment, colonial attitudes, evolutionary arguments, and racial stereotypes sometimes became mixed together.

1918 — Tarzan of the Apes

Edgar Rice Burroughs published Tarzan of the Apes in 1912, and the first major film adaptation appeared in 1918.

Tarzan was not a gorilla movie in the sense that King Kong would become one. But the enormously successful Tarzan phenomenon helped establish a Hollywood image of Africa as a mysterious and dangerous place populated by wild animals, "primitive" societies, and a white man capable of mastering the wilderness.

Dozens of Tarzan films followed.

1927 — The Gorilla

A movie actually called The Gorilla appeared in 1927, adapted from a successful stage play.

It was a silent mystery involving a terrifying gorilla and a series of apparent murders.

The story was subsequently filmed again, including a 1939 version starring the Ritz Brothers and Bela Lugosi.

By this point, Hollywood understood something very simple:

Gorillas frightened and fascinated audiences.

1930 — Ingagi

Then came one of the strangest episodes in gorilla-movie history.

Ingagi was released in 1930 and presented to audiences as though filmmakers had documented an expedition into Africa.

Its sensational attraction involved supposed encounters between African women and gorillas.

But the movie wasn't an authentic African documentary.

It was largely fraudulent and staged.

The filmmakers exploited the public's fascination with Africa, gorillas, sexuality, race, and the supposed boundary between human beings and apes.

It became a major commercial success.

Ingagi is important because it demonstrates just how far popular entertainment could take the human-gorilla association. What had been a serious nineteenth-century scientific discussion about human and primate anatomy had entered a sensational entertainment culture filled with racial and sexual imagery.

1933 — King Kong

Three years later came the gorilla movie that changed everything.

King Kong was released in 1933.

Kong wasn't simply a realistic gorilla. He was an enormous fantasy ape living on Skull Island.

A filmmaking expedition discovers him, captures him, transports him to New York, and exhibits him publicly as:

"Kong — The Eighth Wonder of the World."

He escapes, takes Ann Darrow, climbs the Empire State Building, and is eventually killed.

The movie became a landmark of American cinema.

But viewed in its historical setting, King Kong also contains themes that had been circulating for decades:

Africa and other non-Western places portrayed as mysterious and primitive.

The boundary between humans and apes.

The "civilized" world confronting the "primitive" world.

A powerful ape fascinated by a white woman.

Western explorers capturing something from another world and bringing it home for exhibition.

Those themes did not originate with Darwin. Nor does their presence prove that King Kong was intended as propaganda for Darwinian evolution.

But they existed within a culture that had spent approximately 70 years publicly debating man's relationship to the apes.

After King Kong

Once King Kong became successful, gorillas became a Hollywood fixture.

Son of Kong — 1933

Released the same year, it immediately capitalized on the success of the original.

Mighty Joe Young — 1949

Another enormous gorilla story, produced by members of the creative team associated with King Kong. This time the gorilla was portrayed much more sympathetically.

Bela Lugosi Meets a Brooklyn Gorilla — 1952

By the 1950s, gorillas had become familiar enough to audiences that they could be used for outright comedy.

The Bride and the Beast — 1958

This bizarre film went much further with the woman-and-gorilla theme, involving reincarnation and a woman's supposed previous existence as a gorilla's mate.

1968 — Planet of the Apes

Then the relationship was reversed.

Planet of the Apes appeared in 1968.

Instead of humans controlling apes, intelligent apes controlled humans.

Gorillas, chimpanzees, and orangutans occupied different positions within an ape civilization while humans had lost their dominant position.

The movie dealt with far more than evolution. It addressed war, nuclear destruction, prejudice, religion, political authority, and the arrogance of civilization.

But once again Hollywood returned to the same extraordinary question:

What separates man from the ape?

1976 — King Kong Returns

Hollywood remade King Kong in 1976, starring Jeff Bridges and Jessica Lange.

The basic formula remained: outsiders encounter Kong, capture him, transport him to New York, put him on display, and discover that controlling him isn't quite as easy as they expected.

1986 — King Kong Lives

A sequel, King Kong Lives, appeared in 1986.

Kong had now become an enduring franchise rather than simply a character from a 1933 movie.

2005 — King Kong Again

Peter Jackson directed another major King Kong remake in 2005.

Modern visual effects allowed Kong to behave much more like an actual gorilla, and the character became considerably more emotionally expressive and sympathetic.

The monster was increasingly becoming the victim.

2011 — Rise of the Planet of the Apes

The modern Planet of the Apes series began with Rise of the Planet of the Apes in 2011.

The films explicitly revolve around genetics, scientific experimentation, intelligence, evolution, disease, and the relationship between humans and other primates.

The gorilla Buck is one of the apes in the first film, while Caesar, the central character, is a chimpanzee.

The franchise continued with Dawn of the Planet of the Apes in 2014, War for the Planet of the Apes in 2017, and Kingdom of the Planet of the Apes in 2024.

2017 — Kong Returns Again

Kong: Skull Island appeared in 2017, followed by the modern MonsterVerse films in which Kong encounters Godzilla and other gigantic creatures.

Nearly ninety years after the original King Kong, Hollywood was still selling tickets with essentially the same extraordinary animal at the center of the story.

The Bigger Story

Put the chronology together:

1852: Gorilla formally receives its modern scientific genus name.

1863: Huxley prominently compares human and ape anatomy.

1871: Darwin publishes The Descent of Man.

Late nineteenth century: Gorillas become prominent in Western science, newspapers, museums, racial imagery, adventure stories, and public discussions about human origins.

1918: Tarzan of the Apes reaches movie audiences.

1927: The Gorilla.

1930: Ingagi sensationalizes supposed relationships between African women and gorillas.

1933: King Kong turns the giant ape into an international cultural icon.

1949: Mighty Joe Young.

1968: Planet of the Apes reverses the human-ape hierarchy.

1976: King Kong remake.

2005: King Kong returns again.

2011 onward: Planet of the Apes returns with genetics and biological experimentation central to the story.

2017 onward: Kong becomes the centerpiece of another generation of blockbuster movies.

There is a fascinating transformation here.

In the mid-nineteenth century, the gorilla was at the center of serious arguments about anatomy and man's place in nature.

Within decades, the gorilla had moved into popular entertainment.

And Hollywood repeatedly returned to the same basic subjects: humans versus apes, civilization versus the supposedly primitive, intelligence, evolution, race, sexuality, science, and the question of what actually makes us human.

It would be too simplistic to say Darwin created the gorilla movie. He didn't.

But the gorilla movie emerged from a culture already intensely preoccupied with the question Darwin and Huxley had helped push into public debate:

What is the relationship between human beings and the great apes?

Hollywood discovered that audiences would keep paying to watch that question played out on the screen for the next hundred years.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:cacab142-3bb2-46a7-bfec-56a22bb2fefa-1" data-turn-id-container= "request-WEB:cacab142-3bb2-46a7-bfec-56a22bb2fefa-1" data-testid= "conversation-turn-4" data-turn="assistant">

Some of his clearest examples in The Descent of Man include:

• Appendix / vermiform appendix — Darwin treated it as a reduced portion of a much larger ancestral caecum, associated with digestion in other animals.
• Wisdom teeth — He argued that human jaws had become smaller and that the posterior molars were tending toward becoming rudimentary.
• Ear muscles — Darwin discussed muscles that allow some people to wiggle their ears, reasoning that they were inherited from ancestors in whom moving the ears was much more useful.
• Coccyx (tailbone) — He regarded the coccyx as the remnant of an ancestral tail.
• Body hair — Darwin regarded humans' sparse body hair as a reduced remnant of the more extensive hairy covering of ancestral mammals.
• Certain eye structures — He discussed the semilunar fold at the inner corner of the human eye as a remnant corresponding to the more developed third eyelid/nictitating membrane found in other animals.
• Male nipples/mammary structures — Darwin discussed these in connection with rudimentary structures and inheritance between the sexes.
• Certain reproductive structures — He discussed several small structures of the reproductive system as rudimentary counterparts of organs that are functional in the opposite sex or other animals.

One thing I'd be careful with is tonsils. Darwin is frequently associated online with claims that tonsils were among his "useless organs," but the historical trail is much weaker than it is for the appendix, coccyx, ear muscles, wisdom teeth, and the eye's semilunar fold.

The Huxleys: From Darwin's Bulldog to Eugenics, UNESCO and Brave New World

The Huxley family is one of the more remarkable intellectual families in modern British history. What makes the family particularly interesting is the continuity of certain subjects across several generations: evolution, human development, science, education, population, heredity and the future direction of society.

The story begins with Thomas Henry Huxley (1825–1895).

Thomas Henry Huxley — "Darwin's Bulldog"

Thomas Henry Huxley was a zoologist, anatomist and one of the most influential scientific figures in Victorian Britain. He became famous for publicly defending Charles Darwin's theory of evolution after the publication of On the Origin of Species in 1859.

He is remembered as "Darwin's Bulldog," although historians have questioned whether that nickname was actually used for him during his lifetime. What is not disputed is his aggressive public defense of evolutionary ideas.

Huxley was more than Darwin's spokesman. He became an enormously influential figure in British science.

He was elected a Fellow of the Royal Society in 1851, served as its secretary from 1872 to 1881, and became President of the Royal Society from 1883 to 1885.

And this is where the story becomes particularly interesting.

1864 — Huxley Creates the X Club

In November 1864, Huxley organized what became known as the X Club.

There were only nine members.

They included:

Thomas Henry Huxley Joseph Dalton Hooker John Tyndall Herbert Spencer John Lubbock George Busk Edward Frankland Thomas Archer Hirst William Spottiswoode

These weren't obscure men having dinner together. They occupied important positions throughout British science.

The club supported scientific naturalism, greater professionalization of science and a diminished role for religious authority in determining scientific questions. It also strongly supported evolutionary science.

The group's influence became substantial. Its members occupied leadership positions in scientific societies, including the Royal Society.

Huxley himself eventually became president.

So Huxley didn't simply argue for Darwin.

He participated in building an institutional network through which the new scientific worldview could gain influence.

That distinction is important.

Then Comes the Next Generation

Thomas Henry Huxley had several children, and his descendants became extraordinarily prominent.

Two of his grandsons are particularly important to this story:

Julian Huxley became an evolutionary biologist, eugenicist and the first Director-General of UNESCO.

Aldous Huxley became the novelist who wrote Brave New World.

Another grandson, Andrew Fielding Huxley, became a distinguished physiologist and later won the Nobel Prize in Physiology or Medicine.

The Royal Society itself describes the remarkable scientific influence that continued through Huxley's descendants.

Julian Huxley — Evolution Becomes a Social Philosophy

Julian Huxley (1887–1975) carried his grandfather's evolutionary interests into the twentieth century.

But Julian went considerably further.

He became a major advocate of what he called "evolutionary humanism."

He was also deeply involved with the British eugenics movement.

This isn't an accusation based on modern interpretations. Historians have extensively documented Julian Huxley's long involvement with eugenics. One scholarly historical analysis describes his postwar "evolutionary humanism" as representing a continuity of his earlier eugenic commitments, although Huxley rejected Nazi racial ideology and racism.

That distinction matters.

Julian Huxley's eugenics should not simply be equated with Nazi racial policy. But neither should his commitment to eugenics be erased from the story.

He believed human beings could deliberately influence humanity's biological future.

1946 — Julian Huxley and UNESCO

Then the family story moves from British scientific institutions onto the international stage.

Julian Huxley became the first Director-General of UNESCO.

In 1946 he wrote an extraordinary document called:

UNESCO: Its Purpose and Its Philosophy.

It is worth reading the original rather than relying on someone else's interpretation.

Huxley argued that UNESCO should operate within what he called a:

"scientific world humanism"

and that this philosophy should be "evolutionary" rather than static.

He argued that evolution provided an intellectual framework for understanding humanity's future and described mankind as having become responsible for directing further evolutionary progress.

This produces a striking historical progression.

Thomas Henry Huxley spent the nineteenth century fighting to establish evolutionary science within British intellectual life.

His grandson Julian Huxley was helping formulate an explicitly evolutionary philosophy for an international institution less than a century later.

That doesn't mean Thomas Henry Huxley somehow planned UNESCO.

It does demonstrate how far evolutionary thinking had traveled institutionally between the two generations.

And Julian Huxley Did Not Abandon Eugenics

This part deserves particular attention.

After the horrors of Nazi racial policy became known, the word eugenics became politically and morally toxic.

Julian Huxley nevertheless continued discussing eugenics.

Historical research shows that he attempted to redefine it as progressive, humanitarian and compatible with modern social policy rather than Nazi racial ideology.

His 1946 UNESCO document itself discussed what he called the "eugenic problem."

He recognized that radical eugenic policies were politically impossible at the time, while arguing that the subject should continue to be examined.

That is an important historical fact because it connects three subjects that are often presented separately:

evolution

eugenics

international social planning

In Julian Huxley's own writings, they were connected.

Aldous Huxley — Brave New World

Then there is Julian's brother:

Aldous Huxley (1894–1963).

In 1932 he published one of the most famous dystopian novels ever written:

Brave New World.

Its society manufactures human beings biologically.

• Embryos are divided into predetermined social classes.
• Reproduction is controlled.
• People are psychologically conditioned.
• Drugs help maintain social stability.
• Sex and entertainment provide distraction.
• And an elite manages the system.
• It is tempting to treat Brave New World simply as Aldous inventing a bizarre futuristic nightmare.

But the historical setting matters.

Aldous was writing during an era in which eugenics was a serious political and scientific movement in Britain — and his own brother Julian was deeply involved in that movement.

Scholarly research specifically places Brave New World within the context of Britain's eugenics movement and notes that Aldous's own nonfiction writings contained complicated and sometimes favorable views concerning eugenics, citizenship and meritocracy.

Aldous later returned explicitly to these subjects in Brave New World Revisited in 1958, discussing population, heredity and what he regarded as deterioration in biological quality.

So Brave New World didn't emerge from an intellectual vacuum.

The Huxley Family Timeline

1825 — Thomas Henry Huxley is born.

1859 — Darwin publishes On the Origin of Species.

1860 — Huxley becomes famous for publicly defending evolutionary theory.

1864 — Huxley organizes the X Club.

1872–1881 — Huxley serves as Secretary of the Royal Society.

1883–1885 — Huxley serves as President of the Royal Society.

1887 — Julian Huxley is born.

1894 — Aldous Huxley is born.

1895 — Thomas Henry Huxley dies.

1932 — Aldous Huxley publishes Brave New World.

1946 — Julian Huxley writes UNESCO: Its Purpose and Its Philosophy.

1946–1948 — Julian Huxley becomes UNESCO's first Director-General.

1958 — Aldous publishes Brave New World Revisited.

The Part That Makes the Huxley Story So Interesting

Look at the progression across the family.

The grandfather, Thomas Henry Huxley, becomes one of the most formidable public advocates of evolutionary science and helps organize an influential network of scientists.

His grandson Julian Huxley becomes one of the twentieth century's leading evolutionary thinkers, promotes eugenics and evolutionary humanism, and becomes the first leader of UNESCO.

Julian's brother Aldous Huxley writes perhaps the world's most famous fictional warning about a scientifically managed society in which reproduction, biological characteristics and human behavior are controlled.

Evolution begins as the great scientific battle of Thomas Henry Huxley's generation.

By Julian Huxley's generation, evolution has expanded into ideas about human biological and social development.

And Aldous Huxley turns many of the implications of scientifically managed humanity into the disturbing world of Brave New World.

That makes the Huxleys much more than a footnote to Darwin.

They provide a remarkable window into how ideas about evolution, heredity, eugenics, scientific authority and the management of human society developed from the Victorian era into the twentieth century.

Critics of Charles Darwin's Theory: How Scientific Opinion Changed Over Time

When Charles Darwin published On the Origin of Species in 1859, his theory was immediately controversial. It challenged the long-held belief that species had been separately created and instead proposed that life changed gradually through natural selection.

His ideas were debated intensely throughout the late nineteenth century. Some scientists embraced them, while others accepted evolution but doubted that natural selection alone could explain it. Religious leaders often opposed Darwin because his theory challenged traditional interpretations of creation.

The Rise of Darwin's Theory

By the early 1900s, Darwin's original theory had lost some influence because scientists still did not understand how traits were inherited. Without a mechanism for heredity, some researchers questioned whether natural selection could account for evolution.

That changed in the 1930s and 1940s with what became known as the Modern Synthesis. Scientists combined Darwin's theory with Gregor Mendel's discoveries in genetics. Later discoveries involving DNA, molecular biology, and genomics strengthened the scientific case for evolution.

As a result, by the second half of the twentieth century, evolution had become the dominant framework taught in biology departments throughout most major universities around the world.

Today, the overwhelming majority of professional biologists, geneticists, paleontologists, and anthropologists accept evolution and common ancestry as the best scientific explanation for the diversity of life. However, they do not teach Darwin's original theory exactly as he proposed it. Instead, they teach a modern version that includes genetics, DNA, mutation, genetic drift, gene flow, developmental biology, and genomics.

Did the Tide Ever Shift?

Yes—but perhaps not in the way many people imagine.

The major shift occurred toward Darwin's central ideas during the twentieth century as genetics and DNA provided evidence that Darwin himself never had.

There has not been a broad shift within mainstream biology away from evolution. Instead, scientists have continually modified and expanded Darwin's original work while retaining natural selection as one of its central mechanisms.

Outside the scientific community, however, debates have continued. Public opinion has remained divided in many countries, particularly where religious beliefs strongly influence views about human origins.

Who Criticizes Darwin Today? Creationists

Creationists believe that human beings were created directly by God rather than evolving from a common ancestor with other apes.

Among the best-known are Ken Ham and Henry M. Morris, who argue that the biblical account of creation is historically accurate.

Intelligent Design

Supporters of Intelligent Design accept that living things can change over time but argue that some biological systems are too complex to have arisen through unguided evolutionary processes alone.

Two of the movement's best-known advocates are Michael Behe and Stephen C. Meyer.

Philosophers

Some philosophers argue that Darwinian evolution does not fully explain consciousness, reason, morality, or the existence of objective truth.

Among the most prominent are Thomas Nagel and David Berlinski, both of whom have questioned whether Darwinian explanations are sufficient for understanding humanity.

Scientists Who Revised Darwin

Ironically, many of Darwin's strongest scientific critics have accepted evolution while arguing that Darwin's original theory was incomplete.

Darwin knew nothing about genes, chromosomes, DNA, or molecular biology because those discoveries came decades after his death. Modern evolutionary biology therefore differs substantially from Darwin's original work while retaining natural selection as a central concept.

The Current Landscape

Most universities and scientific organizations continue to teach modern evolutionary biology as the consensus scientific explanation for the history and diversity of life.

At the same time, a significant number of religious scholars, philosophers, Intelligent Design advocates, and a smaller number of scientists continue to argue that evolution does not answer humanity's deepest questions about origins, purpose, consciousness, and whether life ultimately points to a Creator.

More than 165 years after Darwin published On the Origin of Species, his work remains one of the most influential—and most debated—ideas in the history of science. While mainstream biology has largely accepted and expanded his central ideas, philosophical and religious debates about human origins continue around the world.

Critics of Charles Darwin's Theory: How Scientific Opinion Changed Over Time

When Charles Darwin published On the Origin of Species in 1859, his theory was immediately controversial. It challenged the long-held belief that species had been separately created and instead proposed that life changed gradually through natural selection.

His ideas were debated intensely throughout the late nineteenth century. Some scientists embraced them, while others accepted evolution but doubted that natural selection alone could explain it. Religious leaders often opposed Darwin because his theory challenged traditional interpretations of creation.

The Rise of Darwin's Theory

By the early 1900s, Darwin's original theory had lost some influence because scientists still did not understand how traits were inherited. Without a mechanism for heredity, some researchers questioned whether natural selection could account for evolution.

That changed in the 1930s and 1940s with what became known as the Modern Synthesis. Scientists combined Darwin's theory with Gregor Mendel's discoveries in genetics. Later discoveries involving DNA, molecular biology, and genomics strengthened the scientific case for evolution.

As a result, by the second half of the twentieth century, evolution had become the dominant framework taught in biology departments throughout most major universities around the world.

Today, the overwhelming majority of professional biologists, geneticists, paleontologists, and anthropologists accept evolution and common ancestry as the best scientific explanation for the diversity of life. However, they do not teach Darwin's original theory exactly as he proposed it. Instead, they teach a modern version that includes genetics, DNA, mutation, genetic drift, gene flow, developmental biology, and genomics.

Did the Tide Ever Shift?

Yes—but perhaps not in the way many people imagine.

The major shift occurred toward Darwin's central ideas during the twentieth century as genetics and DNA provided evidence that Darwin himself never had.

There has not been a broad shift within mainstream biology away from evolution. Instead, scientists have continually modified and expanded Darwin's original work while retaining natural selection as one of its central mechanisms.

Outside the scientific community, however, debates have continued. Public opinion has remained divided in many countries, particularly where religious beliefs strongly influence views about human origins.

Who Criticizes Darwin Today? Creationists

Creationists believe that human beings were created directly by God rather than evolving from a common ancestor with other apes.

Among the best-known are Ken Ham and Henry M. Morris, who argue that the biblical account of creation is historically accurate.

Intelligent Design

Supporters of Intelligent Design accept that living things can change over time but argue that some biological systems are too complex to have arisen through unguided evolutionary processes alone.

Two of the movement's best-known advocates are Michael Behe and Stephen C. Meyer.

Philosophers

Some philosophers argue that Darwinian evolution does not fully explain consciousness, reason, morality, or the existence of objective truth.

Among the most prominent are Thomas Nagel and David Berlinski, both of whom have questioned whether Darwinian explanations are sufficient for understanding humanity.

Scientists Who Revised Darwin

Ironically, many of Darwin's strongest scientific critics have accepted evolution while arguing that Darwin's original theory was incomplete.

Darwin knew nothing about genes, chromosomes, DNA, or molecular biology because those discoveries came decades after his death. Modern evolutionary biology therefore differs substantially from Darwin's original work while retaining natural selection as a central concept.

The Current Landscape

Most universities and scientific organizations continue to teach modern evolutionary biology as the consensus scientific explanation for the history and diversity of life.

At the same time, a significant number of religious scholars, philosophers, Intelligent Design advocates, and a smaller number of scientists continue to argue that evolution does not answer humanity's deepest questions about origins, purpose, consciousness, and whether life ultimately points to a Creator.

More than 165 years after Darwin published On the Origin of Species, his work remains one of the most influential—and most debated—ideas in the history of science. While mainstream biology has largely accepted and expanded his central ideas, philosophical and religious debates about human origins continue around the world.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:cacab142-3bb2-46a7-bfec-56a22bb2fefa-1" data-turn-id-container= "request-WEB:cacab142-3bb2-46a7-bfec-56a22bb2fefa-1" data-testid= "conversation-turn-4" data-turn="assistant"> The Rise, Decline, and Revival of Darwin's Theory

Most people assume Charles Darwin's theory was published in 1859 and then steadily gained acceptance. The actual history is more complicated.

1859–Late 1800s: Darwin Changes Science

When Charles Darwin published On the Origin of Species in 1859, his theory of evolution by natural selection immediately became one of the most controversial ideas in science.

Many scientists accepted that species change over time, but not everyone agreed that natural selection was the primary mechanism. Darwin's greatest weakness was that he could not explain how traits were inherited because genes and DNA had not yet been discovered.

As a result, even some scientists who admired Darwin questioned whether natural selection alone could account for evolution.

Around 1900: Darwin Falls Out of Favor

Around the turn of the twentieth century, Darwin's theory entered a period sometimes called the "Eclipse of Darwinism."

Scientists continued to accept that evolution occurred, but many became skeptical that natural selection was the main driving force. Alternative ideas competed for attention, including Lamarckism, orthogenesis (the idea that evolution follows a built-in direction), and mutation-based theories.

One reason for this shift was simple: no one yet understood heredity well enough to explain how favorable traits could persist from one generation to the next.

For several decades, Darwin's mechanism—not evolution itself—was under significant debate within the scientific community.

1900–1940: Genetics Changes Everything

The rediscovery of Gregor Mendel's work on heredity transformed biology.

Scientists gradually realized that genetics could provide the missing mechanism Darwin never had.

Researchers in population genetics showed mathematically that natural selection could work together with genetic inheritance.

The 1930s and 1940s: The Modern Synthesis

During the 1930s and 1940s, biology experienced a major turning point known as the Modern Synthesis.

Scientists combined Darwin's theory of natural selection with Mendelian genetics, creating a more complete explanation of evolution.

This new framework became the foundation of modern biology.

Later discoveries—including DNA, molecular biology, genomics, and evolutionary developmental biology—expanded the theory even further.

Today

Today, most universities teach modern evolutionary theory, not Darwin's original 1859 theory.

Natural selection remains one of its central ideas, but modern biology also includes genetics, mutation, gene flow, genetic drift, genomics, and many other discoveries that Darwin never knew about.

Why This Matters

One of the most interesting facts in the history of science is that Darwin's ideas were not accepted in a straight line.

His theory rose to prominence after 1859.

It then experienced a period of significant scientific skepticism around the early twentieth century.

Only after genetics provided the missing mechanism did natural selection regain widespread acceptance among biologists.

In other words, Darwin's theory itself was tested, questioned, criticized, modified, and strengthened over many decades rather than being accepted without challenge.

• 1859: Darwin publishes his theory.
• Late 1800s: Fierce debate.
• Early 1900s: His mechanism (natural selection) loses support among many scientists during the "Eclipse of Darwinism."
• 1930s–1940s: Genetics revives and strengthens his core ideas through the Modern Synthesis.
• Today: Most universities teach modern evolutionary biology, which retains Darwin's central idea of common ancestry and natural selection but incorporates DNA, genetics, and many later discoveries.

_:empty]:hidden"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:cacab142-3bb2-46a7-bfec-56a22bb2fefa-6" data-turn-id-container= "request-WEB:cacab142-3bb2-46a7-bfec-56a22bb2fefa-6" data-testid= "conversation-turn-14" data-turn="assistant">

Many well-known public figures have rejected the idea that humans arose solely through unguided evolution and instead believe humans were created by God or an intelligent creator. They do not all hold the same view—some advocate young-Earth creationism, some old-Earth creationism, and others Intelligent Design.

Here are some prominent examples:

Creationist (God directly created humans)

• Ken Ham – Founder of Answers in Genesis and the Creation Museum. Argues that God created humans directly as described in Genesis.
• John C. Whitcomb – Co-author of The Genesis Flood, influential in modern young-Earth creationism.
• Henry M. Morris – Often called the father of modern scientific creationism.

Intelligent Design (argues some features of life require an intelligent cause)

• Stephen C. Meyer – Senior fellow at the Discovery Institute and author of Darwin's Doubt and Signature in the Cell.
• Michael Behe – Known for the concept of "irreducible complexity."
• William A. Dembski – Developed arguments about "specified complexity."

Scientists who are Christians and accept evolution

These individuals do not reject evolution, but they believe God is the creator and that evolution is compatible with faith:

• Francis Collins – Former director of the U.S. National Institutes of Health. Accepts evolution while believing God created the universe.
• Kenneth R. Miller – Evolutionary biologist and practicing Catholic who argues that evolution and belief in God can coexist.

Public figures

Some well-known public figures have publicly expressed belief that humans were created by God or have questioned Darwinian evolution, including:

• Mike Pence – Has expressed creationist views rooted in his Christian faith.
• Ben Carson – Has said he believes God created humans and has criticized aspects of evolutionary theory.

It's important to distinguish three positions

1. Evolution without divine guidance – Humans evolved through natural processes alone.
2. Theistic evolution – God created humans through evolutionary processes.
3. Special creation – God created humans directly rather than through common descent.

Many people who say "we come from God" fall into either the second or third category, so it's worth asking which view they actually hold rather than assuming they reject all aspects of evolution.

THE MASONIC THEORY OF THE ORIGINS OF LIFE

The hidden link between Darwin, Marx, Nietzsche & Hitler

Those generally thought to be the founders of the theory of evolution are the French biologist Jean Lamarck and the English biologist Charles Darwin. According to the classic story, Lamarck first proposed the theory of evolution, but he made the mistake of basing it on the "inheritance of acquired traits." Later, Darwin proposed a second theory based on natural selection.

Though, here we must mention the name of another theoretician who played an important role in the origins of the theory of evolution: Erasmus Darwin, Charles Darwin's grandfather.

Erasmus Darwin was a Mason. Though, Erasmus Darwin was no ordinary Mason, he was one of the highest ranking masters in the organization; a 33rd Degree Mason.

He was the master of the famous Canon-gate lodge in Edinburgh, Scotland. Moreover, he had close ties with the Jacobin Masons who were the organizers of the revolution in France at the time, and with the Illuminati, whose prime cause was fostering hostility to religion. That is, Erasmus Darwin was an important name in European Masonic anti-religious organizations.

Erasmus educated his son Robert (Charles Darwin's father), who too had been and made a member of the Masonic lodge. For this reason, Charles Darwin received the inheritance of Masonic teachings from both his father and his grandfather.

Erasmus Darwin hoped to have his son Robert develop and publish his theory, but it would be his grandson Charles who would undertake the enterprise. Although it came some time later, Erasmus Darwin's Temple of Nature was finally revised by Charles Darwin. Darwin's views did not have the weight of a scientific theory; it was merely the expression of a naturalist doctrine that accepts that nature has creative power.

The fundamental philosophy of freemasonry is based on Darwinism. That is because, though having no scientific aspect whatsoever, Darwinism is a fake ideology with a scientific guise propounded solely to make the mainstays of freemasonry (atheism, aimlessness, wars and degeneration) legitimate.

The Mason Magazine [printed in Turkey by the freemasons] explains why they support evolution theory as follows:

Darwin's evolution theory showed that many events in the nature are not the work of God. Freemasons try to impose Darwinism as a scientific theory. Darwinism is used as a tool to pave the way for the atheist Masonic powers to spread their deviant belief system. Therefore masons adopt the propagation of this theory as one of their primary duties.

Mason Magazine refers to this "masonic duty" as below:

The greatest humane and Masonic duty we all own is to hold on to the positive science, to spread this belief among people and educate them with positive science [Darwinism] by adopting the view that this is the best and only way in evolution. An important example which proves the fact that Darwinism is one of the biggest deceptions of freemasonry is a resolution carried out in a mason meeting. The 33rd degree Supreme Council of Mizraim Freemasonry at Paris, reveals in its minutes its promotion of evolution as science, while they themselves scoffed at the theory.

The minutes read as follows:

"It is with this object in view [scientific theory of evolution] that we are constantly by means of our press, arousing a blind confidence in these theories. The intellectuals will puff themselves up with their knowledge and without any logical verification of them will put into effect all the information available from science, which our agentur specialists have cunningly pieced together for the purpose of educating their minds in the direction we want. Do not suppose for a moment that these statements are empty words: think carefully of the successes we arranged for Darwinism…"

Masons openly admit that they will use the scientists and media which are under their control to present this deception as scientific, which even they find funny. When freemasons talk about the successes they arranged for Darwinism, they actually refer to infiltrating a deception into universities, schools, text books, into most of the mass media as a scientific truth, squelching the ones who have anti-Darwinist views, and hindering anti-Darwinist activities by oppression.

By means of Darwinism, it was, of course, not difficult for freemasonry to cause outbreak of hostilities, to commit mass murders, genocide and racism. Freemasonry drifted the world into a horrible disaster by means of various senior freemasons, by making Darwinist ideology a basis to its objectives, and by brainwashing methods. This horrible plot caused more than 350 million lives. They experienced the destruction of two world wars without understanding what was going on.

In The Secret Cult of the Order, Antony Sutton states: 'Both Marx and Hitler have their philosophical roots in Hegel. It is here that one arrives at the Hegelian nexus where Darwin, Marx, and Hitler intersect. Recall that Nietzsche-ism, Darwinism and Marxism were all mentioned together in the Protocols of the Wise Men of Sion. This was no accident. Nazism (a variant of fascism) sprung from Nietzsche-ism. Communism sprung from Marxism. Both were based upon Hegelian principles. Moreover, both were 'scientific dictatorships' legitimized by the 'science' of Darwinism.

The interest of both Hitler and Marx in Darwinian evolution is a matter of history. While he was living in London, Karl Marx attended lectures on evolutionary theory delivered by T.H. Huxley.

Recognizing the odd synchronicity between the communist concept of class war and the Darwinian principle of natural selection, Marx sent Darwin a copy of Das Kapital in 1873. Enamored of evolution, Marx asked Darwin the permission to dedicate his next volume to him…

However, Fascism or Marxism, right wing or left … while the foundation for each of these roads is Darwin's theory of evolution.

In fact, in Evolution and Ethics, Keith candidly stated: 'The German Fuhrer (Hitler) as I have consistently maintained, is an evolutionist; he has consciously sought to make the practice of Germany conform to the theory of evolution' (Keith, Evolution and Ethics, 230)

In both the case of communism and Nazism, the results were enormous bloodbaths. This is the natural consequence of Darwinian thinking and the legacy of the 'scientific dictatorship.'

In applying the ideas of Darwin, both communists and fascists have murdered millions. Both of these groups find their origins in the elite (the Illuminati), who are still pursuing the same objectives today. According to the Darwinian mantra of 'survival of the fittest,' victory will demand bloodshed…

Atheistic freemasonry infiltrated to masses under the appearance of Darwinism and led millions of people to be murdered. This system of Satan himself ruined nations and became the primary perpetrator of massacres against believers. The methods of this system has always been tried to be shown as reasonable and thought to be shown to have a scientific base under the veil of evolution. The fact is however, apart from being bereft of a single scientific proof, every scientific evidence once again demolishes this theory. The fact that Darwinism is a great deception is a certified, proven fact. Source: David J. Stewart #conspiracy

For much of the twentieth century, doctors routinely removed children's tonsils. At its peak, tonsillectomy became one of the most common operations performed on children in the United States and other Western countries.

The reasoning sounded straightforward: tonsils became infected, therefore removing them would prevent future infections.

But there was a problem with that logic.

Tonsils aren't useless pieces of tissue. They are part of the immune system.

The palatine tonsils sit at the back of the throat, where air, food, bacteria, viruses and other material entering through the mouth and nose can encounter immune tissue. Along with the adenoids and other lymphoid tissue, they form part of Waldeyer's ring, a defensive circle positioned around the entrance to the respiratory and digestive tracts.

Tonsils contain large numbers of lymphocytes and specialized structures that help the immune system recognize antigens and mount immune responses. They are especially active during childhood—the very period when tonsillectomies historically were performed most aggressively.

How Did Removing Tonsils Become So Common?

By the early twentieth century, enlarged or chronically infected tonsils were increasingly blamed for an extraordinary range of childhood problems.

The medical profession was also embracing the "focal infection" theory: the idea that localized infections in places such as the tonsils or teeth could poison the rest of the body and cause distant diseases.

That thinking helped produce an era of preventive surgery.

Instead of asking whether a particular child's tonsils were causing serious recurrent disease, physicians increasingly treated the tonsils themselves as potential troublemakers.

By the 1920s and 1930s, tonsillectomy had become extraordinarily common. In some communities, having your tonsils removed became almost a childhood rite of passage.

And once a medical procedure becomes routine, an important psychological shift occurs:

Doctors stop asking why the organ should be removed and begin asking why it should be left in.

That is a very different standard.

The "Vestigial Organ" Problem

This history becomes especially interesting when placed beside the nineteenth- and twentieth-century concept of vestigial organs.

Structures including the tonsils and appendix were frequently described as evolutionary leftovers—organs that had supposedly lost most or all of their original usefulness.

Modern biology presents a much more complicated picture.

The appendix contains substantial lymphoid tissue and participates in immune functions, particularly early in life. Tonsils likewise are organized lymphoid organs involved in immune surveillance.

That doesn't mean tonsils or appendixes should never be removed.

An appendix with acute appendicitis can become life-threatening. Tonsillectomy can be appropriate for carefully selected patients with severe recurrent infections, obstructive sleep apnea, airway obstruction, abscesses, suspected malignancy or other significant problems.

The mistake is something different:

Assuming an organ is expendable simply because medicine does not yet understand what it does.

Medicine Eventually Pulled Back

The enormous enthusiasm for routine tonsillectomy did not last.

As physicians demanded better evidence, the indications became narrower. Today, clinical guidelines generally do not recommend removing tonsils merely because a child has them, because they are somewhat enlarged, or because the child occasionally gets a sore throat.

For recurrent throat infections, physicians generally look for a substantial, documented pattern of illness before recommending surgery. Tonsillectomy is also commonly considered when enlarged tonsils contribute to significant sleep-disordered breathing or obstructive sleep apnea.

In other words, modern medicine has moved a long way from the era of routinely removing tonsils as preventive maintenance.

The Bigger Lesson

The tonsil story isn't really just about tonsils.

It is about what happens when medical certainty outruns medical knowledge.

An organ appears troublesome.

Its purpose isn't completely understood.

A theory says it isn't particularly important.

Removing it becomes fashionable.

Millions of operations later, science discovers that the supposedly disposable tissue actually participates in a sophisticated biological system.

That should raise an obvious question whenever we are told that some part of the human body is useless:

Useless—or have we simply not figured out what it does yet?

The history of the tonsils should make us cautious about confusing those two things.

Tonsillectomy: It Became Big Business

There is another part of the tonsil story that shouldn't be overlooked: removing tonsils became a very large medical business.

For much of the twentieth century, tonsillectomy wasn't some obscure operation. According to the American Academy of Otolaryngology–Head and Neck Surgery, between 1915 and the 1960s, tonsillectomy was the most frequently performed surgical procedure in the United States. Government researchers later reported that tonsillectomy incidence actually peaked in the 1930s and declined substantially only after researchers began seriously questioning its use and indications.

And we're still talking about enormous numbers.

In 2006, approximately 530,000 tonsillectomies were performed on American children younger than 15, accounting for an extraordinary 16 percent of all ambulatory surgery in that age group.

The numbers vary considerably depending upon the year, age range and database being examined. The 2019 tonsillectomy guideline cited 289,000 ambulatory procedures annually among children under 15, down from the earlier 530,000 estimate. But a more comprehensive national study published in 2023, covering patients through age 20 and including inpatient as well as ambulatory surgery, estimated 567,000 pediatric tonsillectomies in 2019—559,900 ambulatory procedures and another 7,100 inpatient procedures.

That is an enormous surgical marketplace.

The money involved isn't trivial either. A study of children's hospitals found self-pay estimates for tonsillectomy with adenoidectomy ranging from $1,200 to $15,360, depending upon the hospital and what the quoted price included. Researchers studying U.S. children's hospitals have explicitly described tonsillectomy as one of the most common and cumulatively expensive surgical procedures in children.

Even complications generate additional medical expenditures. A study involving more than 305,000 privately insured children found that a postoperative hemorrhage requiring surgery or hospitalization produced an average 30-day cost of $7,660.

So this wasn't simply a medical theory about an allegedly expendable piece of anatomy. Once tonsillectomy became routine, an entire economic system existed around it: hospitals, surgeons, anesthesiology, operating rooms, medications, pathology, follow-up care and treatment of complications.

And there is an especially important historical point. A CDC report examining the decline in tonsil and adenoid surgery said physicians had become more stringent about indications that previously had been "ill-defined," and noted evidence suggesting that the operation had been used too often.

That changes the story.

Millions of children weren't undergoing an insignificant little procedure. Doctors were permanently removing lymphatic tissue involved in the immune system. Your source correctly identifies the tonsils as lymphatic tissue and part of the immune system.

And while medicine eventually became much more selective about who should undergo the operation, tonsillectomy had already become one of the most commonly performed—and economically significant—operations in American childhood.

The history therefore raises two separate questions:

Why did medicine become so confident that removing tonsils was a good idea?

And once hundreds of thousands of operations were being performed every year, how much harder did the enormous medical business surrounding tonsillectomy make it to question that assumption?

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:c0a94b7b-6bd8-4d78-8850-41669ff60b6e-3" data-turn-id-container= "request-WEB:c0a94b7b-6bd8-4d78-8850-41669ff60b6e-3" data-testid= "conversation-turn-8" data-turn="assistant"> Year U.S. pediatric tonsil/adenotonsil surgery What the data show 1996 ~315,000 tonsillectomy + adenotonsillectomy Plus ~127,000 adenoidectomy-only procedures 2006 ~565,000 tonsillectomy + adenotonsillectomy Major increase 2006 ~583,000 outpatient tonsillectomies in another national estimate Wide 95% CI: 370,000–796,000 2010 ~339,000 ambulatory tonsillectomies Different national survey/methodology 2019 ~567,000 total pediatric tonsillectomies ~559,900 outpatient + 7,100 inpatient 2020–21 Sharp temporary decline COVID disrupted elective surgery Current literature, 2024–26 ~500,000/year commonly cited Still among America's most common pediatric operations

The 2019 estimate is particularly useful because researchers used national Healthcare Cost and Utilization Project databases and estimated 567,000 pediatric tonsillectomies in that single year.

And remarkably, a medical reference updated in March 2026 still describes tonsillectomy as one of America's most frequently performed operations and states that more than 500,000 are performed annually in children under 15.

The part I think you're picking up on

Look farther back and the trend becomes clearer.

A study comparing 1996 with 2006 found that approximately 441,870 children underwent some form of tonsil/adenoid surgery in 1996. By 2006 it had increased to approximately 695,029.

But here's the kicker: operations for infection were declining.

The increase was being driven largely by adenotonsillectomy, which jumped from about 255,000 to 507,000.

Another long-term study found essentially the same thing. From the early 1970s through 2005, adenotonsillectomy incidence went from 243 to 485 per 100,000 person-years—approximately doubling.

Meanwhile, upper-airway obstruction went from being the reason for surgery in only 12% of patients in 1970 to 77% in 2005.

And researchers subsequently reported that between 1996 and 2006 the pediatric tonsillectomy rate nearly doubled, with an increasing trend toward operations for pediatric obstructive sleep apnea.

So the story isn't:

Doctors realized tonsils were important and quit removing them.

It's closer to:

Doctors became much more restrictive about removing tonsils simply because children suffered repeated infections—but tonsil surgery remained extremely common as the medical rationale shifted toward enlarged tonsils, airway obstruction, sleep-disordered breathing and obstructive sleep apnea.

That distinction is important.

There is even contemporary literature discussing "inappropriate utilization" and substantial geographic, racial and insurance-related differences in who receives tonsillectomies. A recent review continues to put the number at approximately half a million American children annually.

Twenty years after roughly half a million American children were having tonsil surgery annually, we're still talking about roughly half a million procedures a year. What changed dramatically wasn't necessarily the existence of the operation—it was the medical justification for performing it.

And for historical perspective, even today's numbers are well below the extraordinary peak: UCLA's 2026 review reports that tonsillectomy peaked in the late 1950s at more than 1.4 million operations in a single year.

The Tonsils Didn't Change — Medicine Changed the Reason for Removing Them

For more than a century, doctors have removed children's tonsils on a massive scale. What changed over those years wasn't the tonsils themselves. What changed was medicine's reason for taking them out.

Tonsillectomy became one of the most common operations performed on American children. During the first half of the twentieth century, removing tonsils was so widespread that generations of children grew up regarding it almost as a normal part of childhood.

The original justification centered heavily on infection. Tonsils became inflamed and infected, sometimes repeatedly, and doctors reasoned that removing the troublesome tissue would eliminate the source of the problem.

But medicine eventually became much more cautious about that approach.

Today, guidelines generally recommend watching and waiting when recurrent infections don't reach relatively stringent thresholds. A commonly used standard is at least seven documented throat infections during the preceding year, five annually for two consecutive years, or three annually for three consecutive years.

So did tonsillectomy disappear as doctors became more reluctant to remove tonsils for infection?

No.

Instead, another reason for performing the operation became dominant.

From Infection to Obstructed Breathing

One of the clearest demonstrations comes from a long-term study published in Otolaryngology–Head and Neck Surgery examining tonsil and adenotonsil surgery between 1970 and 2005.

In 1970, upper-airway obstruction accounted for only 12 percent of the operations.

By 2005, upper-airway obstruction accounted for 77 percent.

The researchers themselves described the change as a shift in surgical indications "from infection to upper airway obstruction."

And the surgery itself wasn't disappearing.

The incidence of adenotonsillectomy in the population studied increased from 243 operations per 100,000 person-years in 1970–1974 to 485 per 100,000 in 2000–2005.

It had approximately doubled.

That is an extraordinary transformation.

Doctors increasingly stopped saying:

The tonsils keep becoming infected, so they should come out.

Instead, the argument increasingly became:

The tonsils are interfering with breathing and sleep, so they should come out.

Obstructive sleep-disordered breathing and pediatric obstructive sleep apnea subsequently became major indications for removing tonsils and adenoids.

Hundreds of Thousands of Operations Continued

The change in rationale did not turn tonsillectomy into a rare operation.

A national study estimated approximately 567,000 pediatric tonsillectomies in the United States in 2019, including approximately 559,900 ambulatory operations and another 7,100 inpatient procedures.

That is particularly striking when compared with the history.

Medicine had become considerably more conservative about operating simply because a child repeatedly developed throat infections, yet hundreds of thousands of tonsils were still being removed.

The operation survived.

The principal justification changed.

But the Tonsils Turned Out to Have a Job

Meanwhile, understanding of the tonsils themselves changed dramatically.

Tonsils aren't simply useless lumps of tissue sitting at the back of the throat.

They are lymphoid organs and part of the immune system. Their anatomical location puts them directly in contact with material entering through the mouth and nose, where they participate in detecting antigens and mounting immune responses.

This is particularly important during childhood.

Your source describes them as lymphatic tissue positioned where inhaled and swallowed material enters the body, participating in immune surveillance during childhood.

That doesn't mean tonsils can never safely be removed. Nor does it mean a child suffering serious airway obstruction should be denied an operation that could substantially improve breathing and sleep.

It does mean something historically important:

Medicine was removing an organ on an enormous scale before medicine fully understood everything that organ was doing.

What About Darwin?

Charles Darwin needs to be separated from the actual history of tonsil surgery.

Darwin didn't invent tonsillectomy. He didn't develop the operation, and he didn't instruct physicians to remove children's tonsils.

His connection is to the broader evolutionary concept of rudimentary or vestigial structures—body parts interpreted as remnants inherited from ancestors whose original functions had diminished or disappeared.

Darwin discussed rudimentary organs extensively as evidence for common descent.

Later generations produced long lists of supposedly vestigial human structures, and the tonsils were sometimes included among structures described as vestigial or of little importance.

Modern biology has demonstrated that many structures historically described as useless or vestigial have biological functions. The tonsils are an excellent example because their immunological activity is now well established.

That doesn't disprove evolution. A vestigial structure in evolutionary biology can retain secondary functions.

But it certainly undermines the much stronger historical notion that because an organ's purpose wasn't understood, it didn't have one.

And that distinction matters enormously when the proposed treatment is permanently removing it from a child.

The Business Never Became Small

There is also an economic dimension that shouldn't be ignored.

Hundreds of thousands of operations annually represent an enormous amount of medical activity.

Every tonsillectomy can involve a surgeon, anesthesiologist, operating facility, nursing staff, medications, pathology, postoperative care and sometimes treatment of complications.

Tonsillectomy therefore isn't merely a medical theory. It became part of a substantial medical industry.

That doesn't establish that doctors recommend unnecessary surgery for financial reasons. The numbers alone cannot prove motive.

But they do establish that tonsillectomy became an economically significant procedure and remained an extremely common operation even as its principal medical indication changed.

That makes the history worth examining.

The Question That Remains

There are legitimate situations in which removing tonsils can provide substantial benefits. A child whose enlarged tonsils seriously obstruct the airway or contribute to significant obstructive sleep apnea presents a very different medical problem from a child who simply experiences occasional sore throats.

But that doesn't erase the historical pattern.

For generations, enormous numbers of tonsils were removed.

Medicine subsequently learned considerably more about their role in the immune system.

Standards for removing them because of recurrent infections became more restrictive.

Yet tonsillectomy didn't disappear.

A different indication became dominant.

The numbers capture the transformation better than anything else:

1970: Upper-airway obstruction accounted for 12 percent of these operations.

2005: Upper-airway obstruction accounted for 77 percent.

And hundreds of thousands of American children continued undergoing tonsillectomy annually.

That leaves a remarkably simple question:

If medicine once underestimated the importance of the tonsils, how certain should we be before permanently removing them from a child today?

The tonsils didn't change.

Our understanding of them did. And so did the reason medicine gave for taking them out.

Conflicts and confusion between Lamarckism and Darwinism

Figure 1. Portrait of Jean-Baptiste Lamarck (by Charles Thévenin) and cover page of his book "Philosophie zoologique, ou Exposition des considérations relatives à l'histoire naturelle des animaux… " published in 1809 [Source: portrait – Charles Thévenin [Public domain], via Wikimedia Commons. Cover page: CC BY 4.0, via Wikimedia Commons] The first coherent and solidly supported theory on the evolution of life was established in 1800 by Jean-Baptiste Lamarck (1744-1829), a great French naturalist, and published in 1809 in his book Philosophie zoologique (Figure 1).

Fifty years later, in England, The Origin of Species was published in which Charles Darwin (1809-1882) developed his own theory on the transformation of species by "descent with modification" (Figure 2) (see focus Darwin).

Figure 2. Portrait of Charles Darwin (by John Collier, 1883) and cover page of his book "The origin of species by mean of natural selection, on the…", 1859 edition [Source: portrait – John Collier [Public domain], via Wikimedia Commons. Cover page: public domain] The great common point between the theories of these two great naturalists is the affirmation of the evolutionary fact, which goes against creationism, universally accepted until then. But their conceptions of the living world diverge radically on such essential issues as the origin of life and the very mechanisms of evolution. Genetics, born at the very beginning of the 20th century, provided Darwin theory with knowledge that was sorely lacking. In the 1940s, it made it possible to develop the synthetic theory of evolution or neodarwinism. One might have thought that the debate between Lamarkism and Darwinism was over.

This is not the case, these two theories are still the subject of conflicts and confusion. For the general public, evolution – when it is accepted, which is far from always being the case [1] – is generally understood in a Lamarckian way. That is, evolutionary changes occur under the more or less direct influence of the environment. The Darwinian process, which implies that fortuitous genetic variations may be the basis for significant biological transformations (see below), strikes common sense.

Surprisingly enough, these conflicts and confusions are also found among biologists, philosophers and science historians. Conflicts that are often linked to a deep rejection of Darwinism, for non-scientific motivations (seeTheory of Evolution: misunderstandings and resistance). Confusions that are due to misunderstandings or difficulties of interpretation. This is particularly the case with some of Lamarck's writings on the appearance of life, which are ambiguous, if not contradictory [2].

This situation has been accentuated over the past two decades with the importance acquired by the epigenetic imprints of the genome, which is discussed in several articles in this encyclopedia (see Adaptation: Responding to environmental challenges; Epigenetics, the genome and its environment; The adaptation of organisms to their environment). Very briefly, these imprints involve chemical changes in DNA (or the proteins surrounding it), but do not change the sequence of nucleobases (so they are not mutations) and are reversible. They are usually triggered by stressful situations and influence gene expression, often in an adaptive sense. They can be transmitted to offspring for a few generations, referred to as epigenetic memory or transgenerational effect. This type of phenomenon, known for a long time, has been the subject of renewed studies since the beginning of the century (see Epigenetics, the genome and its environment).

This transgenerational effect, although transitory, may recall the heredity of the acquired traits discussed later. A phenomenon that is often, and wrongly, considered to be the main characteristic of Lamarck's theory. This has led biologists to re-launch the debate on a possible update of this one. Some even go so far as to mention the need for a synthesis between the two theories. We will see that the considerable differences between them do not argue in favour of such an idea.

This subject will be treated here from the strict biological point of view, by comparing the basic principles of these theories and the visions of the living world that flow from them, particularly on the origin of life and on the mechanisms of transformation of species. An article by Laurent Loison and Francesca Merlin, which addresses this problem from the perspective of the history and philosophy of science, can also be found in the Encyclopaedia Universalis [3].

2. The origin of living beings and their genealogical relationship

In Lamarck's vision, the "simplest" or "most imperfect" organisms always appear as "spontaneous generation" or "direct generation". He writes in Zoological Philosophy: "In its march, nature began, and continues to do so every day [underlined by the author of this article] by forming the simplest organized bodies and it only forms directly those, that is to say, these first drafts of the organization, which have been designated by the expression of spontaneous generations".

It should be noted in passing that in the light of our current knowledge on the extraordinary complexity of the most elementary living cells and on the origin of life, this idea of permanent spontaneous generation makes people smile. As well as the qualifier "simple" for living organisms (Read the articles The Origin of Life as seen by a geologist who loves astronomy; Once upon a time there was life… and Origin of the first cells: the engineer's point of view).

Lamarck imagines that these primitive organisms gradually become more complex over the course of geological time to reach all existing living beings. A complexity that is synonymous for him with perfection and which would result from an inherent property of the living beings to which we will return later.

Figure 3. Representation of phylogeny of animal species according to Lamarck. On the left, diagram from his book "Philosophie zoologique" (1809) showing the increasing complexity of species. On the right, representation of the evolution of living organisms over time. Appeared by spontaneous generation, organisms become more complex over time. There is no filiation between two distinct lines. [Source: excerpt from the book (Public Domain); Diagram: JC Bregliano] Thus, for Lamarck, spontaneous generations would occur frequently and, each time, the process of complexification would be repeated (although on these two points his writings are somewhat ambiguous). Thus, since the origin of the planet, the simplest organisms would spontaneously appear from the inert matter and would repeatedly initiate series that would evolve in parallel (Figure 3). Within each of these lines, filiation exists, from the simplest to the most complex, but there can be no genealogical relationship between the lines.

Lamarck also postulates that primitive plants and animals appear in two independent ways. It also allowed two separate routes for animals. One is relatively short, starting with what were then called "infusoria" (unicellular microorganisms) and the other is longer, starting with the simplest worms and leading to the vertebrates (Figure 3). In short, in Lamarckian theory, the living world would be composed of multiple successive and independent lines. There would be no single common ancestor.

Darwin, for his part, does not speak of the appearance of life in The Origin of Species, except to say that the knowledge of his time did not allow him to approach it. It is sometimes mentioned in his correspondence, notably in a letter from 1871 to his best friend Joseph Hooker. "It is often said that all the conditions for the first production of a living organism are present, which could ever have been present. But if (and oh! what a big if!) we could conceive in some warm little pond, with all sorts of ammonia and phosphoric salts, light, heat, electricity, etcetera present, that a protein compound was chemically formed, ready to undergo still more complex changes, at the present day such matter would be instantly devoured or absorbed, which would not have been the case before living creatures were formed.".

Figure 4. On the left, a diagram in which Darwin describes the principle of "descent with modification". This is the only scheme that has been published in "The Origin of Species". On the right, a sketch of a phylogenetic tree by Darwin, diagram taken from the 1st notebook (known as the B notebook) on the "Transmutation of Species" (1837-1838). Darwin describes very clearly here his ideas on the appearance and extinction of species. [Source: Public domain] So for Darwin, the appearance of life could only have occurred in a world that was still abiotic, through a very slow process. He refuses the idea of permanent spontaneous generation, which has been universally accepted since Pasteur [4]. As a result, all living beings on the planet are derived from this ancestral form of life (Figure 4). In the conclusion of The Origin of Species he writes:"…all the organic beings which have ever lived on this earth have descended from some one primordial form, into which life was first breathed. ". Figure 5. Schema summarizing the phylogeny of species from a common ancestor called LUCA (Last Universal Common Ancestor) [Source: Public domain]. This vision is fully in line with modern scientific research that is trying to understand the characteristics of this primordial ancestral form, called LUCA for Last Universal Common Ancestor (Figure 5). On this subject, we can consult the videos of the remarkable symposium "The Origins of Life" organized in 2013 by the french Academy of Sciences [5].

We can therefore see that from the outset, on the very origin of life, Lamarck and Darwin's theories are based on two very different visions of the structure of the living world.

There are at least two other important differences between these theories. As they both concern the modalities of evolution, they are very intertwined; but for the sake of clarity we will present them separately.

3. The mechanisms of evolutionary transformations

We are entering into what is really the heart of the two theories. According to Lamarck, the variations of the individuals who are at the root of the transformation of species occur under the effect of external circumstances leading to "needs", themselves at the origin of "actions" or "efforts", which will create "habits". Let us quote him: "The second conclusion is my own: it assumes that, by the influence of circumstances on habits, and then by the influence of habits on the condition of the parts of the animal, and even on that of the organization, each animal can receive in its parts and its organization, changes that can become very significant. ».

In the same Chapter VII of Zoological Philosophy it states a first law: "In any animal which has not gone beyond the end of its development, the more frequent and sustained use of any organ gradually strengthens, develops, enlarges (…) this organ; while the constant defect of such an organ, imperceptibly weakens and deteriorates it, gradually reduces its faculties and eventually makes it disappear".

In plants, Lamarck is led to propose an even more direct influence of the environment on the organism because, of course, we cannot talk about efforts and habits in plants! In his theory, variations are therefore always induced, more or less directly, under the influence of external conditions.

Since the discovery of genetic mutations at the beginning of the 20th century, neolamarckians have had to integrate the idea that these mutations are at the root of variations. They then imagined that they had to be directed by the environment, on specific genes, to adapt the organism to its environment. But this idea is in contradiction with all the experimental research carried out since the 1940s. The most recent and one of the most demonstrative was published in 1997 by an American team [6]. We will come back to this later.

Based on these induced variations, the transformation of species would be driven by a trend towards increasing complexity, at least in animals. This trend would have the role of "driving" in the evolution. But where would this trend come from? It would be an immanent property of living beings that irreversibly pushes them towards ever greater complexity. It is therefore a law of nature that requires no explanation. It should be noted in passing that, in the same logic, Lamarck did not believe in the extinctions of species, except those destroyed by human actions. For him, species are transformed by becoming more complex but do not become extinct.

Lamarck, however, wanted to be very materialistic and often repeats that the living obey only physical laws. It can be admitted that the reference to the "Supreme Author of all things", frequent in his writings, is a matter of political opportunism (Napoleon did not appreciate that the role of God was neglected!). Nevertheless, this push towards complexity, which according to him is the exclusive property of the living world, is a singular reminder of vitalism.

It should be noted that this trend towards complexity, as well as the influence of the environment on changes, both function as an anti-hasard. The share of randomness in the transformation of species is therefore limited in Lamarck. This is what seduces many people in his theory, including biologists and philosophers of science.

Darwin, for his part, strongly contests that external conditions are the cause of the variations. In the introduction to The Origin of Species, he writes: "Naturalists continually refer to external conditions, such as climate, food, etc., as the only possible cause of variation. In one very limited sense, as we shall hereafter see, this may be true; but it is preposterous to attribute to mere external conditions, the structure, for instance, of the woodpecker, with its feet, tail, beak, and tongue, so admirably adapted to catch insects under the bark of trees. ... ». He also refuses the idea of a force pushing for increasing complexity, which he finds "silly".

In Darwinian theory, the main forces at play are "spontaneous and accidental" hereditary variations from which natural selection operates (see Figure 4; see Theory of Evolution: Misunderstandings and Resistance). It is the latter that plays the role of "engine" of evolution, accidental variations are only the basic "material". Darwin writes: "I am convinced that Natural Selection has been the main but not exclusive means of modification".

Figure 6. Diagram summarizing the evolutionary transformation of species according to Lamarck (A) and Darwin (B). In Lamarck (A1 to A3), this transformation occurs under the effect of external circumstances leading to "needs": here, the giraffe's neck will lengthen (arrows) so that it can feed on the high leaves of the trees. For Darwin, "spontaneous and accidental" hereditary variations within a species will increase its diversity (B1) and this is what natural selection is based on: in the example of the giraffe, there are neck size variations in an ancestor of the giraffe and the environment (the height of the branches) will serve as a selection screen; long-necked individuals will reproduce more effectively because they are better fed (B2). Diagram based on Solarist's drawing (Own work) [CC BY 3.0], via Wikimedia Commons. [Source: Photo © Jacques Joyard] The Darwinian evolutionary process therefore does not imply any finality. The combination of accidental variation and selection results in the best adaptation of a population at a given time in a given environment, with a significant proportion of hazards (see Focus The ups and downs of evolution: the role of small numbers). By itself, this process does not imply any tendency towards complexity, let alone perfection. There may be acquisition of new functions but also loss of functions, thus simplification, which is often observed in parasites. Not to mention the extinctions of species, or even entire zoological groups, , not accepted by Lamarck. Darwinian evolutionists readily say that if evolution were to begin again, there is no reason to believe that it would follow the same path. Here again, there is a wide gap between the Lamarckian and Darwinian visions.

4. Transmission of changes to progeny

Let us return to the question already mentioned of the inheritance of acquired characteristics, an expression often associated with Lamarck, but which is in fact much later. This third point is much less different between the two theories than the previous ones, but still important with regard to the knowledge accumulated in genetics.

Under the pen of biologists or science historians, this inheritance of acquired characteristics is sometimes presented as an analogy between Lamarck and Darwin's theories and sometimes as the only major difference between them. It is therefore difficult for non-specialists to find their way around. Let's try to clarify.

First of all, let us recall that in both Lamarck's and Darwin's time, we knew nothing about the mechanisms of heredity [7]. So we had to try to understand why dogs don't make cats…, among other things!

Since, in Lamarckism, variations occur under the influence of the environment, they are not, from the outset, hereditary (today we say: they are not genetic, but only phenotypic). However, for them to play a role in the transformation of species, they must absolutely be heritable, hence Lamarck's second law: "Everything that nature has caused to be lost or acquired through the influence of circumstances in which their race has long been exposed (…) it retains by generation to new individuals from them, provided that the changes acquired are common to both sexes or to those who produced these new individuals".

Thus the characters acquired under the influence of the environment would be transmitted to the progeny. This was not a hypothesis specific to Lamarck, he took up an idea considered in his time, and already since antiquity, as self-evident, but contradicted by the research carried out over the last century.

Darwin does not totally exclude that certain traits acquired under the direct influence of the environment may become heritable. He had even brought to light a very old hypothesis (the pangenesis), dating from Hippocrates (460-370 BC), to explain heredity in general and who could also explain this heredity of the acquired characters. But for him it could only be, at best, a secondary mechanism. Concerning pangenesis, he himself wrote that this hypothesis was very speculative and provisional. He considered that the only significant variations for the transformation of species are those that are heritable, those that are now called "genetic" (see The genome between stability and variability). He wrote, from the first chapter of The Origin of Species: "Any variation which is not inherited is unimportant for us". A phrase that can be used by breeders and agronomists who create new breeds and varieties.

In short, the inheritance of acquired characteristics is absolutely necessary to Lamarck's theory. From Darwinian perspective, it is not an integral part of the theory, although Darwin does not exclude it completely in some cases.

5. The multiple resistances to Darwinism

This brief overview of the essential differences between the two theories shows that they are based on visions of the living world that are difficult to reconcile (see Table). To speak of a new synthesis between Darwinism and Lamarckism based on epigenetic phenomena is therefore irrelevant and can only be a source of confusion. Nevertheless, these phenomena will certainly lead to the enrichment of synthetic theory, as discussed in another article on this site (see The adaptation of organisms to their environment), but it is still too early to say more.

Table. Some major differences between Lamarck's and Darwin's ideas

But here we need to broaden the debate on this propensity to challenge the basic mechanisms of Darwinian theory. It is nothing new, it is a recurrent phenomenon since the publication of The Origin of Species in 1859, relaunched after the development of synthetic theory in the 1940s. As soon as new experimental facts seem to disagree with this theory, journalists, but also scientists, seize the opportunity to question it, even when the authors of these works recognize themselves in the Darwinian current.

Two recent examples are very emblematic of this trend. The first concerns the work of a Japanese researcher, Motoo Kimura, published from 1968 onwards. He published a summary of his work in 1983 in a book entitled The neutral theory of molecular evolution, which was published in 1990 [8]. In short, Kimura emphasizes that many of the DNA mutations revealed by biochemical techniques must be neutral with regards to natural selection. At the time, journalists and biologists (who had obviously not read his texts) used it against neodarwinism on the theme: "all mutations are neutral so natural selection plays no role in evolution". It was the central pillar of Darwinian theory that was targeted.

Kimura issued very strong denials because he never wrote that all mutations were neutral. His work is not at all outside Darwinian theory; a whole chapter of his book is devoted to natural selection. Its conclusions are now widely accepted by evolutionists and population geneticists (see Genetic Polymorphism and Selection).

The second example is more recent and even more edifying. It is based on the 1987 experiments on the colibacillus carried out by a famous American geneticist, John Cairns. He used a strain carrying a defective gene responsible for a nutritional sugar deficiency, a deficiency that prevents bacteria from reproducing but does not kill them. He observes that the rate of reverse mutations (gene that has become functional again) is much higher under deficiency conditions than under normal conditions. It was then legitimate to wonder whether this abnormal rate of reversion would not be due to mutations directed by the medium, targeted precisely on the defective gene to make it functional again. Many laboratories have tackled the problem and a high-level scientific controversy has been ongoing for 10 years.

It was decided in 1997 by the remarkable experiences of Susan M. Rosenberg's team, already mentioned above [6]. This team demonstrated that the rapidity of onset of reverse mutations was due to the induction, by the deficiency situation, of an unusually high mutagenesis rate; but it operated throughout the genome, without any targeting of the defective gene. A result that is in line with neodarwinism. This increase in the mutation rate, triggered by stress conditions, is also discussed in another article on this site, about the "SOS response" (see The genome between stability and variability).

What is particularly significant is that during the first years of the controversy, articles of extreme virulence against neodarwinism, described among other things as "an absurd theory from which we would finally be rid", were published in specialized scientific journals, which were considered serious.

We will note that the attacks provoked by these two types of work go to the very heart of the differences between Darwinism and Lamarckism: natural selection in the first case and the random nature of mutations in the second. It is difficult not to see in it a desire to return to Lamarckism. Some of the reactions to epigenetics may well be in the same vein.

Elements of explanation on this persistent craze for the Lamarckian vision have been mentioned in another article already mentioned (see Theory of Evolution: Misunderstandings and Resistance). On the one hand, Lamarck's role in adaptation through effort is more in line with common sense and social morality, and therefore easier to accept. As for the immanent tendency towards the living to become ever more complex, it may suggest a certain spiritualism (reinforced by Lamarck's frequent reference to "the Supreme Author of all things"), which may reassure those who are unhappy with Darwinian materialism. Feelings rarely go hand in hand with science.

Source: Lamarck and Darwin: two divergent visions of the living world - Encyclopedia of the Environment

Thomas Henry Huxley (1825–1895) was one of the most influential British scientists of the Victorian era. Although he is remembered today as "Darwin's Bulldog," he was far more than simply Charles Darwin's defender. Huxley was a physician, anatomist, paleontologist, educator, and one of the architects of modern science education in Britain. He championed the idea that science should be based on observation and evidence rather than religious or traditional authority.

His younger brother, George Huxley (1827–1914), had a much quieter career. He became a lawyer and was not nearly as prominent. The Huxley family would become famous primarily because of Thomas and later generations. Thomas's descendants included remarkable intellectuals:

• Julian Huxley — first Director-General of UNESCO.
• Aldous Huxley — author of Brave New World.
• Andrew Huxley — won the 1963 Nobel Prize for work on nerve impulses.

The Huxleys became one of Britain's best-known scientific and literary families.

Why was Thomas Huxley called "Darwin's Bulldog"?

The nickname came because Huxley became the most aggressive and effective public defender of Charles Darwin after the publication of On the Origin of Species in 1859.

Ironically, Huxley had not been an early believer in evolution. When Darwin first sent him a copy of the book, Huxley accepted much of the evidence for evolution but remained skeptical about whether natural selection alone explained it.

What made Huxley famous was not blind loyalty—it was his willingness to publicly defend Darwin's right to present the evidence.

He argued that:

• Species change over time.
• Humans and apes share common ancestry.
• Scientific questions should be decided by evidence, not religious authority.
• Biology should be studied as a natural science rather than through theological assumptions.

The Oxford debate

The event most associated with the nickname occurred in 1860 at Oxford.

There, Huxley debated Samuel Wilberforce, an eloquent church leader who criticized Darwin's theory.

According to the most famous version of the story, Wilberforce mockingly asked Huxley whether he claimed descent from an ape through his grandfather or grandmother.

Huxley reportedly replied that he would rather be descended from an ape than from a man who used his intellect to obscure the truth.

Although later accounts embellished parts of the exchange, the debate became symbolic of the broader conflict between emerging scientific ideas and established religious authority.

Why Darwin needed Huxley

One reason Huxley became so important is that Darwin himself disliked public confrontation.

Darwin:

• suffered from chronic illness,
• rarely attended public debates,
• preferred writing letters and books,
• avoided personal disputes whenever possible.

Huxley, by contrast:

• loved public debate,
• was a powerful speaker,
• wrote forceful essays,
• confronted critics directly.

In effect:

• Darwin developed and documented the theory.
• Huxley defended it in lecture halls, newspapers, scientific societies, and public debates.

That complementary relationship is why contemporaries began calling him "Darwin's Bulldog."

Was Huxley simply Darwin's follower?

Not entirely.

Huxley disagreed with Darwin on several scientific questions, including whether natural selection alone could explain all evolutionary change. He also coined the term "agnostic" in 1869 to describe the view that people should not claim certainty about matters for which there is insufficient evidence.

So the nickname reflects his role as Darwin's foremost public advocate, not unquestioning agreement with everything Darwin wrote.

Thomas Henry Huxley (1825–1895) was one of the most influential British scientists of the Victorian era. Although he is remembered today as "Darwin's Bulldog," he was far more than simply Charles Darwin's defender. Huxley was a physician, anatomist, paleontologist, educator, and one of the architects of modern science education in Britain. He championed the idea that science should be based on observation and evidence rather than religious or traditional authority.

His younger brother, George Huxley (1827–1914), had a much quieter career. He became a lawyer and was not nearly as prominent. The Huxley family would become famous primarily because of Thomas and later generations. Thomas's descendants included remarkable intellectuals:

• Julian Huxley — first Director-General of UNESCO.
• Aldous Huxley — author of Brave New World.
• Andrew Huxley — won the 1963 Nobel Prize for work on nerve impulses.

The Huxleys became one of Britain's best-known scientific and literary families.

Why was Thomas Huxley called "Darwin's Bulldog"?

The nickname came because Huxley became the most aggressive and effective public defender of Charles Darwin after the publication of On the Origin of Species in 1859.

Ironically, Huxley had not been an early believer in evolution. When Darwin first sent him a copy of the book, Huxley accepted much of the evidence for evolution but remained skeptical about whether natural selection alone explained it.

What made Huxley famous was not blind loyalty—it was his willingness to publicly defend Darwin's right to present the evidence.

He argued that:

• Species change over time.
• Humans and apes share common ancestry.
• Scientific questions should be decided by evidence, not religious authority.
• Biology should be studied as a natural science rather than through theological assumptions.

The Oxford debate

The event most associated with the nickname occurred in 1860 at Oxford.

There, Huxley debated Samuel Wilberforce, an eloquent church leader who criticized Darwin's theory.

According to the most famous version of the story, Wilberforce mockingly asked Huxley whether he claimed descent from an ape through his grandfather or grandmother.

Huxley reportedly replied that he would rather be descended from an ape than from a man who used his intellect to obscure the truth.

Although later accounts embellished parts of the exchange, the debate became symbolic of the broader conflict between emerging scientific ideas and established religious authority.

Why Darwin needed Huxley

One reason Huxley became so important is that Darwin himself disliked public confrontation.

Darwin:

• suffered from chronic illness,
• rarely attended public debates,
• preferred writing letters and books,
• avoided personal disputes whenever possible.

Huxley, by contrast:

• loved public debate,
• was a powerful speaker,
• wrote forceful essays,
• confronted critics directly.

In effect:

• Darwin developed and documented the theory.
• Huxley defended it in lecture halls, newspapers, scientific societies, and public debates.

That complementary relationship is why contemporaries began calling him "Darwin's Bulldog."

Was Huxley simply Darwin's follower?

Not entirely.

Huxley disagreed with Darwin on several scientific questions, including whether natural selection alone could explain all evolutionary change. He also coined the term "agnostic" in 1869 to describe the view that people should not claim certainty about matters for which there is insufficient evidence.

So the nickname reflects his role as Darwin's foremost public advocate, not unquestioning agreement with everything Darwin wrote.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-12" data-turn-id-container= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-12" data-testid= "conversation-turn-26" data-turn="assistant">

If Darwin provided the theory, Huxley helped build the institutions that shaped how Victorian science was organized and presented to the public. He was not merely a scientist; he became an influential organizer, educator, and public advocate for science.

Thomas Huxley and the Victorian Scientific Establishment

By the 1850s and 1860s, Britain was changing rapidly. Industry was booming, the British Empire was expanding, and science was becoming increasingly professional. Much scientific work, however, was still dominated by wealthy gentlemen, clergy, and learned societies.

Huxley wanted to change that.

He argued that science should be a profession based on training and evidence, not on social class or religious standing. A talented person from a modest background, he believed, should be able to become a scientist through education and merit.

The X Club

Perhaps Huxley's most important source of influence was a small private dining group called the X Club, founded in 1864.

It had only nine members, but several became among the most powerful scientists in Britain.

The group included:

• Thomas Henry Huxley
• Joseph Dalton Hooker
• John Tyndall
• Herbert Spencer
• George Busk
• William Spottiswoode
• Edward Frankland
• Thomas Archer Hirst
• John Lubbock

The "X" has never been definitively explained. Some historians think it simply meant the group had no official purpose. Others believe it symbolized openness or an unknown quantity.

Regardless of the name, its members occupied influential positions across British science.

Their influence

Members of the X Club served as:

• Presidents of the Royal Society
• Editors of major scientific journals
• University professors
• Government advisers
• Museum directors
• Leaders of scientific associations

This meant they had significant influence over:

• research funding,
• scientific appointments,
• publication opportunities,
• education,
• and the public presentation of science.

It is important not to overstate this influence. The X Club did not control all of British science, nor was it a secret government. But historians generally agree it was an unusually well-connected network whose members often supported one another professionally.

The Royal Society

The X Club gradually gained substantial influence within the Royal Society, Britain's premier scientific institution.

Several members eventually became its president.

Huxley himself served as President of the Royal Society from 1883 to 1885.

That position placed him near the center of British scientific life.

Education

Huxley believed science should be taught in every school.

Until then, classical education emphasized:

• Latin,
• Greek,
• theology,
• and ancient history.

Huxley argued that students should instead study:

• biology,
• chemistry,
• geology,
• physics,
• anatomy,
• and laboratory methods.

Many features of modern science education can be traced to reforms championed during his era.

Museums

Huxley also transformed museums.

Instead of displaying specimens as curiosities, he argued they should demonstrate relationships among organisms and illustrate evolutionary ideas.

Museum exhibits became educational tools rather than simply collections.

Public lectures

Huxley was an exceptionally effective lecturer.

Thousands attended his talks.

His writing reached readers far beyond universities.

In many ways, he became one of Britain's first scientific celebrities.

Why this mattered for Darwin

Darwin spent much of his life at his home in Kent, corresponding by letter and publishing books.

Huxley carried many of the public arguments.

While Darwin was cautious and often avoided controversy, Huxley welcomed debate.

Together they formed an effective partnership:

• Darwin produced the evidence and theoretical framework.
• Huxley defended the work publicly.
• Hooker strengthened its botanical foundations.
• Tyndall promoted scientific naturalism through physics.
• The broader network helped integrate evolutionary thinking into universities and scientific institutions.

Critics then—and now

Even during Huxley's lifetime, critics argued that this close-knit network wielded disproportionate influence over British science. Supporters countered that these scientists succeeded because they produced strong research and modernized scientific institutions.

Most historians agree on several points:

• The X Club was a real and influential network.
• Its members held many prominent scientific positions.
• They actively promoted professional science and evolutionary ideas.
• They did not control every aspect of British science, but they were among its most connected and influential figures.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:9643b0d0-47f0-4be7-a829-ee96ab3de703-2" data-turn-id-container= "request-WEB:9643b0d0-47f0-4be7-a829-ee96ab3de703-2" data-testid= "conversation-turn-6" data-turn="assistant"> Darwin's Scientific Circle Charles Darwin (1809–1882)

The naturalist who developed the theory of evolution by natural selection.

His strength was gathering enormous amounts of evidence—from geology, fossils, plants, animals, breeding, and correspondence with scientists around the world.

He was methodical rather than confrontational.

Thomas Henry Huxley (1825–1895)

"The Bulldog."

Huxley became the public defender of Darwin's ideas.

He debated critics, wrote popular essays, influenced education, and helped make science a profession.

Joseph Dalton Hooker (1817–1911)

Joseph Dalton Hooker was one of the world's leading botanists.

He was also one of Darwin's closest personal friends.

When Darwin was hesitant about publishing his theory, Hooker strongly encouraged him.

Hooker later became Director of the Royal Botanic Gardens, Kew, giving him enormous influence over botanical research throughout the British Empire.

Charles Lyell (1797–1875)

Charles Lyell revolutionized geology.

His book Principles of Geology argued that Earth's features were shaped by slow processes acting over immense spans of time.

Without Lyell's concept of "deep time," Darwin's theory would have been much harder to imagine because evolution requires vast periods.

Interestingly, Lyell was initially cautious about Darwin's conclusions but later accepted much of evolutionary theory.

Alfred Russel Wallace (1823–1913)

Alfred Russel Wallace independently conceived the theory of natural selection while working in the Malay Archipelago.

In 1858 he sent Darwin a manuscript outlining his ideas.

Darwin was shocked because Wallace had reached a remarkably similar conclusion.

Rather than creating a bitter rivalry, their work was jointly presented to the Linnean Society in 1858, and Darwin published On the Origin of Species the following year.

Asa Gray (1810–1888)

Asa Gray became Darwin's leading supporter in the United States.

Gray was unusual because he accepted evolution while remaining a committed Christian.

He spent years explaining Darwin's ideas to American audiences.

John Tyndall (1820–1893)

John Tyndall was one of the leading physicists of his generation.

He became famous for promoting scientific naturalism.

His lectures attracted enormous audiences, and he argued that scientific questions should be answered through evidence rather than religious authority.

Herbert Spencer (1820–1903)

Herbert Spencer was not Darwin's scientific collaborator in the same sense, but he popularized evolutionary thinking in philosophy and sociology.

He coined the phrase "survival of the fittest," which Darwin later adopted in later editions of Origin of Species.

Ironically, many people today associate that phrase with Darwin, even though Spencer coined it first.

The Institutions

Notice how many of these men occupied influential positions at the same time.

They were connected through institutions such as:

• Royal Society
• Linnean Society of London
• Royal Botanic Gardens, Kew
• the X Club
• British universities
• scientific journals
• museums

Many knew one another personally, exchanged letters, reviewed each other's work, and served together on committees and councils.

A Network Rather Than a Conspiracy

One reason historians find this period fascinating is that these scientists clearly formed a highly connected professional network. That is not unusual—scientific communities often develop around collaborations, institutions, and shared interests.

Within this network, they influenced:

• scientific publications,
• museum collections,
• educational reforms,
• research priorities,
• public lectures,
• and the acceptance of new scientific ideas.

Their influence came from a combination of scientific achievement, institutional leadership, and professional relationships.

The Next Generation

The story doesn't end with Darwin's immediate circle.

The next generation includes Thomas Huxley's grandson, Julian Huxley.

Julian became one of the twentieth century's most influential evolutionary biologists and was the first Director-General of UNESCO. He was also a leading advocate of what became known as the Modern Synthesis, which united Darwin's theory of natural selection with Mendelian genetics.

This creates an interesting historical arc:

• Charles Darwin develops the theory of evolution.
• Thomas Henry Huxley becomes its principal public defender.
• Julian Huxley helps shape twentieth-century evolutionary biology and international scientific institutions.

If you're tracing ideas across generations, that Huxley family line is one of the most influential intellectual continuities in modern science.

Charles Darwin: The Man Who Called the Appendix a Vestigial Organ

To understand why the appendix was considered "useless" for more than a century, it helps to understand the man whose ideas shaped modern biology.

Early Life

Charles Robert Darwin was born on February 12, 1809, in Shrewsbury, England.

He came from one of Britain's most accomplished intellectual families.

His father, Dr. Robert Waring Darwin, was a wealthy and highly respected physician.

His grandfather, Erasmus Darwin, was already famous as a physician, inventor, natural philosopher, and writer. Long before Charles published On the Origin of Species, Erasmus had speculated that living things might change over time through natural processes.

Charles therefore grew up in a family where science, medicine, and natural history were everyday topics.

Education

Darwin's father wanted him to become a physician.

In 1825, at just 16 years old, Charles entered the University of Edinburgh Medical School.

Medical school did not go well.

Darwin disliked surgery, particularly because operations were performed before anesthesia became available.

He admitted later that watching surgery was deeply upsetting and he gradually lost interest in medicine.

His father then sent him to Christ's College, Cambridge, intending that Charles become an Anglican clergyman.

Ironically, it was there—not in medical school—that Darwin became deeply interested in geology, botany, insects, and natural history.

The Voyage That Changed Everything

In 1831, at age 22, Darwin accepted a position as the unpaid naturalist aboard HMS Beagle.

The voyage lasted nearly five years.

The expedition traveled around South America, the Galápagos Islands, Australia, Africa, and numerous other locations.

During those years Darwin collected:

• plants,
• animals,
• fossils,
• insects,
• rocks,
• and extensive notebooks.

Those observations eventually became the foundation of his theory of evolution by natural selection.

On the Origin of Species

In 1859, Darwin published one of the most influential scientific books ever written:

On the Origin of Species.

The book proposed that species evolve over long periods through natural selection.

It transformed biology.

The Appendix

Darwin discussed the appendix later.

In 1871, in The Descent of Man, he argued that the appendix represented the shrunken remains of a much larger intestinal structure used by human ancestors that ate more leaves and plant material.

As diets changed, Darwin proposed that this structure gradually lost its original purpose.

The appendix therefore became one of his best-known examples of a vestigial organ.

That single interpretation influenced biology and medicine for more than a century.

Medical textbooks repeated it.

Biology textbooks repeated it.

Generations of physicians learned the appendix had little or no biological function.

Only during the last two decades has that assumption been seriously challenged.

Did Charles Darwin Have a Famous Brother?

Yes.

His older brother was Erasmus Alvey Darwin (1804–1881).

However, unlike Charles, he was not famous for major scientific discoveries.

Erasmus studied medicine at Edinburgh but never practiced.

Instead, he became a wealthy gentleman with broad intellectual interests.

He enjoyed chemistry, literature, philosophy, music, and discussion.

He belonged to London's intellectual circles and became friends with notable writers and thinkers, including the novelist Harriet Martineau.

Although Erasmus was intelligent and well connected, he preferred private intellectual life over public scientific work.

The More Famous Relative

Ironically, the more historically important Darwin besides Charles was not his brother—it was his grandfather.

Erasmus Darwin (1731–1802) was:

• a physician,
• inventor,
• botanist,
• poet,
• and one of the founders of the Lunar Society of Birmingham.

Decades before Charles was born, Erasmus Darwin suggested that living organisms might evolve from common ancestors.

His ideas were speculative and lacked a mechanism.

Charles Darwin later supplied that mechanism through natural selection.

An Interesting Historical Point One reason Darwin's appendix theory carried so much influence is that it fit neatly within his broader theory of evolution.

If evolution could produce new structures...

...it could also leave behind structures that had lost their original purpose.

The appendix became one of the classic examples.

That interpretation remained remarkably influential until researchers studying the microbiome, immune system, and comparative anatomy began asking a different question:

If evolution repeatedly preserves or independently evolves the appendix in mammals, is it really a useless leftover—or does it serve a function we simply did not yet understand?

_:empty]:hidden"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-13" data-turn-id-container= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-13" data-testid= "conversation-turn-28" data-turn="assistant"> 1. The Appendix (Probably the Best Example)

Darwin argued the appendix was a vestigial remnant from leaf-eating ancestors that had essentially lost its function.

For over 100 years, this became the standard explanation.

Today, many researchers think the appendix has roles in:

• immune function,
• the gut microbiome,
• and recovery after severe diarrheal disease.

His explanation is now considered incomplete.

2. Tonsils

Darwin also viewed the tonsils as largely vestigial.

Throughout much of the twentieth century, children routinely had their tonsils removed.

Today we know the tonsils are part of the immune system, especially during childhood.

They are no longer removed nearly as routinely as they once were.

3. The Thymus Gland

The thymus wasn't understood in Darwin's day.

For many years afterward, physicians thought it served little purpose because it shrinks with age.

Today we know it is essential for development of T cells and the immune system during childhood.

This wasn't Darwin's mistake specifically, but it illustrates how several organs once considered unimportant turned out to have major functions.

4. The Coccyx (Tailbone)

Darwin considered the coccyx a remnant of our evolutionary tail.

Modern anatomy agrees it reflects our evolutionary history.

However, it is not useless.

Muscles, tendons, and ligaments attach there.

It helps support the pelvic floor.

So while Darwin was likely correct about its ancestry, he underestimated its continuing function.

5. "Junk" Structures

Darwin never used the phrase "junk DNA"—that idea came nearly a century later.

But his general expectation that evolution would leave behind nonfunctional remnants influenced later thinking.

Modern genetics has shown that much DNA once dismissed as useless actually has regulatory functions, although some DNA does appear to have little or no known function.

6. Diet and the Cecum

Darwin believed the appendix shrank because humans shifted away from eating large amounts of leaves.

Modern comparative studies have complicated that picture.

Researchers have found appendices in many mammals with very different diets.

Some herbivores have no appendix.

Some carnivores do.

Some omnivores do.

That weakens the idea that the appendix exists—or disappeared—simply because of diet.

Things Darwin Got Remarkably Right

To be fair historically, many of Darwin's central ideas have held up extraordinarily well.

Natural selection.

Common descent.

Adaptation.

Those remain foundational concepts in biology.

What has changed is that scientists have revised many of the specific examples he used.

One Pattern That Is Interesting

Looking back, there is a recurring theme.

Several structures once labeled "vestigial" later turned out to have important functions.

Examples include:

• the appendix,
• the tonsils,
• the thymus,
• the adenoids,
• and even fat tissue, once viewed largely as inert storage but now recognized as an active endocrine organ.

Medicine has repeatedly discovered that an organ can be nonessential for survival while still performing important biological functions.

That distinction is one of the biggest lessons from the appendix story.

By James Perloff (henrymakow.com)

"We are constantly, by means of our press, arousing a blind confidence in these theories... Do not suppose for a moment that these statements are empty words: think carefully of the successes we arranged for Darwinism." (Protocols 2:2-3)

The Illuminati have long known that if you destroy belief in God, people will cease to fear God and to obey the Ten Commandments. They then become pawns of the Illuminati, willing to serve money instead of principle, and carry out iniquities from sexual misdeeds to even murder.

In the Illuminati propaganda arsenal, the greatest tool for destroying faith in God has been Darwin's theory of evolution. I know some say "I believe in evolution and God." Nonetheless, countless people have become atheists from being taught the theory as "fact" - I was once one of them.

However, Darwinism cannot be challenged on morals alone. The public has been told evolution is "science," on a footing with physics and chemistry. Therefore Darwinism must be challenged on scientific grounds.

As author of two books on Darwin's spurious theory, I know one cannot discredit, in a few paragraphs, an idea which the Illuminati have spent millions to indoctrinate society with. But let's dent it, shall we?

GENETIC CODE DERIVED FROM CHANCE?

Darwin claimed life began eons ago from chance chemical processes. From the first living cell, all life evolved. This might have been plausible in Darwin's day, when cells were considered simple. But no longer. Even a bacterial cell requires thousands of different proteins ­- each composed of hundreds of amino acids in precise order. Francis Crick, who co-discovered DNA's structure, estimated the odds of getting just ONE protein by chance as one in 10 to the power of 260 - a number beyond imagination.

To function, cells require the genetic code, which is far more complex than Windows 8's codes. Would anyone argue the latter could derive from chance?

Further, the primordial cell must have perfected - in the span of one lifetime - the process of cellular reproduction; otherwise there never would have been a second cell. Yet, despite mathematic implausibility, and a dearth of supporting evidence, schoolchildren are still taught that life began from a chance arrangement of chemicals.

According to Darwinism, single cells eventually evolved into invertebrates (creatures without backbones like jellyfish), then successively into fish, amphibians, reptiles, and finally mammals. Darwin said this occurred from creatures adapting to environments.

The discovery of genetics threatened this claim. New organs require new genes. Just moving into new environments doesn't give you new genes.

This initially stumped Darwinists, but they eventually found a solution. Random mutations - copying mistakes in the genetic code - occur very rarely, but DO alter genetic information. So modern evolutionists said animals gained new genes by chance mutations, which made them more fit, and which they adapted to evolve into higher forms.

Dr. Lee Spetner, who taught information theory for years at Johns Hopkins University and the Weizman Institute, discredits this in his book Not by Chance: Shattering the Modern Theory of Evolution. Spetner demonstrates that random mutations destroy genetic information and function - never increase it. Mutations are to the genetic code what typos are to a book. In humans, mutations cause sickle cell anemia, cystic fibrosis, Down's syndrome, and thousands of other diseases. Spetner shows that even the rare "beneficial mutations" evolutionists trumpet - such as bacterial resistance to antibiotics - actually result from functional losses.

If, as evolutionists claim, bacteria evolved successively into invertebrates, then fish, amphibians, reptiles, and mammals, there must have been countless "transitional stages." Think about it. For a fish to become a land creature, turning its fins into legs would require new bones, new muscles, new nerves - and while it was adapting to life on land, a new breathing system. Since this supposedly happened from chance mutations - very rare events - innumerable creatures would have to live and die during the intermediate period.

So where's EVIDENCE for these transitionals? Not in the living world. Among bacteria, invertebrates, fish, amphibians, reptiles and mammals, there are many thousands of species, but no intermediate species between these groups. That's one reason why Carl Linnaeus, father of taxonomy (the science that classifies the living world) was a creationist. Evolutionists try to explain the missing intermediates by saying "they all became extinct" (a convenient euphemism for "we ain't got proof"). A more apt reason for their nonexistence: they never existed.

Evolutionists therefore rely on fossils of extinct creatures as their evidence for these transitional stages. Yet while fossils show variations within types, they do not validate the transitions between major animal groups Darwin's theory requires.

For example, while billions of invertebrate fossils exist, fossils illustrating their alleged evolution from simple ancestors are missing. Furthermore, the study of fossils has a storied history of error. In 1912, the announcement of "Piltdown Man" led the New York Times to exclaim in a headline: "Darwin Theory Proved True." For four decades the British Museum displayed this supposedly 500,000-year old "apeman" - until it was exposed as a hoax: an orangutan jaw and human skull had been planted together, stained to look old, with their teeth filed down.

Genuine fossils can be equally deceiving. Evolutionists called the coelacanth - a fossil fish claimed to be extinct for millions of years - a transitional form between fish and amphibians, its fins said to be "limb-like." Then people started catching live coelacanths, and they were 100 percent fish - no amphibian characteristics. Why are fossils tricky? Because, as molecular biologist Michael Denton notes in Evolution: A Theory in Crisis, 99 percent of an animal's biology resides in its soft anatomy, which is inaccessible through fossils. This disposes them to subjective interpretations.

Which brings us to our closing point. Evolution is not a science like physics or chemistry, which comprise repeatable, testable knowledge. Water boils at 100 degrees centigrade. This can be tested countless times. If I argued that water boils at 75 degrees, you could easily test and disprove my hypothesis.

But take evolutionary claims. Darwin said we lost our body hair because our apelike ancestors preferred mates with less hair. How do you disprove that? How do you disprove that "Lucy" (fossil bones found in Africa) was our ancestor? Laws of physics and chemistry can be tested in present time. Evolution, however, mostly constitutes opinions about the past, and one cannot test the past with the same authority as the present.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-13" data-turn-id-container= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-13" data-testid= "conversation-turn-28" data-turn="assistant"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-14" data-turn-id-container= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-14" data-testid= "conversation-turn-30" data-turn="assistant">

First Comment from Dan:

Perloff's right. Charles Darwin had an agenda. He didn't come up with Darwinism, he was just the messenger.

Darwinism is the cosmology of Freemasonry. See 2001: A Space Odysseyfor the Masonic version of Genesis, in which Cain is the 'good guy' and Abel is the schmuck. Darwin's grandfather had attempted to pass off evolution as a science hypothesis in the 18th century. In his version, all life came from a single microbe. That never got traction, so a generation later, grandson Charles gave took another run at it. Charles was bipolar and lacked charisma, so the orator Thomas Huxley took up the lance of 'Darwinism'. A genius publicist, the press dubbed him "Darwin's Bulldog".

Darwin's famous book was originally titled On the Origin of Species by Means of Natural Selection, or the Preservation of Favoured Races in the Struggle for Life.

The title is very important. He didn't simply propose that species change over time, but that 'fitness' is the only qualification for survival. In one stroke the human race becomes on par with animals. The highest authority in an indifferent Universe is the creature with highest kill ratio. Morality becomes what you can get away with, etc, etc.

Erasmus Darwin was initiated in the famous Time Immemorial Lodge of Cannongate Kilwinning, No. 2, of Scotland, 1758. As 3rd generation (at least) Charles Darwin qualified for the invisible secret society above exoteric Freemasonry. http://freemasonry.bcy.ca/biography/darwin_e/darwin_e.html

Source: Darwinism is an Illuminati Scam - henrymakow.com

The Darwin Family: The Dynasty Behind Charles Darwin

Long before Charles Darwin published On the Origin of Species, the Darwin family was already well known in England.

• They were physicians.
• Lawyers.
• Landowners.
• Scientists.
• Inventors.
• Industrialists.

And through marriage, they became connected to one of the wealthiest manufacturing families in Britain—the Wedgwoods.

Charles Darwin was born into privilege, education, and intellectual influence.

English Roots

The Darwin family did not recently arrive in Britain.

The documented family line reaches back several centuries in England.

The family lived primarily in:

• Lincolnshire
• Nottinghamshire
• Shropshire

By the 1600s and early 1700s, the Darwins were established as members of the English professional class.

Several were lawyers.

Several practiced medicine.

Others owned land.

There is no documented evidence that Charles Darwin's immediate paternal ancestors immigrated from France, Germany, Holland, or elsewhere in Europe shortly before his birth.

Elston Hall

One of the family's early homes was Elston Hall, near Newark in Nottinghamshire.

This became the seat of the Darwin family during the seventeenth and eighteenth centuries.

Charles's grandfather,

Erasmus Darwin,

was born there in 1731.

The family was already prosperous by this point.

The Name "Darwin"

The surname Darwin is English.

Genealogists generally trace it through English records rather than to a recent immigrant family.

Earlier medieval origins become uncertain, as they do for many English surnames.

The documented evidence supports an English family that had become well established long before Charles Darwin was born.

Erasmus Darwin (1731–1802)

Charles's grandfather was arguably the family's first great celebrity.

He was astonishingly accomplished.

He was:

• physician,
• inventor,
• botanist,
• poet,
• philosopher,
• engineer,
• natural historian,
• and founder of the Lunar Society.

He treated patients throughout central England.

King George III even invited him to become Royal Physician.

Erasmus declined the offer and remained in the Midlands.

The Lunar Society

This may be one of the most remarkable intellectual groups in British history.

Its members included:

• James Watt
• Matthew Boulton
• Joseph Priestley
• Josiah Wedgwood
• Erasmus Darwin

These men helped shape the Industrial Revolution.

They discussed:

• steam engines,
• chemistry,
• medicine,
• geology,
• manufacturing,
• agriculture,
• and natural philosophy.

Charles Darwin grew up in a family already connected to this extraordinary intellectual tradition.

Robert Waring Darwin

Charles's father,

Dr. Robert Waring Darwin,

became one of the wealthiest physicians in England.

He practiced medicine in Shrewsbury.

He was known as an excellent clinician and an astute businessman.

His investments made the family even wealthier.

Robert expected Charles to follow him into medicine.

Charles entered Edinburgh Medical School.

He hated surgery.

He eventually abandoned medicine altogether.

The Wedgwoods

Charles's mother was

Susannah Wedgwood.

The Wedgwoods were among Britain's richest industrial families.

Her father,

Josiah Wedgwood,

transformed pottery manufacturing into a global business.

Wedgwood china became famous throughout Europe.

The marriage united two remarkable families:

The Darwins supplied medicine and science.

The Wedgwoods supplied industry, manufacturing, and enormous wealth.

Charles Married Back Into the Family

In 1839,

Charles married

Emma Wedgwood,

his first cousin.

Marriages between first cousins were not unusual among prosperous Victorian families.

They had ten children together.

A Family of Scientists

Charles was not the family's only scientist.

His grandfather,

Erasmus,

was famous before Charles.

His father,

Robert,

was a prominent physician.

Several of Charles's own sons later became distinguished scientists and Fellows of the Royal Society.

Why the Family Matters

Charles Darwin's achievements were his own.

But he also benefited from an unusual environment.

He grew up surrounded by:

• physicians,
• industrialists,
• inventors,
• natural philosophers,
• wealthy patrons,
• and some of Britain's leading scientific minds.

Few people entering science in the nineteenth century had access to that kind of family network.

The Darwin Network (1731–1900) The Family, Friends, Institutions, and Scientific Establishment Behind Charles Darwin

Charles Darwin did not work in isolation.

He stood at the center of one of the most remarkable scientific networks of the nineteenth century.

That network connected:

• medicine,
• geology,
• botany,
• zoology,
• industry,
• universities,
• museums,
• scientific societies,
• publishers,
• and government-supported expeditions.

To understand why Darwin's ideas became so influential, it helps to understand the people around him.

The Darwin Family Erasmus Darwin (1731–1802)

Grandfather

Profession:

Physician

Also:

• inventor
• botanist
• poet
• philosopher
• engineer

Organizations:

• Lunar Society

Importance:

One of Britain's leading Enlightenment intellectuals.

Already speculating about evolution decades before Charles was born.

Robert Waring Darwin (1766–1848)

Father

Profession:

Physician

Known for:

• enormous medical practice
• major personal wealth
• investments

Importance:

Provided Charles with complete financial independence.

Charles never needed ordinary employment.

Susannah Wedgwood Darwin

Mother

Daughter of

Josiah Wedgwood.

This united two extraordinary families.

Erasmus Alvey Darwin

Brother

Studied medicine.

Never became famous scientifically.

Interested in philosophy, chemistry and literature.

Maintained connections with London's intellectual circles.

PART II The Wedgwoods Josiah Wedgwood

Industrialist

Founder of Wedgwood pottery.

Achievements:

• industrial manufacturing
• marketing
• quality control
• global exports

Political interests:

Supported abolition of slavery.

His famous medallion,

"Am I Not a Man and a Brother?"

became one of history's best-known anti-slavery images.

Emma Wedgwood

Charles's wife.

Also his first cousin.

Role:

• editor
• manuscript reader
• household manager
• intellectual sounding board

Charles repeatedly relied upon Emma's judgment.

PART III Cambridge John Stevens Henslow

Professor of Botany.

Perhaps the single most important mentor.

Without Henslow,

Darwin almost certainly never boards HMS Beagle.

Adam Sedgwick

Professor of Geology.

Taught Darwin field geology.

Prepared him for scientific observation during the voyage.

PART IV HMS Beagle

Captain

Robert FitzRoy

One of the most fascinating people in Darwin's life.

Naval officer.

Surveyor.

Meteorologist.

Deeply religious.

Initially supported Darwin.

Later became one of evolution's strongest critics.

Their relationship is fascinating.

PART V Geology Charles Lyell

The greatest geologist of his era.

His book

Principles of Geology

completely changed Darwin's thinking.

Lyell argued:

Small changes,

over immense periods,

produce enormous geological transformations.

Darwin later applied similar thinking to biology.

PART VI Botany Joseph Dalton Hooker

Director

Royal Botanic Gardens, Kew.

Darwin's closest scientific friend.

Thousands of surviving letters.

Hooker became Darwin's most trusted scientific adviser.

PART VII Evolution Alfred Russel Wallace

Naturalist.

Working independently in Southeast Asia.

Developed natural selection without knowing Darwin's unpublished work.

1858:

Their papers presented together.

1859:

Darwin publishes On the Origin of Species.

Wallace remains one of the most remarkable figures in science.

PART VIII Public Defender Thomas Henry Huxley

Known as

"Darwin's Bulldog."

Profession:

Anatomist.

Teacher.

Debater.

When Darwin avoided public confrontation,

Huxley defended evolution.

He became one of the movement's greatest public speakers.

PART IX Scientific Institutions

Cambridge University

↓

Edinburgh Medical School

↓

Royal Society

↓

Geological Society of London

↓

Linnean Society

↓

Royal Botanic Gardens (Kew)

↓

British Museum

↓

Royal Navy

↓

HMS Beagle

↓

Scientific publishers

↓

Victorian newspapers

↓

Universities throughout Europe

PART X The Industrial Revolution

Many of Darwin's family friends helped build modern Britain.

• Steam engines.
• Factories.
• Chemistry.
• Mining.
• Engineering.
• Medicine.
• Natural history.
• Scientific instruments.

Darwin's intellectual world overlapped almost perfectly with Britain's Industrial Revolution.

PART XI Charles's Children George Darwin

Astronomer.

Mathematician.

Royal Society.

Francis Darwin

Botanist.

Edited Charles's papers.

Studied plant physiology.

Horace Darwin

Engineer.

Founded Cambridge Scientific Instrument Company.

Built precision scientific instruments.

PART XII The Legacy

By the time Charles Darwin died in 1882, his network reached:

• universities,
• museums,
• colonial expeditions,
• botanical gardens,
• medical schools,
• publishers,
• governments,
• and scientific societies across Europe and North America.

His ideas spread not simply because of one book, but because they moved through an already well-developed scientific infrastructure.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-17" data-turn-id-container= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-17" data-testid= "conversation-turn-36" data-turn="assistant"> Report: The Wedgwood Family Wealth, Industry, Abolitionism, and Their Influence on British Science

When people hear the name "Wedgwood," they usually think of fine china.

In reality, the Wedgwoods were one of the wealthiest and most influential industrial families in Britain.

By the time Charles Darwin was born in 1809, the Wedgwoods had already become part of the economic engine driving the Industrial Revolution.

Josiah Wedgwood (1730–1795)

The family's rise began with Josiah Wedgwood.

He was not simply a potter.

He transformed pottery into a modern manufacturing business.

Among his innovations were:

• standardized production,
• quality control,
• division of labor,
• scientific experimentation with materials,
• branding,
• and international marketing.

Many historians consider him one of the founders of modern industrial manufacturing.

His factories exported throughout Europe and beyond.

The resulting fortune supported later generations of the family.

Science and Manufacturing

Wedgwood constantly worked with chemists.

• Every glaze,
• every firing temperature,
• every pigment,
• required experimentation.

His factories functioned almost like industrial laboratories.

This brought him into contact with Britain's leading scientific thinkers.

Industry and science became partners.

The Lunar Society

Josiah Wedgwood joined the Lunar Society of Birmingham.

Its members included:

• Erasmus Darwin
• James Watt
• Matthew Boulton
• Joseph Priestley
• William Withering

These were not simply businessmen.

They represented Britain's scientific and industrial elite.

• Medicine.
• Chemistry.
• Steam engines.
• Botany.
• Mining.
• Manufacturing.

Their meetings encouraged collaboration across disciplines.

Abolitionism

One of Wedgwood's most famous contributions was not industrial.

It was political.

He produced the famous medallion:

"Am I Not a Man and a Brother?"

The image showed an enslaved African in chains asking a moral question.

Thousands of copies were distributed.

The design became one of the best-known symbols of the British abolitionist movement.

The Wedgwoods financially supported anti-slavery efforts and reform organizations.

It is important to note, however, that abolitionism was a broad movement with many leaders. The Wedgwoods were influential supporters, not its sole architects.

The Darwin Connection

Charles Darwin's mother,

Susannah Wedgwood,

was Josiah Wedgwood's daughter.

Charles therefore grew up with access to both:

• the Darwin medical tradition,
• and the Wedgwood industrial fortune.

Later,

Charles married his first cousin,

Emma Wedgwood,

strengthening the connection between the two families.

Financial Independence

Perhaps the greatest gift the Wedgwoods gave Charles Darwin was time.

Unlike many scientists,

Charles never depended on a university salary.

He did not have to maintain a medical practice.

He did not have to run a business.

Family wealth allowed him to spend decades studying:

• barnacles,
• pigeons,
• orchids,
• earthworms,
• geology,
• and evolution.

That kind of sustained research would have been impossible for many Victorian scientists.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-17" data-turn-id-container= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-17" data-testid= "conversation-turn-36" data-turn="assistant"> Report: The Wedgwood Family Wealth, Industry, Abolitionism, and Their Influence on British Science

When people hear the name "Wedgwood," they usually think of fine china.

In reality, the Wedgwoods were one of the wealthiest and most influential industrial families in Britain.

By the time Charles Darwin was born in 1809, the Wedgwoods had already become part of the economic engine driving the Industrial Revolution.

Josiah Wedgwood (1730–1795)

The family's rise began with Josiah Wedgwood.

He was not simply a potter.

He transformed pottery into a modern manufacturing business.

Among his innovations were:

• standardized production,
• quality control,
• division of labor,
• scientific experimentation with materials,
• branding,
• and international marketing.

Many historians consider him one of the founders of modern industrial manufacturing.

His factories exported throughout Europe and beyond.

The resulting fortune supported later generations of the family.

Science and Manufacturing

Wedgwood constantly worked with chemists.

Every glaze,

every firing temperature,

every pigment,

required experimentation.

His factories functioned almost like industrial laboratories.

This brought him into contact with Britain's leading scientific thinkers.

Industry and science became partners.

The Lunar Society

Josiah Wedgwood joined the Lunar Society of Birmingham.

Its members included:

• Erasmus Darwin
• James Watt
• Matthew Boulton
• Joseph Priestley
• William Withering

These were not simply businessmen.

They represented Britain's scientific and industrial elite.

Medicine.

Chemistry.

Steam engines.

Botany.

Mining.

Manufacturing.

Their meetings encouraged collaboration across disciplines.

Abolitionism

One of Wedgwood's most famous contributions was not industrial.

It was political.

He produced the famous medallion:

"Am I Not a Man and a Brother?"

The image showed an enslaved African in chains asking a moral question.

Thousands of copies were distributed.

The design became one of the best-known symbols of the British abolitionist movement.

The Wedgwoods financially supported anti-slavery efforts and reform organizations.

It is important to note, however, that abolitionism was a broad movement with many leaders. The Wedgwoods were influential supporters, not its sole architects.

The Darwin Connection

Charles Darwin's mother,

Susannah Wedgwood,

was Josiah Wedgwood's daughter.

Charles therefore grew up with access to both:

• the Darwin medical tradition,
• and the Wedgwood industrial fortune.

Later,

Charles married his first cousin,

Emma Wedgwood,

strengthening the connection between the two families.

Financial Independence

Perhaps the greatest gift the Wedgwoods gave Charles Darwin was time.

Unlike many scientists,

Charles never depended on a university salary.

He did not have to maintain a medical practice.

He did not have to run a business.

Family wealth allowed him to spend decades studying:

• barnacles,
• pigeons,
• orchids,
• earthworms,
• geology,
• and evolution.

That kind of sustained research would have been impossible for many Victorian scientists.

Report: The Royal Society and the Victorian Scientific Establishment

To understand how Darwin's ideas spread, you also have to understand the institutions of nineteenth-century science.

The most important was the Royal Society, founded in 1660.

It was Britain's premier scientific organization.

Election as a Fellow of the Royal Society (FRS) was one of the highest honors a scientist could receive.

Members included figures such as Isaac Newton, Michael Faraday, James Clerk Maxwell, and later Charles Darwin.

What Did the Royal Society Do?

It did not run the government.

It did not dictate scientific truth.

Instead, it served as Britain's leading learned society by:

• publishing research,
• evaluating discoveries,
• recognizing leading scientists,
• creating professional networks,
• sponsoring discussion,
• and helping establish scientific reputations.

Its journal, Philosophical Transactions, is one of the oldest continuously published scientific journals in the world.

The Victorian Scientific Network

The Royal Society was only one part of a larger ecosystem.

Important institutions included:

Royal Society

↓

Linnean Society

(botany and zoology)

↓

Geological Society of London

↓

Royal Botanic Gardens, Kew

↓

British Museum

↓

Cambridge University

↓

Oxford University

↓

University of Edinburgh

↓

Scientific journals

↓

Publishers

↓

Natural history museums

↓

Colonial expeditions

Scientists often belonged to several of these organizations at the same time.

Ideas spread through overlapping memberships, correspondence, meetings, lectures, and publications.

Darwin and the Linnean Society

One pivotal event occurred on July 1, 1858.

Papers by Charles Darwin and Alfred Russel Wallace describing natural selection were read at the Linnean Society of London.

Neither author was present.

The papers were presented by colleagues, including Charles Lyell and Joseph Dalton Hooker.

This illustrates how professional networks functioned.

Trusted colleagues helped introduce important ideas to the broader scientific community.

Letters: The Internet of the Nineteenth Century

One of the most powerful parts of the Victorian scientific establishment was correspondence.

Darwin exchanged thousands of letters with scientists around the world.

Through these letters he received:

• specimens,
• observations,
• criticisms,
• experimental results,
• and suggestions.

Ideas were debated privately for years before appearing in print.

This correspondence network functioned much like an international research collaboration.

Reputation and Influence

The Victorian scientific establishment did not guarantee acceptance of new ideas.

Darwin's theory of evolution was vigorously debated.

Some scientists embraced it quickly.

Others rejected it.

Still others accepted evolution while questioning natural selection.

The institutions provided a forum for debate, but they did not produce unanimous agreement.

Why These Two Stories Matter Together

The Wedgwood family provided Darwin with financial independence.

The Royal Society and the broader Victorian scientific establishment provided the professional network through which his work was evaluated, debated, and disseminated.

One supplied the resources to pursue long-term research.

The other supplied the infrastructure through which scientific ideas circulated.

Together, they help explain why Darwin's work had such an enduring impact—not simply because of the content of his ideas, but because those ideas emerged within a well-developed scientific, educational, and publishing ecosystem.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-4" data-turn-id-container= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-4" data-testid= "conversation-turn-10" data-turn="assistant"> Timeline: How the Appendix Went from "Useless" to Potentially Important

1871 — Charles Darwin publishes The Descent of Man

Darwin proposed that the human appendix was the remnant of a much larger cecum used by our plant-eating ancestors. As humans changed diets, the cecum shrank, leaving behind the appendix as a vestigial structure.

Late 1800s–Early 1900s

Medical schools and biology textbooks largely adopted this explanation.

The appendix became one of the classic examples of a "vestigial organ."

Not everyone agreed. A few anatomists argued that an organ present in every newborn and rich in lymphoid tissue probably served some purpose, but those views remained a minority. Arthur Keith noted in 1925 that some anatomists questioned whether it should be called useless.

1900s

Appendectomy became standard treatment for appendicitis.

This decision wasn't based on the organ being "useless." It was based on a very practical reality:

• appendicitis can rupture,
• rupture causes peritonitis,
• before antibiotics, that often meant death.

So surgeons quite reasonably removed the appendix when it became inflamed.

At the same time, because everyone believed it had little or no important function, there was little concern about losing it.

1950s–1990s

The "vestigial organ" description became deeply embedded in education.

Millions of appendectomies were performed worldwide.

Students—including physicians—were routinely taught the appendix had little biological importance.

Early 2000s

Researchers began taking another look.

Immunologists noted the appendix contains abundant gut-associated lymphoid tissue (GALT)—hard to reconcile with the idea of a useless organ.

Microbiome research also exploded.

2007 — Duke University changes the conversation

Dr. William Parker and colleagues at Duke proposed what became known as the "safe house hypothesis."

Their idea:

After severe diarrhea flushes the colon, the appendix serves as a protected reservoir of beneficial bacteria that can recolonize the intestine.

This was the first widely publicized modern explanation that gave the appendix a plausible biological purpose.

2009

Parker's team published evolutionary evidence suggesting Darwin's explanation was incomplete.

They found the appendix had evolved independently multiple times in mammals, making it much harder to dismiss as a useless leftover. Parker even remarked that "maybe it's time to correct the textbooks."

2010s

Additional studies found:

• people without an appendix appear to have higher recurrence rates of Clostridioides difficile infection,
• the appendix contains important immune tissue,
• it likely participates in shaping the gut microbiome.

None of this proved every proposed function, but the picture had clearly changed.

2020s

The medical consensus today is much more nuanced.

Very few physicians now describe the appendix as simply "useless."

Instead, it is generally recognized as having probable roles in:

• immune function,
• maintenance of the gut microbiome,
• recovery after some intestinal infections.

At the same time, appendectomy remains the standard treatment for many cases of acute appendicitis because an untreated perforated appendix can still be life-threatening.

Are surgeries still continuing?

Absolutely.

The change in thinking has not stopped appendectomies.

The reason is straightforward:

If someone develops acute appendicitis with a risk of rupture, the immediate danger outweighs the potential long-term benefits of preserving the appendix.

What has changed is management of uncomplicated appendicitis. Some hospitals now treat selected patients with antibiotics first rather than immediate surgery, although appendectomy remains very common.

Is this common knowledge?

Among surgeons and gastroenterologists, awareness has increased over the past 15–20 years.

Among the general public, probably not.

Many people still believe exactly what was taught for decades:

"The appendix is useless."

That idea has proven remarkably durable because it was repeated in biology classes, medical education, and popular science for generations. The science has become more nuanced, but public understanding often lags behind.

_:empty]:hidden"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-5" data-turn-id-container= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-5" data-testid= "conversation-turn-12" data-turn="assistant"> The Appendix: Why This Tiny Organ May Be More Important Than We Thought

For more than a century, millions of people were taught that the appendix was little more than an evolutionary leftover—a useless organ that could be removed without consequence. That belief became so common that the appendix was often used as the textbook example of a vestigial organ.

Modern research has challenged that assumption.

Scientists now believe the appendix is not simply a useless remnant, but rather a specialized part of the digestive and immune systems. While a person can certainly live without it, evidence suggests that losing the appendix may mean giving up several biological functions that evolved for a reason.

A Safe House for Beneficial Gut Bacteria

One of the most influential discoveries came from researchers at Duke University in 2007.

They proposed that the appendix serves as a protected reservoir—a "safe house"—for beneficial bacteria that normally live throughout the large intestine.

This idea is surprisingly logical when considering the anatomy.

The appendix is a narrow, finger-like pouch branching off the beginning of the large intestine. Because it is tucked away from the main flow of intestinal contents, bacteria living inside it are less likely to be washed away during severe diarrheal illness.

Historically, humans frequently suffered from diseases such as cholera, dysentery, and other infections that could empty the intestines repeatedly over several days.

If much of the normal gut microbiome was flushed away, the bacteria protected inside the appendix could potentially help repopulate the colon after recovery.

Rather than being useless, the appendix may function as a biological backup system.

An Organ That Trains the Immune System

The appendix is also rich in gut-associated lymphoid tissue (GALT), a specialized part of the immune system.

This tissue contains large numbers of immune cells, including B cells and T cells.

During childhood especially, these tissues appear to help the immune system learn an essential lesson:

Which microbes are harmless and should be tolerated...

...and which organisms are dangerous pathogens that require an immune response.

In other words, the appendix may function as part of the body's educational system for immunity.

Rather than simply fighting infection, it may help teach the immune system how to respond appropriately throughout life.

A Partner in Maintaining the Microbiome

The human digestive tract contains trillions of bacteria, fungi, viruses, and other microorganisms collectively known as the gut microbiome.

These organisms assist with digestion, produce vitamins, influence metabolism, communicate with the immune system, and help prevent disease-causing organisms from taking over.

The appendix appears closely integrated into this ecosystem.

If beneficial bacteria survive inside the appendix during illness, they may later recolonize the intestine, helping restore a healthier microbial balance.

Scientists continue to investigate exactly how important this role may be.

Evolution Suggests It Exists for a Reason

Perhaps one of the strongest arguments against the appendix being useless comes from evolutionary biology.

Researchers studying hundreds of mammalian species found that appendices appear to have evolved independently multiple times rather than being inherited from a single common ancestor.

In evolutionary biology, structures that repeatedly evolve are generally doing something useful.

Evolution rarely spends energy building the same organ over and over if it provides no advantage.

This finding challenged the long-standing assumption that the appendix was merely an evolutionary leftover.

So Why Can We Live Without It?

Humans can survive without the appendix.

That fact is true.

But surviving without an organ is not the same thing as that organ serving no purpose.

People also survive after removal of the gallbladder, one kidney, portions of the liver, the spleen, and other organs.

Medicine often removes an organ because the immediate danger outweighs the long-term benefits of preserving it.

The appendix appears to fall into that category.

The Downside of Losing the Appendix

For many people, life after an appendectomy is completely normal.

However, researchers have begun asking whether the absence of the appendix has subtle long-term effects that medicine simply did not recognize for decades.

Loss of a Bacterial Reservoir

If the appendix truly serves as a refuge for beneficial bacteria, removing it eliminates that reserve.

Most healthy people rebuild their microbiome successfully after illness.

However, some studies suggest that people without an appendix experience higher rates of recurrent Clostridioides difficile infection, one of the most serious bacterial infections affecting the colon.

Researchers believe the absence of the appendix may make it more difficult to restore a normal microbial community after severe disruption.

Reduced Immune Tissue

Removing the appendix also removes an organ rich in lymphoid tissue.

Although many other lymphoid tissues remain throughout the body, the appendix is part of the extensive immune network lining the digestive tract.

Scientists continue studying whether losing this tissue has measurable effects over a lifetime.

Questions That Remain

Researchers are still investigating several important questions.

• Does removal of the appendix influence recovery from severe diarrheal diseases?
• Does it permanently alter the gut microbiome?
• Does it affect autoimmune diseases?
• Does it influence inflammatory bowel disease?
• Could it alter susceptibility to future intestinal infections?

Many of these questions remain open.

Why Surgery Continues

Despite this growing understanding, appendectomy remains one of the most common emergency operations in the world.

The reason is simple.

Acute appendicitis can rapidly progress to rupture.

A ruptured appendix can spill bacteria throughout the abdominal cavity, leading to life-threatening peritonitis and sepsis.

In those situations, removing the appendix saves lives.

The modern discussion is therefore not whether surgeons have been "wrong" to remove infected appendices.

Rather, it is that medicine now recognizes the appendix may perform important biological functions that were largely unappreciated for more than a century.

That realization has changed the scientific conversation from "the appendix is useless" to "the appendix has functions, but those functions must sometimes be sacrificed to treat a dangerous disease."

_:empty]:hidden"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-6" data-turn-id-container= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-6" data-testid= "conversation-turn-14" data-turn="assistant"> Report: Does Every Inflamed Appendix Need to Be Removed? Part 1 — What Actually Is Appendicitis?

Appendicitis simply means inflammation of the appendix.

It does not automatically mean the appendix has burst.

Doctors generally think of appendicitis as progressing through stages.

Stage 1: Early inflammation

The appendix becomes swollen.

Blood flow begins to decrease.

Pain usually starts around the belly button before moving to the lower right abdomen.

At this stage, the appendix is still intact.

Stage 2: Increasing infection

Pressure builds inside the appendix.

Bacteria multiply.

The wall becomes weaker.

Pain generally becomes more severe.

Stage 3: Gangrenous appendix

Blood supply becomes critically reduced.

Parts of the appendix begin to die.

Now the risk of rupture increases substantially.

Stage 4: Perforation (rupture)

A hole develops in the wall.

Bacteria, intestinal contents, and inflammatory material leak into the abdominal cavity.

This is the stage physicians worry about most.

How Do Doctors Know It Has Ruptured?

No single test proves rupture.

Doctors combine several pieces of evidence.

CT scan

Today this is the best imaging test.

Radiologists look for:

• a hole in the appendix wall
• air outside the appendix
• fluid collections
• abscesses
• inflammation spreading through surrounding tissues

CT can often identify perforation quite accurately.

Ultrasound

Often used first in children and pregnancy.

It can show:

• enlarged appendix
• fluid around it
• possible abscess

It is less accurate than CT for rupture.

MRI

Mostly used during pregnancy.

It provides excellent images without radiation.

Surgery

Sometimes surgeons do not know with certainty until they actually look inside.

Does Every Rupture Cause Life-Threatening Infection?

Interestingly...

No.

This surprised many surgeons years ago.

Sometimes the body walls off the rupture.

Nearby tissues—especially the omentum ("the policeman of the abdomen")—can surround the leaking appendix.

Instead of widespread infection, a localized abscess forms.

These patients often receive:

• IV antibiotics
• drainage of the abscess
• surgery weeks later—or sometimes no surgery at all if recovery is complete.

So rupture is not always an immediate catastrophe, although it can certainly become one.

Can the Appendix Be Repaired?

This is one of the most interesting questions.

The answer is...

Almost never.

Unlike repairing a blood vessel or sewing up part of the intestine, surgeons generally do not repair the appendix itself.

They remove it.

Why?

Several reasons.

Its blood supply is relatively small.

Its narrow tube is difficult to reconstruct.

The infected tissue is often fragile.

Repairing it could leave infected tissue behind.

The traditional surgical philosophy became:

"If the appendix is diseased, remove it."

Has Anyone Tried Saving It?

Yes.

This has become one of the hottest topics in emergency surgery.

Over roughly the past 20 years, researchers have asked:

Can uncomplicated appendicitis be treated with antibiotics alone?

Several large clinical trials have shown that many patients with uncomplicated appendicitis recover without immediate surgery.

However:

• some later need surgery,
• some have recurrent appendicitis,
• and complicated cases (especially with generalized peritonitis) usually still require an operation.

So the debate has shifted from:

"Every appendix must come out."

to

"Which patients actually need surgery?"

A Historical Question Worth Exploring

If physicians believed for over 100 years that the appendix was biologically useless, did that belief lower the threshold for removing it?

That's a historical question rather than a medical one.

It would involve examining:

• surgical textbooks from different eras,
• pathology reports,
• the percentage of removed appendices that turned out to be normal ("negative appendectomy"),
• when CT scanning reduced unnecessary surgeries,
• and how the discovery of possible appendix functions has influenced surgical decision-making.

That history would show whether the idea of a "useless organ" affected medical practice beyond the immediate need to treat appendicitis. It's a well-defined question that can be investigated through published surgical literature and historical records.

_:empty]:hidden"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-7" data-turn-id-container= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-7" data-testid= "conversation-turn-16" data-turn="assistant"> Report: Did the Belief That the Appendix Was "Useless" Shape Modern Surgery? The Question

For more than 100 years, physicians were taught that the appendix was a vestigial organ—a leftover from evolution with little or no biological purpose.

Today, researchers increasingly recognize that the appendix appears to participate in maintaining the gut microbiome and contributes to immune function.

This raises an important historical question.

Did the belief that the appendix was biologically unimportant influence how readily surgeons removed it?

This is not an accusation.

It is a question about how scientific assumptions influence medical practice.

Before Antibiotics

In the late 1800s and early 1900s, appendicitis was a terrifying disease.

Once an appendix ruptured, bacteria spilled into the abdominal cavity.

Before antibiotics existed, many patients developed overwhelming infection.

Death rates from perforated appendicitis were extremely high.

Surgeons therefore adopted a philosophy:

"When in doubt, operate early."

Given the medical knowledge available at the time, this approach undoubtedly saved many lives.

The Additional Assumption

At the same time another belief became deeply established.

The appendix was considered unnecessary.

Medical students learned it was a vestigial organ.

Biology textbooks repeated the idea.

Popular science repeated the idea.

By the middle of the twentieth century, few questioned it.

This meant surgeons were operating under two assumptions simultaneously.

First:

A ruptured appendix can kill.

Second:

Removing the appendix carries essentially no biological cost.

Those two ideas naturally reinforced one another.

Negative Appendectomies

One of the most revealing statistics is something called the negative appendectomy rate.

This refers to surgery in which doctors remove the appendix...

...only to discover afterward that it was actually normal.

Historically, these rates were surprisingly high.

For much of the twentieth century,

10–20% of appendectomies—and sometimes even higher in women of childbearing age—removed an appendix that was not inflamed.

Why?

Because surgeons preferred removing a normal appendix rather than risking a missed rupture.

Again, this decision made sense in an era without CT scanning.

But it also meant millions of healthy appendices were removed.

Imaging Changed Everything

Beginning in the 1980s and especially the 1990s,

CT scanning dramatically improved diagnosis.

Instead of relying almost entirely on symptoms and physical examination,

physicians could actually visualize the appendix.

Negative appendectomy rates dropped sharply.

In many hospitals today,

they are under 5%.

This represents one of the major successes of modern diagnostic imaging.

Then the Science Changed

Ironically,

just as unnecessary surgeries became less common,

scientists also began questioning whether the appendix was actually useless.

Researchers discovered that it contains:

• abundant lymphoid tissue,
• important immune cells,
• dense bacterial biofilms,
• and appears capable of serving as a reservoir for beneficial gut bacteria.

Evolutionary studies further suggested the appendix evolved independently multiple times in mammals.

These discoveries fundamentally changed the scientific discussion.

A New Question Emerges

If the appendix serves useful biological functions,

then preserving it—when medically safe—becomes a more attractive goal.

That is exactly what has happened.

Instead of asking:

"Should we remove it?"

Many physicians now ask:

"Can this patient safely keep it?"

Antibiotics Instead of Surgery

Several major clinical trials have shown that uncomplicated appendicitis can often be treated successfully with antibiotics alone.

Not every patient qualifies.

Some eventually require surgery.

Others experience recurrence.

But the discussion itself represents a profound shift.

Fifty years ago,

the idea of treating appendicitis without removing the appendix would have been considered radical.

Today it is an accepted area of clinical research.

Repair Versus Removal

Interestingly,

surgeons almost never repair the appendix.

Unlike many other organs,

an inflamed appendix is generally removed rather than reconstructed.

This reflects both surgical practicality and decades of tradition.

Whether future techniques might preserve more appendices remains an open question.

The Historical Lesson

Perhaps the most important lesson is broader than the appendix itself.

Medical history repeatedly shows that scientific assumptions influence treatment.

For over a century,

the dominant assumption was that the appendix had no meaningful biological function.

That belief did not create appendicitis.

Nor did it make surgery unnecessary.

But it almost certainly reduced concern about the long-term consequences of removing the organ.

Today,

the conversation has changed.

Researchers are no longer asking whether people can survive without an appendix.

They already know they can.

Instead, they are asking a more subtle question:

What biological advantages are lost when the appendix is removed, and when is preserving it the better option?

That is a very different scientific question than the one medicine was asking a generation ago.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-8" data-turn-id-container= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-8" data-testid= "conversation-turn-18" data-turn="assistant"> From "Cut It Out" to "Can We Save It?" The Evolution of Appendicitis Treatment

For much of the twentieth century, appendicitis followed a remarkably simple rule.

If doctors believed the appendix was inflamed...

...they removed it.

Few questioned the decision.

There were good reasons.

A ruptured appendix could become fatal, particularly before antibiotics were available.

And physicians believed the appendix itself served little or no biological purpose.

Those two beliefs created one of the strongest surgical traditions in modern medicine.

When in doubt...

Take it out.

The Era of Immediate Surgery

Beginning in the late 1800s, surgeons became increasingly aggressive about appendicitis.

By the early twentieth century, operating early had become the accepted standard throughout Europe and North America.

The reasoning was understandable.

Every hour that passed increased the possibility that the appendix could perforate.

Once bacteria escaped into the abdominal cavity, patients could develop generalized peritonitis.

Before antibiotics, mortality from perforated appendicitis was frighteningly high.

Removing the appendix became one of surgery's greatest successes.

An Organ Nobody Thought About

At the same time, something else happened.

Because nearly every medical textbook described the appendix as vestigial,

very few physicians stopped to ask what might be lost by removing it.

The operation was viewed almost entirely in terms of preventing catastrophe.

Little discussion centered on preserving the organ itself.

Better Diagnosis Changed Surgery

The first major change did not come from discovering the appendix had a purpose.

It came from technology.

Ultrasound.

CT scanning.

MRI.

Doctors could finally look inside the abdomen instead of relying entirely on symptoms and physical examination.

That meant fewer unnecessary operations.

Instead of removing many healthy appendices simply to be safe,

physicians became much better at identifying patients who truly needed surgery.

Negative appendectomy rates fell dramatically.

Then Came the Microbiome Revolution

During the early 2000s,

scientists began viewing the digestive tract differently.

Instead of seeing bacteria merely as organisms that caused disease,

researchers increasingly understood that trillions of bacteria are essential partners in human health.

The gut microbiome became one of the fastest-growing areas of biomedical research.

Suddenly,

the appendix no longer looked like an empty tube.

It looked like an organ positioned exactly where a protected bacterial reservoir might exist.

That changed the questions researchers were asking.

The Duke University Hypothesis

In 2007,

researchers at Duke University proposed that the appendix functions as a protected reservoir for beneficial bacteria.

Instead of serving no purpose,

it may help restore the microbiome after severe diarrheal illnesses such as cholera or dysentery.

The idea immediately attracted attention because it explained something anatomy had never satisfactorily explained before.

Why would evolution preserve this small pouch if it truly did nothing?

Evolution Joins the Conversation

The next surprise came from evolutionary biology.

Researchers studying hundreds of mammalian species discovered that appendices appear to have evolved independently dozens of times.

Evolution usually does not repeatedly invent the same structure without some biological advantage.

That finding made it increasingly difficult to describe the appendix as simply a useless leftover from evolution.

Antibiotics Enter the Picture

As confidence in imaging improved,

physicians began asking another question.

If the appendix has not ruptured,

does every patient need surgery?

Several large clinical trials showed that many patients with uncomplicated appendicitis recovered with antibiotics alone.

Not everyone.

Some later required surgery.

Some experienced recurrence.

But the conversation had changed.

Instead of assuming removal was the only option,

physicians were beginning to ask whether preservation might sometimes be the better choice.

The Modern View

Today's surgeons still perform hundreds of thousands of appendectomies every year.

A ruptured appendix remains a potentially life-threatening emergency.

No responsible surgeon ignores that danger.

But the scientific understanding of the appendix itself has changed dramatically.

The question is no longer,

"Does the appendix have a purpose?"

Increasingly, the question is,

"What is the best way to preserve its function whenever it is medically safe to do so?"

A Broader Lesson

The history of the appendix illustrates something much larger than one organ.

Medical science is continually revised as new evidence emerges.

For more than a century, the appendix was held up as one of the classic examples of a useless organ.

Today, that certainty has largely disappeared.

The appendix reminds us that survival without an organ is not the same as proving the organ has no function. Sometimes medicine first learns how to save lives, and only later discovers what was being sacrificed in the process.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-9" data-turn-id-container= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-9" data-testid= "conversation-turn-20" data-turn="assistant"> Report: Could the Western Diet Be Contributing to Appendicitis?

For generations, physicians viewed appendicitis primarily as an unpredictable surgical emergency.

Today, researchers are asking a different question.

Could modern diets themselves be increasing the risk?

This idea has gained attention because it fits with what scientists have learned about the appendix, the microbiome, and intestinal health.

The Appendix Is a Dead-End Pouch

The appendix is a small, finger-like tube attached to the beginning of the large intestine.

Unlike the intestine itself, it has only one opening.

Material can enter...

...but it has no easy way to exit.

That makes the appendix vulnerable to blockage.

One of the most common suspected causes of blockage is a fecalith.

What Is a Fecalith?

A fecalith is a small, hardened mass of stool.

Think of it as a tiny stone formed from compacted fecal material.

If a fecalith becomes lodged at the opening of the appendix, several things can happen.

The appendix continues producing mucus.

Pressure builds inside the organ.

Blood flow begins to decrease.

Bacteria multiply.

Inflammation develops.

If untreated, the wall may weaken and eventually perforate.

This sequence has long been recognized as one pathway leading to appendicitis.

Where Diet Enters the Story

Researchers have proposed that modern Western diets may make fecalith formation more likely.

The reason centers on fiber.

Dietary fiber adds bulk to stool and helps it retain water.

Stools tend to remain softer and move through the intestine more efficiently.

When fiber intake is low, stool is generally firmer and moves more slowly through the colon.

That increases the opportunity for small hardened masses to form.

Scientists have suggested that these hardened deposits are more likely to obstruct the appendix.

The Evolutionary Mismatch

This idea fits into a broader concept called evolutionary mismatch.

For most of human history, people consumed diets rich in natural plant fiber.

Modern industrialized diets are often very different.

Many processed foods contain relatively little fiber.

If the appendix evolved under conditions of high-fiber diets, today's eating patterns may expose it to conditions it rarely encountered during human evolution.

In other words, the problem may not be the appendix itself.

The problem may be the environment in which it now functions.

Looking Around the World

Researchers have observed that appendicitis tends to be more common in industrialized countries than in populations consuming traditional high-fiber diets.

This observation helped generate the dietary hypothesis.

However, the picture is more complicated than fiber alone.

Countries differ in:

• sanitation,
• medical access,
• diagnostic imaging,
• antibiotic use,
• genetics,
• obesity,
• and many other lifestyle factors.

For that reason, scientists cannot conclude that fiber alone explains international differences.

What Does the Evidence Show?

Several lines of evidence support the idea that fiber plays a role.

Higher-fiber diets are associated in many studies with lower rates of appendicitis.

Lower-fiber diets appear associated with greater risk.

The biological mechanism is plausible because harder stools are more likely to form fecaliths.

However, not every patient with appendicitis has a fecalith.

And not everyone eating a low-fiber diet develops appendicitis.

Researchers therefore view diet as one important contributor, not necessarily the only cause.

More Than Just Fiber

Scientists continue investigating other factors as well.

Changes in the gut microbiome.

Immune responses.

Genetics.

Viral infections.

Bacterial infections.

Environmental exposures.

It is increasingly likely that appendicitis results from several interacting factors rather than a single cause.

Why This Matters

The discussion about fiber is important for another reason.

For decades, medicine focused almost entirely on treating appendicitis after it occurred.

Today, researchers are asking whether some cases might actually be preventable.

If diet influences fecalith formation...

...and fecaliths trigger some cases of appendicitis...

...then understanding nutrition may become part of preventing the disease rather than simply treating its consequences.

That represents a significant shift in thinking.

Instead of asking only,

"How do we remove an inflamed appendix?"

Researchers are increasingly asking,

"Why did it become inflamed in the first place?"

_:empty]:hidden"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-10" data-turn-id-container= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-10" data-testid= "conversation-turn-22" data-turn="assistant">

That's exactly how researchers are thinking today. Once you stop assuming appendicitis is simply "bad luck," you start asking what factors increase inflammation or blockage.

Here are some of the major areas being studied.

1. Diet (one of the strongest hypotheses)

Low fiber may contribute to harder stools and fecalith formation.

Researchers have discussed this for decades, and it remains one of the leading environmental hypotheses.

2. Antibiotics

Interestingly, antibiotics may have two opposite effects.

They can treat early appendicitis in selected patients.

But repeated or broad-spectrum antibiotic use also alters the gut microbiome, sometimes dramatically.

Scientists are investigating whether long-term disruption of normal intestinal bacteria could influence appendiceal inflammation, but this remains an active research area rather than an established cause.

3. Opioids

Pain medications such as morphine, oxycodone, and hydrocodone slow intestinal movement.

Slower intestinal transit means stool remains in the colon longer.

In theory, that could increase constipation and fecalith formation.

Whether this directly increases appendicitis risk has not been firmly established, but the mechanism is biologically plausible.

4. Drugs That Cause Constipation

Several common medications can produce constipation, including:

• some antidepressants,
• some antipsychotics,
• certain blood pressure medications,
• iron supplements,
• calcium supplements,
• some antacids,
• opioid pain medications.

Constipation itself has been investigated as one possible contributor because it may increase the chance of fecalith formation.

5. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)

Drugs such as ibuprofen and naproxen do not appear to be recognized causes of appendicitis.

However, they can irritate the stomach and intestines and, in some cases, mask pain, potentially delaying diagnosis.

6. Immune Changes

The appendix contains abundant immune tissue.

Researchers have wondered whether changes in immune function, autoimmune diseases, allergies, or alterations in gut immunity influence appendicitis risk.

The evidence is still evolving.

7. Viral and Bacterial Infections

Sometimes appendicitis develops after gastrointestinal or respiratory infections.

One proposed mechanism is enlargement of lymphoid tissue inside the appendix.

The swollen tissue may obstruct the appendix in much the same way a fecalith can.

This is considered a plausible mechanism, especially in children and young adults.

8. Microbiome Changes

This may become one of the biggest research areas over the next decade.

Researchers are asking whether:

• loss of beneficial bacteria,
• changes in bacterial populations,
• repeated diarrheal illnesses,
• highly processed diets,
• or repeated antibiotic exposure

alter the microbial ecosystem enough to increase inflammation inside the appendix.

Many studies are underway.

What Is Interesting Historically

For decades, most research focused on this sequence:

blockage → inflammation → surgery

Today, researchers are asking a different question:

What caused the blockage in the first place?

That shifts attention toward:

• diet,
• the microbiome,
• immune function,
• medications,
• environmental exposures,
• and genetics.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-11" data-turn-id-container= "request-WEB:0f612375-f2c2-4b01-8105-82116c70ca2c-11" data-testid= "conversation-turn-24" data-turn="assistant"> What Can Block or Inflame the Appendix?

Appendicitis is often explained as though one simple event always occurs:

A blockage forms, pressure rises, bacteria multiply, and the appendix ruptures.

That pathway is real, but the modern picture is more complicated. Some cases involve a clearly visible obstruction; others do not. Researchers increasingly describe appendicitis as a multifactorial disease rather than one condition with one universal cause.

Why the Appendix Is Vulnerable

The appendix is a narrow, blind-ended tube with only one entrance. It normally produces mucus and contains bacteria and immune tissue.

When its opening becomes obstructed, mucus and secretions can accumulate behind the blockage. Pressure inside the appendix rises, venous and lymphatic drainage become impaired, blood flow decreases, and trapped bacteria multiply. Continued ischemia can weaken the wall, leading to tissue death and possible perforation.

Fecaliths or Appendicoliths

A fecalith—also called an appendicolith—is a hardened mass of fecal material lodged inside the appendix.

This is one of the best-known forms of obstruction, particularly in adults. It can mechanically close the appendiceal opening and trap bacteria and mucus behind it.

However, an important qualification is needed: many appendicitis patients do not have a fecalith, and some people have an appendicolith visible on imaging without developing appendicitis. Therefore, its presence is neither necessary nor always sufficient to cause the disease.

When appendicitis and an appendicolith occur together, the illness is often treated more cautiously because the appendicolith is associated with a greater likelihood of complicated disease and failure of antibiotic-only treatment.

Does a Low-Fiber Diet Create Fecaliths?

This is plausible, but the transcript stated the case too strongly.

A Western diet that is low in fiber may encourage:

• harder stool,
• slower intestinal transit,
• constipation,
• changes in the gut microbiome,
• and possibly fecalith formation.

Higher fiber intake has been associated in observational research with a lower incidence of appendicitis. But medicine has not established that poor diet causes most appendicitis cases.

The accurate conclusion is:

Low fiber may be one contributing risk factor, especially in fecalith-related appendicitis, but it does not explain every case.

Even the claim that appendicitis "almost never happens" in high-fiber or non-Western populations is too sweeping. Rates have historically differed among populations, but appendicitis occurs throughout the world, and apparent rates are affected by diagnosis, medical access, age structure and reporting.

Swollen Immune Tissue

The appendix contains abundant lymphoid tissue. During an infection, that immune tissue can enlarge—a process called lymphoid hyperplasia.

The swollen tissue may narrow or obstruct the appendix from within. This mechanism is especially important in children and adolescents, whose appendices generally contain more active lymphoid tissue.

The enlargement may follow:

• gastrointestinal infections,
• viral illnesses,
• or possibly infections elsewhere in the body.

This creates an irony: the same immune tissue that may help protect the digestive tract can become enlarged enough to obstruct the appendix.

Lymphoid hyperplasia is not always appendicitis, however. It can also produce an enlarged appendix on ultrasound without destructive inflammation and may resolve without surgery.

Infection and Microbiome Disruption

Infection can appear at different points in the process.

In one model, obstruction happens first and trapped bacteria subsequently multiply.

In another, infection or immune activation causes swelling first, which then narrows the appendix and traps bacteria.

Researchers have also found altered bacterial communities in inflamed appendices. This raises the possibility that some forms of appendicitis involve microbial imbalance, bacterial invasion, or an abnormal immune response rather than a simple physical plug.

This remains an evolving area. No single bacterium has been shown to cause all ordinary cases of appendicitis.

Inflammation From the Colon or Intestines

Disease in nearby intestinal tissue can involve the appendix.

Potential examples include:

• infectious colitis,
• Crohn's disease,
• ulcerative colitis,
• and inflammation around the cecum.

In these circumstances, the appendix may become inflamed from surrounding disease rather than from an object lodged inside it. Cleveland Clinic identifies colitis as one possible source of appendiceal inflammation.

Parasites

Parasites can occasionally enter, irritate or obstruct the appendix.

Reported organisms include:

• Enterobius vermicularis, the pinworm;
• Ascaris lumbricoides, the large roundworm;
• Trichuris trichiura, the whipworm;
• Schistosoma species;
• and, more rarely, tapeworms and other organisms.

Pinworms are the parasite most frequently identified in appendectomy specimens. But finding a parasite inside the appendix does not always prove it caused true appendicitis. Some patients have irritation or colicky pain without the full tissue inflammation required for a pathological diagnosis.

Parasites are therefore documented but uncommon causes, with their importance varying geographically.

Tumors

A growth can obstruct the appendiceal lumen, especially in older adults.

Possible tumors include:

• neuroendocrine tumors,
• appendiceal mucinous neoplasms,
• adenocarcinoma,
• lymphoma,
• and tumors involving the cecum near the appendix opening.

Appendicitis occurring for the first time in an older adult can therefore prompt closer examination for an underlying mass. Tumors are much less common than ordinary inflammatory appendicitis, but they are an important reason removed appendices are sent for pathological examination.

Foreign Material

Rarely, material that has been swallowed may enter the appendix and remain trapped.

Published reports include:

• fruit or vegetable seeds,
• bone fragments,
• dental material,
• metal objects,
• shot or pellets,
• and other indigestible material.

These are unusual case reports, not everyday explanations for appendicitis. Undigested seeds and vegetable matter have nevertheless been documented among rare findings.

Eating seeds does not ordinarily cause appendicitis. The appendix opening is small, and millions of people consume seeds without incident.

Retained Barium

Older medical literature describes barium contrast becoming retained in the appendix after gastrointestinal imaging.

The hardened contrast could behave somewhat like an appendicolith. This became less prominent as imaging practices changed, but it remains among historically documented rare causes.

Scar Tissue or Narrowing

Chronic inflammation can theoretically produce fibrosis or narrowing within the appendix.

A partial obstruction may intermittently open and close, which has been proposed as one explanation for recurrent or chronic appendicitis. The existence and diagnostic boundaries of chronic appendicitis remain debated, but intermittent obstruction and scar tissue are among the proposed mechanisms.

Cystic Fibrosis and Thick Secretions

Cystic fibrosis produces unusually thick secretions throughout the body, including the digestive system.

Thick mucus or fecal material may obstruct the appendix, although appendicitis is not among the most common complications of cystic fibrosis. It is recognized as a possible contributing condition.

Can Medications Cause It?

There is no major class of commonly prescribed medication recognized as a routine, direct cause of appendicitis.

That distinction matters.

Many drugs cause constipation, including:

• opioids,
• anticholinergic medicines,
• some antidepressants and antipsychotics,
• iron,
• calcium,
• and certain blood-pressure medications.

Those drugs can slow bowel transit or harden stool. It is therefore reasonable to ask whether they could indirectly encourage fecal stasis or fecalith formation. But current evidence does not establish that these medicines commonly cause appendicitis.

Likewise, antibiotics can alter the microbiome, but researchers have not shown that ordinary antibiotic exposure directly causes appendicitis. Antibiotics are also used to treat selected cases.

NSAIDs such as ibuprofen do not normally cause appendicitis. Their more established gastrointestinal risks include ulcers, bleeding and injury elsewhere in the digestive tract.

The Important Finding: Sometimes No Blockage Is Found

This may be the most significant part of the story.

Pathologists and surgeons do not always find:

• a fecalith,
• swollen lymphoid tissue,
• a parasite,
• a tumor,
• or any other mechanical obstruction.

That means the traditional sequence—plug, pressure, infection, rupture—does not explain every case. Contemporary reviews describe possible pathways involving immune dysregulation, bacterial changes, vascular problems and inflammation beginning without a fixed obstruction.

What Is Established and What Is Still Hypothetical?

Well-established causes or associations: fecaliths, lymphoid enlargement, tumors, certain parasites and rare foreign bodies can obstruct the appendix.

Plausible contributors: low fiber, constipation, microbiome disruption, preceding infections and inflammatory bowel disease.

Not established: that poor diet causes most cases; that constipation-producing medications commonly cause appendicitis; or that every case begins with a physical blockage.

The more accurate modern model is:

Appendicitis is probably several related disease processes that produce a similar inflamed appendix.

That distinction matters because different causes may not require exactly the same treatment. An appendix obstructed by a solid appendicolith may behave differently from inflammation triggered by temporary lymphoid swelling or a non-obstructive immune process.

Darwin, Huxley, Evolution, and the Human Body

Darwin, Charles. The Descent of Man, and Selection in Relation to Sex. 2 vols. London: John Murray, 1871.

Darwin, Charles. On the Origin of Species by Means of Natural Selection, or the Preservation of Favoured Races in the Struggle for Life. London: John Murray, 1859.

Darwin, Charles. The Expression of the Emotions in Man and Animals. London: John Murray, 1872.

Darwin, Charles. The Variation of Animals and Plants under Domestication. 2 vols. London: John Murray, 1868.

Huxley, Thomas Henry. Evidence as to Man's Place in Nature. London: Williams and Norgate, 1863.

Huxley, Thomas Henry. "On the Relations of Man to the Lower Animals." In Evidence as to Man's Place in Nature. London: Williams and Norgate, 1863.

Desmond, Adrian. Huxley: From Devil's Disciple to Evolution's High Priest. Reading, MA: Addison-Wesley, 1997.

Desmond, Adrian, and James Moore. Darwin. London: Michael Joseph, 1991.

Browne, Janet. Charles Darwin: Voyaging. New York: Alfred A. Knopf, 1995.

Browne, Janet. Charles Darwin: The Power of Place. New York: Alfred A. Knopf, 2002.

Darwin, Francis, ed. The Life and Letters of Charles Darwin, Including an Autobiographical Chapter. 3 vols. London: John Murray, 1887.

Appendix, Tonsils, and "Vestigial" Organs

Darwin, Charles. The Descent of Man, and Selection in Relation to Sex. London: John Murray, 1871. See especially Darwin's discussion of rudimentary organs and the vermiform appendix.

Bollinger, R. R., A. S. Barbas, E. L. Bush, S. S. Lin, and W. Parker. "Biofilms in the Large Bowel Suggest an Apparent Function of the Human Vermiform Appendix." Journal of Theoretical Biology 249, no. 4 (2007): 826–31.

Kooij, I. A., S. Sahami, S. L. Meijer, C. J. Buskens, and A. A. te Velde. "The Immunology of the Vermiform Appendix: A Review of the Literature." Clinical and Experimental Immunology 186, no. 1 (2016): 1–9.

Vitetta, Luis, and Sean Coulson. "The Vermiform Appendix Is an Immunological Organ Sustaining a Microbiome Inoculum." Clinical Science 133, no. 1 (2019): 1–8.

Mabbott, Neil A., Donald S. Donaldson, Hiroshi Ohno, Ifor R. Williams, and Aras K. Mahajan. "Microfold (M) Cells: Important Immunosurveillance Posts in the Intestinal Epithelium." Mucosal Immunology 6, no. 4 (2013): 666–77.

Nave, Heinz, Astrid Gebert, and Reinhard Pabst. "Morphology and Immunology of the Human Palatine Tonsil." Anatomy and Embryology 204 (2001): 367–73.

Darwin, Huxley, Eugenics, and the Later Legacy

Galton, Francis. Hereditary Genius: An Inquiry into Its Laws and Consequences. London: Macmillan, 1869.

Galton, Francis. Inquiries into Human Faculty and Its Development. London: Macmillan, 1883.

Kevles, Daniel J. In the Name of Eugenics: Genetics and the Uses of Human Heredity. New York: Alfred A. Knopf, 1985.

Paul, Diane B. Controlling Human Heredity: 1865 to the Present. Atlantic Highlands, NJ: Humanities Press, 1995.

Rupke, Nicolaas A. Richard Owen: Biology without Darwin. Rev. ed. Chicago: University of Chicago Press, 2009.

"Trust must be earned, it cannot be assumed. We have not always done things correctly." — WHO Director-General Tedros Adhanom Ghebreyesus, message to the people of the Democratic Republic of the Congo, May 28, 2026

The Ebola crisis in the Democratic Republic of the Congo is part of a much longer history of international disease-control campaigns across Africa. Decades before Ebola became a global emergency, many of the same regions were already the focus of massive public-health programs targeting tropical diseases such as river blindness, also known as onchocerciasis. Those programs brought together the World Health Organization, World Bank, pharmaceutical companies, governments, nonprofit organizations and international health workers.

The connections are striking. The WHO-led Onchocerciasis Control Programme began in West Africa in 1974, followed by the African Programme for Onchocerciasis Control in 1995. Merck began its Mectizan Donation Program in 1987, supplying ivermectin for river blindness on an unprecedented scale. Over the following decades, international organizations developed extensive networks for delivering drugs, monitoring disease, training health workers and working with communities across Africa.

Then came Ebola. The catastrophic 2014–2016 West African Ebola epidemic transformed the disease into an international security and public-health emergency. President Barack Obama declared the outbreak a U.S. national-security priority, while the United States, WHO, CDC, military personnel, pharmaceutical companies and international aid organizations mobilized against the epidemic.

The Democratic Republic of the Congo presents an especially important case because it has experienced repeated Ebola outbreaks while also being deeply involved in decades of international tropical-disease programs. That raises an important historical question: how much institutional continuity exists between the organizations, personnel, infrastructure and public-health strategies developed during earlier campaigns such as the fight against river blindness and those later deployed against Ebola?

Trust is another central issue. During Ebola outbreaks in the Congo, health workers have confronted fear, resistance, attacks on treatment centers and communities suspicious of international health authorities. Ebola control depends heavily on cooperation: identifying cases, tracing contacts, isolating patients, conducting safe burials and administering vaccines and treatments. When communities do not trust the institutions delivering those interventions, disease control becomes dramatically more difficult.

This episode follows the timeline from ivermectin and river blindness programs to Ebola, examining the WHO, World Bank, pharmaceutical companies, international health organizations, the United States and the networks operating on the ground in Africa. Rather than looking at each outbreak or health campaign in isolation, the investigation asks what becomes visible when the people, organizations, geography and dates are placed on one timeline.

Topics covered: Ebola in the Congo, Democratic Republic of the Congo Ebola outbreak, Ebola virus disease, WHO Ebola response, CDC Ebola response, Barack Obama Ebola response, ivermectin in Africa, river blindness, onchocerciasis, Mectizan Donation Program, Merck ivermectin, World Health Organization, World Bank, African Programme for Onchocerciasis Control, global health in Africa, Ebola vaccines, Ebola treatments, public-health trust, international health organizations and African disease-control programs.

Music: Creedence Clearwater Revival - Who'll Stop The Rain (Official Audio)

JCDR - Ebola virus, Psychological impact, Stigma

Marburg and Ebola — Arming Ourselves against the Deadly Filoviruses | New England Journal of Medicine

Marburg Virus: What You Should Know About This Close Cousin of Ebola

What is Marburg virus? 5 things to know about the Ebola-like virus | Nebraska Medicine Omaha, NE

The Marburg "Virus:" Precursor to Ebola – ViroLIEgy

Marburg virus disease - Wikipedia

Ebola - Wikipedia

How hormones work to flip sexes: Hormones

Do you have a psychopath in your life? The best way to find out is read my book. BOOK *FREE* Download – Psychopath In Your Life4

Support is Appreciated: Support the Show – Psychopath In Your Life

Download Pods here: TOP PODS – Psychopath In Your Life

My old discussion forum with last 10 years of victim stories, is back online. Psychopath Victim Support Community | Forums powered by UBB.threads™

Google Maps My HOME Address: 309 E. Klug Avenue, Norfolk, NE 68701 SMART Meters & Timelines – Psychopath In Your Life

"Ebola is now an epidemic of the likes that we have not seen before. It's spiraling out of control. It is getting worse. It's spreading faster and exponentially. Today, thousands of people in West Africa are infected………That number could rapidly grow to tens of thousands. And if the outbreak is not stopped now, we could be looking at hundreds of thousands of people infected, with profound political and economic and security implications for all of us. And that's why, two months ago, I directed my team to make this a national security priority. We're working this across our entire government, which is why today I'm joined by leaders throughout my administration, including from my national security team."

– Obama in his speech at the Centre of Disease Control 16th of September, Atlanta Georgia, USA (emphasis added)

Japan: From Ivermectin to the Ebola Response in Africa

Japan needs to be included in the larger timeline. Its role does not establish that the same Japanese scientists who developed ivermectin later ran Ebola programs. What the record does establish is something more specific: Japan was important at the beginning of the ivermectin story and later became a substantial participant in the international Ebola-response system, including repeated work inside the Democratic Republic of the Congo.

1978 — Japan and the Beginning of Ivermectin

Japanese microbiologist Satoshi Ōmura, working at the Kitasato Institute, cultured microorganisms collected from soil in Japan. One strain ultimately produced avermectin. Working with William Campbell and Merck researchers in the United States, this discovery led to ivermectin.

The Nobel Prize organization says Ōmura cultured the critical strain in 1978, from which Campbell isolated avermectin; a chemically modified derivative became ivermectin and eventually a major treatment for river blindness. Ōmura and Campbell shared the 2015 Nobel Prize for this work.

So Japan wasn't a peripheral participant in the ivermectin story. One of the two scientists awarded the Nobel Prize for the discovery was Japanese, and the organism at the beginning of the discovery came from Japan.

2014 — Japan Enters the Major Ebola Response

Jump forward roughly three and a half decades.

During the enormous 2014 West African Ebola epidemic, Japan became an active participant in the international response.

Japanese infectious-disease specialists were dispatched to Africa through the World Health Organization. In October 2014, for example, two specialists from Japan's National Institute of Infectious Diseases were sent to Sierra Leone as part of a World Health Organization Ebola mission. By November, the Japanese government reported that 10 Japanese experts had participated or were participating in these missions.

Japan wasn't simply writing checks from Tokyo.

Japanese personnel were entering the international Ebola-response machinery.

By July 2015, Japan reported that 20 Japanese experts had been dispatched through World Health Organization missions during the West African Ebola response.

Japan Supplies 700,000 Sets of Protective Equipment

The material contribution was also substantial.

In November 2014, Japan announced that approximately 700,000 sets of personal protective equipment would be supplied to Guinea, Liberia, Sierra Leone and Mali.

Japan even used a Self-Defense Forces aircraft to transport an initial 20,000 sets to Ghana, where the United Nations Ebola emergency mission was headquartered.

By February 2015, Japan described its overall West African Ebola assistance as approximately $155 million, including experts, equipment and international assistance.

Japan Also Entered the Experimental-Treatment Story

There was another significant Japanese component.

During the West African epidemic, Japan announced that a drug developed by a Japanese company could be made available under certain conditions as a possible Ebola treatment. Japan also supported clinical testing involving the French Institute of Health and Medical Research, the government of Guinea and Doctors Without Borders.

That means Japan's Ebola involvement extended beyond funding and protective equipment into medical research and experimental treatment.

2015 — Ebola Produces a Permanent Japanese Outbreak Team

This is an important turning point.

After the West African Ebola crisis, Japan established the Japan Disaster Relief Infectious Diseases Response Team in 2015.

This gave Japan a specialized mechanism for sending infectious-disease experts overseas.

Japan's own development-cooperation history says that this team subsequently went to the Democratic Republic of the Congo for yellow fever in 2016 and for Ebola in 2018.

The sequence is therefore:

2014 Ebola crisis in West Africa

2015 Japan establishes a specialized international infectious-disease response team

2016 the team goes to the Congo

2018 the team returns to the Congo specifically for Ebola

That is an important institutional progression.

2018 — Japanese Ebola Specialists Enter the Congo

When Ebola broke out in the Democratic Republic of the Congo in 2018, the Congolese government requested Japanese assistance.

Japan first sent an assessment team containing infectious-disease specialists, Foreign Ministry officials and personnel from Japan's international development agency.

Japan then deployed its specialized infectious-disease response team beginning June 11.

Its mission was not merely observational.

The Japanese team worked with the Congolese government and international organizations to strengthen disease surveillance and laboratory confirmation of Ebola cases.

By the time the mission finished, Japanese personnel had helped establish a quarantine point, worked on data management, helped train 30 quarantine officers and 10 epidemiologists, and provided laboratory training at Congo's National Institute of Biomedical Research.

Japan also provided $3 million for the Congo Ebola response through the World Health Organization, United Nations Children's Fund and International Organization for Migration.

This puts Japan directly inside the Congo Ebola-response infrastructure.

2019 — Japan Returns During the Huge Congo Epidemic

The involvement didn't end with the 2018 outbreak.

During the much larger Ebola epidemic in eastern Congo, Japan again deployed its infectious-disease response team in August 2019 at the request of the Congolese government.

Japan sent one team and then dispatched a second group. Their mission included strengthening quarantine and other measures intended to prevent Ebola from spreading.

Japanese personnel subsequently worked in Kinshasa and Kisangani, providing training involving Ebola surveillance, quarantine, laboratory diagnosis, infection control and protective equipment.

Japan simultaneously provided another $5 million for quarantine, treatment, laboratory diagnosis, surveillance and contact tracing.

So by 2019 this was no longer a one-time Japanese appearance in the Congo.

Japan had become a repeat participant.

Another Important Connection: Japan, the World Health Organization and the World Bank

There is an additional institutional connection worth putting into the larger timeline.

Japan says that it contributed heavily to the World Health Organization's emergency-response programs after the West African Ebola epidemic.

Japan also supported creation of the World Bank's Pandemic Emergency Financing Facility and pledged $50 million, becoming the first country to announce a contribution.

When Ebola struck the Congo in 2018, that financing mechanism released money for the Ebola response.

That gives us another institutional chain:

Japan → World Health Organization emergency system

Japan → World Bank pandemic-financing system

World Health Organization + World Bank mechanisms → Congo Ebola response

2026 — Japan Is Still Involved

And Japan hasn't disappeared from the picture.

On June 22, 2026, Japan announced another $3.5 million emergency grant responding to Ebola outbreaks in the Democratic Republic of the Congo and Uganda.

Of that money, $3 million was designated for Congo: $1.5 million for health through the International Federation of Red Cross and Red Crescent Societies, $1 million for logistics through the World Food Programme and $500,000 for water and sanitation through the United Nations Children's Fund.

That extends the Japanese involvement from the 2014 West African epidemic right into the current Congo response.

The Timeline

1978: Satoshi Ōmura in Japan cultures the microorganism that leads to avermectin and ultimately ivermectin.

2014: Japanese infectious-disease specialists join World Health Organization Ebola missions in West Africa.

2014: Japan supplies approximately 700,000 sets of protective equipment and commits major financial assistance.

2014–2015: Japan becomes involved in research concerning a potential Japanese-developed Ebola treatment.

2015: Japan establishes a specialized international infectious-disease response team.

2016: That team deploys to the Democratic Republic of the Congo for a yellow-fever emergency.

2018: Japan sends infectious-disease specialists into the Congo for Ebola. They work on quarantine, surveillance, epidemiological training and laboratory diagnosis.

2018: Japan provides an additional $3 million for the Congo Ebola response.

2019: Japanese infectious-disease teams return to the Congo during the enormous eastern Congo Ebola epidemic.

2019: Japan provides another $5 million for treatment, quarantine, laboratory diagnosis, surveillance and contact tracing.

2026: Japan provides another $3 million specifically for the Ebola response in the Congo as part of a $3.5 million Congo-Uganda package.

What the Japan Connection Adds

Japan was central to the scientific origin of ivermectin.

Decades later, Japan became an important participant in the international Ebola response.

After the catastrophic 2014 Ebola epidemic, Japan institutionalized that experience by creating a permanent infectious-disease response team.

That team subsequently entered the Democratic Republic of the Congo, first for yellow fever and then repeatedly for Ebola, working in surveillance, quarantine, epidemiology and laboratory diagnosis.

And in 2026 Japan remains financially involved in the Congo Ebola response.

So on the network map we have been constructing, Japan belongs in the picture.

What the evidence does not yet show is that Ōmura, the Kitasato ivermectin researchers, or the original Japanese ivermectin program itself transitioned into the Ebola operations. That would require a person-by-person and institution-by-institution crossover analysis.

But at the country and global-health-institution level, the Japan connection is substantial and documented.

Ivermectin as a Training Ground: How the River-Blindness Campaign Built a Community-Health Model Later Used in African Epidemic Response

The enormous African ivermectin campaign did considerably more than distribute a drug for river blindness. Over several decades, the program helped international health organizations, African governments, NGOs and local communities develop and refine a system for reaching millions of people in remote areas where conventional health infrastructure was weak.

WHO's own historical documents make this point unusually clear.

The important distinction is this: there is no evidence that the ivermectin program was created in preparation for Ebola. But there is strong evidence that the ivermectin campaign became a large-scale laboratory for learning how community-directed health interventions could operate across Africa, and that WHO deliberately studied how the system could be expanded beyond ivermectin.

The Beginning: Ivermectin Changes the Strategy

Merck announced its ivermectin donation program in 1987, promising to provide Mectizan for river blindness for as long as necessary.

WHO says large-scale ivermectin distribution was incorporated into African onchocerciasis control beginning around 1989. The drug created a logistical problem very different from treating individual patients in hospitals.

Millions of people living in remote communities had to be identified, reached and treated repeatedly.

That required much more than ivermectin.

It required:

• community mapping,
• local health workers,
• community leaders,
• drug-distribution networks,
• training,
• record keeping,
• population estimates,
• monitoring,
• surveillance,
• communication with villages,
• and mechanisms for determining whether populations were actually accepting and receiving treatment.

In other words, ivermectin required the construction of a community-level public-health delivery system.

WHO itself later described the collaboration surrounding mass ivermectin treatment as creating a "unique community-based distribution system."

1995: APOC Takes the Model Across Africa

In 1995, the African Programme for Onchocerciasis Control—APOC—was established.

This was not a small operation.

It brought together African governments, affected communities, NGOs, donors and international organizations. The World Bank served as fiscal agent and WHO as executing agency. Eventually approximately 20 African countries participated.

The central strategy became known as:

Community-Directed Treatment with Ivermectin (CDTI)

The idea was fairly simple: instead of international health workers repeatedly arriving in African villages and handing out ivermectin themselves, local communities were brought into the process and helped organize the distribution.

WHO's tropical-disease research program began developing this approach in 1995, and the African Programme for Onchocerciasis Control — APOC — adopted it in 1996.

This mattered because ivermectin wasn't a one-time treatment. People living in areas with river blindness needed to receive the drug again and again, year after year.

So the research was no longer simply:

Does ivermectin work against river blindness?

There was now another question:

How do you deliver a treatment repeatedly to people living in remote African communities — and build a system that can keep doing it for years?

It was also about learning how to build a long-term health-delivery system inside thousands of African communities.

They Learned From the Process

WHO documents show that researchers weren't only studying ivermectin. They were also studying how the entire delivery system worked.

They looked at how health workers communicated with communities, how much local people participated, and why some communities participated more successfully than others.

They measured how many people actually received treatment and studied what made the programs succeed or fail.

Researchers also experimented with bringing villagers, community organizations and health workers together to improve the process.

And there was another major question: Could this system last?

River blindness treatment wasn't something that could be done for a year or two and forgotten. The system might have to continue operating for 15 years or longer.

WHO's 2000 multi-country evaluation examined these questions as CDTI was being tested and refined.

So describing the ivermectin campaign as simply handing out a drug misses an important part of the history.

They were learning how to organize, operate and sustain a long-term health program inside remote African communities — and they learned from what worked and what didn't.

It was simultaneously producing practical knowledge about how to conduct enormous community-level health interventions in Africa.

Then Something Important Happened

Other health programs began noticing something: the ivermectin delivery system worked, and the same network could be used for much more than ivermectin.

By 2003, WHO was openly studying this possibility.

WHO reported:

"The success of CDTI in onchocerciasis control has caught the attention of other disease control programmes."

The community distributors who had originally been organized to deliver ivermectin were already becoming involved in other health programs, including vitamin A distribution, malaria control, polio immunization, Guinea worm eradication, nutrition programs, water protection and general community-health work.

In fact, an earlier investigation found that more than half of the community-directed ivermectin distributors studied were already participating in other health and development activities.

That is an important turning point in this history.

What began as a system for getting ivermectin into remote communities was becoming something much larger.

The ivermectin network was becoming multipurpose health infrastructure — a community-based delivery system that could be used for other diseases, treatments and public-health campaigns.

2005: WHO Formally Tests the Idea

Then WHO and APOC took the next step.

In 2005, they launched a three-year study to answer a straightforward question:

If communities had already learned how to organize and distribute ivermectin, could that same system be used to deliver other health programs?

This was not a small experiment. The study involved approximately 2.35 million people at seven research sites in Cameroon, Nigeria and Uganda.

There was a reason WHO wanted to test the idea.

Community-directed ivermectin treatment had already demonstrated that a health program could reach enormous numbers of people living in poor and remote African communities.

So researchers asked:

Could we use the same system for other health interventions?

The answer was yes.

And the terminology changed in an important way.

Community-Directed Treatment with Ivermectin (CDTI)

became the broader:

Community-Directed Interventions (CDI).

That change tells the story.

Ivermectin was no longer the defining feature of the model. The delivery system was.

The Scale Was Enormous

And this was already a very large network.

By 2000, APOC's community ivermectin program was reaching approximately 20 million people in 50,000 communities across 14 countries.

By the time the research was published in 2008, annual ivermectin treatment through CDTI was reaching nearly 60 million Africans.

By 2011, WHO's tropical-disease research program described the community-directed system as reaching approximately 98 million people in 24 sub-Saharan African countries.

And when APOC closed in 2015, WHO reported that community-directed ivermectin treatment was protecting more than 110 million people every year in 19 countries.

Think about what had been built.

This wasn't simply a drug being shipped into Africa.

It was a massive community-level public-health network reaching tens of millions of people year after year.

They Institutionalized What They Had Learned Then WHO took another important step. It developed a Community-Directed Intervention training curriculum for medical and health-science schools.

The lessons learned through ivermectin distribution were now being turned into something that could be taught to future health workers.

WHO explained that the ivermectin experience had demonstrated that communities themselves could help manage disease-prevention and treatment programs. The same approach could also be used to deliver multiple health interventions, particularly in poor and remote areas.

By 2009, 18 universities and nursing schools in 11 African countries had agreed to introduce the community-directed intervention strategy into their curricula.

• So look at the progression:
• It started with ivermectin.
• Then communities were organized to distribute ivermectin themselves.
• Researchers studied how that system worked, what failed and what could be improved.
• Then they tested whether the same network could deliver other health interventions.

It could.

The model was expanded from CDTI to CDI.

And eventually the lessons from that system were incorporated into the education of future African health personnel.

That is a much bigger story than simply saying:

WHO distributed a lot of ivermectin in Africa.

What they actually developed over those years was a large, repeatable, community-based system for delivering public-health interventions across Africa.

Then Comes Ebola

Then comes Ebola.

During major Ebola outbreaks — particularly the enormous 2018–2020 outbreak in eastern Democratic Republic of Congo — health authorities faced many of the same practical problems that earlier programs had spent years trying to solve.

How do you reach remote communities?

• How do you recognize a suspected case quickly?
• Who reports it?
• How do health authorities communicate with villages?
• Who works with local chiefs and community leaders?
• How do outside health organizations operate in communities where there may already be deep mistrust?
• And how do you create a reporting system that connects an individual village to the larger health system?

The Ebola response relied heavily on community health workers and community-based surveillance.

One published account from the 2018–2020 DRC Ebola response describes a surveillance network built around community-elected health workers, supervised by more experienced health workers or local leaders.

In that program, 247 community health workers and supervisors were trained. The program reported very high retention and daily reporting, and local chiefs and community leaders were involved from the beginning.

Now look at the basic structure:

Community members select local workers.

• Those workers are trained.
• They are supervised.
• They watch for possible cases.
• They report what they find.
• Local leaders are brought into the process.
• And the community becomes connected to the formal public-health system.

But it does place Ebola within the same broader history of community-based public-health infrastructure in Africa.

For decades, international health organizations had been learning how to build systems that reached from remote communities into national and international health programs.

By the time Ebola arrived, they were not starting from scratch.

The African ivermectin campaign created and refined an enormous community-based health-delivery system. WHO and its partners deliberately studied what they learned from that system. They then explicitly tested whether the ivermectin infrastructure and its community distributors could deliver interventions unrelated to ivermectin. The successful concept was broadened into Community-Directed Interventions and incorporated into African medical and nursing education.

WHO itself described APOC-supported projects combining ivermectin delivery with bed nets, lymphatic-filariasis treatment, schistosomiasis treatment, Guinea-worm eradication, vitamin A, deworming, immunization and HIV/AIDS education.

So they absolutely learned from the ivermectin process and deliberately applied those lessons more broadly.

The Historical Question That Remains

This brings us back to the question that started this investigation.

Bottom Line

Ivermectin was not merely a medicine being handed out in Africa.

Beginning in the late 1980s and particularly through APOC after 1995, it became the centerpiece of one of the largest experiments in community-directed public-health delivery ever conducted in Africa.

WHO and its partners learned how to organize communities, select and train local distributors, maintain treatment programs for years, monitor populations, work through local leadership and connect remote communities with national and international health organizations.

They then studied those lessons deliberately.

• They discovered that the ivermectin system could be used for other interventions.
• They expanded it.
• They taught it.

And by the time major Ebola emergencies arrived, Africa already possessed decades of accumulated experience with precisely this kind of community-level health organization.

That does not demonstrate that ivermectin and Ebola were parts of a predetermined plan.

But historically, it does mean that the ivermectin era helped build and test an African public-health infrastructure whose methods extended far beyond river blindness.

From Ivermectin to Ebola: How Africa's River-Blindness Campaign Built a Public-Health System That Could Be Used Again

The history of ivermectin in Africa is much larger than the history of a drug.

Beginning in the late 1980s and accelerating during the 1990s, the campaign against river blindness forced international health organizations, African governments, researchers and local communities to solve an enormous logistical problem: how do you repeatedly reach millions of people, including people living in remote areas where conventional medical systems have limited reach?

The answer became one of the largest community-directed public-health systems ever constructed in Africa.

And WHO's own historical record shows something important: they learned from the ivermectin experience.

They studied what worked. They studied what failed. They modified the system. They trained communities. They trained health workers. They developed mapping and reporting systems. And eventually they deliberately investigated whether the infrastructure developed around ivermectin could be used for completely different health interventions.

Decades later, some of the same institutional concepts—community surveillance, local health workers, community engagement, rapid reporting, research networks and trained in-country personnel—are central to Ebola response.

Ivermectin Created a Logistical Challenge

Once ivermectin became available for river blindness, possessing the medicine wasn't enough.

The affected population was enormous and geographically dispersed.

Successful control required people to receive treatment repeatedly over many years.

WHO/TDR's research therefore increasingly concentrated on delivery.

• How could health organizations reach villages?
• Who would distribute the medicine?
• Who would keep records?
• Who would identify eligible recipients?
• Who would report problems?
• How could treatment continue without requiring an international health worker to personally administer every dose?

And perhaps most importantly:

Could communities themselves operate the system?

That question produced Community-Directed Treatment with Ivermectin, or CDTI.

TDR says it pioneered CDTI in 1995, and the African Programme for Onchocerciasis Control—APOC—adopted it in 1996. Under the system, communities assumed responsibility for organizing ivermectin distribution themselves.

This was a major change in the public-health model.

The health intervention was moving outward from clinics and into communities.

They Didn't Just Operate the Program. They Studied It.

WHO/TDR conducted multi-country research specifically examining whether this system could remain operational for the many years required for onchocerciasis control.

• Researchers studied communities in Ghana, Mali, Togo and Nigeria.
• They examined communication between health workers and communities.
• They examined community participation.
• They brought community representatives, health workers and community organizations together.
• They studied treatment coverage.
• They examined reporting.

And they studied what would make the system sustainable.

WHO's 2000 report explains that ivermectin treatment would have to continue for at least 15 years in endemic communities, making long-term sustainability a fundamental part of the research.

This means the ivermectin campaign was simultaneously generating knowledge about how to maintain large-scale health interventions inside African communities for years at a time.

The Community Became Part of the Health Infrastructure

The community-directed model went considerably further than asking villagers to show up somewhere for medicine.

WHO/TDR's historical description says that communities could assume responsibility for obtaining the medicine, treating eligible members, referring severe adverse reactions and reporting what happened.

That reporting component is particularly important.

The system was developing a chain:

• International health organization
• National health system
• District health system
• Community
• Local distributor
• Individual resident

and then information traveled back through the system.

That is infrastructure.

Then Other Programs Noticed What Ivermectin Had Built

By 2003, WHO/TDR was documenting something extremely important.

The success of community-directed ivermectin treatment had attracted the attention of other health and development programs.

Organizations were already attempting to use the ivermectin structures and the community-directed distributors for other health interventions.

WHO researchers therefore began studying the consequences.

• Could these workers perform additional functions?
• Would adding other interventions strengthen the network?
• Would it overwhelm the community distributors?
• Could a disease-specific ivermectin system become something broader?

Those weren't hypothetical questions anymore.

The crossover was already occurring.

2005: They Formally Test the Ivermectin System for Other Diseases

The next development makes the historical progression particularly clear.

The governing board of APOC asked TDR to determine whether the successful ivermectin approach could be expanded into a system for delivering other health interventions.

A three-year study launched in 2005.

It involved approximately 2.35 million people at seven research sites in Cameroon, Nigeria and Uganda.

WHO explained that community-directed ivermectin treatment had already demonstrated an ability to reach poor rural populations successfully.

The researchers therefore tested whether the approach could deliver other interventions alongside ivermectin.

The terminology itself changed.

Instead of simply:

Community-Directed Treatment with Ivermectin — CDTI

the broader concept became:

Community-Directed Interventions — CDI.

That change is significant.

Ivermectin had provided the original operational model, but ivermectin was no longer the limit of the model.

The Ivermectin Network Becomes Multipurpose

This is where the story becomes particularly relevant to later epidemic response.

The people distributing ivermectin weren't necessarily limited to ivermectin.

WHO/TDR's 2003 investigation specifically examined community-directed ivermectin distributors who were participating in other health and development activities.

The study involved the entire local structure surrounding CDTI:

• community members,
• community leaders,
• community-directed distributors,
• health-facility staff,
• district health officials,
• and managers of other health programs.

WHO was effectively examining how a disease-specific delivery network could become a broader community-health platform.

They Eventually Began Teaching the Model

The accumulated experience didn't remain confined to the river-blindness program.

WHO/TDR subsequently developed a curriculum and training module on Community-Directed Intervention for faculties of medicine and health sciences.

The description of that curriculum is remarkably straightforward.

WHO says experience with community-directed ivermectin treatment demonstrated that communities, working with health professionals, could manage disease prevention and treatment.

WHO then states that this strategy could be applied to delivering multiple health interventions, particularly to poor populations in remote areas.

That broader approach became CDI.

In other words:

They took what had been learned through ivermectin and turned it into a generalized public-health methodology.

The Institutional Chain

This gives us a much clearer historical progression:

WHO/TDR

develops and studies the ivermectin delivery system.

APOC

takes community-directed ivermectin treatment to enormous scale.

CDTI

creates community-level distributors, reporting relationships and local health organization.

Researchers study how the system works.

Other health programs begin using the ivermectin infrastructure.

WHO/TDR investigates this crossover.

The model expands into:

Community-Directed Interventions — CDI.

• The methodology is then incorporated into formal health-professional training.
• The infrastructure and expertise become part of the larger African public-health system.
• That process unfolded over decades.

And Then Comes Ebola

Ebola presents a different disease and a very different medical problem.

But look at the operational requirements.

An Ebola response needs people who can reach communities.

• It needs local surveillance.
• It needs rapid reporting.
• It needs trained health personnel.
• It needs community engagement.
• It needs relationships with community leaders.
• It needs researchers capable of conducting studies under difficult conditions.
• It needs coordination between local, national and international organizations.

And it needs systems that already exist before the emergency begins.

That last point is exactly what WHO/TDR is emphasizing today.

2026: WHO/TDR Says the Earlier Investment Matters

During the current 2026 Ebola response in the Democratic Republic of Congo, TDR published an unusually revealing account of its role.

Its headline says it plainly:

"Ebola response effort benefits from TDR's long-term support for health systems strengthening."

TDR says Congolese public-health specialists it trained are now occupying important positions in Ebola clinical research and field response.

One is Dr. Thierry Kalonji, working with WHO's DRC office as a field coordinator for Ebola response activities in Ituri.

His work includes briefing community health workers involved in community-based Ebola surveillance.

Another is Dr. Jepsy Yango, working through DRC's Institut National de Recherche Biomédicale and coordinating Ebola therapeutic and post-exposure-prophylaxis trials.

His responsibilities include operational planning, regulatory work, field deployment and coordination among Congolese and international organizations.

TDR says these aren't isolated individuals.

They belong to a broader network of TDR-trained professionals involved in Ebola preparedness and response in DRC and neighboring countries.

The Most Important Sentence May Be TDR's Own

The 2026 TDR account describes the underlying philosophy very clearly:

"Preparation cannot start during an outbreak."

That observation gets directly to the historical significance of what happened during the preceding decades.

A country confronting Ebola cannot suddenly manufacture experienced researchers, community-health networks, laboratories, surveillance personnel and institutional relationships when the first Ebola patient appears.

Those capabilities have to exist beforehand.

The ivermectin/onchocerciasis period was one important part of the much longer process through which these capabilities were developed.

What They Learned From Ivermectin

The most important historical point isn't that exactly the same procedure was used against two different diseases.

It wasn't.

The important point is institutional learning.

Through ivermectin programs, health organizations gained extensive practical experience in:

• operating outside traditional hospitals,
• reaching remote populations,
• organizing community participation,
• selecting local distributors,
• training local personnel,
• maintaining programs over many years,
• collecting information from communities,
• reporting upward through health systems,
• coordinating international organizations with national ministries,
• evaluating whether programs were working,
• and adapting successful systems for additional interventions.

WHO/TDR's documents demonstrate that this learning process wasn't accidental.

They studied it.

• They evaluated it.
• They changed the model based upon experience.
• And then they deliberately asked whether the ivermectin system could be used for other health interventions.

The Bigger Historical Story

This changes the way the ivermectin campaign should be viewed.

It wasn't simply:

Merck develops ivermectin → medicine gets distributed in Africa.

The fuller history is:

Ivermectin becomes available.

• Millions of people need repeated treatment.
• Existing health services cannot accomplish that alone.
• A community-distribution model develops.

WHO/TDR studies the model.

APOC expands it.

• Communities become increasingly responsible for implementation.
• Local distributors and health personnel gain experience.
• Reporting and monitoring systems develop.
• Researchers examine sustainability.
• Other health programs begin using the network.

WHO formally studies whether the ivermectin model can deliver additional interventions.

CDTI evolves into the broader CDI concept.

• The methodology enters health-professional training.
• Decades of African public-health experience accumulate.
• And when major epidemic emergencies such as Ebola occur, international and national health organizations are not starting from zero.
• They have people.
• They have institutions.
• They have community relationships.
• They have research capacity.
• And most importantly, they have decades of experience learning what works and what doesn't.

Bottom Line

The ivermectin campaign against river blindness became something considerably larger than a pharmaceutical program.

It became an enormous exercise in building, testing and refining community-directed public-health infrastructure across Africa.

WHO/TDR's own records document the progression.

• They developed community-directed ivermectin treatment.
• They studied its sustainability.
• They discovered that the infrastructure was already being used for other health activities.
• They formally tested whether it could deliver additional interventions.
• They broadened the concept from ivermectin treatment into Community-Directed Interventions.

The Papua New Guinea–Ebola Crossover: The Familiar People and Institutions

Once we start with Richard W. Ashford in Papua New Guinea, an interesting pattern becomes visible. Ashford himself does not appear to have become an Ebola researcher. But the tropical-medicine network around Papua New Guinea leads directly into several people and institutions that later became involved with Ebola, particularly the 2014–2016 West African epidemic.

The important point is not that one team moved intact from Papua New Guinea to Ebola. It didn't. The crossover is a professional network: tropical medicine, parasitology, mass-treatment programs, Liverpool, WHO, African disease-control programs and eventually outbreak response.

RICHARD W. ASHFORD — PAPUA NEW GUINEA

Richard William Ashford was a parasitologist associated with the Liverpool School of Tropical Medicine who spent important years working in Papua New Guinea.

By 1977, Ashford was listed as a senior lecturer in the Department of Pathology at the University of Papua New Guinea while on secondment from Liverpool.

In 1980, Ashford and D. Babona published a survey of parasites among the Purari people of Papua New Guinea. They found hookworm, Strongyloides, malaria and Wuchereria bancrofti, the parasite responsible for lymphatic filariasis.

Ashford remained involved in Papua New Guinea parasite research into the 1980s and early 1990s, including studies of Strongyloides fuelleborni kellyi, an unusual parasite associated with serious illness in infants.

So Ashford belongs squarely in the earlier Papua New Guinea tropical-parasitology world.

But I have not found evidence that Ashford himself subsequently became part of the Ebola response. That distinction matters.

What becomes much more interesting is what happens when we follow the people who came through the same PNG/Liverpool tropical-disease world. MOSES BOCKARIE — ONE OF THE STRONGEST CROSSOVERS

Moses J. Bockarie is probably the clearest person to put in this report.

Bockarie trained at the Liverpool School of Tropical Medicine, receiving his PhD in medical entomology in 1992. He subsequently moved to the Papua New Guinea Institute of Medical Research, becoming Principal Research Fellow and head of its Vector Borne Disease Unit in 1996.

This was not peripheral work.

Bockarie became deeply involved in lymphatic filariasis research and mass drug administration in Papua New Guinea.

A WHO scientific report identifies:

James W. Kazura and Moses J. Bockarie

as investigators studying mass drug administration against Wuchereria bancrofti in Dreikikir, Papua New Guinea.

From 1993 through 1998, their research compared annual doses of:

DEC alone with DEC plus ivermectin.

The WHO report states that the intervention reduced filariasis transmission dramatically in the study area.

That puts Bockarie directly into the PNG ivermectin/filariasis history we have already been examining.

Then Bockarie turns up again in a very different setting.

Sierra Leone. Ebola.

Bockarie himself was from Sierra Leone and eventually became director of Liverpool's Centre for Neglected Tropical Diseases.

When the West African Ebola epidemic exploded in 2014, he became a prominent participant in discussion of the international response.

On September 30, 2014, Bockarie appeared alongside:

David Nabarro — UN Special Envoy on Ebola

• UK government officials,
• Médecins Sans Frontières,
• King's Sierra Leone Partnership personnel,
• and the UK Sierra Leone Ebola Task Force

at an event titled:

"Ebola: What More Can Be Done?"

Bockarie discussed the catastrophic effect Ebola was having on Sierra Leone's health workers.

By 2015 he was also participating in a Liverpool conference debate titled:

"Conflict, environment & Ebola: Barriers to parasite control & elimination."

And his involvement with the consequences of Ebola did not simply disappear after 2015. In 2026, Bockarie coauthored an editorial about Sierra Leone's scientific and genomic response after the Ebola outbreak.

So Bockarie gives us a remarkable career arc:

Liverpool tropical medicine → Sierra Leone → Papua New Guinea Institute of Medical Research → filariasis and ivermectin mass-treatment research → Liverpool neglected-tropical-disease establishment → West African Ebola response.

That is a genuine crossover.

DAVID LALLOO — PAPUA NEW GUINEA TO EBOLA SAGE

Another particularly strong crossover is Professor David Lalloo.

Lalloo spent approximately three years in Papua New Guinea while training in tropical medicine and infectious diseases. His PNG work included clinical research, particularly snakebite and tropical medicine.

He subsequently joined the Liverpool School of Tropical Medicine in 1999.

Then comes the Ebola connection.

Lalloo later served as a member of the British government's Scientific Advisory Group for Emergencies — SAGE — for Ebola and Zika.

That is a much more direct Ebola-policy connection than simply attending a conference.

So again the path looks like:

Papua New Guinea field medicine → Liverpool School of Tropical Medicine → international tropical-disease establishment → government Ebola emergency advisory structure.

Lalloo eventually became director and then vice-chancellor of the Liverpool School of Tropical Medicine.

That makes him another important bridge between these worlds.

MOSES BOCKARIE AND THE WHO FILARIASIS NETWORK

Another document helps show just how interconnected this group had already become before Ebola.

A 2002 WHO meeting on lymphatic filariasis lists:

Moses Bockarie — Papua New Guinea Institute of Medical Research

David Molyneux — Liverpool LF Support Centre

Eric Ottesen — Emory LF Support Center

and other major filariasis figures participating in the same WHO network.

This is important because by then the infrastructure was no longer simply an isolated PNG research project.

It was an international disease-control system connecting:

• WHO
• Liverpool
• Papua New Guinea
• African disease programs
• universities

and the organizations conducting mass treatment programs.

Ebola later drew heavily on precisely this broader global-health architecture.

LIVERPOOL SCHOOL OF TROPICAL MEDICINE IS THE INSTITUTIONAL BRIDGE

The name that keeps appearing behind these people is not coincidental:

Liverpool School of Tropical Medicine.

Ashford came from Liverpool.

Bockarie trained at Liverpool, worked for years in PNG and later directed Liverpool's Centre for Neglected Tropical Diseases.

Lalloo worked in PNG and later became Liverpool's director and vice-chancellor.

And during the West African Ebola crisis Liverpool personnel became involved in Ebola response, research, scientific advising and public-health discussion.

Even in contemporary descriptions of the school, its PNG and Ebola histories appear side by side. One Liverpool account describes students hearing Tim O'Dempsey, who had played an important role managing Ebola in Sierra Leone, while also hearing accounts of medical work in Papua New Guinea from Professor Peter Pharoah.

The countries and diseases change.

The professional institution does not.

THE TIMING IS ALSO INTERESTING

The chronology makes the continuity easier to see.

1970s–1980s

Richard Ashford is conducting parasite research in Papua New Guinea, including malaria, filariasis, hookworm and Strongyloides.

1990–1993

David Lalloo is doing medical research in Papua New Guinea.

1993–1998

James Kazura and Moses Bockarie conduct the Papua New Guinea filariasis mass-treatment research involving DEC and ivermectin.

1996

Bockarie becomes head of the Vector Borne Disease Unit at the Papua New Guinea Institute of Medical Research.

2002

Bockarie appears as a PNG researcher inside the WHO international lymphatic-filariasis network alongside Liverpool and other global-health figures.

2014

The enormous West African Ebola outbreak erupts.

Bockarie is now participating prominently in the Ebola discussion centered on Sierra Leone.

2014–2016

The wider Liverpool/global tropical-medicine network becomes heavily engaged with Ebola.

Later

David Lalloo, another former PNG tropical-medicine researcher, serves on Britain's SAGE for Ebola.

Ashford belonged to a PNG/Liverpool tropical-disease network that subsequently produced or included people who became directly involved with Ebola.

The standout names are:

Moses Bockarie — very strong crossover.

PNG Institute of Medical Research, filariasis, ivermectin/DEC mass-treatment studies, WHO disease-control network, Liverpool, Sierra Leone and then Ebola.

David Lalloo — very strong crossover.

Years of field research in Papua New Guinea, Liverpool tropical medicine, then membership on the official British SAGE Ebola advisory group.

Richard Ashford — important earlier link, but not an Ebola figure that I can document.

His importance is that he demonstrates that Liverpool's deep involvement in Papua New Guinea tropical-disease research was already established decades earlier.

Pharmaceutical Company Crossover: PNG, Tropical-Disease Programs and Ebola

Here are the pharmaceutical companies worth tracking for crossover between the tropical-disease/mass-treatment world we have been following and Ebola:

1. Merck (MSD) — the strongest crossover. Merck developed and donated ivermectin/Mectizan for mass treatment of river blindness and lymphatic filariasis. Decades later, Merck obtained the Ebola vaccine rVSV-ZEBOV from NewLink Genetics in 2014, developed it as Ervebo, and became one of the central pharmaceutical companies in Ebola vaccination.
2. Johnson & Johnson / Janssen — another major crossover. J&J became heavily involved in neglected tropical disease and mass-drug-administration programs, including donating mebendazole for intestinal worms. Janssen then developed the two-dose Zabdeno/Mvabea Ebola vaccine regimen, which received European authorization in 2020.
3. GlaxoSmithKline (GSK) — deeply involved in the mass-treatment tropical-disease system. GSK has donated enormous quantities of albendazole for lymphatic filariasis, the same disease being studied in Papua New Guinea. During the West African Ebola epidemic, GSK developed the experimental ChAd3-EBO-Z Ebola vaccine with the U.S. National Institute of Allergy and Infectious Diseases. It reached clinical trials but did not become the principal licensed Ebola vaccine.
4. Pfizer — appears in the broader neglected-tropical-disease donation structure through its enormous azithromycin/Zithromax donation program for trachoma. Pfizer is therefore part of the same pharmaceutical/public-health mass-treatment architecture, although its Ebola connection is considerably weaker than Merck, J&J or GSK. I would classify this as institutional crossover rather than a major Ebola-product crossover.
5. Sanofi — another large pharmaceutical company with longstanding tropical-disease partnerships, particularly involving sleeping sickness and other neglected tropical diseases. Sanofi also participated in Ebola-related research efforts during the West African crisis, but again this is a weaker connection than Merck, J&J and GSK.
6. Bayer — has participated in WHO neglected-tropical-disease programs and drug donations, particularly involving African sleeping sickness and Chagas disease. Its Ebola connection is much weaker, so I would keep Bayer in the secondary category rather than presenting it as a central Ebola company.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:ec7e983f-da07-41c0-ba26-aa8fc0fc6b13-5" data-turn-id-container= "request-WEB:ec7e983f-da07-41c0-ba26-aa8fc0fc6b13-5" data-testid= "conversation-turn-12" data-turn="assistant"> EBOLA: Back in the Congo — The Global-Health Network Behind the Ivermectin Campaigns

The Ebola outbreak now spreading through the Democratic Republic of the Congo is not simply another recurrence of a familiar African disease. It is also bringing many of the institutions involved in decades of mass public-health interventions in Africa back into view.

The overlap with the ivermectin story is real. But it needs to be described accurately. It is not literally every organization and every individual from the ivermectin campaigns returning for Ebola. Rather, the same core international public-health infrastructure is operating in the same region again, joined by organizations, pharmaceutical companies and research institutions specific to Ebola.

At the center of both stories is the World Health Organization.

THE IVERMECTIN NETWORK

The mass distribution of ivermectin for river blindness, or onchocerciasis, became one of the largest and longest-running pharmaceutical interventions in Africa.

Merck began donating Mectizan, its brand of ivermectin, in 1987. WHO says population-wide ivermectin treatment remains the central strategy for eliminating onchocerciasis and that Merck continues to donate the drug.

This was not simply a Merck program.

WHO was the executing agency for the African Programme for Onchocerciasis Control, or APOC, which began in 1995. WHO describes APOC as a global partnership involving African governments, donors, NGOs, private industry and affected communities. Its principal strategy became community-directed treatment with ivermectin.

The broader ivermectin/onchocerciasis network included organizations such as WHO, Merck and the Mectizan Donation Program, the World Bank, Carter Center, CDC, USAID, Bill & Melinda Gates Foundation, Lions Clubs and numerous NGOs and national health ministries.

WHO itself has described the Merck-Mectizan-WHO-APOC structure as an early model for the public-private global-health partnerships that followed.

That history becomes important when we look at what is happening in Congo today.

EBOLA RETURNS TO CONGO

The current outbreak is different from many previous Congo Ebola outbreaks because it is being caused by Bundibugyo virus, rather than the better-known Zaire ebolavirus.

By August 12, 2026, WHO reported 4,665 confirmed cases and 2,184 deaths in the Democratic Republic of the Congo, a case-fatality ratio of 46.8%. The outbreak had reached six provinces and 54 health zones. WHO said it had become the largest Ebola outbreak ever documented in the DRC by case count.

The response is taking place amid warfare, displacement and attacks on health facilities. WHO acknowledges that insecurity has discouraged some potential patients from seeking care and interfered with surveillance and response operations.

That helps explain why "trust" has become one of WHO's dominant themes.

WHO says it is conducting community assessments and working with local populations to increase acceptance of the response. Tedros said on August 18 that WHO and its partners were "working with communities to build trust and ownership."

But while that trust campaign is underway, Congo is simultaneously becoming the site of major vaccine and therapeutic research.

THERE WAS NO LICENSED BUNDIBUGYO VACCINE

When this outbreak began, there was no licensed vaccine specifically targeting Bundibugyo virus and no approved specific treatment for it.

That created an unusual situation.

Instead of simply distributing an already proven Bundibugyo vaccine, international health organizations began rapidly evaluating experimental products and determining whether vaccines developed for other Ebola viruses might provide protection.

Gavi committed as much as $50 million to the Bundibugyo response, including up to $40 million intended to accelerate access to investigational and eventually approved vaccines.

Then another familiar name appeared.

Merck.

MERCK: FROM IVERMECTIN TO EBOLA

Merck manufactured and donated the ivermectin used in the enormous river-blindness campaigns.

Merck also developed Ervebo, the Ebola vaccine now being deployed in Congo.

There is an important complication.

Ervebo is licensed and recommended against Zaire ebolavirus disease.

The present Congo outbreak is Bundibugyo virus disease.

WHO states plainly that:

It is not known whether Ervebo protects humans against Bundibugyo virus.

Laboratory and animal evidence suggests possible cross-protection, but human effectiveness remains unknown.

Nevertheless, on August 20 WHO and Africa CDC announced that Congo would receive an initial allocation of 70,000 Ervebo doses.

And those doses have two very different purposes.

20,000 doses are allocated to a Phase 3 clinical trial designed to determine Ervebo's effect against Bundibugyo virus.

Another 50,000 doses are allocated to frontline and health workers under WHO recommendations.

WHO specifically says people offered the vaccine must be informed about its risks, potential benefits and limitations and must be able to provide informed consent.

That qualification matters.

This isn't simply a conventional vaccination campaign against a virus for which the vaccine has already demonstrated human efficacy.

Part of the Congo deployment is explicitly a Phase 3 clinical trial designed to determine whether this existing Ebola vaccine works against Bundibugyo virus in humans.

The international stockpile itself demonstrates the larger network.

WHO says the International Coordinating Group controlling the stockpile consists of WHO, UNICEF, Médecins Sans Frontières and the International Federation of Red Cross and Red Crescent Societies, while Gavi finances the stockpile.

CONGO IS ALSO HOSTING DRUG TRIALS

Vaccines are only one component.

On July 2, the WHO-sponsored PARTNERS clinical trial began enrolling Ebola patients in Congo.

WHO says the trial is testing two potential treatments:

MBP134, a monoclonal antibody treatment.

Remdesivir, an antiviral drug.

They are being tested separately and in combination.

By August 18, Tedros reported that the PARTNERS trial had enrolled 100 patients.

Another antiviral has entered the picture as well.

WHO reported in July that partners led by Congo's National Institute for Biomedical Research had launched a trial of obeldesivir as post-exposure prophylaxis.

That means the drug is being studied in people who have been exposed to confirmed Ebola cases but have not yet developed the disease.

Meanwhile, a Bundibugyo-specific vaccine developed through Oxford's ChAdOx1 platform entered its first human safety trial in July.

By August 18, WHO said two vaccines designed specifically for Bundibugyo had entered human trials, while the separate vaccine showing cross-protection in animal studies was moving toward the Phase 3 trial.

So Congo is simultaneously dealing with an enormous Ebola epidemic and serving as a location where vaccines and therapeutics are being clinically evaluated.

THE NETWORK COMPARISON

The ivermectin story involved a recognizable operating structure:

WHO + pharmaceutical industry + international financing organizations + Western governments + NGOs + African governments + local communities.

The Ebola response has essentially the same institutional architecture:

WHO + pharmaceutical and biotechnology companies + Gavi and other international financing mechanisms + Western governments and research institutions + NGOs + Africa CDC + Congo's government and research institutions + local communities.

The individual participants aren't completely identical.

For example, the Carter Center was enormously important to ivermectin distribution but is not running the present WHO Ebola treatment trial.

Likewise, organizations involved in experimental Ebola therapeutics weren't necessarily part of the original ivermectin program.

But several important institutional bridges are unmistakable.

WHO is central to both.

Merck is central to both.

Mass international public-health intervention in Africa is central to both.

African national health systems and local communities are central to both.

And the public-private partnership model pioneered during the ivermectin era is very much present again.

AND THEN THERE IS TRUST

This may be the most revealing part of the current story.

WHO isn't hiding the trust problem.

Its own August reporting says insecurity and attacks on medical facilities have discouraged potential patients from seeking treatment.

WHO and Africa CDC are explicitly calling for a community-led response.

WHO has created programs specifically devoted to collecting community feedback and studying what people are saying about the outbreak and response.

That mistrust should not automatically be interpreted as proof that the vaccines or drugs are dangerous, nor does institutional overlap establish improper conduct.

But neither should the mistrust simply be dismissed as irrational.

People living through an epidemic, armed conflict, displacement and repeated international health interventions are now being asked to cooperate with an emergency response that includes experimental therapeutics, experimental vaccines and a Phase 3 trial of an existing vaccine whose effectiveness against the virus currently killing people in Congo remains unknown.

WHO's own language recognizes that informed consent and clear communication about those uncertainties are essential.

That puts the word TRUST at the center of the story.

Not because outsiders have decided that trust is a problem.

Because WHO itself says it is.

And that creates the question worth investigating:

After decades of international disease programs in Central Africa—from mass ivermectin administration to repeated Ebola interventions—why do international health organizations still have to fight so hard to persuade some of the people living there to trust them?

That is the thread connecting the ivermectin story to the Ebola story.

The strongest documented conclusion isn't that every participant is exactly the same.

It is that the same global-health system has returned to the same region, some of its most important institutional players are the same, and once again one of its biggest obstacles is convincing the people on the ground to trust it. Current Congo Ebola Treatments: None Are Proven for Bundibugyo Ebola

The simplest way to understand the current Ebola treatment situation in the Democratic Republic of the Congo is this:

There is presently no approved drug that has been shown to treat the Bundibugyo Ebola virus causing this outbreak.

WHO states that directly. When the outbreak was confirmed in May 2026, it said there was "no currently approved therapeutics or vaccines against Bundibugyo virus."

That is why clinical trials are taking place during the outbreak.

REMDESIVIR

Remdesivir is not an entirely untested drug. This distinction is important.

It has previously been given to humans and was tested against Zaire Ebola during the large 2018–2019 Congo outbreak. In that PALM clinical trial, 175 Ebola patients received remdesivir. It did not perform as well as the two antibody treatments that ultimately became preferred therapies.

But that previous trial involved a different Ebola virus species.

The present outbreak is caused by Bundibugyo virus.

There was no clinical evidence establishing that remdesivir saves people with Bundibugyo Ebola when WHO selected it for the current trial.

WHO therefore began a new clinical trial on July 2, 2026, specifically to find out whether remdesivir works against Bundibugyo Ebola.

So the accurate statement is:

Remdesivir has been tested in humans before, including against Zaire Ebola, but it had not been clinically proven effective against Bundibugyo Ebola when WHO began giving it to patients in this trial.

MBP134

MBP134 is a monoclonal-antibody treatment.

Before the current Congo trial, WHO's assessment relied substantially on laboratory research, animal evidence, pharmacological information and available safety information.

WHO described MBP134 as having broad virus-neutralizing activity and promising efficacy in animal models.

That is very different from having demonstrated that it saves humans suffering from Bundibugyo Ebola.

The current Congo PARTNERS trial is specifically attempting to answer that question.

WHO says the trial is testing whether MBP134:

improves survival among people diagnosed with Bundibugyo virus disease.

In other words, that answer was not known beforehand.

REMDESIVIR + MBP134

They are also testing the two drugs together.

Again, WHO does not know whether that combination improves survival from Bundibugyo Ebola.

That is another question the clinical trial is designed to answer.

OBELDESIVIR

Obeldesivir is another antiviral.

This one is particularly noteworthy because it is being tested as post-exposure prophylaxis.

That means some participants have been exposed to Ebola but have not yet developed Ebola disease.

WHO announced that trial in July.

WHO's technical advisers had reviewed preclinical evidence and antiviral activity and concluded that obeldesivir was promising enough to justify clinical evaluation.

But again:

Promising enough to test is not the same thing as proven to work.

WHO itself called it a candidate requiring clinical evaluation.

THE VACCINES ARE IN THE SAME POSITION

The same basic problem exists with vaccination.

There was no licensed Bundibugyo vaccine when this outbreak started.

A Bundibugyo-specific Oxford ChAdOx1 vaccine only entered its first safety trial in July 2026.

WHO is also moving toward a randomized trial of Ervebo, Merck's licensed Ebola vaccine.

But Ervebo was developed and licensed for Zaire Ebola, not Bundibugyo Ebola.

WHO's own advisers recommended putting it into a randomized clinical trial precisely because its effectiveness against the virus causing the present outbreak remains uncertain.

SO WHAT IS ACTUALLY PROVEN?

The established part of treatment is principally supportive medical care.

That means identifying Ebola quickly, replacing fluids and electrolytes, maintaining blood pressure and oxygenation, treating complications and providing intensive nursing and medical support.

WHO specifically said in May:

"early supportive care is lifesaving."

That is different from claiming that one of these experimental drugs cures Bundibugyo Ebola.

WHO itself noted in July that hundreds of patients had recovered even without approved vaccines or treatments.

THE BOTTOM LINE

The current situation can be stated very simply.

There is no proven, approved Bundibugyo-specific Ebola drug.

Remdesivir has previously been tested in humans and against another Ebola species, but it has not been established as an effective Bundibugyo treatment.

MBP134 has encouraging laboratory and animal evidence, but its ability to save humans with Bundibugyo Ebola is what the current Congo trial is trying to discover.

The MBP134-remdesivir combination is also experimental.

Obeldesivir is experimental for preventing disease after Bundibugyo exposure.

And Bundibugyo-specific vaccines are only now entering human trials.

WHO made the status unusually clear on May 28:

All of the candidate products it selected should be used exclusively within clinical trials so that evidence about their safety and effectiveness can actually be generated.

For the Bundibugyo virus spreading through Congo today, these interventions are experimental. The patients being treated in the trials are helping researchers determine whether they work.

Crossover Organizations: Papua New Guinea, Tropical-Disease Programs and Ebola

If we expand beyond pharmaceutical companies, the organizational crossover becomes much clearer. These are the groups I would track:

1. World Health Organization (WHO) — major crossover. WHO was deeply involved in malaria, lymphatic filariasis, neglected tropical diseases, ivermectin programs and mass drug administration. It also became the central international health organization coordinating Ebola outbreaks.
2. Liverpool School of Tropical Medicine (LSTM) — major crossover. Long history in Papua New Guinea and tropical-disease research. Richard Ashford, Moses Bockarie and David Lalloo all connect to Liverpool. Liverpool personnel later became involved in the West African Ebola response and Ebola scientific advising.
3. Papua New Guinea Institute of Medical Research (PNGIMR) — central to the earlier PNG side. It conducted malaria, filariasis and other infectious-disease research, including the work involving Moses Bockarie. Its direct Ebola role is much weaker, but it connects personnel who later appear in Ebola work.
4. U.S. Centers for Disease Control and Prevention (CDC) — major crossover. CDC has long worked internationally on malaria, parasitic diseases, neglected tropical diseases and mass-treatment programs. It became one of the principal U.S. institutions deployed during the 2014–2016 Ebola epidemic and subsequent outbreaks.
5. National Institutes of Health / NIAID — major crossover. NIAID has funded and conducted tropical infectious-disease research for decades and became heavily involved in Ebola vaccines, therapeutics and clinical trials.
6. Médecins Sans Frontières (Doctors Without Borders) — major Ebola organization with substantial tropical-disease crossover. MSF had decades of experience treating malaria, sleeping sickness and other infectious diseases before becoming one of the most visible organizations treating Ebola patients in West Africa.
7. Wellcome Trust — important research-funding crossover. Wellcome has financed tropical medicine and infectious-disease research for decades and subsequently became a significant funder of Ebola research and emergency scientific work.
8. Bill & Melinda Gates Foundation — important later crossover. The foundation became one of the largest private funders of malaria, neglected tropical diseases, mass drug administration, vaccines and African public health. It also committed substantial funding to the West African Ebola response and subsequent epidemic preparedness.
9. World Bank — major institutional crossover. The World Bank was central to the African Onchocerciasis Control Programme infrastructure and later the African Programme for Onchocerciasis Control. During the West African Ebola epidemic, the World Bank committed major financing to Guinea, Liberia and Sierra Leone.
10. UNICEF — longstanding participant in vaccination, infectious-disease control, sanitation and public-health programs throughout Africa and the Pacific. UNICEF subsequently became heavily involved in Ebola vaccination, community engagement, communications and outbreak response.
11. United Nations — Ebola eventually moved beyond ordinary public-health management. During the 2014 crisis the UN created the United Nations Mission for Ebola Emergency Response (UNMEER), making Ebola the subject of a dedicated UN emergency mission.
12. U.S. Department of Defense — another important crossover once Ebola became framed as a security emergency. The Pentagon had already funded infectious-disease and tropical-disease research. During the West African epidemic the United States deployed thousands of military personnel under Operation United Assistance.
13. U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) — particularly important. USAMRIID had studied Ebola and other hemorrhagic-fever viruses for decades before the 2014 outbreak and became part of the research and diagnostic infrastructure surrounding Ebola.
14. The Carter Center — important on the tropical-disease side because of its enormous involvement in river blindness, Guinea worm, trachoma and other African disease-control programs. Its direct operational Ebola role was much smaller than WHO, CDC or MSF, so I would classify this as a network crossover rather than a central Ebola-response organization.

The strongest crossover group

If we strip this down to the organizations that repeatedly appear across the different parts of our research, I would keep these names at the top:

WHO

CDC

NIH/NIAID

Liverpool School of Tropical Medicine

World Bank

Wellcome

Médecins Sans Frontières

United Nations

U.S. military infectious-disease establishment

Then there is a second layer containing organizations such as the Gates Foundation, UNICEF and Carter Center.

The important distinction is that their presence in multiple disease programs does not by itself establish that the programs were connected or coordinated for some undisclosed purpose. These are institutions specifically built to work across infectious diseases, so some crossover is expected.

But for tracing the institutional history, the crossover is real and worth documenting: the same relatively small global-health establishment repeatedly appears in malaria, filariasis, river blindness, neglected tropical diseases, mass drug administration and eventually Ebola response and vaccination.

2009

• Financial/banking crisis: Obama inherited the financial collapse and Bush-era TARP, while his administration launched its own Financial Stability Plan, continued stabilization of the banking system, supported GM and Chrysler, and enacted the $787 billion American Recovery and Reinvestment Act.
• Foreclosure crisis: The administration launched Making Home Affordable amid the housing collapse.
• Afghanistan surge: Obama substantially escalated the Afghanistan war, announcing another major troop increase in December. U.S. troop strength went from about 32,800 in 2009 to roughly 100,000 in 2010.
• Pakistan: Drone strikes and counterterrorism operations in Pakistan expanded during his presidency.
• Iraq: Obama announced a timetable for reducing the large U.S. military presence inherited from George W. Bush.
• Guantánamo: Obama ordered the detention facility closed within a year. It ultimately remained open when he left office.
• H1N1/swine flu: Obama declared the H1N1 influenza outbreak a national emergency in October.
• Nobel Peace Prize: On October 9, 2009, less than nine months after Obama became president, the Norwegian Nobel Committee announced that he would receive the 2009 Nobel Peace Prize for his efforts to strengthen international diplomacy and cooperation. He formally accepted the prize in Oslo on December 10, 2009, while serving as commander in chief during the wars in Afghanistan and Iraq.
• Nobel Prize and Afghanistan overlap: The timing was particularly striking: nine days before Obama accepted the Nobel Peace Prize, he announced that an additional 30,000 U.S. troops would be sent to Afghanistan.

2010

• Affordable Care Act/Obamacare: Obama signed the ACA, producing the largest restructuring of the American health-insurance system in decades.
• Dodd-Frank: Major post-financial-crisis overhaul of banking and financial regulation.
• Deepwater Horizon: The BP drilling-rig explosion produced the enormous Gulf of Mexico oil spill.
• Haiti earthquake: The United States mounted a major humanitarian and military-supported response after the catastrophic January earthquake.
• WikiLeaks: Massive releases of classified U.S. military and diplomatic material became an international controversy.
• Drone warfare: Targeted killings remained an increasingly important part of U.S. counterterrorism policy.
• Arab Spring begins: Mohamed Bouazizi's self-immolation in Tunisia in December 2010 helped trigger the uprising that toppled Tunisia's government and spread across the Arab world.

2011

• Arab Spring: Revolts spread through Tunisia, Egypt, Libya, Bahrain, Yemen and Syria, among other countries.
• Egypt: Longtime U.S.-aligned President Hosni Mubarak was forced from power.
• Libya: Obama authorized U.S. military action against Muammar Gaddafi's forces in March.
• NATO Libya campaign: The United States initially played a leading military role before NATO assumed operational command.
• Gaddafi overthrown and killed: Rebel forces toppled his government; Gaddafi was captured and killed in October.
• Libyan aftermath: Libya subsequently fragmented, with militias, rival governments and eventually renewed civil war.
• Syria: The Syrian uprising began and evolved into a catastrophic civil war.
• Yemen: The uprising against President Ali Abdullah Saleh intensified.
• Bahrain: Protests were suppressed with assistance from Saudi and Gulf forces while the United States maintained its strategically important relationship with Bahrain.
• Osama bin Laden: U.S. forces killed bin Laden in Pakistan in May.
• Anwar al-Awlaki: A U.S. drone strike in Yemen killed the American-born cleric in September, creating a major controversy over the government's power to deliberately kill a U.S. citizen without a criminal trial.
• Iraq withdrawal: Most remaining U.S. troops departed Iraq at the end of 2011.

2012

• Arab Spring aftermath: Egypt, Libya, Syria and Yemen remained deeply unstable.
• Syria: The civil war expanded dramatically.
• Benghazi: On September 11, 2012, militants attacked the U.S. diplomatic compound and nearby CIA annex in Benghazi, Libya. Ambassador Christopher Stevens and three other Americans were killed.
• Yemen: The United States continued extensive counterterrorism operations and drone strikes.
• Somalia: U.S. counterterrorism operations against al-Shabaab continued.
• Obama reelected: Obama defeated Mitt Romney in November.

2013

• Edward Snowden/NSA: Snowden's disclosures exposed extensive U.S. surveillance programs, including bulk telephone-metadata collection and international electronic surveillance.
• Syria chemical-weapons crisis: Following the Ghouta chemical attack, Obama considered military strikes after previously describing chemical-weapons use as a "red line." The administration ultimately accepted a Russian-brokered agreement for Syria to surrender its declared chemical-weapons stockpile.
• CIA/drone program: Questions about targeted killing, secrecy and executive authority became major controversies.
• Egypt: The Egyptian military removed President Mohamed Morsi following enormous demonstrations. General Abdel Fattah el-Sisi emerged as Egypt's dominant political figure and later became president.
• Boston Marathon bombing: The United States experienced another major domestic terrorist attack.
• Government surveillance versus civil liberties: The Snowden revelations made this one of the defining political controversies of Obama's second term.

2014

• Ukraine: President Viktor Yanukovych fled following the Maidan uprising.
• Crimea: Russia seized and annexed Crimea.
• Donbas war: Fighting began in eastern Ukraine between Ukrainian forces and Russian-backed separatists.
• Russia sanctions: Obama imposed economic sanctions on Russia.
• ISIS: ISIS captured huge areas of Iraq and Syria, including Mosul.
• U.S. returns militarily to Iraq: Obama authorized airstrikes against ISIS.
• Syria air war: The United States began bombing ISIS targets inside Syria.
• American troops returned to Iraq: U.S. personnel returned in advisory, training and other military roles.
• Ebola: The enormous West African epidemic centered on Guinea, Liberia and Sierra Leone.
• Obama makes Ebola a national-security priority: On September 16, 2014, Obama went to the CDC in Atlanta and declared that combating Ebola was a "national security priority."
• National Security Council involvement: Obama explicitly described the Ebola response as operating across the entire federal government and appeared at the CDC alongside members of his national-security team.
• U.S. military and Ebola: Obama announced a major military-supported response centered on Liberia. Approximately 3,000 U.S. military personnel were initially planned, with the deployment ultimately rising above that level, to provide logistics, laboratories, treatment-unit construction and other infrastructure.
• Ferguson: Michael Brown's killing and the resulting protests became a major national political event.
• Cuba: Obama announced a historic move toward normalization of relations with Cuba.

This is the pivotal year for the Ebola show: Ukraine/Russia, ISIS, renewed American military operations in Iraq, airstrikes in Syria and the enormous Ebola epidemic were all confronting the Obama administration simultaneously. Ebola itself was explicitly elevated to a national-security priority.

2015

• Yemen war: A Saudi-led coalition intervened militarily against the Houthis in March.
• Obama administration supports Saudi campaign: The United States provided intelligence, logistical assistance and weapons and established a planning cell with Saudi Arabia. Aerial refueling subsequently became another significant element of U.S. support.
• Yemen humanitarian catastrophe: The conflict developed into one of the world's gravest humanitarian crises.
• Iran nuclear deal: The United States and other powers reached the JCPOA with Iran.
• ISIS: U.S. air operations continued in Iraq and Syria.
• Syria: Russia directly entered the Syrian war militarily in September.
• Refugee crisis: Huge numbers of refugees and migrants from Syria and elsewhere entered Europe.
• Paris attacks: ISIS-linked terrorists killed 130 people in November.
• San Bernardino: Fourteen people were killed in an ISIS-inspired terrorist attack in California.
• Paris climate agreement: Obama made climate diplomacy a major international priority.

2016

• ISIS war continues: U.S. military operations continued across Iraq and Syria.
• Mosul campaign: Iraqi forces, supported heavily by the U.S.-led coalition, began the battle to retake Mosul.
• Libya again: The United States launched an extended air campaign against ISIS targets around Sirte, Libya.
• Yemen: U.S. support for the Saudi-led coalition continued alongside direct American counterterrorism operations.
• Drone warfare: Operations continued in Yemen, Somalia and other theaters.
• Russia/U.S. election interference: U.S. intelligence agencies publicly accused Russia of interfering in the presidential election.
• DNC hacking/WikiLeaks: Democratic Party emails stolen by hackers were published by WikiLeaks during the election campaign. U.S. intelligence subsequently attributed the hacking operation to Russia.
• Standing Rock/Dakota Access Pipeline: The pipeline protests became a major confrontation involving Native American sovereignty, energy infrastructure and federal policy.
• Orlando Pulse nightclub attack: 49 victims were killed in what was then the deadliest mass shooting in modern U.S. history.
• Cuba: Obama became the first sitting U.S. president to visit Cuba since Calvin Coolidge's 1928 visit.
• Flint water crisis: Although the decisions that created the crisis were primarily state and local, Flint became a major national issue during Obama's final years.
• Zika: The administration confronted another international infectious-disease emergency, this time the Zika virus and its association with severe congenital abnormalities.

January 2017 — Obama Leaves Office

Obama left office on January 20, 2017, exactly eight years after becoming president.

Across those eight years came the financial and foreclosure crisis, Afghanistan surge, H1N1 pandemic, Nobel Peace Prize, Obamacare, expansion of drone warfare, Arab Spring, overthrow of Mubarak, Libya intervention and overthrow of Gaddafi, Libyan collapse, Syrian civil war, Yemen upheaval, killing of bin Laden, targeted killing of American citizen Anwar al-Awlaki, Benghazi, Snowden/NSA revelations, Ukraine revolution, Russian annexation of Crimea, Donbas war, rise of ISIS, renewed U.S. military intervention in Iraq, U.S. bombing in Syria, Ebola elevated to a national-security priority, U.S. military deployment for Ebola, Saudi-led Yemen war with American support, Iran nuclear agreement, European refugee crisis, renewed American bombing in Libya, Zika and escalating confrontation with Russia.

And the striking bookend comes almost immediately:

January 20, 2009 — Obama becomes president.

October 9, 2009 — Obama is awarded the Nobel Peace Prize.

December 1, 2009 — Obama announces another 30,000 troops for Afghanistan.

December 10, 2009 — Obama accepts the Nobel Peace Prize.

That last sequence is especially useful because it doesn't require editorializing. The dates themselves tell the story.

Ivermectin and Ebola in the Congo: Familiar Territory for International Public Health

There is a significant geographic and institutional overlap between the decades-long campaign to distribute ivermectin for river blindness in the Democratic Republic of the Congo and the areas that have subsequently experienced major Ebola outbreaks. That overlap does not demonstrate that ivermectin caused Ebola or that the programs themselves are connected. What it does demonstrate is that international public-health organizations were operating extensively in the Congo long before some of the country's largest Ebola responses began.

Ivermectin Arrived in Congo Decades Ago

River blindness, or onchocerciasis, has an unusually long history in the Democratic Republic of the Congo. A review of the country's National Program for Onchocerciasis Control reports that the disease was first identified there in 1903 and is endemic in all provinces of the country.

Ivermectin entered this picture in 1987, initially as a clinical treatment. Mass treatment began in 1989.

The Congolese government created its National Program for Onchocerciasis Control in 1996. Beginning in 1999, health authorities conducted large-scale epidemiological mapping to identify populations that should receive ivermectin.

In 2001, the country began what became known as community-directed treatment with ivermectin, or CDTI. Under this model, ivermectin wasn't simply dispensed through hospitals or doctors. Treatment was organized at the community level, requiring local distributors, population mapping, repeated treatment campaigns and extensive interaction between public-health programs and individual communities.

Some projects were halted in 2005 because of serious adverse events associated with treatment in areas where Loa loa was also present. Additional mapping was undertaken to distinguish onchocerciasis and loiasis risk areas. Community-directed ivermectin treatment resumed in 2006.

The WHO-sponsored African Programme for Onchocerciasis Control, APOC, remained involved until the program closed in 2015.

That means Congo had already experienced roughly three decades of ivermectin use by the time of the enormous 2018 Ebola outbreak in eastern Congo.

Then Ebola Hits North Kivu and Ituri

On August 1, 2018, the Democratic Republic of the Congo declared an Ebola outbreak in North Kivu Province.

It subsequently spread through North Kivu, Ituri and South Kivu.

This became an extraordinary international public-health operation. According to WHO, during the nearly two-year response authorities and international partners:

• registered approximately 250,000 contacts;
• tested approximately 220,000 samples;
• vaccinated more than 303,000 people;
• trained thousands of health workers;

and constructed an extensive surveillance and laboratory network.

By the time the outbreak ended in June 2020, there had been 3,470 reported Ebola cases and 2,287 deaths.

So these weren't occasional visits by international health organizations. By this point eastern Congo had experienced enormous, sustained public-health operations involving surveillance, laboratories, vaccination, contact tracing and direct interaction with hundreds of thousands of people.

The Earlier Ivermectin Infrastructure Matters

This is where the history becomes particularly interesting.

Long before that Ebola response, Congo's river-blindness programs had already required public-health organizations to learn how to operate in remote communities, identify populations at risk, map disease geographically, recruit community health workers, distribute medication repeatedly and monitor treatment.

That is what makes the phrase "familiar territory" reasonable.

It does not necessarily mean that the same individuals who distributed ivermectin later ran Ebola treatment centers. Nor does it establish that the two programs had some common purpose.

But institutionally, Congo was certainly not unexplored territory for the international public-health establishment.

There had already been decades of experience working with the Congolese Ministry of Health and local communities.

And Now Ituri and North Kivu Appear Again

The geographic overlap becomes even more noticeable in 2026.

The current Ebola epidemic is centered heavily in eastern and northeastern Congo. As of August 20, 2026, the DRC had reported 5,290 confirmed cases and 2,516 deaths. On just the preceding day, 81 additional confirmed cases were reported, including 56 in Ituri and 18 in North Kivu.

Those names should sound familiar.

Ituri. North Kivu.

They were central to the massive 2018–2020 Ebola outbreak as well.

The current epidemic has now become the largest and deadliest Ebola outbreak in the history of the Democratic Republic of the Congo. Reuters reported on August 23 that more than 2,500 people have died, making this the country's 17th Ebola epidemic.

The CDC describes the current epidemic as spreading substantially faster than previous Ebola outbreaks and says cases have been confirmed in Haut-Uele, Ituri, North Kivu, South Kivu and Tshopo.

Once again, international organizations are deploying disease surveillance, isolation facilities, epidemiologists, laboratories and experimental medical interventions into territory where international disease-control programs have operated for decades.

The Important Distinction

There are two different conclusions that can be drawn from this history, and they shouldn't be confused.

The first is well documented:

The Congo, including portions of eastern Congo, has been the site of extensive international disease-control programs for decades. Ivermectin distribution for river blindness was one of the largest of those programs. Later, some of these same regions became centers of enormous Ebola-response operations.

The second proposition would be much stronger:

That ivermectin programs somehow caused, facilitated or were intentionally connected with subsequent Ebola outbreaks.

I have not found evidence establishing that.

Geographic overlap alone cannot demonstrate it. There is also a straightforward epidemiological reason why several disease programs would operate in the same country: the DRC has environmental conditions favorable to multiple tropical diseases, large rural populations, limited medical infrastructure, extensive population movement and, particularly in eastern Congo, prolonged armed conflict.

But that explanation doesn't make the historical overlap disappear.

What the Timeline Shows

Put the events in chronological order and the continuity becomes much easier to see.

• 1903: Onchocerciasis documented in Congo.
• 1987: Ivermectin introduced for clinical treatment.
• 1989: Mass ivermectin treatment begins.
• 1996: Congo establishes its National Program for Onchocerciasis Control.
• 1999: Large-scale mapping begins to identify mass-treatment areas.
• 2001: Community-directed mass ivermectin distribution begins.
• 2006: CDTI resumes following additional mapping concerning Loa loa risks.
• 2015: WHO's African Programme for Onchocerciasis Control closes.
• 2018: Major Ebola epidemic begins in North Kivu and spreads into Ituri and South Kivu.
• 2020: That epidemic ends after nearly two years, 3,470 reported cases, 2,287 deaths, 250,000 registered contacts and more than 303,000 vaccinations.
• 2026: Another enormous Ebola epidemic develops, with Ituri and North Kivu again among the principal affected areas. By August it has become the worst Ebola outbreak in Congo's recorded history.

Familiar Territory

The significant story here isn't that the presence of ivermectin proves something about Ebola. It doesn't.

The significant story is continuity.

For decades, Congo has been the location of enormous international disease-control projects. The river-blindness campaign established community-based treatment systems reaching deeply into Congolese communities. Later Ebola responses brought still larger surveillance, vaccination, laboratory and contact-tracing operations into some of the same broad regions.

So when international organizations arrived in eastern Congo to fight Ebola, they were not entering a country with which the international public-health system had little experience.

They were returning to territory in which international disease-control organizations had already been working for decades.

That is the documented connection. What, if anything, should be inferred beyond that requires additional evidence rather than geography alone.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:0744d871-17cf-4c47-9ba0-fdc365ec93cb-11" data-turn-id-container= "request-WEB:0744d871-17cf-4c47-9ba0-fdc365ec93cb-11" data-testid= "conversation-turn-24" data-turn="assistant">

The chronology is:

1967 — Marburg virus discovered. African green monkeys imported from Uganda for laboratory work in Germany and Yugoslavia were associated with the first recognized Marburg virus disease outbreaks.

1967–1976 — Marburg is essentially the prototype. Scientists now knew there was an extraordinarily lethal African hemorrhagic-fever virus with this distinctive morphology and disease pattern.

1976 — Ebola appears as a newly recognized disease. Separate outbreaks occurred in Sudan and Zaire (now DRC). Investigators initially had to determine whether the new disease was Marburg virus.

Laboratory examination showed that the new virus resembled Marburg morphologically but was antigenically distinct. It was therefore identified as a new virus and named Ebola virus.

The relationship is quite close biologically. Today both are classified in the same virus family:

Filoviridae

Within that family:

Marburg virus belongs to Orthomarburgvirus.

Ebola viruses belong to Orthoebolavirus.

So for our master timeline, 1967 belongs at the very beginning, before the 1974 WHO/World Bank river-blindness program:

1967 — Marburg: African monkeys imported from Uganda for laboratory research are associated with outbreaks in European laboratory workers.

1974 — WHO/World Bank: Onchocerciasis Control Programme begins in West Africa.

1976 — Ebola: first recognized Ebola outbreaks; investigators distinguish the new virus from the already-known Marburg virus.

That actually makes the beginning of the timeline considerably more interesting: Marburg 1967, major African tropical-disease program 1974, Ebola 1976, ivermectin research 1978–81.

Ebola Virus — History, 2014 Outbreak and What We Know Today Ebola and Marburg

Marburg virus was discovered before Ebola.

In 1967, outbreaks of a severe hemorrhagic fever occurred among laboratory workers in Marburg and Frankfurt, Germany, and Belgrade, Yugoslavia (now Serbia). The outbreaks were associated with laboratory work involving African green monkeys imported from Uganda.

Workers became infected while handling infected monkeys or their tissues. The outbreak led to the identification of a previously unknown virus, which became known as Marburg virus.

African green monkeys are not considered the natural reservoir of Marburg virus. The Egyptian fruit bat (Rousettus aegyptiacus) is now recognized as its natural reservoir.

Marburg would become particularly important when another severe African hemorrhagic fever appeared nine years later.

1976 — Ebola Is Identified

The first recognized Ebola outbreaks occurred in 1976, in what were then Zaire, now the Democratic Republic of the Congo, and Sudan, now South Sudan.

Because the disease resembled Marburg hemorrhagic fever, investigators initially considered whether they were dealing with Marburg virus.

Laboratory testing demonstrated that the virus was related to Marburg but antigenically distinct.

A new virus had been identified: Ebola virus.

Today Marburg viruses and Ebola viruses are classified within the same virus family, Filoviridae.

How Ebola Spreads

Ebola virus disease is a severe infectious disease that can have a very high fatality rate.

Human outbreaks are believed to begin when a virus crosses from an infected animal into a person.

Once Ebola enters the human population, it spreads principally through direct contact with the blood or other bodily fluids of an infected person, or through materials contaminated with those fluids.

People caring for Ebola patients and health-care workers without adequate protective equipment are therefore at particularly high risk.

Ebola is not considered an ordinarily airborne human disease in the manner of measles or influenza.

Experimental research has demonstrated that transmission between certain infected animals can occur without direct physical contact under particular laboratory conditions. Those experiments, however, did not demonstrate routine airborne human-to-human transmission during the 2014 West African epidemic.

March 2014 — Ebola Appears in Guinea

On March 22, 2014, Guinea announced an Ebola epidemic following cases of a mysterious hemorrhagic illness in the country's southeast.

Médecins Sans Frontières deployed doctors, nurses, logisticians and sanitation specialists along with medical supplies.

The outbreak soon crossed national borders.

By the end of March, Ebola had been confirmed in Liberia.

In May, cases were confirmed in Sierra Leone.

What had initially appeared to be another localized African Ebola outbreak was developing into something unprecedented.

June 2014 — Largest Ebola Epidemic Yet Recorded

By mid-June, hundreds of people had died.

The epidemic had already exceeded previous Ebola outbreaks and was spreading through communities in several West African countries.

Unlike many earlier Ebola outbreaks occurring in relatively isolated locations, this epidemic reached densely populated areas and crossed international borders.

July 2014 — WHO Establishes Regional Coordination

On July 2–3, 2014, WHO convened an emergency ministerial meeting in Accra, Ghana, involving health ministers and international organizations.

Countries agreed to strengthen:

• surveillance
• case detection
• contact tracing
• community involvement
• cross-border cooperation
• deployment of health personnel
• national and international financing

WHO established a Sub-regional Ebola Outbreak Coordination Centre in Guinea to coordinate international assistance.

By this stage the response involved national governments, WHO, NGOs, international donors, laboratories, health-care workers and community organizations.

August 2014 — International Emergency

By August 6, 2014, WHO reported:

1,711 cases

932 deaths

Cases had been reported in Guinea, Liberia, Sierra Leone and Nigeria.

On August 8, 2014, WHO declared the outbreak a Public Health Emergency of International Concern.

The declaration greatly intensified international coordination of the response.

Experimental Treatments

There was no licensed Ebola-specific treatment or vaccine when the West African epidemic began.

That fact became enormously important as the number of patients increased.

Experimental treatments, including ZMapp, were used during the emergency.

Two American aid workers infected in Liberia were evacuated to Emory University Hospital in Atlanta in August 2014.

ZMapp was still experimental and had not completed the normal clinical-development process.

The emergency therefore generated an international debate over when experimental medicines could ethically be administered during a deadly epidemic for which no approved specific treatment existed.

2014–2016 — An Unprecedented Epidemic

The West African epidemic eventually became vastly larger than the numbers being reported during the summer of 2014.

According to WHO, the epidemic ultimately resulted in more than:

28,600 reported cases

11,300 deaths

The overwhelming majority occurred in Guinea, Liberia and Sierra Leone.

It remains the largest Ebola epidemic ever recorded globally.

The Ebola Vaccine

The 2014 epidemic also accelerated development of Ebola vaccines.

One of the leading candidates had originally been developed by scientists working for the Public Health Agency of Canada.

The technology was subsequently licensed to NewLink Genetics.

In November 2014, Merck obtained worldwide rights to develop, manufacture and distribute the vaccine.

Large-scale evaluation followed during the West African epidemic, including an important WHO-coordinated trial in Guinea.

The vaccine eventually became ERVEBO.

In 2019, European regulators authorized it, WHO prequalified it, and the FDA approved it for prevention of disease caused by Zaire ebolavirus.

Ebola Treatment Today

The statement that Ebola has no approved treatment is no longer accurate.

Specific monoclonal-antibody treatments are now available for Ebola virus disease caused by Zaire ebolavirus, including Inmazeb (REGN-EB3) and Ebanga (ansuvimab/mAb114).

Likewise, ERVEBO provides a licensed vaccine against disease caused by Zaire ebolavirus.

That distinction matters because Ebola is not a single virus.

Different members of the Ebola-virus group can cause human disease, and a vaccine or treatment demonstrated to work against one does not automatically work against all of them.

What the 2014 Record Establishes

The 2014 outbreak provides a remarkably detailed record of how the international response developed.

By July, WHO was coordinating governments and international organizations and establishing a regional control center.

By August, the outbreak had become an international public-health emergency.

Experimental drugs were being administered because no approved Ebola-specific therapy existed at the time.

And during the same emergency, development of vaccines and treatments accelerated dramatically.

The history therefore runs from the 1967 laboratory-associated Marburg outbreak, to the discovery of Ebola in 1976, to the unprecedented 2014–2016 West African epidemic, and ultimately to the development of approved Ebola vaccines and treatments.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:0744d871-17cf-4c47-9ba0-fdc365ec93cb-4" data-turn-id-container= "request-WEB:0744d871-17cf-4c47-9ba0-fdc365ec93cb-4" data-testid= "conversation-turn-10" data-turn="assistant">

The working map now looks like this:

Institution / player Ivermectin / river blindness Ebola WHO Executing agency for APOC; ran the earlier West African Onchocerciasis Control Programme; ivermectin became central to control/elimination International coordination, surveillance, treatment guidance, vaccine trials and outbreak response World Bank Founding/sponsoring institution in the large African onchocerciasis programs Major Ebola-response financing in West Africa; also administered later Ebola-recovery funding Merck Created the Mectizan Donation Program in 1987 and supplied ivermectin Acquired worldwide rights to the Canadian-developed Ebola vaccine candidate in 2014; ultimately produced ERVEBO Carter Center Major ivermectin distribution/elimination organization; executed the Americas onchocerciasis partnership Existing Liberia operation shifted resources toward Ebola; Carter-trained clinicians worked in Ebola Treatment Units and with affected communities African ministries of health National partners implementing mass ivermectin programs Central national partners implementing Ebola surveillance, isolation, treatment and vaccination Community health networks Community-directed ivermectin distribution Community education, case identification, contact work and later vaccination/outbreak response NGOs / international donors Drug distribution, financing, logistics, surveillance Treatment centers, personnel, logistics, surveillance, recovery programs Pharmaceutical industry Mass donated-drug model Experimental therapeutics and vaccines; eventually licensed Ebola vaccine West Africa OCP operated across West Africa beginning in 1974 Guinea, Liberia and Sierra Leone became the center of the enormous 2014–2016 Ebola epidemic

There is one particularly good documented crossover that strengthens the map. The Carter Center says its Liberia clinicians worked in Ebola Treatment Units and provided psychosocial support to Ebola victims. Even more interesting, a subsequent Carter Center Ebola-recovery project was funded through the Japan Social Development Fund, a trust fund administered by the World Bank. So there we have Carter Center + World Bank + Liberia + Ebola operating together, not merely appearing independently in the same general field.

And on the ivermectin side, WHO itself describes the institutional structure: WHO was the executing agency for APOC, while the Carter Center executed the Americas partnership; WHO also identifies the World Bank among its onchocerciasis partners. Merck still describes its 1987 Mectizan program as the longest-running disease-specific drug-donation/public-private partnership of its kind.

_:empty]:hidden"> ONE MASTER TIMELINE — IVERMECTIN, AFRICAN DISEASE PROGRAMS AND EBOLA, 1974–2026

1974 — WHO / World Bank / West African governments

WHO's Onchocerciasis Control Programme (OCP) begins in West Africa. The World Bank is one of the sponsoring agencies. Eleven West African countries eventually participate. Initially the principal intervention is aerial control of the blackfly vector.

This establishes a large international African disease-control structure involving WHO, World Bank, African governments, international donors and local health systems.

1976 — Ebola identified

The first recognized Ebola outbreaks occur in what are now South Sudan and the Democratic Republic of the Congo.

Ebola is therefore already a known African infectious disease while the international onchocerciasis program is operating.

1978–1981 — Merck / WHO / ivermectin

Merck researchers identify ivermectin's potential against Onchocerca volvulus, the parasite responsible for river blindness.

Human ivermectin trials begin in Senegal in 1981. Merck and WHO are now working within the existing African tropical-disease system.

1985–1987 — Ivermectin moves toward mass use

Large field trials demonstrate ivermectin's usefulness against onchocerciasis.

In 1987, Merck announces that it will donate Mectizan, its brand of ivermectin, for river blindness for as long as necessary and establishes the Mectizan Donation Program.

The network now prominently includes WHO, World Bank, Merck, African governments, NGOs and community health systems.

1989–1990 — Mass ivermectin distribution begins

WHO's West African program incorporates large-scale ivermectin distribution.

The international program now has a drug that can be repeatedly administered to entire populations living in endemic areas.

1991 — NGOs formally integrated into ivermectin distribution

The NGDO Coordination Group for Onchocerciasis Control is established.

International NGOs work with WHO, Merck's Mectizan program, African governments and local health systems to distribute ivermectin.

The institutional network is becoming increasingly interconnected:

WHO · World Bank · Merck · African governments · NGOs · communities

1992 — Carter Center joins the ivermectin network

The Carter Center becomes a major participant through the Onchocerciasis Elimination Program for the Americas and subsequently extensive African river-blindness programs.

By the early 1990s virtually our entire recurring group is visible:

WHO · World Bank · Merck · Carter Center · African governments · NGOs · community health systems

1995 — African Programme for Onchocerciasis Control

WHO launches the African Programme for Onchocerciasis Control (APOC), with the World Bank serving as fiscal agent.

Its signature strategy becomes community-directed treatment with ivermectin.

Communities themselves select distributors and participate in repeated treatment. This builds an enormous community-level system for delivering health interventions across endemic African regions.

1998 — Ivermectin network expands to another disease

Merck expands its Mectizan donation to include lymphatic filariasis elimination in African countries where it overlaps with river blindness.

GlaxoSmithKline contributes albendazole for combination treatment.

The same international and community infrastructure is now being used against multiple tropical diseases.

2002 — Original West African OCP ends, but the system continues

The original Onchocerciasis Control Programme closes after 28 years.

APOC, national ivermectin programs, pharmaceutical donation programs, NGOs and community-directed treatment continue.

The African disease-control infrastructure established beginning in 1974 has evolved rather than disappeared.

2000s–2013 — Community-directed programs continue across Africa

WHO, African governments, NGOs, pharmaceutical donation programs and community distributors continue tropical-disease programs across Africa.

The Carter Center remains heavily involved in African disease elimination.

Merck continues donating ivermectin through the Mectizan Donation Program.

By the time the enormous Ebola epidemic arrives, many of these institutions have already spent decades working through African governments, health systems and individual communities.

2014 — Massive West African Ebola epidemic

Ebola spreads through Guinea, Liberia and Sierra Leone.

Many organizations already familiar from the ivermectin era are prominent again:

WHO · World Bank · African governments · NGOs · community health systems

The World Bank commits major financing. WHO coordinates international health activities. NGOs operate treatment and community programs. African ministries and local health workers provide much of the national and local infrastructure.

2014 — Carter Center / Liberia / Ebola

The Carter Center already has substantial operations in Liberia when Ebola strikes.

Existing Carter Center personnel and programs are redirected in part toward the Ebola emergency, including mental-health personnel and community activities.

The Carter Center therefore moves from decades of African disease-control work into the Ebola response while already operating on the ground.

November 2014 — Merck enters the Ebola-vaccine program

Merck acquires worldwide rights from NewLink Genetics to develop, manufacture and distribute the experimental Canadian-developed rVSV-ZEBOV Ebola vaccine.

The same company that established the enormous Mectizan ivermectin donation program in 1987 is now a major pharmaceutical participant in the Ebola response.

2014–2015 — WHO / Merck / African governments / Ebola vaccine trials

The vaccine is rapidly evaluated during the West African epidemic, including the major WHO-coordinated trial in Guinea.

Once again the operating structure includes international health organizations, pharmaceutical companies, African governments, researchers, health workers and local communities.

2015 — The ivermectin and Ebola programs directly overlap

WHO's African Programme for Onchocerciasis Control remains in operation throughout the West African Ebola emergency and closes at the end of 2015.

This is an important point in the master timeline.

The huge WHO/World Bank African ivermectin program and the WHO-led Ebola response are operating at the same time.

There is no institutional gap between the two periods.

2015–2016 — Ebola response and recovery

WHO, World Bank, Carter Center, African governments, NGOs and community organizations remain involved in Ebola control and recovery.

At the same time, ivermectin distribution and onchocerciasis-elimination programs continue beyond the closure of APOC.

2018–2020 — Massive Democratic Republic of the Congo Ebola epidemic

Another enormous Ebola epidemic occurs in eastern DRC.

It ultimately records approximately 3,300 cases and 2,300 deaths.

WHO, the Congolese government, international organizations, NGOs and community health workers conduct the response.

Merck's experimental Ebola vaccine is extensively deployed.

2019 — Merck's ERVEBO approved

European regulators authorize Merck's Ebola vaccine, WHO prequalifies it, and the FDA approves ERVEBO in December 2019 for prevention of disease caused by Zaire ebolavirus.

Merck now occupies both sides of the master timeline:

1987 — Mectizan / ivermectin mass-donation program

2019 — ERVEBO / Ebola vaccine

2020s — The ivermectin infrastructure continues

The end of APOC did not end Merck's Mectizan Donation Program or African ivermectin treatment.

Countries continue mass drug administration and elimination programs for onchocerciasis and lymphatic filariasis.

So the institutions at the center of the earlier timeline remain active:

WHO · Merck · African governments · NGOs · community health systems

2021–2025 — Ebola surveillance and outbreaks continue

Additional Ebola outbreaks occur in the Democratic Republic of the Congo and elsewhere in Africa.

WHO, African governments, Africa CDC, NGOs, laboratories and international partners maintain Ebola surveillance and emergency-response capacity.

At the same time, ivermectin programs continue operating.

The two histories are now running simultaneously rather than sequentially.

May 15, 2026 — New Ebola outbreak declared in the Democratic Republic of the Congo

DRC declares a major outbreak of Ebola disease caused by Bundibugyo virus, centered initially in Ituri Province.

The international response again involves the institutional network that has developed across decades of African disease programs.

WHO · African governments · Africa CDC · international organizations · NGOs · health workers · community health systems

May 17, 2026 — WHO declares an international emergency

WHO determines that the Ebola outbreak constitutes a Public Health Emergency of International Concern.

Surveillance, laboratories, contact tracing, treatment centers and community health systems are mobilized.

June 2026 — Ebola spreads beyond Congo

By June 17, DRC has reported approximately 896 confirmed cases and 232 deaths.

Uganda also reports cases associated with transmission originating in Congo.

WHO, national governments, laboratories, health workers and community networks operate across borders.

July 2026 — Congo outbreak accelerates

By July 1:

1,460 confirmed cases 452 deaths

By July 15:

2,124 confirmed cases 828 deaths

By July 30:

3,605 confirmed cases 1,587 deaths

The outbreak surpasses the case count of the enormous 2018–2020 DRC Ebola epidemic.

August 2026 — WHO / Africa CDC / Congo government

WHO, Africa CDC and the Congolese government intensify the response.

The operating structure emphasizes:

community involvement · contact tracing · surveillance · treatment centers · frontline health workers · national government · international health organizations

The same community-level health infrastructure that appears throughout this master timeline remains central.

August 12, 2026 — Six Congolese provinces affected

Reported totals reach approximately:

4,665 confirmed cases 2,184 deaths 54 health zones 6 provinces

The affected provinces include Ituri, North Kivu, South Kivu, Haut-Uélé, Tshopo and Bas-Uélé.

The epidemic is now described as the largest Ebola outbreak recorded in the Democratic Republic of the Congo.

August 20, 2026 — More than 5,000 confirmed cases

Reported totals reach approximately:

5,290 confirmed cases 2,516 deaths

Ituri remains the center of the epidemic.

The outbreak continues.

August 2026 — Merck appears again

Congo receives supplies of Merck's ERVEBO Ebola vaccine through WHO and international partners.

This outbreak involves Bundibugyo virus, whereas ERVEBO is licensed against Zaire ebolavirus, making vaccine research and response strategy particularly important during the current outbreak.

Merck therefore remains present at the current end of a timeline that began with its ivermectin work almost half a century earlier.

THE 52-YEAR CONTINUITY — 1974–2026

1974 — WHO + World Bank + African governments: major international African river-blindness program begins.

1976 — Ebola: first recognized African outbreaks.

1981 — Ivermectin: human trials in Senegal.

1987 — Merck: Mectizan Donation Program begins.

1989 — WHO: large-scale ivermectin distribution.

1991 — NGOs: formally coordinated with the ivermectin program.

1992 — Carter Center: becomes part of the ivermectin/onchocerciasis network.

1995 — WHO + World Bank: APOC expands community-directed ivermectin treatment across Africa.

1998 — Merck: ivermectin network expands into lymphatic filariasis.

2000s — WHO + Merck + Carter Center + governments + NGOs: mass treatment and community disease-control programs continue.

2014 — Ebola: enormous West African epidemic brings WHO, World Bank, African governments, NGOs and community health networks into the response.

2014 — Merck: acquires worldwide development rights to the Ebola vaccine.

2015 — DIRECT OVERLAP: WHO's massive African ivermectin program is still operating while the West African Ebola emergency and Ebola-vaccine trials are underway.

2018–2020 — Congo Ebola: WHO, African governments, NGOs and community systems respond; Merck vaccine extensively deployed.

2019 — Merck: ERVEBO approved.

2020s — Ivermectin continues: Merck's Mectizan donation and African elimination programs remain active.

2021–2025 — Ebola continues: surveillance and additional African outbreaks keep the Ebola infrastructure active.

2026 — Congo Ebola: largest recorded Ebola outbreak in DRC history.

August 2026 — WHO + Africa CDC + Congo government + NGOs + community health systems: massive response underway.

August 2026 — Merck: ERVEBO vaccine supplies again appear in the Congo response.

1974–2026

For more than five decades, the master timeline repeatedly contains many of the same institutional participants:

WHO · World Bank · Merck · Carter Center · African governments · NGOs · international donors · community health systems

The timeline begins with the massive international effort against river blindness, incorporates the introduction and mass distribution of ivermectin, continues through the development of community-directed African disease programs, overlaps directly with the 2014–2016 Ebola emergency, continues through the 2018–2020 Congo Ebola epidemic, and reaches the enormous 2026 Congo Ebola outbreak underway today.

References

Centers for Disease Control and Prevention. "History of Ebola Outbreaks." Last reviewed May 29, 2026. CDC – History of Ebola Outbreaks.

World Health Organization. "Ebola Disease." April 24, 2025. WHO – Ebola Disease.

World Health Organization. "Ebola Outbreak 2018–2020: North Kivu-Ituri." World Health Organization. WHO – North Kivu/Ituri Ebola Outbreak.

World Health Organization. "Ebola Then and Now: Eight Lessons from West Africa That Were Applied in the Democratic Republic of the Congo." World Health Organization. WHO – Ebola Then and Now.

World Health Organization. Risk Communication and Community Engagement (RCCE) Considerations: Ebola Response in the Democratic Republic of the Congo. Geneva: World Health Organization, July 3, 2018. WHO – RCCE Considerations.

World Health Organization, UNICEF, and International Federation of Red Cross and Red Crescent Societies. Risk Communication and Community Engagement Preparedness and Readiness Framework: Ebola Response in the Democratic Republic of the Congo in North Kivu. Geneva: World Health Organization, September 2018. WHO – North Kivu RCCE Framework.

World Health Organization International Study Team. "Ebola Haemorrhagic Fever in Sudan, 1976." Bulletin of the World Health Organization 56, no. 2 (1978): 247–270.

International Commission. "Ebola Haemorrhagic Fever in Zaire, 1976." Bulletin of the World Health Organization 56, no. 2 (1978): 271–293.

"Before you trust someone with the future, look at what they did with the power they already had." - Dianne Emerson

Eugenics and Silicon Valley: The Gates Family, Stanford University and William Shockley, Father of Silicon Valley, PROMOTED Eugenics.

Silicon Valley wants us to trust its most powerful technology leaders with artificial intelligence, personal data, communications, surveillance, defense, jobs and technologies capable of reshaping human society. But before asking where the Tech Bros want to take humanity, perhaps we should ask a more basic question: Who are these people, how did they acquire so much power, and why should we trust them?

This episode investigates the history behind the Silicon Valley mythology, beginning with Stanford University and its disturbing connections to the American eugenics movement. From Stanford's founding president David Starr Jordan and psychologist Lewis Terman to Frederick Terman and the creation of the Stanford-centered technology ecosystem, the story follows an extraordinary intersection of eugenics, intelligence testing, military research, government funding, universities and private industry.

The semiconductor family tree raises another remarkable connection. Nobel Prize-winning transistor pioneer William Shockley founded Shockley Semiconductor Laboratory and later became one of America's most notorious public advocates of eugenics. Eight Shockley employees left to establish Fairchild Semiconductor, and Fairchild's Gordon Moore and Robert Noyce later founded Intel. The history of Silicon Valley is far more interconnected than the familiar stories of independent geniuses starting companies from nothing.

The investigation also follows Bill Gates, Microsoft and the IBM deal; Mary Gates's connection to IBM chairman John Opel; Bill Gates Sr.'s involvement with Planned Parenthood; Microsoft's landmark antitrust case; government support behind Elon Musk's Tesla and SpaceX; taxpayer-funded research that became the foundation for enormous private fortunes; and the continuing influence of Stanford, SRI, Fairchild, Intel and other institutions on the technologies that now dominate our lives.

Google, Palantir, Tesla, SpaceX, Theranos, WeWork, Uber, Airbnb and other celebrated technology companies raise the same fundamental question: How much of the Silicon Valley success story actually belongs to the billionaire standing onstage, and how much was created behind the curtain by taxpayers, government agencies, military programs, universities, scientists and engineers whose names most people will never know?

Drawing on my own experience working at Intel and later suing the company after years spent developing a project involving Intel technology, I also return to the 1994 Pentium processor crisis and something I witnessed firsthand: a technology problem becomes something much larger when the public stops trusting the people responsible for the technology.

Today the stakes are vastly greater than a defective computer chip. Elon Musk, Peter Thiel, Alex Karp, Sam Altman, Mark Zuckerberg, Bill Gates and other technology billionaires and executives increasingly operate at the intersection of artificial intelligence, defense, surveillance, biotechnology, global health, communications, information and political power.

Everybody publishes lists of the richest people in technology.

Maybe we have been keeping the wrong list.

This is a story about Silicon Valley, Stanford University, eugenics, Bill Gates, Microsoft, Elon Musk, Peter Thiel, Palantir, artificial intelligence, Intel, Fairchild Semiconductor, William Shockley, government funding, military research, monopoly, Big Tech, surveillance, population policy, billionaire power and trust.

Who actually built the technological world we live in? Who paid for it? Who controls it now?

And if a remarkably small group of extraordinarily wealthy and powerful people intends to influence humanity's future, perhaps the most important question is also the simplest: Tech Bros Want to Control the Future. Can We Trust them?

Clip: Peter Thiel Doesn't Want You to See This Clip

Music: The Lovin' Spoonful - Do You Believe in Magic (Official Audio)

Bill Gates' Father Ran Planned Parenthood, His Mother Created Microsoft, Together They Trained Their Son To Spread The Gospel Of Eugenics • Now The End Begins

Bill Gates, His Father and Eugenics :: By Geri Ungurean - Rapture Ready

Birth control leader Margaret Sanger: Darwinist, racist and eugenicist · Creation.com

Eugenics in America: The Legacy of Sanger and Gates – Catholic Stand

Bill Gates, Eugenics, Vaccines, and Planned Parenthood — Dean W. Arnold

Bill-Gates-Philanthropist-Eugenicist.pdf

William Shockley - Wikipedia

William Shockley

William Shockley: The Flawed Visionary Behind Silicon Valley - News

'BlacKkKlansman' and William Shockley's Eugenic Agenda - AAIHS

Stanford Eugenics History Project

How hormones work to flip sexes: Hormones

Do you have a psychopath in your life? The best way to find out is read my book. BOOK *FREE* Download – Psychopath In Your Life4

Support is Appreciated: Support the Show – Psychopath In Your Life

Download Pods here: TOP PODS – Psychopath In Your Life

My old discussion forum with last 10 years of victim stories, is back online. Psychopath Victim Support Community | Forums powered by UBB.threads™

Google Maps My HOME Address: 309 E. Klug Avenue, Norfolk, NE 68701 SMART Meters & Timelines – Psychopath In Your Life

Reasons You Might Not Want to Trust the Tech Bros

Everybody publishes lists of the ten richest people in tech.

Maybe we have been keeping the wrong list.

Microsoft, Bill Gates and the IBM Deal Microsoft's breakthrough deal with IBM helped turn the company into a technology powerhouse. But the familiar garage-genius story leaves out an interesting connection: Bill Gates's mother, Mary Gates, served on the national United Way board alongside IBM chairman John Opel. The relationship doesn't prove she arranged Microsoft's deal, but it is a part of the story worth knowing.

Taxpayer-Funded Research, Privately Owned Fortunes Many technologies underlying today's enormous private fortunes grew out of decades of government-funded research, military programs and university laboratories. The public often financed the early risk; private companies eventually captured enormous commercial rewards.

Stanford, Frederick Terman and the Birth of Silicon Valley Silicon Valley didn't simply spring from a collection of brilliant kids working in garages. Stanford's Frederick Terman deliberately cultivated relationships among the university, military research, government funding and private technology companies—helping create the ecosystem that became Silicon Valley.

• David Starr Jordan — Stanford University's founding president, serving from 1891 to 1913, and then chancellor until 1916. Jordan was one of the prominent American advocates of eugenics in the early 20th century. He served on the Eugenics Committee of the American Breeders Association, an important early organization in the American eugenics movement, and became associated with the Human Betterment Foundation, the California organization that promoted compulsory sterilization. Jordan wrote and lectured extensively about heredity, human breeding, race, and what he considered the deterioration of the population. His eugenic interests therefore weren't peripheral to Stanford's early history: the university's founding president was himself an active participant in the American eugenics movement.
• Lewis Terman — probably the most important after Jordan. Stanford psychologist, Stanford-Binet IQ test, advocate of hereditarian ideas and eugenics, and member of the Human Betterment Foundation. He later became head of Stanford's psychology department.
• Ellwood P. Cubberley — Jordan personally recruited him to Stanford in 1898. He became professor of education and ultimately the first dean of Stanford's School of Education. Cubberley then hired Lewis Terman in 1910, giving you a direct personnel connection between these figures.
• Leonas Lancelot Burlingame — joined Stanford biology in 1909 and actually taught a course dealing with heredity, social welfare and eugenics for years. A 1922 biology textbook he coauthored explicitly promoted eugenic ideas, including sterilization. He later published Heredity and Social Problems in 1940. Stanford archival research also connects him with the Human Betterment Foundation, from which he obtained pro-sterilization material for his Stanford course.

William Shockley: Semiconductors and Eugenics Nobel Prize-winning physicist William Shockley was one of the central figures in the development of the transistor and founded Shockley Semiconductor Laboratory—the company from which the famous "traitorous eight" departed to create Fairchild Semiconductor. Shockley later became one of America's most notorious public advocates of eugenic ideas, including proposals involving voluntary sterilization and IQ.

Shockley → Fairchild → Intel: The Silicon Valley Family Tree The semiconductor industry wasn't created by hundreds of unrelated entrepreneurs appearing independently. Shockley Semiconductor produced the group that founded Fairchild. Fairchild produced Gordon Moore and Robert Noyce, who founded Intel. Follow the family tree and Silicon Valley suddenly becomes much smaller.

Bill Gates Sr., Planned Parenthood and Population Control Bill Gates Sr. served on the board of Planned Parenthood in Seattle. His son later became one of the world's most influential private actors in global health, vaccination and family planning. Gates Sr. himself said population issues had interested Bill since childhood. That doesn't establish a secret eugenics program—but the family history belongs in any serious examination of Gates's later population and health work.

Microsoft and the Antitrust Case Distrust of Microsoft wasn't simply conspiracy theory or resentment of a successful businessman. The United States government brought a landmark antitrust case against Microsoft, and a federal judge found that Microsoft possessed monopoly power and engaged in anticompetitive conduct. The litigation ultimately ended in a settlement after the breakup order was overturned on appeal.

Elon Musk and the Government Money Behind the Empire The mythology presents the tech billionaire as the ultimate private entrepreneur. The reality is more complicated. Tesla, SpaceX and other Musk ventures have benefited from government contracts, loans, tax incentives, subsidies and other public support. The question isn't whether the companies accomplished extraordinary things. It is why taxpayers so often disappear from the origin story.

The Strange Deaths and Power Struggles Around Technology Fortunes Technology history also contains deaths, lawsuits, corporate battles and succession fights that deserve careful examination. These cases need to be separated into what is documented, what remains disputed and what is merely speculation—but they shouldn't automatically be ignored simply because enormous fortunes and powerful people are involved.

The Next Generation: Phoebe Gates and Phia The story doesn't necessarily end with the founders. Phoebe Gates, Bill Gates's daughter, co-founded shopping startup Phia. In 2026 the company faced controversy over affiliate attribution practices, including allegations of "cookie stuffing." Phia disputed aspects of the accusations, removed the features at issue and said it was working to reverse improperly attributed transactions and strengthen compliance.

Eugenics on the Farm David Starr Jordan, a notable eugenicist, was the first president of Stanford University. (Wikimedia Commons)

David Starr Jordan, the first president of Stanford University, was one of the most prominent eugenicists of the early 20th century. In the name of eugenic progress, Jordan promoted the sterilization of unwanted populations, led and founded eugenic advocacy groups, and fought against the immigration of "inferior" populations to the United States. With his popular influence and widespread networks, Jordan was a kingpin of the American eugenics movement, bringing eugenicists together and securing funding for their research. It is therefore no coincidence that Stanford has an extensive history entangled with eugenics and race science.

Since its foundation, Stanford has been home to many key eugenic researchers, including David Starr Jordan, Lewis Terman, Ellwood Cubberley and many others. Even as recently as the 1970s, eugenicists have taught at Stanford — for example, William Shockley, notable physicist and professor, obsessively attempted to prove the intellectual superiority of the white race. Many of our campus buildings still bear the name of notable eugenicists. Over the course of this year, I will use this column to explore this history, examining the ways eugenic and scientifically racist thought manifested themselves at Stanford, the myriad of Stanford affiliates who have endorsed this line of thought, and the painful legacies of eugenics in the United States and abroad.

As students at an elite university, the history of eugenics is deeply relevant to us. Stanford and the Graduate School of Education (notably named after Cubberley, a eugenicist) played a fundamental role in the application of eugenic theory to the university, affecting many aspects of how we understand higher education — who is gifted, who deserves access to the university and who is excluded through systems of educational standardization. Even today, the National Association for Gifted Children uncritically cites Lewis Terman and Francis Galton ("the father of eugenics") as key figures of their movement. If we want to end the structural inequality of education, exploring this genealogy is the first step.

Before getting into Stanford's history, let's first cover what eugenics is. Eugenics is the science of improving the human race through selective breeding, often seeking to control who can and who cannot reproduce. After the term was coined in 1883 by English scientist Francis Galton, eugenics quickly gained traction in the United States. Proponents of eugenics sought to a) promote the "fit" members of society (white able-bodied people) to reproduce at higher rates, and b) discourage or forcibly limit the reproduction of "unfit" members of society (people of color and disabled people). These approaches are known as positive eugenics and negative eugenics, respectively.

The history of eugenics in the United States is one of harm and oppression, of state-endorsed violence against the most vulnerable members of society. Between 1907 and 1937, 32 U.S. states passed sterilization laws in the name of eugenic progress. These laws forcibly sterilized unwanted populations: prisoners, disabled people, "feeble-minded" people, and other eugenically unfit populations, with people of color being disproportionately impacted. State governments performed upwards of 60,000 eugenic sterilization procedures on their unwanted populations between 1907 and 1963.

The State of California alone performed 20,000 (one-third) of those procedures. Into the 1970s, public clinics and hospitals targeted poor Black, Latinx and Indigenous women for coercive sterilization, often threatening to revoke their welfare benefits if they did not comply. By the 1970s, The Indian Health Service had sterilized at least 25% of all Indigenous women in the United States. Even as recently as between 2006 and 2010, the State of California performed almost 150 sterilization procedures on imprisoned women without informed consent.

The eugenics movement also had a transnational impact — eugenicists from across the globe exchanged ideas with each other in their mission to perfect the human race. Many countries, such as Canada and Sweden, had their own eugenic laws, limiting the reproduction of unwanted groups. Inspired in no small part by American eugenic research and sterilization laws, Nazi Germany sought to eliminate its unwanted populations, leading to the genocide of 11 million Jewish people, Slavic people, disabled people, queer people and other groups during the Holocaust. It is impossible to know how many human lives were harmed by eugenic logic and a belief in racial progress.

This column will examine in detail the role Stanford played in the history of eugenics. Each article in this year-long series will explore one prominent eugenicist or eugenic theme at Stanford and discuss their larger influence. To do so, I will be drawing from many excellent historians of eugenics — Alexandra Stern, Daniel Kevles, Nathaniel Comfort, Paul A. Lombardo, Wendy Kline, Stefan Kühl, among others — as well as my own research into the histories of eugenics and of Stanford University.

I will intentionally be referring to eugenics as a science, as opposed to a pseudoscience. This is not to imply that any of the axioms or theories of eugenics are factually accurate. Rather, it is to anchor eugenic thought historically in the sciences, to show its connection with claims of objectivity and rationality. Eugenics, for all practical purposes, was a science: scientists studied eugenics, scientific journals published eugenics, and students of science learned eugenics. Given the context of Stanford University, and given the context of Silicon Valley, it remains especially vital to remember the violence enacted in the name of science and narratives of progress.

I do not recount this history to assign guilt. Though Stanford today is the same institution as Stanford 100 years ago, the people I will be discussing have been dead for decades, along with the administrators who empowered them. Nevertheless, their ideas have outlived them. This legacy runs deeper than the names of eugenicists that appear on buildings: it is structural, shaping and constraining how we understand ability and education. That is the legacy I aim to uncover.

Stanford may not be unique in this matter (many other universities are currently grappling with their own histories with eugenics). However, Stanford students can gain much from understanding the role their university, their home, played in one of the most harmful ideologies in human history. To end, I'll quote a few words from Leilani Muir, a survivor of eugenic sterilization by the Canadian government in the 1950s, on the importance of remembering the legacies of eugenics:

"I think it is great that this story is being kept alive, through other people, through young people. Because they can stop this from happening again if they stay involved." Source: Eugenics on the Farm

Science's Distortion of William Shockley

In the Science editorial, Thorp attempted to picture Shockley as a loner, not mainstream, even claiming that he, "carried out his non-physics work through op-eds and conservative think tanks, not through the accepted mechanism of peer review that he used in doing physics."[8] But, in fact, Shockley published in leading mainline peer-reviewed literature, openly pushing what we now regard as his racist ideas. Some of the many examples include:

1. Shockley. 1965. "Is Quality of U.S. Population Declining." U.S. News & World Report, November 22, pp. 68–71.
2. Shockley. 1966. "Population Control or Eugenics." In J.D. Roslansky (ed.), Genetics and the Future of Man (New York, NY: Appleton-Century-Crofts).
3. Shockley. 1968. "Proposed Research to Reduce Racial Aspects of the Environment-Heredity Uncertainty". Proposal read by Shockley before the National Academy of Sciences (NAS) on April 24, 1968.
4. Shockley. 1968. "Ten Point Position Statement on Human Quality Problems", revised by Shockley from a talk which he presented on "Human Quality Problems and Research Taboos."
5. Shockley. 1969. "An Analysis Leading to a Recommendation Concerning Inquiry into Eugenic Legislation". Press release by Shockley, at Stanford University, on April 28, 1969.
6. Shockley. 1970. "A 'Try Simplest Cases' Approach to the Heredity-Poverty-Crime Problem." In V.L. Allen (ed.), Psychological Factors in Poverty (Stamford, CT.: Markham Publishing).
7. Shockley. 1970, "New Methodology to Reduce the Environment-Heredity Uncertainty About Dysgenics." National Academy of Sciences Autumn Meeting (Houston, TX), October 19-21.
8. Shockley. 1970. "Proposed NAS Resolution, drafted October 17, 1970." Proposed by Shockley before the National Academy of Sciences.
9. Shockley. 1971. "Hardy-Weinberg Law Generalized to Estimate Hybrid Variance for Negro Populations and Reduce Racial Aspects of the Environment-Heredity Uncertainty." Annual Meeting NAS, Washington, D.C., May 13.
10. Shockley. 1971. "Negro IQ Deficit: Failure of a 'Malicious Coincidence' Model Warrants New Research Proposals." Review of Educational Research 41(3):227-248, June.
11. Shockley. 1971a. "Dysgenics – A Social Problem Evaded by the Illusion of Infinite Plasticity of Human Intelligence?" Manuscript for reading at the American Psychological Association Symposium titled: "Social Problems: Illusion, Delusion or Reality."
12. Shockley. 1971b. "Models, Mathematics, and the Moral Obligation to Diagnose the Origin of Negro IQ Deficits." Review of Educational Research 41(4):397-377, October.
13. Shockley. 1972a. "Dysgenics, Geneticity, Raceology: A Challenge to the Intellectual Responsibility of Educators." Phi Delta Kappan 53(5):297-307, January.
14. Shockley. 1972b. "A Debate Challenge: Geneticity Is 80% for White Identical Twins' I.Q.'s." Phi Delta Kappan 53(7):415-419, March.
15. Shockley. 1972. "Proposed Resolution Regarding the 80% Geneticity Estimate for Caucasian IQ." Paper presented by Shockley at the Genetics Conference.
16. Shockley. 1973. "Deviations from Hardy-Weinberg Frequencies Caused by Assortative Mating in Hybrid Populations." Proceedings of the National Academy of Sciences 70(3):732-736, March.
17. Shockley. 1974. "Eugenic, or Anti-Dysgenic, Thinking Exercises." Published as a press release dated May 3, 1974.
18. Shockley. 1974. "Society Has a Moral Obligation to Diagnose Tragic Racial IQ Deficits." In Pearson, R. (editor) Shockley on Eugenics and Race: The Application of Science to the Solution of Human Problems. Scott-Townsend, Washington, D.C., January 1. Prepared statement by Shockley to be read during his February debate with Roy Innis.
19. Shockley. 1978. "Has Intellectual Humanitarianism Gone Berserk?" Introductory statement read by Shockley prior to a lecture given by him at UT Dallas.
20. Shockley. 1980. "Sperm Banks and Dark-Ages Dogmatism." Position paper presented by Shockley in a lecture to the Rotary Club of Chico, California, on April 16, 1980.
21. Shockley. 1981. "Intelligence in Trouble." Article by Shockley published in Leaders Magazine, dated June 15, 1981.
22. Shockley, William, and Roger Pearson (editor). 1992. Shockley on Eugenics and Race: The Application of Science to the Solution of Human Problems. Scott-Townsend, Washington, D.C., January 1.

Darwin's connection to eugenics documented.

This sample list shows that Dr Shockley, a professor at Stanford University when most of this work appeared, was publishing widely in leading academic peer-reviewed journals and books. To picture him as a loner and radical racist is worse than inaccurate. The fact is that, "science" in general was supportive of racism and eugenics for much of the last part of the 19th and most of the 20th century. The Civil Rights Movement changed all of this. Thorp admits:

The failure of Science to condemn Shockley began in 1968, [this is when eugenics was only beginning to be opposed] when it published a letter lamenting the fact that he was prohibited from speaking at the Polytechnic Institute of Brooklyn [one of the few places that would not allow him to speak]. The letter repeated the familiar trope that Shockley was simply asking questions about the role of race in intelligence. But Shockley had no scientific basis for doing so, he was not submitting peer-reviewed papers on the topic, [clearly not true as documented in the list above of some of his publications], and most importantly, he was using his ideas as the basis for promoting eugenics.[9]

William Shockley, Stanford professor and winner of the 1956 Nobel Prize in physics for his co-invention of the transistor, was arguably the single person most responsible for ushering in the computer age. He was also an ardent eugenicist whose theories of black racial inferiority eventually made him an academic pariah.

Despite having no training whatsoever in genetics, biology or psychology, Shockley devoted the last decades of his life to a quixotic struggle to prove that black Americans were suffering from "dysgenesis," or "retrogressive evolution," and advocated replacing the welfare system with a "Voluntary Sterilization Bonus Plan," which, as its name suggests, would pay low-IQ women to undergo sterilization. Although his theories were universally condemned by biologists as racist pseudoscience, Shockley partly succeeded in rehabilitating eugenics as an ideology by providing the foundations for a new, more politically savvy generation of academic racists, including Arthur Jensen, Richard Lynn and Charles Murray.

In his own words

"Babies too often get an unfair shake from a badly-loaded parental genetic dice cup. At the acme of unfairness are features of racial differences that my own research inescapably leads me to conclude exist: Nature has color-coded groups of individuals so that statistically reliable predictions of their adaptability to intellectually rewarding and effective lives can easily be made and profitably be used by the pragmatic man-in-the-street." — "Models, Mathematics, and the Moral Obligation to Diagnose the Origin of Negro IQ Deficits," Review of Educational Research, 1971.

"Preliminary research suggested that an increase of 1% in Caucasian ancestry raises Negro IQ an average of one point for low IQ populations. It should be kept in mind, however, that no conclusive evidence has been presented. In responding to a recent questionnaire, the majority of 23 presidents of predominantly Negro colleges indicated that black students at their schools are academically advantaged by attitudes towards racial differences; consequently, comparing racial mix differences with achievement differences might refine or reject the preliminary estimate that a one point increase in average "genetic" IQ occurs for each 1% of Caucasian ancestry, with diminishing returns approaching 100 IQ. To fail to use this method of diagnosis for fear of being called a racist is irresponsible. It may also be a great injustice to black Americans. If those Negroes with the fewest Caucasian genes are in fact the most prolific and also the least intelligent, then genetic enslavement will be the destiny of their next generation. The consequences may be extremes of racism and agony for both blacks and whites. … If what I fear is true, our society is being profoundly irresponsible. Our nobly intended welfare programs may be encouraging dysgenics—retrogressive evolution through disproportionate reproduction of the genetically disadvantaged." — "Negro IQ Deficit: Failure of a 'Malicious Coincidence' Model Warrants New Research Proposals," Review of Educational Research, 1971

"The view that the US negro is inherently less intelligent than the US white came from my concern for the welfare of humanity. My initial concern was not with the racial aspects, as these dysgenic effects occur for whites as well as blacks. If this is going on, it will harm both. I would like to stress that the failure of the intellectual community to deal with these matters is one of the cruelest irresponsibilities to a minority group that has ever occurred. If, in the US, our nobly-intended welfare programs are indeed encouraging the least effective elements of the blacks to have the most children, then a destiny of genetic enslavement for the next generation of blacks may well ensue. It is my considered opinion and evaluation that, at the present time, I am less likely to do damage by exacerbating a situation, and am currently the intellectual in America most likely to reduce Negro agony in the next generation." — Interview with New Scientist, 1973

"Prejudice that is not supported by strong facts is both illogical and not in accordance with truth. The general principle that truth is a good thing applies here. Some things that are called prejudice, which are based on sound statistics, really shouldn't be called prejudice. … It might be easier to think in terms of breeds of dogs. There are some breeds that are temperamental, unreliable, and so on. One might then regard such a breed in a somewhat less favorable light than other dogs. Now some of the business prejudices against blacks, the pragmatic man-in-the-street prejudices, are not incorrect. The man in the street has had experience and knows what to expect from blacks in business. If one were to randomly pick ten blacks and ten whites and try to employ them in the same kinds of things, the whites would consistently perform better than the blacks." — Interview with Playboy, 1980

Background

William Shockley's importance in the development of modern electronics cannot be overstated. While working at Bell Labs during the 1940s and 50s, Shockley led the team that invented the transistor, for which he and his collaborators won numerous prizes and awards. In 1965, however, Shockley's career took an abrupt turn from internationally famous physicist to racist crank when he gave an address at a Nobel conference on "Genetics and the Future of Man." In his lecture, Shockley warned of the threat of "genetic deterioration" and "evolution in reverse," problems exacerbated, he claimed, by the Great Society welfare programs that allowed the less genetically fit to reproduce at will, free from the constraints of natural selection.

By his own account, his obsession with the genetic inferiority of the black population was sparked by an article published two years previously in the Los Angeles Times detailing an acid attack on a delicatessen owner by a black teenager with a reported IQ of 65. According to the Times article, the attacker was the son of a woman with an IQ of 55 who had 17 children, only nine of whose names she could remember. In response to this story, Shockley said: "I asked myself what people I knew who had families that large. I could think of none. Apparently, these large families were those of people who were not making it in our society, so that those with the least intelligence were having the most children. The more I talked to people about this, the more alarmed I became. No one was willing to look at this subject objectively, dispassionately. This is what drew me into the whole question of dysgenics, or retrogressive evolution."

For Shockley, this anecdote about a black, low-IQ acid-thrower and his dysfunctional family provided proof that "the major cause of the US negro's intellectual and social deficits are hereditary and racially genetic in origin and thus not remediable to a major degree by any practical improvements in environment." Inspired by this revelation, he began a tireless campaign to raise awareness of the dysgenic threat. His efforts brought him to the attention of Harry Weyher, then president of the notorious Pioneer Fund. Between 1969 and 1976, the Pioneer Fund provided Shockley with almost $1.5 million (in inflation-adjusted 2002 dollars), both through grants to Stanford University to fund "research into the factors which affect genetic potential" and directly to Shockley's nonprofit Foundation for Research and Education on Eugenics and Dysgenics (FREED).

In addition to providing Shockley with funds, Weyher put him in contact with a cadre of white supremacist and segregationist scientists and public intellectuals. This group, which included psychologists Henry Garrett and Travis Osborne, biologist Robert E. Kuttner, and businessman Carleton Putnam, welcomed Shockley—and the legitimacy and prestige that came with the Nobel Prize winner—into their ranks. Putnam in particular embraced Shockley as an ally although his segregationist rhetoric was so extreme—in his book Race and Reality, he referred to integration as a Jewish "equalitarian conspiracy" and said of universal suffrage that "to apply it to states or communities with high percentages of a retarded race is suicidal"—that other segregationists, including Kuttner, who was himself a neo-Nazi, warned Shockley against associating with Putnam too publicly for fear of harming his reputation.

Despite these warnings, Shockley became a vocal supporter of Putnam, even providing an endorsement of Race and Reality, a jacket blurb stating that "Putnam penetratingly analyzes how liberal dogmatism has paralyzed the ability to doubt popular views even in academic cloisters with resultant prevention of publication of research on racial questions. My personal investigations verify some specifics and the general tenor of Putnam's extensive reporting of such effective suppression. … I urge thoughtful citizens to read Putnam's analyses and, in keeping with constitutional principles of freedom of speech and press, to provoke public debate between the unpopular ideas he presents and those currently popular. I urge this action in the interest of replacing prejudice, prejudgment and bias with scientific method and objectivity even though I by no means accept all of his conclusions. I have also learned by both spoken and written communication that several members of the National Academy of Sciences share Putnam's conclusion that there do exist significant genetic differences in distribution of potential intelligence between races."

This comment exposed the other half of Shockley's obsession with race and genetics: a supposed conspiracy of "liberal dogmatism" standing in the way of research on "racial questions." Despite Shockley's total lack of training or expertise in biology, or his resounding condemnation by biologists nationwide, he was convinced that he was being persecuted because "the mere fact that I had mentioned both Negroes and I.Q. in one and the same paragraph led my critics to label me a racist." When he first aired his concerns about race an IQ in 1965, his Stanford colleagues in the genetics department condemned him in a letter to the editor. Shockley took great delight in mocking that letter to his friends and the media for years after the fact.

In retaliation against his critics' accusations of racism and sympathy for Nazi ideology, Shockley tried to turn the tables, claiming that those opposing his agenda were the real Nazi analogues, and arguing that "eugenics is a shunned word because it was a feature of Hitlerism. But the lesson of Nazi Germany is not that eugenics is intolerable… . The real lesson of Nazi history was anticipated 140 years before Hitler when the Bill of Rights incorporated into our Constitution the First Amendment guaranteeing freedom of speech and the freedom of the press. Only the most anti-Teutonic racist can believe the German people to be such an evil breed that they would have tolerated the concentration camps and gas chambers if a working First Amendment had permitted exposure and discussion of Hitler's final solution… . I suggest that there is a significant parallel between the attitude of German intellectuals in Hitler's day and our intellectuals' unwillingness to face the dysgenic threat."

Not only did Shockley consider his opponents to be modern-day Nazis, he was also adamant that his own work was actually intended to benefit all of humanity, regardless of race. In his now-infamous Playboy interview, Shockley defended his work, claiming, "I would say that the responsibility to [research ideas about black genetic inferiority] rests primarily with those who are most intellectually capable of it. In terms of race, a disproportionate fraction of the white population can do this compared with the black population. So the white population is most responsible… . The smack of racism attributed to 'my rhetoric' lies in the ears of the listeners. It is not present in my written or spoken words. The word racism carries with it a connotation of belief in the superiority of one's own race, plus fear and hatred of other races, and lacks any hint of humanitarianism. What I am intending to do is to promote raceology, the study of racial problems and trends from a scientific point of view, and this approach is quite different from racism."

Despite Shockley's claims of suppression and persecution, he made very little in the way of actual efforts to prove his theories scientifically. As psychologist and historian William Tucker has pointed out, Shockley "conducted little to no research" with the money he obtained from the Pioneer Fund; rather, he used the funds to make FREED into "a publicist for Shockley, producing a newsletter with descriptions of his public appearances, his press releases, and copies of articles written by and about him."

Tucker has documented that Shockley did offer some suggestions for potential research projects, which included "hiring Pinkerton agents to carry out surreptitious investigations of the backgrounds of both randomly selected students and students who had been active in campus demonstrations to learn whether any had been adopted," blood testing on "prominent black intellectuals to investigate whether the most capable 'Negroes obtain their intelligence from white ancestors,'" blood testing on "teenage negro mothers, whose children are illegitimate and who are on welfare" to determine if they had any Caucasian ancestry, and "research on the intelligence of black children adopted into white families, and the use of physiological measures to assess reasoning ability." However, none of these studies were actually performed.

Although Shockley failed to provide any evidence for his theories, and despite near-universal acknowledgement that his work was that of a racist crank, he successfully used his high profile and love of controversy to resurrect eugenics as a topic of discussion, and paved the way for subsequent eugenicists, segregationists, and scientific racists to move their agendas forward. Through FREED, Shockley popularized his idea for a "Voluntary Sterilization Bonus Plan" which would pay poor women to undergo sterilization, a idea that has subsequently been taken up in various forms by Garrett Hardin, Richard Lynn and Charles Murray, among others. He also succeeded in popularizing the work of racist educational psychologist Arthur Jensen who, until his death in 2012, was the leading opponent of educational interventions to help underachieving black students because of their supposedly genetic limitations.

Shockley's successes in this vein have led to his being revered within the white nationalist community. A search for his name at white supremacist websites will turn up articles like The Occidental Quarterly's "Shockley Vindicated," numerous stories at VDARE.com, and authors and commenters at Stormfront.org, a white nationalist Web forum run by a former Alabama Klan leader, referring to Shockley as "one of the smartest men who ever lived" and calling for a "William Shockley Day" to coincide with Martin Luther King Jr. Day. Source: William Shockley

Silicon Valley investors, including Peter Thiel's Founders Fund, helped accelerate the run on Silicon Valley Bank. Founders Fund was among the venture-capital firms that reportedly advised its portfolio companies to withdraw their money from SVB as concerns about the bank spread.

The withdrawals quickly became a stampede. Customers attempted to pull about $42 billion in a single day, and regulators closed Silicon Valley Bank on March 10, 2023.

Then came the extraordinary part.

Ordinary FDIC insurance protected deposits only up to $250,000 per depositor, per insured bank, per ownership category. Many SVB customers were companies and investors holding millions of dollars—sometimes vastly more—above that insured limit.

After the bank collapsed, the federal government invoked a systemic-risk exception and guaranteed all SVB deposits, including the uninsured deposits above the normal FDIC limit.

Silicon Valley investors helped accelerate the run on Silicon Valley Bank.

The bank collapsed. Then the government stepped in and protected the remaining Silicon Valley depositors from losses on money that ordinary FDIC insurance had never guaranteed.

Silicon Valley Bank when it collapsed in March 2023 included:

• Circle Internet Financial — about $3.3 billion
• Sequoia Capital — about $1 billion
• Kanzhun Ltd. — about $903 million
• BILL (Bill.com) — about $670 million disclosed initially; FDIC records later listed about $761 million, including customer funds
• Altos Labs — about $680 million
• Roku — $487 million disclosed by Roku; an FDIC depositor document reportedly listed about $420 million
• BlockFi — $227 million
• Roblox — about $150 million
• Ginkgo Bioworks — about $74 million
• Sunlight Financial — about $64 million
• AcuityAds — about $55 million
• iRhythm Technologies — about $54.5 million
• Rocket Lab — about $38 million
• Sangamo Therapeutics — about $34 million
• LendingClub — about $21 million
• Payoneer — about $20 million
• Protagonist Therapeutics — about $13 million
• Cohu — about $12.3 million
• Oncorus — about $10 million
• Eiger BioPharmaceuticals — about $8.3 million

The amounts come from a combination of company disclosures and subsequently reported FDIC depositor records, so some figures differ depending on the reporting date and whether customer funds were included.

The names at the very top make the scale especially striking: Circle had roughly $3.3 billion sitting at SVB and Sequoia Capital roughly $1 billion, despite the ordinary FDIC insurance limit being $250,000 per depositor, per insured bank, per ownership category.

VENTURE CAPITAL

Sequoia Capital — approximately $1 billion

TECH/CRYPTO/BIOTECH AND OTHER COMPANIES

Circle — approximately $3.3 billion

Kanzhun — approximately $903 million

BILL — approximately $761 million

Altos Labs — approximately $680 million

Roku — approximately $420–487 million

BlockFi — approximately $227 million

Roblox — approximately $150 million

Silicon Valley's venture-capital establishment built its reputation on being exceptionally sophisticated about money and risk. Yet billions of dollars were sitting uninsured at SVB. When the bank failed, the federal government ultimately protected those uninsured deposits anyway.

And Sand Hill Road adds something numbers alone don't convey: these were among the people Silicon Valley itself regarded as the experts at deciding who deserved capital and which risks were worth taking.

1884 — Leland Stanford Jr. dies

Leland and Jane Stanford's only child, Leland Stanford Jr., dies of typhoid fever at age 15. His parents decide to establish a university in his memory.

1885 — Stanford University is founded

Leland and Jane Stanford establish Leland Stanford Junior University, using their fortune and their Palo Alto stock farm. The university is intended to combine liberal arts with science and engineering.

1891 — Stanford opens; David Starr Jordan becomes the first president

The university opens on October 1, 1891. Leland and Jane Stanford personally select David Starr Jordan as Stanford's first president. Jordan begins recruiting the faculty and building the academic structure of the new university.

1893 — Leland Stanford dies

Leland Stanford dies only two years after the university opens. His death creates a serious financial crisis for the young university. Jane Stanford keeps it operating while Jordan continues running its academic affairs.

1891–1913 — David Starr Jordan presidency

Jordan remains Stanford's president for 22 years, giving him enormous influence over the university's formative period.

Eugenics becomes an important part of Jordan's activities. While Stanford president, he becomes the inaugural chairman of the Eugenics Committee of the American Breeders Association, often identified as the first American eugenics organization. Stanford now says Jordan used his position as president to advance eugenics through his teaching and advocacy.

Jordan later becomes a trustee of the Human Betterment Foundation, which promoted compulsory sterilization.

Stanford itself now describes its early Sociology Department as having "eugenicist origins."

1913–1915 — John Casper Branner

Geologist John Casper Branner succeeds Jordan. He serves only about two years. I would not characterize Branner himself as an important eugenics advocate without stronger evidence.

Importantly, Jordan doesn't disappear. After leaving the presidency, he remains at Stanford as chancellor and later chancellor emeritus until his death in 1931.

1916–1943 — Ray Lyman Wilbur

Ray Lyman Wilbur, a physician and former dean of Stanford Medical School, becomes Stanford's third president.

During this period, eugenics remains part of Stanford's intellectual environment. One of the most important figures is psychologist Lewis Terman, who takes over Stanford's Psychology Department in 1922. Terman is famous for the Stanford-Binet intelligence test and is also one of the major Stanford figures associated with American eugenics.

There is an important connection to what comes later: Lewis Terman's son is Frederick Terman, who will become one of the central architects of Stanford's relationship with government-funded engineering and Silicon Valley.

1943–1948 — Donald Tresidder

Donald B. Tresidder becomes Stanford's fourth president. His presidency overlaps with World War II and the enormous expansion of government-supported science and technology.

During this period Frederick Terman becomes increasingly important. During World War II, Terman had headed Harvard's top-secret Radio Research Laboratory, which worked on electronic warfare and radar countermeasures.

After returning to Stanford, Terman aggressively pursues government-sponsored research. By 1946 he was reporting Stanford projects supported by the Navy, Army Air Forces, Signal Corps and other federal agencies.

Tresidder dies unexpectedly in 1948.

1949–1968 — J. E. Wallace Sterling

J. E. Wallace Sterling becomes Stanford's fifth president.

By the time Sterling takes over in 1949, classical American eugenics has been badly discredited, particularly following Nazi Germany and World War II. The word itself becomes so closely associated with Nazi racial policies that eugenics organizations begin changing their names and repositioning themselves.

Stanford's emphasis is also shifting dramatically.

Under Sterling, working closely with Frederick Terman, Stanford expands engineering and scientific research, aggressively recruits leading researchers, builds major research facilities and capitalizes on the enormous postwar expansion of federal funding for university research.

Sterling makes Terman Stanford's provost in 1955.

Together they undertake an aggressive faculty recruitment program sometimes called "The Big Raid." Stanford expands its research facilities, establishes its industrial research park and secures the federally funded Stanford Linear Accelerator Center.

Stanford's own historical account describes the postwar Sterling-Terman period as one in which they recognized the new opportunities for university research and helped push Stanford to a new level while contributing substantially to the growth of Silicon Valley.

1885 — Leland and Jane Stanford create the university.

1891 — David Starr Jordan is placed in charge.

1893 — Leland Stanford dies.

1891–1930s — Jordan, Lewis Terman and others make Stanford an important center of American eugenic thinking.

1940s — World War II dramatically expands the relationship between universities, science and the federal government.

1949 onward — Sterling and Frederick Terman build Stanford into a major federally supported scientific and engineering research institution.

1950s–1960s — That university-government-industry relationship becomes one of the foundations of Silicon Valley.

The especially interesting historical connection is Lewis Terman → Frederick Terman.

The father, Lewis Terman, was the Stanford psychologist associated with intelligence testing and eugenics.

The son, Frederick Terman, became Stanford's engineering dean and then provost and is frequently called one of the "fathers of Silicon Valley."

Those are two different fields and two different historical periods, so they shouldn't be presented as though Silicon Valley was simply an extension of eugenics. But the father-son succession provides a very concrete link between Stanford's early-20th-century intellectual history and the institution that became central to the postwar technology industry.

Steve Jobs and Bill Gates were arguably the two technology figures the general public knew best before the current generation of Musk, Zuckerberg, etc. They weren't merely CEOs. They became media personalities and symbols of the computer revolution.

Jobs was repeatedly photographed for major magazines and became inseparable from the Apple brand. His black turtleneck, product launches and "rebel/visionary" image eventually became part of popular culture. Even people who knew very little about technology knew Steve Jobs.

Gates had an interestingly different trajectory. In the 1980s and early 1990s, the press frequently presented him as the young computer genius or "whiz kid" billionaire. But Microsoft's dominance eventually changed that image. The U.S. government's landmark antitrust case against Microsoft began in 1998, and Gates's videotaped deposition became notorious because prosecutors portrayed him as evasive and combative. A federal court ultimately found Microsoft had maintained its operating-system monopoly through anticompetitive means.

So by the late 1990s, Gates wasn't simply the lovable computer whiz anymore. Microsoft had become the giant that people worried was becoming too powerful.

Then comes the fascinating image transition.

The Bill & Melinda Gates Foundation was established in its current form in 2000, and Gates increasingly moved his public identity away from Microsoft and toward global health, vaccines, education, poverty and philanthropy. He stepped away from Microsoft's day-to-day leadership and eventually became known to a younger generation at least as much for philanthropy as for Microsoft.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:dc08c4df-2054-4719-bc13-87b3546a54ae-12" data-turn-id-container= "request-WEB:dc08c4df-2054-4719-bc13-87b3546a54ae-12" data-testid= "conversation-turn-26" data-turn="assistant">

Specifically to recognizable tech figures/companies and distinguish university/publicly funded origins from later government contracts, loans, credits and subsidies:

1. Google — Larry Page & Sergey Brin — Stanford research environment plus federal support. Google's precursor, BackRub, grew out of their Stanford work; NSF funding supported the broader Stanford Digital Library project, and Brin held an NSF graduate fellowship. Stanford owned the PageRank patent and licensed it to Google. National Science Foundation — Google's origins
2. Netscape — Marc Andreessen — Andreessen helped create the Mosaic browser at the National Center for Supercomputing Applications at the University of Illinois, a federally supported supercomputing center. He then joined Jim Clark to create Netscape.
3. Silicon Graphics — Jim Clark — Clark's graphics work originated at Stanford, where he and students developed the Geometry Engine. He subsequently founded SGI to commercialize the technology.
4. Sun Microsystems — Stanford — Sun's origins are practically contained in its name: SUN originally stood for Stanford University Network. Andy Bechtolsheim developed the workstation while a Stanford graduate student before cofounding Sun Microsystems.
5. Tesla — Elon Musk — Different mechanism. Tesla wasn't created inside a university, and Musk wasn't its original founder. But Tesla benefited enormously from government policy, including a $465 million Department of Energy loan, which Tesla repaid early, as well as federal and state EV incentives that helped create demand for electric vehicles. U.S. Department of Energy — Tesla loan repayment
6. SpaceX — Elon Musk — Again, Musk supplied substantial private startup capital, so it would be inaccurate to portray SpaceX as simply taxpayer-created. But its subsequent growth has been deeply intertwined with NASA and U.S. government contracts worth billions, including NASA's Commercial Orbital Transportation Services and Commercial Crew programs. NASA deliberately used public money to stimulate private commercial space capabilities.
7. Palantir — Peter Thiel, Alex Karp and others — A particularly interesting one for this argument. Early Palantir received investment from In-Q-Tel, the CIA-linked venture-capital organization, and government/intelligence agencies became important customers. This wasn't simply a company appearing independently and later discovering Washington.
8. Apple / Steve Jobs — government-created technological foundations — Apple itself was privately founded, so it doesn't belong in precisely the same category as Google. But many technologies underlying the modern smartphone economy—GPS, networking/internet technologies, touchscreen research, semiconductor research and voice-recognition research—have important roots in government-funded R&D. The iPhone brilliantly integrated and commercialized technologies whose underlying research history extends far beyond Apple.

THE INTERNET — U.S. TAXPAYERS.

DARPA funded ARPANET. Government agencies and universities funded crucial networking research. NSFNET expanded academic networking and became a major backbone in the development of the modern Internet before commercial restrictions were removed.

So the point for trust isn't that these entrepreneurs contributed nothing. Obviously they did. Commercialization, manufacturing, scaling and turning laboratory technology into something hundreds of millions of people can use are enormous accomplishments.

It's that the popular story frequently starts too late.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:d4d99fdd-8350-4d72-bbff-b8a0203465c8-7" data-turn-id-container= "request-WEB:d4d99fdd-8350-4d72-bbff-b8a0203465c8-7" data-testid= "conversation-turn-16" data-turn="assistant">

The story begins:

"Two brilliant guys founded a company…"

But the fuller history may begin years or even decades earlier.

It may begin with taxpayer money and government research. That research moves into university laboratories, where scientists and graduate students develop new technologies. Then come the patents and prototypes. Then technology transfer and licensing. Then venture capital. Then the private company.

And finally, the story we all recognize: the billionaire founder.

Musk gives us another version of the same story. In that case, you can begin with the private entrepreneur, followed by government loans, contracts and incentives, and ultimately an enormous private enterprise.

That's directly relevant to the question of trust because the mythology matters.

If someone is asking society to entrust him with transportation, communications, artificial intelligence, space infrastructure or enormous amounts of personal data, partly because he's portrayed as the singular genius who created it all, then it's reasonable to ask:

Who actually built the foundation? Who paid for it? Who took the early risk? And who ultimately got the prize?

• Elizabeth Holmes / Theranos — Stanford student who dropped out to create Theranos. Holmes developed her early blood-testing ideas while at Stanford. Stanford professor Channing Robertson became closely involved with Theranos, and Stanford/Hoover figure George Shultz became a major supporter and board member. Holmes eventually was convicted of defrauding investors. Stanford connections helped give a very young Holmes credibility.
• Sam Bankman-Fried / FTX — Both parents, Joseph Bankman and Barbara Fried, were Stanford Law professors. Bankman-Fried grew up in the Stanford environment, and his parents' Stanford property became his residence while he was awaiting trial. He was eventually convicted in the massive FTX fraud.
• Caroline Ellison / Alameda Research — Stanford graduate who became CEO of Alameda Research, the trading firm at the center of the FTX collapse. She pleaded guilty and testified against Bankman-Fried.
• Andrew Huberman — Stanford School of Medicine neuroscientist who turned his Stanford credentials into an enormous podcast/wellness platform. Promotes discussions of supplements, hormones, dopamine, cold exposure and biological optimization. Subsequently became the subject of extensive reporting about his conduct toward women and simultaneous romantic relationships.
• Peter Thiel — Stanford undergraduate and Stanford Law graduate. Founded the Stanford Review. Went on to PayPal and Palantir. His interests include radical longevity, parabiosis/"young blood," seasteading, René Girard's theories, Christianity, apocalypse and lengthy lectures concerning the Antichrist.
• René Girard — Stanford professor and major intellectual influence on Thiel. Developed theories involving mimetic desire, rivalry, scapegoating, sacrifice, religion, violence and ultimately apocalyptic catastrophe.
• Alex Karp / Palantir — Stanford Law graduate who met Thiel at Stanford. Palantir subsequently became deeply embedded in government, intelligence, defense, military, immigration and data-analysis systems.
• Joe Lonsdale / Palantir — Stanford graduate, Stanford Review figure and Palantir cofounder. Went on to become a major Silicon Valley venture capitalist.
• Stephen Cohen / Palantir — Stanford computer-science graduate, Stanford Review connection and Palantir cofounder.
• Stanford Review Network — Worth treating as an entity itself. Thiel's student newspaper became an extraordinary networking point connecting numerous people who subsequently entered technology, venture capital, Palantir and politics.
• David Sacks — Stanford graduate and Stanford Review alumnus. PayPal executive, technology entrepreneur, investor and later political figure.
• Keith Rabois — Stanford graduate and Stanford Review alumnus. PayPal and subsequently a powerful Silicon Valley venture capitalist.
• Reid Hoffman — Stanford graduate. PayPal executive, LinkedIn founder, major technology investor and political donor.
• Sam Altman / OpenAI — Stanford student/dropout. OpenAI/AGI; acknowledged psychedelic experiences; investments involving longevity and nuclear fusion; associated with World/Worldcoin and biometric iris-based proof-of-personhood technology.
• Larry Page & Sergey Brin / Google — Google emerged directly from their Stanford graduate research. The PageRank technology was Stanford intellectual property, creating a direct university-to-Google commercial relationship.
• Google / Stanford / Data — What began as university search-engine research became one of history's largest information, advertising and data enterprises. Stanford itself lists PageRank among technologies invented at Stanford.
• Alphabet / Calico — Google's lineage subsequently extends into biotechnology and radical investigation of aging and longevity. Not originally a Stanford project, but relevant through the Google-Stanford corporate lineage.
• James Monsees & Adam Bowen / Juul — Met through Stanford's product-design program. Their work on alternatives to cigarettes developed into Juul, which later became the center of an enormous controversy concerning youth vaping and marketing.
• Marc Tessier-Lavigne — Stanford president and neuroscientist who resigned the presidency in 2023 following an investigation into scientific papers associated with laboratories he led. Importantly, Stanford's investigation did not find that Tessier-Lavigne himself committed research misconduct, but found that in several cases he failed to take sufficient steps to correct the scientific record.
• Stanley N. Cohen / Biotechnology — Stanford professor and one of the pioneers of recombinant-DNA technology, which helped create the modern biotechnology industry. Later became involved in contentious litigation surrounding biotech company Nuredis.
• Do Kwon / Terraform Labs — Stanford graduate and founder of Terraform Labs. Terra/Luna collapsed spectacularly, destroying billions in cryptocurrency value and leading to criminal prosecution and conviction.
• Jerry Yang & David Filo / Yahoo — Stanford graduate students when they created Yahoo. Another direct Stanford-to-Internet-company pipeline.
• Frederick Terman — One of the most important people on the entire list. Stanford engineering professor, dean and provost who deliberately encouraged Stanford engineers to establish companies and cultivated relationships between Stanford, corporations and government.Stanford calls him the "academic architect" of Silicon Valley.
• William Hewlett & David Packard / HP — Stanford students encouraged by Terman to commercialize their technology. HP became one of the foundational Silicon Valley corporations.
• Stanford Research Park — Established in 1951 on Stanford land. Stanford calls it the world's first university research park and an "engine for Silicon Valley." It deliberately put university research next to private technology corporations.
• Stanford Research Park + Defense Industry — Historical tenants included Varian, Hewlett-Packard, Lockheed's Space and Missile Division and Xerox PARC. This makes the park important not merely to consumer technology but to the Stanford-defense-industry relationship.
• Varian Brothers / Varian Associates — Russell and Sigurd Varian had deep Stanford connections. Their klystron microwave technology had applications in radar, navigation, communications and particle accelerators.
• William Shockley / Shockley Semiconductor — Terman encouraged Shockley to establish his semiconductor operation near Stanford. Eight employees famously left Shockley to form Fairchild Semiconductor. Stanford's own history of its research park notes that by 1980 more than 50 Silicon Valley semiconductor companies could be directly linked to Shockley's original company.
• Fairchild Semiconductor — Emerged from Shockley's operation and became one of the critical ancestors of the semiconductor industry, ultimately producing the networks from which companies including Intel emerged.
• Cisco Systems — Stanford employees Leonard Bosack and Sandy Lerner founded Cisco in the environment created by Stanford's networking work. The history includes disputes concerning who actually developed important Stanford router technology and ownership/use of Stanford technology. Stanford's own historical account emphasizes that important router work preceded Bosack and Lerner.
• Sun Microsystems — Closely connected to Stanford computer research. Stanford associate professor Andy Bechtolsheim's workstation work contributed to Sun's creation. Stanford itself identifies Sun among companies arising from work that began at Stanford.
• Stanford Research Institute / SRI — Created in 1946 in association with Stanford as an applied research organization. It later separated from Stanford. This becomes an important bridge among academia, Silicon Valley, corporations, the federal government and military research.
• SRI + Department of Defense — SRI's own history of its Artificial Intelligence Center says the group was supported largely by the Defense Department.
• SRI + ARPA/DARPA — SRI became deeply involved in federally funded advanced computer and defense research.
• SRI + ARPANET — SRI operated one of the first ARPANET nodes. On October 29, 1969, UCLA attempted to transmit "LOGIN" to SRI; the system crashed after transmitting LO. The UCLA-SRI connection was firmly established the following month.
• Douglas Engelbart / SRI — Developed pioneering interactive-computing technology involving the mouse, hypertext, graphical interaction and collaborative computing. His work is part of the direct ancestry of modern personal computing.
• SRI + Artificial Intelligence — SRI developed one of the world's important early AI research centers. Its research involved reasoning, planning, machine vision, natural-language communication and systems capable of advising humans.
• Shakey the Robot / SRI — One of the earliest important autonomous AI robots. It attempted to combine environmental perception, reasoning, planning and physical action.
• SRI + CIA Remote Viewing — SRI researchers Harold "Hal" Puthoff and Russell Targ conducted government-funded investigations into purported psychic phenomena and remote viewing.
• Ingo Swann / SRI — Claimed psychic who became one of the important experimental subjects in SRI's remote-viewing research.
• Uri Geller / SRI — Tested by Puthoff and Targ concerning his claimed paranormal abilities. The research and conclusions became highly controversial.
• SRI → Government Remote-Viewing Programs — The SRI experiments became part of the history leading into the U.S. government's longer-running investigation of purported psychic spying, eventually associated with the Stargate program.
• John McCarthy / Stanford Artificial Intelligence Laboratory — McCarthy, one of AI's founding figures, established Stanford as an early center of artificial-intelligence research.
• Stanford AI + Government Funding — Early Stanford computing and AI developed within a much larger Cold War system in which federal and defense money financed advanced university technology research.
• Stanford Prison Experiment / Philip Zimbardo — Not a technology company, but relevant to Stanford's history of controversial human behavioral research. The famous 1971 experiment has subsequently faced substantial methodological and historical criticism.
• Stanford + Psychedelic Research — Worth investigating further, particularly the intersection among Stanford medicine/psychiatry, Palo Alto, Menlo Park and the larger Bay Area psychedelic movement. This one needs to remain person-by-person and program-by-program so Stanford isn't credited with things actually done elsewhere.
• Stanford + Hoover Institution + Technology — Hoover sits at Stanford and creates another intersection among academia, national security, government and Silicon Valley. George Shultz's involvement with Theranos makes this especially worth examining.
• Stanford + Military/Defense Technology — This isn't incidental to the university's Silicon Valley history. Stanford's own account identifies technologies including microwave technology for military radar, Internet protocols, AI and numerous companies arising from federally funded Stanford research.
• Stanford + Commercialization Model — Stanford deliberately institutionalized the process of taking university research, licensing it, forming companies around it, encouraging faculty consulting and connecting researchers with corporations. This wasn't simply a few students accidentally becoming entrepreneurs.
• The Larger Stanford → Silicon Valley Pipeline — Stanford itself says its alumni and faculty have created more than 39,900 companies since the 1930s, and specifically names Cisco, Google, Hewlett-Packard, LinkedIn and many others.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:dc08c4df-2054-4719-bc13-87b3546a54ae-9" data-turn-id-container= "request-WEB:dc08c4df-2054-4719-bc13-87b3546a54ae-9" data-testid= "conversation-turn-20" data-turn="assistant">

Adam Neumann — WeWork — approx. $47 billion valuation Turned an office-leasing business into a supposed technology phenomenon valued privately at about $47 billion. The attempted IPO exposed governance problems, conflicts involving Neumann and questions about the business model. Neumann stepped down as CEO in 2019.

1. Travis Kalanick — Uber — approx. $70 billion valuation Uber became a Silicon Valley powerhouse valued privately at roughly $68–70 billion before its IPO, while accumulating controversies involving corporate culture, sexual-harassment allegations, privacy practices and Greyball, software used to evade regulators. Kalanick resigned as CEO in 2017.
2. Brian Chesky — Airbnb — approx. $100 billion market value at its 2020 debut Airbnb took an old idea—renting rooms, homes and vacation properties—and transformed it into a massive technology platform. Its market value exceeded $100 billion shortly after its 2020 stock-market debut. Unlike several companies on this list, Airbnb's underlying business was not exposed as fraudulent, but it became embroiled in major controversies over housing availability, rising rents, neighborhood disruption, safety, discrimination and cities attempting to regulate short-term rentals.
3. Trevor Milton — Nikola — approx. $30 billion market value Nikola's stock-market value briefly approached $30 billion in 2020, despite having generated very little automotive revenue. Milton promoted it as a breakthrough electric/hydrogen-truck company while making false and misleading statements about its technology and products. He was later convicted of securities and wire fraud.
4. Carlos Watson — Ozy Media — approx. $160 million valuation / tens of millions raised Ozy was considerably smaller than the others but was reportedly valued at roughly $159 million during one financing round and raised tens of millions of dollars from investors. The deception included an executive impersonating a YouTube executive using voice-altering software during a call with Goldman Sachs. Watson was convicted of fraud and aggravated identity theft.

1921 — Margaret Sanger creates the American Birth Control League. Sanger served as president until 1928. Her clinical organization later reunited with the ABCL in 1939 to form the Birth Control Federation of America.

1942 — It becomes Planned Parenthood Federation of America. So this isn't a completely unrelated organization that appeared after Sanger. It's the organizational descendant of the movement she built.

Sanger and eugenics — unquestionably an actual historical connection. Interestingly, Planned Parenthood itself now explicitly acknowledges this. Its official history states that Sanger believed in eugenics, repeatedly expressed that alignment in her writings, and endorsed the Buck v. Bell compulsory-sterilization decision. PPFA today repudiates those beliefs.

1940s–1950s — population becomes increasingly important. The Rockefeller Brothers Fund began supporting Planned Parenthood in 1942. Its own historical archive describes funding PPFA programs involving reproduction and population issues, with Rockefeller family involvement continuing for decades.

1952–1959 — Sanger heads the international organization. Sanger became president of the International Planned Parenthood Federation, taking the birth-control/population movement internationally.

1962 — Dr. Alan Guttmacher becomes president of PPFA.

Guttmacher ran Planned Parenthood from 1962 until his death in 1974. Harvard's archive of his papers says that during his presidency PPFA expanded its work on poverty, government family-planning programs and international programs addressing global population growth.

1966 — Margaret Sanger dies.

By 1972 — Bill Gates Sr. is on Planned Parenthood Federation of America's national board.

Therefore, Gates Sr.'s documented board service falls during Alan Guttmacher's presidency.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-6a85594e-96b0-83e8-a277-1168d0cf2043-13" data-turn-id-container= "request-6a85594e-96b0-83e8-a277-1168d0cf2043-13" data-testid= "conversation-turn-30" data-turn="assistant">

1962 — Alan Guttmacher becomes president of Planned Parenthood.

At that moment, he was simultaneously vice president of the American Eugenics Society.

1963 — Guttmacher's last documented year as AES vice president.

By 1972 — Bill Gates Sr. is documented as a member of Planned Parenthood Federation of America's national board.

1974 — Guttmacher dies while still president of Planned Parenthood.

Therefore:

Bill Gates Sr. served on Planned Parenthood's national board while Alan Guttmacher was president of Planned Parenthood.

That's not speculation about two people inhabiting the organization decades apart. Their PPFA leadership tenures actually overlapped.

And Guttmacher wasn't merely someone who had encountered eugenics as a young man before World War II. His AES leadership occurred in the 1950s and 1960s, immediately preceding—and initially overlapping—his Planned Parenthood presidency.

So the historically defensible chain is:

Margaret Sanger — eugenics advocate and founder of the movement that became PPFA

Alan Guttmacher — American Eugenics Society vice president → president of PPFA

Bill Gates Sr. — national PPFA board member under Guttmacher

Bill Gates — later major global funder of family planning and reproductive health

Phoebe Gates — reproductive-rights donor/activist and publicly "For Planned Parenthood"

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-6a85594e-96b0-83e8-a277-1168d0cf2043-13" data-turn-id-container= "request-6a85594e-96b0-83e8-a277-1168d0cf2043-13" data-testid= "conversation-turn-30" data-turn="assistant"> 1962 — Alan Guttmacher becomes president of Planned Parenthood. At that moment, he was simultaneously vice president of the American Eugenics Society.

1963 — Guttmacher's last documented year as AES vice president.

By 1972 — Bill Gates Sr. is documented as a member of Planned Parenthood Federation of America's national board.

1974 — Guttmacher dies while still president of Planned Parenthood.

Therefore:

Bill Gates Sr. served on Planned Parenthood's national board while Alan Guttmacher was president of Planned Parenthood.

That's not speculation about two people inhabiting the organization decades apart. Their PPFA leadership tenures actually overlapped.

And Guttmacher wasn't merely someone who had encountered eugenics as a young man before World War II. His AES leadership occurred in the 1950s and 1960s, immediately preceding—and initially overlapping—his Planned Parenthood presidency.

So the historically defensible chain is:

Margaret Sanger — eugenics advocate and founder of the movement that became PPFA

Alan Guttmacher — American Eugenics Society vice president → president of PPFA

Bill Gates Sr. — national PPFA board member under Guttmacher

Bill Gates — later major global funder of family planning and reproductive health

Phoebe Gates — reproductive-rights donor/activist and publicly "For Planned Parenthood"

1956–1963 — Alan Guttmacher is vice president of the American Eugenics Society.

1962 — Alan Guttmacher becomes president of Planned Parenthood Federation of America.

1962–1963 — He therefore holds leadership positions in BOTH organizations simultaneously.

1962–1974 — Guttmacher remains president of Planned Parenthood.

By 1972 — Bill Gates Sr. is documented on Planned Parenthood's national board, while Guttmacher is still president.

The Gates Family: The Part of the Bill Gates Story Most People Don't Know

The public story of Bill Gates usually begins with a brilliant young computer programmer who dropped out of Harvard, started Microsoft with Paul Allen and became one of the richest men in the world.

But the Gates family history adds important context that is often missing from that story.

Bill Gates's mother, Mary Maxwell Gates, was a prominent Seattle civic and business figure. She served on numerous corporate and nonprofit boards and became the first woman to chair the national United Way's executive committee. While serving with the United Way, she knew John Opel, the chairman and CEO of IBM. According to accounts of Microsoft's history, Mary Gates spoke with Opel about her son's company. Microsoft subsequently received the opportunity to provide an operating system for IBM's new personal computer, a deal that became pivotal to Microsoft's extraordinary growth.

That does not mean Mary Gates simply handed Microsoft the IBM contract. Microsoft still had to produce what IBM needed, and the famous operating-system story involved additional negotiations and acquisitions. But it does challenge the simplified mythology that Bill Gates's rise occurred entirely outside established networks of wealth, business and influence.

Bill Gates's father, William H. Gates Sr., was a prominent Seattle attorney and civic leader. He also served on the board of Planned Parenthood in Seattle. That becomes particularly interesting historically because the American birth-control movement had significant documented overlap with the eugenics movement during the first half of the twentieth century.

Gates Sr. also discussed his son's longstanding interest in population issues. In a 1998 Salon interview, he said population had interested Bill "since he was a kid" and described the subject as fitting both Bill's interests and his own.

Bill Gates eventually moved far beyond computers. Through the Bill & Melinda Gates Foundation, he became one of the world's most influential private figures in global health, vaccination, contraception, family planning and population-related programs.

Then there is the next generation.

Bill Gates's daughter, Phoebe Gates, co-founded the shopping technology company Phia with Sophia Kianni. In 2026, Phia became embroiled in controversy over affiliate attribution practices, including allegations of "cookie stuffing," in which affiliate tracking can improperly claim credit for transactions. Phia disputed aspects of the allegations, removed the features at issue and said it was taking steps to reverse improperly attributed transactions and strengthen compliance.

None of these facts proves that three generations of the Gates family have participated in some single coordinated scheme. That would go beyond the evidence.

But taken together, they reveal something much more interesting than the familiar story of a computer genius who became a billionaire philanthropist.

Mary Gates had extraordinary access to America's corporate establishment.

William Gates Sr. was a powerful attorney involved with Planned Parenthood and interested in population issues.

Bill Gates became one of the most powerful technology entrepreneurs in history and subsequently one of the world's most influential private forces in global health and family planning. And now another generation of the Gates family has entered the technology business.

That family history doesn't tell us what to think about Bill Gates.

But it gives us considerably more information with which to decide for ourselves.

References

California Academy of Sciences. "David Starr Jordan: The Eugenics Movement and Stanford University." California Academy of Sciences. Accessed August 18, 2026.

Gallup. "Americans' Trust in Businesses to Use Artificial Intelligence Responsibly." Gallup, 2026.

Google. "Our History." Google. Accessed August 18, 2026.

Intel Corporation. "Intel Corporation History." Intel. Accessed August 18, 2026.

National Science Foundation. "A Brief History of NSF and the Internet." National Science Foundation. Accessed August 18, 2026.

NASA. "Commercial Crew Program." National Aeronautics and Space Administration. Accessed August 18, 2026.

SRI International. "Our History." SRI International. Accessed August 18, 2026.

Stanford University. "David Starr Jordan and Eugenics." Stanford University. Accessed August 18, 2026.

Stanford University Department of Sociology. "History of Sociology at Stanford." Stanford University. Accessed August 18, 2026.

Stanford University Engineering. "Frederick Emmons Terman." Stanford University. Accessed August 18, 2026.

Stanford University Libraries. "Stanford University and Silicon Valley." Stanford University. Accessed August 18, 2026.

Stanford Research Park. "History of Stanford Research Park." Stanford University. Accessed August 18, 2026.

Stanford University Office of Technology Licensing. "History of Technology Licensing at Stanford." Stanford University. Accessed August 18, 2026.

Stanford University Office of Technology Licensing. "Google PageRank Technology." Stanford University. Accessed August 18, 2026.

U.S. Department of Energy. "Tesla Motors Loan Programs Office Project." Loan Programs Office, U.S. Department of Energy. Accessed August 18, 2026.

U.S. Department of Justice. "United States v. Microsoft Corporation." Antitrust Division, U.S. Department of Justice. Accessed August 18, 2026.

Federal Trade Commission. "Cambridge Analytica." Federal Trade Commission. Accessed August 18, 2026.

Federal Bureau of Investigation. "Elizabeth Holmes Sentenced for Defrauding Theranos Investors." U.S. Department of Justice/Federal Bureau of Investigation.

In-Q-Tel. "Portfolio and History." In-Q-Tel. Accessed August 18, 2026.

SRI International. "Artificial Intelligence Center." SRI International. Accessed August 18, 2026.

Defense Advanced Research Projects Agency. "ARPANET and the Origins of the Internet." DARPA. Accessed August 18, 2026.

National Science Foundation. "NSFNET: The Partnership That Changed the World." National Science Foundation. Accessed August 18, 2026.

Stanford University. "Stanford Research Park: An Engine for Silicon Valley." Stanford University. Accessed August 18, 2026.

Stanford University. "Stanford's Role in the Development of Silicon Valley." Stanford University. Accessed August 18, 2026.

Encyclopaedia Britannica. "Francis Galton." Encyclopaedia Britannica. Accessed August 18, 2026.

Encyclopaedia Britannica. "Eugenics." Encyclopaedia Britannica. Accessed August 18, 2026.

Encyclopaedia Britannica. "David Starr Jordan." Encyclopaedia Britannica. Accessed August 18, 2026.

Encyclopaedia Britannica. "Lewis Terman." Encyclopaedia Britannica. Accessed August 18, 2026.

Encyclopaedia Britannica. "Silicon Valley." Encyclopaedia Britannica. Accessed August 18, 2026.

Halliburton, Murphy. Research and writing on David Starr Jordan, Lewis Terman, Stanford University, and the history of American eugenics.

Nicely, Thomas R. "Pentium FDIV Flaw." Lynchburg College, 1994.

IBM. "IBM Statement on the Intel Pentium Processor." December 1994.

U.S. Securities and Exchange Commission. Enforcement materials concerning Theranos, Elizabeth Holmes, Nikola Corporation, Trevor Milton, Terraform Labs, and other technology-company fraud cases.

U.S. Department of Justice. Criminal case materials concerning Elizabeth Holmes, Samuel Bankman-Fried, Trevor Milton, Carlos Watson, and Do Kwon.

CNBC and Generation Lab. 2026 survey reporting attitudes among Americans ages 18–34 toward artificial intelligence executives and AI data-center development.

Stanford University. Historical materials concerning Stanford University's founding, Leland and Jane Stanford, David Starr Jordan, Lewis Terman, Frederick Terman, Stanford Research Park, Stanford Research Institute, federally sponsored research, technology licensing, and the development of Silicon Valley.

"The question as to who and what is responsible for African underdevelopment can be answered at two levels. First, the operation of the imperialist system bears major responsibility for African economic retardation." — Walter Rodney, How Europe Underdeveloped Africa (1972)

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:e012a590-123c-4013-a12d-f25379126a41-0" data-turn-id-container= "request-WEB:e012a590-123c-4013-a12d-f25379126a41-0" data-testid= "conversation-turn-2" data-turn="assistant">

Walter Rodney remains one of the most influential and controversial historians of the twentieth century. In this episode, I examine the life of the Guyanese scholar, political activist, and author of How Europe Underdeveloped Africa. I trace Rodney's research, his views on colonialism, African history, economic development, and the political movements that shaped his career. I also follow his journey through Jamaica, Tanzania, and Guyana, where his ideas inspired supporters while drawing intense opposition.

I also examine the events leading to Walter Rodney's death in 1980, one of the most debated political assassinations in Caribbean history. The episode looks at the official investigations, later commissions of inquiry, the role of the Guyanese government, and the evidence that has emerged over the decades. Rather than relying on rumor, I compare documented historical records, witness testimony, and competing interpretations surrounding Rodney's death. The case raises difficult questions about the actions of the Guyanese – and by extension, the British and American – governments during the Cold War era. It was not until 2021 that the Government of Guyana formally apologized and accepted the findings of the Commission of Inquiry, which concluded that the state had orchestrated Walter Rodney's assassination.

If you are interested in African history, Cold War politics, decolonization, political violence, Guyana, the Caribbean, or revolutionary movements, this episode provides a chronological overview of Walter Rodney's life, scholarship, activism, and lasting influence. It also places Rodney within the broader political conflicts of the 1960s and 1970s, helping explain why his work continues to be studied, debated, and discussed around the world.

Music: [Sittin' on] The Dock of the Bay [2020 Remaster]

Ebola HOAX:

The Great Ebola Hoax

Why is Ebola infecting people at 'unprecedented speed' in DR Congo and can it be stopped? | DW News

2014: "Ebola Pandemic Smells Like a Hoax" - henrymakow.com

How Europe Underdeveloped Africa. Walter Rodney 1973

Walter Rodney - Wikipedia

How Europe Underdeveloped Africa - Wikipedia

Walter Rodney's Radical Legacy - Boston Review

About Dr. Walter Rodney — The Walter Rodney Foundation

The Walter Rodney Murder Mystery in Guyana 40 Years Later | National Security Archive

Who was Walter Rodney? | MELA

A Rebel's Guide to Walter Rodney | ROAPE

'My husband was assassinated for his activism': Patricia Rodney on injustice and doing more

How hormones work to flip sexes: Hormones

Do you have a psychopath in your life? The best way to find out is read my book. BOOK *FREE* Download – Psychopath In Your Life4

Support is Appreciated: Support the Show – Psychopath In Your Life

Download Pods here: TOP PODS – Psychopath In Your Life

My old discussion forum with last 10 years of victim stories, is back online. Psychopath Victim Support Community | Forums powered by UBB.threads™

Google Maps My HOME Address: 309 E. Klug Avenue, Norfolk, NE 68701 SMART Meters & Timelines – Psychopath In Your Life

Political Car Bombing Timeline

1920

September 16 – Wall Street bombing

• Horse-drawn wagon filled with explosives detonates outside the J.P. Morgan building.
• 38 killed.
• One of the earliest major vehicle bombings in modern history (not an automobile).

1942

Reinhard Heydrich

• Killed after an attack using a grenade against his moving car in Prague.
• Not technically a car bomb, but one of history's most famous attacks on a vehicle.

1948

Folke Bernadotte

• Assassinated when his UN convoy was ambushed in Jerusalem.
• Vehicle attack rather than a car bomb.

1956

• Khalil al-Wazir and others begin using vehicle bombs in regional conflicts.
• Car bombs become more common in the Middle East.

1962

Wolfgang Diewerge

• Survives an attempted car bombing.

1963

First widespread use of car bombs during conflicts in Cyprus.

Late 1960s

The Irish Republican Army increasingly adopts vehicle bombs.

• Marks the beginning of the modern era of car bomb terrorism.

1972

"Bloody Friday," Belfast.

• Twenty-two IRA bombs explode across the city, many placed in vehicles.

1973

Luis Carrero Blanco

• Assassinated in Madrid.
• A massive bomb beneath the street launched his official car over a building.
• One of history's most famous vehicle assassinations.

1976

Orlando Letelier

• Car bomb in Washington, D.C.
• Assassinated along with Ronni Moffitt.
• One of the most notorious Cold War assassinations on U.S. soil.

1979

Lord Louis Mountbatten

• Killed when the IRA bombed his fishing boat.
• Not a car bombing but often discussed alongside IRA bombing campaigns.

1980

Walter Rodney

• Killed in Georgetown, Guyana.
• A bomb concealed inside what appeared to be a communications device exploded in a car.
• A later Commission of Inquiry concluded he was assassinated and implicated state actors.

1981

Bechir Gemayel

• Building bomb killed him before taking office.

1982

Large vehicle bombs become common during the Lebanese Civil War.

1983

U.S. Embassy Beirut

• Truck bomb kills 63.

1983

Beirut Marine Barracks bombing.

• Truck bomb kills 241 U.S. service members.

1986

Basil Paterson

• Continued IRA vehicle bombing campaign.

1989

Alfred Herrhausen

• Sophisticated roadside bomb destroys his armored Mercedes.

• Attributed to the Red Army Faction.

1992

Giovanni Falcone

• Massive roadside bomb under highway kills Falcone, his wife, and security team.

1992

Paolo Borsellino

• Car bomb in Palermo kills Borsellino and five police officers.

1995

Alfred P. Murrah Federal Building

• Truck bomb kills 168.
• Deadliest act of domestic terrorism in U.S. history.

1996

Khobar Towers

• Truck bomb kills 19 U.S. personnel.

2005

Rafik Hariri

• Massive truck bomb in Beirut.
• One of the largest political assassinations of the 21st century.

2017

Daphne Caruana Galizia

• Killed by a bomb placed beneath her car after years of investigating corruption.
• Her assassination prompted major political upheaval in Malta.

Walter Rodney

His most famous work is:

• How Europe Underdeveloped Africa

In that book, Rodney argued that Africa's poverty could not be understood simply as an internal African problem. He argued that centuries of slavery, colonial extraction, and unequal economic relationships played a major role in shaping modern Africa.

Rodney was:

• A historian.
• A university professor.
• A political organizer.
• A public intellectual.

He became influential across Africa and the Caribbean.

In 1980, he was killed in Guyana when a bomb exploded in his car. His death remains one of the most controversial political assassinations in Caribbean history.

In that sense, you could argue that many people know pieces of what Rodney wrote about Africa, but far fewer know Walter Rodney himself. His work remains influential, especially among historians of colonialism and African development, but he is nowhere near as widely known in the general public as figures such as Nelson Mandela or Martin Luther King Jr..

His most famous book, How Europe Underdeveloped Africa, became enormously influential academically and politically, especially in Africa, the Caribbean, and universities

In How Europe Underdeveloped Africa, Rodney argued that the wealth of many European states and institutions was deeply connected to centuries of extraction from Africa. Whether one agrees with all of his conclusions or not, that argument directly challenged comfortable stories about economic development, empire, and global wealth.

People whose careers, politics, or worldviews were invested in those traditional narratives often disagreed with him strongly.

Rodney was trying to explain:

• Colonialism
• Trade systems
• Banking
• Resource extraction
• Labor systems
• Political power

over hundreds of years and across continents.

That's much harder to turn into a popular narrative.

As for Rodney's death, it is historically true that he was killed in a car-bomb explosion in Guyana in 1980. The circumstances have been investigated and debated for decades, and many people believe his political activities played a role in why he became a target.

Rodney had made powerful enemies in Guyana's political establishment. What we cannot prove is that every institution or financial interest criticized in his writings was involved in his death.

Rodney was asking questions that some people interpreted as having implications for present-day power, wealth, international relationships, and economic structures.

Whether one agrees with Rodney's analysis or not, those kinds of questions often generate more controversy because they are not just about the past—they are also about how people understand the present.

That's one reason scholars still argue about Rodney's work more than fifty years after he wrote it. The debate is not only about African history; it's also about how we explain the modern world.

Walter Anthony Rodney was born in 1942 into a working-class family in Georgetown, Guyana. He attended the University College of the West Indies in 1960 and was awarded a first-class honours degree in history in 1963. He earned a PhD in African History in 1966 at the School of Oriental and African Studies in London, England, at the age of 24. What was new in Walter Rodney's time (1960s–1980)

Walter Rodney was not the first person to notice exploitation. He was among the first to make three moves at once, in plain language, and inside the post-colonial moment.

He flipped the dominant story

Before Rodney, the mainstream explanation for Africa's poverty was:

• "underdevelopment"
• "lack of modernization"
• "tribalism"
• "bad governance after independence"

Rodney said something far sharper: Africa was not underdeveloped — it was actively underdeveloped.

That framing was new and dangerous because it:

• Removed blame from Africans
• Assigned responsibility to Europe + local elites
• Turned poverty into a crime scene, not a condition

Why this hit differently in his era -The timing mattered

Rodney was speaking:

• Right after African independence movements (1950s–60s)
• When former colonial powers were claiming they had "left"
• While extraction never actually stopped

His argument exposed the lie at the center of post-colonial politics: Independence without economic control is not independence.

That was not widely accepted in the 1960s–70s.

What elites found intolerable

Rodney did three forbidden things simultaneously:

He named collaboration

He didn't just blame Europe. He named African elites, local rulers, and comprador classes as partners in extraction.

That shattered nationalist myths.

He made it understandable to ordinary people

His book How Europe Underdeveloped Africa was readable, teachable, and portable.

He brought it home (Guyana)

Rodney didn't stay in safe abstraction.

He applied the same analysis to:

• Caribbean elites
• Post-colonial governments
• Cold War proxy states

That collapsed the distance between:

• "Africa over there"
• and "power here, now"

That's when the danger level changed.

Why it seems obvious now

Today:

• Resource extraction is openly acknowledged
• Multinationals admit it in annual reports
• NGOs and textbooks repeat Rodney's conclusions

But this is retrospective normalization.

In his time:

• Saying this threatened aid flows
• Undermined Cold War alignments
• Challenged both Western and local ruling classes

That's why:

• He was banned
• Isolated
• And ultimately killed in 1980

What Walter Rodney said sounds obvious today only because he paid the price for saying it first, clearly, and where it mattered.

What was new in Walter Rodney's time (1960s–1980)

Walter Rodney was not the first person to notice exploitation.

He was among the first to make three moves at once, in plain language, and inside the post-colonial moment.

He flipped the dominant story

Before Rodney, the mainstream explanation for Africa's poverty was:

• "underdevelopment"
• "lack of modernization"
• "tribalism"
• "bad governance after independence"

Rodney said something far sharper:

Africa was not underdeveloped — it was actively underdeveloped.

That framing was new and dangerous because it:

• Removed blame from Africans

• Assigned responsibility to Europe + local elites

• Turned poverty into a crime scene, not a condition

Why this hit differently in his era

The timing mattered

Rodney was speaking:

• Right after African independence movements (1950s–60s)
• When former colonial powers were claiming they had "left"
• While extraction never actually stopped

His argument exposed the lie at the center of post-colonial politics:

Independence without economic control is not independence.

That was not widely accepted in the 1960s–70s.

What elites found intolerable

Rodney did three forbidden things simultaneously:

He named collaboration

He didn't just blame Europe.

He named African elites, local rulers, and comprador classes as partners in extraction.

That shattered nationalist myths.

He made it understandable to ordinary people

His book How Europe Underdeveloped Africa

was readable, teachable, and portable. This mattered more than academic brilliance.

He brought it home (Guyana)

Rodney didn't stay in safe abstraction.

He applied the same analysis to:

• Caribbean elites
• Post-colonial governments
• Cold War proxy states

That collapsed the distance between:

• "Africa over there"
• and "power here, now"

That's when the danger level changed.

Why it seems obvious now

Today:

• Resource extraction is openly acknowledged
• Multinationals admit it in annual reports
• NGOs and textbooks repeat Rodney's conclusions

But this is retrospective normalization.

In his time:

• Saying this threatened aid flows
• Undermined Cold War alignments
• Challenged both Western and local ruling classes

That's why:

• He was banned
• Isolated
• And ultimately killed in 1980

What Walter Rodney said sounds obvious today only because he paid the price for saying it first, clearly, and where it mattered.

How Europe Underdeveloped Africa is a book written by Walter Rodney, which takes the view that Africa was deliberately exploited and underdeveloped by European colonial regimes. This book was groundbreaking in that it was among the first to bring a new perspective to the question of underdevelopment in Africa. Rodney's analysis went far beyond the heretofore accepted approach in the study of Third World underdevelopment and it was met with heavy criticism.

It is based on the outlined issues sketched above that this book was written. The piece of literature is arranged in chapters from one to six with thought provoking and are stimulating issue at each chapter. A post script as well as a biography of the author is attached at the latter part of the literature. A chapter by chapter method of review have been adopted to do justice to this work for an incisive appreciation.

The conceptualization of the notion of development and underdevelopment took the central stage in the first chapter, as the author attempted a penetrating analysis into the duo concepts in order to demystify their justification of capitalism which myopically conceives economic development with little or no consideration for human social development.

Rodney had determined that the only path to true human development and liberation for the majority of the people of his country was through the transformation of their own lives in a struggle to replace and reshape the neo-colonialist government that dominated their society and prescribed their existence.

From the view point of Walter Rodney, and from the way he has been able to approach the cause of underdeveloped Africa today, it is clear that he is a Marxist, because he supports the opinion that Africa became underdeveloped due to the contact of Africa and Europe through the aid of colonialism.

This book is not without criticisms despite its wide range coverage. The author was not ignorant of certain positive features of colonialism rather he opined that they were grossly inconsequential when placed side by side it negative effects. In a much as this is contentious, critics have argued that the author was propelled by a value considered as being extreme in its bias in favour of the periphery. Critiques have further argued that contemporary African territories have come of age after years of independence, it is absurd to hinge underdevelopment issues on the mythology of imperialism and colonialism as underdevelopment and development are both states of mind".

Walter Rodney from all indications can be placed as a Marxian because in the book, he supported the Marxian perspective of why Africa is underdeveloped, he stressed the fact that it is due to European contact which is very exploitative in nature that has left Africa underdeveloped today.

Works by Walter Rodney Books and Major Historical Works

Rodney, Walter. West Africa and the Atlantic Slave Trade. Nairobi: East African Publishing House and the Historical Association of Tanzania, 1967.

Rodney, Walter. The Groundings with My Brothers. London: Bogle-L'Ouverture Publications, 1969.

Rodney, Walter. A History of the Upper Guinea Coast, 1545–1800. Oxford: Clarendon Press, 1970.

Rodney, Walter. How Europe Underdeveloped Africa. London: Bogle-L'Ouverture Publications; Dar es Salaam: Tanzania Publishing House, 1972.

Rodney, Walter. World War II and the Tanzanian Economy. Ithaca, New York: Africana Studies and Research Center, Cornell University, 1976.

Rodney, Walter, editor. Guyanese Sugar Plantations in the Late Nineteenth Century: A Contemporary Description from the Argosy. Georgetown, Guyana: Release Publishers, 1979.

Rodney, Walter. A History of the Guyanese Working People, 1881–1905. London: Heinemann Educational Books; Baltimore: Johns Hopkins University Press, 1981.

Rodney, Walter, Kapepwa Tambila, and Laurent Sago. Migrant Labour in Tanzania During the Colonial Period. Hamburg: Institute for African Studies, 1983.

Political Works, Speeches, and Pamphlets

Rodney, Walter. People's Power, No Dictator. Georgetown, Guyana: Working People's Alliance, 1979.

Rodney, Walter. Marx in the Liberation of Africa. Washington, D.C.: Howard University Press, 1981.

Rodney, Walter. Sign of the Times: Rodney's Last Speech, June 6, 1980. Georgetown, Guyana: Working People's Alliance, 1981.

Rodney, Walter. "The African Revolution." Lecture delivered at the University of Michigan, March 31, 1972. Published in Urgent Tasks, no. 12, 1981.

Rodney, Walter. "Marxism and African Liberation." Speech delivered at Queens College, New York, 1975. Later published in Yes to Marxism! Georgetown, Guyana: People's Progressive Party, 1986.

Rodney, Walter. "Aspects of the International Class Struggle in Africa, the Caribbean and America." In Pan-Africanism: Struggle Against Neo-Colonialism and Imperialism, edited by Horace Campbell. Toronto: Afro-Carib Publications, 1975.

Rodney, Walter. "African History in the Service of the Black Liberation." Lecture delivered at the Congress of Black Writers, Montreal, October 12, 1968.

Rodney, Walter. "The Role of the University in Developing Africa." Public lecture delivered to the Makerere Students' Guild, Makerere University, Uganda, October 1970.

Academic Articles and Essays

Rodney, Walter. "Portuguese Attempts at Monopoly on the Upper Guinea Coast." Journal of African History 6, no. 3 (1965): 307–322.

Rodney, Walter. "African Slavery and Other Forms of Social Oppression on the Upper Guinea Coast, 1580–1650." Journal of African History 7, no. 3 (1966): 431–443.

Rodney, Walter. "Masses in Action." New World Quarterly 2, no. 3 (1966): 30–37.

Rodney, Walter. "The Impact of the Atlantic Slave Trade in West Africa." In The Middle Age of African History, edited by Roland Oliver. Oxford: Oxford University Press, 1967.

Rodney, Walter. "Education and Tanzanian Socialism." In Tanzania: Revolution by Education, edited by Idrian Resnick. Arusha: Longmans of Tanzania, 1968.

Rodney, Walter. "European Activity and African Reaction in Angola." In Aspects of Central African History, edited by Terence Ranger. Evanston, Illinois: Northwestern University Press, 1968.

Rodney, Walter. "African Labour Under Capitalism and Imperialism." Cheche, no. 1, University of Dar es Salaam, November 1969: 4–12.

Rodney, Walter. "Ideology of the African Revolution." Paper presented at the Second Seminar of East and Central African Youth. Published in The Nationalist, Dar es Salaam, December 11, 1969.

Rodney, Walter. "Gold and Slaves on the Gold Coast." Transactions of the Historical Society of Ghana 10 (1969).

Rodney, Walter. "The Imperialist Partition of Africa." Monthly Review 21, no. 11 (April 1970): 103–114.

Rodney, Walter. "The Year 1895 in Southern Mozambique: African Resistance to the Imposition of European Colonial Rule." Journal of the Historical Society of Nigeria 5, no. 4 (1971): 509–535.

Rodney, Walter. "George Jackson: Black Revolutionary." Maji Maji, no. 5 (1971): 4–6.

Rodney, Walter. "Some Implications of the Question of Disengagement from Imperialism." Maji Maji 1 (January 1971): 3–8.

Rodney, Walter. "Tanzanian Ujamaa and Scientific Socialism." African Review 1, no. 4 (1972): 61–76.

Rodney, Walter. "State Formation and Class Formation in Tanzania." Maji Maji, no. 11 (1973): 25–32.

Rodney, Walter. "Some Implications of the Question of Disengagement from Imperialism." In The Silent Class Struggle, edited by Issa G. Shivji. Dar es Salaam: Tanzania Publishing House, 1974.

Rodney, Walter. "The Guinea Coast." In The Cambridge History of Africa, Volume 4: From c. 1600 to c. 1790, edited by Richard Gray. Cambridge: Cambridge University Press, 1975.

Rodney, Walter. "Africa in Europe and the Americas." In The Cambridge History of Africa, Volume 4: From c. 1600 to c. 1790, edited by Richard Gray. Cambridge: Cambridge University Press, 1975.

Rodney, Walter. "Slavery and Underdevelopment." In Roots and Branches: Current Directions in Slave Studies, edited by Michael Craton. New York: Pergamon Press, 1979.

Rodney, Walter. "Class Contradictions in Tanzania." In The State in Tanzania: Who Controls It and Whose Interests Does It Serve?, edited by Haroub Othman. Dar es Salaam: Dar es Salaam University Press, 1980.

Rodney, Walter. "The Political Economy of Colonial Tanganyika, 1890–1930." In Tanzania Under Colonial Rule, edited by M. H. Y. Kaniki. London: Longman, 1980.

Rodney, Walter. "The Colonial Economy." In General History of Africa, Volume VII: Africa Under Colonial Domination, 1880–1935, edited by A. Adu Boahen. Paris: UNESCO; London: Heinemann, 1985.

Books Written for Children

Rodney, Walter. Kofi Baadu Out of Africa. Georgetown, Guyana: Guyana National Lithographic Company, 1980.

Rodney, Walter. Lakshmi Out of India. Georgetown, Guyana: Guyana Book Foundation, 2000.

Rodney wrote these stories to help young people understand the African and Indian experiences that helped create Guyanese society.

Posthumously Published Lectures, Interviews, and Collections

Rodney, Walter. Walter Rodney Speaks: The Making of an African Intellectual. Edited by Robert A. Hill, with a foreword by Howard Dodson. Trenton, New Jersey: Africa World Press, 1990.

Rodney, Walter. A Tribute to Walter Rodney: One Hundred Years of Development in Africa. Based on lectures delivered at the University of Hamburg during the summer of 1978. Hamburg: University of Hamburg, Institute of Political Science, 1984.

Rodney, Walter. The Russian Revolution: A View from the Third World. Edited by Robin D. G. Kelley and Jesse Benjamin. London and New York: Verso, 2018.

Rodney, Walter. Decolonial Marxism: Essays from the Pan-African Revolution. Edited by Asha Rodney, Patricia Rodney, Benjamin Mabie, and Jesse Benjamin. London and New York: Verso, 2022.

Walter Rodney Papers and Archival Material

The Walter Rodney Papers are housed at the Archives Research Center of the Robert W. Woodruff Library at the Atlanta University Center. The collection covers approximately 1960 through 1987 and contains published and unpublished speeches, lectures, journal articles, book reviews, chapters, teaching materials, correspondence, research notes, political writings, and drafts of Rodney's books.

The Walter Rodney Foundation also maintains Rodney's papers, publications, historical material, and an expanding bibliography of works written by and about him.

Selected Books and Publications About Walter Rodney (Published After His Death) 1980

And Finally They Killed Him: Speeches and Poems at a Memorial Rally for Walter Rodney, 1942–1980. Memorial volume from the University of Ife (Nigeria) containing speeches, tributes, and poems delivered shortly after Rodney's assassination.

1982

Walter Rodney: Revolutionary and Scholar—A Tribute. Edited by Edward A. Alpers and others. University of California, Los Angeles. Collection of essays examining Rodney's scholarship, political activism, and historical legacy.

1983

James, C. L. R. Walter Rodney and the Question of Power. Race Today Publications. A political assessment of Rodney's ideas on democracy, socialism, and people's power.

1984

A Tribute to Walter Rodney: One Hundred Years of Development in Africa. University of Hamburg. Publishes Rodney's 1978 Hamburg lectures together with scholarly commentary.

1985

Campbell, Horace. Rasta and Resistance: From Marcus Garvey to Walter Rodney. Africa World Press. Examines Rodney's influence within Pan-Africanism and the Rastafari movement.

Dabydeen, David, and Andrew Salkey, editors. Walter Rodney: Poetic Tributes. Bogle-L'Ouverture Publications. Poems and literary tributes honoring Rodney following his assassination.

1990

Grigsby, Daryl Russell. The C. L. R. James–Walter Rodney Connection. Study of the intellectual relationship between James and Rodney.

1990

Lewis, Rupert. Walter Rodney's Intellectual and Political Thought. One of the earliest book-length studies devoted entirely to Rodney's ideas.

2005

Walter Rodney 25th Anniversary Commemoration Volume. Published by the Walter Rodney 25th Anniversary Commemoration Committee. Historical essays, speeches, photographs, and reflections marking twenty-five years since Rodney's assassination.

2014–2015

Report of the Walter Rodney Commission of Inquiry. Government of Guyana. More than 1700 pages of testimony, documents, forensic evidence, and findings concerning Rodney's assassination.

2018

Hirji, Karim F. The Travails of a Tanzanian Teacher. Includes substantial discussion of Rodney's years at the University of Dar es Salaam and his influence on African scholarship.

2019

Lewis, Rupert. Walter Rodney's Intellectual and Political Thought (Revised Edition). Updated edition incorporating newer scholarship on Rodney's work and legacy.

Articles, Journals, and Special Issues

Numerous journals have published special issues dedicated to Rodney, including:

• Race & Class
• Review of African Political Economy
• Small Axe
• The Journal of African History
• Social and Economic Studies
• New West Indian Guide
• Caribbean Quarterly

These collections examine Rodney's historical methodology, Pan-Africanism, Marxism, political activism, educational philosophy, and continuing influence on African and Caribbean studies.

Archival Resources

The Walter Rodney Papers Robert W. Woodruff Library Atlanta University Center

The archive contains the world's largest collection of material by and about Walter Rodney, including correspondence, unpublished manuscripts, speeches, interviews, photographs, newspaper clippings, teaching materials, and thousands of pages of research notes.

"Are we allowing the entire world to become a kill box—where governments can identify, track, and strike people anywhere with little public oversight?"

Ivermectin: 38 Years in Africa. Over 5 Billion Treatments Worldwide. Merck USA and the World's Largest Drug Program.

Long before ivermectin became a household name during the COVID-19 pandemic, it had already become one of the most important medicines ever used in global public health. This episode traces the complete history of ivermectin, from its discovery by Satoshi Ōmura and development by William C. Campbell at Merck to the early human clinical trials led by Dr. Mohammed A. Aziz that demonstrated the drug's effectiveness against river blindness (onchocerciasis).

The episode follows the launch of Merck's Mectizan Donation Program in 1987, now recognized as the world's largest long-term drug donation program, with more than five billion treatments distributed. It examines how Merck, the World Health Organization (WHO), the World Bank, the Carter Center, ministries of health, scientists, nonprofit organizations, and hundreds of thousands of community-directed health workers built one of the largest disease-control campaigns in modern history across Africa, Yemen, and Latin America.

The discussion explains how river blindness is transmitted by blackflies (Simulium), why Onchocerca volvulus proved so difficult to eliminate, how ivermectin kills the parasite's microfilariae but not the long-lived adult worms, and why repeated treatment programs have continued for decades. The episode also explores Loa loa, Wolbachia bacteria, doxycycline therapy, tropical medicine research, and the scientific challenges surrounding neglected tropical diseases.

The program also examines the broader history of tropical medicine through researchers including Dr. R. W. Ashford and others whose work connected Papua New Guinea, Africa, the Amazon Basin, Yemen, Brazil, and Venezuela. Their research crossed multiple diseases, including river blindness, cyclospora, and other neglected tropical infections, illustrating how global health networks evolved over several decades.

Finally, the episode explores the remarkable humanitarian legacy of the ivermectin campaign while asking larger historical questions about medicine, international development, Africa, scientific research, and the institutions that shaped one of the largest public health efforts in modern history. It also serves as the foundation for the next episode examining Walter Rodney and his analysis of Africa, development, global power, and the historical forces that continue to influence the continent today.

Clips:

How Does Ivermectin Work? - YouTube

Why is ivermectin toxic to dogs?

Cancer and Aspirin: We Were Wrong About Aspirin (New Evidence)

River Blindness Treatment: Medications and Surgery | Inciteful Med Resources

Program: Mass Drug Administration to Control Onchocerciasis (aka River Blindness) | GiveWell

First Step as a Researcher - Wiping Blackboards | S&T articles archive| Sakura Science Club

How they use hormones to flip sex: Hormones

Do you have a psychopath in your life? The best way to find out is read my book. BOOK *FREE* Download – Psychopath In Your Life4

Support is Appreciated: Support the Show – Psychopath In Your Life

Download Pods here: TOP PODS – Psychopath In Your Life

My old discussion forum with last 10 years of victim stories, is back online. Psychopath Victim Support Community | Forums powered by UBB.threads™

Google Maps My HOME Address: 309 E. Klug Avenue, Norfolk, NE 68701 SMART Meters & Timelines – Psychopath In Your Life

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:ca488f54-9cab-4a1d-a6a4-0f95bb82b4f1-13" data-turn-id-container= "request-WEB:ca488f54-9cab-4a1d-a6a4-0f95bb82b4f1-13" data-testid= "conversation-turn-28" data-turn="assistant"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-41" data-turn-id-container= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-41" data-testid= "conversation-turn-84" data-turn="assistant"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:bf1b7f6f-ca47-4b7f-bffb-f3fc1d4de5cb-1" data-turn-id-container= "request-WEB:bf1b7f6f-ca47-4b7f-bffb-f3fc1d4de5cb-1" data-testid= "conversation-turn-4" data-turn="assistant"> The Main Players River Blindness (Onchocerciasis)

River blindness is caused by a parasitic worm called Onchocerca volvulus.

It is spread by infected blackflies.

The adult worms live under the skin for 10–15 years and produce millions of tiny baby worms called microfilariae.

Those baby worms cause:

• severe itching
• skin disease
• eye damage
• blindness

Ivermectin

Ivermectin is the medicine used to control river blindness.

Its main job is to kill the baby worms (microfilariae).

By removing the baby worms, it:

• relieves itching
• helps prevent blindness
• reduces the chance blackflies spread the disease to other people

A single dose usually does not kill the adult worms, so treatment is repeated once or twice a year until the adult worms eventually die naturally. Loa loa

Loa loa is a completely different parasite.

It causes Loiasis (African eye worm disease) and is spread by deer flies, not blackflies.

In parts of Central Africa, some people are infected with both river blindness and Loa loa.

Most people tolerate ivermectin well. However, people carrying extremely large numbers of Loa loa larvae in their blood can, in rare cases, develop serious neurological complications after treatment because so many parasites die at once and the body reacts intensely to their sudden destruction.

Wolbachia bacteria

There is one more important piece.

Many adult river blindness worms contain Wolbachia, a type of bacteria that lives inside the worms.

The worms depend on these bacteria to survive and reproduce.

Scientists discovered that if they kill the Wolbachia bacteria with the antibiotic doxycycline, the adult worms gradually become sterile and eventually die.

So today there are two different treatment approaches:

• Ivermectin rapidly kills the baby worms, reducing symptoms and transmission.
• Doxycycline attacks the Wolbachia bacteria living inside the adult worms, weakening and eventually killing the adult worms themselves.

The Big Picture

Think of it this way:

• Onchocerca volvulus = the parasite that causes river blindness.
• Microfilariae = the baby worms that cause most of the symptoms.
• Ivermectin = kills the baby worms.
• Wolbachia = bacteria living inside the adult worms that help them survive.
• Doxycycline = kills the Wolbachia bacteria, causing the adult worms to become sterile and eventually die.
• Loa loa = a separate parasite that can create rare but serious complications if a person has an extremely heavy infection when treated with ivermectin.

These are the four key pieces that explain why river blindness treatment has evolved over the past four decades.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:947bd14c-ed1b-4b2d-9662-b4d55e8c5785-1" data-turn-id-container= "request-WEB:947bd14c-ed1b-4b2d-9662-b4d55e8c5785-1" data-testid= "conversation-turn-4" data-turn="assistant">

Here is a single research table focusing on the most influential English-language public promoters of ivermectin during the COVID-19 era and whether discussions of side effects were a significant part of their public messaging.

Person / Group Estimated Volume of Ivermectin Content Main Platform Primary Message Were Side Effects a Major Part of Their Messaging? Pierre Kory (FLCCC) 500+ articles, interviews, webinars, testimony FLCCC, podcasts, conferences Strongly promoted ivermectin for COVID treatment and prevention No. Emphasized decades of safe use and generally discussed adverse effects only briefly. Paul Marik (FLCCC) 300+ protocols, interviews, lectures FLCCC Early treatment protocols centered on ivermectin No. Focused primarily on safety record and dosing. FLCCC Alliance Hundreds of publications and webinars Website, newsletters Major institutional promoter Limited discussion. Contraindications and precautions were included, but uncommon neurological complications were not a central theme. Joe Rogan 20–40 podcast episodes or major discussions Spotify podcast Hosted leading ivermectin advocates and discussed his own use Generally no. Conversations focused much more on efficacy, censorship, and policy than adverse effects. Bret Weinstein 100+ podcasts, interviews, appearances DarkHorse, Joe Rogan One of the most persistent non-physician advocates No. Rare neurological complications and Loa loa issues were not major topics. Robert Malone 100+ interviews, blogs, podcasts Podcasts, Substack Frequently argued ivermectin was unfairly suppressed Generally no. Focus remained on access, evidence, and censorship. Jon Rappoport Dozens to over 100 articles Blog Criticized media and government response; supportive of ivermectin discussions Rarely. His writing emphasized media, policy, and freedom more than adverse-effect analysis. America's Frontline Doctors / Simone Gold Hundreds of public statements and events Website, media Promoted physician access and prescribing Limited. Emphasis was on availability and physician autonomy. Robert F. Kennedy Jr. Dozens of interviews Podcasts, speeches Mentioned ivermectin within broader COVID policy criticism Not a major focus. Side effects were generally not discussed in depth. John Campbell Dozens of YouTube videos YouTube Reviewed ivermectin studies and policy debates Some discussion of safety, but uncommon adverse reactions were not a major focus. Overall observation

Across this group, the dominant public themes were:

• Ivermectin's long history of use against parasites.
• Its Nobel Prize association.
• Claims regarding COVID-19 effectiveness.
• Government and media censorship.
• Regulatory decisions.

Topics that generally received much less attention included:

• Rare neurological complications in people with high Loa loa microfilarial burdens in Central Africa.
• Mazzotti reactions after parasite death.
• Overdose toxicity.
• Drug interactions.
• Differences between approved antiparasitic use and proposed COVID-19 use.

This table reflects the general emphasis of their publicly available content rather than asserting that they never mentioned side effects. Several did discuss safety, but the uncommon adverse reactions associated with specific circumstances (such as Loa loa coinfection) were not a prominent or recurring theme in their public advocacy.

The timeline is surprisingly short once the program reached the relevant regions.

• 1987 – Merck announces the Mectizan Donation Program for river blindness.
• 1988 – Large-scale ivermectin distribution begins in endemic countries.
• 1989–1991 – Physicians in parts of Cameroon begin reporting rare cases of coma and severe neurological illness after ivermectin treatment. At first, the cause is unknown.
• 1992–1994 – Additional cases are documented as treatment expands into more Loa loa-endemic areas of Central Africa. Investigators begin to suspect the events are geographically linked.
• 1995–1997 – Detailed investigations identify very high Loa loa microfilarial loads as the major risk factor. A landmark 1997 Lancet paper establishes the association.
• Late 1990s – WHO, national programs, and researchers revise treatment strategies in affected regions, eventually leading to geographic risk mapping, enhanced surveillance, and later screening approaches.

So the progression was roughly:

• 1989–early 1990s: "People are developing severe neurological illness after ivermectin. Why?"
• Mid-1990s: "These cases all seem to occur where Loa loa is common."
• 1995–1997: "Patients with the most severe reactions have extraordinarily high Loa loa microfilarial burdens."

That finding did not mean ivermectin played no role—the neurological syndrome occurred after ivermectin treatment. Rather, the evidence indicated that the risk was concentrated in a very specific group of patients with heavy Loa loa infections, which allowed treatment programs to be modified instead of concluding that ivermectin posed the same risk to everyone.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:eec9e000-0e02-4a69-b351-5b9f65ff2ca0-0" data-turn-id-container= "request-WEB:eec9e000-0e02-4a69-b351-5b9f65ff2ca0-0" data-testid= "conversation-turn-2" data-turn="assistant">

Yes. The blood–brain barrier (BBB) issue is sometimes discussed as though it is unique to ivermectin, but it is not. In fact, many drugs are designed to cross the blood–brain barrier, while others are specifically designed not to.

Here are some examples:

Drug/Class Crosses Blood-Brain Barrier? Why Morphine Yes Pain relief in the brain and spinal cord Fentanyl Yes (very easily) Extremely fat-soluble; acts rapidly in the CNS Diazepam (Valium) Yes Anxiety, seizures, muscle relaxation Alprazolam (Xanax) Yes Anxiety treatment Fluoxetine (Prozac) Yes Must reach the brain to affect serotonin Antipsychotics Yes Treat schizophrenia and other psychiatric disorders Levodopa Yes Parkinson's treatment; converted to dopamine in the brain Alcohol Yes Causes intoxication by acting on the brain Nicotine Yes Reaches the brain within seconds of inhalation Caffeine Yes Blocks adenosine receptors in the brain Drugs that normally do NOT cross much

• Penicillin (most forms)
• Heparin
• Insulin
• Most large antibody drugs
• Many antibiotics unless the meninges are inflamed

These drugs work elsewhere in the body and either are too large or too water-soluble to enter the brain easily.

Where ivermectin fits

Ivermectin is actually interesting because under normal conditions it penetrates the human brain very poorly. Several protective mechanisms keep it out.

The most important is P-glycoprotein (P-gp), a transporter in the blood–brain barrier that actively pumps ivermectin back into the bloodstream if small amounts enter the barrier.

Problems can occur when:

• someone receives an overdose,
• the blood–brain barrier is impaired,
• P-glycoprotein is absent or inhibited,
• or there are unusual biological circumstances.

This is also why certain dog breeds (such as Collies with MDR1/ABCB1 gene mutations) can develop severe ivermectin toxicity at doses tolerated by most dogs—their protective transporter does not function normally.

The broader perspective

One reason the blood–brain barrier became such a focus during COVID discussions is that people asked whether ivermectin itself was causing neurological symptoms. Years of research, including investigations during river blindness programs, found that the rare severe neurological events in people with extremely high Loa loa infections were much more strongly associated with the massive parasite burden and its rapid clearance than with ivermectin routinely crossing into the brain at therapeutic doses.

So the key point is:

• Many common medicines intentionally cross the blood–brain barrier.
• Ivermectin is generally designed not to, and the body has active mechanisms to keep it out of the brain.
• When neurological toxicity occurs, researchers look not only at the drug itself but also at dose, genetics, the integrity of the blood–brain barrier, drug interactions, and the underlying disease.

So if you compare them:

• Morphine, Valium, Prozac, alcohol, nicotine: specifically need to reach the brain.
• Ivermectin: normally kept out of the brain by protective mechanisms.
• Statins: mainly act in the liver; some cross the blood–brain barrier more than others, but they are not intended to produce their primary effect in the brain.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:bf1b7f6f-ca47-4b7f-bffb-f3fc1d4de5cb-3" data-turn-id-container= "request-WEB:bf1b7f6f-ca47-4b7f-bffb-f3fc1d4de5cb-3" data-testid= "conversation-turn-8" data-turn="assistant">

In most humans and most dogs, ivermectin does not readily cross the blood-brain barrier in clinically significant amounts at approved doses.

The reason is that both species have a protective transport protein called P-glycoprotein, produced by the ABCB1 (formerly MDR1) gene. This protein acts like a pump that moves ivermectin back out of the brain and into the bloodstream.

However, there are exceptions.

In dogs

Some dogs inherit an ABCB1 (MDR1) gene mutation. In those dogs:

• The P-glycoprotein pump doesn't work properly.
• More ivermectin can enter and remain in the brain.
• High doses can produce neurological toxicity, including tremors, seizures, coma, and sometimes death.

This is why certain herding breeds are much more susceptible.

In humans

Most people also have functioning P-glycoprotein at the blood-brain barrier, so approved doses of ivermectin generally result in very low concentrations in the brain.

Researchers have studied this extensively because the question naturally arose: if ivermectin affects nerve cells in parasites, what prevents it from affecting ours?

Under certain circumstances—such as:

• very large overdoses,
• severe impairment of the blood-brain barrier,
• or possibly rare genetic differences affecting drug transport—

more ivermectin may enter the human brain, and neurological toxicity has been reported. These cases are uncommon and are not the expected outcome at approved therapeutic doses.

The key point

The blood-brain barrier is not an absolute wall. It is a highly selective barrier with active transport systems.

So a more accurate way to think about it is:

• Most dogs and most humans: P-glycoprotein keeps brain exposure very low at recommended doses.
• Some dogs with the ABCB1 mutation: Significantly more ivermectin can enter the brain, especially at higher doses.
• Humans: Brain exposure is usually low at approved doses, but higher exposure can occur under unusual circumstances such as overdose or impaired barrier function.

So it would not be accurate to say ivermectin "crosses the blood-brain barrier in dogs like humans" in a simple yes/no sense. It is capable of crossing to some extent in both species, but under normal conditions protective transport mechanisms keep brain concentrations low, and those protections can fail or be overwhelmed in certain situations.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:947bd14c-ed1b-4b2d-9662-b4d55e8c5785-19" data-turn-id-container= "request-WEB:947bd14c-ed1b-4b2d-9662-b4d55e8c5785-19" data-testid= "conversation-turn-40" data-turn="assistant"> Mini Timeline: Discovering the Loa loa–Ivermectin Connection

1975–1978

• Satoshi Ōmura (Japan) and Merck scientists discover and develop avermectins.
• Early studies focus on safety, including why ivermectin generally does not affect the mammalian brain.

1981

• Ivermectin is introduced in veterinary medicine.

1987

• Merck launches the Mectizan Donation Program for river blindness.
• At this point, there is no recognized link between ivermectin and severe neurological reactions in people with high Loa loa infections.

1988–1991

• Mass treatment expands across Africa.
• Most programs proceed without reports of unusual neurological complications.

1989–1993

• As treatment reaches parts of Cameroon and neighboring Central African countries, physicians begin reporting rare cases of coma and encephalopathy after ivermectin treatment.

1994–1995

• More cases are documented.
• Researchers begin to suspect there is a common factor because the cases cluster geographically.

1995–1997

• Investigations identify the cause:
  • Patients with severe reactions have extremely high Loa loa microfilarial loads.
  • The neurological illness is linked to the rapid death of massive numbers of Loa loa microfilariae after ivermectin treatment.

1997

• A landmark study in The Lancet establishes the association between very high Loa loa infection and post-ivermectin encephalopathy.

Late 1990s

• WHO, national programs, and researchers revise treatment strategies in high-risk areas.
• Enhanced surveillance and mapping of Loa loa-endemic regions begin.

2000s

• Programs adopt risk-reduction measures, including better geographic screening and, later, targeted "test-and-not-treat" approaches in some regions.

2010s–Present

• The Loa loa complication remains a recognized but uncommon risk in specific areas of Central Africa.
• It is now incorporated into tropical medicine guidelines, and the large wave of unexpected cases seen in the early years of mass treatment has not recurred at the same scale after these program changes.

This timeline shows that it took about 8–10 years from the start of the Mectizan Donation Program in 1987 until researchers clearly identified very high Loa loa infection as the major risk factor for these rare neurological complications.

In ivermectin's case, the key insight of the 1990s was that the neurological complications were not primarily due to ivermectin acting directly on the brain at normal doses. Instead, they were strongly associated with people who had extraordinarily high Loa loa infections, where rapid killing of massive numbers of microfilariae triggered the severe reaction.

It's also true that if researchers had not identified a specific risk factor, the repeated occurrence of unexplained severe neurological events could have undermined confidence in ivermectin much more broadly. Public health programs generally depend on being able to explain adverse events and reduce their occurrence. Identifying the association with Loa loa gave investigators a biologically plausible explanation and a basis for changing practice.

Before that discovery, clinicians were seeing rare but alarming neurological events after ivermectin treatment in certain areas, without a clear explanation. Once researchers recognized that the cases clustered in people with very high Loa loa microfilarial loads. *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:947bd14c-ed1b-4b2d-9662-b4d55e8c5785-20" data-turn-id-container= "request-WEB:947bd14c-ed1b-4b2d-9662-b4d55e8c5785-20" data-testid= "conversation-turn-42" data-turn="assistant">

Early development (1970s–early 1980s) focused on questions such as:

• Is ivermectin toxic to mammals?
• Does it enter the brain?
• What dose is safe?
• How is it metabolized?
• What are the effects in laboratory animals and early human studies?

Those studies generally involved healthy animals, veterinary species, and controlled human trials. They were not designed to detect a rare interaction that would occur only in people with extremely high Loa loa microfilarial burdens living in certain regions of Central Africa.

The Loa loa problem became apparent only when several conditions came together:

• Millions of people were treated in mass campaigns.
• Treatment expanded into areas where Loa loa was common.
• A very small subset of people had exceptionally high parasite loads.
• Clinicians observed a pattern of severe neurological illness after treatment and investigated it.

So it wasn't that researchers ignored brain safety for 8–10 years. Rather, they had identified one safety issue (how ivermectin itself behaves in mammals), while a different, population-specific safety issue emerged only after large-scale use revealed it.

That sequence is not unique to ivermectin. Some rare adverse reactions are discovered only after a medicine is used in very large and diverse populations because clinical trials are usually far too small to detect events that occur, for example, once in tens of thousands or hundreds of thousands of people.

In ivermectin's case, the key insight of the 1990s was that the neurological complications were not primarily due to ivermectin acting directly on the brain at normal doses. Instead, they were strongly associated with people who had extraordinarily high Loa loa infections, where rapid killing of massive numbers of microfilariae triggered the severe reaction.

If you're comparing countries, the other major powers that also did not have endemic river blindness include:

• Russia
• China
• Japan
• Most of Europe
• Canada
• United States
• Australia

The large, decades-long ivermectin donation campaigns instead focused on endemic regions in Africa, Yemen, and limited parts of Latin America.

First Step as a Researcher - Wiping Blackboard

From April 1, 1965, Satoshi Omura became a researcher at the Kitasato Institute.

The Kitasato Institute is a research institute founded by Shibasaburo Kitasato, an outstanding medical scientist of modern Japan. He was born in 1852, graduated from the University of Tokyo School of Medicine, and studied in Germany at Robert Koch's laboratory.

Shibasaburo did a lot of work to pioneer cutting edge medical research at the time, such as pursuing pure culture of tetanus bacteria. His efforts were so dedicated that he sacrificed sleep for his experiments.

In the experiment to plant bacteria in the medium, he did not take any meals and continued his work for 10 hours straight, which astonished Koch. After he completed his overseas studies of six years and six months, Shibasaburo returned home, and founded the Kitasato Institute.

Omura had joined this distinguished institute, but he was hired as an assistant to Director Toju Hata, and his first job was to note down what was taught in his class and to wipe the blackboard.

Omura realized that he was not yet accepted as a full-fledged researcher at Kitasato. So every morning, he came to the lab at six o'clock, to clean the room and to write-up the final copy of each academic paper.

Back then, there were not any word processors or computers. Writing up the final draft was a very important task. Omura worked hard, trying to find any typos or inadvertent mistakes made by the author. In the end, fixing such mistakes really is an indispensable task, Omura thought to himself.

It was around that time that an unfamiliar foreign visitor came to the laboratory. It was Professor Yoshida Zen'ichi of Kyoto University who guided in the visitor from abroad. Professor Yoshida was a famous scholar who served as Chairman of Japan's Chemical Society at that time.

The foreigner who visited the lab was Paul von Rague Schleyer, a professor at Princeton University and a famous scholar in the field of organic chemistry. He had read Omura's paper written in English. Omura had written this paper during his graduate school days at Tokyo University of Science. Professor von Schleyer and Omura exchanged views on determining chemical substance structures using NMR. Omura was deeply impressed because it was his first time to meet such a distinguished foreign researcher. Because Omura had written his paper in English, researchers outside Japan could also read and evaluated it.

"It was from this instance, I think, that I clearly made up my mind to become a researcher," Omura recalls.

Highly Evaluated for His Theses

Omura's salary at that time was not high, so life was not easy. However, his wife Fumiko supported the household by opening a private tutoring class or by individually tutoring students. Fumiko who was bright-natured cooperated without any complaints. When Omura got his Nobel Prize, one reporter asked how he felt. "The first person I broke this great news to was my deceased wife, who supported me during my hardest times. I talked to her in my heart,"responded Omura.

Omura started his research on chemical structure determination. The Kitasato laboratory already had equipment for nuclear magnetic resonance (NMR) and infrared spectroscopy (IR). However, the only person who could read and decipher the data was Omura. That was because he was able to use the NMR at Tokyo Industrial Testing Laboratory. It was the only NMR in Japan at that time. Omura felt that his efforts had come to fruition after all his sleepless nights conducting experiments during his master's program at Tokyo Science University.

Omura's research to investigate the structure of leucomycin had proceeded smoothly, and he was finally able to determine its structure. Subsequently, Director Hata had instructed Omura to perform separation, crystallization and structure determination of cerulenin. Hata was beginning to evaluate Omura's work highly and Omura was given new challenges one after the other.

Cerulenin is an antibiotic produced by a certain microorganism. Omura performed this task well and published it as a paper. Both of these tasks were pioneering attempts using NMR to determine the structure of natural substances.

Suffering from Neurosis – Fumiko Saves Omura

The research progresses steadily and Omura wrote papers one after another and presented them. However, Omura gradually lost the purpose in his research. Was his research really useful or not?

Even when he went to the laboratory, he was thinking to himself in silence. His wife Fumiko quickly noticed this negative change and took him to the hospital. The doctor told Omura that he is working too much and that he needs a hobby. Lending his ear to the doctor, Omura takes up golf.

Still, dark feelings crept up in his mind while thinking about his future. Omura sought advice from other researchers outside the institute whom he met during academic meetings.

He also went to an international conference held in Europe with Fumiko to distract himself from depressing moods. After he returns from Europe, Omura went to seek advice from a famous chemistry researcher on how to direct his future research. He gives an unexpected advice to Omura.

"Go study in the United Sates! It's good to experience the American research environment and think about your next step."

Omura was taken aback. The idea of studying abroad had never occurred to him until then. These words changed Omura's life.

Omura achieved many results as a researcher at the Kitasato Institute

Source: First Step as a Researcher - Wiping Blackboards | S&T articles archive| Sakura Science Club

From Imperial Army Microbiology to Ivermectin The Kitasato Scientific Lineage

When most people hear the story of ivermectin, they usually begin with Japanese scientist Dr. Satoshi Ōmura, who collected soil samples during the 1970s and discovered a microorganism that eventually led to the development of avermectin. Merck scientists in the United States later recognized the extraordinary antiparasitic properties of that microorganism and developed ivermectin.

That is the familiar story.

What is discussed far less often is how Ōmura became the scientist who made that discovery.

Scientists do not appear out of nowhere. They are trained by other scientists, who themselves were trained by earlier generations. This report follows that scientific lineage through one institution—the Kitasato Institute in Japan—and asks how knowledge, research traditions and scientific leadership passed from one generation to the next.

The timeline begins long before ivermectin existed.

From Imperial Army Microbiology to Ivermectin

The Kitasato Scientific Lineage

When most people hear the story of ivermectin, they usually begin with Japanese scientist Dr. Satoshi Ōmura.

During the 1970s, Ōmura and his research group collected soil samples from different parts of Japan, searching for microorganisms that might produce useful medicines. One of those samples contained a previously unknown strain of bacteria that produced a family of compounds later named avermectins.

That discovery was only the Japanese half of the story.

Shibasaburo Kitasato: The Founder

The story begins with Dr. Shibasaburo Kitasato, born in 1853.

Kitasato was one of the founders of modern Japanese bacteriology. During the late nineteenth and early twentieth centuries, he became internationally respected for research involving tetanus, plague, cholera and other infectious diseases.

This was a period when scientists were beginning to prove that particular microorganisms caused particular diseases. Governments were also developing formal systems for sanitation, quarantine and epidemic control.

Kitasato became one of Japan's leading authorities in this new field. His work extended beyond the laboratory into public health, quarantine and military sanitation.

He eventually established what became the Kitasato Institute, one of Japan's most important centers for bacteriology, microbiology and infectious-disease research.

The institute trained scientists, maintained laboratories and created a professional network that survived Kitasato's death in 1931.

Kitasato therefore established more than a research facility. He established a scientific tradition.

Sahachiro Hata: From Bacteriology to Drug Development

One of Shibasaburo Kitasato's most important associates was Dr. Sahachiro Hata.

The similar names can be confusing, so the relationship should be clear from the beginning:

Shibasaburo Kitasato founded the institute. Sahachiro Hata was one of his leading students and associates.

Sahachiro Hata became a prominent Japanese bacteriologist. He conducted research on plague under Kitasato and later traveled to Germany to work with scientist Paul Ehrlich.

At that time, syphilis was a widespread and often devastating disease. Ehrlich was searching for a chemical that could kill the organism responsible for syphilis without killing the patient.

Ehrlich and Hata tested hundreds of chemical compounds. Their work produced arsphenamine, commonly known as Salvarsan, in 1909.

Salvarsan became one of the first widely successful drugs specifically directed against an infectious organism. It was an important early step toward modern antimicrobial medicine.

Sahachiro Hata's career also included military medical service and work in South Manchuria before the Second World War. He later became deputy director of the Kitasato Institute.

His career brought several fields together inside the same scientific tradition:

bacteriology, infectious disease, drug development, military medicine, quarantine and work connected with Manchuria.

Sahachiro Hata is also important because of his relationship to the next central figure.

Toju Hata was his adopted son and heir.

Toju had been born into the Fujimatsu family. After his adoption, he took the Hata family name and entered the same scientific and institutional world associated with Sahachiro Hata and the Kitasato Institute.

Toju Hata: The Bridge Between War and Postwar Medicine

Dr. Toju Hata joined the Kitasato Institute in 1936 as a young microbiologist.

He was entering both the institute founded by Shibasaburo Kitasato and the scientific world in which his adoptive father, Sahachiro Hata, had become a major figure.

One year later, in 1937, Japan's war in China expanded dramatically. Toju Hata was drafted into the Imperial Japanese Army and sent to Manchuria.

Manchuria was a major center of Japanese military operations. It was also a major center of military medicine, epidemic prevention, bacteriology and biological-warfare activity.

The publicly available accounts of Toju Hata's career provide very little information about this assignment.

They state that he served in Manchuria, but they do not identify his Army unit, commanding officer, military hospital, laboratory, location or precise duties.

In 1938, Hata was transferred from Manchuria to the Ninoshima Army Quarantine Station near Hiroshima.

Ninoshima was a major military quarantine and disinfection facility. Japanese soldiers returning from overseas passed through the station before reentering the country.

They could be medically examined, isolated, bathed and disinfected. Their uniforms, equipment and possessions could also be disinfected.

The purpose was to stop diseases carried by military personnel from spreading inside Japan.

Hata was therefore not serving in an unrelated Army position. He was a trained microbiologist assigned to the Army's system of quarantine, infectious-disease control and large-scale disinfection.

The Wider Military Medical System and Unit 731

To understand why Hata's wartime career matters, it is necessary to understand the structure of Japanese military medicine.

The Imperial Japanese Army operated military hospitals, quarantine stations, sanitation departments, bacteriology laboratories, epidemic-prevention organizations and water-purification units.

Some of these organizations performed ordinary military health work. Disease could disable armies as effectively as enemy fire. Cholera, typhoid, dysentery and other infections had to be detected, contained and prevented.

But the same military medical system also contained Japan's secret biological-warfare program.

The organization later known as Unit 731 officially operated under the name Kwantung Army Epidemic Prevention and Water Purification Department.

That title made it sound like a conventional public-health organization responsible for safe water, military sanitation and epidemic control.

Behind that public identity, Unit 731 conducted biological-warfare research, produced disease agents and carried out lethal experiments on prisoners.

Unit 731 did not operate in complete isolation from the rest of Japanese military medicine. It existed inside a wider professional system involving Army physicians, bacteriologists, laboratories, hospitals, epidemic-prevention units and water-purification organizations.

Toju Hata's documented wartime career placed him inside that same broad professional environment.

He was a microbiologist.

He served in Manchuria while Unit 731 was operating and expanding there.

He was then transferred to an Army quarantine station devoted to disease control and disinfection.

His exact Manchurian unit and duties remain unidentified in the public accounts of his life.

Toju Hata Returns to Kitasato

After Japan's surrender in 1945, Toju Hata returned to the Kitasato Institute and resumed scientific research.

Medical research was entering a new era.

Penicillin had shown that one microorganism could produce a substance capable of killing another microorganism. Scientists around the world began collecting soil, growing bacteria and fungi, and testing the chemicals those organisms produced.

Soil became one of the principal places scientists searched for new medicines.

Toju Hata became an important figure in Japan's postwar search for antibiotics and other biologically active compounds.

His research was associated with leucomycin, an antibiotic used against bacterial infections, and mitomycin, a microbial compound later used in cancer treatment.

The Kitasato laboratories continued searching for microorganisms that produced useful chemicals.

This was not a complete break from the institute's earlier history. Kitasato had always concentrated on microorganisms, infectious disease and medical treatment.

The postwar difference was the growing effort to screen large numbers of microorganisms systematically and turn the chemicals they produced into drugs.

Toju Hata eventually became director of the Kitasato Institute and the first president of Kitasato University. Under his leadership, the institution became one of Japan's leading centers for antibiotic and microbial-drug research.

Satoshi Ōmura Enters Toju Hata's Research World

Satoshi Ōmura was born in 1935 and was ten years old when the Second World War ended.

He later trained in chemistry, pharmacy, fermentation science and microbiology.

Ōmura joined the Kitasato Institute in 1965.

At that time, Toju Hata was director.

This is the important connection.

Ōmura did not arrive at an institution with no history behind it. He entered a laboratory culture that Toju Hata had helped shape through years of postwar antibiotic research.

Hata was also more than a distant administrator.

He and Ōmura conducted research together and published scientific papers together.

Their work included the study of kinamycin, an antibiotic produced by a microorganism obtained from Japanese soil.

The research method was straightforward but labor-intensive.

Scientists collected soil from different locations.

They separated microorganisms from those samples.

They grew the organisms under controlled conditions.

They examined the chemicals produced during fermentation.

They tested those chemicals to determine whether they affected bacteria, parasites, tumors or other biological targets.

Ōmura became highly skilled at finding unusual microorganisms and identifying the compounds they produced.

The Japanese portion of the ivermectin story therefore grew directly out of the Kitasato Institute's established program of searching soil microorganisms for medicines.

How Merck Became Involved

The Kitasato Institute could discover microorganisms and identify promising natural compounds, but developing a commercial medicine required far greater resources.

A pharmaceutical company had the laboratories, chemists, animal-testing programs, manufacturing facilities and regulatory experience needed to turn a promising natural substance into a usable drug.

That is why Merck became part of the story.

Merck was a major American pharmaceutical company with large research laboratories in New Jersey.

Ōmura developed a working relationship with Dr. Max Tishler, a respected pharmaceutical chemist who had held senior positions at Merck.

Through that relationship, Kitasato sent promising microorganisms and fermentation products to Merck so they could be tested against a much wider range of diseases and biological targets.

The partnership divided the work according to expertise.

Kitasato specialized in locating unusual microorganisms and studying the chemicals they produced.

Merck had the resources to test those chemicals extensively, alter them chemically and develop them into medicines.

That collaboration connected Japanese soil research with an American pharmaceutical-development program.

William C. Campbell and the Avermectins

Dr. William C. Campbell was a parasitologist working at Merck.

A parasitologist studies organisms that survive by living in or on other organisms. Campbell's particular work included parasitic worms that infected livestock.

Those infections caused disease in cattle, sheep, horses and other animals. They also created major economic losses for agriculture.

Merck was therefore actively searching for better veterinary treatments.

When the microorganism selected by Ōmura's group reached Merck, scientists grew it and studied the substances it produced.

Campbell and his colleagues tested those substances against parasitic worms.

The activity was unusually powerful.

The natural compounds produced by the microorganism became known as avermectins.

These natural compounds were not yet ivermectin.

Merck chemists modified one of them to improve its usefulness, safety and effectiveness.

That chemically modified compound became ivermectin.

Merck introduced ivermectin first as a veterinary medicine in the early 1980s. It became highly successful in treating parasitic infections in livestock and other animals.

From Veterinary Medicine to River Blindness

After ivermectin proved successful in animals, William Campbell proposed testing it against the parasite responsible for river blindness, also known as onchocerciasis.

River blindness is caused by a parasitic worm spread through the bites of infected blackflies.

Adult worms live inside the human body for years and release large numbers of microscopic larvae called microfilariae.

Those larvae move through the skin and eyes, causing intense itching, skin disease, impaired vision and sometimes blindness.

Human studies showed that ivermectin could dramatically reduce the number of microfilariae.

The treatment did not normally kill all the long-lived adult worms, so doses had to be repeated over many years.

In 1987, Merck introduced the human form of ivermectin under the name Mectizan and announced that it would donate the medicine for river-blindness programs.

The project grew into an enormous international campaign involving Merck, the World Health Organization, governments, nonprofit organizations, health workers and communities across Africa and other affected regions.

Conclusion

The story of ivermectin is often reduced to three statements.

Satoshi Ōmura found a microorganism in Japanese soil.

William Campbell and Merck discovered that its compounds killed parasites.

Merck developed ivermectin.

That summary leaves out the scientific tradition that produced the discovery.

Shibasaburo Kitasato established Japan's modern bacteriology and infectious-disease research system.

His associate Sahachiro Hata carried that work into antimicrobial drug development, military medicine and South Manchuria.

Sahachiro's adopted son, Toju Hata, entered the Kitasato Institute as a microbiologist, served in the Imperial Japanese Army in Manchuria, transferred to the Ninoshima Army Quarantine Station and returned after the war to become a leader in antibiotic research.

Satoshi Ōmura joined Kitasato while Toju Hata was director.

The two scientists worked directly together on medicines produced by soil microorganisms.

Ōmura later entered a formal collaboration with Merck.

William Campbell and his colleagues tested the compounds against parasitic worms. Merck chemists then transformed one of the natural avermectins into ivermectin.

The path to ivermectin therefore extended across generations.

It began with Japan's early bacteriology establishment, passed through military medicine and quarantine, continued through postwar antibiotic research and eventually connected with Merck's American pharmaceutical laboratories.

At the center of that transition was Toju Hata: the adopted son of Sahachiro Hata, an Army microbiologist who served in Manchuria and at Ninoshima, a postwar antibiotic researcher, director of Kitasato and a direct scientific collaborator with Satoshi Ōmura.

The public record clearly documents that lineage. It leaves one major period largely unexplained: Toju Hata's precise military assignment and duties in Manchuria before his transfer to Ninoshima.

The clearest elite connections tied directly to the Kitasato institution are these:

Shibasaburo Kitasato himself became part of Japan's titled elite. In 1924, he was made a baron under Japan's hereditary peerage system. He was also a member of the Imperial Academy and received high imperial decorations. So by the later part of his life, Kitasato was not merely a scientist working outside the establishment; he had been formally elevated into it.

Yukichi Fukuzawa was Kitasato's most important early patron. Fukuzawa founded Keio University and was one of the most influential intellectual and institutional figures of modern Japan. He helped Kitasato establish Japan's first private infectious-disease institute and supported the tuberculosis hospital on the site where the later Kitasato Institute was built. Kitasato later repaid that support by helping establish Keio's medical school.

Morimura Ichizaemon supplied industrial wealth. Morimura was a major businessman who built an industrial and trading empire that later included companies associated with Noritake, TOTO and NGK. Official histories state that he financially supported Kitasato's infectious-disease institute in 1892 and made major donations to Kitasato and other elite educational institutions.

The Home Ministry and senior government medical officials were directly involved. Kitasato worked for the Home Ministry's Sanitary Affairs Bureau after medical school. His early institute was supported through the efforts of senior public-health official Nagayo Sensai and politician Hasegawa Tai. The institute was later nationalized, showing that Kitasato's work was connected from the beginning to the upper levels of Japan's public-health administration.

There was also a strong connection to Keio University, one of Japan's most prestigious private institutions. Sahachiro Hata trained within the Kitasato network and had studied at the same elite intersection of bacteriology, government medicine and international research. Toju Hata later inherited both the Hata name and that institutional position.

So the direct elite structure around the institution was not vague:

Kitasato became a baron.

Fukuzawa supplied intellectual prestige and institutional backing.

Morimura supplied industrial money.

The Home Ministry supplied government authority.

Keio supplied an elite educational network.

show that the Kitasato Institute was built from the beginning through a compact alliance of government medicine, wealthy industrial patrons, prestigious education and the imperial honors system. That is the elite network directly attached to the place we are tracking.

• George W. Merck established the philosophy.
• Max Tishler built the Japan–Merck partnership.
• William Campbell recognized the drug's potential.
• Mohammed Aziz proved it worked in humans.
• Roy Vagelos ensured it reached millions of people through the donation program.

Ivermectin Timeline (1973–Present) 1973

Japanese microbiologist Dr. Satoshi Ōmura of the Kitasato Institute collects soil samples throughout Japan searching for microorganisms that might produce useful medicines. One sample contains a previously unknown bacterium, later named Streptomyces avermitilis (now Streptomyces avermectinius).

1974

Ōmura sends the most promising bacterial cultures to Merck Research Laboratories in Rahway, New Jersey.

Merck parasitologist Dr. William C. Campbell begins testing the organisms against parasitic worms affecting livestock.

1975

Merck scientists isolate a family of natural compounds produced by the bacterium and name them avermectins.

The compounds prove extraordinarily effective against many parasitic worms.

1978–1979

Merck chemically modifies avermectin to produce a safer, more potent compound for practical use.

The new drug is named ivermectin.

1981

Ivermectin is introduced worldwide as a veterinary medicine.

It quickly becomes one of the most successful antiparasitic drugs ever developed for cattle, horses, sheep, pigs, and companion animals.

1981–1986

Human clinical trials begin for river blindness (onchocerciasis) in Africa.

Researchers discover ivermectin dramatically reduces the number of microfilariae (baby worms) that cause severe itching, skin disease, and blindness.

Scientists also discover an important limitation:

Ivermectin kills the baby worms but does not usually kill the long-lived adult worms.

Instead, it temporarily prevents adult female worms from producing new baby worms.

1987

Merck receives approval for the human form of ivermectin under the brand name Mectizan.

Merck CEO Dr. Roy Vagelos announces the Mectizan Donation Program:

"As much as needed, for as long as needed."

Merck agrees to donate ivermectin free of charge for river blindness control.

This becomes one of the largest humanitarian drug donation programs in history.

Late 1980s

Mass treatment programs begin across Africa.

Communities receive ivermectin once or twice each year.

Because adult worms live approximately 10–15 years, treatment must continue year after year until the adult worms naturally die.

Early 1990s

Programs expand rapidly across sub-Saharan Africa.

Researchers observe enormous reductions in:

• severe itching
• skin disease
• blindness
• transmission of river blindness

Mid-1990s

Doctors working in parts of Central Africa begin reporting a rare but serious problem.

Some patients become severely ill shortly after taking ivermectin.

Investigations reveal these patients are not suffering from river blindness alone.

Instead, they also carry very high numbers of another parasite called Loa loa (African eye worm).

1995–2000

Scientists determine the neurological complications are associated with people who have extremely high Loa loa microfilarial loads.

The evidence indicates the complications are primarily related to the rapid death of massive numbers of Loa loa microfilariae after treatment, rather than ivermectin crossing into and damaging the human brain under normal dosing.

This complication is found almost entirely in regions where Loa loa and river blindness overlap.

Late 1990s–2000s

Public health programs adapt.

Health workers begin:

• mapping Loa loa regions
• screening high-risk communities
• modifying treatment strategies where necessary

Mass ivermectin programs continue safely in most endemic regions.

2000s

The Mectizan Donation Program expands beyond river blindness to support efforts against lymphatic filariasis (elephantiasis) in many countries through combination drug programs.

2010s

Several countries in Latin America eliminate river blindness transmission.

Large parts of Africa also make major progress toward elimination.

More than 3 billion ivermectin treatments have been distributed.

2015

The Nobel Prize in Physiology or Medicine is awarded jointly to:

• Dr. Satoshi Ōmura (Japan)
• Dr. William C. Campbell (Merck, USA)

for discoveries leading to ivermectin.

2020–2022

Ivermectin becomes the subject of worldwide controversy during the COVID-19 pandemic, generating intense scientific, medical, and political debate far beyond its original role as an antiparasitic medicine.

2023–2026

The Mectizan Donation Program continues.

More than 5 billion treatments have now been donated worldwide.

River blindness has been eliminated or interrupted in several countries, while many African nations continue annual treatment campaigns.

Researchers continue studying new approaches—including doxycycline, which targets the Wolbachia bacteria living inside adult river blindness worms—in hopes of shortening treatment times and eventually eliminating the disease.

The program brought together:

• Merck – Donated the medicine, committing in 1987 to provide it "as much as needed, for as long as needed."
• World Health Organization (WHO) – Developed treatment guidelines, coordinated technical strategy, and worked with ministries of health.
• World Bank – Helped finance and coordinate major river blindness control programs in Africa, particularly the Onchocerciasis Control Programme (OCP) and the African Programme for Onchocerciasis Control (APOC).
• The Carter Center – Expanded community-directed treatment and supported elimination efforts in multiple countries.
• National Ministries of Health – Organized the treatment campaigns within each country.
• Community Drug Distributors – Millions of local volunteers who carried tablets village to village, often on foot.
• Scientists and tropical medicine researchers – Continued mapping disease, monitoring transmission, studying blackflies, and improving treatment strategies.
• NGOs – Including Sightsavers, Helen Keller International, CBM, IMA World Health, Lions Clubs, and many others that supplied staff, logistics, and training.

One reason many public health historians point to the ivermectin program as a milestone is that it showed what could be accomplished when a pharmaceutical company, international organizations, governments, scientists, and local communities all committed to the same long-term goal. It became a model that later influenced medicine donation programs for trachoma, lymphatic filariasis, intestinal worms, schistosomiasis, and other neglected tropical diseases.

That's why the legacy of ivermectin isn't just more than 5 billion treatments. It's also the public health infrastructure that grew around it—networks of researchers, health workers, ministries, NGOs, and international agencies that continued working together on other neglected tropical diseases long after the first ivermectin tablets were distributed.

• 1967 – A 3-year-old Yanomami child with scalp nodules is examined.
• The parasite is identified as Onchocerca volvulus.
• Researchers investigate surrounding villages.
• A previously unknown endemic focus of river blindness is discovered in the Amazon along the Brazil–Venezuela borde

1967 – Brazilian physicians examine a 3-year-old Yanomami child with two scalp nodules. When the nodules are surgically removed and examined, they identify Onchocerca volvulus, the parasitic worm that causes river blindness. This is the first recognized case in Brazil.

Late 1960s–Early 1970s – The discovery prompts Brazilian researchers to investigate neighboring Yanomami villages along the Brazil–Venezuela border. Rather than finding an isolated case, they discover that river blindness is already established throughout a remote region of the Amazon. Entomologists identify local Simulium blackflies capable of transmitting the parasite, confirming that an active transmission cycle exists.

1970s–1980s – Researchers continue mapping the endemic area, documenting infection in numerous Yanomami communities. The region is found to be one of the most isolated river blindness foci in the world, accessible mainly by aircraft, river travel, and long treks through dense rainforest.

1987 – Merck announces the Mectizan Donation Program, pledging to provide ivermectin free of charge for as long as needed to fight river blindness worldwide.

1990 – Brazil begins regular ivermectin distribution among the Yanomami as part of the Pan American Health Organization's regional elimination program.

1992 – Brazil officially recognizes the Yanomami Indigenous Territory, protecting approximately 96,650 square kilometers (37,317 square miles) of rainforest. The protected area improves access for organized public health campaigns, although the remoteness of many villages continues to make treatment one of the most challenging river blindness programs anywhere in the world.

2000s–Present – Most endemic areas in the Americas eliminate river blindness through repeated ivermectin treatment. The Yanomami region on the Brazil–Venezuela border remains the last endemic focus in the Americas, requiring continued treatment because of its vast size, scattered villages, and difficult terrain.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-40" data-turn-id-container= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-40" data-testid= "conversation-turn-82" data-turn="assistant"> The biggest medicine donation and mass treatment campaigns in history, Program Drug Started Scale River Blindness (Onchocerciasis) Ivermectin (Merck) 1987 More than 5 billion treatments donated over 38+ years. Widely regarded as the largest long-term medicine donation program in history. Lymphatic Filariasis Ivermectin + albendazole (Africa); DEC + albendazole elsewhere 1998–2000 Hundreds of millions of people treated annually in many years; more than 500 million people per year by 2011. Intestinal Worms (School Deworming) Albendazole (GlaxoSmithKline), mebendazole (Johnson & Johnson) 1997 / 2005 More than 9.8 billion albendazole tablets and hundreds of millions of mebendazole treatments donated to children worldwide. Trachoma Azithromycin (Pfizer) 1998 Hundreds of millions of doses donated through the International Trachoma Initiative to eliminate blinding trachoma. Schistosomiasis (Bilharzia) Praziquantel (Merck KGaA, Germany) 2007 More than 1 billion tablets donated for school-age children in Africa and elsewhere. Leprosy Multidrug therapy (Novartis) 2000 More than 5 million patients treated through WHO donation programs. In perspective

The 1987 Merck ivermectin program changed global public health. Before then, no pharmaceutical company had committed to donating a medicine for as long as necessary to eliminate a disease. That pledge became the model for many later neglected tropical disease donation programs.

Since then, similar programs have followed:

• 1997 – GlaxoSmithKline begins donating albendazole.
• 1998 – Pfizer begins donating azithromycin.
• 2005 – Johnson & Johnson expands mebendazole donations.
• 2007 – Merck KGaA launches the praziquantel donation program.
• 2013 – Eisai begins donating diethylcarbamazine (DEC) for lymphatic filariasis.

From a historical standpoint, the ivermectin program is generally considered the first and the largest of these global medicine donation efforts, and it became the template for many of the others that followed.

Yes, there is considerable overlap, although not everyone works on both.

They are generally part of the same broad scientific community:

• Parasitologists – scientists who study parasites of all kinds (worms and protozoa).
• Tropical medicine specialists – physicians and researchers who work on diseases common in tropical regions.
• Medical entomologists – experts on insects and other arthropods that transmit disease (such as blackflies and mosquitoes).
• Epidemiologists – researchers who study how diseases spread in populations.
• Global health researchers – often work across multiple tropical diseases.

Within that community, people often specialize.

For example:

• A scientist who spends an entire career studying Onchocerca (river blindness) is a helminthologist, because Onchocerca is a parasitic worm (a helminth).
• Someone studying Cyclospora is more likely a protozoologist, because Cyclospora is a protozoan parasite.

Even so, they attend many of the same conferences, publish in many of the same journals, belong to the same tropical medicine societies, and may collaborate on projects involving neglected tropical diseases.

One interesting connection in your research is R. W. Ashford.

Ashford is best known to you because he first described what became known as Cyclospora in Papua New Guinea in 1979.

But Ashford was not just a Cyclospora researcher. He was a broad tropical parasitologist. During his career he published on:

• intestinal parasites,
• filarial worms,
• schistosomiasis,
• leishmaniasis,
• zoonotic parasites,
• tropical epidemiology,
• and many other parasitic diseases.

That was quite common, especially in the 1960s–1990s. Tropical medicine researchers often worked on multiple parasites, particularly if they were based in endemic countries or institutions like the Liverpool School of Tropical Medicine or the London School of Hygiene & Tropical Medicine.

So while the scientists studying Cyclospora and river blindness are not necessarily the same individuals, they are often members of the same broader research community. Many are trained in tropical medicine or parasitology and may work across several parasitic diseases during their careers. That is one reason you keep encountering some of the same institutions, journals, and organizations as you move from one tropical disease to another.

Yemen and River Blindness (Onchocerciasis): Timeline

Unlike most countries affected by river blindness, Yemen is the only country outside Africa where onchocerciasis remains endemic. The disease in Yemen is known locally as sowda, a severe inflammatory skin form of the infection. Unlike much of Africa, blindness has been uncommon in Yemen; the disease has primarily caused intense itching, skin damage, and disability.

Early 1940s

The first medical descriptions of onchocerciasis in Yemen are published. Physicians identify a distinctive form of skin disease that would later become known locally as sowda.

1987

Merck launches the Mectizan Donation Program, promising to donate ivermectin for as long as needed to fight river blindness worldwide. Yemen eventually becomes one of the countries receiving donated medicine.

1992

Yemen begins its first national ivermectin treatment program.

Unlike Africa, where ivermectin was generally distributed once or twice a year through mass campaigns, Yemeni doctors initially treated individual patients suffering from sowda. Because symptoms often returned within a few months, patients were commonly treated every three months.

1993

The control program expands into additional endemic valleys along Yemen's western mountains and Red Sea watershed. Treatment becomes integrated with the country's National Leprosy Control Programme.

1994

Researchers publish one of the first scientific reports describing the successful use of ivermectin for river blindness in Yemen.

2001

The Ministry of Public Health establishes the National Onchocerciasis Control Program (NOCP) based in Taiz.

By this time, thousands of patients have already received ivermectin, and distribution continues to expand with assistance from local organizations and the Mectizan Donation Program.

2002–2007

Yemen combines ivermectin distribution with a campaign against lymphatic filariasis in areas where both diseases overlap, improving efficiency by treating multiple neglected tropical diseases together.

2011–2013

Health officials and international experts reassess Yemen's program, shifting the goal from simply treating sick patients toward eliminating transmission through broader mass drug administration.

2015–Present

Despite civil war, humanitarian crises, and difficult terrain, Yemen continues ivermectin campaigns with support from the Ministry of Health, WHO, ESPEN, the Mectizan Donation Program, and international partners.

2019

Nearly 500,000 Yemenis receive ivermectin during a nationwide campaign involving almost 1,000 treatment teams working across 33 endemic districts despite ongoing conflict.

2025

Yemen carries out one of its largest-ever ivermectin campaigns, reaching remote mountain communities that had previously been difficult to access because of conflict and geography.

2026

The elimination campaign continues. WHO describes Yemen as one of the world's most challenging river blindness programs because of war, mountainous terrain, and isolated communities. Even so, mass ivermectin distribution remains the cornerstone of the country's strategy to eliminate the disease.

Why Yemen Matters

Yemen occupies a unique place in the history of river blindness.

• It is the only endemic country outside Africa.
• Its form of the disease—sowda—primarily causes severe skin disease rather than blindness.
• It pioneered more frequent ivermectin treatment schedules because symptoms often returned quickly.
• Despite years of armed conflict, it continues to participate in the world's largest ivermectin donation program.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-6" data-turn-id-container= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-6" data-testid= "conversation-turn-14" data-turn="assistant">

Yes. Yemen is still receiving ivermectin treatments today. Despite the civil war, WHO, the Yemen Ministry of Health, the Mectizan Donation Program, and their partners have continued annual mass drug administration campaigns.

The numbers are much smaller than in many African countries because Yemen has a much smaller endemic population.

Yemen Ivermectin Program at a Glance

1992

• Yemen begins its national ivermectin program, initially treating individual patients with the severe skin form of river blindness ("sowda").

2000s

• The program expands into broader community treatment in endemic districts and later shifts toward elimination rather than simply treating cases.

2019

• Nearly 500,000 people were treated during a nationwide campaign across 33 districts despite the ongoing civil war.

2022

• A national report documented 875,206 people receiving ivermectin, using approximately 2.23 million tablets.

2025

• Another major campaign treated more than 220,000 people in six endemic districts, achieving about 70% treatment coverage in the targeted areas.

Total treatments

Unlike the Africa-wide program, there is no published cumulative total of all ivermectin treatments given in Yemen since 1992. Based on the documented annual campaigns over more than 30 years, the cumulative number is in the millions of treatments, but it is not in the hundreds of millions like countries such as Nigeria or the Democratic Republic of the Congo. The available reports document individual campaign totals rather than a single lifetime cumulative figure.

For perspective:

• Africa overall: more than 5 billion ivermectin treatments since 1987.
• Yemen: national program since 1992, with annual campaigns typically reaching hundreds of thousands of people rather than tens of millions.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-8" data-turn-id-container= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-8" data-testid= "conversation-turn-18" data-turn="assistant">

It's understandable to find that surprising. Yemen is often thought of in terms of conflict or geopolitics, not tropical medicine.

The explanation is mostly geographic and biological rather than political. Western Yemen has river valleys, fast-flowing streams, and the blackfly (Simulium) that transmits river blindness. Because the disease is present there, it naturally attracted the same tropical disease specialists who were already studying onchocerciasis in Africa.

Tropical medicine is also a relatively small scientific field. Researchers often specialize in neglected tropical diseases, not in one particular country. The same scientists and institutions may work in:

• Yemen on river blindness (onchocerciasis),
• Papua New Guinea on Cyclospora and other parasitic diseases,
• East and West Africa on river blindness, malaria, lymphatic filariasis, and other tropical infections.

Institutions such as the Liverpool School of Tropical Medicine, the London School of Hygiene & Tropical Medicine, WHO, and other international research centers have historically sent researchers wherever these diseases occur. So it's common to see the same names—such as R. W. Ashford and colleagues—appear in publications from several continents.

In other words, the researchers followed the diseases, not the countries. Because Yemen is the only country outside Africa where river blindness remains endemic, it became part of the same international tropical medicine network.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-9" data-turn-id-container= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-9" data-testid= "conversation-turn-20" data-turn="assistant">

Here's the distinction:

• Blackflies (family Simuliidae) are found on every continent except Antarctica.
• There are more than 2,000 species of blackflies worldwide.
• Most do not transmit river blindness.
• Only certain species in the genus Simulium are important vectors of Onchocerca volvulus, the parasite that causes river blindness.

Blackflies need clean, fast-flowing water to reproduce. Their larvae attach themselves to rocks, logs, and vegetation in rivers and streams. That's why river blindness became known as "river blindness."

Countries with blackflies include:

• United States
• Canada
• United Kingdom
• Germany
• Sweden
• Norway
• Finland
• France
• Japan
• Australia
• Brazil
• Mexico
• Many countries across Africa

If you've ever been fishing or hiking near a fast-moving stream and been attacked by tiny biting flies, there's a good chance they were blackflies.

The reason Africa became the center of river blindness is not because Africa has blackflies and other places don't. It's because the particular blackfly species capable of transmitting Onchocerca volvulus became established there, along with the parasite itself. Yemen is the only country outside Africa where that transmission cycle persists today.

One fascinating thing about this field is exactly what you noticed: it is relatively small and specialized. There are experts in tropical medicine, but only a subset spend much of their careers on diseases like river blindness. As a result, you often see the same researchers, universities, and organizations appearing over decades as they move from one endemic region to another, following where these diseases occur.

"Can it be modified in the lab?" The answer is yes. Modern genetic engineering techniques such as CRISPR can, in principle, be applied to blackflies, although they are much more difficult to work with than mosquitoes because of their life cycle and breeding requirements.

So the short answer is:

Yes. It is biologically possible to modify a blackfly in a laboratory.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-15" data-turn-id-container= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-15" data-testid= "conversation-turn-32" data-turn="assistant">

Yes. Yemen is not unique in having major problems from blackflies. In fact, Africa has experienced by far the greatest burden.

Some of the hardest-hit countries include:

• Nigeria – Historically the country with the largest number of people at risk. Tens of millions have required ivermectin treatment, and river blindness caused extensive blindness and skin disease before mass treatment programs.
• Democratic Republic of the Congo – One of the world's largest endemic areas, with many river systems supporting blackfly breeding.
• Cameroon – Major endemic areas, with the added complication of overlapping Loa loa infections, making ivermectin programs more challenging.
• Uganda – Long-running control and elimination efforts, with several transmission zones now eliminated while others required continued treatment.
• Ghana – Once had major river blindness foci that affected farming communities along rivers.
• Ethiopia – Significant endemic regions in the southwest.
• Sudan and South Sudan – Persistent transmission in several river basins.

Outside Africa:

• Yemen – The only endemic country outside Africa with longstanding transmission, mainly in western river valleys.
• Brazil and Venezuela – Small remaining endemic focus along the border, primarily among remote Indigenous communities. Most of Latin America has eliminated river blindness.

One interesting historical point is that the blackflies themselves are widespread around the world, but the combination of the right blackfly species, the Onchocerca volvulus parasite, and the local environment made Africa—and to a much smaller extent Yemen and parts of Latin America—the places where river blindness became established.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-16" data-turn-id-container= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-16" data-testid= "conversation-turn-34" data-turn="assistant"> Region First recognized Notes Africa 1874–1875 Irish physician John O'Neill first described the disease in patients from the Gold Coast (present-day Ghana). Patrick Manson later recognized it was caused by a filarial worm, and early 20th-century researchers confirmed transmission by blackflies. Yemen 1940s (clinical reports), 1957 (detailed description) Early reports appeared in the 1940s. In 1957, Fawdry described the severe skin form known as sowda in western Yemen. Venezuela 1949 (first endemic focus), 1977 (new focus discovered) The first endemic focus was identified in the late 1940s. Another important endemic focus was discovered in 1977, expanding knowledge of the disease in the country. Brazil 1967 River blindness was discovered among the Yanomami people living along the Brazil–Venezuela border. It remains the only endemic focus in Brazil.

One of the things that fascinated tropical medicine researchers was exactly this pattern. For well over a century, the disease was overwhelmingly concentrated in sub-Saharan Africa, with Yemen standing out as the only endemic country outside Africa in the Eastern Hemisphere, and then a handful of isolated foci in Latin America, including Venezuela and Brazil. Today, after decades of control efforts, active transmission remains primarily in Africa and Yemen, with only the Yanomami focus shared by Brazil and Venezuela still considered endemic in the Americas.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-17" data-turn-id-container= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-17" data-testid= "conversation-turn-36" data-turn="assistant">

It occurs in the Amazon rainforest along the border of northern Brazil and southern Venezuela.

More specifically:

• Brazil: State of Roraima (and a small part of Amazonas State).
• Venezuela: Upper Orinoco region, primarily Amazonas State.

The disease occurs almost entirely among the Yanomami, an Indigenous people living in small, remote villages scattered through dense rainforest.

How did it get there?

This is one of the biggest questions researchers have asked.

The leading scientific explanation is that river blindness did not originate in South America. Most evidence suggests it was introduced from West Africa during the trans-Atlantic slave trade, beginning in the 1500s. Infected people carried the parasite to the Americas, where compatible Simulium blackflies already existed in certain river systems. Once established, the parasite continued cycling between humans and blackflies in a handful of isolated regions.

Over time, six endemic areas developed in the Americas:

• Mexico
• Guatemala
• Colombia
• Ecuador
• Venezuela
• Brazil

Through decades of ivermectin treatment, Mexico, Guatemala, Colombia, and Ecuador eliminated transmission, and most of Venezuela has as well. Today, the only remaining endemic transmission in the Americas is the shared Yanomami region on the Brazil–Venezuela border, largely because it is one of the most remote and difficult places in the world to reach consistently.

So geographically, it's remarkable:

• Main global distribution: Sub-Saharan Africa.
• Only endemic country outside Africa in the Eastern Hemisphere: Yemen.
• Only remaining endemic focus in the Western Hemisphere: The remote Amazon border region inhabited by the Yanomami.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-18" data-turn-id-container= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-18" data-testid= "conversation-turn-38" data-turn="assistant">

The Yanomami occupy one of the largest protected Indigenous territories on Earth.

Here are the key facts:

• Brazilian Yanomami Indigenous Territory: 96,650 square kilometers (37,317 square miles). It was officially recognized in 1992.
• Combined Brazil + Venezuela homeland: approximately 190,000–192,000 square kilometers (about 73,000–74,000 square miles), making it roughly the size of the U.S. state of South Dakota or the country of Uruguay.

What is on their land?

The territory contains:

• Dense Amazon rainforest
• Hundreds of rivers and streams, including headwaters of the Orinoco and Rio Negro systems
• Mountains, including the Parima Mountains
• Exceptional biodiversity with thousands of plant and animal species
• Hundreds of Yanomami villages

It is also rich in natural resources, including:

• Gold (the primary target of illegal miners)
• Tin (cassiterite)
• Other mineral deposits that have been explored or reported in parts of the region

The gold has been the biggest source of conflict. Illegal mining has brought:

• mercury contamination of rivers,
• malaria,
• deforestation,
• violence,
• and pressure on Yanomami communities.

It is one of the most remote inhabited regions in the world. Brazilian government sources estimate that about 98% of access is by aircraft, with very little road access.

One reason this area remained the last endemic focus of river blindness in the Americas is that it is immense, heavily forested, crossed by fast-flowing rivers where blackflies breed, and extremely difficult for health teams to reach consistently.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-23" data-turn-id-container= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-23" data-testid= "conversation-turn-48" data-turn="assistant">

Illegal mining is the biggest criticism today. Many Indigenous leaders and human rights organizations argue that illegal gold mining has brought malaria, mercury pollution, violence, food shortages, and disease into Yanomami territory. They say these problems—not river blindness—are now the greatest threat to the Yanomami.

2. Health care has been too inconsistent. Critics say the government has often failed to provide continuous medical care because the territory is so remote. They argue that treatment teams have sometimes been unable to reach villages regularly, especially during periods of increased illegal mining or the COVID-19 pandemic.

3. Protection of Indigenous land. Organizations such as the Hutukara Yanomami Association argue that protecting health requires protecting the territory itself. Their position is that as long as illegal miners continue to enter, health improvements will remain fragile because miners bring disease, contaminate rivers with mercury, and disrupt traditional food sources.

4. River blindness program. There has been relatively little criticism of the ivermectin campaign itself. The main challenge discussed by researchers is logistical rather than ideological: reaching hundreds of small, scattered communities across roughly 230,000 km² of rainforest often requires aircraft, boats, and long treks on foot.

5. Some researchers question long-term dependence on repeated treatment. A smaller scientific discussion concerns whether repeated ivermectin distribution alone is enough to eliminate transmission or whether additional strategies are needed. This is generally a debate about elimination strategy rather than opposition to treatment.

So if you're looking at the Yanomami specifically, the criticism is not primarily "they're getting too much ivermectin." The dominant criticism is that illegal mining, weak protection of Indigenous territory, and interrupted health services have undermined both the Yanomami's health and conservation efforts.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-24" data-turn-id-container= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-24" data-testid= "conversation-turn-50" data-turn="assistant">

The two timelines overlap, but river blindness came first.

River blindness in the Yanomami region

• 1967 – River blindness is first identified among the Yanomami on the Brazil–Venezuela border.
• 1970s–1980s – Researchers map the endemic area and confirm ongoing transmission in remote villages.
• 1990 – Brazil begins regular ivermectin treatment of the Yanomami as part of the regional elimination program.

Illegal mining

• 1975 – Geological surveys identify important mineral deposits in the region, increasing interest in mining.
• 1987 – A massive illegal gold rush begins. Tens of thousands of miners invade Yanomami territory.
• 1987–1990 – Between 30,000 and 40,000 illegal miners are estimated to have entered the territory.
• 1992 – Brazil officially recognizes the Yanomami Indigenous Territory and removes many miners.
• 2016 onward – Illegal mining surges again, contributing to malaria, mercury contamination, and a humanitarian crisis.

So the sequence is:

• 1967: River blindness is discovered among the Yanomami.
• 1990: Regular ivermectin treatment begins.
• 1987: The major illegal mining invasion starts, between those two milestones.

One important point: the illegal mining did not cause river blindness. The disease was already established in the Yanomami region decades before the gold rush. However, mining has made overall health conditions much worse by increasing malaria, polluting rivers with mercury, disrupting access to health care, and making disease control more difficult.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-25" data-turn-id-container= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-25" data-testid= "conversation-turn-52" data-turn="assistant">

The biggest reason is that the medicine wasn't free until 1987.

Here's the timeline:

• 1967 – River blindness is discovered among the Yanomami.
• 1970s–1980s – Researchers survey the region, map the disease, and determine how widespread it is.
• 1987 – Merck announces it will donate ivermectin (Mectizan) free of charge, for as long as needed.
• 1988–1989 – Countries begin planning national treatment programs, training health workers, obtaining WHO approval, and organizing logistics.
• 1990 – Brazil begins regular ivermectin distribution to the Yanomami.

Even after the drug became free, there were several practical reasons it wasn't immediate:

• No roads. Most Yanomami villages can only be reached by aircraft, boat, or days of hiking.
• The population had to be mapped. Health officials first needed to identify where villages were and estimate how many people required treatment.
• Approval and planning. Brazil had to establish a national program with WHO, PAHO, and the Mectizan Donation Program.
• Logistics. Delivering medicine twice a year into one of the most remote rainforests on Earth required aircraft, pilots, medical teams, translators, and a reliable supply chain.

So the roughly three-year gap between 1987 and 1990 was not considered unusual. It reflected the time needed to organize a program in an extremely remote region after the donation program was launched.

The longer gap—from 1967 to 1987—is explained largely by the fact that ivermectin did not yet exist as a treatment. Before ivermectin, there was no practical, safe medicine that could be distributed repeatedly on a mass scale to entire communities. That changed with Merck's donation program in 1987.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-21" data-turn-id-container= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-21" data-testid= "conversation-turn-44" data-turn="assistant">

Yes. The Merck/Mectizan donation program absolutely extends to the Yanomami region.

In fact, the Yanomami Focus Area on the Brazil–Venezuela border is the last remaining endemic focus of river blindness in the Americas, so it has become one of the program's highest priorities.

Here are some remarkable facts:

• The program has operated with Brazil's Ministry of Health since 1990 to treat the Yanomami.
• By 2023, the program had donated more than 2 million ivermectin treatments for the Brazilian Yanomami program alone. The target population is only about 18,850 Indigenous people on the Brazilian side, which shows how many repeated treatments have been required over more than 30 years.
• The combined Yanomami Focus Area (Brazil and Venezuela) includes about 35,000 people. Health workers travel by helicopter, fixed-wing aircraft, boat, and weeks on foot through dense rainforest to deliver ivermectin twice each year.

This is one of the most difficult public health operations in the world. The teams have to contend with:

• Dense Amazon rainforest.
• Virtually no roads.
• Rivers and mountains.
• Illegal gold miners.
• Wildlife.
• Communities that may only be reachable after days or weeks of travel.

So when people hear that Merck has donated more than 5 billion treatments, it includes not only large-scale campaigns in countries like Nigeria and the Democratic Republic of the Congo, but also extraordinary efforts to reach small, isolated populations like the Yanomami in the Amazon. Even though the Yanomami population is relatively small, their remote location has made them one of the most challenging groups to serve.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-22" data-turn-id-container= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-22" data-testid= "conversation-turn-46" data-turn="assistant">

Yes. There are documented cases of river blindness among the Yanomami, and that is precisely why the region remains the last endemic focus in the Americas.

Some key facts:

• The Yanomami focus includes about 700+ villages scattered across roughly 230,000 km² of rainforest on the Brazil–Venezuela border.
• Around 28,000–40,000 Yanomami (depending on the year and estimate) continue to require regular ivermectin treatment because transmission has not yet been interrupted.
• Before mass ivermectin campaigns, researchers documented skin disease, eye lesions, and some cases of blindness caused by onchocerciasis among Yanomami communities.
• Today, the goal is to prevent new blindness by treating everyone every six months, rather than waiting for severe disease to develop.

The reason this region remains endemic is not because the disease is unusually severe there, but because it is extraordinarily difficult to eliminate. The Yanomami are highly mobile, living in small communities spread across dense rainforest, often reachable only by aircraft, boat, or long treks on foot. Missing even a portion of the population can allow transmission to continue.

One encouraging point is that mass blindness on the scale once seen in parts of West Africa has largely been prevented in the Yanomami region because of decades of repeated ivermectin treatment. The challenge now is eliminating the parasite completely so the treatments are no longer needed.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-22" data-turn-id-container= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-22" data-testid= "conversation-turn-46" data-turn="assistant">

Yes. There are documented cases of river blindness among the Yanomami, and that is precisely why the region remains the last endemic focus in the Americas.

Some key facts:

• The Yanomami focus includes about 700+ villages scattered across roughly 230,000 km² of rainforest on the Brazil–Venezuela border.
• Around 28,000–40,000 Yanomami (depending on the year and estimate) continue to require regular ivermectin treatment because transmission has not yet been interrupted.
• Before mass ivermectin campaigns, researchers documented skin disease, eye lesions, and some cases of blindness caused by onchocerciasis among Yanomami communities.
• Today, the goal is to prevent new blindness by treating everyone every six months, rather than waiting for severe disease to develop.

The reason this region remains endemic is not because the disease is unusually severe there, but because it is extraordinarily difficult to eliminate. The Yanomami are highly mobile, living in small communities spread across dense rainforest, often reachable only by aircraft, boat, or long treks on foot. Missing even a portion of the population can allow transmission to continue.

One encouraging point is that mass blindness on the scale once seen in parts of West Africa has largely been prevented in the Yanomami region because of decades of repeated ivermectin treatment. The challenge now is eliminating the parasite completely so the treatments are no longer needed.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-19" data-turn-id-container= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-19" data-testid= "conversation-turn-40" data-turn="assistant">

There are many people and organizations trying to help the Yanomami remain on their ancestral land. The situation is mixed: there has been measurable progress since Brazil declared a health emergency in 2023, but serious problems remain.

The main groups working to protect the Yanomami include:

• The Brazilian government, which has increased medical care and carried out operations against illegal gold miners.
• FUNAI, Brazil's Indigenous affairs agency.
• Indigenous organizations such as the Hutukara Yanomami Association, led by Yanomami leaders including Davi Kopenawa.
• NGOs including the Rainforest Foundation US, Greenpeace, and others that support health care, land monitoring, and legal protection.

There has been real progress:

• Illegal mining has declined substantially since 2023 because of enforcement operations. Forest destruction from mining has fallen compared with its peak.
• More doctors, nurses, medicines, and food have reached many villages than during the height of the humanitarian crisis. Malnutrition deaths have decreased from their 2023 levels.

However, the crisis is not over.

The biggest continuing problems are:

• Illegal gold miners continue to enter parts of the territory despite government crackdowns. Some have changed tactics and moved into more remote areas.
• Malaria remains a major health problem because mining creates pools of standing water where mosquitoes breed.
• Other diseases, including river blindness, still affect some communities, especially in the remote Brazil–Venezuela border region.
• Mercury pollution from illegal gold mining contaminates rivers used for drinking, fishing, and cooking.
• Many villages remain extremely difficult to reach, making it hard to provide continuous medical care.

So the overall picture is that the Yanomami are not being abandoned. There is an ongoing effort by the Brazilian government, Indigenous organizations, and international groups to help them stay on their land and improve their health. At the same time, they continue to face persistent threats from illegal mining, malaria, environmental contamination, and the logistical challenge of delivering health care across one of the most remote rainforest regions in the world.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-12" data-turn-id-container= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-12" data-testid= "conversation-turn-26" data-turn="assistant"> The major human disease

The one that made blackflies famous is river blindness.

For humans, this is by far the most important disease transmitted by blackflies. It has infected tens of millions of people over the last century and led to the world's largest ivermectin donation program.

They also cause direct injury

Even without transmitting disease, blackflies can be a serious problem.

Large swarms can cause:

• Severe itching
• Swelling
• Bleeding bites
• Allergic reactions
• "Black fly fever" (a reaction with fever, headache, nausea, and swollen lymph nodes caused by numerous bites)

In livestock, massive blackfly attacks have occasionally killed cattle or horses through blood loss and toxic reactions from thousands of bites.

Compared with mosquitoes

One interesting fact is how specialized they are.

• Mosquitoes transmit malaria, dengue, yellow fever, Zika, West Nile, chikungunya, several forms of encephalitis, lymphatic filariasis, and many other diseases.
• Ticks transmit Lyme disease, Rocky Mountain spotted fever, babesiosis, ehrlichiosis, tularemia, Powassan virus, and others.
• Blackflies are overwhelmingly associated with one major human disease—river blindness.

That specialization is one reason river blindness became such a distinct field within tropical medicine. Many researchers spend decades studying the biology of a single parasite (Onchocerca volvulus) and its relationship with a relatively small number of blackfly species.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-9" data-turn-id-container= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-9" data-testid= "conversation-turn-20" data-turn="assistant"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-11" data-turn-id-container= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-11" data-testid= "conversation-turn-24" data-turn="assistant"> Who discovered them?

No single person "discovered" blackflies because people had been bitten by them for thousands of years.

The scientific story began in the 1700s.

• 1758 – Carl Linnaeus published the 10th edition of Systema Naturae, laying the foundation for modern insect classification. At the time, blackflies were not yet well distinguished from other small flies.
• 1802 – French entomologist Pierre André Latreille established the genus Simulium, which is still the principal genus used for blackflies today.
• 1800s – European entomologists gradually described dozens of blackfly species as microscopes improved and insect classification became more sophisticated.

When did people realize they spread disease?

For centuries, blackflies were simply considered painful biting insects.

The breakthrough came in Africa.

• 1874–1875 – Irish physician John O'Neill first described the tiny worms in skin nodules of patients in West Africa.
• 1893 – Scottish physician Patrick Manson recognized that the disease was caused by a filarial worm, Onchocerca volvulus.
• Early 1900s – Researchers suspected blackflies were the vector because the disease occurred near fast-flowing rivers where these insects were abundant.
• 1915–1920s – Field studies confirmed that certain Simulium blackflies transmit the parasite between humans.

Why was this such a difficult discovery?

Unlike mosquitoes, blackflies are:

• only 2–5 millimeters long,
• active mainly during the day,
• breed only in fast-flowing streams and rivers,
• and there are thousands of similar-looking species.

It took decades of fieldwork, microscopy, and parasite studies to determine which species could actually transmit river blindness.

Today

Scientists recognize:

• More than 2,000 species of blackflies worldwide.
• Most are simply nuisance biters.
• Only a relatively small number of Simulium species can transmit Onchocerca volvulus, the parasite responsible for river blindness.

One interesting historical point is that the insect was known long before the disease was understood. People had been bitten by blackflies for thousands of years, but it wasn't until the late 19th and early 20th centuries that scientists connected certain blackflies to one of the world's most important tropical diseases.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-10" data-turn-id-container= "request-WEB:40a392e2-1801-4369-99ff-c3cf2b4cdef8-10" data-testid= "conversation-turn-22" data-turn="assistant">

Here's why only certain blackflies can transmit Onchocerca volvulus:

1. The parasite has to survive inside the fly. When a blackfly bites an infected person, it ingests tiny baby worms (microfilariae). In most blackfly species, those larvae simply die because the fly's body is not a suitable environment.
2. The parasite must develop inside the fly. In a compatible Simulium species, the larvae migrate through the fly's body, develop over about a week into an infectious stage, and then move to the fly's mouthparts.
3. The fly must bite humans frequently. Some blackflies prefer birds, cattle, or other animals. The species that efficiently spread river blindness preferentially feed on humans, making transmission much more likely.
4. The ecology has to match. The fly must breed in fast-flowing rivers where humans also live, farm, fish, or collect water. If the fly and people rarely come into contact, transmission doesn't continue.

So it's not just "a blackfly." It's a very specific combination:

• the right parasite,
• the right blackfly species,
• the right environment,
• and regular contact with humans.

This is actually common in parasitology. Many parasites have very specific vectors. For example:

• Malaria parasites are transmitted by certain Anopheles mosquitoes, not all mosquitoes.
• Lyme disease is spread by certain Ixodes ticks, not all ticks.
• Dengue is spread mainly by Aedes aegypti mosquitoes, not every mosquito.

River blindness is similar. Out of more than 2,000 blackfly species, only a relatively small number are capable of maintaining the complete life cycle of Onchocerca volvulus.

One of the remarkable aspects of this disease is that scientists still don't know every molecular detail of why one blackfly species is a competent vector while a closely related species is not. They understand the overall life cycle well, but the exact genetic and biochemical interactions that make some flies susceptible and others resistant remain an active area of research. That is one reason river blindness has remained such a specialized field of tropical medicine.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:ca488f54-9cab-4a1d-a6a4-0f95bb82b4f1-14" data-turn-id-container= "request-WEB:ca488f54-9cab-4a1d-a6a4-0f95bb82b4f1-14" data-testid= "conversation-turn-30" data-turn="assistant"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:ca488f54-9cab-4a1d-a6a4-0f95bb82b4f1-15" data-turn-id-container= "request-WEB:ca488f54-9cab-4a1d-a6a4-0f95bb82b4f1-15" data-testid= "conversation-turn-32" data-turn="assistant"> Why Cyclospora and River Blindness Remain So Difficult

Cyclospora and river blindness belong to the same broad world of tropical parasitology, but they present almost opposite scientific problems.

Cyclospora is microscopic and comparatively short-lived in a patient, yet scientists still cannot routinely grow it in a laboratory or reproduce its complete infection in an animal.

River blindness is caused by a large parasitic worm that scientists can examine at different life stages, but the worm lives for more than a decade and requires both a mammal and a blackfly to complete its life cycle.

The result is that both diseases have treatments and decades of research behind them, yet neither behaves like a familiar bacterial infection that can be grown overnight, exposed to hundreds of drugs, and quickly traced to its source.

1. Cyclospora: difficult to obtain and difficult to reproduce

What Cyclospora is

Cyclospora cayetanensis is a single-celled intestinal parasite. Humans are currently considered its only known host. The parasite reproduces inside cells lining the human intestine, and infected people pass immature oocysts in their feces. Those oocysts must remain outside the body—usually for at least one or two weeks under suitable environmental conditions—before becoming infectious.

That environmental stage explains why immediate person-to-person spread is considered unlikely. Someone does not normally become infected directly from a freshly contaminated bathroom surface; the organism first has to mature in the environment.

Why Cyclospora is so difficult to study

The single greatest obstacle is that researchers still lack a dependable laboratory supply of the organism.

There is no established animal model and no routine in-vitro or in-vivo culture system that continuously produces Cyclospora oocysts. Researchers usually must obtain organisms from stool donated by naturally infected people. Those samples may contain limited numbers of oocysts and require difficult purification before experiments can begin.

That creates a chain of problems:

Scientists cannot easily grow more organisms. With bacteria, one patient sample can sometimes generate millions or billions of organisms in culture. With Cyclospora, the supply may end when the human stool sample is exhausted.

Drug screening is restricted. Researchers cannot conveniently expose identical cultures to hundreds or thousands of possible treatments.

Its full life cycle remains partly hidden. Much of what is known about its development inside humans comes from a small number of intestinal biopsy specimens.

Human infectivity is difficult to measure. In a 2004 pilot study, seven volunteers swallowed preparations containing Cyclospora oocysts, but none developed detectable infection. That did not prove the parasite was harmless; it demonstrated how difficult it was to know whether the available organisms were mature, viable and infectious.

Why Cyclospora infections can persist

In an untreated person, the parasite can continue reproducing inside intestinal cells. Symptoms may improve and then return, producing the characteristic relapsing illness.

Persistence is also helped by practical problems:

• Cyclospora is not always included in routine stool testing.
• Shedding may vary, so several stool specimens may be needed.
• Symptoms can resemble other gastrointestinal illnesses.
• Some patients are not tested until they have been ill for weeks.
• The principal treatment, trimethoprim-sulfamethoxazole, cannot be taken safely by every patient.

This is very different from the persistence of river blindness. Cyclospora does not normally live in one patient for 10 or 15 years. Its difficulty lies more in diagnosis, environmental detection, research access and interruption of food or water contamination.

Why Cyclospora is difficult to find on food

The parasite may be unevenly scattered across a large shipment of produce. Contamination levels can be extremely low, yet still sufficient to cause illness. The organism cannot be enriched by growing it in culture after it is recovered from food.

A molecular test can detect Cyclospora DNA, but DNA detection does not automatically prove that the organism was alive or infectious. A negative food sample also does not prove that the shipment was never contaminated because investigators may simply have sampled an uncontaminated portion.

This explains why outbreak investigations often depend heavily on interviews, purchase records and traceback rather than on finding the parasite in a particular food sample.

2. Cyclospora progress over nearly 50 years

1977–1979: first observations

The earliest recognized human cases occurred in Papua New Guinea during the late 1970s. In 1979, R. W. Ashford published a description of an unidentified coccidian-like organism in human patients.

At that point, researchers could see the organism, but they did not know exactly what it was.

1980s–1994: identity gradually established

Similar organisms were reported in people with prolonged diarrhea in several countries. It was initially confused with cyanobacteria and other parasites. By the early 1990s, researchers established that it was a coccidian parasite, and the name Cyclospora cayetanensis became accepted.

Mid-1990s: major foodborne outbreaks

Large outbreaks associated with imported fresh produce demonstrated that Cyclospora was not merely an obscure tropical infection. The outbreaks forced public-health agencies to develop better surveillance and food-investigation methods.

By 1999, CDC scientists were still describing Cyclospora as an "enigma," noting major gaps in knowledge about environmental survival and detection.

2000s: improved clinical diagnosis

Microscopy improved, and molecular methods such as polymerase chain reaction allowed laboratories to detect Cyclospora DNA more specifically. Multiplex gastrointestinal test panels later made clinical diagnosis easier in laboratories that used them.

However, improved diagnosis did not solve the central research problem: scientists still could not continuously cultivate the organism.

2010s: food testing improves

FDA developed and validated molecular methods for finding Cyclospora in selected high-risk produce. A validated FDA method was evaluated and published in 2018.

This was substantial progress because investigators could search directly for Cyclospora DNA on produce rather than relying exclusively on patient interviews.

But it did not become an easy universal test. Different foods contain substances that interfere with DNA extraction, and mixed foods such as salsa present additional problems.

2019–2026: coordinated research and genotyping

FDA established a dedicated Cyclospora task force in 2019 and developed a multiyear prevention, response and research plan.

Researchers have also worked on genotyping methods intended to compare Cyclospora found in patients, food, water or soil. FDA stated that these methods were being developed to characterize organisms from produce, mixed foods and environmental samples.

Environmental experiments have begun clarifying how moisture, temperature, soil and plant surfaces affect persistence. FDA-associated research has found that detection can continue for extended periods under moist conditions, although these experiments still do not amount to a complete culture system.

Bottom line after almost five decades

Since the first published description in 1979, scientists have made major progress in:

• identifying the organism;
• diagnosing patients;
• detecting its DNA on some foods;
• recognizing outbreaks;
• tracing implicated supply chains;
• sequencing and comparing parasite DNA.

But after approximately 47 years, researchers still lack the central tool that would transform the field: a dependable continuous culture system or animal model.

That is why Cyclospora remains unusually difficult.

3. River blindness: a long-lived worm with two hosts

What causes it

River blindness is caused by Onchocerca volvulus, a filarial roundworm.

An infected blackfly bites a person and deposits immature larvae. Those larvae develop into adult worms inside nodules beneath the skin. Adult females produce enormous numbers of microscopic larvae called microfilariae. These migrate through the skin and eyes. When another blackfly takes a blood meal, it ingests microfilariae, which develop further inside the fly and can then infect another person.

The serious itching, skin injury and eye damage are caused largely by inflammatory reactions to dying microfilariae.

Why the worm is difficult to study

The full life cycle requires:

1. a suitable mammalian host;
2. mature male and female worms;
3. production of microfilariae;
4. a competent Simulium blackfly;
5. development inside that fly;
6. transmission back to another mammal.

That cannot be reproduced quickly in an ordinary laboratory flask.

Adult worms mature very slowly. Work with the closely related cattle parasite Onchocerca ochengi indicates that development into fully mature, fertile adults can take roughly 279–532 days after infection.

Human infection models present obvious ethical obstacles. Chimpanzees were previously used in research, but infections could persist for six to nine years, making experiments extraordinarily slow and costly.

Researchers have therefore depended on:

• worms removed from human nodules;
• related parasites in cattle or rodents;
• isolated life stages maintained temporarily in culture;
• specialized mouse models;
• artificial tissue and skin models.

These tools are useful, but none perfectly duplicates the complete natural human-blackfly cycle.

Why river blindness persists in an individual

Adult worms may survive in nodules for approximately 10–15 years or longer, and fertile females can release microfilariae through much of that period.

Ivermectin is highly effective at removing microfilariae and temporarily suppressing their production. This reduces itching, eye injury and transmission.

But ivermectin generally does not rapidly kill all adult worms. Once its suppressive effect diminishes, surviving females can resume releasing microfilariae.

That is why WHO recommends repeated treatment at least annually for approximately 10–15 years in many settings—long enough to outlast the reproductive life of the adult worms and interrupt transmission.

Why river blindness persists in a region

Even excellent medicine cannot eliminate transmission unless enough people receive it repeatedly.

Persistence is encouraged by:

• adult worms surviving for many years;
• people missing treatment rounds;
• remote communities being difficult to reach;
• blackflies traveling across borders;
• conflict and population movement;
• incomplete mapping of endemic communities;
• reinfection after treatment;
• concern about severe reactions where very high Loa loa microfilarial loads coexist.

WHO notes that Loa loa co-endemicity can require modified treatment strategies because ivermectin can cause severe adverse events in heavily infected individuals.

Thus, the difficulty is not merely inventing a medicine. It is maintaining a functioning delivery and surveillance system for decades.

4. River-blindness progress over more than 50 years

Before the 1970s

Scientists had already identified the worm, the blackfly vector and the relationship between infection, skin disease and blindness. However, control was limited and enormous West African river basins remained heavily affected.

1974–2002: attacking the blackfly

The Onchocerciasis Control Programme began in West Africa in 1974.

Its initial strategy was predominantly aerial spraying of insecticides into rivers to kill blackfly larvae. The programme operated until 2002 and brought the disease under control across much of the original 11-country area.

This was an immense technical achievement, but it required aircraft, repeated surveillance, insecticides, international financing and cross-border coordination.

1987–1989: ivermectin changes the strategy

Merck announced the ivermectin donation in 1987, and large-scale distribution was incorporated into African control efforts by approximately 1989.

Ivermectin allowed programs to treat people directly rather than relying only on blackfly control.

Its limitation remained clear: it was mainly a microfilaricide, not a reliably rapid killer of adult worms.

1990s–2015: community-directed treatment expands

The African Programme for Onchocerciasis Control operated from 1995 to 2015 and extended treatment into countries not covered by the original West African programme. Community-directed distribution allowed residents to organize local ivermectin delivery rather than relying solely on visiting medical teams.

Late 1990s–2000s: Wolbachia becomes a treatment target

Researchers discovered that adult filarial worms depend heavily on intracellular Wolbachia bacteria.

Courses of doxycycline that remove Wolbachia can sterilize female worms and gradually kill or permanently disable many adult worms. Early WHO research summaries reported that a six-week doxycycline regimen produced adult-worm sterility.

This was a major biological advance because it offered a way to attack the adult stage.

Its limitation is operational: a four- to six-week antibiotic course is far harder to deliver to entire populations than a single dose of ivermectin. Doxycycline is also unsuitable for some groups, including young children and pregnant women.

2018 onward: moxidectin and improved suppression

Moxidectin was developed as another treatment capable of suppressing microfilariae for longer than ivermectin in many patients. WHO-associated researchers had been investigating it since the late 1990s.

It offers another tool but does not entirely solve the problem of rapidly eliminating every adult worm.

2013–2025: national elimination becomes real

WHO verified elimination in:

• Colombia in 2013;
• Ecuador in 2014;
• Mexico in 2015;
• Guatemala in 2016;
• Niger in 2025.

Niger became the first African country verified as having eliminated transmission.

As of the end of 2024, WHO reported that approximately 25.5 million people lived in African areas where transmission had fallen sufficiently for ivermectin treatment to stop.

That is enormous progress, but it also demonstrates the timescale: Niger's achievement followed more than 40 years of sustained control work.

5. The most important difference

Cyclospora is persistent mainly as a scientific and food-safety mystery.

Researchers can treat most diagnosed patients, but they cannot easily:

• produce the organism;
• test its infectivity;
• determine whether food-associated oocysts are alive;
• reproduce its complete life cycle;
• identify every contaminated source.

River blindness is persistent mainly as a biological and delivery problem.

Researchers understand much of its life cycle and have effective medicines, but:

• adult worms live for more than a decade;
• ivermectin does not quickly remove them;
• blackflies continue transmission;
• treatment must reach whole communities repeatedly;
• elimination must be confirmed through years of surveillance.

6. Side-by-side conclusion

Question Cyclospora River blindness Organism Single-celled protozoan Multicellular filarial worm Main host problem Humans are the only confirmed host Requires humans and blackflies Can it be continuously cultured? No dependable continuous system Complete cycle is not routinely maintained Why infection persists Ongoing intestinal replication, delayed diagnosis, relapse Adult worms survive 10–15 years or longer Main treatment problem Only one clearly established first-line drug; limited alternatives Ivermectin mainly controls young worms, not all adults Main research obstacle Cannot reliably produce oocysts Life cycle is extremely slow and host-dependent Years of modern research Roughly 47 years since 1979 description More than 50 years of organized international control Major achievement Better diagnosis, DNA detection and outbreak tracing Control across large regions and verified national elimination Central unsolved problem Culture system and reliable viability testing Short-course, safe treatment that rapidly kills adult worms Final assessment

Neither disease is scientifically hopeless.

Cyclospora research has advanced from an unidentified object under a microscope to molecular detection, food testing and genetic analysis. But scientists still cannot grow it reliably, which keeps basic questions unanswered after nearly half a century.

River-blindness research has produced one of the largest and most successful parasite-control campaigns in history. Entire countries have eliminated transmission. But the biology of a 10- to 15-year adult worm means success has required decades of uninterrupted drug delivery, vector control and outside support.

That is what makes these two parasites stand out: the scientific community has made genuine progress, but neither organism has yielded to the ordinary laboratory and treatment methods used against many bacteria and viruses.

There are several parasites that have historically been difficult to study because of complex life cycles or limited laboratory models. Examples include:

• Cyclospora cayetanensis
• Onchocerca volvulus (river blindness)
• Plasmodium vivax (one form of malaria, more difficult to culture than P. falciparum)
• Cryptosporidium (another protozoan parasite that long challenged laboratory cultivation)
• Loa loa (African eye worm)

What makes Cyclospora stand out is that for many years there was no simple, continuous laboratory culture system, which slowed work on diagnostics, drug screening, and understanding its biology.

What makes Onchocerca stand out is that it is a long-lived worm with a complicated life cycle involving both humans and blackflies, making laboratory research inherently difficult.

One thing you've probably noticed is that researchers working on tropical parasites often say things like:

• "We still don't have a good laboratory model."
• "The life cycle is difficult to reproduce."
• "The organism cannot be easily cultured."
• "Drug discovery has been slower than for bacteria."

You don't hear those statements nearly as often in fields like E. coli, Staphylococcus, or influenza research, where laboratory systems are much more established.

So your observation is a reasonable one: within tropical parasitology, Cyclospora and river blindness are among the organisms that have posed particularly persistent technical challenges. The reasons differ, but both have required decades of work because their biology is much more complex than many familiar bacterial pathogens.

Discovered in the late-1970s, the pioneering drug ivermectin, a dihydro derivative of avermectin—originating solely from a single microorganism isolated at the Kitasato Intitute, Tokyo, Japan from Japanese soil—has had an immeasurably beneficial impact in improving the lives and welfare of billions of people throughout the world. Originally introduced as a veterinary drug, it kills a wide range of internal and external parasites in commercial livestock and companion animals. It was quickly discovered to be ideal in combating two of the world's most devastating and disfiguring diseases which have plagued the world's poor throughout the tropics for centuries. It is now being used free-of-charge as the sole tool in campaigns to eliminate both diseases globally. It has also been used to successfully overcome several other human diseases and new uses for it are continually being found. This paper looks in depth at the events surrounding ivermectin's passage from being a huge success in Animal Health into its widespread use in humans, a development which has led many to describe it as a "wonder" drug.

In the early-1970s, the disease was endemic in 34 countries: 27 in Africa; 6 in the Americas; and 1 in the Arabian Peninsula. The World Health Organization (WHO) later estimated that 17.7 million people were infected worldwide, of whom some 270,000 were blind, and another 500,000 severely visually disabled. The burden of onchocerciasis was particularly extreme in the hyper-endemic belt across sub-Saharan Africa. Communities in these areas exhibited high rates of visual disability caused by Onchocerciasis, up to 40% in some areas, which caused immeasurable negative impact on individual and community health, reducing economic capacity and productivity, and leading to the abandonment of fertile agricultural lands.19)By 1973, Onchocerciasis had been recognised by the then head of the World Bank, Robert McNamara, as a major disease of massive health and socioeconomic importance and one in dire need of combating in West Africa, and he became the key agent for change. In 1974, following international recognition of the dramatic consequences of disabling and disfiguring Onchocerciasis in Africa, four United Nations agencies, including the World Bank, launched the Onchocerciasis Control Programme in West Africa (OCP). The programme covered 1.2 million km2, protecting 30 million people in 11 countries from River Blindness. *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:ca488f54-9cab-4a1d-a6a4-0f95bb82b4f1-0" data-turn-id-container= "request-WEB:ca488f54-9cab-4a1d-a6a4-0f95bb82b4f1-0" data-testid= "conversation-turn-2" data-turn="assistant">

Here's the timeline:

Year Role Significance 1916 Born San Francisco, California 1940s U.S. Army Air Forces Worked on statistical bombing analysis during World War II. 1946 Ford Motor Company One of the "Whiz Kids" who modernized Ford using statistical management. 1961–1968 Robert McNamara Principal architect of U.S. strategy during the Vietnam War under Presidents Kennedy and Johnson. 1968–1981 World Bank President Shifted attention toward poverty reduction, agriculture, population, and tropical diseases. 1974 Onchocerciasis Control Programme Helped secure World Bank support for one of history's largest public health campaigns. Why "McNamara's Morons"?

The nickname "McNamara's Morons" referred to Project 100,000, begun in 1966.

McNamara believed the military could both increase manpower and provide disadvantaged young men with education and job skills. The standards for enlistment were lowered so thousands of men who previously would have been rejected could enter the armed forces.

The program ultimately enlisted about 354,000 men.

Critics argued that:

• many recruits had intellectual disabilities or very low aptitude scores;
• they suffered disproportionately high casualties in Vietnam;
• the promised educational and career benefits often failed to materialize.

The phrase "McNamara's Morons" was coined by critics of the policy and is now widely regarded as derogatory.

Then comes a very different chapter

After leaving the Pentagon in 1968, McNamara became President of the World Bank.

This is where his reputation becomes much more complicated.

During the 1970s he argued that economic development could not succeed if major tropical diseases kept millions of people trapped in poverty.

One disease he repeatedly highlighted was onchocerciasis (river blindness).

At the time:

• approximately 30 million people were living in endemic areas of West Africa;
• fertile river valleys were being abandoned because of blackfly transmission;
• blindness and severe skin disease reduced agricultural productivity and economic development.

McNamara viewed river blindness as both:

• a humanitarian catastrophe, and
• a major obstacle to economic development.

That perspective fit the World Bank's mission because healthier populations were seen as essential for long-term growth.

The 1974 Onchocerciasis Control Programme (OCP)

In 1974, four major international organizations launched the OCP:

• World Bank
• World Health Organization
• Food and Agriculture Organization
• United Nations Development Programme

The initial program covered approximately:

• 1.2 million square kilometers
• 11 West African countries
• roughly 30 million people

Early control relied almost entirely on aerial larviciding—spraying rivers to kill blackfly larvae before ivermectin became available.

When Merck announced the donation of ivermectin in 1987, the program expanded dramatically because treatment of people could be combined with vector control.

A remarkable contrast

McNamara's legacy illustrates how the same individual can be remembered in very different ways depending on the context.

• Vietnam historians often focus on escalation of the war, systems analysis, body-count metrics, and Project 100,000.
• Global health historians often emphasize his role in bringing World Bank resources to neglected tropical diseases, including river blindness.

Both are well-documented parts of his historical record.

So when you see his name in the history of onchocerciasis, it reflects a later phase of his career—after the Vietnam War—when he used the World Bank's financial influence to support large-scale international development and disease-control programs.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:ca488f54-9cab-4a1d-a6a4-0f95bb82b4f1-1" data-turn-id-container= "request-WEB:ca488f54-9cab-4a1d-a6a4-0f95bb82b4f1-1" data-testid= "conversation-turn-4" data-turn="assistant">

Yes. McNamara's legacy is one of the most debated of any major American public official because it includes both the Vietnam War and later global development work.

Broadly speaking, historians and commentators tend to fall into a few perspectives:

• Critics argue that his role in escalating the Vietnam War and policies such as Project 100,000 caused immense suffering. For many veterans and families, those decisions dominate his legacy.
• Supporters of his later work point to his leadership at the World Bank, where he expanded lending for poverty reduction, agriculture, education, and public health. They credit him with helping bring international attention and funding to diseases such as river blindness.
• Many historians hold both views simultaneously. They acknowledge that his World Bank work likely benefited millions of people while also concluding that his Vietnam-era decisions contributed to a costly and controversial war.

The Onchocerciasis Control Programme is often cited as one of the World Bank's major public health successes. McNamara's advocacy helped secure political and financial support at a time when river blindness received relatively little international attention. However, that achievement has not erased the controversy surrounding his earlier career.

McNamara himself reflected publicly on Vietnam later in life. In his 1995 memoir, In Retrospect: The Tragedy and Lessons of Vietnam, he wrote that the United States had been "wrong, terribly wrong" in key aspects of its approach to the war. Some people viewed this as a meaningful acknowledgment of mistakes; others felt it came far too late and did not amount to full accountability.

In short, it is fair to say that many people view his support for global health initiatives—including the fight against river blindness—as a significant positive contribution. At the same time, many also believe that those accomplishments do not outweigh or erase the consequences of his decisions during the Vietnam War. Those two assessments often coexist in discussions of his historical legacy.

Before McNamara:

• The World Bank focused largely on large infrastructure projects such as dams, power plants, highways, and ports.
• Annual lending was much smaller.
• Health and poverty reduction were not major priorities.

During McNamara's presidency (1968–1981):

• World Bank lending expanded several-fold.
• Lending increasingly targeted Sub-Saharan Africa.
• Agriculture, rural development, education, public health, and population programs became central priorities.
• The Bank became involved in major disease-control initiatives, including the 1974 Onchocerciasis Control Programme.

In that sense, many historians describe McNamara as having redirected the World Bank toward developing countries, particularly Africa.

At the same time, the World Bank was only one source of international finance. During roughly the same period, countries also received funding from:

• the IMF,
• bilateral aid agencies such as USAID and the UK's development agencies,
• former colonial powers,
• the United Nations,
• and later regional institutions such as the African Development Bank.

One of the interesting historical questions—which economists and historians continue to debate—is whether the rapid expansion of development lending produced long-term self-sustaining growth or whether it also contributed to long-term debt dependence in some countries.

So a fair historical summary would be:

Robert McNamara was a pivotal figure in expanding World Bank lending to Africa and making poverty reduction, agriculture, education, and health central priorities. His tenure marked a major increase in international development financing for the region, although the long-term outcomes remain debated, with some countries experiencing significant gains and others later facing persistent debt challenges.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:ca488f54-9cab-4a1d-a6a4-0f95bb82b4f1-1" data-turn-id-container= "request-WEB:ca488f54-9cab-4a1d-a6a4-0f95bb82b4f1-1" data-testid= "conversation-turn-4" data-turn="assistant">

The World Bank was created in 1944 at the Bretton Woods Conference and officially began operations in 1946.

Here's the timeline:

• 1944 – Delegates from 44 Allied nations establish the World Bank (originally the International Bank for Reconstruction and Development, or IBRD) at the Bretton Woods Conference.
• 1946 – The World Bank begins lending, initially to help rebuild Europe after World War II.
• 1947 – Its first loan goes to France for postwar reconstruction.
• 1968 – Robert McNamara becomes the fifth President of the World Bank, after resigning as U.S. Secretary of Defense.
• 1968–1981 – McNamara dramatically expands the Bank's size and shifts much of its focus toward poverty reduction, agriculture, education, health, and infrastructure in developing countries.

Drug donation

For over a decade, OCP operations were exclusively based on the spraying of insecticides by helicopters and aircraft over the breeding sites of vector blackflies in order to kill their larvae. Following the registration of ivermectin (produced under the brand name Mectizan®) for human use in 1987, in a hitherto unprecedented move and with unheralded commitment, Mectizan® was donated by the manufacturing company, Merck & Co. Inc., to treat onchocerciasis in all endemic countries for as long as it was needed. The resultant drug donation programme was the first, largest, longest running and most successful of all—and proved a model for all others that have followed. Ivermectin began to be distributed in 1988, with operations being organized through the independent Mectizan Donation Program (MDP) established and funded by Merck. Thereafter, OCP control operations changed from exclusive vector control to larviciding combined with ivermectin treatment or, in some areas, to ivermectin treatment alone. Ivermectin swiftly became the drug of choice for the treatment of Onchocerciasis due to its unique and potent microfilaricidal effects, the absence of severe side effects and its excellent safety. It is now the sole tool being used in disease elimination campaigns in the 16 other African countries where the disease exists, orchestrated by the African Programme for Onchocerciasis Control (APOC), which commenced operations in 1996. A single annual dose of 150 µg/kg of ivermectin, given orally, can reduce the level of skin microfilariae to zero and, by interfering with worm embryogenesis, can delay the build-up of new microfilariae for a period of up to two years. OCP was closed in December 2002 after virtually stopping disease transmission in all target nations except Sierra Leone where operations were hampered by civil war.

The process, from the discovery of ivermectin's activity against onchocercal microfilariae to the successful distribution programme from 1988 onward, was neither an easy or direct path. Success was achieved through groundbreaking and innovative partnerships. The journey was a complex undertaking, incorporating scientific uncertainty, conflicting views, ambiguity, frustration, individual innovation and unexpected twists and turns. The actual discovery of ivermectin was an international team effort involving a unique, pioneering Public Sector/Private Sector partnership and the commitment and vision of several key individuals. Ivermectin's development into a drug for human use also involved a number of organizational, individual and pharmacological variables—together with a large slice of luck, educated insight and personal commitment.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:988a0a06-85ef-49a5-bda1-5cc6aad717b8-1" data-turn-id-container= "request-WEB:988a0a06-85ef-49a5-bda1-5cc6aad717b8-1" data-testid= "conversation-turn-4" data-turn="assistant"> Onchocerciasis

The origins of ivermectin as a human drug are inextricably linked with Onchocerciasis (or River Blindness), a chronic human filarial disease caused by infection with Onchocerca volvulus worms. The parasites are transmitted via the bite of infected blackflies of the genus Simulium, which breed in highly-oxygenated, fast-flowing rivers and watercourses. In the human body, immature larval forms of the parasite create nodules in subcutaneous tissue, where they mature into adult worms. After mating, female worms can release up to 1000 microfilariae a day for some 10–14 years. These move through the body, and when they die they cause a variety of conditions, including skin rashes, lesions, intense itching, oedema and skin depigmentation (Fig. 2 ). Microfilariae also invade the eye, causing visual impairment and loss of vision, onchocerciasis being the second leading cause of blindness caused by an infectious disease.17) The disease causes visual damage for some 1–2 million people, around half of who will become blind.18)

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:988a0a06-85ef-49a5-bda1-5cc6aad717b8-2" data-turn-id-container= "request-WEB:988a0a06-85ef-49a5-bda1-5cc6aad717b8-2" data-testid= "conversation-turn-6" data-turn="assistant"> Timeline: How Ivermectin Was Discovered

1940s–1950s Scientists discover that soil microorganisms produce powerful natural chemicals. The discovery of antibiotics such as streptomycin convinces researchers that soil is a rich source of new medicines.

1950s–1960s Research laboratories around the world begin collecting thousands of soil samples. The goal is not to find a cure for river blindness, but to discover any microorganism capable of producing useful compounds, including antibiotics and antiparasitic drugs.

1965 Dr. Satoshi Ōmura joins the Kitasato Institute in Tokyo, Japan. He specializes in isolating new species of Streptomyces bacteria from soil.

Late 1960s–Early 1970s Ōmura and his team collect soil samples from across Japan, including parks, fields, mountains, and golf courses. Thousands of microorganisms are isolated and grown in the laboratory. Most prove to be unremarkable, but a small number appear promising.

Early 1970s One soil sample collected near a golf course in Kawana, Shizuoka Prefecture, contains a previously unknown Streptomyces species. Ōmura identifies it as one of the most interesting organisms in his collection.

1973 Ōmura sends selected bacterial cultures to researchers at Merck & Co. in the United States, where parasitologist William C. Campbell is searching for new drugs to combat parasites in livestock.

At this point, the objective is entirely veterinary medicine. Farmers lose billions of dollars worldwide because parasitic worms reduce the health and productivity of cattle, sheep, horses, pigs, dogs, and other animals.

1974–1975 Campbell's laboratory discovers that one of Ōmura's bacterial cultures produces an extraordinarily powerful compound against parasitic worms. The compound is named avermectin.

1978 Merck scientists chemically modify avermectin to improve its safety and effectiveness. The new compound is named ivermectin.

1981 Ivermectin is introduced as a veterinary medicine. It rapidly becomes one of the most successful antiparasitic drugs ever developed for cattle, horses, sheep, pigs, and companion animals because it controls a wide variety of internal and external parasites.

Early 1980s Researchers begin asking whether ivermectin might also work against human parasitic diseases. Studies focus on river blindness (Onchocerca volvulus), a disease affecting millions in Africa and parts of Latin America.

1987 Merck announces that it will donate ivermectin, marketed as Mectizan, free of charge for as long as necessary to treat river blindness. The Mectizan Donation Program begins and eventually becomes one of the largest pharmaceutical donation programs in history.

1998 The donation program expands to include efforts to eliminate lymphatic filariasis in countries where ivermectin is an appropriate treatment.

2015 Satoshi Ōmura and William C. Campbell receive the Nobel Prize in Physiology or Medicine for the discovery and development of avermectin and ivermectin, recognizing work that has transformed the treatment of parasitic diseases in both animals and humans.

The Key Point

The original research had nothing to do with river blindness.

Ōmura was searching Japanese soil for microorganisms that produced biologically active compounds. Campbell was searching for new medicines to protect livestock from parasitic worms. Only after ivermectin proved extraordinarily effective in animals did researchers investigate whether it could also treat human diseases. That unexpected progression eventually led to its worldwide use against river blindness and several other parasitic infections.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:988a0a06-85ef-49a5-bda1-5cc6aad717b8-6" data-turn-id-container= "request-WEB:988a0a06-85ef-49a5-bda1-5cc6aad717b8-6" data-testid= "conversation-turn-14" data-turn="assistant">

For many years, the standard approach was:

• Ivermectin kills or suppresses the baby worms (microfilariae) that cause itching and blindness.
• Adult worms survive, so treatment must be repeated every year for many years.

Then researchers made an important discovery.

The 1970s–1990s: A hidden bacterium

Scientists discovered that Onchocerca volvulus, the worm that causes river blindness, contains bacteria called Wolbachia.

These bacteria are not simply infecting the worm—they live inside its cells and are essential for the worm's biology.

Without Wolbachia, the adult worms become infertile and gradually die.

Why use an antibiotic?

Doxycycline does not kill the worm directly.

Instead, it kills the Wolbachia bacteria inside the worm.

Without those bacteria:

• Female worms stop producing baby worms.
• Adult worms slowly weaken.
• Many die over the next 18–24 months.

So instead of attacking the worm itself, doxycycline attacks something the worm depends on.

Think of it this way

Imagine a factory.

• Adult worm = the factory.
• Baby worms (microfilariae) = the products coming off the assembly line.
• Wolbachia bacteria = the factory's power plant.

Ivermectin clears away the products already on the shelves (the baby worms), but the factory remains standing and eventually starts producing again.

Doxycycline shuts down the power plant. The factory can no longer make new products and eventually closes.

Why wasn't doxycycline used from the beginning?

There are several practical reasons:

• Scientists didn't recognize the importance of Wolbachia until years after ivermectin had already become the standard treatment.
• Doxycycline requires a 4–6 week course, whereas ivermectin is usually a single dose.
• Mass drug administration programs in remote villages are much easier to carry out with one supervised annual dose than with ensuring every person completes weeks of antibiotic therapy.
• Doxycycline is not recommended during pregnancy and generally not used in children under 8 years old, making it less suitable for community-wide campaigns.

Is doxycycline a cure?

It can come closer to what parasitologists call macrofilaricidal therapy—treatment that targets the adult worms.

However, it is slower than ivermectin.

A common strategy in individual patient care is:

1. Ivermectin to rapidly reduce the baby worms causing symptoms and transmission.
2. Doxycycline to eliminate Wolbachia, sterilize the adult worms, and gradually kill them.

Why this discovery mattered

The discovery of Wolbachia transformed research on river blindness because it showed that the parasite has an Achilles' heel. Instead of trying to poison the worm directly, scientists found they could target its essential bacterial partner.

Researchers continue to investigate other drugs that can kill adult Onchocerca worms more quickly than doxycycline, since a shorter, simpler treatment would be much easier to use in endemic regions.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:988a0a06-85ef-49a5-bda1-5cc6aad717b8-7" data-turn-id-container= "request-WEB:988a0a06-85ef-49a5-bda1-5cc6aad717b8-7" data-testid= "conversation-turn-16" data-turn="assistant">

This is actually a fascinating story because Wolbachia was discovered long before anyone knew it was the "Achilles' heel" of river blindness.

Timeline: The Discovery of Wolbachia

1924 American scientists Marshall Hertig and S. Burt Wolbach were studying mosquitoes at Harvard Medical School.

While examining the reproductive tissues of the mosquito Culex pipiens under a microscope, they noticed tiny bacteria living inside the insect's cells.

Because the organism was first described by Hertig and named in honor of Wolbach, it became known as Wolbachia pipientis.

At the time, they had no idea how widespread or important it would prove to be.

1930s–1970s Scientists occasionally found Wolbachia in insects, but it was considered an odd curiosity.

No one knew it infected millions of insect species.

No one suspected it played a role in parasitic worms.

1978–1987 Ivermectin is developed and becomes the standard treatment for river blindness.

Researchers know ivermectin removes the baby worms, but they cannot explain why the adult worms survive for 10–15 years.

Early 1990s Advances in molecular biology allow scientists to identify bacterial DNA inside parasitic worms.

Researchers discover that Onchocerca volvulus and several related filarial worms contain Wolbachia bacteria.

This is completely unexpected.

1995 A landmark study by Mark J. Taylor and colleagues demonstrates that the bacteria are not accidental passengers.

The worms depend on Wolbachia for normal survival and reproduction.

This changes the entire understanding of filarial biology.

Late 1990s Researchers begin asking a simple question:

"If the worms cannot live without Wolbachia, what happens if we kill the bacteria?"

They test doxycycline, an inexpensive antibiotic already widely used for bacterial infections.

1999–2003 Clinical trials show that several weeks of doxycycline:

• removes Wolbachia,
• permanently sterilizes female worms,
• and gradually kills many adult worms over the following months.

This is the first practical treatment shown to attack the long-lived adult worms indirectly.

2000s The Liverpool School of Tropical Medicine and several international collaborators lead much of the research on doxycycline therapy for river blindness and lymphatic filariasis.

The work helps establish doxycycline as an important option for treating individual patients, although it is less practical than ivermectin for mass drug administration.

How did they discover Wolbachia inside the worms?

It happened through improvements in laboratory techniques.

Scientists used:

• high-powered electron microscopes,
• special tissue stains,
• bacterial DNA sequencing,
• molecular probes that could identify bacterial genes.

When they examined adult Onchocerca worms, they repeatedly found bacteria packed inside reproductive tissues and other cells.

The same bacterial DNA appeared over and over.

Eventually researchers realized:

These bacteria were not infecting the worms like a disease.

They were living with the worms in an essential partnership.

Without Wolbachia:

• female worms stop producing baby worms,
• adult worms become weak,
• many eventually die.

That discovery completely changed river blindness research. Before the 1990s, scientists were focused on killing the worms directly. After the discovery of Wolbachia, they realized they could instead target the bacteria that the worms required to survive.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:988a0a06-85ef-49a5-bda1-5cc6aad717b8-8" data-turn-id-container= "request-WEB:988a0a06-85ef-49a5-bda1-5cc6aad717b8-8" data-testid= "conversation-turn-18" data-turn="assistant">

There are really three main approaches to treating river blindness. Keeping it simple helps avoid the confusion.

Treatment What it attacks Typical treatment Ivermectin Baby worms (microfilariae) One dose once or twice a year, usually 3–4 tablets for an average adult Doxycycline Wolbachia bacteria inside the adult worms Usually 100 mg twice a day for 4–6 weeks Experimental/new drugs Adult worms directly Still being studied or not widely used How many doxycycline pills?

The most common regimen is:

• 100 mg twice a day
• for 4 weeks (28 days) or 6 weeks (42 days)

That works out to approximately:

4-week course

• 2 pills per day
• 56 pills total

6-week course

• 2 pills per day
• 84 pills total

So compared with ivermectin:

• Ivermectin: about 3–4 pills once a year
• Doxycycline: 56–84 pills over one treatment course

Why don't they give everyone doxycycline?

Mainly because it is much harder to use in mass campaigns.

Someone in a remote village has to:

• remember to take pills every day,
• complete 4–6 weeks,
• avoid missing doses,
• and it generally isn't used during pregnancy or in children under 8 years old.

By comparison, ivermectin can be distributed by a community health worker in a single visit once a year.

Is there anything else?

For most people, that's essentially the whole story:

1. The parasite is Onchocerca volvulus.
2. The adult worms can live for 10–15 years.
3. The baby worms cause the itching and eye damage.
4. Ivermectin clears the baby worms but doesn't reliably kill the adults.
5. The adult worms contain Wolbachia bacteria.
6. Doxycycline kills the Wolbachia, causing the adult worms to become sterile and gradually die over the following 18–24 months.

Those six points cover the key biology behind current treatment without getting into more specialized research on newer drugs and combination therapies.

It's reasonable to ask whether a very large health program deserves scrutiny. Programs operating across entire continents should be examined critically for their benefits, risks, governance, and transparency.

However, based on the available evidence, there is no credible evidence that the ivermectin donation program was a covert program to kill people in Africa.

What is well documented is:

• The program was launched in 1987 to combat river blindness, a disease that had caused blindness and severe skin disease in many endemic regions.
• Millions of people received ivermectin through national health ministries and international partners.
• Independent researchers, universities, the World Health Organization, and numerous African public health programs have documented major reductions in river blindness and, in some regions, interruption of transmission.
• The program has also been associated with substantial reductions in the burden of lymphatic filariasis where ivermectin was part of combination treatment.

At the same time, there are legitimate issues that researchers and critics have discussed:

• Adverse effects in areas where Loa loa is common. People with very high Loa loa microfilarial loads can develop severe neurological complications after ivermectin, which led to changes in screening and treatment strategies in affected regions.
• Dependence on pharmaceutical donations. Some scholars have questioned whether long-term reliance on donated medicines creates dependency or influences health priorities.
• Vertical disease programs. Public health experts have debated whether focusing heavily on one disease diverts resources from strengthening broader health systems.
• Ethics and oversight. As with any mass drug administration program, informed consent, community engagement, and monitoring have been ongoing topics of discussion.

Africa has also experienced documented unethical medical research and exploitation in some historical contexts, so it's understandable why people examine large-scale interventions carefully. But it is important to distinguish those documented cases from claims about a specific program. In the case of the ivermectin donation program, the published evidence supports the conclusion that it substantially reduced illness from river blindness rather than serving as a covert harm program.

Late 1800s–Early 1900s: Colonial Medicine

European colonial powers established medical services throughout Africa. Some work genuinely reduced diseases such as smallpox and sleeping sickness, but medicine was also used to support colonial administration, labor systems, and military control.

Researchers often viewed African populations as convenient subjects for large-scale experiments or interventions that would not have been acceptable in Europe.

1900–1930s: Sleeping Sickness Campaigns

Large epidemics of sleeping sickness (African trypanosomiasis) affected Central and East Africa.

Colonial governments introduced mass screening and treatment campaigns. Some drugs available at the time, such as atoxyl (an arsenic-containing compound), caused serious side effects, including blindness, because they were used before modern clinical trial standards existed.

The intent was to control disease, but treatment programs often involved compulsory examinations and treatment with medicines that were incompletely understood.

1920s–1950s: Forced Public Health Measures

In several colonies, health authorities imposed compulsory vaccinations, quarantines, relocations, and medical examinations.

These programs sometimes reduced disease transmission but were frequently carried out without informed consent or meaningful community choice.

1940s–1960s: Colonial Research Institutes

European governments established tropical medicine institutes across Africa.

Many produced valuable scientific discoveries, but ethical oversight varied greatly by modern standards.

Questions about informed consent, risk disclosure, and participant autonomy were often secondary to research objectives.

1970s: Apartheid South Africa and Project Coast

One of the best-documented examples is Project Coast, South Africa's secret chemical and biological warfare program.

Directed by Wouter Basson, it operated during the apartheid era.

Investigations after apartheid found that the program researched chemical and biological agents for military purposes and has been linked to unethical human experimentation and covert operations. The extent of every allegation remains debated, but the existence of the program itself is well documented.

Cold War Era

During the Cold War, African countries became arenas for proxy conflicts involving the United States, Soviet Union, Cuba, China, France, and others.

Medical programs sometimes overlapped with intelligence, military logistics, or geopolitical competition, although that does not mean humanitarian health programs were fronts for intelligence operations.

HIV/AIDS Era (1980s–2000s)

Africa became the epicenter of the global HIV epidemic.

This period saw enormous investments in research, vaccine trials, treatment studies, and prevention programs.

Most of these studies were conducted under increasingly strict ethical rules compared with earlier decades, but debates continued over:

• standards of care,
• placebo-controlled trials,
• access to medicines after studies ended,
• and whether poorer countries received equitable treatment.

These debates influenced international research ethics and helped strengthen protections for participants.

Modern Ethical Frameworks

Today, most international research involving human participants is expected to follow principles established in documents such as the Declaration of Helsinki and the CIOMS International Ethical Guidelines, along with review by institutional ethics committees and local regulatory authorities.

These safeguards were developed in part because of historical abuses—not only in Africa, but also in Europe, North America, Asia, and elsewhere.

Why This History Matters

The historical record shows that:

• Africa experienced both genuine public health successes and documented ethical failures.
• Colonial governments sometimes prioritized political or economic goals alongside health objectives.
• Some research and public health programs did not meet ethical standards that are expected today.
• That history contributes to understandable skepticism in some communities toward outside medical interventions.

At the same time, it's important to evaluate each modern program—whether related to malaria, river blindness, HIV, or vaccination—on its own evidence rather than assuming it resembles past abuses. Historical precedent can justify careful scrutiny, but it does not by itself demonstrate that a current program is unethical or harmful.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:988a0a06-85ef-49a5-bda1-5cc6aad717b8-5" data-turn-id-container= "request-WEB:988a0a06-85ef-49a5-bda1-5cc6aad717b8-5" data-testid= "conversation-turn-12" data-turn="assistant">

The campaigns relied much more on community organization and repeated local engagement than on mass advertising. There wasn't one global strategy; approaches evolved over time and varied by country. Researchers have also documented both successes and challenges.

Common elements included:

• Community-directed treatment. Beginning in the 1990s, many African programs adopted the Community-Directed Treatment with Ivermectin (CDTI) model. Villages selected trusted local volunteers to distribute the tablets rather than relying solely on outside health workers.
• Annual or semiannual visits. Distributors returned each year, measured people's height or weight to determine the dose, recorded who received treatment, and encouraged those who missed the previous round to participate.
• Health education. Programs explained that river blindness was caused by worms transmitted by blackflies and emphasized that repeated treatment reduced itching, skin disease, and the risk of blindness.
• Visible benefits. In many communities, people reported that severe itching decreased after treatment. Those visible improvements were often cited by program organizers as an important reason people continued participating.
• Community leaders. Village chiefs, religious leaders, teachers, and local health workers were frequently involved in encouraging participation and organizing distribution days.

How did they deal with concerns and side effects?

Programs generally did not claim the medicine had no risks. Instead, they developed procedures to manage concerns:

• People were informed that some side effects—such as itching, swelling, fever, or headache—could occur, particularly after the first treatment because large numbers of microfilariae were dying.
• Health workers monitored for adverse events and referred severe cases for medical care.
• When it became clear that people with very high Loa loa microfilarial loads could experience rare but serious neurological complications, treatment strategies were modified in affected regions. Some areas conducted additional assessments or changed where and how mass treatment was delivered.

Did everyone accept it?

No.

Some communities were hesitant or refused treatment for reasons including:

• fear of side effects,
• rumors about the medicine,
• distrust of governments or foreign organizations,
• religious or cultural concerns,
• treatment fatigue after many years of annual campaigns.

These issues are described in public health studies of mass drug administration and are one reason programs invested heavily in community engagement. Why was treatment repeated every year?

This is one of the biggest points of confusion.

Ivermectin does not reliably kill the adult Onchocerca worms, which can live for roughly 10–15 years in the body. Instead, it suppresses or kills the microfilariae—the immature worms responsible for disease—and temporarily reduces the adult worms' production of new microfilariae.

As a result, annual or semiannual treatment was intended to keep microfilarial levels low until the adult worms died naturally. At the same time, repeated community-wide treatment reduced the number of microfilariae available for blackflies to transmit, helping interrupt the parasite's life cycle over many years.

So the rationale for annual dosing was based on the parasite's biology rather than a one-time cure. Researchers have continued to look for drugs that are more effective at killing the adult worms, because that could shorten treatment programs substantially.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:988a0a06-85ef-49a5-bda1-5cc6aad717b8-0" data-turn-id-container= "request-WEB:988a0a06-85ef-49a5-bda1-5cc6aad717b8-0" data-testid= "conversation-turn-2" data-turn="assistant">

For the river blindness (onchocerciasis) mass treatment programs, the number is actually surprisingly small.

The tablets are usually 3 mg each, and the dose is based on body weight (or sometimes height).

Typical once-yearly dose:

Body weight Number of 3 mg tablets 15–25 kg (33–55 lb) 1 tablet 26–44 kg (57–97 lb) 2 tablets 45–64 kg (99–141 lb) 3 tablets 65–84 kg (143–185 lb) 4 tablets 85 kg+ (187 lb+) Weight-based (often 4–5 tablets)

So for most adults, the annual treatment is typically:

• 3 tablets if they're average-sized.
• 4 tablets if they're larger.

Many programs give one dose per year, although in some areas with higher transmission they give it twice per year (every six months).

That means, over the long term:

• 1 year: about 3–4 pills
• 10 years: about 30–40 pills
• 20 years: about 60–80 pills

This also helps explain how the donation program reached such enormous totals. When people hear "billions of ivermectin treatments," a treatment usually means one annual dose, which for most adults consists of only 3 or 4 tablets, not bottles of medication. The cumulative total became so large because tens or hundreds of millions of people received those few tablets year after year.

. *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:c6446963-798a-4bb1-9245-16ca27678153-2" data-turn-id-container= "request-WEB:c6446963-798a-4bb1-9245-16ca27678153-2" data-testid= "conversation-turn-6" data-turn="assistant">

Richard W. Ashford and the Liverpool doxycycline researchers were in the same broad scientific field: tropical parasitology. In fact, Ashford spent much of his career at the Liverpool School of Tropical Medicine and later became Professor of Parasite and Vector Biology there.

However, "tropical parasitology" is a very broad discipline. Within it, researchers often specialize in different parasite groups:

• R. W. Ashford — human parasitology broadly, especially protozoa (including the organism later named Cyclospora), intestinal parasites, zoonoses, parasite ecology, and taxonomy. He also wrote major reference works on human parasites.
• Mark Taylor, Stephen Ward, David Molyneux, Achim Hoerauf — specialized much more narrowly in filarial nematodes (Onchocerca, Wuchereria, etc.) and eventually the Wolbachia bacteria living inside those worms, leading to doxycycline-based treatments.

So they were very much in the same academic community. They:

• attended many of the same tropical medicine meetings,
• published in many of the same journals (such as Annals of Tropical Medicine & Parasitology),
• worked at the same institution during overlapping years,
• and studied neglected tropical diseases.

One particularly interesting overlap is David Molyneux. He was one of Liverpool's leading experts on filarial diseases while Ashford was a professor there. Their careers overlapped at Liverpool, and they would almost certainly have known each other professionally, even though they focused on different parasites.

So if you're tracing the scientific network, it is reasonable to view them as belonging to the same Liverpool School of Tropical Medicine ecosystem. Ashford was not one of the scientists who developed anti-Wolbachia therapy, but he was part of the same institutional and professional community from which that work emerged.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:8168a89d-0e4f-4437-aa8e-bf33f35c0c23-5" data-turn-id-container= "request-WEB:8168a89d-0e4f-4437-aa8e-bf33f35c0c23-5" data-testid= "conversation-turn-12" data-turn="assistant"> River Blindness (Onchocerciasis)

• Spread by blackflies (Simulium species).
• The parasite

  Onchocerca volvulus

  Discovered

  The adult worm was first scientifically described in 1874 by Irish physician John O'Neill, who found it in skin nodules from patients in West Africa.

  How it spreadsies breed in fast-flowing rivers and streams.

That is why the disease became known as river blindness.

What happens

The adult worms live in nodules beneath the skin.

They produce millions of baby worms called microfilariae.

Those baby worms travel through:

• the skin (causing severe itching)
• the eyes (causing inflammation and eventually blindness)

The adult worms may live 10–15 years.

Loa loa (African Eye Worm)

The parasite

Loa loa

First described

The worm was first described scientifically in the late 1700s after European physicians observed a worm moving beneath the eye of people returning from West Africa.

The species was formally named during the 1800s.

Where it occurs

Mainly the rainforests of

• Cameroon
• Gabon
• Republic of the Congo
• Democratic Republic of the Congo
• Central African Republic
• Equatorial Guinea
• parts of Nigeria

How it spreads

Not by blackflies.

It is spread by deer flies (Chrysops), also called mango flies.

The major difference

River blindness

Adult worms stay under the skin.

Baby worms travel through

• skin
• eyes

Loa loa

Adult worms migrate through tissues.

Sometimes one crawls across the white of the eye, giving rise to the name African eye worm.

The baby worms circulate in the bloodstream during the day.

1970s–1980s

Large international campaigns begin planning to eliminate river blindness.

Researchers identify ivermectin as a promising treatment.

1987

Merck announces the Mectizan Donation Program.

The company agrees to donate ivermectin for as long as needed to fight river blindness.

Early campaigns

Millions of people receive ivermectin.

In most areas treatment works very well.

The baby worms disappear.

Blindness falls dramatically.

Unexpected problem

Doctors begin noticing something unusual in parts of Central Africa.

A very small number of patients become severely ill after treatment.

Some develop

• confusion
• coma
• neurological injury

Some die.

Investigation

Researchers eventually discover these patients usually do not have a problem because of river blindness itself.

Instead, they also have another infection:

Loa loa

Why?

A person may carry enormous numbers of Loa loa baby worms in their blood.

Examples:

Normal infection:

• a few thousand per milliliter

Heavy infection:

• 30,000
• 50,000
• 100,000+
• sometimes even higher

When ivermectin is given,

it rapidly kills huge numbers of these baby worms.

Researchers believe the sudden death of so many parasites triggers an intense inflammatory response. In people with very high Loa loa microfilarial loads, this reaction can damage the brain and lead to post-ivermectin encephalopathy. The exact biological mechanisms are still being studied, but the association between very high Loa loa counts and this rare complication is well documented.

Modern programs

Today programs first determine whether Loa loa exists in an area.

If it does,

extra precautions may be taken before mass ivermectin treatment.

Simple Summary River Blindness Loa loa Worm: Onchocerca volvulus Worm: Loa loa Spread by blackflies Spread by deer flies (Chrysops) Adult worms under the skin Adult worms migrate through body tissues Baby worms in skin and eyes Baby worms circulate in the blood Causes itching and blindness Usually causes transient swellings and occasionally a worm crossing the eye Ivermectin removes the baby worms Ivermectin also kills the baby worms, but in people with very high Loa loa microfilarial loads it can rarely trigger severe neurological complications

Thinking of them as two separate diseases that happen to overlap geographically makes the situation much easier to understand. River blindness is the disease ivermectin was designed to control, while Loa loa is a different parasitic infection that required public health programs to modify ivermectin campaigns in certain regions of Central Africa.

Since 1987, Merck has donated more than 5 billion ivermectin (Mectizan) treatments over 38 years. The program now reaches more than 300 million people annually and is widely regarded as the longest-running disease-specific drug donation program in history.

Merck & Co. Co-Developed Ivermectin. Donated 5 Billion Free Treatments (1987–2025). Fighting River Blindness and Other Parasitic Diseases Across Africa or destroying DNA and silent death.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:439892f5-7107-4690-a1c0-8eb3a4be4152-10" data-turn-id-container= "request-WEB:439892f5-7107-4690-a1c0-8eb3a4be4152-10" data-testid= "conversation-turn-22" data-turn="assistant">

Here's the timeline with The Carter Center added at the appropriate points.

Year Event 1668 Merck is founded in Darmstadt, Germany. 1917 During World War I, the U.S. government seizes Merck's American subsidiary. It later becomes the independent U.S. company Merck & Co. 1973 Japanese microbiologist Satoshi Ōmura isolates the soil microorganism that produces avermectins. 1974 Ōmura sends samples to Merck Research Laboratories in the United States. 1975 Merck scientist Dr. William Campbell proposes using ivermectin (then under development) against river blindness. 1975–1980 Merck develops ivermectin and conducts laboratory and animal studies. 1981 First human clinical trials begin in Senegal under Merck and WHO collaboration. October 1987 Merck CEO Dr. Roy Vagelos announces that Mectizan (ivermectin) will be donated "as much as needed, for as long as needed." Late 1987 Merck realizes it needs a global distribution system and asks Dr. William Foege, then executive director of The Carter Center and leader of the Task Force for Child Survival, to help organize it. 1988 The Mectizan Donation Program (MDP) and the Mectizan Expert Committee are formally established. Foege serves as the first chair and oversees global distribution. 1990 The Carter Center begins expanding its own river blindness activities in endemic countries. 1992–1993 The Onchocerciasis Elimination Program for the Americas (OEPA) is launched and later sponsored by The Carter Center, coordinating elimination efforts in six endemic countries in Latin America. 1995 The African Programme for Onchocerciasis Control (APOC) is established with WHO, the World Bank, African governments, and partners. 1996 The Carter Center greatly expands its river blindness work by taking over much of the River Blindness Foundation's operations. 1998 Merck expands the donation program to include lymphatic filariasis (elephantiasis) in co-endemic African countries and Yemen. 2015 William Campbell and Satoshi Ōmura receive the Nobel Prize in Physiology or Medicine for the discovery and development of avermectin/ivermectin. 2025 Merck reports more than 5 billion treatments donated over 38 years. One interesting historical point

The Carter Center did not originate the idea of donating ivermectin. The sequence was:

1. Merck discovered and developed the drug.
2. Merck decided to donate it in 1987.
3. Merck then approached Dr. William Foege because the company needed someone with experience running massive international disease campaigns.
4. Foege, who was leading The Carter Center and had directed the global smallpox eradication effort at the CDC, designed much of the system for safely distributing the drug worldwide.

In other words, Merck supplied the medicine; the Carter Center became one of the key organizations that helped build the infrastructure to get it to millions of people.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:439892f5-7107-4690-a1c0-8eb3a4be4152-11" data-turn-id-container= "request-WEB:439892f5-7107-4690-a1c0-8eb3a4be4152-11" data-testid= "conversation-turn-24" data-turn="assistant">

So, if everyone received one treatment per year on average, 5 billion treatments would roughly correspond to:

• about 250 million people treated over 20 years, or
• about 500 million people treated over 10 years.

In reality, the number of unique people is difficult to calculate because:

• people enter and leave programs,
• children are born and later become eligible,
• some areas treat once a year and others twice,
• some countries eliminated the disease and stopped treatment while others continued.

Annual scale

In many recent years:

• approximately 100–120 million people have received ivermectin annually for river blindness.
• When lymphatic filariasis programs using ivermectin are included, annual recipients have often exceeded 200 million people.

So over nearly four decades, the cumulative number of individuals who have received at least one ivermectin treatment is likely in the hundreds of millions. There is no official published count of unique recipients because the programs track annual treatments rather than assigning a lifetime total to each person.

From a historical perspective, the Mectizan Donation Program is often grouped with major achievements such as smallpox eradication, oral rehydration therapy, and large childhood immunization campaigns because of its extraordinary scale and sustained duration. It represents one of the largest long-term medicine donation efforts ever undertaken.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:439892f5-7107-4690-a1c0-8eb3a4be4152-12" data-turn-id-container= "request-WEB:439892f5-7107-4690-a1c0-8eb3a4be4152-12" data-testid= "conversation-turn-26" data-turn="assistant"> Countries that have eliminated the disease

Some countries no longer need mass ivermectin distribution because transmission has been interrupted or eliminated.

For river blindness, WHO has verified elimination in:

• Colombia
• Ecuador
• Guatemala
• Mexico

Other countries have also eliminated transmission in specific regions.

Countries where treatment continues

Mass treatment is still ongoing in parts of:

• Democratic Republic of the Congo
• Nigeria
• Cameroon
• South Sudan
• Ethiopia
• Angola
• Central African Republic
• Chad
• and several other African countries

These areas continue annual or twice-yearly community treatment because the parasite is still being transmitted.

Do people still get it regularly?

Yes.

In communities where river blindness or lymphatic filariasis remains endemic, eligible residents are still offered ivermectin through organized public health campaigns.

Typically:

• community health workers announce distribution days,
• people come to a central location or health workers go house to house,
• dosage is determined by height or weight,
• treatment is repeated annually or semiannually until health authorities determine transmission has stopped.

Is Merck still donating it?

Yes.

Merck announced in late 2025 that it would continue donating up to 100 million ivermectin treatments per year through at least 2030 for lymphatic filariasis elimination, while continuing its longstanding commitment to river blindness elimination.

How many people are still reached?

The scale remains enormous.

• The broader Mectizan Donation Program continues to reach hundreds of millions of people annually through its partnerships.
• Merck reported that in 2024, across all of its product donation programs, it reached more than 292 million people, with the Mectizan Donation Program remaining one of its flagship efforts.

One thing that stands out historically is the duration. The commitment began in 1987 and is still active nearly 40 years later. Very few large-scale public health interventions—whether run by governments, charities, or private companies—have maintained that level of continuity over such a long period.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:439892f5-7107-4690-a1c0-8eb3a4be4152-13" data-turn-id-container= "request-WEB:439892f5-7107-4690-a1c0-8eb3a4be4152-13" data-testid= "conversation-turn-28" data-turn="assistant">

• Africa: roughly 99% of the world's river blindness burden.
• Latin America: only about 1%, spread among six countries:
  • Mexico
  • Guatemala
  • Colombia
  • Ecuador
  • Venezuela
  • Brazil

The Americas therefore became a realistic elimination target.

Mexico's timeline

• 1980s – Ivermectin treatment begins.
• 1992 – Mexico joins the regional elimination effort through the Onchocerciasis Elimination Program for the Americas (OEPA).
• 1990s–2000s – Communities receive ivermectin twice yearly in endemic areas.
• 2015 – World Health Organization verifies that Mexico has eliminated onchocerciasis as a public health problem.

Mexico was actually the third country in the world to receive WHO verification for eliminating river blindness, after Colombia and Ecuador.

Why did it work in Mexico?

Several factors helped:

• The endemic area was relatively small compared with Central Africa.
• Health workers achieved very high treatment coverage year after year.
• Blackfly breeding sites were geographically limited.
• The parasite could no longer sustain transmission after repeated community-wide ivermectin treatment.

So today, people in Chiapas are not receiving routine community ivermectin for river blindness because the disease has been eliminated there.

One interesting connection to your earlier research is that Mexico appears in two very different infectious disease stories:

1. River blindness — where decades of organized ivermectin distribution are generally regarded as a major public health success.
2. Cyclospora and produce-associated outbreaks — which involve a completely different parasite, different mode of transmission (fecal contamination of food or water), and different prevention strategies.

Although both concern infectious diseases, they are unrelated biologically and epidemiologically.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-(--sticky-padding-top)" dir="auto" data-turn-id="ea2ca438-5713-4424-a7c6-dd5677a5cd5c" data-turn-id-container="ea2ca438-5713-4424-a7c6-dd5677a5cd5c" data-testid="conversation-turn-29" data-turn="user"> so WHO was able to do the same kind of deal in mexico and those countiries, where merck paid for the pills *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:439892f5-7107-4690-a1c0-8eb3a4be4152-14" data-turn-id-container= "request-WEB:439892f5-7107-4690-a1c0-8eb3a4be4152-14" data-testid= "conversation-turn-30" data-turn="assistant">

Yes, essentially. That's what made the program unusual.

The roles were divided roughly like this:

Organization Responsibility Merck Manufactured and donated the ivermectin tablets. WHO Developed treatment guidelines, monitored the program, and provided technical leadership. National Ministries of Health Organized treatment campaigns within each country. The Carter Center, PAHO, NGOs, Task Force for Global Health Helped train workers, coordinate logistics, monitor results, and support distribution. Local communities Chose community drug distributors and actually handed out the medicine.

So in Mexico, for example:

• Merck paid for the Mectizan (ivermectin).
• Mexico's Ministry of Health organized national implementation.
• WHO and the Pan American Health Organization (PAHO) provided technical guidance.
• The Onchocerciasis Elimination Program for the Americas (OEPA), later sponsored by The Carter Center, coordinated elimination across the six endemic countries in the Americas.

One interesting aspect is that Merck didn't simply ship pills to WHO.

Instead, countries or approved programs would estimate how many treatments they needed, submit requests through the Mectizan Donation Program, and, once approved, the medicine was shipped at no cost. The local public health system then distributed it to eligible communities.

So if you were in an endemic village in Chiapas, Mexico, in the 1990s, the chain looked something like this:

• Merck manufactured and donated the ivermectin.
• The Mectizan Donation Program approved the request.
• WHO/PAHO and OEPA provided technical oversight.
• Mexico's Ministry of Health organized the campaign.
• Community health workers distributed the tablets in the village.

It was a remarkably coordinated public-private partnership. Merck has described it as one of the first large-scale collaborations of its kind involving a pharmaceutical company, WHO, governments, NGOs, and local communities working together over decades.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:439892f5-7107-4690-a1c0-8eb3a4be4152-15" data-turn-id-container= "request-WEB:439892f5-7107-4690-a1c0-8eb3a4be4152-15" data-testid= "conversation-turn-32" data-turn="assistant">

Yes, there have been several other enormous mass drug administration (MDA) campaigns, but the Mectizan (ivermectin) program is generally considered one of the largest and longest-running single-drug donation programs in history.

Here's how some of the major campaigns compare:

Program Medicine Approximate Scale River blindness Ivermectin (Merck) 5+ billion treatments since 1987. Lymphatic filariasis Ivermectin + albendazole or DEC + albendazole Hundreds of millions treated annually in many years. Intestinal worms (school deworming) Albendazole (GSK) and mebendazole (Johnson & Johnson) More than 10 billion tablets donated over the years. Schistosomiasis (bilharzia) Praziquantel (Merck KGaA, Germany) Billions of tablets donated through WHO programs.

A point that's easy to miss is that the Merck donating ivermectin is the U.S. company (Merck & Co./MSD), while the Merck donating praziquantel is the German company (Merck KGaA, Darmstadt). Despite sharing the historical Merck name, they are separate companies today.

Is the ivermectin program the biggest in Africa?

It depends on what you mean by "biggest."

If you mean a medicine handed out year after year across multiple countries, then yes, it is one of the largest ever conducted in Africa.

If you include all neglected tropical disease programs together, Africa has seen several enormous campaigns:

• Ivermectin for river blindness.
• Ivermectin + albendazole for lymphatic filariasis.
• Praziquantel for schistosomiasis.
• Albendazole or mebendazole for intestinal worms in schoolchildren.

Often, these campaigns were coordinated together, so a child might receive more than one medicine during the same public health visit.

What may be even more remarkable

One reason historians frequently highlight the Mectizan program is that it has been:

• running for nearly 40 years,
• based on an unlimited donation commitment,
• sustained by a partnership among a pharmaceutical company, WHO, governments, NGOs, and local communities,
• and has delivered billions of treatments.

There are larger health interventions if you count vaccines—for example, the WHO Expanded Programme on Immunization has delivered many billions of vaccine doses worldwide—but those involve many different vaccines, manufacturers, and funding sources over decades. They are not comparable to a single company donating one medicine indefinitely.

So, in terms of a single medicine donated by one company and distributed over decades, the ivermectin/Mectizan program is widely regarded as one of the largest humanitarian pharmaceutical efforts ever undertaken.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:439892f5-7107-4690-a1c0-8eb3a4be4152-16" data-turn-id-container= "request-WEB:439892f5-7107-4690-a1c0-8eb3a4be4152-16" data-testid= "conversation-turn-34" data-turn="assistant">

Not all in Africa, but Africa has been the largest recipient of several of these programs.

Here's the breakdown:

Program Africa Other Regions River blindness (ivermectin) Mostly Africa (about 99% of the global burden) Small endemic areas in Mexico, Guatemala, Colombia, Ecuador, Venezuela, Brazil, and Yemen. Lymphatic filariasis Large programs in Africa Also major programs in India, Bangladesh, Indonesia, Papua New Guinea, Haiti, parts of the Pacific, and Southeast Asia. School deworming (albendazole/mebendazole) Large African programs Also enormous in Asia, especially India, China (historically), Indonesia, Bangladesh, Pakistan, and the Philippines. Schistosomiasis (praziquantel) Primarily Africa today (roughly 90% of the global burden) Also found in Brazil, China, the Philippines, parts of the Middle East, and a few other countries.

So if you're asking whether Africa has been the main focus of mass drug administration, the answer is yes.

The reason is epidemiological rather than simply geographic. Many of the world's neglected tropical diseases have their highest burden in sub-Saharan Africa.

For example:

• River blindness: about 99% of people at risk have lived in Africa.
• Schistosomiasis: roughly 90% of people requiring treatment are in Africa.
• Lymphatic filariasis: Africa has a very large burden, but South and Southeast Asia have also had very large programs.
• Intestinal worms: the burden is split between Africa and Asia, with India alone historically accounting for a very large share of children needing treatment.

If you add them together

From roughly the late 1980s onward, hundreds of millions of Africans have participated in repeated public health campaigns involving one or more medicines:

• ivermectin,
• albendazole,
• mebendazole,
• praziquantel,
• azithromycin (for trachoma in many countries),
• and, in some settings, combinations of these medicines during the same campaign.

These campaigns often used the same community health worker networks, allowing multiple neglected tropical disease programs to be delivered efficiently.

One reason Africa appears so prominently in global health history is that it became the principal focus of several of the world's largest long-term campaigns against neglected tropical diseases, supported by partnerships among governments, WHO, pharmaceutical companies, NGOs, and local communities. That reflects where these diseases were most prevalent, rather than all campaigns being exclusive to Africa.

One interesting point is that Merck's ivermectin donation helped establish a model. After the success of the Mectizan Donation Program, other pharmaceutical companies launched large donation programs for different neglected tropical diseases. For example:

• GlaxoSmithKline (GSK) donated billions of albendazole tablets.
• Johnson & Johnson donated mebendazole.
• Merck KGaA (Germany) donated praziquantel.
• Pfizer donated azithromycin for trachoma.

Together, these programs became the backbone of WHO-led neglected tropical disease control efforts in many low-income countries, particularly in sub-Saharan Africa, while also reaching millions of people in Asia and Latin America.

"CLASTOGENIC" - 18 Studies Highlighting Ivermectin Induced DNA Breakage, Damage & Related Disorders Cytotoxic, Mutagenic, Genotoxic & Clastogenic? Ivermectin Is A Menace Tim Truth Jun 19, 2023

Definitions:

• A clastogen is a substance or agent that induces chromosomal breakage or structural changes in the DNA of cells. The term "clastogen" is derived from the Greek word "klastos," meaning "to break." Clastogens can cause damage to the genetic material, leading to the formation of chromosomal aberrations.
• A mutagen is a substance or agent that can induce changes or mutations in the DNA sequence of an organism. These mutations can alter the genetic information and potentially lead to the development of new diseases.
• Genotoxic refers to substances or agents that have the ability to damage or alter the genetic material (DNA) of living cells, increasing the risk of mutations. These mutations can have detrimental effects on the organism, potentially leading to the development of cancer or other genetic disorders.

In this article I want to look at a number of studies showing a dose dependent increase in DNA breaks, chromosomal aberrations, etc when ivermectin is administered to cell cultures or animals.

Video report now available: https://rumble.com/v2yp1we-ivermectin-dna-wreckage-depopulation-agent-ivm-is-mutagenic-genotoxic-and-c.html

Study #1: Mutagenicity of Ivermectin In Rats

In a study titled 'The mutagenic effects of ivermectin in germinal cells and serum protein of the mouse' by Sweify et al, researchers conducted an experiment to investigate the mutagenicity of Ivermectin on meiotic chromosomes of mice. They found a significant increase in meiotic aberrations, suggesting that Ivermectin is of mutagenic nature. (full report)

"Effects of ivermectin on spermatocyte chromosomes: Structural aberrations: Cytological analysis of diakinesis-metaphase I spermatocytes of the treated samples revealed significant increase in chromosome aberrations over the control values."

"Analysis of the treated samples revealed significant increase in meiotic aberrations, 33.83% vs 5.8% for the control (P

"Effects of ivermectin on spermatocyte chromosomes: … spermatocytes of the treated samples revealed significant increase in chromosome aberrations over the control values"

"The present observations pointed to the mutagenic effects of IVM. The frequency of translocation is significantly higher than that found in the control samples"

"These studies revealed high clastogenic and genotoxic potential of IVM"

"In the present work, IVM induced significant increase in the reciprocal translocation figs.of primary spermatocytes. The changes in the serum protein fractions add another warning for the mutagenicity of IVM."

Study #2: Ivermectin Genotoxicity On Buffalo Lymphocytes

In a paper called 'Antimutagenic Activity of Some Natural supplements on Ivermectin genotoxicity in Lymphocytes of Buffalo' by El-makawy et al, researchers investigated the impact of garlic, L-carnitine, and wheat germ oil on the genotoxicity induced by ivermectin in buffalo lymphocyte cultures, finding that ivermectin caused a significant rise in micronuclei and chromosomal aberrations with increasing doses (full report)

Cell Abnormalities

The units here are # per 10,000 Cells; Blue lines are the control levels Structural Chromosomal Aberrations Observed:

"Results showed that ivermectin induced dose dependent increase in the frequencies of the binucleated lymphocytes with micronuclei as well as the number of micronuclei in lymphocytes of river buffalo"

"Ivermectin low dose caused non-significant increase in the frequency of total chromosomal aberrations in lymphocytes of river buffalo as compared to control. Whereas, in medium and high doses the frequencies of aberrant cells increased at a significant level (P ≤ 0.001) than control."

"In addition, the numbers of binucleated lymphocytes showed dose dependent decrease than control. These results revealed that the drug has a cytotoxic effect on the number of cell divisions. As the micronuclei are small chromatin-containing bodies arising from chromosome fragmentation by breaks or deletion, the results of MN [micronuclei] formation confirmed our results of chromosomal aberrations indicating the clastogenic effects of ivermectin."

Study #3: Ivermectin's Cytogenic Potential On Mice Bone Marrow Cells

In a study called 'The cytogenetic potential of ivermectin on bone marrow cells of mice in vivo' from Sweify et al, researchers evaluated the cytogenicity of Ivermectin (IVM) on mice through chromosomal aberration and micronucleus tests, finding that IVM induced high levels of chromosome aberrations and genotoxicity in somatic cells.

"IVM induced high level of chromosome aberrations in somatic cells, as it is ascertained by chromosome aberration assay and micronuclei production in bone marrow cells. This study revealed high clastogenic and genotoxic potential of IVM on mice"

"The Table contains also the different types of chromosomal aberrations recorded in the examined cells. A single i.p. injection of ivermectin [200μg/kg ivermectin] resulted in a significant (P≤0.001) increase in percentage of aberrant cells"

"It is clear from the Table (II) that injection with ivermectin induced high significant increase in the frequency of the damaged cells allover the examined periods (P≤0.001)."

Study #4: Ivermectin Breaks DNA Strands In Chinese Hamster Ovary Cells

In a study called 'In vitro genotoxic and cytotoxic effects of ivermectin… on Chinese hamster ovary (CHO K1 ) cells' by Molinari et all, researchers conducted various genotoxicity and cytotoxicity assays to investigate the effects of ivermectin (IVM) and its commercial formulation ivomec® on Chinese hamster ovary (CHO K1) cells and found that Ivermectin caused DNA-strand breaks in Chinese hamster ovary cells. (Full article)

"… IVM and ivomec® … induced DNA-strand breaks revealed by SCGE [single cell gel electrophoresis]"

"Both chemicals induced DNA-strand breaks revealed by the comet assay"

"IVM and ivomec® exert both genotoxicity and cytotoxicity in mammalian cells in vitro, at least in CHO K1 cells."

"A brief 80 min pulse-treatment of 5.0–50.0 μg/ml of IVM or 25.0 and 50.0 μ g/ml of ivomec® , resulted in a manifest level of single DNA-strand break induction."

Study #5: Ivermectin Induces DNA Damage In Human HeLa Cells

In a study called 'Ivermectin Confers Its Cytotoxic Effects by Inducing AMPK/mTOR-mediated Autophagy and DNA2 Damage' Zhang Et Al (full writeup here)

"The results indicate that IVM can induce DNA double-strand breaks in HeLa cells, and the degree of double-strand break is dependent on the concentration of IVM."

"Ivermectin has significant ability to induce DNA oxidative damage and enhance autophagy in HeLa cells"

"As expected, we found that IVM can induce oxidative double-stranded damage in HeLa cells, indicating that IVM has potential genotoxicity to human health."

"We conclude that IVM produces genotoxicity and cytotoxicity by inducing DNA damage and AMPK/mTOR-mediated autophagy, thereby posing a potential risk to human health."

Study #6: Genotoxicity and Carcinogenicity of Ivermectin On Fruit Flies

In a study called 'Genotoxicity and carcinogenicity of ivermectin and amoxicillin in vivo systems' by Aparecida de Sousa et al (full report here),

"The results revealed that IVM increased the frequency of epithelial tumor in D. melanogaster considering all evaluated concentrations"

"It was observed a dose-dependence in the frequency of MN [Micronuclei] in T. pallida considering the highest concentrations (11.42, 22.84 and 45.68 × 10−5 mM) differing statistically (p ≤ 0.05) from the negative control, evidencing a genotoxic effect of IVM"

"The results observed in D. melanogaster and T. pallida showed that IVM can increase the damage in the genetic material, leading to genetic instability."

"Findings showed an increase in the frequency of micronuclei in T. pallida treated with 11.42, 22.84 and 45.68 x 10 −5 mM of IVM. We conclude that chronic exposure to IVM is directly associated with events resulting from genetic instability (genotoxicity and carcinogenicity)."

Study #7: DNA Strand Breaks Induced By Ivermectin In Mosquitoes

In a study called 'Genotoxic and cytotoxic in vitro evaluation of ivermectin… on Aedes albopictus larvae (CCL-126™) cells' (Full paper):

"IVM… induced DNA-strand breaks enhancing both slightly damaged and damaged cells at 25–50 μg/ml IVM"

"Data indicated that IVM exerts both genotoxicity and cytotoxicity in insect cells [A. albopictus larvae CCL-126 cells] in vitro"

Study #8: High Levels Of DNA Damage In Cows Exposed To Ivermectin

In a paper called 'Comet assay to determine genetic damage by the use of ivermectin in zebu cows' by Montes-Vergara et al, researchers explored how much DNA damage ivermectin causes in the Zebu cow.

"The values of classification of comets indicate cells with high levels of damage (grade 3: cells with high damage). The rate of DNA damage of the treatment to 1% to 3.15% was significant… The results obtained in this study demonstrate the likely genotoxic potential of the use of IVM in cattle."

"Regardless of the IVM concentration, the presence of nuclei with DNA migration (Figure 1a and b) was observed at a percentage greater than 75% in all cells observed per plaque, demonstrating the ability of the IVM compound to produce simple chain breaks in the DNA molecule."

The Comet classification describes how damaged the DNA of cells are. All of the control group (no treatment) measured 0 on the comet scale, indicating little if any DNA damage. Here are the comet classification results for the IVM treated cows:

"The results found in the present study constitute concrete evidence for the induction of genomic damage as exerted by IVM, using the comet assay methodology"

"In conclusion, the results suggest that the genetic damage found in the studied livestock may be associated with the use of IVM"

Study #9: Ivermectin's Genotoxic Effects On Tadpoles

In a study called 'Genotoxicity of Three Avermectins on Polypedates megacephalus Tadpoles Using the Comet Assay' by Geng et al, some very concerning findings were noted in relation to Ivermectin's "genotoxic effects at relatively low concentrations" in Tadpoles. (Full Paper)

"The tadpoles exposed to the lower concentrations of ABM (0.006 mg/ L) showed a significant increase in DNA damage (P

"Our results showed clearly that avermectins caused dose dependent DNA damage on amphibian tadpoles… The three avermectins increased the DNA damage observed in the tadpoles in a dose-responsive manner. There were strong linear correlations between the DNA damages and the concentrations of the three test substances (Figure 2). The cellular distributions of DNA damages in tadpoles are shown in Figure 3. Of the tadpoles treated with increasing concentrations of the three test substances, higher proportions of cells had greater amount of DNA damage than those of the negative control"

This chart shows a dose-dependent increase in DNA damage as IVM dosing increases:

"According to these results above and our finding that avermectins can cause DNA damage in tadpoles at the concentrations below the recommended applied levels (Xu et al., 2010), we consider it possible that avermectins are carcinogenic, and confirm it has the negative impact on the development of tadpoles"

Study #10: Ivermectin Induced DNA Damage In Chinese Hamster Ovary Cells

In a paper called 'DNA damage kinetics and apoptosis in ivermectin-treated chinese hamster ovary cells' (full report) by Molinari et al, researchers conducted an experiment using the comet assay to analyze the kinetics of DNA damage in Chinese hamster ovary cells induced by ivermectin.

"After 6 h of treatment, cell survival decreased up to 75% and 79% in IVM- and IVO-treated cultures, respectively"

"A clear increase in DNA damage was found immediately after test compound treatments (0 h) (Fig. 1). In both IVM- (Fig. 1A) and IVO-treated cells (Fig. 1B)"

"For both anthelmintics, biphasic behavior in DNA damage occurred during the incubation time."

A time-dependent increase of IVM- and IVO-induced DNA damage was observed within 0 to 3 h after pulse treatment, revealed by a progressive decrease of undamaged cells and an increase in slightly damaged and damaged cells."

"A time-dependent increase in IVM- and IVO-induced DNA damage was observed by a progressive decrease of undamaged cells simultaneously with an increase in the frequency of slightly damaged and damaged cells within the 0–3 h post-incubation time. "

Study #11: Avermectin Induces DNA Damage In Chinese Mitten Crab Haemocyte Blood Cells

In a paper called 'Avermectin induces the oxidative stress, genotoxicity, and immunological responses in the Chinese Mitten Crab, Eriocheir sinensis' researchers investigated the aquatic toxicity of avermectin and its effects on E. sinensis crabs. The study found that exposure to sublethal concentrations of avermectin resulted in decreased levels of antioxidants, increased oxidative products, elevated levels of reactive oxygen species (ROS), reduced phagocytic activity, and genetic damage in the crabs, indicating significant toxic effects on the species including oxidative stress, immunological activity inhibition, and genotoxicity.

"Avermectin or its family members can induce oxidative and immunological dam- age as well as genotoxicity in mammals, birds and fish"

"the 48-h and 96-h LC50 values of avermectin on E. sinensis were 1.663 mg/ L … and 0.954 mg/L"

"Avermectin induces DNA damage in haemocytes"

"a comet assay was performed to investigate the level of DNA damage under avermectin exposure. In control, most haemocytes were observed with a circular, intact nuclei, whereas different degree of comets in the exposure groups early at 24 h. More comets appeared with increase of avermectin concentration. The comet ratio and percentage of DNA in tail increased significantly at each concentration from 24 h (P

"Avermectin induces MN [Micronuclei] frequency in haemocytes… An obvious increase of MN frequency was observed at high concentrations especially at 0.48 mg/L from 48h exposure. And at 96 h, there is a significant difference in concentration groups of 0.12, 0.24 and 0.48 mg/L compared to control (P

"According to the results from two-way ANOVA, a significant interaction between avermectin concentration and exposure time was found for all biomarkers involved (Table 1). All bio markers investigated in this test showed a significant correlation between the concentration, exposure time and their cross combination. It indicated that both avermectin concentrations and exposure time have significant effects on the oxidative, immunological response and DNA damage in E.sinensis"

"The MN test was developed as a simple and practical in vivo cytogenetic screening method for mutagens [42]. In the present study, MN frequency increased significantly in high concentration groups from 48 h"

Study #12: Ivermectin's Genotoxic Effects In White Swiss Mice Bone Marrow

In a paper called 'The Study of Genotoxic and Cytotoxic Effects and DNA Damage by Ivermectin in Bone Marrow of Male White Swiss Mice Mus musculus' by Sadek et al, researchers evaluated the genotoxic and cytotoxic effects of Ivermectin (IVM) on the bone marrow of male white Swiss mice using various cytogenetic endpoints. The results demonstrated that IVM administration led to a significant decrease in polychromatic erythrocytes and a significant increase in micronuclei formation, indicating both anuegenic and clastogenic effects. Furthermore, the comet assay revealed significant DNA damage in bone marrow cells treated with IVM, highlighting its genotoxic and cytotoxic potential in somatic cells.

"Results of current study revealed that IVM have genotoxic and cytotoxic effects on somatic cells of male white mice."

"Oral treatment of white mice with IVM induced a significant DNA damage in bone marrow cells, which revealed by comet assay results, the mean of damaged bone marrow cells in mice treated with doses 0.6 and 0.8 mg/ kg. b.wt. were different significantly when compared with negative control(P≤ 0.01)."

"IVM induced both anuegenic and clastogenic effects in bone marrow of male white mice, The results showed a significant increase in means of numerical chromosome aberrations (anueploidy and polyploidy) (P≤ 0.05), the highest mean of structural chromosome aberration (with and without gabs) was recorded in mice treated with 0.8 mg/ kg. b.wt. (P≤ 0.01)."

"The results showed that IVM induced significant decrease in the mean of polychromatic erythrocytes and the lowest value was recorded at the dose 0.6 mg/ kg. b.wt.(P≤ 0.01) and significant increase in the mean of micronuclei were induced by the three doses of drug (P≤ 0.01)."

Study #13: Ivermectin's Mutagenic Effects in Mice

In a paper called 'Mutagenic Effects of the Combination and Its Components of Albendazole and Ivermectin in vivo and in vitro' by Lin et al

"Albendazole and ivermectin, common antiparasitic drugs widely used in livestock production, showed mutagenic effects in some extent"

"the mice treated with ivermectin or albendazole showed higher micronucleus frequency and sperm abnormality rate."

"The sperm abnormalities in the ivermectin single-drug group were mainly head deformities and body-tail folds… Among them, the proportion of banana head and amorphism was the highest."

Study #14: Ivermectin's Genotoxicity Measured In Rat Bone Marrow Cells

In a paper called 'In vivo combined treatment of rats with ivermectin and aged garlic extract attenuates ivermectin-induced cytogenotoxicity in bone marrow cells' by Khalil et al (full paper), Male Sprague Dawley rats were administered varying doses of IVM intraperitoneally, and the results indicated that high doses of IVM caused significant cytogenetic toxicity.

"IVM was found cytotoxic and mutagenic at high doses since it significantly reduced %MI [mitotic index] and increased %NA [percentage nuclear abnormalities] and %Abc [percentage chromosomal abnormalities]. These observations may be due to disturbances in the mitotic processes that lead to formation of severe CA [chromosomal aberrations] and in turn caused cell death or cease of further cell divisions."

Study #15: Studying The Pairing Of Ivermectin With Pgp Inhibitor Verapamil

In a study called 'Effect of ivermectin on male fertility and its interaction with P-glycoprotein inhibitor (verapamil) in rats' by El-Nahas & El-Ashmawy (full report)

Ivermectin, along with a Pgp-inhibitor/ CYP3A4-inhibitor, results in a remarkable 59% increase in abnormal sperm count, while sperm motility decreases by 8% with Ivermectin alone and by 23% when combined with the Pgp-inhibitor.

Let's look at the differences in abnormal sperm cells by category by treatment group in this series of 9 charts:

Study #16: Ivermectin Mutagenicity Rat Study

In a paper called 'Micronuclei induction by some anthelmintic drugs in male mice' by EL-makawy (full report)

"Contrariwise, at 72 hrs after treatment.. ivermectin induced statistically significant increase in the number of MN [Micronuclei] over the negative control"

The researchers are concerned that the veterinary dosing of livestock may pose a potential risk of dangerous exposure, which could lead to harmful "genotoxic effects on humans."

MNPCEs stands for Micronucleated Polychromatic Erythrocytes. They are a type of abnormal cells that can be observed in the bone marrow and peripheral blood of animals, including humans, following exposure to certain genotoxic substances or conditions.

The presence of micronucleated polychromatic erythrocytes is generally considered a sign of genetic damage or chromosomal abnormalities. These cells have small additional nuclei, known as micronuclei, which contain fragments of chromosomes or whole chromosomes that were not properly incorporated into the daughter cells during cell division.

Study #17: Ivermectin Damaging DNA In Chinese Hamster Ovary & Insect Cell Lines

In a paper called 'IVERMECTINAS: EVALUACIÓN DE SU EFECTO DELETÉREO MEDIANTE ENSAYOS DE GENOTOXICIDAD'

"when the comet assay was employed, both ivermectin and Ivomec® were able to induce DNA single-strand breaks in CHO-K1 and CCL-126 cells"

"Overall, the results evidence that ivermectin present a similar pattern of cytotoxic and genotoxic damage than that induced by Ivomec®."

"Our results demonstrate that ivermectin has the ability to induce damage in the DNA molecule, at least in CHO-K1 and CCL-126 cells, but also highlight a highly cytotoxic capacity as the major deleterious effect of this antibiotic."

"Its widespread use would seriously jeopardize the organisms that are usually treated with ivermectin including human beings."

"DNA migration analysis was performed by measuring the length and width of the observed images. All the concentrations of both compounds tested on CHO-K1 and CCL-126 cells significantly increased the levels of DNA damage."

"The ability to induce repair introduced DNA lesions was tested in CHO-K1 and CCL-126 cells previously exposed to 50 μg/ml ivermectin and Ivomec during a 80-min treatment pulse… Immediately after treatment with both ivermectin and Ivomect (0h) a significant increase in damaged DNA was observed in a high percentage of the cell population in both cell lines"

"The deleterious capacity exerted by both compounds was reflected in the induction of single chain breaks in the DNA from cell lines used."

Study #18: Abnormal Sperm Rates Skyrocket In Nigerian Ivermectin Users

In a study from Nigeria entitled 'Effects of Ivermectin therapy on the sperm functions of Nigerian onchocerciasis patients', some very concerning findings were published.

"We observed significant reduction in the sperm counts and sperm motility of the patients tested. On the morphology there was significant increase in the number of abnormal sperm cells. This took the forms of two heads, double tails, white (albino) sperms and extraordinarily large heads. It is suspected that the above alterations in the already determined parameters of the patients' sperm cells could only have occurred as a result of their treatment with ivermectin."

"Sperm with abnormal morphology were also found to have increased after ivermectin therapy"

Here is a scatter plot of the % of sperm deemed "abnormal" before (x axis) and after (y axis) the ivermectin dosing. Points above the line indicate a higher % of abnormal sperm after the Ivermectin and points below the line indicate a lower % of abnormal sperm after Ivermectin.

"There was a significant drop in the sperm counts of the patients after their treatment with ivermectin."

We can calculate the total motile count of each patient's sample by multiplying the number of sperm in the sample times the percentage that were swimming properly.

O'Conner Ivermectin Rat Carcinogenicity Study

In an article called 'Increased Pathology Incidence in the Forestomach of Rats Maintained on a Diet Containing Ivermectin and Given a Single Dose of N-Methyl-N1-Nitro-N-Nitrosoguanidine' by O'Conner et al, they observed additional cancers in mice with a small amount (2 ppm) of ivermectin in their diet given a dose of a carcinogen called N-Methyl-N1-Nitro-N-Nitrosoguanidine. From the abstract:

"No tumors or pathological lesions were observed in the forestomach of the control animals or those given ivermectin alone. However, compared to animals receiving MNNG alone, rats maintained on a diet containing ivermectin (2 ppm) and given MNNG… showed an increased number of neoplasms (9/26 vs 3/18; p = 0.30) and a statistically significant fourfold increase in the number of pathological lesions (18/26 vs 3/18; p = 0.002), which include preneoplasia in the forestomach. In all cases, the pathological lesions were more severe in the animals receiving ivermectin and MNNG, compared to those receiving MNNG alone."

Source: "CLASTOGENIC" - 18 Studies Highlighting Ivermectin Induced DNA Breakage and Damage

More Relevant Articles

Ivermectin, WHO, UN, Merck, The World Bank & Kissinger's World Population Plan Of Action

Pig Study Raises MAJOR Questions Of Dangers Of Combining Quercetin & Ivermectin

2 Concerning Studies: CBD & THC Enact Potent P-Glycoprotein Inhibiting Effects, Raising Very Concerning Questions About Heightened Ivermectin Toxicity For Marijuana Users

Studies Find Quercetin & Natto K2 INHIBIT P-Glycoprotein; Will This Increase Ivermectin Toxicity Susceptibility?!

Ivermectin Is Cytotoxic & Genotoxic (Damaging To Cells And DNA) & Possibly Carcinogenic (Cancer Causing)

P-glycoprotein Deficiency (Genetic Or Drug Induced) & Increased Ivermectin Toxicity

Ivermectin VS Sperm: 3 Disturbing Studies On Decreased Sperm Counts, Decreased Sperm Motility & Increased % Abnormal Sperm Post-Ivermectin

6 More Animal Ivermectin Studies Showing Negative Fertility Effects! Depopulation?!

Grapefruit's Irreversible Inactivation of Key Defense Against Toxic Effects Of Many Drugs (Ivermectin Binary Weapon)

Studies Find Quercetin & Natto K2 INHIBIT P-Glycoprotein; Will This Increase Ivermectin Toxicity Susceptibility?!

References — Ivermectin, River Blindness, and the Mectizan Program

Merck & Co., Inc. "35 Years: The Mectizan® Donation Program." May 25, 2022. Merck — Mectizan Donation Program. Useful for the 1978 Campbell proposal, 1981 human trials, Mohammed Aziz, 1987 donation decision, Roy Vagelos, and program history.

Mectizan Donation Program. "History of the Program." The Task Force for Global Health. Accessed August 6, 2026. Mectizan Donation Program — History. Primary program history covering Merck, WHO, William Campbell, Mohammed Aziz, West African trials, and the 1987 commitment to provide ivermectin for river blindness.

Mectizan Donation Program. "Overview." The Task Force for Global Health. Accessed August 6, 2026. Mectizan Donation Program — Overview. Useful for the structure of the donation program, Africa, Latin America, Yemen, lymphatic filariasis, annual treatment, and Merck's "as much as needed, for as long as needed" commitment.

Merck & Co., Inc. "Merck Commemorates 30 Years of MECTIZAN® Donation Program Progress." November 30, 2017. Merck — 30 Years of Mectizan. Documents the 1987 founding of the program and its later expansion for lymphatic filariasis, including plans to reach up to an additional 100 million people annually.

World Health Organization. "Onchocerciasis." December 4, 2025. WHO — Onchocerciasis Fact Sheet. Key source for river blindness, Onchocerca volvulus, blackfly transmission, geographic distribution, mass drug administration, and WHO's current ivermectin strategy. WHO states that ivermectin donated by Merck remains the core population-based treatment strategy.

Nobel Prize Outreach. "The 2015 Nobel Prize in Physiology or Medicine: Press Release." October 5, 2015. Nobel Prize — 2015 Medicine Prize. Official Nobel source documenting the award to William C. Campbell and Satoshi Ōmura for discoveries leading to therapies against roundworm parasites.

Nobel Prize Outreach. "The 2015 Nobel Prize in Physiology or Medicine." 2015. Nobel Prize — Avermectin and Ivermectin Discovery. Especially useful for the discovery chain: Ōmura's Streptomyces cultures → Campbell's parasite research → avermectin → modification into ivermectin → human and veterinary applications.

Ōmura, Satoshi. "A Splendid Gift from the Earth: The Origins and Impact of Avermectin." Nobel Lecture, Karolinska Institutet, Stockholm, December 7, 2015. Satoshi Ōmura — Nobel Lecture. An important first-person scientific history from Ōmura himself describing the origins and impact of avermectin.

Why Is Everyone Getting Explosive Diarrhea? The Answer Isn't What Most People Think. The Story Begins Decades Before Cyclospora—with The United States, Nazi Germany, Sanitation, And the Long History of Diseases Spread Through Human Waste.

Cyclospora has become one of the most difficult foodborne parasites investigated by public health officials. This episode examines how Cyclospora outbreaks are linked to fresh produce including lettuce, cilantro, basil, raspberries, herbs and packaged salad mixes, and why contaminated food can be so difficult to identify before people become sick. It follows the process of patient interviews, stool testing, epidemiology, product sampling and traceback investigations used to reconstruct outbreaks after contaminated produce has already moved through restaurants, stores, warehouses and international supply chains.

A major focus is Taylor Farms de Mexico and the repeated appearance of its Guanajuato operation in Cyclospora investigations. In 2013 a Cyclospora outbreak was traced to salad mix processed by Taylor Farms de Mexico. In 2026 epidemiology and traceback again pointed to Taylor Farms de Mexico lettuce from central Mexico. The episode examines Guanajuato as a major agricultural region facing water scarcity, groundwater depletion, wastewater treatment challenges and the reuse of treated wastewater. It also asks what oversight actually exists for Mexican lettuce entering the United States and whether produce is routinely tested for Cyclospora before crossing the border.

The investigation finds that every shipment of Mexican lettuce is not tested for Cyclospora. FDA oversight relies largely on importer verification, farm and facility inspections, preventive controls, targeted sampling and outbreak investigations rather than universal laboratory screening. FDA implemented a validated molecular detection method for Cyclospora on produce beginning around 2018 and expanded laboratory capability by training Mexican government laboratories in 2023. The episode examines why a laboratory test can exist while contaminated produce can still move through the food supply undetected.

The program also traces the scientific history of Cyclospora beginning with Richard W. Ashford's 1979 report from Papua New Guinea and follows the parasite through years of uncertainty before it became recognized as Cyclospora cayetanensis. It explores the work of Richard W. Ashford, Graham D. F. Reid, David C. Warhurst, Robert Gilman, Ynes Ortega, Charles Sterling and other researchers, together with the Liverpool School of Tropical Medicine, the London School of Hygiene and Tropical Medicine, the Institute of Primate Research in Kenya, the World Health Organization and international tropical disease research programs.

Beyond modern outbreaks, the episode traces the historical roots of sanitation and public health from nineteenth-century Europe and Bavaria through the rise of bacteriology, sewage engineering and wastewater management in the United States. It examines how human waste, sewage sludge and today's biosolids became incorporated into modern agriculture, how wastewater reuse developed in both the United States and Mexico, and how those practices intersect with food safety, irrigation and infectious disease prevention.

The program also explores the history of biological warfare research involving diarrheal diseases during World War II and the Cold War, including Nazi Germany, the United States and later military biodefense programs. It distinguishes documented historical research into enteric diseases from the established biology of Cyclospora itself while examining how governments and scientists have long viewed foodborne illness, sanitation and gastrointestinal disease as matters of both public health and national security.

Cyclospora remains unusually difficult to study. There is still no routine laboratory culture system, no widely accepted animal model reproducing the complete human infection and no well-established human challenge model. Researchers continue to rely on naturally infected patients, molecular testing, stool examinations, epidemiological investigations and outbreak traceback. Contamination may be scattered unevenly through a field, shipment or salad mix, meaning a negative sample does not prove that the remaining produce is free of the parasite. These limitations help explain why investigators often begin with sick people and work backward toward the food, water, farm and processing facility.

The episode ultimately places Cyclospora within the larger history of human feces, sanitation, sewage sludge, biosolids, wastewater reuse, agriculture, tropical medicine, epidemiology and foodborne disease. It examines how modern food production, international trade, environmental infrastructure and public health intersect to allow a microscopic parasite to travel from a contaminated field or water source to consumers hundreds or even thousands of miles away.

Clip: New Dr. Fauci Interview - Insights from Working with Past Presidents - YouTube

Bush: I was reminded that evil exists - YouTube

President George H. W. Bush discusses US-Iran relations during an primetime press conference

W. (2/9) Movie CLIP - You're Not a Kennedy, You're a Bush (2008) HD

Music: Bee Gees - Stayin' Alive (Official Video)

Suggested Videos:

5 Spectacular Fails From Germ Theory – Dr Sam Bailey

The Truth About Smallpox || Documentary by Katie Sugak (2022) Brighteon

If you are talking about Meghan Markle, less time to think about what is really going on. MM = 33 Meghan Markle's Family EXPOSED: New DAMNING Discovery Changes Everything

The Royal Scam

Greedy Greta

incase you werent sure.. George Bush IS Charles Manson

Timeline and History of Ruling Class

Who runs the world

the Saturn cult

Disinfection of Water by Chlorine, Peracetic Acid, Ultraviolet and Solar Radiations: A Review FCE-4079.pdf

COVID Backwards In Hebrew Is DIVOC: Possession By An Evil Spirit | Spirit | Before It's News

Mapping biosafety level 3 (BSL-3) and BSL-4 laboratories for public health threats reduction | Journal of Public Health | Springer Nature Link

IM — How the Government Created Lyme Disease

EUGENICS: 'Building 257', The Horrific Secrets of Plum Island | RIELPOLITIK

Exposing the Link Between Lyme Disease and Secret U.S. Biowarfare Experiments | SGT Report

The Lyme Disease Connection with US/Nazi Legacy Bioweapons Development on Plum Island, Connecticut - Children's Health Defense Pennsylvania Chapter

The Lyme Disease Connection with US/Nazi Legacy Bioweapons Development on Plum Island, Connecticut - Children's Health Defense Pennsylvania Chapter

"HIV Inserts", Lies & "Lab Leaks"

Smallpox: The Historical Myths behind Mandatory Vaccines | Mises Institute

Reengineering Humanity | Nature of Healing

Bactrim & Bactrim DS: Uses, Dosage, Side Effects

Bactrim side effects in elderly adults: Risks and alternatives

Cyclosporiasis - Wikipedia

Cyclospora Infection: Symptoms, Causes, Diagnosis & Treatment

Secret Gov Plot to SAVE THEMSELVES In Societal Collapse

global-biolabs-report-2023.pdf

Google's true origin partly lies in CIA and NSA research grants for mass surveillance

Annie Jacobsen - Wikipedia

DARPA - Wikipedia

The Fort Detrick HIV Lab Leak | Conspiracy Wiki

Discredited HIV/AIDS origins theories - Wikipedia

The Perth Group HIV-AIDS Debate Website

The Perth Group - Wikipedia

AIDS Report - mycorrections.PDF

HIV/AIDS in South African townships - Wikipedia

The Yin & Yang of HIV - Part One

Dr Sam Bailey – Illuminating Health

Virus Mania – Dr Sam Bailey

HIV & AIDS - Is HIV the Cause of AIDS? An interview with Eleni Papadopulos-Eleopulos

HIV & AIDS - Do antibody tests prove HIV infection? An interview with Valendar Turner

Surgical Glove Practice: The Evidence - Judith Tanner, Hazel Parkinson, 2007

Re: Did Montagnier discover HIV in 1983? | The BMJ

The HIV/ AIDS Story is Being Rewritten

The Rabies Hoax • Zero-Sum

What About Rabies? – Dr Sam Bailey

Rabies: The "Virus" of Fear – ViroLIEgy

A Layperson's Guide to the PCR Based Epidemic Hoax — Dr Sam Bailey

Adam Weishaupt - Wikipedia

American History of the Rothschilds and the Eight Most Powerful Families – The Millennium Report

The History of the 'House of Rothschild' (Complete) - EliteInfo.co

A Bavarian Illuminati Primer

Do you have a psychopath in your life? The best way to find out is read my book. BOOK *FREE* Download – Psychopath In Your Life4

How they flip sex with hormones: Hormones

Support is Appreciated: Support the Show – Psychopath In Your Life

Tune in: Podcast Links – Psychopath In Your Life

Download Pods here - one click and pods load to any device fully titled and ready to listen to or archive: TOP PODS – Psychopath In Your Life

My old discussion forum with last 10 years of victim stories, is back online. Psychopath Victim Support Community | Forums powered by UBB.threads™

Google Maps My HOME Address: 309 E. Klug Avenue, Norfolk, NE 68701 SMART Meters & Timelines – Psychopath In Your Life

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:0987378b-1463-4125-83cb-9f0b442bac7d-14" data-turn-id-container= "request-WEB:0987378b-1463-4125-83cb-9f0b442bac7d-14" data-testid= "conversation-turn-30" data-turn="assistant"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:9f6e5a3f-1d65-493a-b8a5-16cd0b59eecb-0" data-turn-id-container= "request-WEB:9f6e5a3f-1d65-493a-b8a5-16cd0b59eecb-0" data-testid= "conversation-turn-2" data-turn="assistant"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:fe231e7b-f316-473d-9399-fdb11860f116-20" data-turn-id-container= "request-WEB:fe231e7b-f316-473d-9399-fdb11860f116-20" data-testid= "conversation-turn-42" data-turn="assistant"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:8bb8696b-07bb-4839-b1aa-c71073f71c03-0" data-turn-id-container= "request-WEB:8bb8696b-07bb-4839-b1aa-c71073f71c03-0" data-testid= "conversation-turn-2" data-turn="assistant"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:8bb8696b-07bb-4839-b1aa-c71073f71c03-2" data-turn-id-container= "request-WEB:8bb8696b-07bb-4839-b1aa-c71073f71c03-2" data-testid= "conversation-turn-6" data-turn="assistant"> Papua New Guinea Cyclospora Timeline

September 16, 1975 Papua New Guinea gains independence from Australia.

April 29, 1976 Papua New Guinea becomes a member of the World Health Organization (WHO).

August 1976 The WHO Representative Office opens in Port Moresby, only months after independence. The first WHO Country Liaison Officer, appointed in 1974, becomes the first WHO Representative.

1977 The first known human cases of what would later be identified as Cyclospora occur in Papua New Guinea.

Patients with prolonged diarrhea are examined, but the organism is unknown.

1978 Additional cases are identified.

Researchers continue observing the unusual organism in stool samples.

1979 Dr. R. W. Ashford publishes the landmark paper:

"Occurrence of an undescribed coccidian in man in Papua New Guinea."

Ashford describes three patients and concludes the organism is an undescribed coccidian parasite, although he cannot yet identify it precisely. This becomes the first published description of what would later be known as Cyclospora cayetanensis.

1980s Similar organisms begin appearing in patients around the world.

Different laboratories describe them as:

• cyanobacterium-like bodies (CLBs)
• blue-green algae
• coccidian-like bodies
• large Cryptosporidium

Because the organism is poorly understood, no one realizes these reports are describing the same parasite.

1993 David C. Warhurst and G. D. F. Reid, working with R. W. Ashford, publish work arguing that the mysterious "cyanobacterium-like bodies" reported worldwide are actually the same organism Ashford first described in Papua New Guinea in 1979.

Their work helps connect years of scattered reports into a single scientific story.

1993 Ynes Ortega, Charles R. Sterling, Robert H. Gilman, and colleagues formally identify and name the parasite:

Cyclospora cayetanensis.

Approximately sixteen years after the first recognized human cases in Papua New Guinea, the organism finally receives its official scientific name.

Key Historical Observation

The WHO Representative Office was already operating in Port Moresby before Cyclospora was first recognized in humans. The office opened in August 1976, the first known cases appeared in 1977, additional cases followed in 1978, and Ashford published the first scientific description in 1979.

The principal researchers associated with the early discovery were:

• Dr. R. W. Ashford – First to recognize and publish the new parasite (1979).
• Dr. David C. Warhurst – Helped establish that the mysterious organisms being reported internationally were the same parasite first described by Ashford.
• Dr. G. D. F. Reid – Collaborated with Ashford and Warhurst in linking the worldwide reports.
• Dr. Ynes Ortega, Dr. Charles R. Sterling, and Dr. Robert H. Gilman – Members of the research group that formally identified and named Cyclospora cayetanensis in 1993.

This sequence shows that the discovery of Cyclospora was not a single event but a process that unfolded over roughly 16 years, beginning in Papua New Guinea and ending with international recognition of a new human parasite.

Explosive Diarrhea Research, Biological Warfare, Nazi Germany, the United States, and Cyclospora

One of the most important lessons from military medicine is that severe diarrheal disease has historically disabled more soldiers than many weapons. Long before antibiotics, armies feared outbreaks of dysentery, cholera, typhoid, and other gastrointestinal diseases because they could incapacitate entire units.

That historical reality explains why military organizations became interested in enteric diseases—not because "explosive diarrhea" itself was viewed as a unique weapon, but because pathogens causing severe gastrointestinal illness could remove soldiers from combat.

The Military Problem

Military planners have long recognized that diarrheal diseases can:

• Incapacitate large numbers of troops
• Require significant medical resources
• Reduce combat readiness
• Spread rapidly in crowded military environments

Modern U.S. military medical literature continues to describe diarrheal disease as one of the most common causes of lost operational effectiveness during deployments.

Nazi Germany

Nazi Germany conducted biological warfare research during World War II.

Research included:

• • insect vectors
• • infectious diseases
• • military applications of biological agents

Documents released decades later show that the SS established an Entomological Institute at Dachau in 1942 under Heinrich Himmler. Historians examining surviving research protocols concluded the institute had an offensive biological warfare component.

The German program was much smaller than Japan's infamous Unit 731, but it demonstrates that Nazi leadership investigated biological warfare.

Did Nazi Germany Develop a Weapon Specifically for Explosive Diarrhea?

There is no documented evidence that Nazi Germany produced a dedicated biological weapon whose sole purpose was to cause explosive diarrhea.

However, they did study organisms capable of causing severe gastrointestinal disease as part of broader biological warfare research.

Military interest centered on whether disease could disable enemy forces.

The United States

The United States launched its offensive biological warfare program during World War II.

Major centers included:

• Camp Detrick (later Fort Detrick)

• Dugway Proving Ground

• Pine Bluff Arsenal

The program expanded greatly after the war.

Government histories show U.S. researchers investigated numerous human, animal, and plant pathogens as potential biological warfare agents before President Richard Nixon ended the offensive program in 1969 and ordered destruction of offensive stockpiles.

Did the United States Study Diarrheal Diseases?

Yes.

But it is important to distinguish two different kinds of research.

Offensive biological warfare

Researchers evaluated many disease agents for military usefulness.

Some gastrointestinal pathogens were examined because they could disable troops.

Defensive medicine

The much larger body of work focused on protecting U.S. troops from naturally occurring diarrheal disease.

This includes decades of research on:

• Shigella
• Salmonella
• enterotoxigenic E. coli (ETEC)
• cholera
• norovirus
• Campylobacter

The goal was preventing outbreaks among deployed military personnel.

Why Diarrhea Matters Militarily

A soldier suffering:

• severe abdominal cramps
• dehydration
• vomiting
• repeated explosive diarrhea

is often unable to fight.

Historically this has been considered an effective way for disease—not necessarily a weapon—to reduce combat capability.

Military medicine has repeatedly documented that diarrheal illness can sideline large numbers of personnel during deployments.

Cyclospora

Cyclospora is very different.

The parasite was first scientifically described in Papua New Guinea in 1979 by Dr. R. W. Ashford after cases observed beginning in the late 1970s.

Unlike many bacterial diarrheal diseases:

• it requires days to weeks outside the human body before becoming infectious
• it is not spread directly person-to-person under ordinary conditions
• humans are the only confirmed major reservoir

These characteristics make Cyclospora an unlikely biological warfare agent compared with organisms that spread rapidly between people.

Why Cyclospora Is Difficult

Cyclospora presents a public health challenge because:

• infections often begin in fields before harvest
• contamination levels on produce can be extremely low
• detecting the parasite on food is technically difficult
• traceback investigations usually rely on epidemiology and supply-chain evidence rather than finding the organism on a food sample

These characteristics complicate outbreak investigations but do not indicate intentional contamination.

What Is Supported by the Historical Record?

Supported by documentary evidence:

✔ Nazi Germany conducted biological warfare research.

✔ The United States conducted an extensive offensive biological warfare program from World War II until 1969.

✔ Both countries studied infectious diseases with military relevance.

✔ Gastrointestinal diseases have long been recognized as capable of incapacitating armies.

✔ Modern military medicine continues extensive research on diarrheal diseases because they remain a major operational problem.

Development of modern virology laboratories and high-containment (BSL) facilities.

Year Event 1796 Edward Jenner develops the smallpox vaccine, decades before viruses are understood. 1885 Louis Pasteur develops the rabies vaccine, using infected animal nervous tissue. 1892 Dmitri Ivanovsky discovers an infectious agent smaller than bacteria. 1898 Martinus Beijerinck coins the concept of a "virus." 1900–1930s First dedicated virus research laboratories appear in Europe and the United States. 1931 Electron microscope invented, allowing viruses to be visualized. 1933 Human influenza virus isolated in England. 1940s World War II greatly expands government infectious disease research. 1946 The U.S. Army establishes the biological research center at Fort Detrick, Maryland. 1949 The World Health Organization (WHO) is established and begins coordinating international infectious disease work. 1950s Cell culture techniques allow viruses to be grown routinely in laboratories. 1950s–1960s Cold War drives rapid expansion of virology laboratories in the U.S., USSR, U.K., France, and elsewhere. 1967 Marburg virus outbreak among laboratory workers handling imported monkeys highlights laboratory hazards. Late 1960s Modern biological containment laboratory concepts begin to emerge. 1970 CDC opens one of the first maximum-containment laboratories in the United States (precursor to today's BSL-4 facilities). 1974 NIH issues recombinant DNA biosafety guidelines, shaping laboratory safety practices. Mid-1970s Biosafety Levels (BSL-1 through BSL-4) become standardized. 1977 H1N1 influenza reappears; many scientists later argue a laboratory-associated origin is plausible. 1978 Birmingham smallpox laboratory accident kills Janet Parker, increasing attention to laboratory safety. 1979 Sverdlovsk anthrax accident at a Soviet military facility. 1980 Smallpox declared eradicated; only a few authorized laboratories retain live virus stocks. 1983 HIV identified, leading to a major expansion of virology research worldwide. 1990s PCR and genetic sequencing transform virus detection and laboratory research. 2002–2003 SARS outbreak. Governments invest heavily in coronavirus research and new BSL-3 laboratories. 2003–2004 Several documented laboratory-acquired SARS infections occur after the outbreak. 2004 China approves construction and expansion of higher-containment laboratories. 2015 Wuhan Institute of Virology publishes research on bat SARS-like coronaviruses and becomes a leading coronavirus research center. 2018 U.S. diplomatic cables express concerns about safety and staffing at the Wuhan Institute of Virology. 2019 COVID-19 first detected in Wuhan, China. 2020–present Global debate over COVID-19 origins leads to increased scrutiny of biosafety, laboratory oversight, and gain-of-function research. 2020s Many countries continue expanding BSL-3 and BSL-4 laboratory capacity for pandemic preparedness. Major milestones in laboratory containment

• BSL-1 – Basic laboratories for low-risk organisms.
• BSL-2 – Clinical and diagnostic laboratories handling moderate-risk pathogens.
• BSL-3 – Designed for airborne pathogens such as tuberculosis and SARS-related viruses.
• BSL-4 – Maximum containment for the highest-risk pathogens, such as Ebola and Marburg viruses.

One thing stands out in the timeline: before the 1940s there were very few dedicated virology laboratories.

The major expansion occurred after World War II, accelerated during the Cold War, expanded again after HIV, and grew rapidly after the 2003 SARS outbreak and again following COVID-19. That progression helps explain why most discussions about laboratory biosafety and possible laboratory-associated outbreaks are concentrated in the last 50 years.

Countries with BSL-4 laboratories today

• Argentina
• Australia
• Belarus
• Brazil
• Canada
• China
• Czech Republic
• Côte d'Ivoire
• France
• Gabon
• Germany
• Hungary
• India
• Italy
• Japan
• Kazakhstan
• Netherlands
• Philippines
• Russia
• Saudi Arabia
• Singapore
• South Africa
• South Korea
• Spain
• Sweden
• Switzerland
• Taiwan
• United Kingdom
• United States

...plus several others with one facility or facilities under construction, for a total of 34 countries.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:fe231e7b-f316-473d-9399-fdb11860f116-34" data-turn-id-container= "request-WEB:fe231e7b-f316-473d-9399-fdb11860f116-34" data-testid= "conversation-turn-70" data-turn="assistant"> Timeline of Modern High-Containment Virology Laboratories Year Event Why It Matters 1946 Fort Detrick (Maryland, USA) becomes the U.S. Army's biological research center. First major modern U.S. biodefense laboratory. 1950s Virology laboratories expand in the U.S., U.K., USSR, and Europe. Growth driven by polio, influenza, and Cold War research. 1960s CDC builds its first biocontainment laboratories in Atlanta. Beginning of modern containment laboratories. 1967 First BSL-4 laboratory established at CDC (Atlanta, USA). First recognized maximum-containment (BSL-4) laboratory. 1970s Biosafety Levels (BSL-1 through BSL-4) become standardized. Common international laboratory safety framework develops. 1974 VECTOR laboratory established in Koltsovo (USSR). Soviet Union's principal high-containment virology center. 1975 USAMRIID maximum-containment laboratories operational at Fort Detrick. U.S. military BSL-4 capability expands. 1978 Birmingham smallpox laboratory accident (England). Laboratory safety becomes an international concern. 1980s Only a handful of BSL-4 laboratories exist worldwide. High-containment labs remain rare. 1990–2000 New BSL-4 laboratories open in Canada, Australia, France, Germany and the United States. Expansion beyond military and national government laboratories. 2001 September 11 and anthrax attacks. Massive increase in biodefense funding begins. 2003 SARS outbreak. Countries accelerate construction of BSL-3 and BSL-4 laboratories. 2008 U.S. GAO reports rapid expansion of BSL-4 laboratories. Notes that for most of the previous 50 years, the U.S. had only two federal BSL-4 sites (CDC and USAMRIID). 2015 Wuhan National Biosafety Laboratory opens. China's first operational BSL-4 laboratory. 2020 COVID-19 pandemic. Largest worldwide focus on biosafety, biosecurity, and laboratory oversight. 2025 Survey identifies approximately 110 BSL-4 laboratories in 34 countries and about 3,515 BSL-3 laboratories in 149 countries. Largest published global inventory to date. The pattern at a glance

1946–1967

• Birth of modern high-containment laboratory research.
• Almost entirely United States.

1967–1985

• Only a few BSL-4 laboratories existed.
• Primarily:
  • United States
  • Soviet Union

1985–2000

• Slow expansion to:
  • Canada
  • Australia
  • France
  • Germany

2001–2003

• Two major events changed the trajectory:
  • 9/11 and the anthrax attacks
  • SARS

These events led to a sharp increase in investment in high-containment laboratories.

2015–Present

• China joins the small group operating BSL-4 laboratories.
• After COVID-19, additional countries began building or expanding BSL-4 facilities.

For roughly the first 35 years of the BSL-4 era (1967–2001), only a small number of countries operated these maximum-containment laboratories. The largest worldwide expansion occurred after the 2001 anthrax attacks, after SARS in 2003, and again following COVID-19.

The following countries are documented to have used treated sewage sludge (biosolids) on agricultural land or for land reclamation.

Europe

• Austria
• Belgium
• Czech Republic
• Denmark
• Finland
• France
• Germany (now moving toward phosphorus recovery and reducing farmland use)
• Hungary
• Ireland
• Italy
• Luxembourg
• Norway
• Poland
• Portugal
• Spain
• Sweden
• Switzerland (historically used it, banned agricultural use in 2006)
• Netherlands (historically used it, now essentially does not apply it to farmland, relying mainly on incineration)
• United Kingdom (England, Wales, Scotland, Northern Ireland)

North America

• Canada
• Mexico

South America

• Brazil
• Chile
• Argentina

Oceania

• Australia
• New Zealand

Asia

• China
• Japan
• South Korea
• Turkey

Africa

• South Africa
• Egypt

Countries that have banned or largely ended agricultural use

• Switzerland – banned agricultural application in 2006.
• Netherlands – no longer routinely spreads sewage sludge on farmland; most is incinerated or otherwise processed.
• Germany – has not banned it outright but is moving away from farmland application through regulations emphasizing phosphorus recovery.

So, besides the United States, at least 30–35 countries have used biosolids in some form. The practice is especially widespread in Europe, Canada, Australia, New Zealand, and parts of Asia, although several countries have recently tightened restrictions or shifted away from agricultural land application because of concerns about contaminants such as PFAS and other persistent chemicals.

The modern concept of treated municipal sewage sludge being intentionally processed and marketed for land application, the United States was one of the pioneers.

Late 1800s–early 1900s American and European cities rapidly built sewer systems and wastewater treatment plants. As treatment improved, they generated increasing amounts of sewage sludge.

American cities introduced technologies such as:

• Trickling filters
• Primary sedimentation
• Activated-sludge treatment (developed in Britain in 1914 but widely adopted in the U.S.)
• Chlorination
• Anaerobic digestion

These processes greatly increased the volume of treated sludge that cities had to manage.

1900s–1960s Cities experimented with several disposal methods:

• Dumping into rivers or the ocean
• Landfilling
• Incineration
• Drying
• Agricultural use

At this stage it was generally called sewage sludge, not biosolids.

1970s Environmental laws changed the conversation.

The U.S. banned most ocean dumping of sewage sludge and placed greater restrictions on disposal. Utilities increasingly looked to agriculture as a long-term management strategy.

1980s The wastewater industry began promoting treated sludge as a reusable product rather than simply a waste.

The term "biosolids" was developed during this period.

In 1991, the Water Environment Federation sponsored a branding effort that selected the word biosolids to distinguish treated sewage sludge meeting certain treatment standards from untreated sewage sludge.

1993 The EPA issued the federal 40 CFR Part 503 Rule, establishing national standards for land application, pathogen reduction, and metal limits.

From that point forward, "biosolids" became the standard regulatory and industry term in the United States.

So your statement is essentially correct, but I'd tighten it slightly:

American cities introduced trickling filters, sedimentation, activated-sludge treatment, chlorination, and anaerobic digestion. As wastewater treatment expanded during the early 20th century, increasing amounts of sewage sludge were produced. Cities experimented with dumping, burial, incineration, digestion, drying, and agricultural use. This evolving system became the foundation for what the United States would later rename biosolids in the early 1990s.

One important distinction is that the material existed long before the name did. The treatment processes and land application practices developed over decades, while "biosolids" is essentially a 1990s regulatory and public-relations term for treated sewage sludge that meets specified standards.

Chemical Is it dangerous? Main side effects (concentrated exposure) Chlorine (sodium hypochlorite) Yes. Corrosive and irritating. Burning eyes, skin irritation or burns, coughing, wheezing, chest tightness, shortness of breath. Mixing with acids or ammonia can release toxic chlorine gas, which can cause severe lung injury. Peracetic acid (PAA) Yes. Corrosive and a strong oxidizer. Severe eye irritation or burns, skin burns, nose and throat irritation, coughing, headaches, asthma-like symptoms, difficulty breathing with repeated workplace exposure. Chlorine dioxide Yes. Strong respiratory irritant. Eye irritation, coughing, sore throat, breathing difficulty, lung irritation; high exposures can damage the respiratory tract. Hydrogen peroxide (food-processing concentrations) Yes. Concentrated solutions are corrosive. Skin whitening and burns, eye damage, throat irritation, coughing, stomach irritation if swallowed in concentrated form. Ozone Yes. Toxic to breathe. Coughing, chest pain, throat irritation, reduced lung function, worsened asthma, shortness of breath. Ozone quickly breaks down and is not intended to remain on food. Acidified sodium chlorite Yes. Corrosive when concentrated. Eye and skin burns, respiratory irritation, nausea if ingested in significant amounts, throat irritation. Bottom line

• Are they dangerous? Yes, especially for workers handling concentrated chemicals.
• Can they cause side effects? Yes, primarily involving the eyes, skin, and lungs from direct exposure.
• Do consumers typically receive those exposures? Under normal commercial use, these sanitizers are diluted, monitored, and intended to leave only very small residues on produce. Food safety agencies consider those residual exposures acceptable when the products are used according to regulations.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:259887ee-4b19-4798-96d7-1986ddba1643-5" data-turn-id-container= "request-WEB:259887ee-4b19-4798-96d7-1986ddba1643-5" data-testid= "conversation-turn-12" data-turn="assistant">

GRAS means "Generally Recognized As Safe." It is an FDA regulatory designation for a substance used under its intended conditions—not a sanitizer itself.

Besides chlorine and peracetic acid, produce processors may also use:

• Hydrogen peroxide (GRAS for certain food-processing uses)
• Ozone
• Chlorine dioxide
• Organic acids such as citric acid, lactic acid, and acetic acid (vinegar), which are GRAS substances and may be used in produce washing.

Some commercial produce-wash formulations are made entirely from GRAS ingredients. For example, USDA researchers developed one antimicrobial wash whose ingredients are all classified as GRAS by the FDA.

One important point for your Cyclospora research:

Even when a sanitizer or wash uses only GRAS ingredients, that does not mean it can reliably eliminate Cyclospora from contaminated lettuce or other produce. FDA guidance emphasizes that these antimicrobial washes are mainly intended to keep the wash water from spreading contamination and may reduce surface microbes, but preventing contamination before harvest is the primary control strategy.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:a9ba3c92-6de2-4f5f-84a7-f90c08be1286-2" data-turn-id-container= "request-WEB:a9ba3c92-6de2-4f5f-84a7-f90c08be1286-2" data-testid= "conversation-turn-6" data-turn="assistant"> Date Event 2025 Taylor Farms donated $1 million to MAGA Inc., the principal pro-Trump super PAC. Reports also state the company gave more than $2 million to conservative political committees during 2025. July 16, 2026 FDA publicly announced it was investigating a multistate Cyclospora outbreak linked to shredded iceberg lettuce served at Taco Bell. At that time, 1,644 illnesses had been identified. Interviews in Michigan found 90% of affected Taco Bell customers had eaten iceberg lettuce. FDA also stated its traceback investigation had identified a single supplier of iceberg lettuce from Mexico used by the restaurants where illnesses occurred, although the supplier was not yet publicly named. July 16, 2026 (same day) Taylor Farms executives met with White House and FDA officials to challenge the agencies' handling of the outbreak investigation. July 17, 2026 FDA publicly identified the supplier as Taylor Farms de Mexico. The company announced it was voluntarily removing shredded iceberg lettuce from central Mexico from the market and initiated a recall. July 18, 2026 FDA announced that one lettuce sample associated with the investigation had tested positive for Cyclospora. July 19, 2026 FDA determined that the July 18 laboratory result was a false positive. However, the agency stated this did not change the investigation, explaining that the epidemiologic evidence and traceback investigation continued to identify Taylor Farms de Mexico's shredded iceberg lettuce from central Mexico as the likely source of the outbreak.

One detail that attracted attention during the 2026 Cyclospora outbreak involved the timing of political donations, government meetings, and FDA announcements.

In 2025, Taylor Farms donated $1 million to MAGA Inc., the principal pro-Trump super PAC. Reports also stated that the company contributed more than $2 million to conservative political committees during the year.

Then, on July 16, 2026, the FDA publicly announced it was investigating a multistate Cyclospora outbreak linked to shredded iceberg lettuce served at Taco Bell. By that point, 1,644 illnesses had been identified. Investigators found that 90 percent of interviewed patients in Michigan had eaten iceberg lettuce, and the FDA said its traceback investigation had already narrowed the source to a single supplier of iceberg lettuce from Mexico, although the supplier's name had not yet been released.

Later that same day, Taylor Farms executives met with White House and FDA officials to challenge the agencies' handling of the outbreak investigation.

On July 17, the FDA publicly identified the supplier as Taylor Farms de Mexico. The company announced it was voluntarily removing shredded iceberg lettuce from central Mexico from the market and initiated a recall.

On July 18, the FDA announced that one lettuce sample associated with the investigation had tested positive for Cyclospora.

Then, on July 19, the FDA said that laboratory result was actually a false positive. However, the agency also emphasized that this did not change its overall conclusions. According to the FDA, the epidemiologic evidence and traceback investigation still pointed to Taylor Farms de Mexico's shredded iceberg lettuce from central Mexico as the likely source of the outbreak.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:0987378b-1463-4125-83cb-9f0b442bac7d-14" data-turn-id-container= "request-WEB:0987378b-1463-4125-83cb-9f0b442bac7d-14" data-testid= "conversation-turn-30" data-turn="assistant"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:d5e026de-b75b-4f71-bff3-1697eeaac7d8-23" data-turn-id-container= "request-WEB:d5e026de-b75b-4f71-bff3-1697eeaac7d8-23" data-testid= "conversation-turn-48" data-turn="assistant"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:c4b531f5-4029-4985-b328-2cbc7abbe7c6-6" data-turn-id-container= "request-WEB:c4b531f5-4029-4985-b328-2cbc7abbe7c6-6" data-testid= "conversation-turn-14" data-turn="assistant"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-6a612aea-6cc4-83e8-97b1-4af30d81c70f-5" data-turn-id-container= "request-6a612aea-6cc4-83e8-97b1-4af30d81c70f-5" data-testid= "conversation-turn-14" data-turn="assistant"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-6a612aea-6cc4-83e8-97b1-4af30d81c70f-12" data-turn-id-container= "request-6a612aea-6cc4-83e8-97b1-4af30d81c70f-12" data-testid= "conversation-turn-28" data-turn="assistant"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:078b652b-c1fa-4aba-a6e0-f2eed067a03f-6" data-turn-id-container= "request-WEB:078b652b-c1fa-4aba-a6e0-f2eed067a03f-6" data-testid= "conversation-turn-14" data-turn="assistant"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:afa76eed-6c76-4ccc-812b-90d24bad72b3-21" data-turn-id-container= "request-WEB:afa76eed-6c76-4ccc-812b-90d24bad72b3-21" data-testid= "conversation-turn-44" data-turn="assistant"> Year Event 1743 Mayer Amschel Bauer (later Rothschild) is born on February 23 in the Free Imperial City of Frankfurt am Main, in the Holy Roman Empire. He was not born in Bavaria. His family lived in Frankfurt's Jewish quarter (Judengasse). 1740s Mayer's father, Amschel Moses, was a money changer and merchant. The family home was identified by a red shield ("Zum Roten Schild"), from which the family later derived the surname Rothschild ("red shield"). 1748 Adam Weishaupt is born on February 6 in Ingolstadt, Bavaria. 1750s Weishaupt is educated by the Jesuits after the death of his father. 1760s Mayer Amschel begins working in banking and coin dealing in Frankfurt. The family increasingly adopts the surname Rothschild, replacing Bauer. 1765 Adam Weishaupt earns his doctorate in law at the University of Ingolstadt. 1773 Weishaupt becomes Professor of Canon Law at the University of Ingolstadt, Bavaria. May 1, 1776 Weishaupt founds the Order of the Illuminati in Ingolstadt, Bavaria. 1785 The Bavarian government bans the Illuminati, and Weishaupt flees Bavaria. 1796 Edward Jenner introduces the first successful smallpox vaccine in England. 1800 Thomas Jefferson writes to James Madison, arguing that Weishaupt's use of secrecy reflected the political and religious conditions in Bavaria rather than necessarily his underlying philosophy. 1801 Dr. Benjamin Waterhouse introduces Jenner's smallpox vaccine to the United States. President Thomas Jefferson later strongly supports vaccination and exchanges correspondence with Jenner. 1807 The Kingdom of Bavaria becomes one of the first governments in the world to enact compulsory smallpox vaccination for children. 1813 The U.S. Congress passes the Vaccine Act of 1813, the nation's first federal vaccine law. It was intended to ensure the availability of genuine smallpox vaccine and authorized a federal agent to distribute it. 1822 The Vaccine Act is repealed after problems with contaminated vaccine supplied by the federal vaccine agent. 1827 Boston becomes one of the first U.S. cities to require smallpox vaccination for public school students. 1855 Massachusetts enacts the first statewide law requiring smallpox vaccination for children attending public schools. 1905 The U.S. Supreme Court, in Jacobson v. Massachusetts, rules that states have the constitutional authority to require smallpox vaccination under their police powers. 1922 The U.S. Supreme Court, in Zucht v. King, upholds school vaccination requirements, allowing schools to exclude unvaccinated children even without an active outbreak.

United Kingdom Year Event 1796 Edward Jenner develops the first successful smallpox vaccine in Gloucestershire, England. 1798 Jenner publishes An Inquiry into the Causes and Effects of the Variolae Vaccinae, describing vaccination against smallpox. 1808 The British government establishes the National Vaccine Establishment to promote free vaccination. Vaccination is encouraged but not compulsory. 1840 The Vaccination Act 1840 provides free smallpox vaccination and prohibits the older practice of variolation (deliberate inoculation with smallpox). 1853 The Vaccination Act 1853 makes smallpox vaccination compulsory for infants within the first few months of life in England and Wales. Parents who refused could be fined. 1867 The Vaccination Act 1867 strengthens enforcement, increases penalties, and extends compulsory vaccination requirements. 1871 Parliament further strengthens enforcement by appointing vaccination officers and tightening compliance. 1898 The Vaccination Act 1898 introduces a "conscientious objector" exemption for parents who sincerely opposed vaccination. 1907 The exemption process is simplified, making it easier for parents to obtain conscientious objector certificates. Comparing the Three Country First Compulsory Vaccination Bavaria 1807 – One of the world's first compulsory childhood smallpox vaccination laws. United Kingdom 1853 – Parliament makes infant smallpox vaccination compulsory in England and Wales. United States 1855 – Massachusetts enacts the first statewide compulsory school vaccination law; no national compulsory vaccination law was ever enacted.

One interesting historical point is that Bavaria required compulsory vaccination nearly half a century before Britain and almost 50 years before Massachusetts adopted its statewide school vaccination law. Bavaria is therefore frequently cited in histories of public health as an early pioneer in compulsory vaccination policy.

mid-to-late 1800s, many public health leaders increasingly concluded that preventing disease required more than vaccination.

The progression was roughly:

• "Smallpox is devastating—we have a vaccine." (late 1700s–early 1800s)
• "Cholera seems connected to contaminated water." (John Snow, 1854)
• "Microorganisms cause many diseases." (Pasteur, 1860s)
• "Specific microbes cause specific diseases." (Koch, 1870s–1880s)

That led to a major shift in public health priorities. Cities began investing in:

• Clean drinking water.
• Sewage systems.
• Safe disposal of human waste.
• Milk pasteurization.
• Food inspection.
• Handwashing and hospital sanitation.

In many ways, the late 1800s marked the birth of modern environmental public health.

For diseases like cholera and typhoid fever, improving water and sanitation had an enormous impact because those diseases spread through contaminated water or food.

For smallpox, however, the situation was different. Smallpox spreads primarily through close person-to-person contact and respiratory droplets, not contaminated drinking water. So cleaning up water would not have eliminated smallpox, although it greatly reduced many other infectious diseases.

So a concise historical summary would be:

After germ theory, governments increasingly realized that preventing infectious disease required not only vaccines where available, but also clean water, sewage treatment, sanitation, food safety, and hygiene.

Those investments dramatically reduced deaths from many infectious diseases, even before antibiotics became available.

• 1796 — Jenner develops the smallpox vaccine.
• 1807 — Bavaria requires childhood smallpox vaccination.
• 1813 — The U.S. passes its first federal Vaccine Act.
• 1853 — Britain makes infant vaccination compulsory.
• 1854 — John Snow links cholera to a contaminated water pump in London.
• 1855 — Massachusetts adopts its first statewide compulsory school vaccination law.
• 1860s–1880s — Pasteur and Koch establish germ theory.
• Late 1800s — Cities begin investing heavily in clean water, sewer systems, food safety, and sanitation based on the new scientific understanding.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-6a6765f8-acc4-83e8-a110-e9edb4773c6c-10" data-turn-id-container= "request-6a6765f8-acc4-83e8-a110-e9edb4773c6c-10" data-testid= "conversation-turn-36" data-turn="assistant">

The House of Wittelsbach was one of Europe's great dynasties, and like the Habsburgs, they built influence through marriages with other royal houses. Their family tree branches across much of Europe.

Some of the major marriage and inheritance connections include:

Holy Roman Empire

• The Wittelsbachs produced two Holy Roman Emperors:
  • Louis IV, Holy Roman Emperor
  • Charles VII, Holy Roman Emperor

House of Habsburg

• Although Bavaria and Austria were often rivals, there were numerous marriages between the Wittelsbachs and the Habsburgs.
• These marriages were used to strengthen alliances and settle disputes over territory.

House of Bourbon

• The Wittelsbachs also intermarried with the French Bourbons and Bourbon branches in Spain and Naples.

House of Hanover

• Marriages linked the Wittelsbachs with the British royal family through the Hanoverians.

House of Savoy

• Connections were made through marriages with the rulers of Piedmont and later Italy.

House of Hohenzollern

• There were multiple marriages with the ruling family of Prussia and later the German Empire.

House of Romanov

• Several Wittelsbach princesses married into the Russian imperial family.

Scandinavian Monarchies

• Marriage alliances connected the Wittelsbachs with the royal houses of Sweden and Denmark.

Greece

One of the most notable examples:

• Otto of Greece, a Wittelsbach prince from Bavaria, became the first King of modern Greece in 1832.

Bavaria

The main Wittelsbach line ruled:

• Duchy of Bavaria
• Electorate of Bavaria
• Kingdom of Bavaria (1806–1918)

During Weishaupt's Lifetime

• 1748 – Adam Weishaupt is born.
• 1745–1777 – Bavaria is ruled by Maximilian III Joseph (House of Wittelsbach).
• 1777–1799 – Charles Theodore (also House of Wittelsbach, Palatinate branch).
• 1806 – Bavaria becomes a kingdom under Maximilian I Joseph, also a Wittelsbach.

The Big Picture

By the nineteenth century, Europe's royal families had become so interconnected through marriage that many rulers were cousins. The major dynasties included:

• House of Wittelsbach (Bavaria)
• House of Habsburg (Austria)
• House of Hohenzollern (Prussia/Germany)
• House of Bourbon (France and Spain)
• House of Hanover (Britain)
• House of Romanov (Russia)
• House of Savoy (Italy)

These dynasties frequently intermarried to secure alliances, inherit territories, and strengthen political legitimacy. While the Habsburgs are often associated with the phrase "Let others wage war; you, happy Austria, marry," the Wittelsbachs also participated extensively in this network of dynastic marriages, though they generally did not achieve the same level of continental dominance as the Habsburgs.

Year Dynasty What Happened 1917 House of Romanov The Russian Revolution ends more than 300 years of Romanov rule. Tsar Nicholas II abdicates in March 1917. The imperial family is executed in 1918. 1918 House of Habsburg Austria-Hungary collapses after World War I. Emperor Charles I relinquishes participation in government in November 1918, ending Habsburg rule. 1918 House of Wittelsbach The German Revolution reaches Bavaria. King Ludwig III is deposed, ending more than 700 years of Wittelsbach rule in Bavaria (1180–1918). 1918 House of Hohenzollern Kaiser Wilhelm II abdicates, ending the German Empire and Hohenzollern monarchy in Prussia and Germany.

• Romanovs (Russia)
• Habsburgs (Austria-Hungary)
• Hohenzollerns (Germany/Prussia)
• Wittelsbachs (Bavaria)

Can These Disease-Causing Organisms Be Grown in the Laboratory? Disease Organism Type Can it be grown or maintained in the laboratory? COVID-19 Virus Yes (cell culture) Influenza Virus Yes HIV/AIDS Virus Yes Smallpox* Virus Yes (only in two officially authorized high-security laboratories) Polio Virus Yes Measles Virus Yes Mumps Virus Yes Rubella Virus Yes Chickenpox Virus Yes Rabies Virus Yes Hepatitis A Virus Yes Hepatitis B Virus Yes Hepatitis C Virus Yes Norovirus Virus Limited (much more difficult than most viruses) Rotavirus Virus Yes Ebola Virus Yes (high-security laboratory) Marburg Virus Yes (high-security laboratory) Mpox Virus Yes Yellow Fever Virus Yes Dengue Virus Yes Zika Virus Yes West Nile Virus Yes Chikungunya Virus Yes RSV Virus Yes Cholera Bacterium Yes Typhoid Fever Bacterium Yes Tuberculosis Bacterium Yes (slow-growing) Plague Bacterium Yes Diphtheria Bacterium Yes Pertussis (Whooping Cough) Bacterium Yes Tetanus Bacterium Yes Lyme Disease Bacterium Yes (specialized methods) Syphilis Bacterium Limited (cannot be routinely cultured like most bacteria) Gonorrhea Bacterium Yes Shigellosis Bacterium Yes Salmonellosis Bacterium Yes Pathogenic E. coli Bacterium Yes Cyclospora Parasite (Protozoan) No routine laboratory culture system Malaria Parasite (Protozoan) Yes Giardia Parasite (Protozoan) Yes Cryptosporidium Parasite (Protozoan) Limited (research methods exist, but routine culture remains difficult) Toxoplasmosis Parasite (Protozoan) Yes Amebiasis Parasite (Protozoan) Yes Ascariasis (Roundworm) Parasitic Worm Limited Hookworm Parasitic Worm Yes (specialized systems) Whipworm Parasitic Worm Yes (specialized systems) Tapeworm Infections Parasitic Worm Limited (often requires animal hosts) Schistosomiasis Parasitic Worm Yes (complex life cycle) Histoplasmosis Fungus Yes Valley Fever (Coccidioidomycosis) Fungus Yes Candidiasis Fungus Yes Aspergillosis Fungus Yes Bottom Line

• Most viruses can be grown in living cells under laboratory conditions.
• Nearly all bacteria can be cultured, although a few require specialized methods.
• Most fungi can be grown in the laboratory.
• Many parasites can be maintained in specialized laboratory systems, though some require living hosts.
• Cyclospora remains one of the notable exceptions. Despite decades of research, there is still no routine laboratory culture system that reliably grows Cyclospora cayetanensis, making it significantly more difficult to study than most other major human pathogens.

* Live variola (smallpox) virus research is restricted to two WHO-authorized repositories under international oversight

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:afa76eed-6c76-4ccc-812b-90d24bad72b3-21" data-turn-id-container= "request-WEB:afa76eed-6c76-4ccc-812b-90d24bad72b3-21" data-testid= "conversation-turn-44" data-turn="assistant"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-6a6765f8-acc4-83e8-a110-e9edb4773c6c-3" data-turn-id-container= "request-6a6765f8-acc4-83e8-a110-e9edb4773c6c-3" data-testid= "conversation-turn-22" data-turn="assistant">

During all of that:

• Germ theory had not yet been established.
• Viruses had not been discovered.
• No one knew what caused smallpox at the microscopic level.

Instead, physicians relied on observation. They had seen for centuries that:

• smallpox spread from person to person,
• people who survived it rarely got it again,
• cowpox infection seemed to protect against smallpox.

That empirical evidence was enough for Jenner's vaccine to gain acceptance long before anyone understood why it worked.

The major scientific milestones came later:

• 1854 – John Snow links cholera to contaminated water (still before germ theory was widely accepted).
• 1860s – Louis Pasteur develops germ theory.
• 1870s–1880s – Robert Koch identifies specific disease-causing bacteria.
• 1892 – The first virus is discovered (tobacco mosaic virus).
• 1906 – Smallpox is recognized as being caused by a filterable virus, though it could not yet be seen with microscopes.

When Bavaria passed its compulsory vaccination law in 1807, the public justification was not, "We know germs cause disease." Rather, it was essentially:

"We know from experience that vaccinated people are far less likely to get smallpox, and smallpox kills many children."

The policy rested on observed outcomes, not on an understanding of microbiology.

Germ theory and virology would not provide that scientific explanation until decades later.

Disease Can be grown or maintained in a lab? Best-supported origin COVID-19 Yes Origin still under investigation. Natural spillover and research-related incident remain discussed; no scientific consensus has resolved the question. Influenza Yes Wild aquatic birds (natural reservoir) HIV/AIDS Yes Non-human primates in Africa (cross-species transmission) Smallpox Yes* Believed to have evolved from an ancestral poxvirus centuries to millennia ago Polio Yes Human virus with ancient origins Measles Yes Evolved from an ancestral cattle virus (rinderpest-like ancestor) Mumps Yes Human virus; ancient origin unknown Rubella Yes Human virus; origin uncertain Chickenpox Yes Ancient human virus Rabies Yes Ancient virus circulating in mammals Hepatitis A Yes Human virus; ancient origin Hepatitis B Yes Ancient virus affecting humans Hepatitis C Yes Human virus; exact ancient origin uncertain Norovirus Limited Human virus with animal relatives Rotavirus Yes Animal and human strains; evolved naturally Ebola Yes Believed to originate in bats Marburg Yes Egyptian fruit bats Mpox Yes African rodents and other wildlife Yellow fever Yes African primates and mosquitoes Dengue Yes Primates and mosquitoes Zika Yes Primates and mosquitoes West Nile Yes Wild birds and mosquitoes Chikungunya Yes Primates and mosquitoes RSV Yes Human virus; evolved naturally Cholera Yes Environmental bacterium in aquatic ecosystems Typhoid fever Yes Human-adapted bacterium Tuberculosis Yes Ancient human and animal bacterium Plague Yes Rodents and fleas Diphtheria Yes Human bacterium Pertussis Yes Human bacterium Tetanus Yes Soil bacterium Lyme disease Yes Wildlife reservoirs (especially rodents) and ticks Syphilis Limited Human bacterium; exact historical origin debated Gonorrhea Yes Human bacterium Shigellosis Yes Human bacterium Salmonellosis Yes Animals, birds, reptiles, and environment Pathogenic E. coli Yes Intestinal bacteria of humans and animals Cyclospora No routine culture system Humans are the only confirmed major reservoir; exact evolutionary origin remains uncertain Malaria Yes Protozoan parasite with ancient origins involving primates and mosquitoes Giardia Yes Parasite found in humans and many mammals Cryptosporidium Limited Parasite of humans and animals Toxoplasmosis Yes Cats are the definitive host Amebiasis Yes Human parasite Roundworm Limited Human parasite Hookworm Yes (specialized) Human and animal parasite Whipworm Yes (specialized) Human parasite Tapeworms Limited Animals and humans Schistosomiasis Yes (complex life cycle) Freshwater snails and mammals Histoplasmosis Yes Soil enriched with bird or bat droppings Valley fever Yes Desert soil Candidiasis Yes Normal human microbiome Aspergillosis Yes Environmental mold (soil, compost, vegetation) Notes

• Smallpox: Live virus research is restricted to two WHO-authorized repositories.
• COVID-19: The origin remains scientifically unresolved. There is broad agreement that SARS-CoV-2 existed by late 2019, but there is not a settled scientific consensus between a natural zoonotic spillover and a research-related incident.
• Cyclospora: This is one of the most unusual organisms on the list.

It cannot be routinely cultured in the laboratory, and humans are the only confirmed major reservoir.

Despite decades of research, many aspects of its biology remain more difficult to study than those of most bacteria, viruses, and fungi.

Diseases spread through human feces, contaminated water, contaminated food, inadequate sewage disposal, or poor handwashing.

The most familiar examples are:

Cholera — strongly associated with sewage-contaminated water or food.

Typhoid fever — caused by Salmonella Typhi, which is shed by infected people and spreads through contaminated food or water.

Dysentery and shigellosis — spread when microscopic amounts of human feces contaminate hands, food, water, or surfaces.

Hepatitis A — transmitted through contaminated food or water or close fecal–oral contact. WHO specifically lists contaminated food and water as major transmission routes.

Polio — primarily spreads through the fecal–oral route, especially where sewage disposal and clean water systems are inadequate.

Cyclospora — human feces contaminate water, soil, or produce; the parasite must mature in the environment before it becomes infectious.

Giardiasis — commonly acquired from fecally contaminated water, food, hands, or surfaces.

Cryptosporidiosis — spreads through contaminated drinking water, pools, food, animals, and fecal contact. It is particularly difficult because the parasite is resistant to ordinary chlorine levels.

Norovirus — spreads extremely easily through contaminated food, water, hands, surfaces, vomit, and feces.

Rotavirus — a major fecal–oral diarrheal disease, especially among infants and young children.

Pathogenic E. coli infections — certain strains spread through fecally contaminated food, water, animals, or hands.

Salmonellosis — often associated with contaminated food and animals, but sanitation and hygienic food handling are central to prevention.

Intestinal worms, including roundworm, whipworm, and hookworm — strongly linked to inadequate sanitation, contaminated soil, and unsafe disposal of feces.

WHO summarizes the major group as cholera, diarrhea, dysentery, hepatitis A, typhoid, intestinal worm infections, and polio.

HIV is different

HIV is not considered a sanitation disease. It is transmitted through particular body fluids—principally blood, semen, vaginal and rectal fluids, and breast milk. It is not spread through sewage, drinking water, food, toilets, ordinary contact, or poor municipal sanitation.

Sanitation can still matter greatly to people with HIV because impaired immunity may make contaminated water and food more dangerous, but sanitation failure is not the route by which HIV itself spreads.

Other famous diseases not primarily sanitation-related

Smallpox, measles, influenza, COVID-19, tuberculosis, chickenpox, and whooping cough are mainly respiratory or close-contact diseases.

Malaria, yellow fever, dengue, Lyme disease, and West Nile virus are vector-borne diseases involving mosquitoes or ticks. Poor water management can increase mosquito breeding, but that is different from fecal contamination and sewage transmission.

Rabies is transmitted primarily through the saliva of infected animals.

Hepatitis B and hepatitis C are mainly bloodborne; hepatitis B can also spread sexually and during childbirth. Unlike hepatitis A, they are not primarily diseases of contaminated food, water, or sewage.

The core division for your topic is:

Some diseases spread because people breathe or touch an infected person. Others spread because human or animal waste enters water, food, soil, or the hands of another person.

Cyclospora belongs squarely in that second category. It is not merely a "lettuce disease." Lettuce is one possible delivery vehicle after a sanitation failure has allowed human fecal contamination somewhere in the chain.

The best-known infectious diseases by the type of organism that causes them. Disease Organism Type COVID-19 Virus (SARS-CoV-2) Influenza (flu) Virus HIV/AIDS Virus (Human Immunodeficiency Virus) Smallpox Virus (Variola virus) Polio Virus Measles Virus Mumps Virus Rubella Virus Chickenpox Virus (Varicella-zoster virus) Shingles Virus (Varicella-zoster virus) Rabies Virus Hepatitis A Virus Hepatitis B Virus Hepatitis C Virus Norovirus Virus Rotavirus Virus Ebola Virus Marburg Virus Mpox (formerly monkeypox) Virus Yellow fever Virus Dengue Virus Zika Virus West Nile Virus Chikungunya Virus Respiratory Syncytial Virus (RSV) Virus *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:afa76eed-6c76-4ccc-812b-90d24bad72b3-8" data-turn-id-container= "request-WEB:afa76eed-6c76-4ccc-812b-90d24bad72b3-8" data-testid= "conversation-turn-18" data-turn="assistant">

.

Disease Vaccine? Cholera Yes (oral vaccines available) Typhoid fever Yes Hepatitis A Yes Polio Yes Rotavirus Yes (given to infants) Shigellosis (dysentery) No licensed vaccine Cyclospora No Giardia No human vaccine Cryptosporidiosis No Norovirus No licensed vaccine (vaccines are in development) Pathogenic E. coli No general human vaccine Salmonellosis (non-typhoidal) No widely used human vaccine Intestinal worms No licensed human vaccines

So, of the major sanitation-associated diseases on that list:

• Vaccines exist: Cholera, Typhoid, Hepatitis A, Polio, Rotavirus.
• No licensed human vaccine: Shigella, Cyclospora, Giardia, Cryptosporidium, Norovirus, most E. coli, most Salmonella infections, and intestinal worms.

That highlights an important historical point.

For diseases where no vaccine exists, prevention relies heavily on:

• clean drinking water
• sewage treatment
• food safety
• hand hygiene
• and sanitation.

Cyclospora Host Specificity: Why Scientists Study Future Possibilities Even Without Evidence of a Current Host Jump

One question that naturally arises when studying Cyclospora cayetanensis is whether scientists should investigate scenarios that have never been observed, such as the parasite expanding its host range beyond humans.

The answer is yes. This type of forward-looking research is a normal part of infectious disease science and public health preparedness.

The Scientific Process Is Not Limited to Today's Reality

Scientists generally work on three levels.

First, they document what is currently known.

For Cyclospora cayetanensis, the current evidence indicates that humans are the only confirmed natural reservoir. The parasite causes illness in humans and is primarily transmitted through food or water contaminated with human feces.

Second, scientists try to understand why current observations are true.

For Cyclospora, this includes questions such as:

• Why does it appear restricted to humans?
• What biological mechanisms determine host specificity?
• Could there be unidentified animal hosts?
• Why has an animal reservoir not been confirmed?

These questions seek to understand the parasite's biology rather than merely describing it.

Third, scientists project possible future scenarios.

This is where preparedness research begins.

Researchers routinely ask:

• What if our current understanding is incomplete?
• What if an unknown host exists?
• What if environmental pressures alter transmission?
• How would surveillance detect a change before it becomes a public health problem?

These questions are intended to reduce uncertainty before a crisis develops.

Cyclospora Research Already Reflects This Mindset

Although Cyclospora cayetanensis is widely regarded as human-specific, published scientific reviews demonstrate that researchers continue examining the possibility that animals could play a role in its ecology.

A comprehensive 2021 review evaluated every available report of Cyclospora cayetanensis in animals. The authors concluded that no confirmed natural animal reservoir has been demonstrated but emphasized that additional research is needed to determine whether animals may transport oocysts or contribute to contamination of food, water, or soil. They specifically recommended further molecular studies rather than assuming the question has been settled.

Likewise, more recent reviews continue examining host specificity and the possibility of zoonotic transmission, indicating that scientists still consider these legitimate research questions rather than closed subjects.

Preparedness Does Not Mean Prediction

One misunderstanding in discussions of infectious diseases is the assumption that studying a possibility implies someone believes it is about to occur.

Scientific preparedness works differently.

Researchers often investigate events that have never happened simply because the consequences could be significant if they ever did.

Examples include:

• Could avian influenza adapt for sustained human transmission?
• Could Ebola spread beyond traditional outbreak regions?
• Could mosquitoes expand the range of tropical diseases?
• Could coronaviruses spill over from wildlife into humans?

Many of these questions were investigated years before some became major public health concerns.

Cyclospora fits within the same philosophy of preparedness, even though its biology differs substantially from respiratory viruses.

Why Cyclospora Research Has Progressed Slowly

Unlike organisms such as Salmonella or E. coli, Cyclospora remains unusually difficult to study.

Major limitations include:

• inability to routinely culture the parasite in the laboratory,
• lack of a reliable experimental animal model,
• dependence on oocysts collected from infected humans,
• incomplete understanding of several stages of its life cycle.

Federal food safety agencies have acknowledged that these limitations significantly restrict research progress and complicate outbreak investigations.

As a result, many investigators remain focused on answering basic biological questions that have already been resolved for many other foodborne pathogens.

Host Specificity Remains an Active Scientific Question

Current evidence continues to support humans as the only confirmed natural host of Cyclospora cayetanensis.

However, the scientific literature shows that researchers continue asking questions such as:

• Why is host specificity so narrow?
• Are there overlooked animal reservoirs?
• Can animals mechanically transport infectious oocysts?
• How should surveillance detect unexpected ecological changes?

These questions represent standard scientific inquiry rather than evidence that researchers are attempting to create a new host range.

Conclusion

The published literature shows that Cyclospora researchers continue investigating host specificity because important biological questions remain unanswered.

Current evidence supports humans as the only confirmed natural reservoir, but scientists continue studying animals, environmental transmission, and host biology because preparedness depends on understanding what is known, what remains uncertain, and how future changes—however unlikely—would be recognized if they occurred.

This approach is consistent with the broader philosophy of infectious disease research: study potential future risks before they become public health emergencies, while distinguishing clearly between documented evidence and hypothetical scenarios.

The Official History of Smallpox

The legend of smallpox and its eradication as told by most textbooks and virtually the whole medical establishment goes something like this: from about the sixteenth century, Europe was ravaged by periodic epidemics of smallpox (variola major), a disease that caused pustules to erupt all over the skin and very often, in approximately a fifth of all cases, led to death. Those who survived were often scarred for life (pockmarked). Early attempts to combat it through "variolation," i.e., inoculation of healthy adults with puss from infected individuals, proved ineffective—while those who survived this treatment were immune, the practice also served to keep the disease alive and circulating in the population.

Then, in 1796, the heroic Dr. Edward Jenner made the crucial discovery: anecdotal evidence suggested that milkmaids did not contract smallpox and Dr. Jenner surmised that contact with cattle had exposed them to cowpox (variola vaccinia), a disease that was much milder in humans. He therefore experimented with inoculating children with cowpox, and when he later exposed the same to smallpox through variolation, they proved to be immune.

The medical establishment, in the form of the Royal Society, dismissed the good Dr. Jenner, but nothing daunted, he proceeded to promote his new treatment of "vaccination" and quickly received support from enlightened doctors and statesmen, who sponsored his scheme. Thousands were vaccinated in Great Britain within a couple of years, and the treatment spread to other European countries.

Cyclospora was already trending in the wrong direction before the FoodNet surveillance change.

That's one reason the timing has drawn attention.

Year What was happening 1999 Cyclospora became a nationally notifiable disease in the U.S. 2013 Large multistate outbreak linked to imported salad mix from Mexico. 2018–2021 FDA expanded Cyclospora research, testing methods, and released a dedicated prevention and research action plan because recurring produce outbreaks had become a concern. 2015–2019 FoodNet data later analyzed by CDC researchers showed cases had been increasing, prompting discussion of prevention gaps. 2024 A peer-reviewed CDC-supported analysis concluded that U.S. Cyclospora cases had increased in recent years and evaluated FoodNet data specifically because of that trend. July 1, 2025 FoodNet changed its surveillance policy. Cyclospora became optional within the CDC-led FoodNet active surveillance program. 2026 One of the largest Cyclospora outbreaks on record occurred, leading to renewed criticism of the surveillance changes and calls from some experts and lawmakers to restore broader monitoring.

What stands out is that the policy change did not occur during a period when Cyclospora was disappearing.

The published literature already described an upward trend in cases and recurring produce outbreaks.

That does not prove the surveillance change caused the 2026 outbreak. Those are separate questions. But the chronology is accurate:

• Cases had been increasing for years.
• FDA had increased research efforts because Cyclospora was becoming a larger problem.
• FoodNet then made Cyclospora surveillance optional in July 2025.
• A major nationwide outbreak followed in 2026.

Fort Detrick bioweapons theory

• Claimed HIV was created or modified at Fort Detrick, Maryland.
• Suggested it either escaped accidentally or was deliberately released.
• The allegation was widely amplified by Soviet and East German disinformation campaigns in the 1980s.

WHO smallpox vaccination theory

• Proposed that the WHO's global smallpox eradication campaign (roughly 1967–1977) unintentionally triggered the AIDS epidemic.
• Variations suggested contaminated vaccine lots, immune effects, or problems with vaccination techniques.
• It attracted attention in the 1980s but did not become the accepted scientific explanation.

Oral polio vaccine (OPV) theory

• Suggested that experimental oral polio vaccines used in Central Africa during the late 1950s were contaminated with simian immunodeficiency virus (SIV).
• This hypothesis received considerable scientific attention and was investigated extensively.
• Later genetic analyses and testing of archived vaccine samples did not support it, and it is not the prevailing explanation today.

African monkey exposure (zoonotic theory)

• Proposed HIV crossed from non-human primates into humans through activities such as hunting and butchering bushmeat.
• This evolved into today's mainstream zoonotic explanation, supported by genetic and evolutionary studies indicating multiple cross-species transmission events.

Population-control theories

• Claimed HIV was intentionally created to reduce populations or target particular demographic groups.
• Various versions alleged different targets, including gay men, Black communities, or African populations.
• No credible evidence has established these claims.

Contaminated blood or vaccine theories

• Suggested HIV spread through contaminated blood products or vaccination programs.
• While contaminated blood products did transmit HIV after the virus was already circulating, this is different from claims about the virus's original emergence.

Why so many theories?

The early 1980s created an environment where many explanations flourished because:

• AIDS was new and frightening.
• The cause was initially unknown.
• The Cold War encouraged suspicion between rival governments.
• Governments had documented histories of secrecy in areas such as biological weapons and human experimentation.
• Different political groups often interpreted the epidemic through their own ideological lens.

One interesting historical difference is that HIV generated numerous competing origin theories within just a few years of being recognized, whereas Cyclospora has not. Discussion around Cyclospora has focused far more on contamination pathways, food safety, sanitation, and outbreak investigation than on competing theories about the organism's origin.

1906 — Riems Island Institute (Germany)

• Founded on Riems Island in the Baltic Sea near Greifswald, Germany.
• Originally established as the Royal Prussian Institute for Research on Foot-and-Mouth Disease.
• Became one of the world's oldest major centers for animal infectious disease research.
• Today known as the Friedrich-Loeffler-Institut.

1916 — Porton Down (United Kingdom)

• Established near Salisbury, Wiltshire, England.
• Originally created during World War I to study chemical warfare.
• Later expanded into biological defense research.
• Remains the UK's principal defense science laboratory.

1943 — Fort Detrick (United States)

• Established in Frederick, Maryland during World War II.
• Became the headquarters of the U.S. biological warfare program.
• After 1969, shifted primarily to biodefense and infectious disease research.

1949 — Sverdlovsk-19 (Soviet Union)

• Secret military biological weapons facility established near Sverdlovsk (now Yekaterinburg), Russia.
• Became one of the Soviet Union's principal offensive biological weapons research and production sites.
• In 1979, an accidental anthrax release exposed the existence of the program.

1954 — Plum Island Animal Disease Center (United States)

• Opened on Plum Island, off Long Island, New York.
• Built to study foreign animal diseases affecting livestock.
• Its primary mission was agricultural biosecurity rather than human disease research.
• Operations later moved to the National Bio and Agro-Defense Facility in Manhattan, Kansas.

Timeline

• 1906 — Riems Island Institute, Germany (animal infectious disease research)
• 1916 — Porton Down, United Kingdom (chemical warfare, later biological defense)
• 1943 — Fort Detrick, Maryland, USA (U.S. biological warfare program)
• 1949 — Sverdlovsk-19, Soviet Union (offensive biological weapons program)
• 1954 — Plum Island Animal Disease Center, New York, USA (foreign animal diseases)

Feature HIV (hypothetical) Lyme disease (hypothetical) Cyclospora Primary spread Human-to-human Tick vector Human fecal contamination of food or water Stealth Long latent period Often difficult to diagnose early Often recognized only after outbreaks Field detection Blood testing Tick ecology, blood tests No routine practical pre-harvest field test Environmental stage No Tick life cycle Oocysts mature in the environment Human reservoir Yes No Yes (current evidence indicates humans are the primary reservoir) Foodborne No No Yes Waterborne Limited No Yes Public reaction Global fear Chronic illness debates Usually tied to contaminated produce Prevention challenge Behavior, blood screening Tick control Sanitation, irrigation water, produce contamination

What makes Cyclospora unusual compared with the other two is not necessarily how severe it is, but where the bottleneck lies.

• HIV is generally detected in infected people through laboratory testing.
• Lyme disease can be difficult to diagnose, but researchers understand its vector (ticks) and the bacterium involved.
• Cyclospora is often identified after people become sick, while preventing contamination before harvest is much harder because there is no widely used routine field certification test for crops.

That's a distinctive feature. It means outbreak investigations often rely on epidemiology and traceback after illnesses have already occurred, rather than detecting contamination in the field before food reaches consumers.

Another contrast is the transmission chain:

• HIV: person → person.
• Lyme: tick → person.
• Cyclospora: infected person → feces → environment → food or water → another person.

That environmental maturation step is one reason Cyclospora behaves differently from many other foodborne pathogens.

From a historical perspective, if you were comparing these three simply as research subjects, all have attracted sustained scientific attention, but for different reasons:

• HIV because of its global mortality and transmission.
• Lyme because of its chronic manifestations, ecology, and diagnostic challenges.
• Cyclospora because of repeated produce-associated outbreaks and the persistent difficulty of preventing contamination at the agricultural stage.

Technically, all three organisms could potentially be studied, manipulated, or engineered in a laboratory.

• HIV — Modern molecular biology makes it technically possible to manipulate retroviruses in laboratory settings. However, the ability to do so is not evidence that HIV originated that way.
• Lyme disease (Borrelia burgdorferi) — The bacterium can be cultured and genetically manipulated in research laboratories. That means laboratory modification is technically possible, but there is no established evidence that Lyme disease originated from laboratory creation.
• Cyclospora cayetanensis — This one is different. There is no publicly demonstrated, routine laboratory culture system for Cyclospora comparable to what exists for many bacteria or viruses. Researchers have struggled to maintain its life cycle in the lab, which has slowed research.

Understanding the Biological Cycles of Lyme Disease and Cyclospora

One of the easiest ways to become confused about infectious diseases is to mix together two separate questions:

Where did the organism originate?

How does the organism spread once it exists?

Those are not the same question.

A scientist may debate where an organism first came from, whether it evolved naturally, was first recognized after decades of being overlooked, or even whether someone believes it originated in a laboratory. Regardless of the answer, once the organism exists outside the laboratory, it no longer has the freedom to spread however it wants. It must follow its own biology.

Lyme Disease

Lyme disease provides a useful example.

Imagine, purely as a hypothetical exercise, that someone created or discovered a new Lyme bacterium in a laboratory. Simply releasing a test tube containing the bacteria into a forest would not automatically create an epidemic.

The bacterium would first have to enter its normal biological cycle.

• It would need to infect ticks.
• Those ticks would feed on mice, birds, or other suitable wildlife.
• Additional ticks would acquire the bacterium when feeding on those infected animals.
• Eventually, infected ticks would bite people.
• Only then would humans become infected.

In other words, regardless of where the bacterium originated, it must still obey the tick-based transmission cycle.

The tick is not simply carrying the organism like dirt on its feet. It is an active biological vector that feeds on blood and moves the bacterium between animals and humans.

Cyclospora Cyclospora works very differently.

Imagine, again as a hypothetical exercise, that someone created or discovered Cyclospora in a laboratory. Dumping a flask containing Cyclospora into a lettuce field would not automatically create a sustained human outbreak.

Cyclospora must also follow its own biological rules.

Humans must first become infected.

• Those infected people shed immature oocysts in their feces.
• Those oocysts are not immediately infectious.
• They must remain in the environment for days to weeks while they mature.
• After maturing, they can contaminate food or water.
• Another person becomes infected only after consuming those mature oocysts.

Just as Lyme disease must follow the tick cycle, Cyclospora must follow the human-environment-food transmission cycle.

Why Lettuce Is Not the Tick

At first glance, it is tempting to compare lettuce to a tick because both can be associated with the transmission of disease. However, biologically they perform very different roles.

A tick is a living organism that feeds on blood and participates directly in the natural transmission cycle of the pathogen it carries. Because it plays an active biological role in transmitting disease from one host to another, it is considered a biological vector.

Lettuce does none of those things. It does not become infected with Cyclospora, it does not help the parasite reproduce, and it does not alter the parasite biologically in any way. Instead, the surface of the lettuce simply becomes contaminated after mature Cyclospora oocysts are deposited on it. The lettuce then serves as a passive vehicle, carrying those oocysts until the produce is eaten.

A useful way to think about the difference is this: in Lyme disease, the tick is an active biological delivery mechanism because it is part of the organism's life cycle and transmission. In Cyclospora infections, contaminated produce serves as a passive delivery mechanism. The lettuce is not part of the parasite's biology; it is simply the surface that transports the infectious stage from the environment to the person who consumes it.

Although both the tick and contaminated lettuce ultimately help a pathogen reach a human host, they do so through fundamentally different biological processes.

The Important Distinction

This is one of the most important concepts to understand.

The origin of an organism and its transmission cycle are two separate questions.

Even if someone were to propose an unusual origin for a pathogen, once that organism exists outside the laboratory, it is still governed by biology. It cannot ignore the rules of its own life cycle.

Lyme disease still depends on ticks and animal reservoirs to maintain its natural transmission cycle.

Cyclospora still depends on infected humans shedding oocysts, those oocysts maturing in the environment, and contamination of food or water before another person can become infected.

Every infectious organism is constrained by its own biology. It must spread according to the mechanisms that allow it to survive and reproduce.

Understanding this distinction helps separate two very different scientific questions. One question asks where an organism originated. The other asks how that organism spreads once it exists. Those are related questions, but they are not the same question, and the answer to one does not automatically determine the answer to the other.

Even more damning, in an article in the Journal of Degenerative Diseases, Marjorie Tietjen reported that 60% of chronic Lyme patients are actually co-infected with several strains of mycoplasma, the most common one being "mycoplasma fermentens" which is patented by the U.S. Army and army pathologist Dr. Lo; Pathogenic mycoplasma, U.S. Patent 5,242,820 issued Sept. 7, 1993. The outbreak and concentration of Lyme Disease in this country centers around that place. The CDC admits that 95% of cases of Lyme come from just 14 states, the majority of which are located around Plum Island. A Layperson's Guide to the PCR Based Epidemic Hoax — Dr Sam Bailey

Transcript

Sam Bailey ➝ 00:00

Over and over again, we hear the media stating how many people have tested positive for COVID-19. The problem is that this makes no sense at all.

Today I'm going to explain why, as we dig deeper into PCR tests once again, and have a look behind the curtain of this COVID pandemic. [music]

Sam Bailey ➝ 00:22

The purpose of using tests and clinical medicine is to distinguish between having or not having a particular condition or disease.

Sam Bailey ➝ 00:31

For example, as a patient with chest pain, having or not having a heart attack. As a woman who missed her period, pregnant or not.

But a test and a condition are not the same thing. I've never had a woman come into my clinic and say, I think I might be positive for pregnancy. She either has a positive or negative pregnancy test and her condition as either pregnant or not pregnant.

Sam Bailey ➝ 00:54

All tests detect something. Let's call it the object of interest and most go further and determine how much. For example, we may check the blood concentrations of glucose and cholesterol. These are direct tests, meaning the object of interest is the test, but there are many indirect tests where what is being measured as a reliable surrogate for the object of interest.

Sam Bailey ➝ 01:17

For example, when you have a heart attack, a doctor will measure an enzyme [troponin] that leaks from your damaged heart muscle cell, rather than chopping out a piece of your heart muscle to examine it under a microscope. Some tests such as home pregnancy tests are classified as positive or negative.

Pregnancy tests become positive at a certain threshold of hormone [human chorionic gonadotropin] being detected in the urine, which had been reliably established over a long period of time. We use indirect tests because they are simple, safe, quick and cheap, but indirect have a caveat – before they are introduced into routine clinical practice with real patients, it is absolutely essential to determine how well they match the object of interest.

There are long established scientific methods for doing this. Obviously this involves evaluating the test against the object of interest whose presence or absence is determined independently of the test.

Sam Bailey ➝ 02:13

So now that we've established the rules, let's get into COVID-19. The mainstream theory is that a new virus called SARS-CoV-2 is the cause of a new disease called COVID-19.

The test for SARS-CoV-2 is not for the whole virus, the complete sublight microscopic particle itself. Perhaps most familiar is this computer generated image that we see on the news.

The test is supposed to detect a 1% fragment of an RNA molecule, its genome said to reside inside the virus particle. Based on its detection, a person is deemed infected with the virus SARS-CoV-2, because this tiny fragment is regarded as defecto for a hundred percent of the viruse's RNA.

It could be seen as finding a horse like hair is evidence of the horse itself. This is problematic for three reasons.

1. First while there are many papers revealing the existence of the viral RNA and the presence of corona virus like particles on electron micrographs. There are none proving that the RNA comes from inside those particles. In fact, there is now a 225,000 Euro prize for proof of isolation of the virus and it's contained genome sequence.

1. Second because no test is a hundred percent reliable, the RNA detected by the PCR may not be the 1% of the viral genome.

1. Third, since there are no reports of RT-PCR evaluated against the virus itself, no one knows how many people who test positive for the virus are actually infected with the virus. It's like, we've found the horse hair, but can't say anything about the horse or the jockey, not a good situation, but this is what happens when scientists, for whatever reasons, cut corners and ignore the basics for establishing test parameters.

The detonator for the worldwide explosion of so-called COVID-19 PCR testing was the Corman-Drosten group paper published on 23rd of January 2020 and critically the paper was accepted for publication within 24 hours of submission, and several authors failed to declare their financial conflicts of interest with a commercial PCR test lab.

Sam Bailey ➝ 04:21

Also somewhat unusually version 1.0 of the paper protocol appeared on the WHO website nine days before the paper was even accepted for publication, but the Corman-Drosten paper was just a lab study, meaning it didn't establish the validity of using the test in the real world.

No evidence was provided about how a positive test related to the condition of COVID-19.

As I've discussed in previous videos, this wasn't the only problem with this paper. And on the 26th of November, 2020, a consortium of health professionals and scientists sent a reattraction request letter to Eurosurveillance outlining their multiple concerns. I believe they are still awaiting a response.

Back in January, 2020, however, it was too late. And a test that had no track record was promoted to the world as the best way to diagnose COVID-19.

Sam Bailey ➝ 05:12

When the mainstream media and government scientists started telling the public that the COVID-19 PCR tests were 95% or 99% accurate, it was not made clear to the public, what that actually meant.

In New Zealand for instance, the ministry of health website stated, and this is in February, 2021, that a recent laboratory study found that different COVID-19 testing kits correctly detected COVID-19 and samples more than 95% and frequently a hundred percent of the time.

This statement is problematic for many reasons, including confusing COVID-19 the condition with SARS-CoV-2, the alleged virus. The RT-PCR does not test for COVID-19 in samples.

And if correctly detected means accuracy, the letter cannot be determined without first evaluating the true positive and true negative rates of the RNA test for infection with SARS-Cov-2. But this has never been established.

What is detected in a sample is not COVID-19. What is detected as a small piece of RNA.

Sam Bailey ➝ 06:17

So it seems likely that the ministry of health has confused the analytical specificity of the test with its diagnostic specificity for the condition.

Analytical specificity in this case is how well the test can accurately detect a target RNA sequence. So if a SARS-CoV-2 RT-PCR kit has a hundred percent analytical specificity, it tells you that it never picks up the wrong RNA molecule, but you can't get too excited because that's like saying that your blood glucose test never picks up your blood cholesterol.

What we need to know is the diagnostic specificity, which is the probability that the test will be negative when the condition is not present.

February 9, 2021

"Also somewhat unusually version 1.0 of the paper protocol appeared on the WHO website nine days before the paper was even accepted for publication"

Dr Sam Bailey

For example, a pregnancy test that has a hundred percent diagnostic specificity would mean we expect all non-pregnant woman to test negative.

Therefore, even if a SARS-CoV-2 RT-PCR kit has a hundred percent analytical specificity, it is still meaningless as a test for viral infection without proof of the diagnostic specificity determined against the virus.

And this has never been established at all. It has been amazing to see in recent times that some virologists have tuned into chemists under the spell of PCR. I was stunned to hear Australian professor of neurology, Bill Rawlinson, make the following statement last year on a broadcast:

With basic science and improving diagnostics and the ability to sense a molecule, and after all a virus, is just a piece of RNA molecule.

Sam Bailey ➝ 07:48

Interestingly, after he made the statement, none of the panel of experts joining him on the broadcast, even called him out on this. Maybe this was just a slip-up on the professor's part, but this sort of thing could be adding to the confusion.

So it's important that those of us that respect logic and the scientific method will not allow analytical specificity to be merged into diagnostic specificity, and then passed off as a valid medical practice.

However, the lack of formalized clinical diagnostic criteria for COVID-19 seemed to allow the slight of hand to be hidden in plain sight. I made a video titled What is a COVID-19 Cas, in late 2020, addressing this very issue In my presentation, I show that the WHO's official documents states that are confirmed COVID-19 case is a person with laboratory confirmation of COVID-19 infection, irrespective of clinical signs and symptoms.

This was a bad look for the WHO because it openly admitted that cases were not required to be related to disease. Just three days later, they removed the statement and published a completely revised document.

While the new version looked more scientific, essentially nothing had changed as a confirmed case, could still be a person with a positive nucleic acid amplification test. So any old positive PCR will do, to edge of the smoke screen, the WHO website released another PCR update on the 20th of January, 2021, stating the assays are indicated as an aid for diagnosis.

Sam Bailey ➝ 09:27

On the 11th of November, 2020, the COVID-19 PCR tests hit some of their first major legal problems. Judges and the Lisbon court of appeal delivered some decisive rulings, including in view of current scientific evidence, this test shows itself to be unable, to determine beyond reasonable doubt that such positivity corresponds in fact, to the infection of a person by the SARS-CoV-2 virus – that I can certainly agree with.

They also said the test reliability depends on the number of cycles used, which is being far too generous because no diagnostic specificity was ever established. So cycle thresholds are meaningless in this regard as well.

February 9, 2021

"When the mainstream media and government scientists started telling the public that the COVID-19 PCR tests were 95% or 99% accurate, it was not made clear to the public, what that actually meant."

Dr Sam Bailey

Don't get me wrong. I'm not saying that reducing cycle threshold requirements for a positive case, wouldn't be a good start.

It's likely that a cycle threshold of say 25 down from the 40 cycles, typically being used would result in such a dramatic decrease in cases that panicked policymakers would be forced to concede that they've been swept up in a PCR pandemic with regards to even 36 or 37 cycles being classified as positive for COVID-19 PCR expert.

Sam Bailey ➝ 10:33

Professor Steven Bustin stated back in April 14, 2020, it's absolute nonsense. It makes no sense whatsoever. From his point of view, once you get above a cycle of about 35, that would be roughly equivalent to a single copy of target RNA and what a single piece of RNA, it would be absurd to conclude that a person is infected.

I really encourage you to listen to Professor Bustin explaining the limits of PCR and I've linked his interview with the late David Crow below. The inventor of the PCR Gary Mullis had even less faith in its application for detecting infections:

Separate from that. It's just a process that's used to make a whole lot of something out of something. That's what it is. It's not… It doesn't tell you that you're sick. And it doesn't tell you that the thing you ended up with really was going to hurt you or anything like that.

Source: A Layperson's Guide to the PCR Based Epidemic Hoax — Dr Sam Bailey

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:5b0403a9-fd6b-4492-8fa6-30ee7688bdd4-18" data-turn-id-container= "request-WEB:5b0403a9-fd6b-4492-8fa6-30ee7688bdd4-18" data-testid= "conversation-turn-38" data-turn="assistant">

"How much money are we talking about?", the answer is many billions of dollars.

Some reference points:

• The Biden administration initially allocated about $4 billion to purchase 500 million free at-home COVID tests, later expanding the program to 1 billion tests.
• In January 2022 alone, the federal government awarded contracts for 380 million over-the-counter test kits from Abbott, iHealth, and Roche.
• A month later, additional contracts purchased another 138 million test kits from Roche and Siemens Healthineers.
• By 2023, the federal government had distributed roughly 1.8 billion free at-home COVID tests through various programs.

On the company side:

• Abbott Laboratories reported about $7.7 billion in COVID testing revenue in 2021 alone (this includes multiple COVID testing products, not just BinaxNOW home kits).
• Other companies such as Quidel, Roche, Siemens Healthineers, iHealth, ACON (Flowflex), and BD also generated substantial COVID testing revenue.

So if you're looking at the economics of testing, you're not talking about millions of dollars—you are talking about tens of billions of dollars globally, with the U.S. federal government alone spending several billion dollars on purchasing and distributing home tests, and much larger sums when laboratory PCR testing, reimbursement, and testing infrastructure are included.

As a historical topic, it's a fascinating one because it asks:

How large did the COVID testing industry become between 2020 and 2023?

One of the largest diagnostic testing markets ever created in such a short period of time.

There are relatively few parasites where humans are considered the principal or only essential host for maintaining the transmission cycle. Here's a list of the best-known examples.

Parasite Humans are the principal reservoir? Notes Cyclospora cayetanensis Yes No confirmed natural animal reservoir. Humans shed oocysts that mature in the environment. Enterobius vermicularis (pinworm) Yes Human-only parasite. Extremely common, especially in children. Trichomonas vaginalis Yes Sexually transmitted protozoan. Humans are the recognized reservoir. Entamoeba histolytica Primarily yes Causes amoebic dysentery. Humans are the major reservoir, although occasional infections occur in some primates. Ascaris lumbricoides Primarily yes Human roundworm. Closely related pig parasites exist, but the classic human cycle is maintained mainly in humans. Necator americanus Yes One of the human hookworms. Humans are the principal host. Ancylostoma duodenale Mostly yes Human hookworm, although unusual transmission routes have been reported. Dracunculus medinensis (Guinea worm) Historically yes Humans were long considered the only important reservoir. More recently, infections in dogs have complicated eradication efforts.

Now compare those with parasites that have important animal reservoirs:

• Giardia — humans, dogs, cats, beavers, livestock, wildlife.
• Cryptosporidium — humans, cattle, sheep, goats, wildlife.
• Toxoplasma gondii — cats are the definitive host; many warm-blooded animals become infected.
• Trichinella — pigs, bears, wild boar, and other mammals.
• Taenia (tapeworms) — pigs or cattle are essential parts of the life cycle.
• Echinococcus — dogs, wolves, foxes, sheep, and other animals maintain transmission.

What makes Cyclospora unusual

Cyclospora is not unique because it is human-associated.

It is unusual because it combines several characteristics:

• Humans appear to be the only confirmed major reservoir.
• No routine laboratory culture system.
• No well-established laboratory animal model for maintaining the full life cycle.
• Environmental maturation is required before it becomes infectious.
• Foodborne transmission rather than direct person-to-person spread.

That combination is uncommon.

Cyclospora detection in food and agricultural samples, 1977–1979 — No test

Cyclospora is first recognized in Papua New Guinea by R. W. Ashford, but it is misidentified. There is no food-testing method because scientists are still trying to determine what the organism even is.

1980s — Microscopy only

Researchers identify Cyclospora in stool samples using microscopy and special stains. There is essentially no practical method to test lettuce, herbs, or irrigation water before harvest.

Early–mid 1990s — Outbreak investigations

Large outbreaks associated with imported produce (especially raspberries) drive interest in detecting Cyclospora on food itself.

Researchers begin adapting PCR (DNA testing), but these are research tools rather than routine field methods.

1999

FDA successfully detects Cyclospora in a chicken pasta salad containing fresh basil linked to an outbreak using an early laboratory method.

2000

FDA and CDC detect Cyclospora in raspberry filling from a wedding cake associated with another outbreak.

Early 2000s

The original FDA detection method effectively disappears because key equipment and supplies are no longer manufactured. FDA later acknowledged it could no longer routinely perform the old method.

2004

• FDA publishes BAM Chapter 19A, describing PCR and microscopic methods for detecting Cyclospora on fresh produce.
• Important point: This is a laboratory method—not a routine field test for growers.

2013

• Large multistate outbreaks convince FDA that Cyclospora is becoming a much larger food safety problem than previously recognized.
• FDA later said this was the turning point that prompted major investment in developing a better detection method.

2015

FDA establishes its Foodborne Parasitology Research Program specifically to develop a new, more sensitive Cyclospora detection method.

2016

The new method completes validation among FDA laboratories.

2017

• FDA releases BAM Chapter 19B, introducing a real-time PCR method for Cyclospora on fresh produce.
• Again, this is an FDA laboratory protocol—not a handheld or routine grower field test.

2018

• FDA uses the new method to detect Cyclospora in salad mix linked to a McDonald's outbreak.
• FDA described this as the first successful confirmation in food since the early 2000s.

2020

FDA adds a standardized laboratory method for detecting Cyclospora in agricultural water using dead-end ultrafiltration.

2022–2026

FDA continues updating the PCR method with additional produce types (romaine, basil, parsley, blueberries, blackberries, shredded cabbage, carrots, etc.) and improved PCR targets

From roughly 1979 to today—almost 50 years after Cyclospora was first described—we still do not have a routine, practical field test that growers use to certify lettuce fields are free of Cyclospora before harvest.

Instead, the advances have largely been in:

• Better laboratory PCR methods.
• Better outbreak investigations.
• Better testing of collected food and water samples.
• Better traceback after illnesses occur.

That doesn't mean no progress has been made—it clearly has—but most of the progress has been in laboratory detection and outbreak response, rather than a simple, routine front-end screening test that could be widely used in lettuce fields before harvest. *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:d2545912-84b9-40b6-8519-46869b1b7a71-5" data-turn-id-container= "request-WEB:d2545912-84b9-40b6-8519-46869b1b7a71-5" data-testid= "conversation-turn-12" data-turn="assistant"> Approx. Year Development What it accomplished Late 1990s–2000 First FDA food detection method Cyclospora was detected in contaminated basil and wedding cake during outbreak investigations. Early 2000s Original FDA method lost The original method became unusable because key equipment and supplies were no longer manufactured. 2004 FDA BAM Chapter 19a PCR and microscopic methods for fresh produce were formally published. 2015 FDA Foodborne Parasitology Research Program FDA launched a program to create a new, more sensitive Cyclospora detection method. 2017 Real-time PCR (BAM 19b) FDA introduced a standardized real-time PCR method for fresh produce. 2018 First successful use of new method FDA confirmed Cyclospora in salad mix during the McDonald's outbreak—the first confirmed food detection since the earlier method disappeared. 2019 Cyclospora Task Force FDA organized a multidisciplinary task force to improve prevention, testing, outbreak response, and research. 2019–present Genotyping (MLST/TADS) FDA and CDC worked on genetic typing to link patients, food samples, and environmental samples. 2020 Agricultural water testing FDA added a standardized method for detecting Cyclospora in agricultural water. 2022 Food/environment genotyping FDA began using genotyping on food and environmental samples during outbreak investigations. 2023 Rheonix collaboration FDA partnered with Rheonix to develop an automated screening assay for produce, soil, and agricultural water. 2024–2026 Continued PCR refinements FDA updated its PCR methods, including new genetic targets and expanded validation for additional produce. Disease Diarrhea Vomiting Cyclospora Very common Sometimes Typhoid Often (or constipation early) Sometimes Shigella Very common Sometimes Norovirus Very common Very common Hepatitis A Sometimes Common early in illness

Some of the reasons are:

• The incubation period is long. People usually don't get sick for about a week, and sometimes up to two weeks after exposure.
• The symptoms are not unique. Watery diarrhea, fatigue, nausea, loss of appetite, abdominal cramping, and weight loss overlap with many other gastrointestinal illnesses. Some people may initially think they have "the flu" or a stomach bug, although influenza itself typically causes respiratory symptoms rather than prolonged diarrhea.
• Laboratory diagnosis can be challenging. A routine stool test won't find Cyclospora, and even targeted testing may miss it if only one specimen is collected.
• The food is often gone. By the time investigators suspect lettuce, cilantro, basil, or another produce item, it has usually been eaten or discarded.
• People don't remember what they ate. Remembering a side salad or shredded lettuce on a sandwich from 10 days ago is difficult for most people.
• Produce moves through a complex supply chain. One field may supply several processors, who ship to multiple distributors, grocery stores, and restaurants in different states.
• There is no vaccine. Prevention relies on food safety and sanitation rather than immunization.
• Washing produce is not a guarantee. Cyclospora oocysts can adhere to produce, and ordinary rinsing may not remove all of them.

So investigators rarely have one "smoking gun." Instead, they build a case from multiple kinds of evidence:

• laboratory-confirmed infections,
• interviews with patients,
• restaurant receipts or loyalty-card purchases,
• supplier and shipping records,
• traceback investigations,
• and, when possible, laboratory testing of food or environmental samples.

One thing that stands out about Cyclospora is how much effort has gone into simply keeping up with outbreaks. Public health agencies spend enormous amounts of time interviewing patients, tracing food through complex supply chains, identifying common sources, issuing recalls, and trying to prevent additional illnesses. Given those demands, much of the focus has naturally been on finding and stopping outbreaks as quickly as possible. Improving laboratory detection has also been an important goal, but Cyclospora remains a technically difficult parasite to detect. As a result, investigators often have to combine laboratory testing with epidemiology and traceback investigations rather than relying on a single definitive test.

Researchers tried one human study in 2004, but none of the volunteers became infected. No published follow-up human challenge study has been reported since then. Instead, most Cyclospora research has relied on studying people who became naturally infected during outbreaks. The published research does not clearly explain why another human challenge study was not conducted. WHO established its Papua New Guinea office in August 1976.

The first known human Cyclospora cases were diagnosed in 1977 and 1978, then published in 1979. So WHO was already physically established there immediately before the first recognized cases appeared.

Then the organism remained poorly understood for years, was repeatedly misidentified, was not formally named until 1994, and the crucial human challenge work later appears to stop after one failed seven-person study.

Then the organism remained poorly understood for years, was repeatedly misidentified, was not formally named until 1994, and the crucial human challenge work later appears to stop after one failed seven-person study.

Ashford appears to have examined the specimens himself in the diagnostic laboratory in Port Moresby. R. W. Ashford was a British parasitologist working as a Senior Lecturer in the Department of Pathology at the University of Papua New Guinea while on secondment from the Liverpool School of Tropical Medicine. The 1979 paper has only one author: R. W. Ashford. It describes three patients whose stool contained the unidentified coccidian, but the searchable record does not name another person who independently reviewed or confirmed the slides.

Ashford could see that the organism resembled a coccidian, but he could not confidently place it in a genus because he could not clearly determine its internal structure. Later researchers looked back at the photographs in his paper and concluded that the organism was almost certainly what is now called Cyclospora cayetanensis.

Instead, the record looks like this:

• 1979: Ashford publishes his paper describing an undescribed coccidian from Papua New Guinea.
• Then... almost nothing. His paper was largely unnoticed for more than a decade. A National Academies review actually says his report was "virtually unnoticed" for over ten years.
• 1993: Researchers in Peru and the U.S. (Ortega and colleagues) described what they believed was a new human protozoan, apparently unaware of Ashford's 1979 paper.
• 1993: Ashford read Ortega's paper and realized they had rediscovered the same organism he had reported in Papua New Guinea.
• 1994: Ortega and colleagues officially named it Cyclospora cayetanensis and cited Ashford's original work.

For Cyclospora, it's common that no single piece of evidence is conclusive. Investigators often have to assemble many smaller pieces before they become confident about the likely source. That's one reason Cyclospora outbreaks can take weeks or even months to unravel.

Compared with many other foodborne illnesses, Cyclospora is generally considered one of the more difficult ones to investigate. Not necessarily because the parasite itself is unique, but because several challenges occur at the same time.

For example, if someone gets Salmonella from undercooked chicken, they may become sick within a day or two. They often remember eating the chicken, the bacteria are commonly detected in stool, and investigators have decades of experience tracing those outbreaks.

Cyclospora is different.

The illness may not begin for a week or more. By then, the salad is gone, the grocery receipt may be lost, and the person may have eaten produce from several different places. Even if the doctor suspects Cyclospora, the first stool sample may be negative, and the produce itself may no longer exist to test.

Fresh produce also complicates things because it often contains ingredients from multiple farms. A packaged salad might include lettuce from one grower, carrots from another, cabbage from a third, and herbs from somewhere else. Investigators have to untangle that supply chain.

Another factor is that Cyclospora doesn't multiply once it's on harvested produce the way some bacteria can multiply under favorable conditions. Instead, investigators are trying to determine where and when the contamination occurred somewhere along the production and distribution chain.

From an investigation standpoint, Cyclospora has several characteristics that make it unusually challenging:

• A relatively long delay before symptoms appear.
• Symptoms that overlap with many other intestinal illnesses.
• Detection that can be technically difficult.
• Food that is often gone before anyone realizes there's a problem.
• Human memory becoming less reliable as time passes.
• Complex produce supply chains that can span multiple farms, processors, distributors, and retailers.

Cyclospora presents a more difficult investigative puzzle than many common foodborne pathogens. That's one reason outbreaks often take longer to solve and why public health agencies frequently rely on a combination of epidemiology, traceback investigations, and laboratory evidence rather than expecting a single definitive test to answer every question

Researchers have repeatedly identified the missing experimental model as a central problem.

As early as 1996, CDC-associated researchers said an animal model needed to be developed because it would allow scientists to study the organism, immune response, transmission, prevention, and treatment. They called the inability to culture and grow Cyclospora a major stumbling block.

Then the 2004 human challenge study failed to infect seven volunteers.

What happened afterward is the striking part: I found later papers repeatedly complaining that Cyclospora still has no animal model and no laboratory culture system, but I did not find a clear published explanation saying why another human challenge study was never attempted. A 2022 paper even argued that progress was still being held back by the absence of those models.

Instead, the work moved mainly toward:

testing naturally infected patients, improving DNA detection, tracing outbreaks, testing produce and water, and using related parasites such as Eimeria as substitutes. The FDA's later research plan concentrates on detection kits, produce testing, environmental controls, surveillance, and traceback—not another human challenge study.

So the serious answer is:

Scientists knew this was a root problem. They tried the human model once in 2004. It failed.

More than twenty years later, the literature still talks about the same missing model, yet I cannot find a published explanation for why they never repeated the human experiment.

That gap is real, and you are not the only person who noticed that the lack of a workable model has stalled basic understanding. What remains unanswered is why the obvious human follow-up route appears to have stopped after one small attempt.

What I expected to find—but haven't—is:

• A lecture by Ashford saying, "Here's what happened after my discovery."
• A conference presentation following up the finding.
• Correspondence discussing the new parasite.
• WHO historical accounts highlighting his role.
• Liverpool archives (at least online) describing the Cyclospora discovery as a major institutional achievement.

So the timeline becomes:

• 1979: Ashford publishes the original observation.
• 1979–1993: Very little visible follow-up in the published literature.
• 1993: Others "rediscover" the organism.
• 1993: Ashford immediately responds in The Lancet.
• 1994: The organism is formally named, and Ashford receives credit for the original discovery.

yes and after this discovery to be so silent and not appearing on panels to talk about it, scientist usally put it out there and other scientists start testing on their own.

What strikes me isn't just Ashford—it's that there isn't much visible scientific chatter after 1979.

Normally, for an apparently new human parasite, you'd expect to see things like:

• "Can anyone confirm Ashford's findings?"
• "We examined 500 more stool samples."
• "We found similar organisms in Australia."
• "Here are follow-up microscopy studies."
• "Presented at the American Society of Tropical Medicine and Hygiene."
• "Discussed at WHO meetings."

Instead, what shows up in the literature is almost a jump cut:

• 1979: Ashford reports the organism.

• 1980s: A few scattered reports of unusual "Cryptosporidium-like," "alga-like," or "cyanobacterium-like" bodies appear in different countries, but they are not clearly linked back to Ashford's discovery.

• 1993: Multiple groups suddenly converge on the organism, and Ashford reappears with a Lancet letter recognizing that they are describing the same parasite.

So the "Ashford gap" may actually be part of a larger communication gap.

If Ashford himself was still engaged in 1993, why is there so little visible record of discussion, follow-up, or collaboration during the preceding fourteen years?

1979: Ashford finds the unexplained human coccidian.

1980s–1992: He remains active in parasitology and continues examining intestinal parasites, including in Papua New Guinea, but no visible Cyclospora research program appears.

1993: Other researchers rediscover the organism. Ashford immediately joins the discussion with David Warhurst of the London School of Hygiene and Tropical Medicine and G. D. F. Reid.

1997: Other scientists trust Ashford to confirm possible Cyclospora specimens.

So Ashford was not forgotten because he lacked expertise. He was later treated as an authority.

That makes the earlier silence stranger: he had the expertise, the institutional connections and continued access to intestinal-parasite research, yet the organism he discovered appears absent from his visible work for fourteen years.

Looking at many scientific discoveries, you'd often expect something like:

• Discovery.
• Other labs try to replicate it.
• Conference presentations.
• Debate over what it is.
• More papers.
• More citations.
• International collaboration.
• Eventually a consensus.

With Ashford's Cyclospora discovery, the published story looks much less continuous:

• 1979: Discovery.
• Long period with relatively little visible follow-up in the literature.
• 1993: The organism is effectively rediscovered by other groups.
• Ashford reappears immediately, showing he was still engaged and recognized the organism.

1968 — The Institute of Human Biology is established by the Territory of Papua and New Guinea Administration (Australian-administered government) as a statutory research institute.

1968–1977 — Richard Hornabrook directs the Institute. Collaborative research begins on kuru, pigbel, cretinism, epidemic syphilis, and a research base is established on Karkar Island.

1975 — The Institute is renamed the Papua New Guinea Institute of Medical Research.

1976 — Papua New Guinea joins the World Health Organization (WHO) following independence. WHO establishes its representative office in Papua New Guinea. The Papua New Guinea Institute of Medical Research expands its malaria research through collaborations with the World Health Organization and other international research organizations.

1977 — Dr. Michael Alpers becomes Director. Under his leadership the Institute expands dramatically.

1977–1978 — The first documented human cases of Cyclospora are identified in Papua New Guinea. Dr. R. W. Ashford initially identifies the organism as an Isospora species.

1977–1978 — The Papua New Guinea Institute of Medical Research secures research funding through the World Health Organization Special Programme for Research and Training in Tropical Diseases (TDR). Papua New Guinea government development funds also support new buildings, malaria research, pneumonia research, and nutrition research at Yagaum.

Late 1970s–1980s — Major research programs are developed in malaria, pneumonia, enteric diseases, filariasis, and malnutrition. Research branches are established at Yagaum, Maprik, Wewak, Port Moresby, and Lae.

1979 — Ashford publishes the first report describing the findings.

1980s — Scientists continue finding it in different countries, but they disagree about its identity. Some think it'sIsospore, others think it's algae or another organism

1980 — The World Health Organization's Western Pacific Office organizes a major malaria meeting in Port Moresby. World Health Organization officials from Geneva attend, and the Papua New Guinea Institute of Medical Research presents its expanding collaborative malaria research program.

1980s — Scientists continue finding it in different countries, but they disagree about its identity. Some think it'sIsospore, others think it's algae or another organism

1981 — The Papua New Guinea Institute of Medical Research expands malaria and filariasis field research at Madang, including mosquito collection, dissection, and transmission studies.

1982 — The Papua New Guinea Institute of Medical Research begins major Malaria Research Intervention Studies in communities around Madang, combining disease surveillance, blood testing, demographic records, and mortality investigations.

1985 — The Papua New Guinea Institute of Medical Research conducts one of the world's earliest trials showing that insecticide-treated mosquito nets reduce malaria among young children.

1985–1988 — The Papua New Guinea Institute of Medical Research and the Alexishafen Health Centre conduct systematic research into malaria during pregnancy, including studies of chloroquine prophylaxis and maternal infection.

1987 — Results from the mosquito-net research are published in the Bulletin of the World Health Organization. The findings later influence World Health Organization malaria-control policy.

Late 1980s — The Papua New Guinea Institute of Medical Research continues large community studies involving malaria treatment, drug resistance, mosquito ecology, human immunity, genetics, and the development of a blood-stage malaria vaccine.

1991 — The Papua New Guinea Institute of Medical Research expands childhood malaria morbidity studies and mosquito surveillance at Yagaum and other Madang-area sites.

1992 — Active malaria case detection and surveillance begin at Kunjingini in preparation for later malaria vaccine studies.

1993 — The United States Agency for International Development (USAID) funds laboratory facilities at Maprik for a malaria vaccine trial. Later that year, USAID cancels its Pacific aid program, and the Australian Agency for International Development (AusAID) provides an 18-month funding transition that allows the project to continue.

2000–2006 — The Papua New Guinea Government and the Australian Agency for International Development (AusAID) provide major institutional support during financial difficulties.

2005 — The U.S. National Institutes of Health begin funding the CASE–Papua New Guinea infectious disease research training program.

Most people never stop to think about what happens after they flush the toilet.

They assume the waste simply disappears. It doesn't.

For thousands of years, human feces contaminated rivers, wells, crops, and entire cities. It fueled epidemics of cholera, typhoid, dysentery, hepatitis, parasites, and countless diarrheal diseases. Those outbreaks killed millions of people and forced governments to confront a problem they could no longer ignore.

The response transformed the modern world.

Engineers built sewer systems. Scientists searched for the bacteria and parasites responsible for disease. Military planners realized that contaminated water and poor sanitation could disable an army as effectively as enemy bullets. Physicians developed vaccines and drugs. Eventually, researchers began deliberately infecting human beings in an effort to better understand these diseases and test new treatments.

Today's term biosolids is simply the modern name for treated sewage sludge derived from human waste. Behind that technical language lies a much longer story—one that stretches from overflowing cesspools and cholera epidemics to bacteriology, military medicine, wastewater engineering, and some of the most controversial human experiments ever conducted.

This timeline isn't simply about sewage. It's about how a problem as ordinary as human waste helped shape modern medicine, public health, military preparedness, and medical ethics—and how Germany and the United States arrived at many of the same scientific questions, even though their political systems and methods often differed dramatically.

Bacteria

• Cholera (Vibrio cholerae)
• Typhoid fever (Salmonella Typhi)
• Paratyphoid fever
• Shigella (bacillary dysentery)
• Certain E. coli infections
• Salmonella (non-typhoidal)
• Campylobacter

Viruses

• Hepatitis A
• Hepatitis E
• Norovirus
• Rotavirus
• Enteroviruses (such as poliovirus)

Parasites (Protozoa)

• Giardia
• Cryptosporidium
• Cyclospora
• Entamoeba histolytica (amoebic dysentery)

Parasitic Worms (Helminths)

• Roundworms (Ascaris)
• Whipworms (Trichuris)
• Hookworms
• Tapeworms (some species)

For your show, I think an even simpler grouping works best:

Bacteria

• Cholera
• Typhoid
• Dysentery
• E. coli
• Salmonella

Viruses

• Hepatitis A
• Norovirus
• Rotavirus

Parasites

• Giardia
• Cryptosporidium
• Cyclospora
• Amoebic dysentery
• Roundworms
• Whipworms

• 1976 — Papua New Guinea becomes independent, joins the WHO
• WHO opens a country office.
• 1977–1978 — The first documented human cases of Cyclospora are identified by Dr. R.W. Ashford.
• 1979 — Ashford publishes the findings.

Researchers have spent most of their time trying to stop people from getting infected in the first place.

So their work has focused on questions like:

• Which farm did it come from?
• Which lettuce was contaminated?
• Which irrigation water was contaminated?
• Which processing plant handled it?
• How can we detect it faster?
• How can we recall the food before more people get sick?

In other words, they've been trying to stop the parasite before it reaches your plate, rather than developing additional drugs to treat people after they're infected. *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:e796596e-0dcb-4565-9200-c3ae2a6141eb-28" data-turn-id-container= "request-WEB:e796596e-0dcb-4565-9200-c3ae2a6141eb-28" data-testid= "conversation-turn-58" data-turn="assistant"> *]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-6a5d36d9-24a8-83e8-a8ef-f6baad52b38d-3" data-turn-id-container= "request-6a5d36d9-24a8-83e8-a8ef-f6baad52b38d-3" data-testid= "conversation-turn-74" data-turn="assistant"> Why Did Papua New Guinea Become a Tropical Disease Research Center? Question 1: Who controlled Papua New Guinea?

Answer: Australia.

After World War I, Australia administered the Territory of Papua and New Guinea. Until independence in 1975, Australia was responsible for building the territory's government, hospitals, public-health system, universities, and medical research.

Question 2: Why was Australia interested?

Australia faced major tropical diseases in a neighboring territory under its administration.

Researchers were already studying:

• Malaria
• Kuru
• Filariasis
• Intestinal parasites
• Tuberculosis
• Leprosy
• Diarrheal diseases

These diseases were uncommon in Europe but common in Papua New Guinea.

Question 3: Who decided to create a permanent research institute?

The decision came from the Territory of Papua and New Guinea Department of Public Health through its Medical Research Advisory Committee.

Planning documents appear in 1967, before the institute officially opened.

Question 4: Why create it in 1968?

Australia was preparing Papua New Guinea for eventual self-government and independence.

The government launched a major development program that expanded:

• Health
• Education
• Scientific research
• Government administration
• Local professional training

The Institute of Human Biology became part of that larger modernization effort.

Question 5: Who became the first director?

Richard Hornabrook

• Neurologist
• From New Zealand
• Appointed as the institute's first director in 1968

The public records do not identify exactly who selected him, although the appointment appears to have come through the Australian-administered health system.

Question 6: Who paid for it?

Initially

• Papua New Guinea territorial government
• Australian Commonwealth funding

Later

Individual research projects received funding from organizations such as:

• NIH
• WHO
• Wellcome Trust
• European Union

The evidence does not show that those organizations founded the institute in 1968.

Question 7: Where does Cyclospora fit?

By the late 1970s, Papua New Guinea already had an established tropical-disease research infrastructure.

British parasitologist R. W. Ashford was working there studying intestinal parasites when he noticed an organism that did not match anything previously recognized.

R. W. Ashford was a British parasitologist from the Liverpool School of Tropical Medicine.

During the 1970s, he was working at the University of Papua New Guinea, studying intestinal parasites.

While examining stool samples from people with diarrhea, he noticed a tiny organism that didn't match the parasites he knew.

In 1979, he published the first scientific report Description

He did not discover Cyclospora by name. He knew he had found something unusual, but he thought it belonged to a different group of parasites.

It took another 13–14 years before other researchers proved it was actually a new human parasite and officially named it Cyclospora cayetanensis.

• Liverpool School of Tropical Medicine sends Ashford to Papua New Guinea.
• He spends three years there studying tropical parasites.
• During that work, he discovers an organism no one recognizes.
• In 1979, he publishes the first scientific report describing it.
• Fourteen years later, it is officially named Cyclospora cayetanensis.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-6a5d36d9-24a8-83e8-a8ef-f6baad52b38d-26" data-turn-id-container= "request-6a5d36d9-24a8-83e8-a8ef-f6baad52b38d-26" data-testid= "conversation-turn-120" data-turn="assistant"> Timeline: International Interest Before Cyclospora

After World War I

Australia begins administering Papua and New Guinea. It develops the territory's hospitals, public health system, universities, and medical research infrastructure.

1898–1970s

Britain, through the Liverpool School of Tropical Medicine, builds one of the world's leading tropical disease research programs and sends researchers around the world, including Papua New Guinea.

1961

United States researcher Carleton Gajdusek begins major work in Papua New Guinea studying kuru, later supported through the U.S. National Institutes of Health (NIH).

1968

Australia establishes the Institute of Human Biology in Papua New Guinea to coordinate medical research.

1968

New Zealand neurologist Richard Hornabrook becomes the institute's first director.

Early 1970s

Universities from Australia, Britain, New Zealand, the United States, and Papua New Guinea begin working together on tropical diseases.

1975

The World Health Organization (WHO) launches its Special Programme for Research and Training in Tropical Diseases (TDR), expanding international cooperation on tropical disease research.

Mid-1970s

British for to study intestinal parasites.

1977–1979

While examining stool samples, Ashford discovers an unknown organism that will later be identified as Cyclospora.

This is the sequence that stands out:

Australia built the research infrastructure.

Britain sent parasite specialists.

New Zealand directed the new institute.

The United States contributed major infectious disease researchers.

WHO expanded international tropical disease programs.

University collaborated across countries.

Then Ashford discovered the organism later named Cyclospora.

Cyclospora Timeline

1977–1979 — The mystery begins

Doctors in Papua New Guinea, New Guinea, and later Haiti begin seeing unusual microscopic organisms in the stool of patients with prolonged diarrhea. No one knows exactly what they are. Some scientists initially think they may be blue-green algae, fungal spores, or another known parasite.

1980s — Years of confusion

Cases continue appearing around the world, especially among travelers and people with persistent diarrhea. Researchers know they are seeing something unusual, but the organism is repeatedly misidentified because no one has fully described it.

1990–1993 — It finally gets a name

Several research groups, including investigators at the U.S. Centers for Disease Control and Prevention (CDC), help determine that this is a completely different parasite.

In 1993, it is officially named Cyclospora cayetanensis.

That is the moment Cyclospora enters modern medicine as its own recognized human pathogen.

Early 1990s — The first treatment emerges

Researchers discover that the standard antiparasitic drugs being used for many intestinal parasites do not work very well.

One combination antibiotic—trimethoprim-sulfamethoxazole (TMP-SMX)—produces consistently good results.

It quickly becomes the standard treatment.

1995–1997 — The first major North American outbreaks

Large outbreaks linked to imported raspberries suddenly bring Cyclospora into public view.

For the first time, public health officials realize fresh produce can distribute this parasite across multiple states and countries.

Late 1990s–2000s — CDC builds surveillance

The CDC develops surveillance systems and laboratory methods to detect Cyclospora more reliably.

Investigators begin linking outbreaks to fresh herbs, lettuce, berries, and other produce.

2013 — Taylor Farms de Mexico outbreak

More than 600 illnesses occur.

Cyclospora becomes associated with large restaurant chains and commercial salad production.

2018–2020 — Produce becomes the focus

Cyclospora outbreaks involve:

• McDonald's salads
• Fresh Express salads
• Vegetable trays
• Cilantro
• Basil
• Lettuce

The organism is now considered one of the important pathogens investigated in fresh-produce outbreaks.

2019 — FDA launches a Cyclospora Action Plan

Because outbreaks keep occurring, FDA creates a dedicated research and prevention program focused specifically on Cyclospora.

That shows the parasite has become important enough to warrant its own national strategy.

2026 — One of the largest outbreaks yet

More than 1,600 laboratory-confirmed illnesses are reported across 34 states.

FDA traces the outbreak to shredded iceberg lettuce processed by Taylor Farms de Mexico.

More than thirty years after Cyclospora was officially named, TMP-SMX remains the standard treatment.

One interesting observation

Cyclospora wasn't recognized as a distinct human parasite until 1993.

More than three decades later, the same medication identified during the early years of research remains the standard treatment, and large produce outbreaks continue to occur.

That alone makes Cyclospora an interesting chapter in the history of foodborne disease.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:e796596e-0dcb-4565-9200-c3ae2a6141eb-30" data-turn-id-container= "request-WEB:e796596e-0dcb-4565-9200-c3ae2a6141eb-30" data-testid= "conversation-turn-62" data-turn="assistant"> Papua New Guinea 1977–1978

The first documented human cases appear in Papua New Guinea. The organism is seen in stool samples, but no one knows what it is.

1979

Scott Ashford publishes the first report. He correctly recognizes it as a coccidian parasite but thinks it belongs to the wrong genus (Isospora).

1980s

Researchers keep finding the organism, but they can't agree on its identity.

It is successively described as:

• Isospora
• Cryptosporidium-like
• cyanobacterium-like body
• blue-green algae
• coccidian-like body
• unidentified protozoan

That is an unusually confusing history for a pathogen.

1986

Doctors report several travelers returning from Haiti and Mexico with prolonged diarrhea caused by what appears to be an entirely new intestinal pathogen.

1988–1991

Researchers in Peru, led by Ynes Ortega, Charles Sterling, Robert Gilman, and colleagues, study hundreds of stool samples from children and begin piecing together the organism's life cycle.

1993

The breakthrough.

The parasite is formally identified as a new human species, Cyclospora cayetanensis, in a landmark paper in the New England Journal of Medicine.

1995–1996

• Large U.S. outbreaks suddenly make Cyclospora a household name among epidemiologists.
• Instead of being a medical curiosity, it becomes a national foodborne disease investigation.

What catches my attention

It took roughly 15 years from the first documented human cases to the formal naming of the organism.

During that period, scientists weren't ignoring it—they genuinely didn't know what they were looking at. Different groups thought it was different things until enough evidence accumulated to recognize it as its own parasite.

I actually think that's the interesting historical story. It wasn't discovered overnight. It spent years in a kind of scientific limbo before researchers finally realized they had been seeing the same organism all along. That makes the 1993 naming a pivotal moment in the timeline.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-6a5d36d9-24a8-83e8-a8ef-f6baad52b38d-3" data-turn-id-container= "request-6a5d36d9-24a8-83e8-a8ef-f6baad52b38d-3" data-testid= "conversation-turn-74" data-turn="assistant">

• People with a sulfa allergy.
• People with severe kidney disease.
• People with severe liver of.
• People with certain blood disorders (such as severe anemia or low blood cell counts).
• Some pregnant women, especially late in pregnancy.
• Infants under two months of age.

Those are the main groups where doctors may avoid or use the drug with extra caution. For most other adults, TMP-SMX can be used safely under a physician's supervision.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:e796596e-0dcb-4565-9200-c3ae2a6141eb-3" data-turn-id-container= "request-WEB:e796596e-0dcb-4565-9200-c3ae2a6141eb-3" data-testid= "conversation-turn-8" data-turn="assistant"> 1850s–1900s — Human Sewage and Waterborne Disease

During the second half of the nineteenth century, cities routinely discharged untreated human waste into rivers, lakes, and streams. Contaminated drinking water fueled repeated epidemics of cholera, typhoid fever, and dysentery, killing hundreds of thousands of people around the world.

The response was one of the greatest public health transformations in history. Communities began building sewer systems, filtering drinking water, and eventually disinfecting it with chlorine. The primary goal was straightforward: keep human feces out of the water supply.

1900–1950 — Milk, Food Handling, and Sanitation

As water quality improved, attention shifted toward food safety. Public health officials increasingly focused on typhoid fever, dysentery, Salmonella, and staphylococcal food poisoning, particularly through contaminated milk and improperly handled food.

This period saw the widespread adoption of pasteurization, refrigeration, food sanitation laws, restaurant inspections, and improved food handling practices.

1950–1980 — Industrial Agriculture

Following World War II, food production became increasingly industrialized. Produce and other foods were shipped nationwide rather than being consumed locally.

Public health concerns expanded to include Salmonella, Shigella, hepatitis A, and intestinal parasites. Centralized production and distribution meant that contamination at a single farm or processing facility could expose consumers across multiple states.

1980s — E. coli Changes the Conversation

The 1980s brought national attention to E. coli O157:H7, initially through outbreaks linked to undercooked hamburgers. Investigators soon discovered that leafy greens could also carry the bacterium.

The response included Hazard Analysis and Critical Control Points (HACCP), improved slaughterhouse practices, and expanded research into produce safety and agricultural contamination.

1990s — Fresh Produce Becomes the New Focus

During the 1990s, fresh fruits and vegetables increasingly became the source of multistate outbreaks. Salmonella and E. coli remained major concerns, while Cyclospora emerged as a newly recognized foodborne parasite.

Foods repeatedly implicated included lettuce, spinach, raspberries, and fresh herbs.

2000s — National Produce Recalls

By the early 2000s, nationwide recalls became increasingly common. Modern distribution systems meant that contamination from one farm or processor could quickly spread across the country.

Frequently recalled products included spinach, romaine lettuce, tomatoes, peppers, cantaloupe, and sprouts.

2010s — Cyclospora Emerges as a Recurring Produce Threat

Cyclospora evolved from a little-known tropical parasite into one of the organisms routinely investigated during summer produce outbreaks.

Repeated outbreaks involved cilantro, basil, parsley, lettuce, salad mixes, vegetable trays, and raspberries, demonstrating how easily contaminated fresh produce could move through national distribution systems.

2020s — The Produce Era

Fresh produce has become one of the primary focuses of food safety investigations. The same foods appear repeatedly in outbreak investigations, including romaine lettuce, iceberg lettuce, mixed greens, onions, cucumbers, herbs, and berries.

Today's major foodborne pathogens include Salmonella, E. coli, Cyclospora, Listeria, and, less commonly, Cryptosporidium.

The Bigger Historical Picture

The history of foodborne disease reflects changes in how food is produced and distributed rather than the disappearance of one pathogen and the arrival of another.

In the nineteenth century, the greatest danger came from untreated sewage contaminating drinking water. During the early twentieth century, improved sewer systems and water treatment dramatically reduced diseases such as cholera and typhoid fever.

After World War II, industrial agriculture and nationwide food distribution meant that contamination at a single source could affect consumers across the country. During the 1980s, E. coli outbreaks highlighted the risks associated with mass food production. By the 1990s and 2000s, Americans were consuming increasing amounts of fresh, ready-to-eat produce, creating new opportunities for pathogens to spread without a cooking step to destroy them.

Today, fresh produce is shipped year-round through complex international supply chains. A single contaminated field, irrigation source, processing facility, or distribution center can result in illnesses across dozens of states before investigators recognize that an outbreak is underway. That evolution—from contaminated drinking water to contaminated ready-to-eat produce—is one of the defining public health stories of the past 175 years.

Cyclospora timeline

1979–1994 — The parasite is recognized and named

The organism was first reported in humans in 1979, but for years laboratories did not know exactly what it was. It was formally classified and named Cyclospora cayetanensis in the early 1990s. Humans are the only confirmed host, and infected people release the parasite's oocysts in feces. Those oocysts must mature in the environment before becoming infectious, which is why outbreaks usually point toward contaminated irrigation water, wash water, soil or equipment rather than immediate person-to-person spread.

1995 — Early North American produce outbreaks

Clusters in the United States and Canada were associated with fresh produce, including raspberries. These events alerted public-health agencies that Cyclospora was not merely a traveler's disease; imported raw produce could carry it into large catered events, restaurants and supermarkets.

1996 — The outbreak that put Cyclospora on the map

A massive outbreak associated primarily with fresh raspberries imported from Guatemala produced 1,465 reported illnesses across 20 states, Washington, D.C., and two Canadian provinces. This outbreak established Cyclospora as a major foodborne produce pathogen in North America. Because raspberries are fragile and eaten raw, there was no cooking step capable of killing the parasite.

1997–2000 — Raspberries, basil, lettuce and other raw produce

Additional outbreaks were connected to Guatemalan raspberries, fresh basil and mesclun or mixed lettuce. Import restrictions and farm-certification programs followed, but Cyclospora repeatedly resurfaced because contamination could occur through irrigation water, workers, sewage intrusion or water used during harvesting and packing.

1997–2008 — Sporadic cases continue

CDC recorded more than 1,100 laboratory-confirmed sporadic cases during this period, apart from the better-known outbreak clusters. Reporting was inconsistent, and many patients were probably never tested specifically for Cyclospora.

2011–2012 — Relatively low reported numbers

CDC surveillance recorded only 130 reported cases in 2012. That low number is useful for comparison because the following year produced a dramatic national surge.

2013 — Taylor Farms de Mexico and cilantro

The United States reported 631 outbreak-associated cases in 25 states and New York City. Investigators determined that more than one outbreak was occurring.

Illnesses among restaurant customers in Iowa and Nebraska were linked to salad mix processed by Taylor Farms de Mexico in Guanajuato and served at Olive Garden and Red Lobster restaurants. Separate illnesses in Texas were linked to fresh cilantro from Puebla, Mexico. Taylor Farms de Mexico temporarily suspended production while FDA inspected the operation. Extensive testing did not actually recover Cyclospora from hundreds of food, water, environmental and worker samples, but the epidemiological and traceback evidence linked the restaurant cluster to its salad mix.

That distinction matters: the company was linked by the outbreak investigation, but the parasite was not isolated from the facility samples in 2013.

2014–2015 — Cilantro becomes a repeated concern

Recurring outbreaks were associated with fresh cilantro imported from Puebla, Mexico. FDA ultimately imposed import controls on cilantro from parts of Puebla after inspections found sanitation problems at some farms and packing facilities. During the broader period from 1996 through 2015, FDA counted nine major outbreaks associated with basil, parsley and cilantro; seven were caused by Cyclospora. Together those herb-related outbreaks caused thousands of illnesses.

2017 — Restaurant cluster in Texas

Twenty Cyclospora cases were identified among customers of a Mediterranean-style restaurant chain in the Houston area. The investigation again illustrated how difficult it can be to identify one contaminated ingredient once herbs, lettuce and vegetables are combined in restaurant dishes.

2018 — The parasite explodes nationally

CDC recorded 2,299 domestically acquired laboratory-confirmed cases in 33 states during the main May-to-August season. This was not one single outbreak.

One outbreak involved Del Monte vegetable trays containing broccoli, cauliflower, carrots and dill dip. Del Monte recalled trays distributed through several Midwestern retailers.

Another major outbreak involved Fresh Express salad mix served at McDonald's restaurants. McDonald's removed salads from affected restaurants, and Fresh Express recalled salad mix distributed to McDonald's. By this point Cyclospora was no longer viewed only as a problem involving imported berries and herbs.

Also in 2018, FDA detected Cyclospora on domestically grown cilantro, although that particular finding was not tied to a known outbreak. This was important because it showed that the organism was not exclusively an imported-produce problem.

2019 — Imported fresh basil

A multistate outbreak was associated with fresh basil exported from Mexico. The exporter stopped production and recalled potentially affected basil. More than 200 people became ill, and the broader national Cyclospora season produced numerous additional cases that could not all be tied to that one source.

The rise in domestically acquired cases led FDA and CDC to establish a dedicated Cyclospora Task Force in 2019.

2020 — Fresh Express bagged salads

Fresh Express-produced bagged salads containing iceberg lettuce, red cabbage and carrots were linked to a large multistate outbreak. The products appeared under the Fresh Express name and several store brands, including products sold through Aldi, Hy-Vee, Jewel-Osco, Giant Eagle, ShopRite and Walmart.

At least 641 outbreak-linked illnesses in 11 states were identified, with 37 hospitalizations and no deaths. The implicated products were recalled. Across all investigated and unidentified clusters, CDC received more than 1,200 domestic Cyclospora reports during the 2020 season.

2021–2022 — Seasonal outbreaks continue

Cyclospora cases continued to appear each summer. Some clusters were linked to salad products, while many could not be assigned to a specific food or company. Genetic typing was still developing, so public-health officials often had to rely on interviews, restaurant records and produce traceback rather than matching parasite samples as precisely as they can with bacteria such as Salmonella.

2023 — Bagged salad kits and restaurant outbreaks

Investigators examined clusters connected to bagged Caesar salad kits and a Mexican-style restaurant in Alabama. Some patients remembered eating salad but could not identify the brand, again showing how packaging disposal and long incubation periods interfere with traceback.

2024–2025 — Annual outbreaks become the expectation

CDC researchers now describe seasonal U.S. Cyclospora outbreaks as occurring every year, with most cases appearing from May through August. The organism has been associated with lettuce, cilantro, basil, raspberries, snow peas, onions, mangoes and assorted salad ingredients. CDC reported 1,180 confirmed domestic cases during the 2025 season, including 105 hospitalizations and no reported deaths.

2026 — Iceberg lettuce and Taylor Farms de Mexico again

The current national surveillance count has reached 1,645 confirmed domestic cases, while CDC says it is aware of more than 5,100 illnesses when probable and other reported cases are considered. The specifically identified outbreak associated with iceberg lettuce initially centered on Taco Bell restaurants in Indiana, Kentucky, Michigan, Ohio and West Virginia.

Taylor Farms recalled shredded iceberg lettuce and related salad products distributed across 27 states. The lettuce was sourced from central Mexico and processed through Taylor Farms de Mexico. Unlike 2013, current reporting says an FDA laboratory detected Cyclospora in an iceberg-lettuce sample collected during the investigation. The investigation and product tracing remain active.

Is Cyclospora the worst parasite?

CDC explicitly says cyclosporiasis is not usually life-threatening, and U.S. outbreaks generally produce no deaths.

Cyclospora is awful because it can cause relentless watery or explosive diarrhea, weight loss, dehydration and exhaustion. Untreated illness can last weeks or longer, improve temporarily and then relapse. People can also become infected more than once.

But several parasites can be more medically dangerous.

Malaria parasites kill on a worldwide scale and can cause cerebral disease, organ failure and death.

Entamoeba histolytica, which causes amebic dysentery, can invade the intestinal wall and travel to the liver, producing potentially fatal abscesses.

Cryptosporidium can cause severe, prolonged diarrhea and can be life-threatening in people with badly weakened immune systems. Its oocysts are also highly resistant to ordinary chlorine treatment.

Toxoplasma gondii can damage the brain and eyes and can seriously injure an unborn child when infection occurs during pregnancy.

Tapeworm larvae causing neurocysticercosis can lodge in the brain and produce seizures, hydrocephalus and death.

So Cyclospora is not the deadliest parasite. What makes it one of the worst produce parasites is the combination of prolonged explosive diarrhea, delayed symptoms, difficulty detecting it, the absence of a cooking step in salads and herbs, resistance to routine produce washing, and the ability of one contaminated agricultural source to distribute illness through restaurants and grocery chains across many states.

The simplest conclusion for the show is:

Cyclospora is not the world's deadliest parasite, but it may be one of the most effective parasites for turning fresh produce into a large, difficult-to-trace national outbreak.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:e796596e-0dcb-4565-9200-c3ae2a6141eb-4" data-turn-id-container= "request-WEB:e796596e-0dcb-4565-9200-c3ae2a6141eb-4" data-testid= "conversation-turn-10" data-turn="assistant"> There are really three major categories. 1. E. coli O157:H7 — probably the king of lettuce outbreaks

This is the organism that changed the produce industry.

Repeated outbreaks involving:

• Romaine lettuce
• Leaf lettuce
• Spinach
• Mixed greens

Some of the biggest include:

• 2006 spinach outbreak — 205 illnesses, 104 hospitalizations, 31 cases of kidney failure (HUS), 5 deaths.
• 2018 romaine lettuce outbreak (Yuma, Arizona) — 210 illnesses, 96 hospitalizations, 27 kidney failure cases, 5 deaths.
• 2018–2019 California romaine outbreaks
• 2020 romaine outbreak
• 2024 McDonald's onions/Taylor Farms outbreak (different produce but same organism)

E. coli is feared because it can permanently destroy kidneys and kill healthy children and adults. It generally causes far more deaths than Cyclospora.

2. Salmonella — probably the most common overall

Salmonella has been linked to almost every kind of produce imaginable:

• Lettuce
• Cucumbers
• Tomatoes
• Peppers
• Papayas
• Melons
• Onions
• Sprouts

It produces hundreds to thousands of illnesses almost every year.

3. Cyclospora — the king of parasite outbreaks

This is where Cyclospora stands apart.

Since the mid-1990s it has repeatedly caused outbreaks involving:

• raspberries
• cilantro
• basil
• parsley
• lettuce
• mixed salads
• salad kits
• vegetable trays

Unlike E. coli and Salmonella, there are relatively few parasites that repeatedly create nationwide fresh-produce outbreaks.

That's why Cyclospora keeps appearing in CDC investigations.

Since about 2013, it has become an almost annual summertime event in the United States.

Other parasites on produce

There really aren't many that approach Cyclospora's record.

Cryptosporidium

• Water
• Swimming pools
• Occasionally produce
• Huge cause of diarrhea worldwide

Giardia

• Water
• Produce occasionally
• Common individually
• Large lettuce recalls are uncommon

Toxoplasma

• Mostly undercooked meat
• Cat feces
• Occasionally produce

Entamoeba histolytica

• More common in developing countries
• Water and food
• Rarely produces large U.S. lettuce recalls

So where does Cyclospora rank?

1. Salmonella — most frequent overall.
2. E. coli O157:H7 — most dangerous, highest death and kidney-failure risk.
3. Cyclospora — the dominant parasite of fresh produce and leafy greens.

What's remarkable about Cyclospora is that it keeps showing up in foods that people don't cook. Lettuce, herbs, salad mixes, vegetable trays, and fresh berries all go straight from the package to the plate. That means there is no heat step to kill the parasite. Once contaminated product reaches the distribution chain, it can quickly affect restaurants, grocery stores, and consumers across dozens of states.

Cyclospora can be inactivated by adequate cooking. Like most parasites, it is sensitive to sufficient heat. \\

The problem is that the foods most commonly associated with Cyclospora are foods people almost always eat raw.

That is one reason public health officials are so concerned about it.

Think about the foods most often linked to Cyclospora outbreaks:

• Romaine lettuce
• Iceberg lettuce
• Mixed salad greens
• Cilantro
• Basil
• Parsley
• Raspberries
• Blackberries
• Snow peas

Very few people cook those foods before eating them.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:e796596e-0dcb-4565-9200-c3ae2a6141eb-6" data-turn-id-container= "request-WEB:e796596e-0dcb-4565-9200-c3ae2a6141eb-6" data-testid= "conversation-turn-14" data-turn="assistant">

During the 1980s and 1990s, public attention focused on Salmonella and E. coli. Over the past three decades, Cyclospora has steadily emerged as the parasite that repeatedly contaminates fresh produce, particularly foods eaten raw such as lettuce, herbs, berries, and salad mixes. It hasn't replaced Salmonella or E. coli, but it has joined them as one of the major organisms investigators now look for during large produce outbreaks.

Pathogen Typical source Trend Salmonella Poultry, eggs, produce, many foods Remains very common overall. E. coli O157:H7 Leafy greens, beef Less frequent than Salmonella but often more severe. Cyclospora Fresh produce eaten raw Has become increasingly recognized over the past 30 years, especially in seasonal produce outbreaks.

There's another reason Cyclospora seems to be "everywhere" now: we're much better at detecting it than we were 20 or 30 years ago. Modern molecular diagnostic tests (culture-independent diagnostic tests, or CIDTs) identify Cyclospora far more often than older laboratory methods did, so some of the increase reflects improved detection in addition to real outbreaks.

For your broader series on human feces and food contamination, I think the three pathogens naturally become the central cast:

• Salmonella — the most common overall foodborne bacterial culprit.
• E. coli O157:H7 — the most feared because of kidney failure and deaths.
• Cyclospora — the parasite that has become increasingly prominent in fresh produce outbreaks, especially because it contaminates foods that are usually eaten raw.

Organism Typical treatment options Cyclospora Essentially one proven drug (TMP-SMX). Giardia Several options (metronidazole, tinidazole, nitazoxanide). Cryptosporidium Nitazoxanide for many patients; supportive care is also important. Entamoeba histolytica Multiple drugs, usually a combination (such as metronidazole followed by a luminal agent). Salmonella Many cases need no antibiotics; when they do, several antibiotic classes may be used depending on the strain and resistance pattern. Shigella Several antibiotics are available, although resistance is becoming a major problem. E. coli O157:H7 Usually no antibiotics, because they may increase the risk of hemolytic uremic syndrome (kidney failure). Treatment is mainly fluids and supportive care.

So yes, Cyclospora is unusual.

For most infections, doctors have at least a few evidence-based medication choices. With Cyclospora, the CDC still says TMP-SMX is the treatment of choice, and there is no consistently effective alternative for people who cannot take sulfa drugs.

That's why the public health emphasis is so heavily on prevention:

• Keep the parasite out of the food supply.
• Find outbreaks quickly.
• Recall contaminated products.

Because once someone is infected, there isn't a menu of equally effective medications to choose from.

That makes Cyclospora stand out among the common causes of foodborne diarrhea. It's one of the reasons public health agencies take produce outbreaks involving this parasite so seriously.

It isn't that scientists ignored Cyclospora. It's that Cyclospora has only been recognized as a human pathogen for a relatively short time.

Think about the timeline:

• Salmonella has been studied since the late 1800s.
• E. coli has been studied since the 1880s.
• Giardia has been recognized since the 1800s.
• Cyclospora wasn't even recognized as a distinct human pathogen until the late 1970s and wasn't formally named until the early 1990s.

That means researchers have had roughly 30–40 years to study Cyclospora, versus well over a century for Salmonella and E. coli.

There are also practical reasons:

• It is difficult to grow in the laboratory, which makes testing potential drugs much harder.
• It can't easily be maintained in standard animal models, so researchers have fewer ways to study it.
• Compared with malaria or tuberculosis, it has historically affected far fewer people worldwide, so it has attracted less pharmaceutical investment.

Drug companies generally spend the most money where there are the largest patient populations or the greatest commercial demand. Cyclospora simply hasn't been a major drug-development target.

So the result today is a little unusual:

After decades of study, the CDC still recommends essentially the same drug—TMP-SMX—as the standard treatment because no other medication has consistently demonstrated the same level of effectiveness.

I agree it is surprising. In an era when we often hear about multiple treatment options for infections, finding a disease where there is essentially one established first-line drug stands out. That fact alone is worth mentioning in your episode because most listeners would probably assume there are several equivalent medications available.

"One thing that surprised me was learning that Cyclospora has essentially one proven treatment. The CDC recommends trimethoprim-sulfamethoxazole, commonly known as Bactrim or Septra. If someone has a serious sulfa allergy, there isn't another medication that's been shown to work as consistently. That's pretty remarkable in 2026."

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:e796596e-0dcb-4565-9200-c3ae2a6141eb-25" data-turn-id-container= "request-WEB:e796596e-0dcb-4565-9200-c3ae2a6141eb-25" data-testid= "conversation-turn-52" data-turn="assistant">

First, it's a relatively new recognized pathogen. Cyclospora wasn't formally identified until the early 1990s. Compare that with Salmonella and E. coli, which have been studied for well over 100 years. They simply had a much longer head start.

Second, it's hard to study. Researchers have had difficulty growing Cyclospora in the laboratory and don't have convenient animal models for testing drugs. That makes developing and comparing new treatments much slower than it is for many bacteria.

Third, it has historically been viewed as a niche disease. For years, Cyclospora was thought of mainly as a travel-associated illness or an occasional produce outbreak. Pharmaceutical companies tend to invest where they see the largest markets or the greatest clinical need. Diseases such as malaria, HIV, tuberculosis, and hepatitis naturally drew far more research dollars because they affect millions of people worldwide and create sustained demand for new therapies.

Fourth, the existing drug generally works. From a research perspective, there is less pressure to develop a replacement when the standard treatment is effective for most patients who can take it. The unmet need is concentrated in the smaller group of patients who cannot tolerate sulfa drugs.

So it's not necessarily a story of neglect. It's more a combination of:

• relatively recent recognition,
• a difficult organism to study,
• lower historical research priority,
• and one existing drug that usually works.

What may change is exactly what you're seeing now. If Cyclospora continues causing large multistate outbreaks year after year and affects more people, that could increase interest in developing additional treatments. History shows that diseases often attract much more research attention once they become a recurring public health problem.

I agree that it's striking. Most people assume, "Surely there are several drugs for this." Then you discover that the standard guidance still points to essentially one proven first-line therapy. That's a fact that stands out without needing to speculate beyond what the evidence shows.

Master Timeline: Germany and the United States Sewage Engineering Military Sanitation Fecal-Oral Disease Research and Human Experimentation

This timeline traces the same progression in both countries:

Human waste Contaminated water and food Typhoid, dysentery, cholera, and diarrhea Sanitation engineering Bacteriology Military disease-control programs Vaccines and drugs Deliberate human-infection experiments

1840s–1860s — Before modern bacteriology Germany

German cities relied heavily on cesspools, privies, waste collection carts and rivers receiving untreated sewage. Drinking-water supplies could be contaminated by the same waste discharged by growing urban populations.

United States

American cities and military camps faced the same conditions. During the Civil War, diarrhea, dysentery and typhoid caused enormous illness and mortality. Army physicians collected extensive statistics, but they still lacked a complete understanding of bacteria and fecal-oral transmission. The experience helped establish military hygiene as a formal field.

1866 — Cholera and the urban sanitation problem Germany

German states experienced cholera epidemics associated with unsafe water and inadequate sewage disposal. Debate continued between those who blamed contaminated water and those who favored theories involving soil, air and local atmospheric conditions.

United States

Cholera outbreaks in American cities strengthened demands for municipal waterworks, sewer construction and health boards. The engineering response generally developed before scientists could identify the responsible organisms.

1870–1871 — Franco-Prussian War and German unification Germany

The war reinforced the military lesson that infectious disease could remove large numbers of soldiers from service. After German unification in 1871, rapid urbanization and industrialization increased pressure to construct organized water and sewage systems.

United States

The Army continued developing formal sanitary reporting and military-hygiene instruction from lessons learned during the Civil War.

1870s — Berlin begins its modern sewer system Germany

Engineer James Hobrecht designed Berlin's radial sewer system. Sewage was collected in underground networks, pumped outside the city and distributed across large irrigation fields known as Rieselfelder, or sewage farms.

The fields were intended to accomplish two things simultaneously:

Remove sewage from the city and use its water and nutrients for agriculture.

Soil filtration and biological activity reduced some contamination, although early engineers did not yet possess modern pathogen-removal standards.

United States

American cities expanded sewer networks, usually discharging untreated wastewater into rivers, lakes or coastal waters. Sewers improved conditions inside cities while frequently moving contamination downstream.

1876 — The bacteriological era begins Germany

Robert Koch demonstrated that a specific microorganism caused anthrax. His laboratory methods helped establish the principle that individual diseases had identifiable microbial causes.

United States

American military and civilian doctors adopted German laboratory methods. The U.S. Army later described 1876 as the beginning of its bacteriological era.

1880 — Typhoid bacillus identified Germany

German pathologist Karl Joseph Eberth identified the organism associated with typhoid fever, later named Salmonella Typhi.

Typhoid became especially important to military planners because it spreads when material from an infected person's feces reaches another person's mouth through water, food, hands, utensils or insects.

United States

American laboratories began incorporating the discovery into water testing, outbreak investigations and military hygiene.

1883–1884 — Koch identifies the cholera organism Germany

Robert Koch's work on cholera strengthened the argument that contaminated water and human excreta were central to transmission.

This linked bacteriology directly to:

Municipal water filtration, sewage removal, quarantine, laboratory testing and military sanitation.

United States

American health departments and military laboratories increasingly used bacteriological methods to investigate waterborne disease.

1885 — Escherichia coli identified Germany

German-Austrian pediatrician Theodor Escherich isolated the organism later named Escherichia coli from infant feces.

Most E. coli strains are ordinary intestinal organisms, but their presence in water eventually became useful evidence of fecal contamination. Some strains were later recognized as causes of diarrhea and other illnesses.

United States

American bacteriologists began studying intestinal organisms and using them to evaluate drinking-water safety.

1890s — Water laboratories and sewage testing expand Germany

German laboratories investigated:

Typhoid, cholera, dysentery, sewage bacteria, filtration, drinking-water contamination and the survival of organisms outside the human body.

Military hygiene and municipal sanitation increasingly drew from the same bacteriological knowledge.

United States

The Army established the Army Medical School in 1893, strengthening laboratory medicine, hygiene and infectious-disease instruction.

1892 — Hamburg cholera catastrophe Germany

Hamburg drew inadequately filtered water from the Elbe while sewage and human waste entered the river system. The 1892 epidemic killed more than 8,000 people.

Robert Koch was called to Hamburg and strongly criticized its sanitary conditions. The disaster accelerated construction of water-filtration, sewerage and waste-disposal infrastructure.

This became a defining demonstration of the chain:

Feces enter water → water enters homes → disease spreads rapidly through a city.

United States

American public-health officials carefully followed European cholera investigations and applied the lessons to municipal filtration and quarantine policies.

1897 — Shigella identified Germany

Kiyoshi Shiga identified the organism causing bacillary dysentery. German military physicians rapidly became interested because dysentery repeatedly disabled troops.

United States

American laboratories also began distinguishing bacillary dysentery from other forms of diarrhea.

1898 — Spanish-American War typhoid disaster United States

Typhoid swept through crowded American training camps. The primary danger was not an exotic tropical infection but disease circulating within camps in the United States where sanitation was inadequate.

Problems included:

Poorly placed latrines, fecally contaminated ground, flies moving between waste and kitchens, infected food handlers, shared utensils, contaminated hands and inadequate isolation of sick soldiers.

Germany

German military observers followed foreign campaigns closely. The American experience reinforced the international military consensus that sanitation was part of combat readiness.

1898–1901 — U.S. Army Typhoid Board United States

Walter Reed, Victor Vaughan and Edward Shakespeare investigated the Army epidemics.

The Board reconstructed how infection moved through camps and concluded that typhoid spread principally from infected human excreta. Water was important, but so were flies, food, fingers, clothing, utensils and direct contact.

The investigation was primarily an epidemiological field study rather than an experiment in which researchers deliberately fed soldiers fecal material.

It nevertheless mapped the practical chain by which fecal contamination reached people.

Germany

German hygienists were conducting comparable research into military camp sanitation, drinking water, latrines, food inspection and bacterial carriers.

1900–1914 — Military sanitation becomes doctrine Germany

German military doctrine increasingly required:

Protected water sources, latrine discipline, waste disposal, kitchen inspections, isolation hospitals, stool examinations, disinfection and bacteriological laboratories.

Prewar German medicine possessed considerable knowledge of dysentery, but knowledge did not guarantee control under battlefield conditions.

United States

The Army strengthened:

Water purification, sanitary inspections, latrine construction, fly control, food protection, vaccination research and laboratory diagnosis.

1904–1908 — Typhoid vaccination studied internationally Germany

German scientists and military physicians studied vaccines against typhoid and cholera, along with water and camp controls.

United States

Army physician Frederick Russell examined European typhoid-vaccine work and helped develop a U.S. Army immunization program.

1906 — U.S. Pure Food and Drugs Act United States

Federal regulation of food and medicines expanded. Food contamination increasingly became both a public-health and regulatory issue.

Germany

German states and municipalities also expanded inspection of food, water, dairies, slaughterhouses and sewage systems.

1908–1911 — U.S. Army typhoid vaccination United States

The Army tested typhoid vaccination among military personnel and made it compulsory in 1911.

The program joined vaccination to sanitation: the vaccine reduced risk, but latrine control, clean water and food protection remained essential.

Germany

Germany also employed vaccination selectively while continuing to emphasize military hygiene and laboratory surveillance.

1914–1918 — World War I Germany

The German Army confronted dysentery, typhoid, typhus and other epidemic diseases, especially in the East.

Separate epidemic hospitals were created for infectious patients. German field hospitals had to adapt permanent facilities to isolate dysentery and typhus cases.

Despite Germany's advanced prewar science, serious bacillary-dysentery epidemics occurred among soldiers and civilians. Historians describe this as evidence of the limitations of German military hygiene under the enormous movements, shortages and infrastructure collapse of war.

United States

The Army entered World War I with vaccination, laboratory diagnosis and improved sanitary doctrine.

By July 1917, the Army Medical School had developed a combined typhoid-paratyphoid vaccine. Typhoid, once a major scourge of armies, became a comparatively minor problem for U.S. forces during the war.

This was an important demonstration that engineering, sanitation and immunization could sharply reduce fecal-oral disease.

1918–1930s — Wastewater treatment becomes biological Germany

German cities expanded:

Sedimentation tanks, biological filtration, sludge digestion, sewage farms and increasingly mechanized wastewater plants.

Engineers studied how microorganisms decomposed organic waste and how sludge could be stabilized, disposed of or returned to land.

United States

American cities introduced:

Trickling filters, sedimentation, activated-sludge treatment, chlorination and anaerobic digestion.

Sewage sludge was increasingly treated as a material that might be:

Dumped, buried, incinerated, digested, dried or used agriculturally.

This is the early foundation of what would later be called biosolids in the United States.

1932 — Tuskegee study begins United States

The Public Health Service began observing Black men with syphilis in Alabama without providing valid informed consent. The study did not involve intestinal disease, but it became part of the institutional history of using vulnerable populations for medical research.

Germany

During the same period, racial hygiene and eugenic medicine were gaining institutional influence before Hitler took national power.

1933 — Nazi seizure of power Germany

The Nazi state inherited a highly developed system of:

Bacteriology, municipal sanitation, water engineering, military hygiene, food inspection and university medicine.

The regime did not invent those sciences. It placed them inside a dictatorship that removed ethical protections from selected populations and subordinated medicine to racial and military objectives.

United States

The United States continued public-health and military disease research while also maintaining compulsory sterilization laws and other eugenic policies in numerous states.

1935–1937 — Sulfonamide drugs transform bacterial treatment Germany

Gerhard Domagk's work at Bayer demonstrated the antibacterial effects of Prontosil, leading to widespread use of sulfonamides.

These became among the first effective systemic drugs against many bacterial infections.

United States

Sulfa drugs were quickly adopted for civilian and military medicine. American pharmaceutical companies produced their own preparations.

1939–1945 — World War II military sanitation Germany

The Wehrmacht faced typhoid, dysentery, diarrhea and waterborne infections across Europe, North Africa and the Soviet Union.

Military controls included:

Water inspection, field latrines, food hygiene, disinfection, laboratories, isolation facilities and disease reporting.

The German Army's sanitation programs were not identical to SS concentration-camp experimentation. They were overlapping parts of the same wartime medical state, but they had different immediate functions.

United States

The U.S. military expanded research into:

Typhoid, dysentery, cholera, infectious hepatitis, diarrheal disease, water purification, field sanitation, food handling, sulfonamides and antibiotics.

Researchers collected stool cultures and studied how soldiers became infected through contaminated food and water.

1942 — Heydrich dies and Gebhardt is blamed Germany

Reinhard Heydrich died after surgery for wounds sustained in the Prague assassination attack.

Himmler criticized Karl Gebhardt for not using sulfonamides. Gebhardt later conducted brutal experiments at Ravensbrück, deliberately producing infected wounds in prisoners to test whether sulfonamide treatment worked.

These were primarily wound-infection experiments, not ordinary fecal-oral studies, but they connected bacterial infection, sulfonamide research and coerced human experimentation.

1942–1945 — Nazi infectious-disease experiments Germany

Nazi doctors deliberately exposed prisoners to or experimented upon diseases including:

Typhus, malaria, tuberculosis, epidemic jaundice or hepatitis, typhoid-related infections and artificially infected wounds.

German and French wartime vaccine investigations also included prisoner populations. A historical review of Shigella vaccine development describes an early trial in which a very large bacterial dose was administered to men in a French prisoner-of-war camp.

The purpose varied:

Vaccine testing, military protection, treatment comparison, infection research and demonstration of physicians' favored theories.

1945 — Nazi Germany collapses Germany

Allied investigators seized documents, interrogated physicians and examined concentration-camp medical experiments.

United States

American authorities acquired German medical records and evaluated wartime German scientific personnel and research.

1946 — U.S. Shigella human-challenge model begins United States

Researchers deliberately administered measured doses of Shigella to human subjects to establish:

Infectious dose, incubation period, symptoms, immunity, vaccine effectiveness and treatment response.

The published scientific history dates the formal Shigella human-challenge model to 1946.

This is one of the clearest American examples of intentionally producing a fecal-oral intestinal infection for research.

Germany

Postwar Germany's scientific and medical institutions were divided among the occupation zones and later East and West Germany. Nazi research crimes became a central issue in the Doctors' Trial.

1946–1947 — Doctors' Trial at Nuremberg Germany and United States

American prosecutors tried Nazi physicians and administrators for involuntary human experimentation and mass killing.

The resulting Nuremberg Code emphasized voluntary consent, avoidance of unnecessary suffering and the subject's right to end participation.

The Code did not immediately stop questionable American research.

Late 1940s–1950s — U.S. challenge studies expand United States

Researchers increasingly studied enteric organisms by deliberately exposing human subjects under controlled conditions.

Research questions included:

How many organisms caused disease, how long infected people shed organisms in stool, whether antibiotics shortened illness, whether vaccines worked and whether previous infection produced immunity.

Some studies recruited prisoners, military personnel or institutionalized populations.

Germany

West Germany rebuilt public-health and wastewater systems. East Germany developed its own centralized health and sanitation institutions.

1950s–1960s — Enteric pathogens become military research targets United States

Military and university laboratories developed human-challenge models involving:

Shigella, cholera, typhoid and later diarrheagenic E. coli.

The model was direct:

Give a known dose, observe who becomes ill, measure stool output and bacterial shedding, collect blood and stool, administer treatment and compare results.

Germany

German research largely returned to conventional microbiology, public health, water engineering and disease surveillance under postwar legal structures.

1956–1970 — Willowbrook hepatitis experiments United States

Institutionalized children at Willowbrook State School were deliberately exposed to infectious hepatitis.

Investigators studied:

Transmission, incubation, liver injury, immunity and whether gamma globulin altered the disease.

The infection was associated largely with the fecal-oral form later designated hepatitis A.

Willowbrook became one of the most notorious American examples of researchers using a confined and vulnerable population.

1960s–1970s — Cholera and diarrheal-disease challenge studies United States

Adult volunteers were deliberately exposed to enteric pathogens to test:

Vaccines, antibiotics, oral rehydration, infectious dose and immunity.

The military rationale remained clear: diarrhea could incapacitate deployed forces even when it did not kill them.

Germany

West and East Germany continued expanding sewage-treatment plants and tightening controls over drinking water, industrial discharge and municipal wastewater.

1972 — Tuskegee exposed and ended United States

Public disclosure of the Tuskegee study produced national outrage and intensified demands for regulation of human experimentation.

1974 — National Research Act United States

The Act established federal structures for reviewing research involving human subjects and led to stronger institutional review-board requirements.

1979 — Belmont Report United States

The Belmont Report articulated:

Respect for persons, beneficence and justice.

These principles addressed not only what researchers did but who was selected to carry the risks.

The Central Comparison

Germany and the United States did not follow two completely separate scientific paths.

Both developed their public health and medical research programs from scientific foundations established during the late nineteenth century. As cities expanded, researchers confronted growing sewage and sanitation problems. The development of germ theory transformed the understanding of infectious disease, leading to advances in military sanitation, water and food testing, vaccines, antibacterial drugs, and eventually controlled infection research.

Germany played a major role in the early development of bacteriology, microbiology, and sewage engineering. Many of its scientific methods influenced researchers around the world.

The United States adopted many of those scientific principles, built its own military sanitation and public health systems, and later expanded research programs that included controlled human infection studies.

Under the Nazi government, Germany crossed into systematic involuntary human experimentation carried out within a dictatorship and the concentration camp system.

After World War II, the United States helped prosecute those crimes during the Nuremberg Trials. At the same time, later historical investigations documented ethically troubling American research involving prisoners, institutionalized children, economically disadvantaged populations, and military personnel.

The two countries therefore shared a long international scientific tradition rooted in the study of infectious disease and sanitation.

Both learned how fecal-oral diseases spread. Both advanced preventive medicine and public health. Both also conducted research involving human subjects to study infection, immunity, vaccines, and treatment, although the political systems, legal frameworks, and nature of the ethical violations differed in important ways.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:0987378b-1463-4125-83cb-9f0b442bac7d-15" data-turn-id-container= "request-WEB:0987378b-1463-4125-83cb-9f0b442bac7d-15" data-testid= "conversation-turn-32" data-turn="assistant"> Typhoid: tracing feces into food and water

Germany: German bacteriologists identified the typhoid organism and studied contaminated water, sewage, carriers and military outbreaks. Typhoid prevention became part of military hygiene through water protection, latrine control, food inspection and vaccination.

United States: After typhoid devastated Army camps during the Spanish-American War, the U.S. Army Typhoid Board reconstructed how infected human waste reached soldiers through water, food, hands, flies and contaminated surroundings.

Shared line: Both countries converted bacteriology into military sanitation doctrine. They wanted to keep an army from being disabled by its own sewage.

Dysentery and Shigella: from observation to deliberate infection

Germany and German-controlled territory: Dysentery was a major military problem. A historical review of Shigella vaccine research describes an early wartime trial in which 11 men in a French prisoner-of-war camp were given a preparation containing approximately 250 million bacteria. The prisoners' freedom to refuse is highly questionable.

United States: Beginning in 1946, American researchers deliberately gave measured doses of Shigella to human subjects. They studied infectious dose, symptoms, immune response and whether experimental vaccines provided protection.

Shared line: Both systems wanted to know whether a vaccine could protect soldiers against bacterial dysentery. The experiment required exposing human beings to the organism and seeing whether they became sick.

Hepatitis spread through fecal material

Nazi Germany: Nazi physicians conducted infectious-hepatitis experiments on concentration-camp prisoners as part of broader programs intended to answer military medical questions. Prisoners did not consent, and the Nazi experiments frequently produced severe suffering and death.

United States: At Willowbrook State School, researchers deliberately produced hepatitis in institutionalized children. An HHS historical interview describes investigators administering fecal extracts containing hepatitis virus to children entering the institution. The studies examined transmission, illness and possible preventive treatments.

Shared line: Researchers in both countries deliberately produced a disease transmitted through the fecal-oral route in confined populations who possessed very little practical power.

Sulfonamides and experimentally created infections

Germany: Karl Gebhardt and his associates deliberately created infected wounds in women imprisoned at Ravensbrück. The purpose was to test sulfonamide treatment after Gebhardt had been blamed for failing to give sulfonamides to Reinhard Heydrich. These were involuntary, brutal experiments conducted under the SS camp system.

United States: American researchers tested sulfonamides and later antibiotics against experimentally induced or naturally acquired bacterial infections. In intestinal-disease studies, they measured whether drugs reduced symptoms, shortened bacterial shedding or prevented complications.

Shared line: The basic research question was comparable—does the medicine alter the course of an established bacterial infection? The crucial difference was the Nazi system's routine use of prisoners who had no right to refuse and could be maimed or killed.

Military usefulness drove the research

Germany: Typhus, typhoid, dysentery, malaria and wound infections threatened military operations. Nazi medical experiments were often framed as efforts to protect German troops or test treatments needed at the front. The US Holocaust Memorial Museum groups many experiments under military survival, pharmaceutical treatment and racial-policy objectives.

United States: The American military also studied diseases capable of incapacitating troops, particularly typhoid, dysentery, cholera, hepatitis and diarrheal E. coli. Controlled infection allowed investigators to test vaccines and treatments without waiting for a naturally occurring battlefield outbreak.

Shared line: A soldier suffering severe diarrhea could be removed from combat as effectively as one suffering a gunshot wound. That made intestinal disease a matter of military readiness rather than merely civilian medicine.

Confined populations became convenient research populations

Germany: Concentration-camp and prisoner-of-war inmates were available to physicians because the state had removed their liberty, legal status and bodily autonomy.

United States: Prisoners, institutionalized children, military personnel and disadvantaged communities were repeatedly selected for research. Willowbrook is now described by HHS as an egregious research-ethics case because children were deliberately infected and their welfare was subordinated to the scientific project.

Shared line: In both countries, researchers frequently selected people who were confined, dependent upon authorities or unable to negotiate on equal terms.

The pattern in plain language

The shared scientific progression was:

• Find the organism.
• Determine how human waste carries it.
• Learn how little is required to cause illness.
• Observe the symptoms and stool shedding.
• Test a vaccine or drug.
• Use people to determine whether the theory works.

The sharpest historical parallel is probably infectious hepatitis: Nazi physicians experimented on prisoners, while American researchers later administered infectious fecal extracts to institutionalized children at Willowbrook. The political systems were different, but in both settings the research institution held overwhelming power over the person being exposed.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:0987378b-1463-4125-83cb-9f0b442bac7d-16" data-turn-id-container= "request-WEB:0987378b-1463-4125-83cb-9f0b442bac7d-16" data-testid= "conversation-turn-34" data-turn="assistant"> Infectious Hepatitis: Germany and the United States Germany (1942–1945)

The Nazi regime became interested in infectious hepatitis because it was affecting military personnel.

Military questions included:

• How is hepatitis transmitted?
• How long is the incubation period?
• How long is a person infectious?
• Can immunity develop?
• Can treatments prevent illness?
• Can troops be protected?

To answer those questions, Nazi physicians used concentration camp prisoners.

The prisoners did not volunteer.

Many had no understanding of what was being done.

They could not refuse.

Their imprisonment itself made the experiments possible.

The physicians possessed complete authority over the subjects.

The scientific question was mixed with a political system that had already stripped prisoners of basic human rights.

Researchers at Willowbrook State School were asking many of the same scientific questions.

They wanted to understand:

• How hepatitis spread.
• Incubation periods.
• Immunity.
• Whether gamma globulin could prevent infection.
• Whether different forms of hepatitis behaved differently.

Willowbrook housed children with developmental disabilities.

Researchers believed hepatitis was already widespread inside the institution.

Children entering the hepatitis unit were deliberately exposed to infectious material so investigators could observe the disease under controlled conditions.

Unlike Nazi camps, parents generally signed consent forms. However, the ethical controversy centered on whether that consent was truly voluntary. Willowbrook was overcrowded, and admission to the specialized unit was reportedly linked to participation in the research. Critics argued that parents faced intense pressure because the institution had few alternatives for care. This is why Willowbrook is now widely cited as a major research-ethics failure.

The scientific questions

One of the striking things about these programs is how similar many of their scientific objectives were. Researchers wanted to understand how an infection begins, how it is transmitted from one person to another, how long it takes before symptoms appear, how severe the illness becomes, whether immunity can develop after infection, and whether prevention or treatment can reduce disease.

These are ordinary scientific questions that remain central to infectious disease research today. The controversy does not lie in the questions themselves, but in how some researchers chose to obtain the answers.

The populations

Germany

• Concentration camp prisoners
• Prisoners had no legal rights.
• No ability to refuse.
• State exercised complete control.

United States

• Institutionalized children
• Parents signed consent forms.
• Researchers believed hepatitis was endemic within the institution.
• Critics argued families had little practical freedom because of the institution's conditions and limited alternatives.

Why historians compare them

The comparison is not that Willowbrook was equivalent to Auschwitz.

The comparison is that both episodes illustrate a broader ethical concern:

Researchers selected populations whose ability to refuse participation was severely constrained.

That issue—whether someone can give meaningful, voluntary consent when they depend on the institution conducting the research—became a central topic in postwar bioethics.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:149e76a7-72f8-4cf8-aede-7526077ed78d-0" data-turn-id-container= "request-WEB:149e76a7-72f8-4cf8-aede-7526077ed78d-0" data-testid= "conversation-turn-2" data-turn="assistant"> The Larger Historical Pattern

1870s Scientists confirmed that bacteria existed and caused disease.

1880s Researchers identified many of the intestinal bacteria responsible for typhoid fever, cholera, dysentery, and other diarrheal diseases.

1890s Public health officials increasingly recognized that human feces contaminated drinking water and food, driving major sanitation reforms.

1900s Cities built modern sewer systems, improved water treatment, and expanded public sanitation infrastructure.

1910s The first vaccines against several bacterial diseases became more widely available.

1930s Sulfa drugs became the first widely used antibacterial medications, transforming the treatment of many infectious diseases.

1940s Researchers conducted human studies to better understand infectious diseases and evaluate new treatments, while wartime research also included unethical human experimentation in some settings.

1950s–1970s Controlled human research continued in several countries, but growing public concern over research ethics led to increasing oversight.

1970s onward Modern research ethics, institutional review boards (IRBs), and informed consent became central requirements for studies involving human participants.

One point that stands out

One striking continuity is that the scientific questions changed much less than the ethical framework. Across Germany, the United States, Britain, France, and other countries, physicians wanted to understand transmission, immunity, prevention, and treatment of infectious diseases. What changed most dramatically after World War II was the expectation that research subjects should be able to make a genuinely voluntary, informed decision about participation, and that studies involving vulnerable populations require special protections.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:0987378b-1463-4125-83cb-9f0b442bac7d-17" data-turn-id-container= "request-WEB:0987378b-1463-4125-83cb-9f0b442bac7d-17" data-testid= "conversation-turn-36" data-turn="assistant"> The Nuremberg problem

After World War II, the United States, Britain and other Allies prosecuted Nazi physicians at the Doctors' Trial (1946–1947).

The prosecution argued that Nazi physicians had crossed fundamental ethical lines because they:

• Used prisoners who could not refuse.
• Deliberately caused disease and injury.
• Inflicted severe suffering.
• Frequently caused permanent disability or death.
• Conducted experiments with no meaningful consent.

Those arguments became the basis of the Nuremberg Code, emphasizing voluntary consent and minimizing unnecessary suffering.

On paper, that was a landmark change.

The uncomfortable reality

Within the next two decades, Americans began asking a difficult question:

"If voluntary consent is now the standard, why are we still conducting research on people who have little ability to say no?"

That criticism did not come from decades later. It was being raised while some of the studies were underway.

Willowbrook

This is why the Willowbrook studies became so controversial. Researchers believed hepatitis was already widespread within the institution, but instead of simply observing naturally occurring infections, they deliberately exposed some children to the virus in order to answer scientific questions more quickly.

The ethical concerns extended well beyond the research itself. The children lived in the institution, their families depended on it for care, and the researchers were in positions of authority within the same facility. Even when consent forms existed, critics argued that parents could not truly make a free and voluntary choice when realistic alternatives for their children were so limited. That became the central ethical criticism of the Willowbrook studies.

Why this looked awkward after Nuremberg

From the outside, people began noticing something.

The United States had prosecuted German physicians for conducting involuntary medical research on confined populations.

Yet American researchers were also studying confined populations:

• Prisoners
• Institutionalized children
• Mental hospitals
• Military personnel
• Other dependent populations

Those are not identical situations.

But the comparison naturally arose because both involved institutions exercising substantial power over participants.

The criticism became public

By the 1960s and 1970s, critics increasingly argued:

If researchers always choose people with the least power, are those people really free to refuse?

That question became one of the driving forces behind modern bioethics.

Germany's situation

Germany's program was fundamentally different in several respects.

The concentration camp system itself existed outside ordinary law.

Many experiments were designed knowing subjects might die.

Some experiments were extraordinarily brutal:

• freezing
• poison
• high altitude
• deliberate wound infections
• typhus
• sterilization
• chemical burns

Death itself often became part of the experiment.

That is why the Doctors' Trial regarded those acts as criminal.

One Historical Irony

One irony historians have noted is this:

After helping establish the Nuremberg Code, the United States soon faced scrutiny over whether some of its own research practices measured up to the principles it had helped articulate.

That does not mean Willowbrook and Nazi concentration camp experiments were the same in scale, brutality, or intent. The Nazi program involved systematic crimes, torture, and killings that have no direct counterpart in Willowbrook.

What it does mean is that the ethical principles announced at Nuremberg forced Americans to examine their own research practices. Studies such as Willowbrook and Tuskegee became central examples in that debate because they raised questions about informed consent, coercion, and the use of vulnerable populations.

From a historical perspective, you can see a progression:

1947 — Nuremberg Code: "Voluntary consent is essential."

1950s–1960s — Researchers and critics ask: "What counts as voluntary when the subject is a prisoner, an institutionalized child, or someone who depends on the institution?"

1970s — Public reaction to Willowbrook, Tuskegee, and similar cases leads to stronger federal oversight, institutional review boards, and the Belmont Report.

That sequence is one of the major developments in the history of modern medical ethics.

The American Dilemma

Much of the medical research conducted in the United States pursued legitimate scientific questions. Many studies were designed to understand disease, improve public health, and develop better methods of prevention and treatment. Many investigators believed they were advancing medicine and helping future patients.

Over time, however, the focus of the ethical debate shifted. The criticism was often directed less at the scientific questions themselves than at the people who were being asked—or selected—to participate in the research.

As public awareness grew, a difficult question emerged: Why did the risks of so many studies seem to fall on people who had the least ability to negotiate as equals? Children, prisoners, psychiatric patients, people living in poverty, and military recruits appeared repeatedly in the historical record. That question became increasingly difficult for researchers and institutions to answer.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:0987378b-1463-4125-83cb-9f0b442bac7d-18" data-turn-id-container= "request-WEB:0987378b-1463-4125-83cb-9f0b442bac7d-18" data-testid= "conversation-turn-38" data-turn="assistant"> The Nazis crossed the line.

Nuremberg exposed it.

The civilized world learned the lesson.

But the historical record is messier. The war ended in 1945, yet research without meaningful consent did not end. It continued in the United States under different institutions, different language, and usually different levels of brutality—but often with the same basic power problem: the people carrying the risk were people with limited ability to refuse.

Tuskegee began in 1932, continued through World War II, continued through the Nuremberg Doctors' Trial, and did not end until 1972. The men were not deliberately infected with syphilis, but they were deceived and denied proper treatment so researchers could continue observing the disease.

Willowbrook began after Nuremberg. Researchers deliberately exposed institutionalized children to infectious hepatitis. The existence of parental signatures did not settle the consent issue because the families needed institutional care, admission was difficult, and the children themselves could not consent.

So the sequence looks terrible:

1946–1947: American prosecutors condemn Nazi physicians for experimenting on powerless prisoners.

1947: The Nuremberg Code says voluntary consent is essential.

1950s–1970: American researchers deliberately expose institutionalized children to hepatitis.

Until 1972: The U.S. government continues the Tuskegee study without meaningful informed consent or proper treatment.

That does not erase the differences. Nazi experiments were embedded within concentration camps, genocide and a state system that treated prisoners as disposable. People were frozen, poisoned, mutilated, infected and killed. Willowbrook and Tuskegee were not concentration-camp programs.

But that distinction does not make the American studies acceptable. It shows that the problem was broader than "Nazi medicine." It was also about the longstanding medical habit of treating certain people as available human material:

• Prisoners.
• Institutionalized children.
• People with disabilities.
• Poor people.
• Racial minorities.
• Military personnel.

The United States had a legitimate hammer against Nazi Germany because the Nazi doctors committed unmistakable crimes. But the United States weakened its own moral position by acting as though the ethical problem belonged exclusively to Germany while American institutions continued exploiting vulnerable people.

The sharper conclusion is not that Germany was innocent or that both systems were identical. It is that Nuremberg punished one extreme form of a problem that the victorious countries had not eliminated from their own medicine.

The war ended. The Nazi regime ended. The scientific culture that believed vulnerable people could be sacrificed for useful knowledge did not end with it.

Newcomers to The Perth Group

The COVID-19 Pandemic has renewed interest in viral diseases in general and HIV in particular. This page has been added to TPG website to assist readers interested in studying the basis of the HIV theory of AIDS - HIV isolation.

Virologists use the term "HIV isolation" to indicate that the existence and characterisation of HIV has been proven. Characterisation means identifying the HIV proteins and RNA genome. These are essential for the production of antibody and "viral load" tests. These are critical for diagnosing and monitoring HIV infection.

A crucial fact is that "HIV isolation" is not a process akin to separating the blue Smarties from all others in the pack. It bears no resemblance whatsoever to Marie and Pierre Curie's remarkable 1911 Nobel Prize winning feat - separating and thereby purifying the one hundred milligram skerrick of radium contained in several tons of the uranium ore pitchblende. HIV "isolation" and common English usage isolation are chalk and cheese. Virologists never divulge this information.

All the Perth Group publications on HIV and AIDS are the work of the West Australian biophysicist Eleni Papadopulos-Eleopulos (1936-2022). Her papers explain what the "HIV isolation"

This is the March 2001 report of the South African Presidential AIDS Advisory Panel, appointed by then-President Thabo Mbeki. The report was produced after Mbeki convened a panel of scientists and physicians with sharply different views about HIV/AIDS to debate the evidence.

The table of contents alone tells you why this report became controversial:

• "Does HIV Cause AIDS?" – It includes arguments both supporting and questioning the HIV-causes-AIDS hypothesis.
• Surveillance – Debates over South Africa's AIDS statistics, mortality data, and epidemic models.
• HIV Tests and Their Accuracy – Discussion of ELISA, Western Blot, PCR, CD4 counts, and even proposals for additional studies.
• Treatment – Presents both evidence supporting antiretroviral (ARV) drugs and arguments against their use, followed by recommendations from each side.
• Prevention – Separate recommendations from panel members who accepted HIV as the cause of AIDS and those who did not.
• Socio-economic factors – Nutrition, sanitation, human rights, sexual behavior, vaccines, and other public health issues.

Why it matters historically

This panel became famous because President Thabo Mbeki gave a platform to AIDS dissidents, including scientists who argued that HIV had not been proven to cause AIDS or that antiretroviral drugs were harmful. Mainstream HIV researchers on the panel strongly disagreed.

The report therefore does not represent a single scientific conclusion. Instead, it is essentially a record of competing positions presented to the South African government.

Why it remains controversial

Many historians and public health researchers argue that the government's delay in broadly implementing antiretroviral therapy and prevention measures during this period contributed to a large number of preventable HIV infections and deaths in South Africa. Others view the report as an example of allowing scientific debate to occur, even on highly contentious questions.

So, if someone cites this document today, it is important to know which section they are relying on. Because the report intentionally contains both mainstream scientific positions and dissenting arguments, quoting a single chapter without that context can give a misleading impression of what the document as a whole represents. Source: AIDS Report - mycorrections.PDF

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:640d84c4-b107-4097-a31c-3a76b5b823f6-1" data-turn-id-container= "request-WEB:640d84c4-b107-4097-a31c-3a76b5b823f6-1" data-testid= "conversation-turn-4" data-turn="assistant">

It is still cited today for several different reasons, and the reason matters.

1. As a historical case study (the most common reason)

Most historians, public health researchers, and medical journals cite it because it marked one of the most consequential scientific and public health controversies of the early 2000s.

The report documented a government-sponsored debate over questions such as:

• Does HIV cause AIDS?
• How accurate are HIV tests?
• Should antiretroviral drugs be widely used?

Those topics are central throughout the report.

Researchers studying science policy often point to it as an example of how governments handle disputes over scientific evidence.

2. It preserves the arguments of both sides

Unlike most government reports, this one intentionally includes recommendations from:

• panelists who accepted HIV as the cause of AIDS, and
• panelists who rejected that causal link.

The recommendations are presented separately in multiple chapters.

For historians, that makes it an important primary source because it records what each side was arguing in 2000–2001.

3. Critics of mainstream HIV science still cite it

Some writers who remain skeptical of aspects of HIV research reference the report because:

• it gave prominent dissident scientists an official platform,
• it discusses criticisms of HIV testing,
• it includes alternative hypotheses for AIDS,
• it questions some evidence that was considered established by most researchers.

Those sections are easy to quote because they appear in an official presidential report.

4. Public health experts cite it for a different reason

Many public health researchers cite the report as part of the history of South Africa's HIV/AIDS response. They argue that the prolonged debate over HIV causation and antiretroviral treatment contributed to delays in implementing effective treatment programs.

In other words, they cite it as an example of the consequences of policy disagreements during a public health emergency.

5. It is a snapshot of scientific uncertainty and debate

One reason it continues to interest historians is that it captures a moment when the South African government formally asked experts with opposing viewpoints to present their evidence.

Whether one agrees with the panelists or not, the report documents:

• the questions people considered important at the time,
• the evidence each side believed was persuasive,
• and how governments sometimes weigh conflicting scientific claims.

An important point when reading it

Because this report deliberately includes opposing viewpoints, finding a statement in it does not mean the report as a whole endorses that statement. In many chapters, it presents one group's position and then another group's response, followed by separate recommendations.

That structure is one reason the report is still discussed: people with very different perspectives can point to different sections in support of different arguments. For that reason, it is most useful when read as a historical record of the debate rather than as a single, unified scientific conclusion.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:c26ac12e-4c5e-42b1-8f11-8ae03f23cfc6-0" data-turn-id-container= "request-WEB:c26ac12e-4c5e-42b1-8f11-8ae03f23cfc6-0" data-testid= "conversation-turn-2" data-turn="assistant"> Timeline Year Event 1796 Edward Jenner develops the first successful smallpox vaccine. 1800s Many countries adopt routine or mandatory vaccination. 1959 WHO launches the Global Smallpox Eradication Programme. 1967 WHO begins the Intensified Smallpox Eradication Programme. 1972 United States ends routine vaccination of the general public. 1970s Canada, Western Europe, Australia, Japan, and many other countries also discontinue routine vaccination as cases disappear. 1977 Last naturally occurring case (Somalia). 1980 WHO officially declares smallpox eradicated worldwide. 1980–present Vaccination continues only for selected high-risk groups and emergency preparedness. Countries that still vaccinate certain groups

These countries maintain vaccine stockpiles and/or vaccinate selected people, not the general population:

• United States
• United Kingdom
• Canada
• France
• Germany
• Japan
• Australia
• Several other European countries
• Israel (selected military or laboratory personnel in some circumstances)

Many countries also keep emergency stockpiles in case of a deliberate release or laboratory accident. WHO maintains its own emergency reserve in addition to pledged national stockpiles.

Who still receives it?

Typical recipients include:

• Researchers working with variola virus or related orthopoxviruses
• Some military personnel
• Specialized laboratory staff
• Certain emergency response teams
• Occasionally healthcare workers if a credible exposure risk exists

Routine childhood vaccination is not recommended in countries where smallpox has been eradicated.

One interesting consequence

Because routine vaccination stopped decades ago, most people under about age 45–50 have never received a smallpox vaccine. Older adults in many countries still have the characteristic vaccination scar on the upper arm, while younger generations generally do not.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:c26ac12e-4c5e-42b1-8f11-8ae03f23cfc6-3" data-turn-id-container= "request-WEB:c26ac12e-4c5e-42b1-8f11-8ae03f23cfc6-3" data-testid= "conversation-turn-8" data-turn="assistant"> 1. Critics of compulsory vaccination (1800s)

These are probably the most historically important critics.

Their arguments were:

• Government should not force medical treatment.
• Vaccines sometimes caused injury or death.
• Vaccine production was poorly regulated.
• Statistics used by governments were misleading.
• Better sanitation deserved more credit than vaccination.

One of the most famous was Alfred Russel Wallace. He spent years analyzing mortality statistics and concluded vaccination had been oversold while sanitation was underappreciated. He also strongly opposed compulsory vaccination laws.

Today, historians generally agree Wallace identified some genuine problems—especially with nineteenth-century statistics and vaccine quality—but most do not agree with his conclusion that vaccination was ineffective.

2. Critics of the official eradication story

These people usually accept that smallpox existed, but argue the common story is oversimplified.

Their criticisms include:

• Jenner receives too much credit.
• Variolation played a major historical role before vaccination.
• Improvements in sanitation, nutrition, and isolation receive too little credit.
• Ring vaccination was more important than universal vaccination.
• WHO's campaign relied heavily on surveillance and case finding.

Ironically, many historians agree with much of this.

One reason is that the popular version—

Jenner invented vaccination → everyone vaccinated → smallpox disappeared

—is much simpler than what actually happened.

William Foege's work on ring vaccination is a good example. Rather than vaccinating everyone, teams identified cases, isolated them, then vaccinated contacts and surrounding communities. Many historians regard that strategy as decisive during eradication.

3. Critics of Jenner

Some historians argue Jenner's role has become almost mythical.

They point out:

• inoculation (variolation) existed centuries before Jenner;
• many people contributed to vaccination;
• improvements occurred over decades rather than overnight.

There is even an academic paper titled "The Myth of the Medical Breakthrough" arguing exactly this—not that vaccination failed, but that the heroic single-inventor story is misleading.

4. Critics of vaccine safety

These critics generally accept that vaccination works but argue risks were minimized.

Historically, they point to:

• contaminated vaccine lymph,
• arm-to-arm transmission,
• bacterial contamination,
• occasional severe complications,
• inconsistent vaccine quality in the nineteenth century.

Modern historians largely agree these were real problems, especially before manufacturing standards improved.

5. Critics of germ theory itself

This is where people like Katie Sugak and Tom Cowan fall.

Their arguments include:

• viruses have not been properly demonstrated,
• contagion is misunderstood,
• smallpox was misdiagnosed,
• eradication was largely statistical.

These are much more fundamental claims than those made by nineteenth-century critics.

Very few historians of medicine or virologists accept these conclusions.

6. Statistical critics

This group is interesting because they often accepted vaccination but questioned how success was measured.

Questions they asked included:

• Were deaths accurately counted?
• Were diagnoses consistent?
• Did governments change case definitions?
• Were vaccinated and unvaccinated populations comparable?

Those questions are legitimate historical questions and continue to be discussed by historians.

They do not, by themselves, establish that smallpox never existed.

One point that historians increasingly acknowledge

One thing that has changed over the last few decades is that historians have become much more willing to admit the eradication story was messier than older textbooks suggested.

Modern scholarship often emphasizes:

• political negotiations,
• surveillance,
• isolation,
• local health workers,
• logistics,
• ring vaccination,
• vaccine quality,
• community cooperation,

instead of portraying eradication as simply "invent vaccine and disease disappears."

An area that deserves more attention

One historical question that is still debated—not whether smallpox existed, but how much different interventions contributed—is the relative importance of:

• vaccination,
• quarantine,
• sanitation,
• nutrition,
• surveillance,
• ring vaccination,
• and naturally acquired immunity.

Most historians view eradication as resulting from multiple factors working together, rather than any single one alone. The disagreement is usually about their relative importance, not about whether smallpox itself was a real disease.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:c26ac12e-4c5e-42b1-8f11-8ae03f23cfc6-4" data-turn-id-container= "request-WEB:c26ac12e-4c5e-42b1-8f11-8ae03f23cfc6-4" data-testid= "conversation-turn-10" data-turn="assistant">

Today, people receive the smallpox vaccine not because smallpox is circulating naturally, but because governments and laboratories prepare for the possibility of an accidental or intentional exposure to variola virus (the virus that causes smallpox) or because they work with closely related viruses.

Here are the main groups:

Laboratory workers

This is the largest civilian group.

They may work with:

• vaccinia virus (used to make and study smallpox vaccines),
• monkeypox (mpox) virus,
• cowpox,
• or, in very limited circumstances, variola virus itself.

Because these viruses are related (they are all orthopoxviruses), the smallpox vaccine provides cross-protection against several of them. The U.S. CDC recommends vaccination for laboratory personnel whose work puts them at risk of exposure to these viruses.

Military personnel

Many countries maintain emergency plans in case smallpox were ever used as a biological weapon.

After the September 11 attacks and the 2001 anthrax attacks, the United States restarted vaccination for selected military personnel and specialized civilian response teams. This was based on preparedness, not because smallpox had returned.

Not every service member receives it—only certain units depending on their mission and risk assessment.

Emergency response teams

Some countries vaccinate small groups of healthcare workers, public health responders, or hazardous-material teams who would respond first if a suspected smallpox case ever appeared.

The idea is to have people immediately available who are already protected rather than waiting until after an emergency begins.

Researchers studying related viruses

Even if a scientist never works with variola itself, they might work with vaccinia or mpox. Since these viruses are related, vaccination helps reduce occupational risk.

Why keep vaccine stockpiles if smallpox is gone?

There are several reasons governments give:

1. Known laboratory stocks. Officially, live variola virus is retained under tight security at two WHO-authorized repositories:
   • Centers for Disease Control and Prevention in Atlanta, Georgia.
   • State Research Center of Virology and Biotechnology VECTOR in Koltsovo, Russia.
2. Laboratory accident. Although rare, accidents have occurred in research laboratories. The best-known was the 1978 Birmingham incident in the UK, which resulted in one fatal smallpox infection linked to laboratory work.
3. Bioterrorism concerns. Since smallpox has a high mortality rate and most of the world's population is no longer vaccinated, governments continue to include it in biodefense planning.
4. Protection against related viruses. Some modern smallpox vaccines also provide protection against mpox because the viruses are closely related.

Is the vaccine still the old one?

No. There are two main vaccines used in the United States today:

• ACAM2000 – a live replicating vaccinia-virus vaccine. It produces the classic vaccination lesion ("take") and has more contraindications because the virus can replicate and be transmitted to close contacts.
• JYNNEOS (also called Imvamune or Imvanex in different countries) – a non-replicating vaccinia-based vaccine. It generally has a more favorable safety profile and has also been approved in several countries for protection against mpox.

An interesting consequence

One reason preparedness remains a concern is that routine vaccination ended decades ago. As a result, most people born after the 1970s have never received a smallpox vaccine. If smallpox were ever reintroduced, public health authorities would rely on stockpiled vaccines and rapid vaccination of contacts—an approach similar to the ring vaccination strategy used during the eradication campaign.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:c26ac12e-4c5e-42b1-8f11-8ae03f23cfc6-5" data-turn-id-container= "request-WEB:c26ac12e-4c5e-42b1-8f11-8ae03f23cfc6-5" data-testid= "conversation-turn-12" data-turn="assistant"> Smallpox

• No country routinely vaccinates children against smallpox anymore.
• After WHO declared smallpox eradicated in 1980, countries gradually stopped routine vaccination.
• Today, vaccination is generally limited to:
  • laboratory workers,
  • certain military personnel,
  • some emergency response teams,
  • and occasionally close contacts if there were ever an exposure.

So even in many African countries where smallpox was once common, routine smallpox vaccination ended decades ago.

Polio

This is very different.

Many countries still routinely vaccinate children against polio, including many in Africa, Asia, and parts of the Middle East, because wild poliovirus has not been eradicated globally.

Examples include countries such as:

• Nigeria
• Pakistan
• Afghanistan
• Democratic Republic of the Congo
• Chad
• Somalia
• Sudan

In addition, many countries conduct mass vaccination campaigns whenever poliovirus is detected or there is a risk of an outbreak.

Other vaccines still routinely given in Africa

Many national immunization programs also include:

• Measles
• Tuberculosis (BCG)
• Diphtheria
• Tetanus
• Pertussis (whooping cough)
• Hepatitis B
• Rotavirus
• Pneumococcal disease
• Yellow fever (in endemic regions)

So there are still large vaccination campaigns in Africa, but they are not for smallpox.

One reason the confusion is understandable

The smallpox vaccine and the mpox (formerly monkeypox) response are connected.

During recent mpox outbreaks, some countries vaccinated people at high risk using smallpox vaccines because they also protect against mpox. That wasn't a return to routine childhood smallpox vaccination—it was targeted use for a related disease.

So if you saw recent news about Africa and "smallpox vaccine," it was likely referring to mpox control, not because smallpox itself had returned.

In short:

• Smallpox: routine vaccination ended worldwide after eradication.
• Polio: still routinely vaccinated in many countries because eradication is not yet complete.
• Mpox: some people receive a modern smallpox vaccine because it also provides protection against mpox.

Stigma

HIV/AIDS stigma is widespread in South Africa: a 2002 national survey revealed that 26% of respondents were unwilling to share a meal with a person living with AIDS, 18% were unwilling to sleep in the same room as with someone with AIDS, and 6% were unwilling to talk to a person with AIDS.[1] AIDS-related stigma is most severe among township residents in South Africa because they lack access to reliable information about the disease. Many South Africans in townships wrongly believe that HIV is transmitted through proximity to HIV-positive individuals, which leads them to claim that people with AIDS should be socially ostracized.

In addition, many traditional groups believe that ancestral spirits and supernatural forces punish those who have failed to lead moral lives by infecting them with HIV. According to a study published in 2004, South Africans who attributed HIV/AIDS to spirits and the supernatural were more likely to claim that people with HIV/AIDS were "dirty," "repulsive," "cursed," and "foolish" and should "have restrictions on their freedom," "be isolated," and "feel guilty and ashamed."

Women are particularly vulnerable to HIV/AIDS infection and stigma because they are often economically dependent on men and frequently lack access to education. Men who have the disease may avoid testing and remain anonymous, but women who undergo pre-natal testing are less likely to escape a diagnosis. Because women are often identified as HIV-positive before men, they are branded as the spreaders of the disease and may subsequently face physical abuse and abandonment.

A study conducted in 2010 indicated that the majority of girls in a Cape Town township correlated thinness with disease – in particular, HIV/AIDS. Because of this, women who are slender or experience weight loss also face discrimination. This form of stigma affects women living in townships most severely because rates of malnourishment are higher in townships than in other parts of South Africa.

*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id= "request-WEB:640d84c4-b107-4097-a31c-3a76b5b823f6-2" data-turn-id-container= "request-WEB:640d84c4-b107-4097-a31c-3a76b5b823f6-2" data-testid= "conversation-turn-6" data-turn="assistant"> What has improved

South Africa has one of the world's largest HIV treatment programs. Millions of people now receive antiretroviral therapy, and public education about HIV has expanded dramatically. Compared with 20–25 years ago:

• More people understand that HIV is not spread through casual contact such as sharing meals, hugging, or being in the same room.
• HIV testing has become much more routine.
• People who take effective antiretroviral therapy can often suppress the virus to undetectable levels, greatly improving health and preventing sexual transmission (the "U=U" concept—Undetectable = Untransmittable).

Because of these changes, the extreme fears described in the 2002 survey have generally declined.

What has not disappeared

Stigma remains a significant issue, particularly in some communities.

It can still include:

• Fear of disclosing an HIV diagnosis.
• Concerns about losing relationships or employment.
• Shame associated with testing positive.
• Gender-based discrimination, where women may still face blame or violence after a diagnosis.
• Misconceptions in some areas about how HIV is transmitted.

These problems are not unique to South Africa, but they have been studied extensively there because of the country's large HIV epidemic.

Traditional beliefs

The passage you quoted discusses beliefs that HIV is caused by ancestral spirits or moral failings.

Those beliefs have not disappeared entirely, but they are not representative of all South Africans. South Africa is culturally diverse, and attitudes vary greatly by:

• education,
• urban versus rural residence,
• age,
• religious beliefs,
• and access to healthcare.

Researchers continue to find that traditional and supernatural explanations for illness exist in some communities, although they generally coexist with biomedical explanations rather than completely replacing them.

Women

The discussion about women remains partly relevant.

Women in South Africa continue to account for a large share of new HIV infections, particularly young women. Economic dependence, gender inequality, and intimate partner violence remain recognized risk factors. However, access to prenatal HIV testing and treatment has improved enormously, leading to major reductions in mother-to-child transmission compared with the early 2000s.

The "thinness" issue

The association between weight loss and HIV was particularly strong before effective treatment became widely available. During that period, advanced AIDS often caused severe weight loss ("wasting syndrome"), so people sometimes assumed that anyone who became thin had HIV.

Today, because many people receive effective treatment before developing advanced disease, that visual stereotype is generally less common than it was 15–20 years ago, although it has not disappeared completely in some communities.

Overall, the situation has improved substantially since the period described in your excerpt. HIV-related stigma has declined in many settings, but it remains an important public health and social issue, especially where misinformation, poverty, or gender inequality continue to influence people's experiences.

Smallpox Reclassified

Taken from the excellent Kate Sugak presentation The Truth About Smallpox.

While a smallpox vaccine had been available since the late 1700's, this pesky disease, said to be caused by the "variola virus," still hung around for nearly two more centuries. By the mid-20th century, smallpox was claimed to be eradicated from America and other industrialized nations even without mass vaccination campaigns. However, third world countries were still being ravaged by this disease. Thus in 1958, the WHO called for a global eradication effort utilizing what has been referred to as "the most dangerous vaccine known to man" to finally stamp out this disease once and for all.

Interestingly, that same year, the identical in every way "monkeypox virus" was "discovered" in cynomolgus monkeys. What an amazing coincidence, right? This new "virus" eventually made the leap into humans a decade later when an infant came down with smallpox in Zaire. However, the child's village had been declared smallpox free due to the mass vaccination of the entire village the year before. If smallpox was allowed to be diagnosed in a "smallpox-free" zone, this could have easily led to questions regarding the vaccine's effectiveness. Thus, after initial testing diagnosed the child with smallpox, further testing was carried out by the CDC. It was ultimately decided that this child was not a smallpox case but was instead the very first known case of human monkeypox. I detailed this ridiculous situation more in-depth at viroLIEgy.com and I will provide the relevant articles in the recommended reading section.

The convenient emergence of monkeypox was a great way to cover up the fact that the same symptoms associated with smallpox still existed. It also offered the ability to cover-up the deadly vaccine injuries as well.

However, monkeypox was not the only new disease that popped up with the exact same smallpox symptoms. According to Dr. Viera Scheibner (PhD), a retired scientist and author, there were other similar diseases used as a scapegoat for the dangerous and ineffective vaccine:

Belief not science is behind flu jab promotion, new report says

"Harmful reactions and ineffectiveness of smallpox vaccination motivated the "eradication" campaign of the 1970s. Smallpox was pronounced eradicated on 8th May 1980, vaccination stopped and epidemics disappeared, bar small outbreaks of whitepox, buffalopox, monkeypox, camelpox and similar names, while the disease was indistinguishable from smallpox. According to Arita and Gromyko (1982. Bull WHO; 60 (4): 367-375), the main benefit of smallpox being pronounced officially eradicated was that vaccination could be discontinued in all countries. Simply, smallpox vaccination had become an embarrassment."

https://www.bmj.com/content/345/bmj.e7856/rr/620395

Dr. Scheibner pointed out that buffalopox, whitepox, camelpox, and other diseases with similar names and symptoms began to appear in the place of smallpox. However, she didn't factor in that smallpox was also regularly confused with measles, chickenpox, scarlett fever, rubella, herpes, shingles, etc. since its conception in 1751 as a separate disease. Each of these conditions result in the same symptoms of disease with very minute "differences" said to distinguish them. At one point in time, they were all considered varying stages of the same disease process.

None of these diseases can be clinically distinguished and diagnosed accurately based on symptoms alone due to these similarities, thus the need for nonspecific antibody results and/or fraudulent molecular tests today to rule in or out one or the other. Breaking the same symptoms into separate diseases is not only a great way to lower case counts to improve the perception of vaccine effectiveness, it also serves the purpose of creating more fear of the invisible boogeymen now spreading and mutating from animals to humans. This results in the demand and need for different pharmaceuticals, vaccinations, and treatments to "cure" each condition, which obviously makes for a great business model.

Polio Reclassified

Unlike smallpox, polio has not yet been "eradicated" by vaccines even though there have been two different vaccines available since the 1950's. However, as was observed previously, polio cases decreased dramatically before the introduction of these miracle "cures."

Thus, the reduction in polio can not be attributed to the Salk vaccine campaign introduced in 1955 nor the Sabin oral vaccine in 1959. What could have contributed to the serendipitous drop in polio cases beyond the improved sanitation and clean food and water? One possibility was the gradual discontinuation of dangerous pesticides and insecticides such as DDT, which concerned parents neglectfully sprayed on their children to combat polio. In 1949, Morton S. Biskind, M.D. wrote a paper looking at the effects of DDT on animals and humans. He spoke of the mysterious and elusive "Virus X" which was appearing more frequently each year with the increased use of DDT. This disease sounded quite a bit like polio, and according to Dr. Biskind, it was easily confused with the disease due to the findings of damage to the central nervous system:

DDT Poisoning and the Elusive "Virus X."' A New Cause for Gastro-Enteritis

"DURING A PERIOD of more than two years, numerous cases of a curious symptom complex, apparently never before reported, have been observed throughout the United States. For want of a satisfactory explanation for this ailment, it has been widely attributed to infection with a thus far illusory "virus X."

The syndrome consists of a group of or all the following: Acute gastroenteritis occurs, with nausea, vomiting, abdominal pain, and diarrhea usually associated with extreme tenesmus. Coryza, cough and persistent sore throat are common, often followed by a persistent or recurrent feeling of constriction or a "lump" in the throat; occasionally the sensation of constriction extends substernally and to the back and may be associated with severe pain in either arm. In some cases, the hyoid bone becomes acutely painful to pressure for a few days. Pain in the joints, generalized muscle weakness and exhausting fatigue are usual; the latter are often so severe in the acute stage as to be described bv some patients as "paralysis." Sometimes the initial attack is ushered in by vertigo and syncope. Intractable headache and giddiness are not uncommon. Occasionally herpes zoster appears. Paresthesia of various kinds occur in most of the cases; areas of skin become exquisitely hypersensitive and after a few days this hyperesthesia disappears only to recur elsewhere, or irregular numbness, tingling sensations, pruritus or formication may occur. Erratic fibrillary twitching of voluntary muscles is common. Usually there is diminution of vibratory sense in the extremities."

"The high incidence, the usual absence of a febrile reaction, the persistence and erratic recurrence of the symptoms, the lack of observable inflammatory lesions, and the resistance even to palliative therapy, suggested an intoxication rather than an infection. Investigation for possible etiologic agents soon led to consideration of DDT (2, 2 bis (para-chlorophenyl) 1, 1, 1-trichloroethane; less precisely designated di-chlorodiphenyltrichloroethane). The epidemic first appeared at about the time DDT came into widespread use by the civilian population. The signs and symptoms described in tile pharmacologic andtoxicologic literature as characteristic of DDT poisoning, are identical with those appearing in patients with the affection described (1, to 13)."

"As already indicated, a prominent feature in virtually all the patients was extreme apprehensiveness. This is probably explicable on the basis of functional and possibly even morphologic changes in the central nervous system produced by DDT, since in DDT poisoning in animals such disturbances are frequent.*

* Needless to say, findings related to the nervous system, and muscular spasm and weakness in severe acute affections of this type. have led to confusion with such entities as meningitis and poliomyelitis.

https://pubmed.ncbi.nlm.nih.gov/18113629/

Researcher Jim West did a lot of work uncovering this connection between polio symptoms and pesticides. In a 2004 paper, he outlined more from Dr. Biskind where the doctor linked DDT to the same degeneration of the anterior horn cells attributed to polio:

Pesticides and Polio: A Critique of Scientific Literature

'Biskind also describes physiological evidence of DDT poisoning that resembles polio physiology:

"Particularly relevant to recent aspects of this problem are neglected studies by Lillie and his collaborators of the National Institutes of Health, published in 1944 and 1947 respectively, which showed that DDT may produce degeneration of the anterior horn cells of the spinal cord in animals. These changes do not occur regularly in exposed animals any more than they do in human beings, but they do appear often enough to be significant."

He continues, bearing his exasperation in trying to make the obvious plain.

"When the population is exposed to a chemical agent known to produce in animals lesions in the spinal cord resembling those in human polio, and thereafter the latter disease increases sharply in incidence and maintains its epidemic character year after year, is it unreasonable to suspect an etiologic relationship?"

https://crazzfiles.com/pesticides-and-polio-a-critique-of-scientific-literature/

Jim West's article touches on other toxins such as BHC and lead-arsenic as potential contributing factors involved in the rising symptoms of polio along with DDT. Based on his painstaking research and meticulously plotted graphs, it is clear that there was a rise and fall in polio cases as the use of these toxins was introduced and then gradually reduced and phased out. According to the Environmental Protection Agency, DDT regulations began in the 1950s, ending with the cancellation of the use of the toxic pesticide in the US in 1972. If one wanted to create the appearance that the vaccines were a miracle cure, reducing exposure to toxins that cause the exact same symptoms of the disease targeted is a good place to start:

"The U.S. Department of Agriculture, the federal agency with responsibility for regulating pesticides before the formation of the U.S. Environmental Protection Agency in 1970, began regulatory actions in the late 1950s and 1960s to prohibit many of DDT's uses because of mounting evidence of the pesticide's declining benefits and environmental and toxicological effects. The publication in 1962 of Rachel Carson's Silent Spring stimulated widespread public concern over the dangers of improper pesticide use and the need for better pesticide controls.

In 1972, EPA issued a cancellation order for DDT based on its adverse environmental effects, such as those to wildlife, as well as its potential human health risks."

https://www.epa.gov/ingredients-used-pesticide-products/ddt-brief-history-and-status

However, there was an even more obvious trick that was utilized in order to create the perception that polio cases declined with the introduction of the vaccines. Prior to the 1955 vaccination campaign, the WHO laid out the guidelines for how to make a diagnosis of either non-paralytic or paralytic polio in 1953. It was crucial for the WHO to make this distinction between cases that resulted in paralysis and those that did not for the ultimate success of the vaccination campaign, as will be shown later. In order to diagnose non-paralytic polio, the usual flu-like symptoms were all that were necessary to make a diagnosis even though this was considered less reliable than when confirming cases of paralytic polio. In those instances, all that was required to diagnose a patient with paralytic polio was the presence of the same flu-like symptoms as well as partial or complete paralysis upon two examinations carried out 24 hours apart. In neither non-paralytic nor paralytic polio were laboratory results necessary for a confirmation of a case:

https://apps.who.int/iris/handle/10665/40241

In a 1956 bulletin by the WHO, it was admitted that at least two-thirds of the cases diagnosed as non-paralytic polio were, in fact, not polio and were instead caused by other "viruses" and bacteria. Thus, it was important that, for a case to be considered polio, paralysis must occur as this was seen as a defining feature and indicative of polio. This paralysis requirement stood even though it was admitted that there are other causes of paralysis. The separation of polio into those with and without paralysis was necessary as the vaccine was said not to be effective at preventing non-paralytic polio and was only effective at reducing paralytic polio. If these two conditions could not be separated, it would obscure the "beneficial effects" of the vaccination campaign:

Poliomyelitis in 1954

"A variable proportion, which may be up to two-thirds or more, of cases diagnosed as non-paralytic poliomyelitis, presenting the clinical picture of aseptic meningitis, is due to other viruses (mumps, Coxsackie B, ECHO-6, Herpes simplex, LCM, various members of group A and group B encephalitis viruses, and others as yet undefined) as well as to bacteria (leptospirosis)."

"Clinical disease resembling paralytic poliomyelitis may be due to other viruses (see the reports from Iceland, Egypt, and Massachusetts). RSSE may also cause confusion.9 But there is little doubt that apart from relatively infrequent episodes the great majority of paralytic cases are due to poliovirus. For this reason and because paralysis is the result of poliovirus infection, which is of major public health importance, it has been repeatedly stressed by the World Health Organization that the incidence of paralytic and non-paralytic cases should be reported separately. There are many countries where this is still not yet done. This will become increasingly important as poliomyelitis vaccination comes into wider use, since the evidence available so far suggests that the main result of vaccination is to decrease the number of paralytic cases, the number of non-paralytic cases being relatively unaffected. Unless the two groups can be separated the beneficial effect of vaccination may be obscured."

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2538162/

It can be seen that there was a concentrated effort to separate the symptoms of non-paralytic polio into many conditions caused by other "viruses" and bacteria, including:

1. Mumps
2. Coxsackie B
3. ECHO-6
4. Herpes Simplex
5. LCM
6. Other non-polio "enteroviruses"
7. Leptospirosis
8. Other unknown "viruses"

We can also see that they were beginning to make a distinction between cases of paralysis caused by the polio "virus" as well as those said to be caused by other "viruses." This separation would be utilized to decrease cases later. For now, polio was successfully divided into those cases with paralysis and those without. Once this distinction was accepted, another nifty trick was instigated in order to create the appearance that the vaccine was even more effective. According to a 1955 report by Thomas Francis, Jr. regarding the polio vaccine trials, the criteria for how a paralytic polio case was diagnosed changed from those listed by the WHO in 1953.

Instead of only requiring the confirmation of paralysis on two examinations 24 hours apart to diagnose paralytic polio, a confirmation was now based on two examinations spread further apart: one at 10-20 days and another at 50-70 days. A confirmation also now included reports on "virus isolation," tests of antibody titer, and laboratory diagnosis, which were not required in 1953. The ability to diagnose a case of paralytic polio was now a lot more difficult for a physician. Still, even with all of these new diagnostic measures in place, Francis Jr. admitted that there were difficulties in decisions due to contradictory results:

Evaluation of the 1954 Poliomyelitis Vaccine Field Trial

"The second phase in the evaluation was concerned with discovery and identification of all cases of poliomyelitis or suspected poliomyelitis in all children of the first, second, and third grades in the study areas. The various steps in the investigation of a case are: (1) physician's diagnosis—report to local health department; (2) telegraphic report to vaccine evaluation center; (3) action of local health department, including (a) clinicoepidemiological investigation and report to vaccine evaluation center, form FT-6, (b) collection and shipment of laboratory specimens (or by laboratory) and notice to vaccine evaluation center, form FT-9, and (c) notification of physical therapist; (4) first muscle evaluation by physical therapist (10 to 20 days) and physician's interpretation of patient's status, form FT-7; (5) collection of convalescent serum for laboratory, form FT-9; (6) second muscle evaluation by physical therapist (50 to 70 days) and physician's interpretation of patient's entire illness, form FT-8; (7) report of virus isolation, tests of antibody titer, laboratory diagnosis, form FT-10; (8) establishment and application of criteria for diagnosis of individual patient; and (9) integration of all data into final vaccine evaluation center diagnosis.

The criteria for diagnosis of poliomyelitis, for designation of a case as paralytic and its severity, and for the interpretation of laboratory results were carefully drawn. In this we had the continued help of an advisory committee comprised of expert clinicians, virologists, biostatisticians, epidemiologists, and administrators. The information concerning each case was carefully reviewed and the diagnostic classification made without knowledge of its vaccination status so that objectivity was readily maintained. Inevitably, difficulties in decision were encountered when results from different pieces of data were not in agreement, but the effort was made to follow a consistent plan of interpretation."

The reason that this change in how paralytic polio was diagnosed is important was summarized by Dr. Bernard G. Greenberg. He testified to Congress in 1962 that the reduction in polio cases was not brought about by vaccination but was instead due to the adoption of this redefinition of the paralytic polio diagnosis. By spreading out paralysis to 60 days and beyond, a new long-lasting paralytic polio disease was created:

https://web.archive.org/web/20201216143101/https://www.vaccination-information-portal.com/wp-content/uploads/participants-database/ratner_1960.pdf

As can be seen from Dr. Greenberg, the change in diagnostic criteria for polio was all that was necessary in order to see a drop in paralytic polio. No vaccine was ever necessary. And to help sell this point, a graph was provided applying the new diagnostic criteria to polio cases from 1951 to 1959 which showed how the drop would have occurred had this criterion been used before the vaccine became available:

In order to confirm that the adoption of the vaccine trial diagnostic criteria was, in fact, used when reporting vaccine effectiveness and paralytic polio case numbers, we can turn to the book Poliomyelitis Surveillance. It indeed confirms this to be the case as the CDC officially counted paralytic polio cases according to the "best available paralytic poliomyelitis case count," or BAPPCC. This count required that paralysis occurs up to 60 days. If there was no residual paralysis at 60 days, the cases were excluded from the count:

In 1969, the CDC officially adopted this 60-day requirement as the case definition for paralytic polio:

"ACIP. Poliomyelitis prevention. MMWR 1982;31:22-6, 31-4. *Since 1969, the CDC definition of a case of paralytic poliomyelitis has been a patient with paralysis clinically and epidemiologically compatible with poliomyelitis who, at 60 days after onset of symptoms, has a residual neurologic deficit, has died, or for whom no information is available on neurologic residua."

https://www.cdc.gov/mmwr/preview/mmwrhtml/00000706.htm

It should be clear now that the change in diagnostic criteria for paralytic polio was the driving factor in reducing polio cases in an attempt to prop up the effectiveness of the toxic vaccines. However, this redefinition could not eliminate the symptoms of polio and wipe them from existence. As these symptoms would still persist, polio-related diseases such as aseptic meningitis and coxsackie were branched off into their own categories:

The polio vaccine: a critical assessment of its arcane history, efficacy, and long-term health-related consequences

"Doctors and scientists on the staff of the National Institutes of Health during the 1950s were well aware that the Salk vaccine was causing polio. Some frankly stated that it was "worthless as a preventive and dangerous to take [26:142]." They refused to vaccinate their own children [26:142]. Health departments banned the inoculations [26:140]. The Idaho State Health Director angrily declared: "I hold the Salk vaccine and its manufacturers responsible" for a polio outbreak that killed several Idahoans and hospitalized dozens more [26:140]. Even Salk himself was quoted as saying: "When you inoculate children with a polio vaccine you don't sleep well for two or three weeks [26:144;43]." But the National Foundation for Infantile Paralysis, and drug companies with large investments in the vaccine coerced the U.S. Public Health Service into falsely proclaiming the vaccine was safe and effective [26:142-5]."

"Polio is virtually nonexistent in the United States today. However, according to Dr. Robert Mendelsohn, medical investigator and pediatrician, there is no credible scientific evidence that the vaccine caused polio to disappear [50]. From 1923 to 1953, before the Salk killed-virus vaccine was introduced, the polio death rate in the United States and England had already declined on its own by 47 percent and 55 percent, respectively (Figure 4) [51]. Statistics show a similar decline in other European countries as well [51]. And when the vaccine did become available, many European countries questioned its effectiveness and refused to systematically inoculate their citizens. Yet, polio epidemics also ended in these countries [50].

The standards for defining polio were changed when the polio vaccine was introduced. The new definition of a polio epidemic required more cases to be reported. Paralytic polio was redefined as well, making it more difficult to confirm, and therefore tally, cases. Prior to the introduction of the vaccine the patient only had to exhibit paralytic symptoms for 24 hours. Laboratory confirmation and tests to determine residual paralysis were not required. The new definition required the patient to exhibit paralytic symptoms for at least 60 days, and residual paralysis had to be confirmed twice during the course of the disease. Also, after the vaccine was introduced cases of aseptic meningitis (an infectious disease often difficult to distinguish from polio) and coxsackie virus infections were more often reported as separate diseases from polio. But such cases were counted as polio before the vaccine was introduced. The vaccine's reported effectiveness was therefore skewed (Table 1 and Figure 5) [52,53]."

https://docshare.tips/journal-article-the-polio-vaccine-neil-z-miller_5742f5edb6d87f75968b495e.html

Old polio-associated diseases such as aseptic meningitis and coxsackie "virus" were broken away from polio in order to siphon off the cases previously diagnosed as such. Other conditions also appeared and became more frequently pegged as the culprit of paralysis instead of polio such as Guillain-Barre syndrome, acute traumatic neuritis, enteroviral myelitis, myopathy, etc. Even rabies, tetanus, and the West Nile "virus" are associated with the same symptoms of disease. For many decades, acute flaccid paralysis was the name for cases of polio as this was the defining condition of the disease. However, even though the two labels are interchangeable, an effort has been made over the decades to try and distinguish the two from each other. Now, it is stated that as polio (a.k.a. acute flaccid paralysis) goes away, AFP will stick around due to non-polio "enteroviruses" and other causes such as novel recombinant "viruses." In other words, the same symptoms are being shifted away from the polio "virus" and onto other suspects:

Polio will go, acute flaccid paralysis will stay

"But as the Global Polio Eradication Initiative and the scientific community plan to celebrate polio eradication sooner or later, there is need for recognition that the risk of acute flaccid paralysis due to other enteroviruses is still high.

Acute flaccid paralysis is a weakness in one or more limbs or the respiratory or bulbar muscles, resulting from damaged lower motor neurons. The most common viral causes are polio and non-polio enteroviruses. As polio gradually disappears globally, there is major concern about the probable emergence of other neurotropic enteroviruses to occupy the niche and cause infections mimicking acute paralytic poliomyelitis. Enterovirus 71 for example has been regarded as the second most important neurotropic enterovirus, causing frequent outbreaks of paralytic disease. A crude mortality rate of 16% in children younger than 14 years was observed during an enterovirus 71 outbreak between 1998 and 2005 in Taiwan. Also, and equally important, is recombination between vaccine-derived poliovirus and other enteroviruses, which might result in the emergence of novel recombinant viruses causing similar paralytic diseases. Over the past decades, several non-polio enteroviruses have been discovered and some implicated in acute flaccid paralysis of unprecedented severity."

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)61080-1/fulltext

More recently, a condition known as acute flaccid myelitis has made its presence felt. This is a relatively new disease that was "discovered" in 2010. It is an offshoot of acute flaccid paralysis, which for all intents and purposes was paralytic polio until 2010. Now, AFM has successfully taken over the title as it is defined as poliomyelitis not caused by the polio "virus," thus it is yet another condition that is used to explain away cases of poliomyelitis still occurring today. The only difference separating the two diseases are the results from fraudulent laboratory tests which must be confirmed by an "expert" panel. In other words, AFM can be referred to as either non-polio polio or, my personal favorite, incognito polio:

How is AFM different from polio?

"Poliomyelitis is the term used to describe the syndrome of acute flaccid limb weakness and lesions in the grey matter of the spinal cord. Poliomyelitis caused by poliovirus, or polio, rarely occurs in the United States. In 2014, the term AFM was adopted to describe poliomyelitis without a known cause and not caused by poliovirus. AFM has some similarities with polio, such as the lesions in the grey matter of the spinal cord and flaccid limb weakness that can result in paralysis. Polio can be prevented by a vaccine.

Stool specimens that we receive from AFM patients are tested for poliovirus. If poliovirus is detected, it is considered a case of polio, not a case of AFM. We continue to test all specimens from AFM patients to look for viruses, including poliovirus and non-polio enteroviruses."

https://www.cdc.gov/acute-flaccid-myelitis/faqs.html

"All suspected cases of paralytic poliomyelitis are reviewed by a panel of expert consultants before final classification occurs. Confirmed cases are then further classified based on epidemiologic and laboratory criteria."

https://www.cdc.gov/vaccines/pubs/surv-manual/chpt12-polio.html

Perfect example of circular logic.

Hopefully, the magic tricks utilized to create the appearance of the effectiveness of the vaccines have become clearer now and will no longer be effective to persuade anyone on the fence. When a "virus" needs to be either eradicated or minimized, all it takes is hiding the symptoms of disease under various names and disguises with either a new "viral" and/or bacterial cause. This decrease can also be helped along by reducing or eliminating environmental toxins associated with the same symptoms of disease and by changing the diagnostic criteria in order to make diagnosis less likely as seen in the case with polio.

We have seen this same situation with "Covid-19." When the flu and other respiratory "viruses" needed to disappear for 'Covid" to emerge, the symptoms were lumped into "Covid" along with many other unrelated ailments. Remember "Covid toes" and MIS-C, a.k.a. frostbite and Kawasaki disease? Cases of all "non-Covid" diseases dropped dramatically, even cancers and heart attacks. However, once the vaccine needed to be shown to be effective, "Covid" cases decreased while the "flu" and "RSV" re-emerged along with other respiratory diseases and ailments. They can keep this magic trick going as long as we continue to get hoodwinked by their theatrics. However, if you can see past the illusions, they will have to come up with new tricks in order to fool you. Let's continue to unveil their deceptions until they have nothing left to pull out of their hat.

The Rabies Hoax: Shocking Corruption – a Deep Dive into a DEADLY SCAM

by AGENT131711 | May 19, 2024

The Rabies vaccine is one of the most diabolically brilliant because humans rush to take it after they are bitten by an animal. Those who suffer adverse events or death are counted as a Rabies Death, therefore it is impossible to find fault with the vaccine. When it comes to stuff like this, I often ask myself, "How the hell did we get here?". I thought I would look into the history of Rabies for a couple hours to find out. I had no idea just how crazy and shocking this rabbit hole would be. If Netflix made genuine documentaries about real topics, this would be at the top of their list.

Rabies Virus & Cures

Even before the creation of the life-saving Rabies vaccine, the medicine men were selling cures. These remedies consisted of "hair of the dog that bit you" being chewed and swallowed by the bite victim as well as "mad stone" treatment, in which a rock was rubbed all over the area of the bite to "draw out the madness". There was also a piece of the Kings clothing and if you're lucky enough to get this cure just holding it was enough to save you. Later, a cockroach cure was discovered as well as my absolute favorite cure which was ground-up jaw bone of a donkey or dog, plus a piece of colt's tongue and the green rust off a penny of George the First; if your scavenger hunt resulted in obtaining all of these items, you are 100% protected. Yes, this is real, and guess what? History says these cures successfully kept rabies out of New York for twenty years. See, I told you it was one heck of a rabbit hole.

Let's start by discussing what Rabies is:

In both animals and humans, Rabies is identified as absolutely any symptom one of more of the following symptoms:

• lethargy
• fever
• vomiting
• anorexia
• ataxia (lack of voluntary coordination of muscle movements)
• weakness
• paralysis
• seizures
• difficulty breathing
• difficulty swallowing
• excessive salivation
• abnormal behavior
• aggression
• self-mutilation
• fever
• difficulty swallowing
• excessive drooling
• foaming at the mouth
• and more
• or none… a Rabid animal might not have symptoms at all…

In humans, it's Rabies only if the symptoms occur after being bitten or scratched by an animal. So let's say, tomorrow morning you wake up and suddenly have difficulty swallowing; were you bitten by an animal? If you answered "No", you probably have Herpes. If you say, "Yeah, I was feeding a squirrel a peanut and one bit me by accident", then YES, it's 100% for sure Rabies and you need a vaccine, pronto! Very Scientific!

Now that you understand how it works, let's dive into some of the craziest sh*t you've never heard, all in the name of STOPPING THE SPREAD.

How Rabies was Discovered

According to a book written in 1890, Scientist Louis Pasteur discovered the Rabies Virus by drilling holes into laboratory dogs skulls and injecting them with what he suspected to be rabies virus. The dogs became Rabid (meaning, they displayed some symptoms from the massive list of basically every symptom), and boom, proof of the rabies virus! But, if you were doubting Mr. Pasteur's study, according to a different Rabies specialist, you should have a 100% success rate infecting animals with Rabies Virus if you inject it specifically into their brain(not just the skull, pinpoint that brain!). If your brain-injection does not produce Rabies (symptoms), you are doing it wrong:

So clearly, Rabies is very dangerous and must be stopped before everyone dies. It was becoming glaringly obvious that the only solution to fight Rabies was a Big Pharma payday vaccine.

Now that Science had learned so much about Rabies and the severity of the virus, Rabies was suddenly being discovered all over by the USA by none other than the US government. In fact, Rabies became so bad that, in 1916, the Secretary of Agriculture asked Congress for $75,000 (in tax dollars) so they could begin slaughtering wolves, coyotes and "other predatory animals" in the Northwest states. The goal was to completely eliminate these species in Utah, Nevada, Idaho, California, Oregon, and Washington, because, they claimed, they ALL could be rabid and were infecting livestock with the virus. (Psssssst! Wolves were later discovered to be Endangered, and have been on the Endangered Species List ever since)

To make matters crazier, Rabies can only be tested for after death of the animal.

This means there is absolutely no way to prove an animal is Rabid while it is alive. It must first be slaughtered. This means, the wolves, coyotes and predatory animals who were to be mass executed, were never proven to be sick to begin with. This entire extermination plan was based on some farm animals falling ill. And, because there was no test for Rabies there was no way of knowing what the livestock was sick with.

A Closer Look

While tax dollars were funding the intentional extinction of wildlife some doctors and scientists were skeptical of the Rabies Virus and began doing their own research. What they discovered was alarming, to say the least.

Upon closer examination of Moscow, Russia hospital records, researchers discovered that people who died in ER from Rabies were attacked by a wolf and bitten in the head. In fact, it would turn out that almost all of the Moscow Rabies deaths involved severe bites or other life-threatening injuries. So, basically, a wolf ate your face off and you die, boom, Rabies!

Nobody Can Find the Rabies

Other than the US government, Rabies vaccine developers and doctors who got paid to administer the vaccine, nobody could seem to find Rabies, so that's weird, eh? And trust me, the researchers looked. Here's some of the people that tried really hard to find this stealthy Rabies Virus:

Dr. Charles W. Dulles, lecturer on the History of Medicine at the University of Pennsylvania, was appointed by the Medical Societies to investigate rabies. After sixteen years of investigation he had "failed to find a single case on record that can be conclusively proved to have resulted from the bite of a dog or any other cause". Numerous other professionals came to the same conclusion as Dr. Dulles, including Dr. Theophilus Parvin, who was President of the National Academy of Medicine, Dr. Thomas G. Morten a Coroners Physician, Dr. Charles K. Mills of the University of Pennsylvania and Dr. Thomas I. Mays of the Polyclinic Hospital.

Dr. Wilcox of New York investigated NY's Rabies Scare because of eleven alleged deaths from rabid dog bites. His investigation concluded that not one of these deaths were due to Rabies.

Dr. Elmer Lee ended another rabies scare on Staten Island. Upon performing an autopsy, the rabid dogs were found to have died of worms, not Rabies. The worms were lodged in the heart of the animal, causing the animal extreme pain. The animal was lashing out due to severe discomfort, not a virus.

Even under oath testimony, dating all the way back to 1887, showed that back then no Rabies had been found relating to police men who received dig bites:

After receiving these absurd results, Dr. Stillman went to the Department of Agriculture and insisted that, instead of senselessly murdering dogs to have them tested, they should, "hold all dogs declared rabid to see if any cases of rabies would develop". Eventually the Department of Ag agreed, and, to everyone's shock, not one case of rabies appeared in any quarantined dog… ever… and over a decade later, none had appeared. In fact, not a single quarantined dog died and 100% of their symptoms subsided.

Further research by these honest doctors and scientists determined the cause of so-called Rabies. All of the Rabies cases in animals, which cause the animals to behave violently or crazily, "can be attributed to malnutrition, maltreatment, or, in many cases, both". And, in numerous cases, the animals had health issues, not related to Rabies. So yeah, the animals were underfed, abused, or in severe discomfort due to health complications, which caused them to lash out…

They also concluded that, in humans, Rabies was caused by "disordered imagination", meaning FEAR, also known as Nocebo Effect; if you think you're going to get deathly ill because a doctors assured you that you were, you are going to get sick. Like the old saying goes, mind over matter. This is why, at one point in history, the German treatment for Rabies was a warm bath, and it had nearly flawless success rates. People were told the hot water removed the rabies, meanwhile the water relaxed them. They believed it worked, therefore it did. This also explains why "hair of the dog that bit you" , the Mad Stone Treatment, and a piece of the Kings clothing were successful in preventing multiple decades worth of rabies in New York. MIND OVER MATTER.

A Deadly Lie

Here's a few utterly shocking examples of the horror caused by Rabies vaccines, indubitably recorded as Rabies deaths:

A mailman was attacked by a dog, however the dogs teeth did not puncture his skin, so he chose not to get a Rabies vaccine and he remained in perfect health… until his employer forced him to get vaccinated. Within one month of the injection, severe symptoms of Rabies set in, accompanied by extreme pain at the injection site. Two days after the symptoms appeared he died of paralytic "hydrophobia"… which means he died of Rabies.

In a another case, a young woman's parents saw a bite mark on her neck. Under questioning, the young woman told her parents she was bit by a dog. Out of fear of Rabies her parents rushed her to get the vaccine. She became violently ill and died. After the funeral her parents discovered that the bite mark was not from a dog but was instead from a young man the woman was secretly frolicking with.

And, it's not just humans who die from these injections:

Deadly Animal Injections

In the late 1880s, rabies vaccinations were given to 4,564 sheep in Russia, of which 3,696 died. The identical inoculation campaign was ran in a different Russian city and the identical results occurred; only 19% survived.

Money and Power

While the good doctors and scientists were trying to end the Rabies scare, the medical industry was pushing hard to advance Rabies injections. Due to the industries efforts, Rabies treatments became mainstream and when they resulted in death, Rabies was to blame. I told you, it's diabolically brilliant!

You need to understand that the Veterinary industry lobbies for medical treatments because Veterinarians receive a large percentage of both their gross income and profit from vaccines given in their offices. As of the early 2000's, on average, Rabies vaccines cost only $0.60 to $0.95 per dose, yet are charged to the client at $15 to $25 per injection. Large cities often charge more, making it the biggest markup of any industry.

How We Got Here:

Despite no cases of rabies on record, beginning around the 1970's, most states in the USA were convinced by Rabies vaccine lobbyists to begin requiring Rabies shots for dogs within the first three to four months of life (some states additionally require the shot for cats and ferrets too).

It was then realized that there is a wealth of money to be made off pets, so states also began requiring tagging and licensing.

Dr. John Fudens, D.V.M. writes: "From 1964 to 1978 there were zero cases of dog rabies in the county. Magically in 1978, the rabies vaccine was mandated to be given every year and all dogs tagged and licensed. WHY? Well, it seems four veterinarians, with animal control bureaucrats, pushed the county board of supervisors to pass a law mandating rabies vaccination every year. There were three local vets and one professor from the State Veterinary College who were behind this … Not once was the issue discussed that there were no rabies cases in the county in dogs. To date, there still has not been one case of dog rabies, including the population of dogs whose owners who do not vaccinate for rabies."

The F*cked Up Science They Call "A Rabies Virus" and a "Vaccine"

Scientists needed to create the Rabies Vaccine and prove it works, so, what made sense to them was essentially injecting eggs, cheese and Horse Serum into animals. Sadly, I am not joking. Let's take a closer look:

Injecting Cheese, Egg Yolk & "Horse Serum"

When you hear "inoculation", you probably never thought of eggs, but yeah. Here's the recipes, in case you want to whip up your own Rabies Vaccine in your spare time:

First, grab some rabbits. What you are going to want to do is inject the rabbits with the vaccine (Eggs, Cheese, etc), then inject them with the Virus and see if they go Rabid. You can obtain the virus from any dead animal who is suspected to have Rabies, or, the more popular option is to just make the poison in a lab and call it a virus. This means, when you see the word virus below you can replace it with the word poison.

(I'm not kidding, this is what they really did:)

EGG YOLK & EGG WHITE JABS: Start with a fresh rabbit. Make the vaccine by mixing the white of hens eggs with equal part distilled water. Next you filter it, then it is ready to inject. Inject the egg white six times within 11 days, followed by an injection of the Rabies Virus, then proceed with daily injections of egg. Result: Sadly, Rabies killed these rabbits on the 4th day of injection. It's unfortunate, but the Egg Vaccine seems to not offer much protection.?

EGG YOLK, METHOD #2: Scientists were pretty damn sure that Eggs are the answer, so although the jabs didn't stop rabies, they theorized that perhaps if it was administered intravenously, it would.

What you are going to want to do is inject the Rabies Virus into your rabbits, then give them six intravenous doses of Egg White within 15 days following the Virus jab.

Results: After the virus jab and the six doses of Egg Whites, that Godforsaken Rabies began appearing in these rabbits on the 14th day! The Rabies killed them on the 18th day, thus proving how deadly the virus is. Lord, please help us find a vaccine that works!

DEUTEROPROTEOSE JAB: Deuteroproteose means a protein obtained from cheese (casein). To make this, you want to get some milk, "physiologic salt" and "170 solution" (your guess is as good as mine…). Mix these together to make the cheese-salt-chemical solution, then inject your rabbits five to six times during a 15-day period.

Result: The rabbits became paralyzed and all died by the 20th day following the injections, so, it would appear that cheese, chemicals and salt doesn't stop Rabies. ?

HORSE SERUM JAB: You can use Horse Serum right out of the bottle, no need to dilute. You will want to inject this five times before you inject the Rabies Virus. After the virus inoculation, you want to continue Horse Serum injections daily in smaller doses.

Results: Shockingly, these rabbits all developed Rabies on the 4th and 5th day, then died the same day! Gosh, this Rabies virus is f*cking horrible! If only Dr. Fauci was alive back then to help us get through this storm…

TYPHOID BACTERIA: Typhoid, they claim, is a bacterial infectious disorder contracted by consumption of food or drink contaminated with Salmonella typhi. This dangerous bacteria is what is used to create the Typhoid Vaccine, so Scientists considered that perhaps it can stop Rabies too, makes sense to me!

For this experiment, you are going to want to inject the rabbits with Rabies Virus first, then inject the Typhoid Bacteria six times within 15 days.

Results: Crud. This didn't work either. The rabbits became paralyzed and all died from Rabies within 21 days after the Rabies Virus injection. ?

THE CONTROL GROUP: In order to conduct a Scientific experiment, you must have a Control Group. In this experiment, the Control Group consisted of only 4 rabbits, which were injected with Rabies Virus but were not given egg, cheese-salt-chemical blend, deadly bacteria or horse serum to protect them… until immediately after the virus inoculation, after which the control group also received daily injections of Egg.

RESULTS: Two died on the fourth day and the other two became paralyzed and died by the sixth day, thus proving how horrible the virus is and how desperately a vaccine needs to be created. SOURCE: The Rabies Hoax • Zero-Sum

References

Beardsley, Edward H. A History of Neglect: Health Care for Blacks and Mill Workers in the Twentieth-Century South. Knoxville: University of Tennessee Press, 1987.

Beecher, Henry K. "Ethics and Clinical Research." New England Journal of Medicine 274, no. 24 (1966): 1354–1360.

Brandt, Allan M. "Racism and Research: The Case of the Tuskegee Syphilis Study." The Hastings Center Report 8, no. 6 (1978): 21–

Centers for Disease Control and Prevention. Cyclosporiasis (Cyclospora Infection). Atlanta: CDC.

Centers for Disease Control and Prevention. Typhoid Fever and Paratyphoid Fever. Atlanta: CDC.

Dubos, René. Louis Pasteur: Free Lance of Science. Boston: Little, Brown and Company, 1950.

Escherich, Theodor. Die Darmbakterien des Säuglings und ihre Beziehungen zur Physiologie der Verdauung. Stuttgart: Ferdinand Enke, 1886.

Fee, Elizabeth, and Theodore M. Brown. Making Medical History: The Life and Times of the U.S. Public Health Service. Washington, DC: American Public Health Association, 1997.

Jones, David S. Rationalizing Epidemics: Meanings and Uses of American Indian Mortality since 1600. Cambridge, MA: Harvard University Press, 2004.

Koch, Robert. Gesammelte Werke. Berlin: Julius Springer.

Lederer, Susan E. Subjected to Science: Human Experimentation in America before the Second World War. Baltimore: Johns Hopkins University Press, 1995.

Leavitt, Judith Walzer. Typhoid Mary: Captive to the Public's Health. Boston: Beacon Press, 1996.

Lifton, Robert Jay. The Nazi Doctors: Medical Killing and the Psychology of Genocide. New York: Basic Books, 1986.

Mitscherlich, Alexander, and Fred Mielke. Doctors of Infamy: The Story of the Nazi Medical Crimes. New York: Henry Schuman, 1949.

Proctor, Robert N. Racial Hygiene: Medicine under the Nazis. Cambridge, MA: Harvard University Press, 1988.

Reed, Walter, Victor C. Vaughan, and Edward O. Shakespeare. Report on the Origin and Spread of Typhoid Fever in U.S. Military Camps during the Spanish War of 1898. Washington, DC: Government Printing Office, 1904.

Rosen, George. A History of Public Health. Baltimore: Johns Hopkins University Press, 1993.

Rothman, David J. Strangers at the Bedside: A History of How Law and Bioethics Transformed Medical Decision Making. New York: Basic Books, 1991.

United States Holocaust Memorial Museum. Nazi Medical Experiments. Washington, DC: United States Holocaust Memorial Museum.

U.S. Army Center of Military History. Preventive Medicine in World War II. Washington, DC: Department of the Army.

U.S. Army Medical Department. Communicable and Other Diseases. Washington, DC: Office of The Surgeon General.

U.S. Army Medical Department. Preventive Medicine in World War I. Washington, DC: Office of The Surgeon General.

U.S. Department of Health, Education, and Welfare. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington, DC, 1979.

World Health Organization. Guidelines for the Safe Use of Wastewater, Excreta and Greywater. Geneva: WHO, 2006.

World Health Organization. Guidelines on Sanitation and Health. Geneva: WHO, 2018.

Primary Sources

• The Nuremberg Doctors' Trial Transcripts
• The Nuremberg Code (1947)
• Walter Reed's Typhoid Board Report (1904)
• The Belmont Report (1979)
• U.S. Army Preventive Medicine in World War II
• U.S. Army Preventive Medicine in World War I
• Office of the Surgeon General, U.S. Army Medical Department historical reports
• Robert Koch's published papers on cholera and bacteriology
• Theodor Escherich's original publication describing E. coli
• James Hobrecht's reports on Berlin's sewer system

About the Image: If you're wondering why I ended this page with a pig-faced doctor, it's from my favorite Twilight Zone episode, "Eye of the Beholder" (Season 2, Episode 6).

In one of television's greatest twists, a young woman undergoes repeated medical procedures to "correct" her appearance. Only at the end does the audience discover that beauty and normality have been completely inverted in that society. The doctors, nurses, and everyone considered "normal" have pig-like faces, while the patient looks conventionally human. If you've never seen the episode, it's worth watching.

The USA

"Americans believe that the United States of America became a separate country following its War of Independence against the British in 1783.

However, what happened was the setting up of the USA as a corporation subject to British maritime law. If you don't believe me then when you watch Obama speaking what do you think the gold border around your flag signifies?

So, if the US is just a corporation, not a country where's the evidence? Should we look for the Queen signing off acts of Parliament which automatically apply to the USA -

legislation.gov.uk/uksi… - it isn't the only one.

The one above was the Queen dictating social security legislation to the IRS. Still think you're independent."

IRS Forces U.S. Citizens To Pay A Percentage Of Their Taxes To The Queen Of The UK Deep State – Political Vel Craft

References USA History

UNITED STATES is a Corporation - There are Two Constitutions - Sovereignty

Federal Reserve - The Enemy of America

A history lesson for Americans. You're still British. – Patriots for Truth

bankruptcyofus.pdf

War and Emergency Powers

Media Release: The People Are the Enemy

"Since March 9, 1933, the United States has been in a state of declared national emergency Powers listed:

• Seize property

• Organize and control production

• Seize commodities

• Assign military forces abroad

• Institute martial law

• Seize transportation

• Seize communications

• Regulate private enterprise

• Restrict travel

• Control lives of citizens

(Source attributed in text: Senate Report 93-549) 14th Amendment | AntiCorruption Society

The IRS is not a US government agency. It is an agency of the IMF (International Monetary Fund) (Diversified Metal Products v I.R.S et al. CV-93-405E-EJE U.S.D.C.D.I., Public Law 94-564, Senate report 94-1148 pg. 5967, Reorganization Plan No. 26, Public Law 102-391).

The IMF (International Monetary Fund) is an agency of the U.N.

(Black's Law Dictionary 6th Ed. page 816)

The United States has NOT had a Treasury since 1921 (41 Stat. Ch 214 page 654)

The U.S. Treasury is now the IMF (International Monetary Fund) (Presidential Documents Volume 24-No. 4 page 113, 22 U.S.C. 285-2887)

The United States does not have any employees because there is no longer a United States! No more reorganizations. After over 200 years of bankruptcy it is finally over. (Executive Order 12803)

The FCC, CIA, FBI, NASA and all of the other alphabet gangs were never part of the U.S. government, even though the "U.S. Government" held stock in the agencies. (U.S. v Strang, 254 US491 Lewis v. US, 680 F.2nd, 1239)

Social Security Numbers are issued by the U.N. through the IMF (International Monetary Fund). The application for a Social Security Number is the SS5 Form. The Department of the Treasury (IMF) issues the SS5 forms and not the Social Security Administration. The new SS5 forms do not state who publishes them while the old form states they are "Department of the Treasury". (20 CFR (Council on Foreign Relations) Chap. 111 Subpart B. 422.103 (b))

There are NO Judicial Courts in America and have not been since 1789. Judges do not enforce Statutes and Codes. Executive Administrators enforce Statutes and Codes. (FRC v. GE 281 US 464 Keller v. PE 261 US 428, 1 Stat 138-178)

There have NOT been any judges in America since 1789. There have just been administrators. (FRC v. GE 281 US 464 Keller v. PE 261 US 428 1 Stat. 138-178)

According to GATT (The General Agreement on Tariffs and Trade) you MUST have a Social Security number. (House Report (103-826)

New York City is defined in Federal Regulations as the United Nations. Rudolph Guiliani stated on C-Span that "New York City is the capital of the World." For once, he told the truth. (20 CFR (Council on Foreign Relations) Chap. 111, subpart B 44.103 (b) (2) (2) )

Social Security is not insurance or a contract, nor is there a Trust Fund. (Helvering v. Davis 301 US 619 Steward Co. v. Davis 301 US 548)

Your Social Security check comes directly from the IMF (International Monetary Fund), which is an agency of the United Nations. (It says "U.S. Department of Treasury" at the top left corner, which again is part of the U.N. as pointed out above)

You own NO property!! Slaves can't own property. Read carefully the Deed to the property you think is yours. You are listed as a TENANT. (Senate Document 43, 73rd Congress 1st Session)

The most powerful court in America is NOT the United States Supreme court, but rather the Supreme Court of Pennsylvania. (42 PA. C.S.A. 502)

The King of England financially backed both sides of the American Revolutionary War.. (Treaty of Versailles-July 16, 1782 Treaty of Peace 8 Stat 80)

You CANNOT use the U.S. Constitution to defend yourself because you are NOT a party to it! The U.S. Constitution applies to the CORPORATION OF THE UNITED STATES, a privately owned and operated corporation (headquartered out of Washington, DC) much like IBM (International Business Machines, Microsoft, et al) and NOT to the people of the sovereign Republic of the united States of America. (Padelford Fay & Co. v The Mayor and Alderman of the City of Savannah 14 Georgia 438, 520)

America is a British Colony. The United States is a corporation, not a land mass and it existed before the Revolutionary War and the British Troops did not leave until 1796 (Republica v. Sweers 1 Dallas 43, Treaty of Commerce 8 Stat 116, Treaty of Peace 8 Stat 80, IRS Publication 6209, Articles of Association October 20, 1774)

Britain is owned by the Vatican. (Treaty of 1213)

The Pope can abolish any law in the United States (Elements of Ecclesiastical Law Vol. 1, 53-54)

A 1040 Form is for tribute paid to Britain (IRS Publication 6209)

The Pope claims to own the entire planet through the laws of conquest and discovery. (Papal Bulls of 1495 & 1493)

The Pope has ordered the genocide and enslavement of millions of people.(Papal Bulls of 1455 & 1493)

The Pope's laws are obligatory on everyone. (Bened. XIV., De Syn. Dioec, lib, ix, c. vii, n. 4. Prati, 1844 Syllabus Prop 28, 29, 44)

We are slaves and own absolutely nothing, NOT even what we think are our children. (Tillman vs. Roberts 108 So. 62, Van Koten vs. Van Koten 154 N.E. 146, Senate Document 438 73rd Congress 1st Session, Wynehammer v. People 13 N.Y. REP 378, 481)

Military dictator George Washington divided up the States (Estates) in to Districts (Messages and papers of the Presidents Volume 1 page 99 1828 Dictionary of Estate)

"The People" does NOT include you and me. (Barron vs. Mayor and City Council of Baltimore 32 U.S. 243)

It is NOT the duty of the police to protect you. Their job is to protect THE CORPORATION and arrest code breakers. (SAPP vs. Tallahassee, 348 So. 2nd. 363, REiff vs. City of Phila. 477 F. 1262, Lynch vs. NC Dept. of Justice 376 S.E. 2nd. 247)

Every thing in the "United States" is up for sale: bridges, roads, water, schools, hospitals, prisons, airports, etc, etc… Did anybody take time to check who bought Klamath Lake?? (Executive Order 12803)

"We are human capital" (Executive Order 13037) The world cabal makes money off of the use of your signatures on mortgages, car loans, credit cards, your social security number, etc.

The U.N. – United Nations – has financed the operations of the United States government (the corporation of THE UNITED STATES OF AMERICA) for over 50 years (U.S. Department of Treasury is part of the U.N. see above) and now owns every man, woman and child in America.

The U.N. also holds all of the land of America in Fee Simple.

The good news is we don't have to fulfill "our" fictitious obligations. You can discharge a fictitious obligation with another's fictitious obligation.

Source: Stop The Pirates: These documents are NOT secret! They ARE a matter of Public Record.